Citrus Sinensis ID: 010012

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520
Protein Sequence
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHccccccccccccccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEcccccEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHccccccccccccccHHHHccHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccHHHHHHcccccccccccccccccccHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccEEccccccccEEEccccHHHHHHHHHHHHHHcccccEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHEEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcccHHHEEEEEEccccEEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEccccccccEEEEEEEccccccHHHHHcccccccHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccccHHHHcccHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mgfsqdtyskssqhnelyassivsdnyceykVYNKHYNELKIKTLLRKMIWDFglscflpslsnnhnnrindddekskgsnlehNKAWLLAEsggaeltstdpqsvhssfrfslcsqvelesmnigasASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHnfskgrvlgrGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAsslhhpnivplvgfcidpeQGLFLIYKYVsggslerhlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNgtercvvhrdikpsnillsskkipklcdfglatwtsapsvpflcktvkgtfgylapeyfqhgkvsdktdVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLdprlkctsrNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWkkhnfsgiidcypqlqqTKSEMKSHLALAMVGvsefeeddhlycr
Flexible Loop (DISEMBL)
mgfsqdtyskssqhneLYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQslersispvaNSLIRLSYGEILAATHNFSKGRVLGRGALSfvfkgkvgllrtsvaikrldkedkesSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNGTERCVVHRDikpsnillsskKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTgrkpiearrlqgeenlVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAAcisseesrrpgIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMvgvsefeeddhlycr
Low Complexity Region (SEG)
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSaqiarviqaaaaCISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Disordered region (IsUnstruct)
****************LYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPS************************************************FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL********KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISS****RPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQ*******HLALAMVGV************
Disordered Region (DISOPRED)
**************************************ELKIKTLLRKMIWDFGLSCF****************************************************************************************************************RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA**LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE*****************************************************
Disordered Region (DISEMBL)
*************HNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAE************FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Disordered Region (DISPRO)
*******************SSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSN******************************************************ELESMNIGASASATVLMVNLENGLCDSRAQEL****************NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE***************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	520	2.2.26 [Sep-21-2011]
Q9LK03	717	Proline-rich receptor-lik	no	no	0.546	0.396	0.404	1e-56
Q5XF57	579	Probable receptor-like se	no	no	0.592	0.531	0.369	1e-56
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.553	0.626	0.405	7e-56
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.553	0.405	0.409	7e-56
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.55	0.557	0.400	1e-55
Q9FE20	456	Serine/threonine-protein	no	no	0.551	0.629	0.392	6e-55
Q8RWW0	744	Receptor-like serine/thre	no	no	0.557	0.389	0.420	6e-55
Q9SGY7	718	Putative proline-rich rec	no	no	0.571	0.413	0.396	7e-55
Q9LV48	652	Proline-rich receptor-lik	no	no	0.557	0.444	0.395	7e-54
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.546	0.394	0.4	9e-54

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  221 bits (563), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 186/299 (62%), Gaps = 15/299 (5%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRE 229
            +Y E+  AT+ FS+  +LG+G   +VFKG   +LR    VA+K+L +   +  + F  E
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKG---MLRNGKEVAVKQLKEGSSQGEREFQAE 398

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
           + I S +HH ++V LVG+CI   Q L L+Y++V   +LE HLH K     G  T+ WS R
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRL-LVYEFVPNNTLEFHLHGK-----GRPTMEWSSR 452

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
            K+A+G A+ ++YLH      ++HRDIK SNIL+  K   K+ DFGLA   S  +   + 
Sbjct: 453 LKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVS 511

Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 409
             V GTFGYLAPEY   GK+++K+DV++FGVVLLEL+TGR+PI+   +  + +LV WA+P
Sbjct: 512 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARP 571

Query: 410 ILHR--GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG 466
           +L++   +   E ++D +L     +  ++AR++  AAAC+ S   RRP ++++  +L G
Sbjct: 572 LLNQVSELGNFEVVVDKKLN-NEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEG 629

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  221 bits (562), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 122/330 (36%), Positives = 192/330 (58%), Gaps = 22/330 (6%)

Query: 151 KWRKIQSLERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS 209
           KWR  ++  +   P    LI+  +Y EI  AT++F +G ++G G  S V++G +   R  
Sbjct: 236 KWRGSETKNK---PKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGR-R 291

Query: 210 VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           +A+KRL KE  D    K F  EL I S + HPN   L+G C+  E+GL+L++++   G+L
Sbjct: 292 IAVKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCV--EKGLYLVFRFSENGTL 349

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              LHE + G     +L W VRYK+A+G+A  + YLH      ++HRDIK SN+LL    
Sbjct: 350 YSALHENENG-----SLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDY 404

Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            P++ DFGLA W            V+GTFGYLAPE    G + +KTD+YAFG++LLE++T
Sbjct: 405 EPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIIT 464

Query: 388 GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACI 447
           GR+P+       +++++LWAKP +  G  +  EL+DP+L+    +  Q+ +++  A+ C+
Sbjct: 465 GRRPVNPT----QKHILLWAKPAMETGNTS--ELVDPKLQ-DKYDDQQMNKLVLTASHCV 517

Query: 448 SSEESRRPGIEEIIAIL-RGEEELIYCTWK 476
                 RP + +++ +L  G E  I  +W+
Sbjct: 518 QQSPILRPTMTQVLELLTNGNEAEIAKSWR 547

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  218 bits (556), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 125/308 (40%), Positives = 178/308 (57%), Gaps = 20/308 (6%)

Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDK-EDKESS 223
           +SL   S  +I  AT NFS   ++GRG  + V++G +  G L   +A+KRL K    E +
Sbjct: 126 SSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKL---IAVKRLTKGTPDEQT 182

Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             F  EL I + + HPN    +G CI  E G+ L+++    GSL   LH   K       
Sbjct: 183 AEFLSELGIIAHVDHPNTAKFIGCCI--EGGMHLVFRLSPLGSLGSLLHGPSK-----YK 235

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L WS RY VALG A+ + YLH G +R ++HRDIK  NILL+    P++CDFGLA W    
Sbjct: 236 LTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQ 295

Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
                    +GTFGY APEYF HG V +KTDV+AFGV+LLEL+TG   ++    + +++L
Sbjct: 296 LTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQSL 351

Query: 404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 463
           VLWAKP+L R   A++EL+DP L     N  ++ R+   A+ CI      RP + +++ +
Sbjct: 352 VLWAKPLLER--KAIKELVDPSLG-DEYNREELIRLTSTASLCIDQSSLLRPRMSQVVEL 408

Query: 464 LRGEEELI 471
           L G E+++
Sbjct: 409 LLGHEDVV 416

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  218 bits (556), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 124/303 (40%), Positives = 185/303 (61%), Gaps = 15/303 (4%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            +Y E+   T  FSK  +LG G    V+KGK+   +  VA+K+L     +  + F  E+ 
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKL-VAVKQLKVGSGQGDREFKAEVE 399

Query: 232 IASSLHHPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           I S +HH ++V LVG+CI D E+   LIY+YV   +LE HLH K     G   L W+ R 
Sbjct: 400 IISRVHHRHLVSLVGYCIADSER--LLIYEYVPNQTLEHHLHGK-----GRPVLEWARRV 452

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           ++A+G A+ +AYLH      ++HRDIK +NILL  +   ++ DFGLA    +     +  
Sbjct: 453 RIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQT-HVST 511

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
            V GTFGYLAPEY Q GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV WA+P+
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571

Query: 411 LHRGMAAVE--ELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE 467
           LH+ +   +  EL+D RL K    N  ++ R+I+ AAAC+     +RP + +++  L  E
Sbjct: 572 LHKAIETGDFSELVDRRLEKHYVEN--EVFRMIETAAACVRHSGPKRPRMVQVVRALDSE 629

Query: 468 EEL 470
            ++
Sbjct: 630 GDM 632

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  218 bits (554), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 119/297 (40%), Positives = 184/297 (61%), Gaps = 11/297 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            +YGE+  AT+ FS+  +LG G   FV+KG +      VA+K+L     +  K F  E+ 
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNN-GNEVAVKQLKVGSAQGEKEFQAEVN 229

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I S +HH N+V LVG+CI   Q L L+Y++V   +LE HLH K     G  T+ WS+R K
Sbjct: 230 IISQIHHRNLVSLVGYCIAGAQRL-LVYEFVPNNTLEFHLHGK-----GRPTMEWSLRLK 283

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +A+  ++ ++YLH      ++HRDIK +NIL+  K   K+ DFGLA   +  +   +   
Sbjct: 284 IAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTR 342

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 411
           V GTFGYLAPEY   GK+++K+DVY+FGVVLLEL+TGR+P++A  +  +++LV WA+P+L
Sbjct: 343 VMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLL 402

Query: 412 HRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG 466
            + +  +  E L D +L     +  ++AR++  AAAC+     RRP +++++ +L G
Sbjct: 403 VQALEESNFEGLADIKLN-NEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEG 458

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  215 bits (548), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 115/293 (39%), Positives = 173/293 (59%), Gaps = 6/293 (2%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            ++ E+ AAT NF     LG G    V+KG++      VA+K+LD+   + ++ F  E++
Sbjct: 74  FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S LHHPN+V L+G+C D +Q L L+Y+++  GSLE HLH+          L W++R K
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD---KEALDWNMRMK 189

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +A G A+ + +LH+     V++RD K SNILL     PKL DFGLA          +   
Sbjct: 190 IAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTR 249

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 411
           V GT+GY APEY   G+++ K+DVY+FGVV LEL+TGRK I++    GE+NLV WA+P+ 
Sbjct: 250 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLF 309

Query: 412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
           +     + +L DPRLK      A + + +  A+ CI  + + RP I +++  L
Sbjct: 310 NDRRKFI-KLADPRLKGRFPTRA-LYQALAVASMCIQEQAATRPLIADVVTAL 360

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  215 bits (548), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 129/307 (42%), Positives = 179/307 (58%), Gaps = 17/307 (5%)

Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
           A S+   +  E+  AT  FS  RVLG G    V++G +    T VA+K L ++++   + 
Sbjct: 331 ALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMED-GTEVAVKLLTRDNQNRDRE 389

Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E+ + S LHH N+V L+G CI+  +   LIY+ V  GS+E HLHE         TL 
Sbjct: 390 FIAEVEMLSRLHHRNLVKLIGICIE-GRTRCLIYELVHNGSVESHLHE--------GTLD 440

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           W  R K+ALG A  +AYLH  +   V+HRD K SN+LL     PK+ DFGLA   +  S 
Sbjct: 441 WDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ 500

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
             +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGR+P++  +  GEENLV 
Sbjct: 501 -HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVT 559

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           WA+P+L      +E+L+DP L  T  N   +A+V   A+ C+  E S RP + E++  L+
Sbjct: 560 WARPLLAN-REGLEQLVDPALAGT-YNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617

Query: 466 GEEELIY 472
               LIY
Sbjct: 618 ----LIY 620

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  215 bits (547), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 122/308 (39%), Positives = 182/308 (59%), Gaps = 11/308 (3%)

Query: 165 VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 224
           +  S I  +Y E+   T  F K  V+G G    V+KG +      VAIK+L     E  +
Sbjct: 351 IGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKG-ILFEGKPVAIKQLKSVSAEGYR 409

Query: 225 AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 284
            F  E+ I S +HH ++V LVG+CI  EQ  FLIY++V   +L+ HLH K   V     L
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCIS-EQHRFLIYEFVPNNTLDYHLHGKNLPV-----L 463

Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            WS R ++A+G A+ +AYLH      ++HRDIK SNILL  +   ++ DFGLA      +
Sbjct: 464 EWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT-A 522

Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 404
              +   V GTFGYLAPEY   GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV
Sbjct: 523 QSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582

Query: 405 LWAKPILHRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
            WA+P L   +    + E++DPRL+     S ++ ++I+ AA+C+     +RP + +++ 
Sbjct: 583 EWARPRLIEAIEKGDISEVVDPRLENDYVES-EVYKMIETAASCVRHSALKRPRMVQVVR 641

Query: 463 ILRGEEEL 470
            L   ++L
Sbjct: 642 ALDTRDDL 649

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  212 bits (539), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 119/301 (39%), Positives = 182/301 (60%), Gaps = 11/301 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            +Y E+  AT+ FS+  +LG+G   +V KG +   +  VA+K+L     +  + F  E+ 
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGK-EVAVKQLKAGSGQGEREFQAEVE 326

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I S +HH ++V L+G+C+   Q L L+Y++V   +LE HLH K     G  T+ WS R K
Sbjct: 327 IISRVHHRHLVSLIGYCMAGVQRL-LVYEFVPNNNLEFHLHGK-----GRPTMEWSTRLK 380

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +ALG A+ ++YLH      ++HRDIK SNIL+  K   K+ DFGLA   S  +   +   
Sbjct: 381 IALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTR 439

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 411
           V GTFGYLAPEY   GK+++K+DV++FGVVLLEL+TGR+P++A  +  +++LV WA+P+L
Sbjct: 440 VMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL 499

Query: 412 HRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE 469
           +R       E L D ++     +  ++AR++  AAAC+     RRP + +I+  L G   
Sbjct: 500 NRASEEGDFEGLADSKMG-NEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVS 558

Query: 470 L 470
           L
Sbjct: 559 L 559

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  211 bits (538), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 118/295 (40%), Positives = 177/295 (60%), Gaps = 11/295 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            SY E+   T  F++  +LG G    V+KG +   +  VA+K+L     +  + F  E+ 
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKV-VAVKQLKAGSGQGDREFKAEVE 417

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I S +HH ++V LVG+CI  +Q   LIY+YVS  +LE HLH K     G   L WS R +
Sbjct: 418 IISRVHHRHLVSLVGYCIS-DQHRLLIYEYVSNQTLEHHLHGK-----GLPVLEWSKRVR 471

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +A+G A+ +AYLH      ++HRDIK +NILL  +   ++ DFGLA          +   
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQT-HVSTR 530

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL 411
           V GTFGYLAPEY   GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV WA+P+L
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLL 590

Query: 412 HRGM--AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
            + +    + EL+D RL+       ++ R+I+ AAAC+     +RP + +++  L
Sbjct: 591 LKAIETGDLSELIDTRLE-KRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	520
224065170	523	predicted protein [Populus trichocarpa]	0.978	0.973	0.752	0.0
224079445	520	predicted protein [Populus trichocarpa]	0.915	0.915	0.787	0.0
363807838	508	uncharacterized protein LOC100808074 [Gl	0.967	0.990	0.712	0.0
359488192	519	PREDICTED: probable receptor-like serine	0.976	0.978	0.709	0.0
356569560	511	PREDICTED: proline-rich receptor-like pr	0.969	0.986	0.709	0.0
449445086	519	PREDICTED: proline-rich receptor-like pr	0.967	0.969	0.711	0.0
297805364	539	kinase family protein [Arabidopsis lyrat	0.913	0.881	0.693	0.0
110738055	548	protein kinase like protein [Arabidopsis	0.919	0.872	0.678	0.0
15240345	552	protein kinase family protein [Arabidops	0.919	0.865	0.678	0.0
356552025	509	PREDICTED: proline-rich receptor-like pr	0.940	0.960	0.672	0.0

>gi|224065170|ref|XP_002301698.1| predicted protein [Populus trichocarpa] gi|222843424|gb|EEE80971.1| predicted protein [Populus trichocarpa]

 Score =  796 bits (2056), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/534 (75%), Positives = 452/534 (84%), Gaps = 25/534 (4%)

Query: 1   MGFSQDTY------SKSSQHNELYASSIVS-DNYCEYKVYNKHYNELKIKTLLRKMIWDF 53
           MGF Q T       S SS  + L AS+I++ D+  +Y       NELK+K  L KM W  
Sbjct: 1   MGFCQGTCRNTKEPSNSSTCDALSASTIIAKDHSFDYD------NELKMKGFLSKMFWQS 54

Query: 54  GLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGG----AELTSTDPQSVHSS 109
           GL+CFLP+ S+    + N+     K  +LEHNKAWLLAESGG    +ELT+ DP SVHSS
Sbjct: 55  GLACFLPNESDETIKKSNN-----KNGSLEHNKAWLLAESGGCGSGSELTNADPHSVHSS 109

Query: 110 FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSL 169
           FRFSLCSQVELESMN+ +SASATVLMVNL+NGL ++RA+ELKWR+IQSLERSISPVANSL
Sbjct: 110 FRFSLCSQVELESMNMNSSASATVLMVNLDNGLNETRAKELKWRRIQSLERSISPVANSL 169

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           +R SY EILAAT+NFSKGRVLGRGALSFVF+GKVG LRT+VAIKRLDKEDKE+SKAFCRE
Sbjct: 170 VRFSYSEILAATNNFSKGRVLGRGALSFVFRGKVGFLRTAVAIKRLDKEDKEASKAFCRE 229

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPW 286
           LMIASSL+H NIVPLVGFCIDPE+GLFL+YKYVSGGSLERHLH+KKK   G      L W
Sbjct: 230 LMIASSLYHSNIVPLVGFCIDPEEGLFLVYKYVSGGSLERHLHDKKKVKVGVKGSSGLSW 289

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           SVRYKVALGIA+++AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP
Sbjct: 290 SVRYKVALGIAQAIAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 349

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 406
           FLCKTVKGTFGYLAPEYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  GEENLVLW
Sbjct: 350 FLCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRPPGEENLVLW 409

Query: 407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG 466
           AKP+L +G  A+EELLDPRL+CT RN+ QI ++IQAA AC+S+EESRRPGI+EII +LRG
Sbjct: 410 AKPLLQKGKGAIEELLDPRLECTLRNTTQIIQMIQAATACVSNEESRRPGIDEIIGMLRG 469

Query: 467 EEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
           EE+ IY   KK NFSGIIDCYPQLQQTKSEM SHLALAM+GVSEFE+DDHL CR
Sbjct: 470 EEQPIYSNRKKSNFSGIIDCYPQLQQTKSEMNSHLALAMLGVSEFEDDDHLCCR 523

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079445|ref|XP_002305868.1| predicted protein [Populus trichocarpa] gi|222848832|gb|EEE86379.1| predicted protein [Populus trichocarpa]

 Score =  793 bits (2047), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/499 (78%), Positives = 437/499 (87%), Gaps = 23/499 (4%)

Query: 33  YNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSN-----LEHNKA 87
           Y +H+ E K+K  L KM W FGL+CF+P          N+ DE SKGSN     LEHNKA
Sbjct: 34  YFEHHYERKMKAFLSKMFWQFGLACFVP----------NESDETSKGSNKKNADLEHNKA 83

Query: 88  WLLAESGG---AELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCD 144
           WLLAESGG   AELT+ DPQSVHSSFRFSLCSQVELESMN+  ++SATVLMVNL+NGL +
Sbjct: 84  WLLAESGGCGGAELTNADPQSVHSSFRFSLCSQVELESMNM--NSSATVLMVNLDNGLNE 141

Query: 145 SRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVG 204
           +RA+ELKWR+IQSLERSISPVANSL+R SY EILAAT+NFSKGRVLGRGALSFVF+GKVG
Sbjct: 142 TRAKELKWRRIQSLERSISPVANSLVRFSYREILAATNNFSKGRVLGRGALSFVFRGKVG 201

Query: 205 LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG 264
            LRT+VAIKRLDKEDKE+SKAFCRELMIASSL+H NIVPLVGFCIDP++GLFL+Y+YVSG
Sbjct: 202 FLRTAVAIKRLDKEDKEASKAFCRELMIASSLYHSNIVPLVGFCIDPDEGLFLVYRYVSG 261

Query: 265 GSLERHLHEKKKGVRGNST---LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI 321
           GSLERHLH+KKKG  G      LPWSVRYKVALGIA+++AYLHNGTERCVVHRDIKPSNI
Sbjct: 262 GSLERHLHDKKKGKGGVKGSSGLPWSVRYKVALGIAQAIAYLHNGTERCVVHRDIKPSNI 321

Query: 322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 381
           LLSSKK+PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK+SDKTDVYAFGVV
Sbjct: 322 LLSSKKVPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVV 381

Query: 382 LLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQ 441
           LLEL++GRKPIEAR+   EENLVLWAKP+L +G  A+EELLDPRLKCT RN+ QI  +IQ
Sbjct: 382 LLELISGRKPIEARKPLREENLVLWAKPLLQKGNEAIEELLDPRLKCTLRNTTQITHMIQ 441

Query: 442 AAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHL 501
           AA ACIS+EESRRPGI+EII ILRGEE+ IY   KK NFSGIIDCYPQLQQTKSEM SHL
Sbjct: 442 AATACISNEESRRPGIDEIIGILRGEEQPIYSNRKKSNFSGIIDCYPQLQQTKSEMNSHL 501

Query: 502 ALAMVGVSEFEEDDHLYCR 520
           ALAM+GVSEFE+DDHLYCR
Sbjct: 502 ALAMLGVSEFEDDDHLYCR 520

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807838|ref|NP_001242440.1| uncharacterized protein LOC100808074 [Glycine max] gi|255635407|gb|ACU18056.1| unknown [Glycine max]

 Score =  763 bits (1970), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/525 (71%), Positives = 445/525 (84%), Gaps = 22/525 (4%)

Query: 1   MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLP 60
           MGFSQD  + S+      +S++V D+YC+Y       ++LK KT LRKM W+FGL+C   
Sbjct: 1   MGFSQDPCTDSNAPTST-SSTLVVDHYCDY-------DKLKFKTFLRKMFWEFGLAC--- 49

Query: 61  SLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGG--AELTSTDPQSVHSSFRFSLCSQV 118
            ++N    R +  D   K +N+E+NKAWLLAESGG  AELT+ DPQSVHSSFRFS CSQV
Sbjct: 50  -VANPSQRRRSSGD--GKKTNMENNKAWLLAESGGCGAELTNADPQSVHSSFRFSFCSQV 106

Query: 119 ELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL 178
           ELES+N+ +SA+ATVLMVNL+NG+ +SRA E+KWR+++SLE+SISPV ++LIR SYGEI+
Sbjct: 107 ELESLNMSSSAAATVLMVNLDNGVSESRANEMKWRRMESLEKSISPVVHTLIRFSYGEIM 166

Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +AT NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKEDKES+KAFCRELMIASSLH 
Sbjct: 167 SATRNFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKEDKESAKAFCRELMIASSLHS 226

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            N+VPL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KKG   +S LPW VRYKVA+GIAE
Sbjct: 227 SNVVPLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKKG---SSPLPWPVRYKVAIGIAE 283

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           +VAYLH+GTERCVVHRDIKPSNILLSS+K PKLCDFGLATWTSAPSVPFLCKTVKGTFGY
Sbjct: 284 AVAYLHSGTERCVVHRDIKPSNILLSSRKTPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 343

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 418
           LAPEYFQHGKVSDKTDVYAFGVVLLEL+TGRKPIEA R  G+ENLVLWAKP L +G  A+
Sbjct: 344 LAPEYFQHGKVSDKTDVYAFGVVLLELITGRKPIEATRPSGDENLVLWAKPFLQKGKGAI 403

Query: 419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKH 478
           EELLDP+LKC+ + S Q+ R+I+AAAAC+++EESRRPGI EIIAIL+GEEE +    KK 
Sbjct: 404 EELLDPQLKCSLKFSNQMGRMIEAAAACVTNEESRRPGIREIIAILKGEEEPLLSKRKKS 463

Query: 479 NFSG---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
           +F G   +IDCY QLQQT +EMKSHLALAM+GV+EFE+DD+LY R
Sbjct: 464 SFLGNGCVIDCYSQLQQTNNEMKSHLALAMLGVAEFEDDDYLYGR 508

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488192|ref|XP_002274329.2| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Vitis vinifera] gi|296087159|emb|CBI33533.3| unnamed protein product [Vitis vinifera]

 Score =  754 bits (1946), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/531 (70%), Positives = 444/531 (83%), Gaps = 23/531 (4%)

Query: 1   MGFSQ----DTYSKSSQHNELYASSIVSDNY-CEYKVYNKHYNELKIKTLLRKMIWDFGL 55
           MG SQ    DT       N  YASS+ +D++ C++       +EL++K+LL+KM+W+FGL
Sbjct: 1   MGCSQGACTDTRKAFDGPNASYASSVTADDHSCDH-------DELRVKSLLKKMVWEFGL 53

Query: 56  SCFLPSLSNNHNNRINDDDEKSKGSN-LEHNKAWLLAESGG--AELTSTDPQSVHSSFRF 112
            C  P ++   ++    + ++ KG N LEHNKAWLLAESGG  AEL++ DPQSVHSSFRF
Sbjct: 54  GCVYP-VNRRRSSGGKGEMQRDKGKNSLEHNKAWLLAESGGCGAELSNADPQSVHSSFRF 112

Query: 113 SLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRL 172
           S CSQVELES+N+ +S +ATVLMVNL+NGL  SR++ELKWR+I+SLERSISPVAN+LIR 
Sbjct: 113 SFCSQVELESLNMSSSTAATVLMVNLDNGLTQSRSKELKWRRIESLERSISPVANTLIRF 172

Query: 173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
            Y EI++AT NF+KGRVLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMI
Sbjct: 173 GYAEIVSATRNFNKGRVLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMI 232

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           ASSL +PNIVPLVGFCIDPE+GLFL+YKYVSGGSLERHLHEKK+GV+G S+LPWSVRYKV
Sbjct: 233 ASSLQNPNIVPLVGFCIDPEEGLFLVYKYVSGGSLERHLHEKKRGVKGYSSLPWSVRYKV 292

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A+G+AESVAYLH+GT+RCVVHRDIKPSNILLSSKKIPKLCDFGLATWT APSVPFLCKTV
Sbjct: 293 AVGVAESVAYLHSGTDRCVVHRDIKPSNILLSSKKIPKLCDFGLATWTPAPSVPFLCKTV 352

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
           KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  GEENLVLWAKP+L 
Sbjct: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRPPGEENLVLWAKPLLQ 412

Query: 413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIY 472
           +   ++E+LLDP LK T +NS QI R++QAAAACI+SEESRRP I+E++ ILRG E    
Sbjct: 413 Q--ESIEQLLDPCLKLTPKNSNQIGRMVQAAAACINSEESRRPSIDEVVVILRGREPNC- 469

Query: 473 CTWKKHNFSG---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
            + KK  F G   + DCY QL QTKSEM+SHLALAM+GV +FE+D H YCR
Sbjct: 470 SSRKKSGFPGNGFVTDCYAQL-QTKSEMRSHLALAMLGVPDFEDDAHFYCR 519

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569560|ref|XP_003552967.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  751 bits (1939), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/527 (70%), Positives = 444/527 (84%), Gaps = 23/527 (4%)

Query: 1   MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLP 60
           MG SQ   + S   +   A ++V D+YC+Y       N+LK +T LRKM W+FGL+C   
Sbjct: 1   MGLSQGPCTDSRDLSN--APTLVVDHYCDY-------NKLKFRTFLRKMFWEFGLAC--- 48

Query: 61  SLSNNHNNRINDDDEKSKG--SNLEHNKAWLLAESGG--AELTSTDPQSVHSSFRFSLCS 116
            ++N    R + +   + G  +NLEHNKAWLLAESGG  AELT+ DPQSVHSSFRFS CS
Sbjct: 49  -VANPSRRRRSSERSSAYGKKTNLEHNKAWLLAESGGCGAELTNADPQSVHSSFRFSFCS 107

Query: 117 QVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGE 176
           QVELES+N+ +S++ATVLMVNL+NG+ +SRA+E+KWR+++SLE+SISPVA+SLIR SYGE
Sbjct: 108 QVELESLNMSSSSAATVLMVNLDNGMSESRAREMKWRRMESLEKSISPVAHSLIRFSYGE 167

Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           I++AT NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKE KES+KAFCRELMIASSL
Sbjct: 168 IMSATRNFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKESKESAKAFCRELMIASSL 227

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  N+VPL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KKG   +S L W VRYKVA+GI
Sbjct: 228 HSSNVVPLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKKG---SSPLLWPVRYKVAIGI 284

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AE+VAYLH+GTERCVVHRDIKPSNILLSS+KIPKLCDFGLATWTSAPS+PFLCKTVKGTF
Sbjct: 285 AEAVAYLHSGTERCVVHRDIKPSNILLSSRKIPKLCDFGLATWTSAPSLPFLCKTVKGTF 344

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
           GYLAPEYFQHGKVSDKTDVYAFGVVLLEL+TGRKPIEARR  GEENLVLWAKP L +G  
Sbjct: 345 GYLAPEYFQHGKVSDKTDVYAFGVVLLELITGRKPIEARRSSGEENLVLWAKPFLQKGKG 404

Query: 417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWK 476
           A+EELLDP+LKC+ + S Q+ R+I+AAAAC+++EESRRPGI EIIAIL+GEEE +    K
Sbjct: 405 AIEELLDPQLKCSLKFSNQMGRMIEAAAACVTNEESRRPGIHEIIAILKGEEEPLLSKRK 464

Query: 477 KHNFSG---IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
           K +F G   +IDCY QLQQT +EMKSHLALAM GV+EFE+DD+LY R
Sbjct: 465 KSSFLGNGCVIDCYSQLQQTNNEMKSHLALAMSGVAEFEDDDYLYGR 511

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445086|ref|XP_004140304.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus] gi|449479863|ref|XP_004155731.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus]

 Score =  743 bits (1918), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/516 (71%), Positives = 431/516 (83%), Gaps = 13/516 (2%)

Query: 17  LYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDE- 75
           L   SI  +   E   ++  YNELKIKTLLRKMIW+ G +C LP       N+   D+E 
Sbjct: 5   LGTCSIQRETPLELDHHHCRYNELKIKTLLRKMIWELGFACILPPARFRRKNQGIQDEEH 64

Query: 76  ---KSKGSNLEHNKAWLLAESG--GAELTSTDPQSVHSSFRFSLCSQVELESMNIGASAS 130
              + +  NLEHNKAWLLAESG  G EL +TDPQSVHSSFRFS CSQVELE+MNIG+S +
Sbjct: 65  PNVEGQNKNLEHNKAWLLAESGAGGGELLNTDPQSVHSSFRFSFCSQVELETMNIGSSTT 124

Query: 131 A-TVLMVNLENGL-CDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGR 188
           A TVLMVNL+NG+  ++  +ELKWR+I+SLE+SISPVA++LIR  Y EIL+AT NFSKGR
Sbjct: 125 AATVLMVNLDNGMMAEALTKELKWRRIESLEKSISPVAHTLIRFRYREILSATRNFSKGR 184

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMIASSLH+PNIVPLVGFC
Sbjct: 185 VLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMIASSLHNPNIVPLVGFC 244

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           IDPE+GLFL+YKYVSGGSLERHLHEKK+G++G  +LPWSVR+K+ALGIAE+VAYLHNGTE
Sbjct: 245 IDPEEGLFLVYKYVSGGSLERHLHEKKRGMKGRFSLPWSVRFKIALGIAEAVAYLHNGTE 304

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK 368
           RCVVHRDIKPSNILL+SKK+PKLCDFGLATWT+APSVPFLCKTVKGTFGYLAPEYFQHGK
Sbjct: 305 RCVVHRDIKPSNILLTSKKMPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAPEYFQHGK 364

Query: 369 VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKC 428
           VSDKTDVYA GVVLLEL+TGRKP EA R  GEENLVLWAKP+L +G  A+ ELLDP++ C
Sbjct: 365 VSDKTDVYAVGVVLLELITGRKPFEA-RAHGEENLVLWAKPLLQKGKGAITELLDPQVTC 423

Query: 429 TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL-IYCTWKKHNFSG---II 484
           T++NS QI ++I+AAAACI+ EESRRPGI EIIAIL+GEE+  +    K+++F G   + 
Sbjct: 424 TTKNSNQIVQMIEAAAACITGEESRRPGILEIIAILKGEEKAPLPSRSKRYSFLGHGCVT 483

Query: 485 DCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
           DCY Q Q T SEM  HLALAM G+ EFE+DD+L+CR
Sbjct: 484 DCYSQFQNTNSEMTGHLALAMSGLPEFEDDDYLFCR 519

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805364|ref|XP_002870566.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316402|gb|EFH46825.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/499 (69%), Positives = 408/499 (81%), Gaps = 24/499 (4%)

Query: 42  IKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTST 101
           IKTLL+KMI+D G +CFLP L+ N  N        S     E+NKAWLLAE+   E  + 
Sbjct: 45  IKTLLKKMIFDLGFACFLPPLAENSGNNNGGAGGGS--GGGENNKAWLLAETA-PENMNP 101

Query: 102 DPQSVHSSFRFSLCSQVELESM--------------NIGASA-SATVLMVNLENGLCDSR 146
           DP SVHSSFRFSLCSQ+ELE M              N+  S  S TVLMVNLENG+ ++ 
Sbjct: 102 DPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSVSGGSTTVLMVNLENGVKET- 160

Query: 147 AQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLL 206
             +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSKGRVLGRGA S+VF+GK+G+ 
Sbjct: 161 TDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSKGRVLGRGACSYVFRGKIGMW 220

Query: 207 RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+GFCIDPE+GLFL+YKYVSGGS
Sbjct: 221 RTTLAIKRLDKEDKESPKSFCRELMIASSLHSFNIVPLLGFCIDPEEGLFLVYKYVSGGS 280

Query: 267 LERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
           LE +LH+KKK  GV+    LPWS RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLS
Sbjct: 281 LEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLS 340

Query: 325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 384
           SKKIPKLCDFGLATWT+APS+PFLCKTVKGTFGYLAPEYFQHGK+SDKTDVYAFGVVLLE
Sbjct: 341 SKKIPKLCDFGLATWTAAPSIPFLCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLE 400

Query: 385 LLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAA 444
           L+TGRKPIEARR  G+ENLV+WAKP+LHRGM A+ ELLDPRLKCT +NS Q+ R+I+AAA
Sbjct: 401 LITGRKPIEARRASGQENLVVWAKPLLHRGMEAIVELLDPRLKCTRKNSVQMERMIRAAA 460

Query: 445 ACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKHNFSGIIDCYPQLQQTKSEMKSHL 501
           AC+ +EESRRPG+EEI++IL+ EE L    + + K  N SG+ID Y QLQQTKSEMK HL
Sbjct: 461 ACVINEESRRPGMEEIVSILKSEEGLEPKTHSSRKNTNISGMIDSYTQLQQTKSEMKCHL 520

Query: 502 ALAMVGVSEFEEDDHLYCR 520
            LAM+GV+EFE+DDH+Y R
Sbjct: 521 DLAMLGVTEFEDDDHVYGR 539

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110738055|dbj|BAF00962.1| protein kinase like protein [Arabidopsis thaliana]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/507 (67%), Positives = 409/507 (80%), Gaps = 29/507 (5%)

Query: 42  IKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHN-----KAWLLAESGGA 96
           IKTLL++MI+D G +CFLP LS+  N+  N+    S G           KAWLLAE+   
Sbjct: 43  IKTLLKRMIFDLGFACFLPPLSSTENSGNNNGGGTSGGGGGGGGGGENNKAWLLAETA-P 101

Query: 97  ELTSTDPQSVHSSFRFSLCSQVELESM--------------NIGASA-SATVLMVNLENG 141
           E  + DP SVHSSFRFSLCSQ+ELE M              N+  S  S TVLMVNLENG
Sbjct: 102 ENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSVSGGSTTVLMVNLENG 161

Query: 142 LCDSRAQ---ELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 198
           + ++      +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSKGRVLGRGA S+V
Sbjct: 162 VKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSKGRVLGRGACSYV 221

Query: 199 FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI 258
           F+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+GFCIDPE+GLFL+
Sbjct: 222 FRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSSNIVPLLGFCIDPEEGLFLV 281

Query: 259 YKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI 316
           YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA+++AYLHNGTE+CVVHRDI
Sbjct: 282 YKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLHNGTEQCVVHRDI 341

Query: 317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVY 376
           KPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFGYLAPEYFQHGK+SDKTDVY
Sbjct: 342 KPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAPEYFQHGKISDKTDVY 401

Query: 377 AFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQI 436
           AFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+L RG+ A+ ELLDPRLKCT +NS Q+
Sbjct: 402 AFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRGIEAIVELLDPRLKCTRKNSVQM 461

Query: 437 ARVIQAAAACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKHNFSGIIDCYPQLQQT 493
            R+I+AAAAC+ +EESRRPG+EEI++IL+GEE +    + + K  N SG+ID Y QLQQT
Sbjct: 462 ERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPETHSSRKTTNISGMIDSYTQLQQT 521

Query: 494 KSEMKSHLALAMVGVSEFEEDDHLYCR 520
           KSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct: 522 KSEMKCHLDLAMLGVTEFEDDDHVYGR 548

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240345|ref|NP_198595.1| protein kinase family protein [Arabidopsis thaliana] gi|21536612|gb|AAM60944.1| protein kinase-like protein [Arabidopsis thaliana] gi|332006850|gb|AED94233.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/507 (67%), Positives = 409/507 (80%), Gaps = 29/507 (5%)

Query: 42  IKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHN-----KAWLLAESGGA 96
           IKTLL++MI+D G +CFLP LS+  N+  N+    S G           KAWLLAE+   
Sbjct: 47  IKTLLKRMIFDLGFACFLPPLSSTENSGNNNGGGTSGGGGGGGGGGENNKAWLLAETA-P 105

Query: 97  ELTSTDPQSVHSSFRFSLCSQVELESM--------------NIGASA-SATVLMVNLENG 141
           E  + DP SVHSSFRFSLCSQ+ELE M              N+  S  S TVLMVNLENG
Sbjct: 106 ENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSVSGGSTTVLMVNLENG 165

Query: 142 LCDSRAQ---ELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 198
           + ++      +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSKGRVLGRGA S+V
Sbjct: 166 VKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSKGRVLGRGACSYV 225

Query: 199 FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI 258
           F+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+GFCIDPE+GLFL+
Sbjct: 226 FRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSSNIVPLLGFCIDPEEGLFLV 285

Query: 259 YKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI 316
           YKYVSGGSLE +LH+KKK  GV+    LPWS RYKVALGIA+++AYLHNGTE+CVVHRDI
Sbjct: 286 YKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLHNGTEQCVVHRDI 345

Query: 317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVY 376
           KPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFGYLAPEYFQHGK+SDKTDVY
Sbjct: 346 KPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFGYLAPEYFQHGKISDKTDVY 405

Query: 377 AFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQI 436
           AFGVVLLEL+TGRKPIEARR  G+ENLV+WAKP+L RG+ A+ ELLDPRLKCT +NS Q+
Sbjct: 406 AFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRGIEAIVELLDPRLKCTRKNSVQM 465

Query: 437 ARVIQAAAACISSEESRRPGIEEIIAILRGEEEL---IYCTWKKHNFSGIIDCYPQLQQT 493
            R+I+AAAAC+ +EESRRPG+EEI++IL+GEE +    + + K  N SG+ID Y QLQQT
Sbjct: 466 ERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPETHSSRKTTNISGMIDSYTQLQQT 525

Query: 494 KSEMKSHLALAMVGVSEFEEDDHLYCR 520
           KSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct: 526 KSEMKCHLDLAMLGVTEFEDDDHVYGR 552

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552025|ref|XP_003544372.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  674 bits (1740), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/516 (67%), Positives = 413/516 (80%), Gaps = 27/516 (5%)

Query: 11  SSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCF--LPSLSNNHNN 68
           S   N L +SS V ++  +YK +N      K+ T L+K +W++  +C   +P   NN   
Sbjct: 11  SGDTNALVSSSAVGNDPSDYKRHNN-----KLMTFLKKTMWEYAFACVGVVPCGGNN--- 62

Query: 69  RINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIG-- 126
               D    + + L+HNKAWLLA+SG AEL S DP+SVHSSFRFS CSQVE+ES N+   
Sbjct: 63  ----DLNGQRKATLKHNKAWLLADSG-AELASADPRSVHSSFRFSFCSQVEVESFNMSYS 117

Query: 127 -ASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFS 185
            ++A+AT LMVNL+    +S+ +ELKWR+IQS E+S+SPVAN+LIR SY EIL+ATHNFS
Sbjct: 118 ASAAAATFLMVNLDY---ESQVKELKWRRIQSPEKSLSPVANTLIRFSYDEILSATHNFS 174

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           K RVLGRGALS VF+G+VG+ RTSVAIKRLDKEDKE  KAFCRELMIASSLH+ N+VPLV
Sbjct: 175 KERVLGRGALSCVFRGRVGIWRTSVAIKRLDKEDKECVKAFCRELMIASSLHNTNVVPLV 234

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           GFCID E+GLFL+YKYVSGGSLE HLH +KKG   +S LPWSVRYKVA+GIAE+VAYLH+
Sbjct: 235 GFCIDSEEGLFLVYKYVSGGSLEHHLHGRKKG---SSPLPWSVRYKVAIGIAEAVAYLHH 291

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
           GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA+WTSAPSVPFLCKTVKGTFGYLAPEYFQ
Sbjct: 292 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLASWTSAPSVPFLCKTVKGTFGYLAPEYFQ 351

Query: 366 HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR 425
           HGKVSDKTDVYA GVVLLELLTGRKPIEA+R  GEENLV+WAKP+L +G  A+EELLD +
Sbjct: 352 HGKVSDKTDVYALGVVLLELLTGRKPIEAKRTPGEENLVVWAKPLLRKGKGAIEELLDSQ 411

Query: 426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTWKKHNFSG--- 482
           +K     + Q+AR+I AAAAC++SEESRRP I EI+AIL+GE E +    +K  + G   
Sbjct: 412 VKYNLSYTDQMARMIDAAAACVTSEESRRPSIGEIVAILKGEVEPVLSRRRKSGYFGNGY 471

Query: 483 IIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLY 518
           +ID YPQLQ+T +EMKSHLALAM+GVSE E+DD LY
Sbjct: 472 VIDYYPQLQETNNEMKSHLALAMLGVSECEDDDFLY 507

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	520
TAIR|locus:2156050	552	AT5G37790 [Arabidopsis thalian	0.782	0.737	0.699	1.5e-179
TAIR|locus:2028967	467	AT1G66460 [Arabidopsis thalian	0.867	0.965	0.655	4.1e-159
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.678	0.444	0.418	1.1e-66
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.667	0.458	0.397	3e-62
TAIR|locus:2160801	705	AT5G63940 [Arabidopsis thalian	0.642	0.473	0.414	3.9e-60
TAIR|locus:2059919	617	AT2G16750 [Arabidopsis thalian	0.644	0.542	0.397	3.2e-58
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.569	0.397	0.407	6.3e-53
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.605	0.833	0.376	6.3e-53
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.573	0.267	0.404	9.6e-53
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.571	0.413	0.386	1.4e-52

TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1519 (539.8 bits), Expect = 1.5e-179, Sum P(2) = 1.5e-179
 Identities = 291/416 (69%), Positives = 348/416 (83%)

Query:   113 SLCSQVELESMNIGASASATVLMVNLENGLCDSRAQ---ELKWRKIQSLERSISPVANSL 169
             SL +     ++++ +  S TVLMVNLENG+ ++      +L+W + +SLE+SISPVAN+L
Sbjct:   138 SLSASSSCRNLSV-SGGSTTVLMVNLENGVKETTGNATDDLRWTRARSLEKSISPVANTL 196

Query:   170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
             +R SYGEI+AAT NFSKGRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRE
Sbjct:   197 VRFSYGEIVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRE 256

Query:   230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWS 287
             LMIASSLH  NIVPL+GFCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS
Sbjct:   257 LMIASSLHSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWS 316

Query:   288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
              RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APSVPF
Sbjct:   317 ARYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPF 376

Query:   348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA 407
             LCKTVKGTFGYLAPEYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEARR  G+ENLV+WA
Sbjct:   377 LCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWA 436

Query:   408 KPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILRGE 467
             KP+L RG+ A+ ELLDPRLKCT +NS            C+ +EESRRPG+EEI++IL+GE
Sbjct:   437 KPLLDRGIEAIVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGE 496

Query:   468 EEL---IYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDDHLYCR 520
             E +    + + K  N SG+ID Y QLQQTKSEMK HL LAM+GV+EFE+DDH+Y R
Sbjct:   497 EGVEPETHSSRKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDDDHVYGR 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028967 AT1G66460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1550 (550.7 bits), Expect = 4.1e-159, P = 4.1e-159
 Identities = 318/485 (65%), Positives = 372/485 (76%)

Query:    49 MIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHS 108
             MI D G  CF+P                 + S+ E NKAWLLAE+   +L  ++  S+ S
Sbjct:     1 MILDLGFPCFVPP----------------RTSSREDNKAWLLAETE-PKLIDSEQHSLQS 43

Query:   109 SFRFSLCSQVELESM----------NIGAS-ASATVLMVNLENGLCDSRAQELKWRKIQS 157
             SFRFSLCSQ+ELE +          N   S  S TVL+VNLEN   +    E+ W +  S
Sbjct:    44 SFRFSLCSQLELEKIKKEKPSLSYRNFPVSEGSETVLLVNLENETGELTG-EMNWSRGLS 102

Query:   158 LERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK 217
             LE+SISPVA+SLIR SY E+L AT NFSK RVLGRGA S+VFKG++G+ R +VAIKRLDK
Sbjct:   103 LEKSISPVADSLIRFSYRELLTATRNFSKRRVLGRGACSYVFKGRIGIWRKAVAIKRLDK 162

Query:   218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
             +DKES K+FCRELMIASSL+ PN+VPL+GFCIDP+QGLFL+YKYVSGGSLER LH+KKK 
Sbjct:   163 KDKESPKSFCRELMIASSLNSPNVVPLLGFCIDPDQGLFLVYKYVSGGSLERFLHDKKKK 222

Query:   278 VRGNS--TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                 +   LPWS RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLSS KIPKLCDFG
Sbjct:   223 KSRKTPLNLPWSTRYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSNKIPKLCDFG 282

Query:   336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
             LATWT+APSVPFLCKTVKGTFGYLAPEYFQHGK+SDKTDVYAFGVVLLEL+TGRKPIEAR
Sbjct:   283 LATWTAAPSVPFLCKTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEAR 342

Query:   396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRP 455
             R  GEENLV+WAKP+LHRG+ A EELLDPRLKCT +NS            C+ +EESRRP
Sbjct:   343 RPSGEENLVVWAKPLLHRGIEATEELLDPRLKCTRKNSASMERMIRAAAACVINEESRRP 402

Query:   456 GIEEIIAILRGEE--EL-IYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFE 512
             G++EI++IL+G E  EL    + KK N  GI+DCYPQLQ+TKSEMKSHL LAM+GV+EFE
Sbjct:   403 GMKEILSILKGGEGIELRTLSSRKKSNLPGIMDCYPQLQRTKSEMKSHLTLAMLGVTEFE 462

Query:   513 EDDHL 517
              DD L
Sbjct:   463 ADDLL 467

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
 Identities = 154/368 (41%), Positives = 220/368 (59%)

Query:   153 RKI-QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVA 211
             RK+ + LE      +++     Y E+++ T NFS    +G+G  S VF+G +   R  VA
Sbjct:   413 RKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRV-VA 471

Query:   212 IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 271
             +K L K+ ++    F  E+ I ++LHH NI+ L+GFC + +  L L+Y Y+S GSLE +L
Sbjct:   472 VKIL-KQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFE-DHNLLLVYNYLSRGSLEENL 529

Query:   272 HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL 331
             H  KK         WS RYKVA+G+AE++ YLHN   + V+HRD+K SNILLS    P+L
Sbjct:   530 HGNKKDPLA---FCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQL 586

Query:   332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
              DFGLA W S  +   +C  V GTFGYLAPEYF +GKV+DK DVYAFGVVLLELL+GRKP
Sbjct:   587 SDFGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKP 646

Query:   392 IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXX-CISSE 450
             I +   +G+E+LV+WAKPIL  G  +  +LLDP L+  + N+             CI   
Sbjct:   647 ISSGCPKGQESLVMWAKPILDDGKYS--QLLDPSLRDNNNNNDDQMQRMALAATLCIRRS 704

Query:   451 ESRRPGIEEIIAILRGEEELIYCTWKKHNFSGI-IDCYPQLQQTKSEMKSHLALAMVGVS 509
                RP +  ++ +L+G+E+ +    ++ N S    +     Q  +S ++SHL LA++ V 
Sbjct:   705 PQARPKMSIVLKLLKGDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDV- 763

Query:   510 EFEEDDHL 517
                EDD +
Sbjct:   764 ---EDDSI 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
 Identities = 145/365 (39%), Positives = 213/365 (58%)

Query:   156 QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL 215
             +++E   + ++ S    +Y E+++ T NF     +G+G  S VF+G +   R  VA+K L
Sbjct:   381 ENVEGLQARISTSCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGR-EVAVKIL 439

Query:   216 DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
              K  +   K F  E+ I ++LHH N++ L+G+C +    L L+Y Y+S GSLE +LH  K
Sbjct:   440 -KRTECVLKDFVAEIDIITTLHHKNVISLLGYCFE-NNNLLLVYNYLSRGSLEENLHGNK 497

Query:   276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             K +       W+ RYKVA+GIAE++ YLHN   + V+HRD+K SNILLS    P+L DFG
Sbjct:   498 KDL---VAFRWNERYKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFG 554

Query:   336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
             LA W S  +   +C  V GTFGYLAPEYF +GK+++K DVYA+GVVLLELL+GRKP+ + 
Sbjct:   555 LAKWASESTTQIICSDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSE 614

Query:   396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRP 455
               + +++LV+WAKPIL        +LLD  L+    NS            CI      RP
Sbjct:   615 SPKAQDSLVMWAKPILDD--KEYSQLLDSSLQ-DDNNSDQMEKMALAATLCIRHNPQTRP 671

Query:   456 GIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTK---SEMKSHLALAMVGVSEFE 512
              +  ++ +L+G+ E++   W K   S  ++    L+  K   S ++SHL LA + +    
Sbjct:   672 TMGMVLELLKGDVEML--KWAKLQVSNPLEDSMLLKDEKLRRSNLQSHLNLAFLDM---- 725

Query:   513 EDDHL 517
             EDD L
Sbjct:   726 EDDSL 730

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 3.9e-60, P = 3.9e-60
 Identities = 145/350 (41%), Positives = 203/350 (58%)

Query:   167 NSLIRL-SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
             +S  RL +Y E+L+ T NF+   ++G G  S+V++G +   R  +A+K L K   +  K 
Sbjct:   344 SSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGR-ELAVKIL-KPCLDVLKE 401

Query:   226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
             F  E+ + +S+HH NIV L GFC +    L L+Y Y+  GSLE +LH  +K  +      
Sbjct:   402 FILEIEVITSVHHKNIVSLFGFCFE-NNNLMLVYDYLPRGSLEENLHGNRKDAK---KFG 457

Query:   286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
             W  RYKVA+G+AE++ YLHN  +  V+HRD+K SN+LL+    P+L DFG A+  S+ S 
Sbjct:   458 WMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASSTSQ 517

Query:   346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
                   + GTFGYLAPEYF HGKV+DK DVYAFGVVLLEL++GRKPI   + +G+E+LVL
Sbjct:   518 HVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQESLVL 577

Query:   406 WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILR 465
             WA PIL  G  A  +LLDP L+  + N             CI      RP I  ++ IL+
Sbjct:   578 WANPILDSGKFA--QLLDPSLENDNSNDLIEKLLLAATL-CIKRTPHDRPQIGLVLKILQ 634

Query:   466 GEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSEFEEDD 515
             GEEE     W K       D    L    + ++SH+ LA++ + +    D
Sbjct:   635 GEEEAT--EWGKQQVRASEDVSAYL----TNIESHINLALLDLEDDAASD 678

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 141/355 (39%), Positives = 205/355 (57%)

Query:   159 ERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK 217
             ++ +  +   + R  SY  +  AT +FS   ++G+G  + V+KG +   +  VA+K L  
Sbjct:   251 DKQLKDILKDINRWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGK-GVAVKILKP 309

Query:   218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
               KE+ K F  E+ I SSL H NI PL+G C+     L  +Y   S GSLE  L      
Sbjct:   310 SVKEAVKEFVHEVSIVSSLSHSNISPLIGVCVHYND-LISVYNLSSKGSLEETL------ 362

Query:   278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +G   L W  R K+A+G+ E++ YLHN     V+HRD+K SN+LLS +  P+L DFGL+
Sbjct:   363 -QGKHVLRWEERLKIAIGLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLS 421

Query:   338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
              W S      + + V GTFGYLAPEYF +GKVSDK DVYAFGVVLLEL++GR  I +   
Sbjct:   422 MWGSKSCRYTIQRDVVGTFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSP 481

Query:   398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGI 457
             +G+E+LV+WAKP++ +G A  +ELLDP +  T  +             C++   + RP I
Sbjct:   482 RGQESLVMWAKPMIEKGNA--KELLDPNIAGTF-DEDQFHKMVLAATHCLTRAATYRPNI 538

Query:   458 EEIIAILRGEEELI-YCTWKKHNFSGIID-CYPQLQQTKSEMKSHLALAMVGVSE 510
             +EI+ +LRGE+++  +   ++ +  G  D  YP      S  + HL+LAMV V +
Sbjct:   539 KEILKLLRGEDDVSKWVKIEEDDEDGFDDEVYPN-----SNTELHLSLAMVDVED 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 126/309 (40%), Positives = 174/309 (56%)

Query:   157 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
             SL  S++  A S+   +  E+  AT  FS  RVLG G    V++G +    T VA+K L 
Sbjct:   322 SLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMED-GTEVAVKLLT 380

Query:   217 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
             ++++   + F  E+ + S LHH N+V L+G CI+      LIY+ V  GS+E HLHE   
Sbjct:   381 RDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRC-LIYELVHNGSVESHLHE--- 436

Query:   277 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                   TL W  R K+ALG A  +AYLH  +   V+HRD K SN+LL     PK+ DFGL
Sbjct:   437 -----GTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGL 491

Query:   337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
             A   +  S   +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGR+P++  +
Sbjct:   492 AREATEGS-QHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQ 550

Query:   397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPG 456
               GEENLV WA+P+L      +E+L+DP L  T  N             C+  E S RP 
Sbjct:   551 PSGEENLVTWARPLL-ANREGLEQLVDPALAGTY-NFDDMAKVAAIASMCVHQEVSHRPF 608

Query:   457 IEEIIAILR 465
             + E++  L+
Sbjct:   609 MGEVVQALK 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 122/324 (37%), Positives = 180/324 (55%)

Query:   143 CDSRAQELKWRKIQSLERSISPVANSLIR--LSYGEILAATHNFSKGRVLGRGALSFVFK 200
             C     E K R   SL  S S  ++ ++    ++ E+  AT NF K  ++G G    V+K
Sbjct:    31 CSVSTSE-KSRAKSSLSESKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYK 89

Query:   201 GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK 260
             G +     + AIK+LD    + ++ F  E+++ S LHHPN+V L+G+C D +Q L L+Y+
Sbjct:    90 GYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYE 148

Query:   261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN 320
             Y+  GSLE HLH+   G      L W+ R K+A G A+ + YLH+ T   V++RD+K SN
Sbjct:   149 YMPLGSLEDHLHDISPG---KQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSN 205

Query:   321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGV 380
             ILL     PKL DFGLA          +   V GT+GY APEY   G+++ K+DVY+FGV
Sbjct:   206 ILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 265

Query:   381 VLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXX 440
             VLLE++TGRK I++ R  GE+NLV WA+P L +      ++ DP L+             
Sbjct:   266 VLLEIITGRKAIDSSRSTGEQNLVAWARP-LFKDRRKFSQMADPMLQ-GQYPPRGLYQAL 323

Query:   441 XXXXXCISSEESRRPGIEEIIAIL 464
                  C+  + + RP I +++  L
Sbjct:   324 AVAAMCVQEQPNLRPLIADVVTAL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 556 (200.8 bits), Expect = 9.6e-53, P = 9.6e-53
 Identities = 127/314 (40%), Positives = 181/314 (57%)

Query:   157 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
             S E SI+P   S    +  EI+ AT+NF + RVLG G    V++G V    T VA+K L 
Sbjct:   696 SFESSIAPFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEG-VFDDGTKVAVKVLK 754

Query:   217 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
             ++D++ S+ F  E+ + S LHH N+V L+G CI+ ++   L+Y+ +  GS+E HLH    
Sbjct:   755 RDDQQGSREFLAEVEMLSRLHHRNLVNLIGICIE-DRNRSLVYELIPNGSVESHLH---- 809

Query:   277 GV-RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             G+ + +S L W  R K+ALG A  +AYLH  +   V+HRD K SNILL +   PK+ DFG
Sbjct:   810 GIDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFG 869

Query:   336 LA-TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
             LA           +   V GTFGY+APEY   G +  K+DVY++GVVLLELLTGRKP++ 
Sbjct:   870 LARNALDDEDNRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 929

Query:   395 RRLQGEENLVLWAKPILH--RGMAAV-EELLDPRLKCTSRNSXXXXXXXXXXXXCISSEE 451
              +  G+ENLV W +P L    G+AA+ ++ L P +   S               C+  E 
Sbjct:   930 SQPPGQENLVSWTRPFLTSAEGLAAIIDQSLGPEISFDS-----IAKVAAIASMCVQPEV 984

Query:   452 SRRPGIEEIIAILR 465
             S RP + E++  L+
Sbjct:   985 SHRPFMGEVVQALK 998

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 521 (188.5 bits), Expect = 1.4e-52, Sum P(2) = 1.4e-52
 Identities = 119/308 (38%), Positives = 172/308 (55%)

Query:   165 VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 224
             +  S I  +Y E+   T  F K  V+G G    V+KG +      VAIK+L     E  +
Sbjct:   351 IGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKG-ILFEGKPVAIKQLKSVSAEGYR 409

Query:   225 AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 284
              F  E+ I S +HH ++V LVG+CI  EQ  FLIY++V   +L+ HLH K   V     L
Sbjct:   410 EFKAEVEIISRVHHRHLVSLVGYCIS-EQHRFLIYEFVPNNTLDYHLHGKNLPV-----L 463

Query:   285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
              WS R ++A+G A+ +AYLH      ++HRDIK SNILL  +   ++ DFGLA       
Sbjct:   464 EWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQ 523

Query:   345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 404
                +   V GTFGYLAPEY   GK++D++DV++FGVVLLEL+TGRKP++  +  GEE+LV
Sbjct:   524 -SHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582

Query:   405 LWAKPILHRGMAA--VEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIA 462
              WA+P L   +    + E++DPRL+     S            C+     +RP + +++ 
Sbjct:   583 EWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAAS-CVRHSALKRPRMVQVVR 641

Query:   463 ILRGEEEL 470
              L   ++L
Sbjct:   642 ALDTRDDL 649

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	520
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-40
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-32
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-24
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-17
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-15
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (436), Expect = 2e-50
 Identities = 75/199 (37%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G    V+  +       VAIK + KED  S      RE+ I   L+HPNIV L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
            D    L+L+ +Y  GGSL+  L E +        L      ++ L I E + YLH    
Sbjct: 61  EDENH-LYLVMEYCEGGSLKDLLKENEGK------LSEDEILRILLQILEGLEYLH---S 110

Query: 309 RCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH- 366
             ++HRD+KP NILL S     KL DFGL+      S   L KT+ GT  Y+APE     
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGK 168

Query: 367 GKVSDKTDVYAFGVVLLEL 385
           G  S+K+D+++ GV+L EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  168 bits (428), Expect = 9e-49
 Identities = 71/230 (30%), Positives = 102/230 (44%), Gaps = 20/230 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +     LG G+   V+  +       VAIK + K+  K+  +   RE+ I   L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L     D ++ L+L+ +Y  GG L   L ++ +       L           I  ++ Y
Sbjct: 61  RLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGR-------LSEDEARFYLRQILSALEY 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    + +VHRD+KP NILL      KL DFGLA             T  GT  Y+APE
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPE 166

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
                      D+++ GV+L ELLTG+ P       G++ L+   K I  
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGK 211

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (416), Expect = 6e-47
 Identities = 86/281 (30%), Positives = 124/281 (44%), Gaps = 31/281 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNI 241
           +   R LG G+   V+K K       VA+K L K  ++S K     RE+ I   L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+    D +  L+L+ +Y  GG L  +L            L      K+AL I   + 
Sbjct: 61  VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGP-------LSEDEAKKIALQILRGLE 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YLH      ++HRD+KP NILL    + K+ DFGLA      S      T  GT  Y+AP
Sbjct: 113 YLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAP 167

Query: 362 EYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           E    G     K DV++ GV+L ELLTG+ P              ++   +   +  +  
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPP--------------FSGENILDQLQLIRR 213

Query: 421 LLDPRLKCTSRNSAQIAR-VIQAAAACISSEESRRPGIEEI 460
           +L P L+      +  +         C++ + S+RP  EEI
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  157 bits (399), Expect = 1e-44
 Identities = 73/212 (34%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +++G +LGRG+   V+          +A+K   L  + +E  +A  RE+ I SSL HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV   G   D E+    I+ +YVSGGSL   L +  K       LP  V  K    I E 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-------LPEPVIRKYTRQILEG 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           +AYLH      +VHRDIK +NIL+ S  + KL DFG A             +V+GT  ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE  +  +     D+++ G  ++E+ TG+ P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (399), Expect = 2e-44
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 185 SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHP 239
           + G+ LG GA   V+KG            VA+K L ++  ++  + F RE  I   L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L+G C + E  L ++ +Y+ GG L  +L + +        L  S     AL IA  
Sbjct: 62  NIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNR-----PKELSLSDLLSFALQIARG 115

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGY 358
           + YL     +  +HRD+   N L+    + K+ DFGL+                K    +
Sbjct: 116 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG--KLPIRW 170

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           +APE  + GK + K+DV++FGV+L E+ T G +P
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  156 bits (396), Expect = 4e-44
 Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 21/215 (9%)

Query: 185 SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHH 238
           + G+ LG GA   V+KGK     G  +  VA+K L KED      + F RE  I   L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PN+V L+G C + E  L+++ +Y+ GG L  +L + +        L  S     AL IA 
Sbjct: 61  PNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 357
            + YL     +  +HRD+   N L+    + K+ DFGL+                K    
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG--KLPIR 168

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           ++APE  + GK + K+DV++FGV+L E+ T G +P
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  155 bits (395), Expect = 7e-44
 Identities = 83/288 (28%), Positives = 127/288 (44%), Gaps = 36/288 (12%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIV 242
           + LG GA   V+KGK+       T VA+K L KED      K F +E  +   L HPN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN--STLPWSVRYKVALGIAESV 300
            L+G C + E  L+L+ +Y+ GG L  +L + +        STL        A+ IA+ +
Sbjct: 60  RLLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GY 358
            YL     +  VHRD+   N L+    + K+ DFGL+         +  K   G     +
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--DDDYYRKKTGGKLPIRW 173

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA 417
           +APE  + G  + K+DV++FGV+L E+ T G  P     L  EE         L +G   
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG--LSNEE-----VLEYLRKGY-- 224

Query: 418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                  RL        ++  ++    +C   +   RP   E++  L 
Sbjct: 225 -------RLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  145 bits (368), Expect = 4e-40
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 59/299 (19%)

Query: 184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 238
              G+ LG GA   V+KG +        T VA+K L +   +E  + F  E  I   L H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L+G C    + L+++ +Y+ GG L   L +          L      ++AL IA+
Sbjct: 61  PNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMALQIAK 113

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL     +  VHRD+   N L++   + K+ DFGL+            + +     Y
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLS------------RDIYEDDYY 158

Query: 359 ------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
                       +APE  + GK + K+DV++FGV+L E+ T G +P              
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------------- 204

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
           +        +  +E+    RL        ++  ++     C + +   RP   E++  L
Sbjct: 205 YPGMSNEEVLELLED--GYRLPRPENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  134 bits (337), Expect = 8e-35
 Identities = 91/292 (31%), Positives = 134/292 (45%), Gaps = 30/292 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSL-HH 238
           ++   R LG G+   V+  +    R  VA+K L K+ +  SK    F RE+ I +SL H 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L  F  D    L+L+ +YV GGSLE  L +  +       L  S    +   I  
Sbjct: 58  PNIVKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGR----KGPLSESEALFILAQILS 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW----TSAPSVPFLCKTVK 353
           ++ YLH    + ++HRDIKP NILL    ++ KL DFGLA       S  S+P L  T  
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 354 GTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
           GT GY+APE          S  +D+++ G+ L ELLTG  P E  +     +  L  K I
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL--KII 227

Query: 411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
           L     ++   L P        S   + +++     ++ +   R      ++
Sbjct: 228 LELPTPSLASPLSPSNPEL--ISKAASDLLK---KLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (321), Expect = 2e-33
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 36/281 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFC-RELMIASSLHHPNIVPLV 245
           + +G+G+   V+  +         +K +D     E  +     E+ I   L+HPNI+   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG---NSTLPWSVRYKVALGIAESVAY 302
               + +  L ++ +Y  GG L + + ++KK  +       L W V+      +  ++ Y
Sbjct: 66  ESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    R ++HRDIKP NI L+S  + KL DFG++   S+     L KTV GT  YL+PE
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPE 173

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
             Q+   + K+D+++ G VL EL T + P E   L     L L    IL           
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KILKGQYP------ 221

Query: 423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 463
                  S+ S+++  ++    + +  +   RP I +I+  
Sbjct: 222 ----PIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 3e-32
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 23/223 (10%)

Query: 184 FSKGRVLGRGALSFVFKG-------KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASS 235
             K +VLG GA   V+KG       KV +    VAIK L ++   +++K    E  + +S
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP++V L+G C      + LI + +  G L  ++   K  +     L W V+      
Sbjct: 66  VDHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------ 117

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           IA+ ++YL    E+ +VHRD+   N+L+ + +  K+ DFGLA         +  +  K  
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL 397
             ++A E   H   + K+DV+++GV + EL+T G KP E    
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  121 bits (305), Expect = 4e-31
 Identities = 80/222 (36%), Positives = 104/222 (46%), Gaps = 25/222 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           LG GA   V K ++       A+K      + +  K   REL I  S   P IV   G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 249 IDPEQG-LFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGIAESV----AY 302
           +D     + +  +Y  GGSL+    + KK+G R           KV   IAESV    +Y
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE--------KVLGKIAESVLKGLSY 120

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    R ++HRDIKPSNILL+ K   KLCDFG+    S   V  L  T  GT  Y+APE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYMAPE 173

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 404
             Q    S  +DV++ G+ LLE+   R P      +GE  L 
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP---EGEPPLG 212

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (303), Expect = 5e-31
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 13/208 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F     +G+G    V+K +       VAIK +  E KE  +    E+ I     HPNIV 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             G     +  L+++ ++ SGGSL+  L    +      TL  S    V   + + + YL
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYL 114

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H+     ++HRDIK +NILL+S    KL DFGL+    + +      T+ GT  ++APE 
Sbjct: 115 HS--NG-IIHRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKA--RNTMVGTPYWMAPEV 168

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                   K D+++ G+  +EL  G+ P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 3e-30
 Identities = 74/214 (34%), Positives = 115/214 (53%), Gaps = 21/214 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+  G ++GRGA   V+KG        VAIK++  E  +    K+  +E+ +  +L HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA--- 297
           IV  +G  I+    L++I +Y   GSL + +  KK G       P S+   VA+ +    
Sbjct: 61  IVKYIGS-IETSDSLYIILEYAENGSLRQII--KKFG-----PFPESL---VAVYVYQVL 109

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH   E+ V+HRDIK +NIL +   + KL DFG+AT  +  S      +V GT  
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPY 164

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           ++APE  +    S  +D+++ G  ++ELLTG  P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (285), Expect = 2e-28
 Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 26/212 (12%)

Query: 188 RVLGRGALSFVFK------GKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPN 240
             LG G    V K      GK+      +A+K +  E ++   K   REL I    + P 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKI------MAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV   G   +    + +  +Y+ GGSL++ L E +  +      P  +  K+A+ + + +
Sbjct: 61  IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRI------PERILGKIAVAVLKGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YLH   +  ++HRD+KPSNIL++S+   KLCDFG+    S   V  L KT  GT  Y+A
Sbjct: 114 TYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGV----SGQLVNSLAKTFVGTSSYMA 167

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  Q    S K+D+++ G+ L+EL TGR P 
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (275), Expect = 5e-27
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 25/221 (11%)

Query: 183 NFSKGRVLGRGALSFVFK------GKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASS 235
           +  + +VLG+G+   V+K      GK+       A+K++    D+E  K   REL    S
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKI------YALKKIHVDGDEEFRKQLLRELKTLRS 55

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
              P +V   G      + + ++ +Y+ GGSL   L +K   +      P  V   +A  
Sbjct: 56  CESPYVVKCYGAFYKEGE-ISIVLEYMDGGSLAD-LLKKVGKI------PEPVLAYIARQ 107

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I + + YLH  T+R ++HRDIKPSN+L++SK   K+ DFG++           C T  GT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGT 163

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
             Y++PE  Q    S   D+++ G+ LLE   G+ P     
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (270), Expect = 2e-26
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 19/226 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHP 239
           +F   RV+G+GA   V   +    +   A+K ++K+    K S +    E  I   L+HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 240 NIVPL-VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            +V L   F    E+ ++L+   + GG L  HL +K K           V++ +   I  
Sbjct: 61  FLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKFWIC-EIVL 111

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           ++ YLH    + ++HRDIKP NILL  +    + DF +AT  +  +   L  +  GT GY
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV 404
           +APE       S   D ++ GV   E L G++P         + + 
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  106 bits (266), Expect = 8e-26
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E+ I   L HPNIV      ID   Q L+++ +Y  GG L + +   +K  +    +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEE 105

Query: 288 VRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
             +++   +  ++   HN +     V+HRD+KP+NI L +    KL DFGLA        
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--KILGHD 163

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
               KT  GT  Y++PE   H    +K+D+++ G ++ EL     P  AR       L L
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-----NQLQL 218

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
            +K         ++E    R+    R S+++  VI+   + ++ +  +RP  EE++
Sbjct: 219 ASK---------IKEGKFRRIP--YRYSSELNEVIK---SMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 8e-26
 Identities = 73/214 (34%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 190 LGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHPNI 241
           LG+G  SF   GKV L+R   T    A+K L K+    ++  +    E  I S ++HP I
Sbjct: 1   LGKG--SF---GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L  +    E+ L+L+ +Y  GG L  HL +      G  +   +  Y  A  I  ++ 
Sbjct: 56  VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSK-----EGRFSEERARFY--AAEIVLALE 107

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YLH+     +++RD+KP NILL +    KL DFGLA      S      T  GT  YLAP
Sbjct: 108 YLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAP 162

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           E           D ++ GV+L E+LTG+ P  A 
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (263), Expect = 3e-25
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 37/234 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSL 236
            +F  G+++G G+ S V   K        AIK LDK     E K   K    E  + + L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRL 58

Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             HP I+ L     D E  L+ + +Y   G L +++ +      G+     +  Y  A  
Sbjct: 59  NGHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFY--AAE 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-- 353
           I  ++ YLH+   + ++HRD+KP NILL      K+ DFG A      S P   K     
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 354 ----------------GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                           GT  Y++PE          +D++A G ++ ++LTG+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  108 bits (272), Expect = 7e-25
 Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 36/282 (12%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+ RG     +KGK         +K ++  +   S            L HPNIV L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLC 752

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              E+G +LI++Y+ G +L   L            L W  R K+A+GIA+++ +LH    
Sbjct: 753 -RSEKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIGIAKALRFLHCRCS 801

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYLAPEYFQH 366
             VV  ++ P  I++  K  P L         S P +  LC   K      Y+APE  + 
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-------LSLPGL--LCTDTKCFISSAYVAPETRET 852

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK---PILHRGMAAVEELLD 423
             +++K+D+Y FG++L+ELLTG+ P +A       ++V WA+      H  M      +D
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDM-----WID 906

Query: 424 PRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
           P ++   S N  +I  V+  A  C +++ + RP   +++  L
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (252), Expect = 5e-24
 Identities = 60/188 (31%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 211 AIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           A+K  R+   D ++ K    E+ +   L HPN+V   G  +  E+ +++  +Y SGG+LE
Sbjct: 29  AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFMEYCSGGTLE 87

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +        L   V     L + E +AYLH      +VHRDIKP+NI L    +
Sbjct: 88  ELLEHGR-------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGV 137

Query: 329 PKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHGKVSDK---TDVYAFGVVLL 383
            KL DFG A      +       +++ GT  Y+APE    GK        D+++ G V+L
Sbjct: 138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197

Query: 384 ELLTGRKP 391
           E+ TG++P
Sbjct: 198 EMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (252), Expect = 5e-24
 Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 26/221 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS--VAIKR--LDKEDKESSKAFCRELM----IASS 235
           ++KG VLG+GA   V+    GL      +A+K+  LD  +  +++    +L     +  S
Sbjct: 2   WTKGEVLGKGAYGTVY---CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV  +G C+D +  + +  ++V GGS+   L   + G      LP  V  K    
Sbjct: 59  LKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSIL--NRFG-----PLPEPVFCKYTKQ 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAP-SVPFLCKT 351
           I + VAYLHN    CVVHRDIK +N++L    I KL DFG A    W     +   + K+
Sbjct: 111 ILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           + GT  ++APE         K+D+++ G  + E+ TG+ P+
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 8e-24
 Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 26/211 (12%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
            G  +G+G    V  G        VA+K L K+D  +++AF  E  + ++L HPN+V L+
Sbjct: 10  LGATIGKGEFGDVMLGD--YRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLL 66

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G  +     L+++ +Y++ GSL  +L       RG + +  + +   AL + E + YL  
Sbjct: 67  GVVLQ-GNPLYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDVCEGMEYLE- 119

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS----APSVPFLCKTVKGTFGYLAP 361
             E+  VHRD+   N+L+S   + K+ DFGLA   S    +  +P     VK T    AP
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-----VKWT----AP 168

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E  +  K S K+DV++FG++L E+ + GR P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 73/212 (34%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            R LG G    V+ G      T VA+K L K    S +AF +E  I   L H  +V L  
Sbjct: 11  ERKLGAGQFGEVWMG-TWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C + E  ++++ +Y+S GSL   L   K G      LP  V   +A  IAE +AYL   
Sbjct: 69  VCSEEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLV--DMAAQIAEGMAYLE-- 120

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 360
             R  +HRD+   NIL+    + K+ DFGLA       +T+     F    +K T    A
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF---PIKWT----A 172

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE   +G+ + K+DV++FG++L E++T GR P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 40/294 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           + LG G    V   +   L  +    VA+K L+   +E  ++ F RE+ I  +L H NIV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 243 PLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
              G C  P  + L LI +Y+  GSL  +L   +  +     L   + +  +  I + + 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLKRL---LLF--SSQICKGMD 123

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYL 359
           YL +   +  +HRD+   NIL+ S+ + K+ DFGLA         +  K    +  F Y 
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL----HRGM 415
           APE  +  K S  +DV++FGV L EL T           G+ +    A+ +      +G 
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGIAQGQ 229

Query: 416 AAVEELLD-----PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
             V  LL+      RL        ++  +++    C  +E   RP   ++I I+
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           + +  R LG GA   V++G             VA+K L +   E  ++ F  E +I S  
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           +H NIV L+G   +     F++ + ++GG L+  L E +      S+L        A  +
Sbjct: 67  NHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVK 353
           A+   YL    E   +HRDI   N LL+ K   ++ K+ DFG+A            + + 
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA------------RDIY 170

Query: 354 GTFGY------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
               Y            + PE F  G  + KTDV++FGV+L E+ + G  P   R  Q
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 36/281 (12%)

Query: 186 KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 240
           K ++LG G    V KG    +   ++  VAIK + D+  +++ +     ++   SL H  
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C  P   L L+ +    GSL  H+ + +  +     L W V+      IA+ +
Sbjct: 71  IVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    E  +VHR++   NILL S  I ++ DFG+A         +     K    ++A
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
            E    G+ + ++DV+++GV + E+++ G +P    R     +L       L +G    E
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKG----E 228

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
            L  P++ CT         V      C   +E+ RP  +E+
Sbjct: 229 RLAQPQI-CT-------IDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 25/220 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIAS 234
           ++   RVLG+GA      G+  L R +     V  K ++      KE   A   E++I S
Sbjct: 1   HYIPIRVLGKGAF-----GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILS 54

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HPNI+      +D +  L +  +Y +GG+L   +  +K  +     + W        
Sbjct: 55  LLQHPNIIAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLF 108

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I  +V+Y+H   +  ++HRDIK  NI L+   + KL DFG++      S   + +TV G
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVG 163

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           T  Y++PE  Q  K + K+D++A G VL ELLT ++  +A
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G ++G G    V +G+    + +V   + D     +++AF  E  + + LHH N+V L+G
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             +    GL+++ + +S G+L   L       RG + +      + +L +AE + YL + 
Sbjct: 67  VIL--HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
             + +VHRD+   NIL+S   + K+ DFGLA               K    + APE  +H
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLAR-----VGSMGVDNSKLPVKWTAPEALKH 171

Query: 367 GKVSDKTDVYAFGVVLLELLT-GRKP 391
            K S K+DV+++GV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 16/209 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   LG G    V+K +       VA+K  RLD E++       RE+ +   L HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+       + L+L+++Y     L+++L ++   +  N      ++  +   +   +A
Sbjct: 61  VKLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGPLSPNL-----IKS-IMYQLLRGLA 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           Y H      ++HRD+KP NIL++   + KL DFGLA     P   +  + V  T  Y AP
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167

Query: 362 EYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
           E     K      D+++ G +  E++TG+
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 76/228 (33%), Positives = 103/228 (45%), Gaps = 51/228 (22%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCRELMIAS 234
           +F   + LG G  SF   G+V L+R        A+K L K      K       E  I  
Sbjct: 2   DFEFIKTLGTG--SF---GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KV 292
           S+ HP +V L G   D    L+L+ +YV GG L  HL  +K G       P +  Y  +V
Sbjct: 57  SIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHL--RKSG---RFPEPVARFYAAQV 110

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVP 346
            L +     YLH+     +V+RD+KP N+LL S    K+ DFG A      T+T      
Sbjct: 111 VLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------ 157

Query: 347 FLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
            LC    GT  YLAPE      +GK     D +A G+++ E+L G  P
Sbjct: 158 -LC----GTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 69/212 (32%), Positives = 105/212 (49%), Gaps = 20/212 (9%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSLHHPN 240
           KG +LG G+   V++G         A+K +      +  +E+ K   +E+ + S L HPN
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV  +G   + E  L++  + V GGSL + L  KK G     + P  V       I   +
Sbjct: 64  IVQYLGTERE-EDNLYIFLELVPGGSLAKLL--KKYG-----SFPEPVIRLYTRQILLGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YLH+   R  VHRDIK +NIL+ +  + KL DFG+A      S     K+ KG+  ++A
Sbjct: 116 EYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMA 169

Query: 361 PEYF-QHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE   Q G      D+++ G  +LE+ TG+ P
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 36/284 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
            + K RV+GRGA   V   +    +  V IK++  E   K+   A   E  +   L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 241 IVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           I+     F  D  + L ++ +Y  GG+L  ++ +     R NS L         + I  +
Sbjct: 61  IIEYYENFLED--KALMIVMEYAPGGTLAEYIQK-----RCNSLLDEDTILHFFVQILLA 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           + ++H    + ++HRD+K  NILL   K + K+ DFG++   S+ S  +   TV GT  Y
Sbjct: 114 LHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCY 167

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 418
           ++PE  +    + K+D++A G VL EL + ++  EA       NL      I+    A +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANLPALVLKIMSGTFAPI 221

Query: 419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
            +   P L+             Q   + ++ + S+RP + +I+A
Sbjct: 222 SDRYSPDLR-------------QLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           V+G GA   V K +       VAIK+    ++D++  K   RE+ +   L H NIV L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
                +  L+L+++YV    LE  L     G+      P +VR      + +++AY H +
Sbjct: 68  AFRR-KGRLYLVFEYVERTLLE-LLEASPGGLP-----PDAVR-SYIWQLLQAIAYCHSH 119

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE--- 362
                ++HRDIKP NIL+S   + KLCDFG A    A     L   V  T  Y APE   
Sbjct: 120 N----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174

Query: 363 -YFQHGKVSDKTDVYAFGVVLLELLTGR 389
               +GK     DV+A G ++ ELL G 
Sbjct: 175 GDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 34/283 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHP 239
           +F   + LG+G+   V+K K        A+K +D      KE   A   E+ I +S++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+      +D  + L ++ +Y   G L + + ++KK  +    +P    +++ + +   
Sbjct: 60  NIISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRK---LIPEQEIWRIFIQLLRG 115

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           +  LH   E+ ++HRD+K +NILL +  + K+ D G++          + KT  GT  Y+
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYM 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE ++    S K+D+++ G +L E+ T   P EAR +Q     V        RG     
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKY--- 218

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
               P +      S  +   I+   + +  +   RP  ++I+A
Sbjct: 219 ----PPI--PPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 20/201 (9%)

Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVG-FCID 250
           G++S V     G   T +A K +    K S  K   REL I      P IV   G F  +
Sbjct: 19  GSVSKVKHIPTG---TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75

Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
               + +  +++  GSL+R    KK G      +P  +  K+A+ + E + YL+N     
Sbjct: 76  NN--ICMCMEFMDCGSLDRIY--KKGG-----PIPVEILGKIAVAVVEGLTYLYN--VHR 124

Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           ++HRDIKPSNIL++S+   KLCDFG+    S   +  +  T  GT  Y++PE  Q GK +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 371 DKTDVYAFGVVLLELLTGRKP 391
            K+DV++ G+ ++EL  G+ P
Sbjct: 181 VKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 24/216 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 73  R-EPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KK 123

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 176

Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
             + K S K+DV+AFGV+L E+ T G  P     L 
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + +G+G    V    +G  R   VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 12  QTIGKGEFGDVM---LGDYRGNKVAVKCI-KNDA-TAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN 121

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
                VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  + 
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 173

Query: 367 GKVSDKTDVYAFGVVLLELLT-GRKP 391
            K S K+DV++FG++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 45/286 (15%)

Query: 190 LGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           LG G    V KG           VA+K L +E   + K  F RE  + + L HP IV L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C      L L+ +    G L ++L       +    +P S   ++A  +A  +AYL  
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYL-------KKRREIPVSDLKELAHQVAMGMAYLE- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 364
              +  VHRD+   N+LL ++   K+ DFG++    A S  +   T  +    + APE  
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE--EL 421
            +GK S K+DV+++GV L E  + G KP                    +  M   E   +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP--------------------YGEMKGAEVIAM 210

Query: 422 LDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           L+   RL        +I  ++    +C       RP   E+ +  R
Sbjct: 211 LESGERLPRPEECPQEIYSIML---SCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 27/211 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + LG G    V  GK    +  VAIK + +E   S   F  E  +   L HPN+V L G
Sbjct: 9   LKELGSGQFGVVHLGK-WRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 247 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
            C   +Q  +F++ +Y++ G L  +L E+K  +     L       +   + E++ YL  
Sbjct: 67  VCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL------DMCSDVCEAMEYLE- 117

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYL 359
                 +HRD+   N L+    + K+ DFGLA       +TS+    F  K       + 
Sbjct: 118 --SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK-------WA 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRK 390
            PE F + + S K+DV++FGV++ E+ +  K
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 48/236 (20%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
            + KG+ LG G  + V+K +       VAIK++   +++ +K      A  RE+ +   L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQEL 59

Query: 237 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-- 293
            HPNI+ L+  F       + L+++++    LE+ + +K            S+    A  
Sbjct: 60  KHPNIIGLLDVFGHK--SNINLVFEFMET-DLEKVIKDK------------SIVLTPADI 104

Query: 294 ----LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
               L     + YLH+     ++HRD+KP+N+L++S  + KL DFGLA    +P+     
Sbjct: 105 KSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 350 KTVKGTFGYLAPEYF-----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
           + V  T  Y APE           V    D+++ G +  ELL  R P     L G+
Sbjct: 162 QVV--TRWYRAPELLFGARHYGVGV----DMWSVGCIFAELLL-RVPF----LPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 94.4 bits (234), Expect = 2e-21
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)

Query: 188 RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 73  RLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG- 246
           V+G GA + V+          VAIKR+D E  ++S     +E+   S  +HPN+V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
           F +  E  L+L+  Y+SGGSL   L   K        L  ++   V   + + + YLH N
Sbjct: 68  FVVGDE--LWLVMPYLSGGSL---LDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTFGYLAPEY 363
           G     +HRDIK  NILL      K+ DFG++   +        + KT  GT  ++APE 
Sbjct: 122 GQ----IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 364 F-QHGKVSDKTDVYAFGVVLLELLTGRKP 391
             Q      K D+++FG+  +EL TG  P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 74/263 (28%), Positives = 110/263 (41%), Gaps = 40/263 (15%)

Query: 190 LGRGALSFVFKGK---VGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPL 244
           LG G+   V +G+    G     VA+K L K DK  +    F +E  I  SL H N++ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G  +     L ++ +    GSL   L +   G         S     A+ IA  + YL 
Sbjct: 62  YGVVLTHP--LMMVTELAPLGSLLDRLRKDALGH-----FLISTLCDYAVQIANGMRYLE 114

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--------WTSAPS--VPFLCKTVKG 354
             ++R + HRD+   NILL+S    K+ DFGL          +       VP        
Sbjct: 115 --SKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-------- 163

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENL--VLWAKPIL 411
            F + APE  +    S  +DV+ FGV L E+ T G +P       G + L  +      L
Sbjct: 164 -FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--GSQILKKIDKEGERL 220

Query: 412 HRGMAAVEELLDPRLKCTSRNSA 434
            R  A  +++ +  L+C + N A
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPA 243

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 6e-21
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G    V+K +       VA+K  R++ E +       RE+ +   L HPNIV L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 248 CIDPEQG-LFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +G ++++++Y+     G L+    +         T    ++      + E + YL
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--------FTES-QIKC-YMKQLLEGLQYL 116

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
           H+     ++HRDIK SNIL+++  + KL DFGLA  +T   S  +  + +  T  Y  PE
Sbjct: 117 HS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPE 171

Query: 363 YFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGE 400
                     + D+++ G +L EL  G KPI     QG 
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLG-KPI----FQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVG 246
             +G+G    V+KG +    T VA+K          K  F +E  I     HPNIV L+G
Sbjct: 1   EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C+  +Q ++++ + V GGSL   L +KK  +     L      +++L  A  + YL + 
Sbjct: 60  VCVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL------QMSLDAAAGMEYLES- 111

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
             +  +HRD+   N L+    + K+ DFG++               +    + APE   +
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 367 GKVSDKTDVYAFGVVLLELLTG 388
           G+ + ++DV+++G++L E  + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 91.9 bits (228), Expect = 7e-21
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLH 237
            +   + +G G+   ++  K         IK +D       +KE+SK   +E+++ + + 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMK 57

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTLPWSVRYKVALG 295
           HPNIV            LF++ +Y  GG L + +  +++GV    +  L W V  +++LG
Sbjct: 58  HPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFV--QISLG 113

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           +     ++H   +R ++HRDIK  NI LS    + KL DFG+A   +      L  T  G
Sbjct: 114 LK----HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVG 164

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
           T  YL+PE  Q+   ++KTD+++ G VL EL T + P E   L 
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.4 bits (227), Expect = 8e-21
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 190 LGRGALSFVFK------GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G+G+   VFK       +V  ++  + + ++++ ++E +     E  + + L    I+ 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMK-QIDLSKMNRREREEA---IDEARVLAKLDSSYIIR 63

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +D +  L ++ +Y   G L + L   ++G        W    ++ LG+A    +L
Sbjct: 64  YYESFLD-KGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H+   + ++HRDIK  N+ L +    K+ D G+A   S  +      T+ GT  YL+PE 
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPEL 172

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
            +    ++K+DV+A GVVL E  TG+ P +A
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            F K   +G G    V++ +       VA+K  R+D E      +  RE+ +  +L HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 241 IVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV-RYK-VAL 294
           IV L    VG  +D    +FL+ +Y      E+ L      +  N   P+S  + K + L
Sbjct: 68  IVELKEVVVGKHLD---SIFLVMEYC-----EQDL----ASLLDNMPTPFSESQVKCLML 115

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            +   + YLH   E  ++HRD+K SN+LL+ K   K+ DFGLA     P+ P   K V  
Sbjct: 116 QLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-- 170

Query: 355 TFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
           T  Y APE            D++A G +L ELL   KP+
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)

Query: 183 NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           N+ +G++LG+GA   V+       G+  L    V       E K+   A   E+ +  +L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGR-ELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H  IV   G C+  ++ L +  +Y+ GGS++  L       +    L  +V  K    I
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-------KAYGALTETVTRKYTRQI 113

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKG 354
            E V YLH+     +VHRDIK +NIL  S    KL DFG +    T   S   + K+V G
Sbjct: 114 LEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSVTG 169

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  +++PE         K DV++ G  ++E+LT + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+  +    +  +AIK + + D    +    E+ + S L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G F I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH  
Sbjct: 75  S--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH-- 125

Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
            +  +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFG--TSKRLAGINPCTETFTGTLQYMAPEVID 182

Query: 366 HGK--VSDKTDVYAFGVVLLELLTGRKP 391
            G        D+++ G  ++E+ TG+ P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 188 RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +V+G G    V +G++ L       VAIK L     +  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +   + + +I +Y+  GSL++ L E       +          +  GIA  + YL
Sbjct: 70  LEG-VVTKSRPVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMKYL 122

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
              +E   VHRD+   NIL++S  + K+ DFGL+         +  K  K    + APE 
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE-- 420
             + K +  +DV++FG+V+ E+++ G +P               +       + AVE+  
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-----------MSN---QDVIKAVEDGY 225

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
            L P + C S        + Q    C   + + RP   +I++ L
Sbjct: 226 RLPPPMDCPS-------ALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 35/218 (16%)

Query: 189 VLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
            LGRG    VF  K          T V +K L K   E+ +  F REL +   L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C + E   ++I +Y   G L++ L   K         P S + KVAL   IA  +
Sbjct: 72  RLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY-- 358
            +L N      VHRD+   N L+SS++  K+            S+  L K V  +  Y  
Sbjct: 131 DHLSNAR---FVHRDLAARNCLVSSQREVKV------------SLLSLSKDVYNSEYYKL 175

Query: 359 ---------LAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
                    LAPE  Q    S K+DV++FGV++ E+ T
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 90.9 bits (225), Expect = 5e-20
 Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 24/193 (12%)

Query: 228 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +P 
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------IPE 102

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
            +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   + 
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLID 156

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQGEENL 403
            +  +  GT  Y++PE  Q    S ++D+++ G+ L+EL  GR PI   +A+ L+     
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA---- 212

Query: 404 VLWAKPILHRGMA 416
            ++ +P++     
Sbjct: 213 -IFGRPVVDGEEG 224

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 21/223 (9%)

Query: 188 RVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
             LG GA   V++G        G     VA+K L K   +  K  F +E  + S+ +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C+  E   ++I + + GG L  +L + +    G   L       + L +A+  
Sbjct: 61  IVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            YL    +   +HRD+   N L+S K     ++ K+ DFGLA         +  K  +G 
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--RDIYKSDYYRKEGEGL 174

Query: 356 FG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
               ++APE    GK + ++DV++FGV++ E+LT G++P  A 
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.9 bits (220), Expect = 7e-20
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+ G   L +  VAIK + +E   S + F  E  +   L HP +V L G C 
Sbjct: 12  IGSGQFGLVWLGY-WLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +    + L+++++  G L  +L   ++G     TL       + L + E +AYL      
Sbjct: 70  E-RSPICLVFEFMEHGCLSDYL-RAQRGKFSQETL-----LGMCLDVCEGMAYLE---SS 119

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
            V+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WSSPEV 172

Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
           F   K S K+DV++FGV++ E+ + G+ P E R
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHPNIVPLVG 246
           + +GA   VF  K        AIK + K D        +   E  I S    P +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
           +    ++ L+L+ +Y+ GG L   L     G      L   V       I  ++ YLH N
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE--NVGS-----LDEDVARIYIAEIVLALEYLHSN 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYL 359
           G    ++HRD+KP NIL+ S    KL DFGL+         +        K + GT  Y+
Sbjct: 113 G----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 360 APEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE      H K     D ++ G +L E L G  P
Sbjct: 169 APEVILGQGHSK---TVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 15/213 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           +++K   +G G    V+KG+       VA+K  RL+ E++       RE+ +   L HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L    +  E  L+LI++++S   L+++L    KG   ++ L  S  Y++  GI    
Sbjct: 61  IVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL--- 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            + H    R V+HRD+KP N+L+ +K + KL DFGLA     P   +  + V  T  Y A
Sbjct: 116 -FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRA 169

Query: 361 PEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPI 392
           PE      + S   D+++ G +  E+ T +KP+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           R LG G    V++G +    T VA+K L K      K F  E  I   L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
           C   E+ ++++ + +  GSL  +L            LP  +   +A  +A  +AYL    
Sbjct: 70  CTL-EEPIYIVTELMKYGSLLEYLQGGAGR---ALKLPQLI--DMAAQVASGMAYLE--- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 361
            +  +HRD+   N+L+    I K+ DFGLA       + +     F    +K T    AP
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---PIKWT----AP 173

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E   + + S K+DV++FG++L E++T GR P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 32/224 (14%)

Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVP 243
           LG GA   V+KG++      L  TSVAIK L +  + +  + F +E  + S L HPNIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTLPWSVRY----KVAL 294
           L+G C   EQ   ++++Y++ G L   L     H       G+ T+  S+       +A+
Sbjct: 73  LLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL------ATWTSAPSVPFL 348
            IA  + YL   +    VHRD+   N L+      K+ DFGL      A +    S   L
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                    ++ PE   +GK + ++D+++FGVVL E+ + G +P
Sbjct: 189 ------PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 240
           + K   +G G    V+K +  L    VAIK++ K   ES    K   RE+ +   L+HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAES 299
           I+ L+      +  L+L+++++          +  K ++     LP S+       + + 
Sbjct: 60  IIKLLD-VFRHKGDLYLVFEFM--------DTDLYKLIKDRQRGLPESLIKSYLYQLLQG 110

Query: 300 VAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           +A+ H +G    ++HRD+KP N+L++++ + KL DFGLA    +P  P+    V  T  Y
Sbjct: 111 LAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWY 164

Query: 359 LAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
            APE        S   D+++ G +  ELL+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 13/213 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F+  R LG G    V++G     R  VAIK L  +D    + F +E+     L H +++ 
Sbjct: 8   FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  +++I + +  GSL   L   +  V   ++L       +A  +AE +AYL
Sbjct: 67  LFAVCSVGEP-VYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYL 120

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
               E+  +HRD+   NIL+    + K+ DFGLA         +L    K  + + APE 
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEA 175

Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
             HG  S K+DV++FG++L E+ T G+ P    
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 243
           RV+G+G    V+ G +      +   A+K L++  D E  + F +E +I     HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVA 301
           L+G C+  E    ++  Y+  G L R+       +R  +  P +V+  +  G  +A+ + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL-RNF------IRSETHNP-TVKDLIGFGLQVAKGME 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYL 359
           YL     +  VHRD+   N +L      K+ DFGLA   +             K    ++
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLT 387
           A E  Q  K + K+DV++FGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 18/221 (8%)

Query: 177 ILAATHNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELM 231
           IL  T  F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + +S+ +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+  
Sbjct: 62  VMASVDNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ-- 117

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
               IA+ + YL    ER +VHRD+   N+L+ + +  K+ DFGLA    A    +  + 
Sbjct: 118 ----IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            K    ++A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 13/181 (7%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     E  + F RE+ I  SL H NIV   G C     + L L+ +Y+  GSL 
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + ++ +     L ++ +      I + + YL  G++R  VHRD+   NIL+ S+  
Sbjct: 96  DYLQKHRERLDHRKLLLYASQ------ICKGMEYL--GSKRY-VHRDLATRNILVESENR 146

Query: 329 PKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
            K+ DFGL          +  +    +  F Y APE     K S  +DV++FGVVL EL 
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205

Query: 387 T 387
           T
Sbjct: 206 T 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH--- 238
           + +  ++GRGA   V++GK       VA+K   LD  D + S    RE+ + S L     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQSQP 61

Query: 239 PNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           PNI    G +   P   L++I +Y  GGS+ R L +           P + +Y +++ I 
Sbjct: 62  PNITKYYGSYLKGPR--LWIIMEYAEGGSV-RTLMKAG---------PIAEKY-ISVIIR 108

Query: 298 E---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           E   ++ Y+H      V+HRDIK +NIL+++    KLCDFG+A             T  G
Sbjct: 109 EVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVG 163

Query: 355 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
           T  ++APE    GK  D K D+++ G+ + E+ TG  P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 16/177 (9%)

Query: 228 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L  KK G      +P 
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPE 98

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           ++  K+++ +   + YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   + 
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLID 152

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
            +  +  GT  Y++PE  Q    + ++D+++ G+ L+E+  GR PI     +  E +
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +VLG+G  SF   GKV L          A+K L K+    D +       + ++A +  H
Sbjct: 1   KVLGKG--SF---GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C   +  LF + +YV+GG L  H+    +        P +  Y  A  I  
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR-----FDEPRARFY--AAEIVL 107

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + +LH   ER +++RD+K  N+LL S+   K+ DFG+        V     T  GT  Y
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
           +APE   +       D +A GV+L E+L G+ P E      E+ L
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG---DDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 34/213 (15%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
            LG G+   V+K         VAIK +    +E  +   +E+ I      P IV   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYG-S 66

Query: 249 IDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
                 L+++ +Y   GS+        + L E++            + Y+   G+     
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKGLE---- 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGY 358
           YLH+      +HRDIK  NILL+ +   KL DFG++   T T A        TV GT  +
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-----NTVIGTPFW 165

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +APE  Q    ++K D+++ G+  +E+  G+ P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           N  K   +G GA   V+K         VAIK++    +        E++I     HPNIV
Sbjct: 23  NLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIV 78

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 +  ++ L+++ +Y+ GGSL   + +          +       V   + + + Y
Sbjct: 79  DYYDSYLVGDE-LWVVMEYMDGGSLTDIITQNFV------RMNEPQIAYVCREVLQGLEY 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+   + V+HRDIK  NILLS     KL DFG A   +         +V GT  ++APE
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPE 186

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G++ +E+  G  P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 61/189 (32%), Positives = 91/189 (48%), Gaps = 34/189 (17%)

Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLP 285
           CRE+ I   ++HPN+V       D    + ++ +++ GGSLE  H+              
Sbjct: 120 CREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHI-------------- 164

Query: 286 WSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
              ++   VA  I   +AYLH    R +VHRDIKPSN+L++S K  K+ DFG++   +  
Sbjct: 165 ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Query: 344 SVPFLCKTVKGTFGYLAPEY----FQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQ 398
             P  C +  GT  Y++PE       HG       D+++ GV +LE   GR P    R Q
Sbjct: 222 MDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-Q 278

Query: 399 GEENLVLWA 407
           G+     WA
Sbjct: 279 GD-----WA 282

Length = 353

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 48/300 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKED-KESSKAFCRELMIASS 235
           K RVLG G       GKV L             VA+K L +E  ++++  + +E+ I  +
Sbjct: 8   KIRVLGEGHF-----GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62

Query: 236 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H NIV   G C +   +GL LI +YV  GSL  +L + K  +        +     A 
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--------AQLLLFAQ 114

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-LCKTVK 353
            I E +AYLH+   +  +HRD+   N+LL + ++ K+ DFGLA         + + +   
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL--------VL 405
               + A E  +  K S  +DV++FGV L ELLT     ++   + EE +        V+
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
               +L RGM         RL C      ++  +++    C  +E   RP    +I IL+
Sbjct: 232 RLIELLERGM---------RLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 37/289 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL------DKEDKESSKAFCRELMIASSL 236
            + KG+ LG GA S  ++ +     T +A+K++        E +E  +A  +E+ + + L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 237 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +HP+I+ ++G  C D    LF+  ++++GGS+   L   K G    +     + Y     
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLS--KYGAFKEAV---IINY--TEQ 111

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSA--PSVPFLCKTV 352
           +   ++YLH   E  ++HRD+K +N+L+ S+ +  ++ DFG A   +A           +
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
            GT  ++APE  +  +     DV++ G V++E+ T + P  A +     +L L  K    
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASA 226

Query: 413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
               ++ E L P L+                  C+  +   RP   E++
Sbjct: 227 TTAPSIPEHLSPGLR-------------DVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 25/200 (12%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFCIDPEQG-LFLIYKYVSGGSL 267
           + I ++  +++E S+   +E+ + S++ HPNIV     F    E G L+++  Y  GG L
Sbjct: 33  INISKMSPKEREESR---KEVAVLSNMKHPNIVQYQESF---EENGNLYIVMDYCEGGDL 86

Query: 268 ERHLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 325
            + ++  ++GV    +  L W V+  +AL       ++H   +R ++HRDIK  NI L+ 
Sbjct: 87  YKKIN-AQRGVLFPEDQILDWFVQICLAL------KHVH---DRKILHRDIKSQNIFLTK 136

Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
               KL DFG+A   +  S   L +T  GT  YL+PE  ++   ++K+D++A G VL E+
Sbjct: 137 DGTIKLGDFGIARVLN--STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194

Query: 386 LTGRKPIEARRLQGEENLVL 405
            T +   EA  ++   NLVL
Sbjct: 195 CTLKHAFEAGNMK---NLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.6 bits (207), Expect = 6e-18
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 22/221 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V++G        + +VA+K        S +  F +E  I     HP+IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G   +    ++++ +    G L  +L   K       +L  +     +  ++ ++AY
Sbjct: 71  KLIGVITENP--VWIVMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L   ++R V HRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 123 LE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPE 178

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN 402
                + +  +DV+ FGV + E+L  G KP      QG +N
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP-----FQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.2 bits (216), Expect = 6e-18
 Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 21/200 (10%)

Query: 210 VAIK--RLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           VAIK  R D  ++E  +A F RE  + + L+HPNIV L+     P   LF +++YV G +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
           L   L     G      LP     ++ L + +++A  HN   + +VHRD+KP NI++S  
Sbjct: 66  LREVL--AADGA-----LPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 327 KI---PKLCDFGLATW---TSAPSVPFLCKT--VKGTFGYLAPEYFQHGKVSDKTDVYAF 378
            +    K+ DFG+ T         V  L +T  V GT  Y APE  +   V+  +D+YA+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 379 GVVLLELLTGRKPIEARRLQ 398
           G++ LE LTG++ ++   + 
Sbjct: 176 GLIFLECLTGQRVVQGASVA 195

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 70/226 (30%), Positives = 93/226 (41%), Gaps = 54/226 (23%)

Query: 189 VLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED------KESSKAFCRELMIASSLH 237
           VLGRG       GKV L          AIK L K D       ES     R    A+S  
Sbjct: 6   VLGRGHF-----GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALG 295
           HP +V L   C   E  +  + +Y +GG L  H+H          + P +V Y   V LG
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV------FSEPRAVFYAACVVLG 113

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK----- 350
           +     YLH   E  +V+RD+K  N+LL ++   K+ DFG            LCK     
Sbjct: 114 LQ----YLH---ENKIVYRDLKLDNLLLDTEGFVKIADFG------------LCKEGMGF 154

Query: 351 -----TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                T  GT  +LAPE       +   D +  GV++ E+L G  P
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 68/286 (23%), Positives = 135/286 (47%), Gaps = 28/286 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D  D ++     +E+ +   L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 63  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPEKTVWKYFVQLCSA 118

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYM 173

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           +PE       + K+D+++ G +L E+   + P    ++    NL    K I        E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI--------E 221

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           +   P L  +   S ++ +++     CI+ +  +RP I  +  + +
Sbjct: 222 QCDYPPLP-SDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 24/219 (10%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESS--KAFCRELMIASSL 236
           KG ++G G+   V+ G        +A+K++         +D++ S   A  RE+ +   L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NIV  +G  +D +  L +  +YV GGS+   L+              ++       I
Sbjct: 64  QHENIVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT----V 352
            + + YLHN   R ++HRDIK +NIL+ +K   K+ DFG++    A S+          +
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +G+  ++APE  +    + K D+++ G +++E+LTG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 183 NFSKGRVLGRGALSFVFKG------------KVGLLRTSVAIKRLDKEDKESSKAFCREL 230
            + KG ++G+G    V+              +V L  T     R D   K+  KA   E+
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATI--AGRHDSRQKDMVKALRSEI 59

Query: 231 MIASSLHHPNIVPLVGFCIDPEQ-GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
                L H NIV  +GF    E   +FL  +YV GGS+   L   +   R    L     
Sbjct: 60  ETLKDLDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCL---RTYGRFEEQLVRFFT 114

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
            +V  G+A    YLH+   + ++HRD+K  N+L+ +  I K+ DFG++  +         
Sbjct: 115 EQVLEGLA----YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Query: 350 KTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKP 391
            +++G+  ++APE         S K D+++ G V+LE+  GR+P
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 85.6 bits (212), Expect = 2e-17
 Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 37/239 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           R++G+G +  V+     +    VA+K++ +   E+    K F RE  IA+ L HP IVP+
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--------I 296
              C D +  ++    Y+ G +L+  L    K V    +L   +  K ++G        I
Sbjct: 68  YSICSDGDP-VYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA------------PS 344
             ++ Y+H+   + V+HRD+KP NILL       + D+G A +                +
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 345 VPFLCKTVKG----TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
           + +   T+ G    T  Y+APE       S+ TD+YA GV+L ++LT   P   RR +G
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKKG 236

Length = 932

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 66  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 116

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 170

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 398
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 77/257 (29%), Positives = 123/257 (47%), Gaps = 38/257 (14%)

Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           E++W+ I+S+  +    I P      +L Y        +N S G+ LG GA   V +   
Sbjct: 2   EVRWKVIESINGNEYVYIDP-----TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATA 56

Query: 204 -GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCI--DPEQG 254
            GL ++   +K   K  K ++     +A   EL I S L +H NIV L+G C    P   
Sbjct: 57  YGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP--- 113

Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           + +I +Y   G L   L  K++       L  S  Y+VA G+A    +L   ++ C+ HR
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA----FL--ASKNCI-HR 165

Query: 315 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHGKVS 370
           D+   N+LL+  KI K+CDFGLA      S       VKG       ++APE   +   +
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLARDIMNDS----NYVVKGNARLPVKWMAPESIFNCVYT 221

Query: 371 DKTDVYAFGVVLLELLT 387
            ++DV+++G++L E+ +
Sbjct: 222 FESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 31/209 (14%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVG 246
           +LG+G    VFKG +   +T VA+K   KED  +E    F  E  I     HPNIV L+G
Sbjct: 2   LLGKGNFGEVFKGTLKD-KTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C    Q ++++ + V GG     L +KK  ++    +      K AL  A  +AYL   
Sbjct: 60  VCTQ-RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV------KFALDAAAGMAYLE-- 110

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSA--PSVPFLCKTVKGTFGY 358
           ++ C+ HRD+   N L+    + K+ DFG++       ++S+    +P     +K T   
Sbjct: 111 SKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-----IKWT--- 161

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            APE   +G+ S ++DV+++G++L E  +
Sbjct: 162 -APEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNIVPL 244
              +G GA   VFK K      +VA+K++     E        RE+    +  HP +V L
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 245 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           +   + P   G  L+ +Y+    L   L ++++       LP +        + + VAY+
Sbjct: 65  LD--VFPHGSGFVLVMEYM-PSDLSEVLRDEER------PLPEAQVKSYMRMLLKGVAYM 115

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           H NG    ++HRD+KP+N+L+S+  + K+ DFGLA   S          V  T  Y APE
Sbjct: 116 HANG----IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170

Query: 363 -YFQHGKVSDKTDVYAFGVVLLELLTGR 389
             +   K     D++A G +  ELL G 
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 38/221 (17%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELM---IA-SSLHHPN 240
           LGRGA   V K +     T +A+KR+      +E K       R LM   I+  S+  P 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDISMRSVDCPY 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            V   G      +G   I   V   SL+   + +++K        T+P  +  K+A+ I 
Sbjct: 62  TVTFYGALF--REGDVWICMEVMDTSLDKFYKKVYDKGL------TIPEDILGKIAVSIV 113

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTF 356
           +++ YLH  ++  V+HRD+KPSN+L++     KLCDFG+    S   V  + KT+  G  
Sbjct: 114 KALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTIDAGCK 167

Query: 357 GYLAPEYF---QHGKVSD-KTDVYAFGVVLLELLTGRKPIE 393
            Y+APE      + K  D K+DV++ G+ ++EL TGR P +
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 58/219 (26%), Positives = 112/219 (51%), Gaps = 14/219 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 239
           NF   + +GRG  S V++    L R  VA+K++   +  D ++ +   +E+ +   L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 240 NIVP-LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           N++  L  F  D E  L ++ +    G L + +   KK  R    +P    +K  + +  
Sbjct: 63  NVIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKR---LIPERTVWKYFVQLCS 117

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           +V ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYY 172

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
           ++PE       + K+D+++ G +L E+   + P    ++
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.1 bits (200), Expect = 4e-17
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 25/191 (13%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VAIK L K+   S +AF  E  +   L HP +V L  + +  ++ +++I +Y+  GSL
Sbjct: 31  TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSL 87

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +        L  +    +A  IAE +A++     +  +HRD++ +NIL+S   
Sbjct: 88  VDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETL 139

Query: 328 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 381
             K+ DFGLA       +T+     F  K       + APE   +G  + K+DV++FG++
Sbjct: 140 CCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEAINYGTFTIKSDVWSFGIL 192

Query: 382 LLELLT-GRKP 391
           L E++T GR P
Sbjct: 193 LTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 29/216 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNIV 242
           F+    +G+G+   V+K         VAIK +D E+ E       +E+   S    P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
              G  +     L++I +Y  GGS         L E                  +   + 
Sbjct: 63  KYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------------ILREVL 108

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 355
             + YLH   E   +HRDIK +NILLS +   KL DFG++   ++       K  T  GT
Sbjct: 109 LGLEYLHE--EG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----SKRNTFVGT 161

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             ++APE  +     +K D+++ G+  +EL  G  P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 190 LGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           LG G    V  GK  G  +  VAIK + KE   S   F  E  +   L H  +V L G C
Sbjct: 12  LGTGQFGVVKYGKWRG--QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              ++ ++++ +Y+S G L  +L E  K  + +  L      ++   + E +AYL +   
Sbjct: 69  -TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL------EMCKDVCEGMAYLES--- 118

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
           +  +HRD+   N L+  +   K+ DFGL+       +TS+    F  +       +  PE
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPE 171

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
              + K S K+DV+AFGV++ E+ + G+ P E
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 28/210 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K      +AF +E  I   L H  +VPL  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +++  GSL   L   K+G      LP  V   +A  IA+ +AY+    ER
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLV--DMAAQIADGMAYI----ER 120

Query: 310 C-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              +HRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 173

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL+T GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           + LG G    V  GK    R    VAIK +  E   S + F  E  +   L HP +V L 
Sbjct: 10  KELGSGQFGVVHLGK---WRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C   ++ L+++ +++  G L  +L +++  +  +  L       +   + E + YL  
Sbjct: 66  GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLER 118

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYL 359
            +    +HRD+   N L+SS  + K+ DFG+        +TS+    F  K       + 
Sbjct: 119 NS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-------WS 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
            PE F   K S K+DV++FGV++ E+ T G+ P E
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.6 bits (199), Expect = 7e-17
 Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 19/212 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF +   LG G  + V+KG+       VA+K   LD E+   S A  RE+ +   L H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHEN 59

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG--NSTLPWSVRYKVALGIAE 298
           IV L    I  E  L L+++Y+    L++++     GVRG  +     S  Y++  GIA 
Sbjct: 60  IVRLHD-VIHTENKLMLVFEYMDK-DLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIA- 114

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
              + H   E  V+HRD+KP N+L++ +   KL DFGLA     P   F  + V  T  Y
Sbjct: 115 ---FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166

Query: 359 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGR 389
            AP+     +  S   D+++ G ++ E++TGR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.6 bits (201), Expect = 7e-17
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V   ++       A+K + KE    D++       + +   + +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+ ++ YL
Sbjct: 61  LHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTFGYLAP 361
           H   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT  Y+AP
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTPNYIAP 165

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
           E  +        D +A GV++ E++ GR P +
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 191 GRGALSFVFK--GKVGLLRTSVAIKRLDKEDKES----SKAFCRELMIASSLHHPNIVPL 244
           GRG    V+K   K G      AIK+  K DKE     S++ CRE+ +   L H N+V L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 245 VGFCIDP-EQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           V   ++  ++ ++L++ Y      +    H + K V    ++  S+ +++  G+     Y
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV----HY 123

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFL-CKTVKGTFG 357
           LH      V+HRD+KP+NIL+  +       K+ D GLA   +AP  P      V  T  
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 358 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEE 401
           Y APE     +   K  D++A G +  ELLT   PI     +G E
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI----FKGRE 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 72/216 (33%), Positives = 99/216 (45%), Gaps = 34/216 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 10  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L   K  +     L ++V+      I
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------I 118

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG-- 354
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL   T A        TVK   
Sbjct: 119 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL---TKAIETDKEYYTVKDDL 172

Query: 355 ---TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
               F Y APE     K    +DV++FGV L ELLT
Sbjct: 173 DSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 192 RGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLHHPNIVPLV 245
           +GA   V+  K        AIK L K D  +       KA    +MI      P +  L 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLY 63

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYL 303
            +    +  L+L+ +Y++GG     +  K  G      LP  W+ +Y     IAE V  +
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLI--KTLGG-----LPEDWAKQY-----IAEVVLGV 110

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
            +  +R ++HRDIKP N+L+      KL DFGL+            K   GT  YLAPE 
Sbjct: 111 EDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPET 164

Query: 364 FQHGKVSDK-TDVYAFGVVLLELLTGRKPIEA 394
              G   DK +D ++ G V+ E L G  P  A
Sbjct: 165 IL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 18/217 (8%)

Query: 190 LGRGALSFVFKG--KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G    V KG  K+   +  VAIK L ++ +K       RE  I   L +P IV ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C    + L L+ +  SGG L + L  KK  +  ++ +   + ++V++G+     YL   
Sbjct: 63  VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMK----YLE-- 112

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQ 365
             +  VHRD+   N+LL ++   K+ DFGL+    A    +  ++  K    + APE   
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 366 HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
             K S ++DV+++G+ + E  + G+KP   ++++G E
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPY--KKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLV 245
           LG G    V   KV     + A+K + K    E  +    F  E  I    +HP IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D ++ ++++ +Y  GG L   L ++  G+    T     R+ +A  +  +  YLHN
Sbjct: 60  RTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFDEYT----ARFYIA-CVVLAFEYLHN 111

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFG 357
              R +++RD+KP N+LL S    KL DFG A        TWT        C    GT  
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-------FC----GTPE 157

Query: 358 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKP 391
           Y+APE     K  D + D ++ G++L ELLTGR P
Sbjct: 158 YVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V K K       VAIK+    ++DK   K   RE+ +   L H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ L+L++++V    L+    + +K   G   L  S   K    I   + + H+ 
Sbjct: 68  VF-RRKKRLYLVFEFVDHTVLD----DLEKYPNG---LDESRVRKYLFQILRGIEFCHSH 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF-- 364
               ++HRDIKP NIL+S   + KLCDFG A   +AP    +      T  Y APE    
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVG 174

Query: 365 --QHGKVSDKTDVYAFGVVLLELLTG 388
             ++G+     D++A G ++ E+LTG
Sbjct: 175 DTKYGR---AVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S ++F  E  I   L H  +V L  + +
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +Y+S GSL   L   K G      LP  V   +A  +A  +AY+    ER
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYI----ER 120

Query: 310 C-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              +HRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 173

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL+T GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 30/224 (13%)

Query: 188 RVLGRGALSFVFKGKVGLL-----RTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNI 241
           R LG GA   VF G+   L     +  VA+K L +    ++ K F RE  + ++  H NI
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNST--LPWSVRYKVAL 294
           V   G C + +    ++++Y+  G L + L              +    L  S   ++A+
Sbjct: 71  VKFYGVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTV 352
            IA  + YL     +  VHRD+   N L+    + K+ DFG++   +T+          V
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD------YYRV 180

Query: 353 KGT----FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            G       ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 15/210 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG+G    V   +V       A K+LDK+    ++  +    E  I   +    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           +  + +  L L+   ++GG L+ H++       G    P +     A  I   + +LH  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-----VGEPGFPEARAIFYAAQIICGLEHLHQ- 113

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
             R +V+RD+KP N+LL      ++ D GLA            K   GT GY+APE  Q 
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQG 168

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
                  D +A G  L E++ GR P   R+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 41/288 (14%)

Query: 190 LGRGALSFVFK-GKVGLLRTSVAIKRLD-------KEDKESSKAF---CREL-MIASSLH 237
           LG GA   V+K  K    +  +A+K ++       K+ +E  K+      E+ +I   L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           HPNIV      ++ ++ L+++   + G  L  H +  K+K  R      W++  ++ L  
Sbjct: 68  HPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             ++ YLH   E+ +VHRD+ P+NI+L       + DFGLA      S      +V GT 
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTI 177

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y  PE  ++    +K DV+AFG +L ++ T + P              ++  +L     
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-------------FYSTNMLSLATK 224

Query: 417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
            VE + +P  +     S  +  VI    +C++ +   RP I ++ A++
Sbjct: 225 IVEAVYEPLPEGMY--SEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 27/221 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+  G++LGRGA   V+          +A+K++  D + +E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 238 HPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   DPE+    I+ +Y+ GGS++  L       +    L  +V  +    I
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 350
            + V+YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      K
Sbjct: 116 LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRIQTICMSGTGIK 167

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +V GT  +++PE         K DV++    ++E+LT + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 27/221 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+  G++LG+GA   V+          +A+K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   DP E+ L +  +++ GGS++  L       +    L  +V  K    I
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 350
            E V+YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      K
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMK 167

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +V GT  +++PE         K D+++ G  ++E+LT + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 3e-16
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL----HHPNIVP 243
           + LG G    V+  +       VAIK++ K  K  S   C  L    SL     HPNIV 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L     + ++ L+ +++Y     +E +L++  K  R       SV   +   I + +A++
Sbjct: 63  LKEVFRENDE-LYFVFEY-----MEGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHI 115

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGYLAP 361
           H +G      HRD+KP N+L+S  ++ K+ DFGLA    S P  P+       T  Y AP
Sbjct: 116 HKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY--TDYVSTRWYRAP 167

Query: 362 EYF-QHGKVSDKTDVYAFGVVLLELLTGR 389
           E   +    S   D++A G ++ EL T R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 62/286 (21%), Positives = 128/286 (44%), Gaps = 28/286 (9%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLH 237
             NF   + +G+G  S V+K    L    VA+K++   +  D ++ +   +E+ +   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++  +   I+  + L ++ +    G L R +   KK  R    +P    +K  + + 
Sbjct: 61  HPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKR---LIPERTIWKYFVQLC 116

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            ++ ++H    + ++HRDIKP+N+ +++  + KL D GL  + S+ +         GT  
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPY 171

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 417
           Y++PE       + K+D+++ G +L E+   + P        + NL    K I       
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEKCDYPP 227

Query: 418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 463
           +              S ++  ++   + CI+ +  +RP I  ++ +
Sbjct: 228 LP---------ADHYSEELRDLV---SRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+K +       VAIK +  E  +  +   +E+ +     HPNIV   G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV---AYLHNG 306
             ++ L+++ +Y  GGSL+               L      ++A    E++   AYLH  
Sbjct: 71  RRDK-LWIVMEYCGGGSLQDIYQV------TRGPLS---ELQIAYVCRETLKGLAYLH-- 118

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEY 363
            E   +HRDIK +NILL+     KL DFG++   T T A       K+  GT  ++APE 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-----KSFIGTPYWMAPEV 172

Query: 364 FQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
                 G    K D++A G+  +EL   + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 43/290 (14%)

Query: 185 SKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
           +K +V+G G    VF+G +   G    +VAIK L     E  +  F  E  I     H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL--GIAE 298
           I+ L G  +   +   +I +Y+  G+L+++L +            +S    V +  GIA 
Sbjct: 68  IIRLEG-VVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAA 118

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 357
            + YL   ++   VHRD+   NIL++S    K+ DFGL+      P   +     K    
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA 416
           + APE   + K +  +DV++FG+V+ E+++ G +P              W     H  M 
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------------YWDMSN-HEVMK 221

Query: 417 AVEE--LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
           A+ +   L   + C S        V Q    C   + +RRP   +I+ +L
Sbjct: 222 AINDGFRLPAPMDCPS-------AVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 77.6 bits (192), Expect = 7e-16
 Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 31/194 (15%)

Query: 210 VAIKRLDKEDKESSKAF----CRELMIASSLHHPNIVPL----VGFCIDPEQGLFLIYKY 261
           VA+K+L K +KE    F     RE+ I   L HPNIV +    VG  +D    ++++ +Y
Sbjct: 33  VALKKL-KMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK---IYMVMEY 87

Query: 262 VSGGSLERHLHEKKKGVRGNSTLPWSV--RYKVALGIAESVAYLHNGTERCVVHRDIKPS 319
           V     E  L    K +      P+       + L +   VA+LH   +  ++HRD+K S
Sbjct: 88  V-----EHDL----KSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTS 135

Query: 320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAF 378
           N+LL+++ I K+CDFGLA    +P  P+    V  T  Y APE     K  S   D+++ 
Sbjct: 136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPELLLGAKEYSTAIDMWSV 193

Query: 379 GVVLLELLTGRKPI 392
           G +  ELLT +KP+
Sbjct: 194 GCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 49/239 (20%)

Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIAS 234
           N   G+ LG G       A +F  KG+ G   T+VA+K L +    S  +    E  +  
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGY--TTVAVKMLKENASSSELRDLLSEFNLLK 58

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLP 285
            ++HP+++ L G C      L LI +Y   GSL   L E +K         G R +S L 
Sbjct: 59  QVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 286 WSVRYKVALG--------IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 + +G        I+  + YL    E  +VHRD+   N+L++  +  K+ DFGL+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Query: 338 ---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
                       S   +P     VK    ++A E       + ++DV++FGV+L E++T
Sbjct: 175 RDVYEEDSYVKRSKGRIP-----VK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 15/210 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+   I  E  L+L+++++    L++ +          S +P  +       + + +
Sbjct: 61  IVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPL-----SGIPLPLIKSYLFQLLQGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           A+ H  + R V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  Y A
Sbjct: 114 AFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 168

Query: 361 PEYFQHGKV-SDKTDVYAFGVVLLELLTGR 389
           PE     K  S   D+++ G +  E++T R
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 14/211 (6%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 245
           RV+G+G+   V   +         IK+L+  +      KA  +E  + S L HPNIV   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKVALGIAESVAYLH 304
                 +  L+++  +  GG L   L E+K K +  N  + W V+      IA ++ YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLH 119

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
              E+ ++HRD+K  N+ L+   I K+ D G+A          +  T+ GT  Y++PE F
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELF 174

Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
            +   + K+DV+A G  + E+ T +    A+
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.6 bits (191), Expect = 8e-16
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 188 RVLGRGALSFVFKGKV-GLL----RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           R +G+GA   VF+ +  GLL     T VA+K L +E     +A F RE  + +   HPNI
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRY---------- 290
           V L+G C   +  + L+++Y++ G L   L H   +     S    S R           
Sbjct: 71  VKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 291 ----KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
                +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+    +    
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-- 184

Query: 347 FLCKTVKGTF---GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              K  +       ++ PE   + + + ++DV+A+GVVL E+ + G +P
Sbjct: 185 -YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 29/205 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFC 248
           +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              +Q ++++ + V GG     L  +   ++    +      ++    A  + YL +   
Sbjct: 63  TQ-KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLES--- 112

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGL---------ATWTSAPSVPFLCKTVKGTFGYL 359
           +  +HRD+   N L++ K + K+ DFG+         A+      +P     VK T    
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP-----VKWT---- 163

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLE 384
           APE   +G+ S ++DV++FG++L E
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 54/295 (18%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+ +G++LG+GA   V+          +A K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 238 HPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   D  E+ L +  +Y+ GGS++  L       +    L  SV  K    I
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC------K 350
            E ++YLH+     +VHRDIK +NIL  S    KL DFG     ++  +  +C      +
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICMSGTGIR 167

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
           +V GT  +++PE         K DV++ G  ++E+LT + P              WA+  
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP--------------WAE-- 211

Query: 411 LHRGMAAVEEL----LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
            +  MAA+ ++     +P+L       + I+   +    CI  E   RP  EE++
Sbjct: 212 -YEAMAAIFKIATQPTNPQL------PSHISEHARDFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 79.3 bits (195), Expect = 1e-15
 Identities = 61/185 (32%), Positives = 92/185 (49%), Gaps = 11/185 (5%)

Query: 252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 311
           +  L LI +Y SGG L + + ++ K       LP+   Y+V L   + V  L     R +
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLK-----EHLPFQ-EYEVGLLFYQIVLALDEVHSRKM 190

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 371
           +HRD+K +NI L    I KL DFG +   S      +  +  GT  YLAPE ++  + S 
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 372 KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILHRGMAAVEELLDPRLKCT 429
           K D+++ GV+L ELLT  +P +    +     VL+ K  P      + ++ LLDP L   
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLL--- 307

Query: 430 SRNSA 434
           S+N A
Sbjct: 308 SKNPA 312

Length = 478

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 72/211 (34%), Positives = 107/211 (50%), Gaps = 30/211 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V    A  IA  +AY+    E
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR----LPQLVDM--AAQIASGMAYV----E 119

Query: 309 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 361
           R   VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + AP
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAP 172

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E   +G+ + K+DV++FG++L EL T GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 24/191 (12%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K L K    S +AF  E  +  +L H  +V L    +  E+ +++I +Y++ GSL
Sbjct: 31  TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VVTKEEPIYIITEYMAKGSL 88

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   K    G   LP  + +     IAE +AY+     +  +HRD++ +N+L+S   
Sbjct: 89  LDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIE---RKNYIHRDLRAANVLVSESL 140

Query: 328 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 381
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 193

Query: 382 LLELLT-GRKP 391
           L E++T G+ P
Sbjct: 194 LYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 65/247 (26%), Positives = 97/247 (39%), Gaps = 57/247 (23%)

Query: 183 NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKED---KESSKAFC--RELM 231
           +F   +V+GRGA   V+       G+V       A+K L K D   +         R+++
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQV------YAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
             +    P IV L  +    E+ L+L+ +Y+ GG L   L   +K V    T  +   Y 
Sbjct: 56  ADA--DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARF---Y- 106

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT------------- 338
               IAE V  L +  +   +HRDIKP NIL+ +    KL DFGL               
Sbjct: 107 ----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 339 --------------WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 384
                                     +  GT  Y+APE  +      + D ++ GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 385 LLTGRKP 391
           +L G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG- 246
           +LG G    V+K    L R  +A+K +  +   E  K    EL I      P I+   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F +  E  + +  +++ GGSL+ +             +P  V  ++A+ + + + YL + 
Sbjct: 68  FFV--ENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSN+L++++   KLCDFG++T      V  + KT  GT  Y+APE    
Sbjct: 115 K---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISG 167

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKP 391
            +    +DV++ G+  +EL  GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 18/224 (8%)

Query: 177 ILAATHNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELM 231
           IL  T    K +VLG GA   V+KG        ++  VAIK L +    +++K    E  
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + + +  P +  L+G C+     + L+ + +  G L  ++ E K  +     L W V+  
Sbjct: 62  VMAGVGSPYVCRLLGICL--TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ-- 117

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
               IA+ ++YL    E  +VHRD+   N+L+ S    K+ DFGLA         +    
Sbjct: 118 ----IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
            K    ++A E   H + + ++DV+++GV + EL+T G KP + 
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V   ++   R   A+K + KE    D++       + +  ++ +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  LF + ++VSGG L  H+  ++K       LP       +  I+ ++ +L
Sbjct: 61  LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNFL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H   ER +++RD+K  N+LL ++   KL D+G+      P       T  GT  Y+APE 
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEI 167

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
            +        D +A GV++ E++ GR P +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 299
              G  +   + L++I +Y+ GGS    L   + G       P+   +++A  + E    
Sbjct: 66  KYYGSYLKGTK-LWIIMEYLGGGSA---LDLLRAG-------PFD-EFQIATMLKEILKG 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWM 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE  Q      K D+++ G+  +EL  G  P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 70/221 (31%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGL--LRTS---VAIKRLDKEDKESSKA---FCRELMIA 233
            +F  G  LG G  SF   G+V +   + +    AIK L K +    K      +E  I 
Sbjct: 18  SDFEMGETLGTG--SF---GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
             L HP IV ++    D E  ++ + ++V GG L  HL       R     P  V     
Sbjct: 73  MELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYH 124

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             +  +  YLH+     +++RD+KP N+LL +K   K+ DFG A       VP    T+ 
Sbjct: 125 AELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC 176

Query: 354 GTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  YLAPE  Q   HGK     D +  GV+L E + G  P
Sbjct: 177 GTPEYLAPEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 63/253 (24%), Positives = 125/253 (49%), Gaps = 33/253 (13%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K++D   ++  +    E++I    HH N+V +    +  ++ L+++ +++ GG+L  
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVMEFLEGGALTD 108

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +   +      +T        V L +  +++YLHN   + V+HRDIK  +ILL+S    
Sbjct: 109 IVTHTRMNEEQIAT--------VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRI 157

Query: 330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++E++ G 
Sbjct: 158 KLSDFGFCAQVSK-EVPKR-KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 390 KPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQA-AAACIS 448
            P              + +P L + M  + + L PR+K    +S +++ V++      + 
Sbjct: 216 PP-------------YFNEPPL-QAMRRIRDNLPPRVK----DSHKVSSVLRGFLDLMLV 257

Query: 449 SEESRRPGIEEII 461
            E S+R   +E++
Sbjct: 258 REPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 25/230 (10%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +VLG+G+   V   ++       AIK L K+    D +       + ++A +  HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   +  LF + +YV+GG L   +   +K     S      R+  A  +  ++ +L
Sbjct: 61  LHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS------RFYAA-EVTLALMFL 112

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           H +G    V++RD+K  NILL ++   KL DFG+        V     T  GT  Y+APE
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPE 166

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
             Q  +     D +A GV++ E++ G+ P EA     E++L    + ILH
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEA---DNEDDLF---ESILH 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 52/168 (30%), Positives = 92/168 (54%), Gaps = 13/168 (7%)

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPW 286
           +E ++ + + HPNIV       + +  L+++ +Y  GG L + +  ++ K    ++ L W
Sbjct: 47  KEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
            V  ++ LG    V ++H   E+ V+HRDIK  NI L+     KL DFG A   ++P   
Sbjct: 106 FV--QMCLG----VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           + C  V GT  Y+ PE +++   ++K+D+++ G +L EL T + P +A
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G+   VFK +       VAIK+    ++D    K   RE+ +   L HPN+V L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE- 67

Query: 248 CIDPEQGLFLIYKYVSGGSLERH--LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               ++ L L+++Y        H  L+E +K  RG   +P  +  K+     ++V + H 
Sbjct: 68  VFRRKRKLHLVFEYCD------HTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH- 117

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF- 364
               C+ HRD+KP NIL++ +   KLCDFG A   + P   +       T  Y APE   
Sbjct: 118 -KHNCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLV 173

Query: 365 ---QHGKVSDKTDVYAFGVVLLELLTG 388
              Q+G      DV+A G V  ELLTG
Sbjct: 174 GDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 26/266 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHE---------KKKGVRGNSTLPWSVRYKVA 293
              G C D +  L ++++Y+  G L + L             +  +    L  S    +A
Sbjct: 71  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++    +     +     
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLV---LWAKP 409
               ++ PE   + K + ++DV++FGV+L E+ T G++P      Q     V   +    
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW----FQLSNTEVIECITQGR 242

Query: 410 ILHRGMAAVEELLDPRLKCTSRNSAQ 435
           +L R     +E+ D  L C  R   Q
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQREPQQ 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 190 LGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 245
           LG G    V KG   + ++  +VA+K L  ++ + +      RE  +   L +P IV ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L + L + K     N T    + ++V++G+     YL  
Sbjct: 63  GIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT---ELVHQVSMGMK----YLE- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  KT  K    + APE  
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   + ++G E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--KGMKGNE 206

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 17/219 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +  +L H NIV L   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANIVTLHDI 71

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E+ L L+++Y+    L+++L        GN     +V+      +   ++Y H   
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYLDNC-----GNLMSMHNVKI-FMFQLLRGLSYCH--- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-YFQH 366
           +R ++HRD+KP N+L++ K   KL DFGLA   S P+  +  + V  T  Y  P+     
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + S   D++  G +L E+ TGR       ++ E +L+ 
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 21/222 (9%)

Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--SKAFCRELM 231
           +G +   T+ +   + +G GA   V   +  L   +VAIK++ K       +K   REL 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +   L H NI+ L    I P + ++ + + + G  L R L  +             ++Y 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQY- 112

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
               I   + Y+H+     VVHRD+KPSNIL++     K+CDFGLA        P +   
Sbjct: 113 FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGY 165

Query: 352 VKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           V   + Y APE      K   + D+++ G +  E+L G KP+
Sbjct: 166 VSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 50/188 (26%), Positives = 96/188 (51%), Gaps = 26/188 (13%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSL- 267
           VA+K++D   ++  +    E++I     HPNIV +   + +  E  L+++ +++ GG+L 
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE--LWVVMEFLEGGALT 104

Query: 268 ----ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL 323
                  ++E++                V L + +++++LH    + V+HRDIK  +ILL
Sbjct: 105 DIVTHTRMNEEQIAT-------------VCLAVLKALSFLHA---QGVIHRDIKSDSILL 148

Query: 324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLL 383
           +S    KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSK-EVPRR-KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206

Query: 384 ELLTGRKP 391
           E++ G  P
Sbjct: 207 EMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCREL-MIASSLHHPNIVPLVG- 246
           +GRGA   V K       T +A+KR+    D++  K    +L ++  S   P IV   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 247 --------FCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                    C++  +  L   YKYV         +E        S +P  +  K+A+   
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYV---------YEVL-----KSVIPEEILGKIAVATV 117

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTF 356
           +++ YL    E  ++HRD+KPSNILL      KLCDFG+    S   V  + KT   G  
Sbjct: 118 KALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGI----SGQLVDSIAKTRDAGCR 171

Query: 357 GYLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            Y+APE            ++DV++ G+ L E+ TG+ P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFC 248
           LG GA   V+K +        A K +  E +E  + F  E+ I S   HPNIV L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
            + +  L+++ ++  GG+L+  + E ++G+    T P  +RY V   + E++ +LH+   
Sbjct: 73  YENK--LWILIEFCDGGALDSIMLELERGL----TEP-QIRY-VCRQMLEALNFLHS--- 121

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQH 366
             V+HRD+K  NILL+     KL DFG+    SA +   L K  T  GT  ++APE    
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 367 GKVSD-----KTDVYAFGVVLLELLTGRKP 391
               D     K D+++ G+ L+EL     P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 19/213 (8%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K        A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L+ +  YV+GG L  HL  ++         P       A  IA ++ YL
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGELFFHLQRERS-------FPEPRARFYAAEIASALGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H      +++RD+KP NILL S+    L DFGL       S      T  GT  YLAPE 
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEV 167

Query: 364 FQHGKVSDKT-DVYAFGVVLLELLTGRKPIEAR 395
               +  D+T D +  G VL E+L G  P  +R
Sbjct: 168 L-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 188 RVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V     K    +    V  K L  +D++       + +   +  +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C      LFL+ +YV+GG L  H+  ++K       LP       A  I  ++ +L
Sbjct: 61  LHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK-------LPEEHARFYAAEICIALNFL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H   ER +++RD+K  N+LL +    KL D+G+      P       T  GT  Y+APE 
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEI 167

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
            +  +     D +A GV++ E++ GR P +
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 241
           RVLG+G+   V   ++       A+K L K+      D E +    R L +A +  HP +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFL 58

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
             L   C      LF + ++V+GG L  H+ + ++     +          A  I  ++ 
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALM 110

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           +LH   ++ +++RD+K  N+LL  +   KL DFG+              T  GT  Y+AP
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAP 165

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           E  Q        D +A GV+L E+L G  P EA
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 76.8 bits (189), Expect = 7e-15
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKA----------F----CR 228
           RVLG GA   V   K        A+K +D E     DK  ++A          F    C 
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E        +P  V ++   +D          Y + G L + +  + K  R         
Sbjct: 98  EDFAKKDPRNPENVLMIALVLD----------YANAGDLRQEIKSRAKTNRT------FR 141

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            ++  L   + +  +H+   + ++HRDIK +NILL S  + KL DFG +   +A     +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
            +T  GT  Y+APE ++    S K D+++ GV+L ELLT ++P +   ++          
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---------- 251

Query: 409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP 455
            ++H+ +A      DP     S    +I        A +SS+  RRP
Sbjct: 252 EVMHKTLAG---RYDPLPPSISPEMQEI------VTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 75.6 bits (186), Expect = 8e-15
 Identities = 71/235 (30%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED--KESSKAFC---RELM 231
            +F   +V+GRGA      G+V L+R        A+K L K +  K S  AF    R++M
Sbjct: 43  EDFDVIKVIGRGAF-----GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 232 I-ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSV 288
             A+S     IV L  +    ++ L+++ +Y+ GG L   +         N  +P  W+ 
Sbjct: 98  AHANS---EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--------SNYDIPEKWAR 145

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            Y      AE V  L        +HRD+KP N+LL      KL DFG      A  +   
Sbjct: 146 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VR 199

Query: 349 CKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
           C T  GT  Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 61/173 (35%), Positives = 86/173 (49%), Gaps = 36/173 (20%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E  +   + HP I+ L  F  + +Q  L+++ +YV GG L  +L  +  G   NST    
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNST---G 103

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTS 341
           + Y  A  I  ++ YLH+   + +V+RD+KP NILL  +   KL DFG A      TWT 
Sbjct: 104 LFY--ASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT- 157

Query: 342 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
                 LC    GT  YLAPE  Q   H K     D +A G+++ E+L G  P
Sbjct: 158 ------LC----GTPEYLAPEVIQSKGHNKA---VDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 74/236 (31%), Positives = 113/236 (47%), Gaps = 38/236 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRELMIAS 234
           +VLG+G  SF   GKV L+R           A+K L K      D+  +K    E  I +
Sbjct: 2   KVLGQG--SF---GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILA 53

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            ++HP IV L  +    E  L+LI  ++ GG L   L    K V         V++ +A 
Sbjct: 54  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEE---DVKFYLA- 105

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK- 353
            +A ++ +LH+     +++RD+KP NILL  +   KL DFGL    S  S+    K    
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSF 158

Query: 354 -GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
            GT  Y+APE       +   D ++FGV++ E+LTG  P + +  +    ++L AK
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 17/213 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K +  +   ++A+K  RL++ED+       RE+ +   + H NI
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L    +  E+ L+L+++Y+    L++H+       + N  L  +  Y++  GI    A
Sbjct: 64  VRLQD-VVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAK-NPRLIKTYLYQILRGI----A 116

Query: 302 YLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           Y H+     V+HRD+KP N+L+       KL DFGLA     P   F  + V  T  Y A
Sbjct: 117 YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171

Query: 361 PEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 392
           PE     +  S   D+++ G +  E++  +KP+
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 290
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 65  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++    +     +  
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                  ++ PE   + K + ++DV++ GVVL E+ T G++P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +V+G+G+      GKV L R        A+K L K+     KE         ++  ++ H
Sbjct: 1   KVIGKGSF-----GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L  F       L+ +  Y++GG L  HL       R    L    R+  A  IA 
Sbjct: 56  PFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA-EIAS 107

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           ++ YLH+     +V+RD+KP NILL S+    L DFGL       +      T  GT  Y
Sbjct: 108 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEY 162

Query: 359 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEAR 395
           LAPE   H +  D+T D +  G VL E+L G  P  +R
Sbjct: 163 LAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVH----KKPLQEVEIA------AICHGAL 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH+      +HRDIK  NILL+     KL DFG A+  S P+  F+     GT  
Sbjct: 126 QGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFV-----GTPY 176

Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           ++APE       G+   K DV++ G+  +E L  RKP
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   VF          VAIK+++ + +   +    E+++   L +PNIV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 244 LV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +  F +  E  LF++ +Y++GGSL   + E        + +  +    V     +++ +
Sbjct: 81  FLDSFLVGDE--LFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEF 130

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH      V+HRDIK  N+LL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 131 LHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 27/192 (14%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 31  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 87

Query: 268 ERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
              L    K   G+   LP  + +     IAE +A++    +R  +HRD++ +NIL+S+ 
Sbjct: 88  LDFL----KSDEGSKQPLPKLIDFSAQ--IAEGMAFIE---QRNYIHRDLRAANILVSAS 138

Query: 327 KIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGV 380
            + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG+
Sbjct: 139 LVCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGI 191

Query: 381 VLLELLT-GRKP 391
           +L+E++T GR P
Sbjct: 192 LLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K  L     A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +     + L+ +  +V+GG L  HL  ++       + P       A  IA ++ YL
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGELFFHLQRER-------SFPEPRARFYAAEIASALGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H+     +V+RD+KP NILL S+    L DFGL       +      T  GT  YLAPE 
Sbjct: 113 HSIN---IVYRDLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEV 167

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
            +     +  D +  G VL E+L G  P   R
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG-F 247
           LG+G    V+K        ++A+K +  E  ES       EL I      P IV   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E  +++  +Y+  GSL++ L+       G   +P  V  ++   + + + +L    
Sbjct: 69  FI--EGAVYMCMEYMDAGSLDK-LYAGGVATEG---IPEDVLRRITYAVVKGLKFLKE-- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           E  ++HRD+KP+N+L++     KLCDFG+    S   V  L KT  G   Y+APE  + G
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 368 KVSD------KTDVYAFGVVLLELLTGRKP 391
             +       ++DV++ G+ +LE+  GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K     +  A+K L K+     KE +       ++  +L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +     + L+ +  YV+GG L  HL  ++  +      P +  Y  A  +A ++ YL
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFY--AAEVASAIGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H+     +++RD+KP NILL S+    L DFGL      P       T  GT  YLAPE 
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEV 167

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
            +        D +  G VL E+L G  P  +R
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + V+KG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E+ L L+++Y+    L+++L +      GNS    +V+  +   +   + Y H   
Sbjct: 73  -IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNSINMHNVKLFL-FQLLRGLNYCH--- 121

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-YFQH 366
            R V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+     
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGS 179

Query: 367 GKVSDKTDVYAFGVVLLELLTGR 389
              S + D++  G +  E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 15/209 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   V+KG     +  VAIK +D E+ E   +   +E+ + S    P I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 66  RYYGSYLKGTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILRE-----ILKGLDY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH  +ER  +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++APE
Sbjct: 117 LH--SER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE 171

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 17/187 (9%)

Query: 210 VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS-- 266
           VA+K L       + + F +E+ I S L  PNI  L+G C      L +I +Y+  G   
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGDLN 107

Query: 267 --LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
             L++H+ E       + +L +S    +A  IA  + YL        VHRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVG 164

Query: 325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHGKVSDKTDVYAFGV 380
                K+ DFG     +  S  +  + V+G       ++A E    GK + K+DV+AFGV
Sbjct: 165 KNYTIKIADFG--MSRNLYSSDY-YR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 381 VLLELLT 387
            L E+LT
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHH-PNIVPLVG- 246
           +G G    V+K +       +A+K++ +   KE +K    +L +    H  P IV   G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F  D +     I   +    L++ L   +  +      P  +  K+ + I +++ YL   
Sbjct: 83  FITDSD---VFICMELMSTCLDKLLKRIQGPI------PEDILGKMTVAIVKALHYLK-- 131

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF- 364
            +  V+HRD+KPSNILL +    KLCDFG+    S   V    KT   G   Y+APE   
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGI----SGRLVDSKAKTRSAGCAAYMAPERID 187

Query: 365 ---QHGKVSDKTDVYAFGVVLLELLTGRKP 391
               + K   + DV++ G+ L+EL TG+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 23/222 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLH 304
            +  ++ L L+++Y     L++ L +      GN     +V+   Y++  G+A    Y H
Sbjct: 73  -VHTDKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLA----YCH 121

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-Y 363
               R V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+  
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176

Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
               + S + D++  G +  E+ +GR       ++ E +L+ 
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 39/285 (13%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +V+G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +   + + ++ +Y+  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 70  LEG-VVTKSKPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLV--GMLRGIASGMKYL 122

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
              ++   VHRD+   NIL++S  + K+ DFGL+      P   +  +  K    + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE- 420
              + K +  +DV+++G+V+ E+++ G +P      Q                + A+EE 
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------------IKAIEEG 225

Query: 421 -LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
             L   + C        A + Q    C   + + RP  E+I++IL
Sbjct: 226 YRLPAPMDCP-------AALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSL-HHPNIVP 243
           LG+GA   V+K      +  VA+K++     +  D  + + F RE+M    L  HPNIV 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTF-REIMFLQELGDHPNIVK 71

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L+     + ++ ++L+++Y     +E  LH     +R N       RY +   + +++ Y
Sbjct: 72  LLNVIKAENDKDIYLVFEY-----METDLHAV---IRANILEDVHKRY-IMYQLLKALKY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGY 358
           +H+G    V+HRD+KPSNILL+S    KL DFGLA         P  P L   V  T  Y
Sbjct: 123 IHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV-ATRWY 178

Query: 359 LAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
            APE      + +   D+++ G +L E+L G+
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G    V+K +  L    VA+K  RL+ ED+       RE+ +   L+HPNIV L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               E  L+L+++++    L++++            +  S  Y++  GIA    Y H+  
Sbjct: 67  VHS-ENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK-SYLYQLLQGIA----YCHS-- 117

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
              V+HRD+KP N+L+  +   KL DFGLA     P   +  + V  T  Y APE     
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGS 174

Query: 368 K-VSDKTDVYAFGVVLLELLTGRKPI 392
           +  S   D+++ G +  E++  R+P+
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 77/299 (25%), Positives = 131/299 (43%), Gaps = 45/299 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 66  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILRE-----ILKGLDY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 359
           LH+  +   +HRDIK +N+LLS     KL DFG+A   T T      F+     GT  ++
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWM 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE  +      K D+++ G+  +EL  G  P                    H  +  ++
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------------HSELHPMK 208

Query: 420 EL-LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA---ILRGEEELIYCT 474
            L L P+    +        + +   AC++ E S RP  +E++    I+R  ++  Y T
Sbjct: 209 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)

Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLER---------HLHEKKKGVR-GNSTLPWSVRYKVAL 294
            G C +    L ++++Y+  G L R          +    + V  G  TL   +   +A 
Sbjct: 73  YGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AIAS 129

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            IA  + YL        VHRD+   N L+    + K+ DFG++    +     +      
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              ++ PE   + K + ++D+++FGVVL E+ T G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           V+G GA   V K +    +  VAIK+    +E++E  +   REL +  +L   NIV L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   L+L+++YV    LE  L E   GV      P  VR  +   + +++ + H  
Sbjct: 68  -AFRRRGKLYLVFEYVEKNMLEL-LEEMPNGV-----PPEKVRSYI-YQLIKAIHWCHKN 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               +VHRDIKP N+L+S   + KLCDFG A   S  S     + V  T  Y +PE    
Sbjct: 120 D---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLG 175

Query: 367 GKVSDKTDVYAFGVVLLELLTGR 389
                  D+++ G +L EL  G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ S L HPNIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----------HEKKKGVRGNSTLPWSVRYKV 292
           L+G  +  EQ L +I+ Y S   L   L            +  K V+  STL  +    +
Sbjct: 73  LLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK--STLEPADFVHI 129

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              IA  + +L   +   VVH+D+   N+L+  K   K+ D GL     A     L    
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                +++PE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     HPNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            +   +  ++ L+++ +Y++GGSL   + E        + +       V     +++ +L
Sbjct: 81  YLDSYLVGDE-LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFL 131

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAP 361
           H+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++AP
Sbjct: 132 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAP 184

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           E         K D+++ G++ +E++ G  P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 71/236 (30%), Positives = 107/236 (45%), Gaps = 64/236 (27%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 232
           +VLG+G       GKV  +R           A+K L K       +D   +KA   E  I
Sbjct: 2   KVLGKGGY-----GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNI 53

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             ++ HP IV L+ +       L+LI +Y+SGG L  HL  +++G+    T         
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTA------CF 104

Query: 293 ALG-IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK- 350
            L  I+ ++ +LH   ++ +++RD+KP NILL ++   KL DFG            LCK 
Sbjct: 105 YLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFG------------LCKE 149

Query: 351 ---------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                    T  GT  Y+APE      HGK     D ++ G ++ ++LTG  P  A
Sbjct: 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKA---VDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 24/239 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHH-PNIVP 243
           +G+G    V++ +    R   A+K L K++  + K        R +++ + L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  F    +  L+L+  Y+SGG L  HL ++ +              +    IAE V  L
Sbjct: 61  L-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGR----------FSEDRAKFYIAELVLAL 109

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGTFGYLAP 361
            +  +  +V+RD+KP NILL +     LCDFGL  A  T   +    C    GT  YLAP
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC----GTTEYLAP 165

Query: 362 EYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           E     K   K  D ++ GV++ E+  G  P  A   Q     + + K    + + + E
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDE 224

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     + HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 87  SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGAL 135

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH+     ++HRDIK  NILL+     KL DFG A+  S P+  F+     GT  
Sbjct: 136 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-PANSFV-----GTPY 186

Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 13/163 (7%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E  + + ++ P IVPL  F     + L+L+  +++GG L  HL  + +            
Sbjct: 43  ERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGR----------FD 91

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
             +     AE +  L N  +  V++RD+KP NILL  +    LCDFGL            
Sbjct: 92  LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-- 149

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             T  GT  YLAPE       +   D +  GV+L E+LTG  P
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 41/216 (18%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            LG G+ + V+KG+  L    VA+K  RL+ E+     A  RE  +   L H NIV L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLHD 70

Query: 247 FCIDPEQGLFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESV 300
             I  ++ L L+++Y+       ++           G      +VR   +++  G+A   
Sbjct: 71  I-IHTKKTLTLVFEYLDTDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLA--- 117

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y H   +R V+HRD+KP N+L+S +   KL DFGLA   S PS  +  + V  T  Y  
Sbjct: 118 -YCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRP 171

Query: 361 P-------EYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           P       EY      S   D++  G +  E+ TGR
Sbjct: 172 PDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 56/238 (23%), Positives = 110/238 (46%), Gaps = 28/238 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G+   V    V      VA+K++D   ++  +    E++I     H N+V +    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ L+++ +++ GG+L   +   +      +         V L + ++++ LH    +
Sbjct: 88  VGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLKALSVLH---AQ 135

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
            V+HRDIK  +ILL+     KL DFG     S   VP   K++ GT  ++APE       
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRR-KSLVGTPYWMAPELISRLPY 193

Query: 370 SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLK 427
             + D+++ G++++E++ G  P              + +P L + M  + + L P+LK
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDNLPPKLK 237

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G     VAIK L     E   + F  E  I     HPNI+ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G  +   + + +I +++  G+L+  L +      G  T+   V   +  GIA  + YL 
Sbjct: 71  EGV-VTKSRPVMIITEFMENGALDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL- 122

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLAP 361
             +E   VHRD+   NIL++S  + K+ DFGL+ +     S P    ++ G     + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 28/224 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           ++LG+G+   VF  ++       AIK L K+    D +       + +++ +  HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 244 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L  +C    ++ LF + +Y++GG L  H+    K       LP +  Y  A  I   + +
Sbjct: 61  L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFY--AAEIICGLQF 111

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT---SAPSVPFLCKTVKGTFGYL 359
           LH+   + +V+RD+K  NILL +    K+ DFG+        A +  F C    GT  Y+
Sbjct: 112 LHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-C----GTPDYI 163

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
           APE     K +   D ++FGV+L E+L G+ P        EE L
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG---HDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 183 NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A S   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      L+ + +YV+GG L   + +      G    P +V Y  A  IA 
Sbjct: 61  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFY--AAEIAI 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WTSAPSVPFLCKTVKGT 355
            + +LH+   + +++RD+K  N++L S+   K+ DFG+     W    +     KT  GT
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT-----KTFCGT 164

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 31/222 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLL--RTS---VAIKRLDK------EDKESSKAFCRELM 231
           +F+   VLG+G  SF   GKV L   + +    AIK L K      +D E +    R L 
Sbjct: 1   DFNFLMVLGKG--SF---GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +      P  +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y 
Sbjct: 56  LPGK---PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFY- 106

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
            A  IA  + +LH+   + +++RD+K  N++L ++   K+ DFG+             +T
Sbjct: 107 -AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRT 160

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
             GT  Y+APE   +       D +AFGV+L E+L G+ P +
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 15/221 (6%)

Query: 186 KGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K   K G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIA 62

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           L   F    ++ ++L++ Y           H   K  +    LP S+   +   I + + 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 302 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTF 356
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 357 GYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 396
            Y APE     +   K  D++A G +  ELLT       R+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 176

Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 46/233 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 241
           +VLG+G+   V   ++       AIK L K+      D E +    R L +A    HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFL 58

Query: 242 VPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             L  FC    ++ LF + +Y++GG L  H+    +     +          A  I   +
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-------YAAEIICGL 109

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK---------- 350
            +LH    + +++RD+K  N+LL      K+ DFG+            CK          
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGM------------CKENMNGEGKAS 154

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
           T  GT  Y+APE  +  K ++  D ++FGV+L E+L G+ P      + E+ L
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG---EDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 73/235 (31%), Positives = 104/235 (44%), Gaps = 35/235 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRE 229
           NF   RVLG GA      GKV L+R           A+K L K     + K +       
Sbjct: 1   NFELLRVLGTGAY-----GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER 55

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
            ++ +    P +V L  +    +  L LI  YV+GG L  HL++     R + T      
Sbjct: 56  QVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTE----- 104

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
            +V + IAE V  L +  +  +++RDIK  NILL S+    L DFGL+    A       
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERA 163

Query: 350 KTVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN 402
            +  GT  Y+APE  + G        D ++ GV+  ELLTG  P     + GE+N
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT---VDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 37/211 (17%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 71

Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             E++ Y
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------------EALNY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 359
           LH   E  ++HRD+K  NIL +     KL DFG++   T T      F+     GT  ++
Sbjct: 119 LH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWM 170

Query: 360 APEYFQHGKVSD-----KTDVYAFGVVLLEL 385
           APE        D     K DV++ G+ L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 30/256 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 136

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA         F+      T 
Sbjct: 137 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTR 186

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y APE        +  D+++ G ++ EL+ G     +   QG +++  W K I   G  
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQWNKVIEQLGTP 241

Query: 417 AVEELLDPRLKCTSRN 432
           + E +   RL+ T RN
Sbjct: 242 SAEFM--NRLQPTVRN 255

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 68/221 (30%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            +G G    V+K +       VA+K  RLD E +       RE+ I   L+H NIV L  
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 247 FCIDPEQGL---------FLIYKYVSG---GSLERHL-HEKKKGVRGNSTLPWSVRYKVA 293
              D +  L         +L+++Y+     G LE  L H  +  ++              
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-----------SFM 122

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTV 352
             + E + Y H    +  +HRDIK SNILL++K   KL DFGLA  + S  S P+  K +
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 353 KGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             T  Y  PE      +     DV++ G +L EL T +KPI
Sbjct: 180 --TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 22/172 (12%)

Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
             +E  +   L H NI+P++  CI+  +  F++Y Y++ G+L+  L + + G   N    
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-A 113

Query: 286 WSVRYKVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            S +  V +   IA  ++YLH    R V+H+DI   N ++  +   K+ D  L    S  
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL----SRD 166

Query: 344 SVP--FLC------KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
             P  + C      + VK    ++A E   + + S  +DV++FGV+L EL+T
Sbjct: 167 LFPMDYHCLGDNENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 30/211 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G+   V+          VA+K++    K+  E  +   +E+     L HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 247 FCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            C   E   +L+ +Y  G +   LE H    KK ++            +  G  + +AYL
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGALQGLAYL 137

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H+     ++HRDIK  NILL+     KL DFG A+  S+P+  F+     GT  ++APE 
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSAS-KSSPANSFV-----GTPYWMAPEV 188

Query: 364 ---FQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                 G+   K DV++ G+  +E L  RKP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 17/212 (8%)

Query: 187 GRVLGRGALSFVFKG-----KVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPN 240
            R LG+G+   V++G       G   T VAIK +++      +  F  E  +    +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +V L+G      Q   ++ + ++ G L+   R    + +   G          ++A  IA
Sbjct: 71  VVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYL     +  VHRD+   N +++     K+ DFG+          +  K  KG   
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMT--RDIYETDYYRKGGKGLLP 184

Query: 358 --YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
             ++APE  + G  + K+DV++FGVVL E+ T
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    +G+ +       +VA+K L  D  DK+ S       M+     
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L+++ +Y S G+L  +L  ++  G+             L +  
Sbjct: 77  HKNIINLLGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDVHNIDYY 190

Query: 349 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNIV 242
           VLG+G+   V   +        AIK L K+      D E +     E  + +    P  +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALQDKPPFL 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             +  C      L+ + +YV+GG L  H+ +      G    P +V Y  A  I+  + +
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFY--AAEISVGLFF 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    R +++RD+K  N++L S+   K+ DFG+        V    +T  GT  Y+APE
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPE 171

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              +       D +A+GV+L E+L G+ P + 
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 30/217 (13%)

Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L   L + +               STL        A  
Sbjct: 74  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 181

Query: 356 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F + RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       G +          A  I   + 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-----GEAGFEEGRAVFYAAEICCGLE 116

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGY 358
            LH   ER +V+RD+KP NILL      ++ D GLA       VP   +T+KG   T GY
Sbjct: 117 DLHQ--ER-IVYRDLKPENILLDDHGHIRISDLGLAV-----HVP-EGQTIKGRVGTVGY 167

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           +APE  ++ + +   D +A G +L E++ G+ P + R+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 70/256 (27%), Positives = 105/256 (41%), Gaps = 64/256 (25%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIA 233
            +F   +V+GRGA      G+V L++        A+K+L K +   KE       E  I 
Sbjct: 1   DDFESIKVIGRGAF-----GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55

Query: 234 SSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           +   +P +V L  +     E  L+LI +Y+ GG +   L  KK       T  +      
Sbjct: 56  AEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFY------ 106

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------- 338
              IAE++  + +  +   +HRDIKP N+LL +K   KL DFGL T              
Sbjct: 107 ---IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 339 -------WTSAPSVPFLCK----------------TVKGTFGYLAPEYFQHGKVSDKTDV 375
                  +    S P   K                TV GT  Y+APE F     + + D 
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKECDW 222

Query: 376 YAFGVVLLELLTGRKP 391
           ++ GV++ E+L G  P
Sbjct: 223 WSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 17/209 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           ++ K   LG G+ + V+KGK  +    VA+K  RL +E+     A  RE  +   L H N
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHAN 64

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+   I  ++ L L+++YV    L +++ +   G+      P +V+  +   +   +
Sbjct: 65  IV-LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLH-----PENVKLFL-FQLLRGL 116

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +Y+H   +R ++HRD+KP N+L+S     KL DFGLA   S PS  +  + V  T  Y  
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRP 171

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTG 388
           P+      + S   D++  G + +E++ G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTS----VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG  A   ++KG + L        VAIK L D  + +    F +E  + + LHHPNIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----GVRGN------STLPWSVRYKVAL 294
           +G  +  EQ + ++++Y++ G L   L  +      G   +      S+L       +A+
Sbjct: 73  LG-VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            IA  + YL   +    VH+D+   NIL+  +   K+ D GL+    +     +      
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              ++ PE   +GK S  +D+++FGVVL E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.9 bits (167), Expect = 2e-12
 Identities = 64/232 (27%), Positives = 94/232 (40%), Gaps = 58/232 (25%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V           VAIK++    +D   +K   RE+ +   L H NI+ L+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 246 GFCIDPEQGLF----------------LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
                P    F                +I    S   L    H               ++
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETDLHKVIK---SPQPLT-DDH---------------IQ 106

Query: 290 ---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPS 344
              Y++  G+     YLH+     V+HRD+KPSNIL++S    K+CDFGLA         
Sbjct: 107 YFLYQILRGL----KYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 345 VPFLCKTVKGTFGYLAPE----YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             FL + V  T  Y APE      ++ K     D+++ G +  ELLT RKP+
Sbjct: 160 KGFLTEYVV-TRWYRAPELLLSSSRYTK---AIDIWSVGCIFAELLT-RKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 86/340 (25%), Positives = 130/340 (38%), Gaps = 83/340 (24%)

Query: 187 GRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+ LGRGA   V +    G+ +++    VA+K L KE   +S  KA   EL I   + HH
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNSTLPWSVR- 289
            N+V L+G C  P   L +I +Y   G+L  +L  K+        K  R         + 
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130

Query: 290 -----------------------------------YKVALGIAESVAY---LHNGTE--- 308
                                              YK  L + + ++Y   +  G E   
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190

Query: 309 -RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
            R  +HRD+   NILLS   + K+CDFGLA               +    ++APE     
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 368 KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLK 427
             + ++DV++FGV+L E+ +                 L A P  + G+   EE    RLK
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS-----------------LGASP--YPGVQIDEEFCR-RLK 290

Query: 428 CTSRNSA---QIARVIQAAAACISSEESRRPGIEEIIAIL 464
             +R  A       +      C  +    RP   E++ IL
Sbjct: 291 EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)

Query: 186 KGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K K   G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVIS 62

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           L   F    ++ ++L++ Y           H   K  +    LP  +   +   I + + 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 302 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTF 356
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 357 GYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 396
            Y APE     +   K  D++A G +  ELLT       R+
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMIASSLHHP 239
           +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I +  + P
Sbjct: 49  KVIGRGAF-----GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 240 NIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGI 296
            +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      
Sbjct: 104 WVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFYT----- 148

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AE V  L       ++HRD+KP N+LL      KL DFG         +   C T  GT 
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTP 207

Query: 357 GYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
            Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 16/213 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPN 240
            + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L    +  ++ L L+++Y      ++ L  KK     N  +   +       + + +
Sbjct: 61  IVRLYD-VLHSDKKLTLVFEYC-----DQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           A+ H      V+HRD+KP N+L++     KL DFGLA     P   +  + V  T  Y  
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRP 167

Query: 361 PEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
           P+     K+   + D+++ G +  EL    +P+
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 187 GRVLGRGALSFVFKGK-VGLL----RTSVAIKRL--DKEDKESSKAFCRELMIASSLHHP 239
           G+ LG GA   V K + VGL      ++VA+K L  D  +K+ S       M+     H 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 240 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKV----- 292
           NI+ L+G C   ++G L+++ +Y + G+L   L  ++  G   +   P      +     
Sbjct: 77  NIINLLGVCT--QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 293 ---ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
              A  +A  + +L   +++C+ HRD+   N+L++   + K+ DFGLA       + +  
Sbjct: 135 VSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLA--RDIHHIDYYR 189

Query: 350 KTVKGTFGY--LAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           KT  G      +APE       + ++DV++FGV+L E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 195 LSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ 253
           L F F  + G  L  +V I R D  +K +   F +E+ I S L  PNI+ L+G C+D E 
Sbjct: 35  LQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-ED 92

Query: 254 GLFLIYKYVSGGSLE-----RHLHEKKK----GVRGNSTLP---WSVRYKVALGIAESVA 301
            L +I +Y+  G L       HL +K++     V     LP   +S    VAL IA  + 
Sbjct: 93  PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YL   +    VHRD+   N L+      K+ DFG++    A     +         ++A 
Sbjct: 153 YL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELL 386
           E    GK +  +DV+AFGV L E+L
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGALSFVFKGK-VGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G    V   + +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK------ 291
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         P  V  +      
Sbjct: 83  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 292 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 142 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 196

Query: 349 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG+G    V   +V       A K+LDK+    K   K    E  I   ++ P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           +  + +  L L+   ++GG L+ H+ +  ++G+     + +S +      I   + +LH 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK---GTFGYLAPE 362
                +V+RD+KP N+LL  +   +L D GLA            KT+    GT GY+APE
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------KTITQRAGTNGYMAPE 164

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +    S   D +A G  + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 13/215 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F + RVLG+G    V   +V       A KRL+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       GN   P     +     AE + 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-----GN---PGFEEERALFYAAEILC 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
            L +      V+RD+KP NILL      ++ D GLA     P    +   V GT GY+AP
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV--KIPEGESIRGRV-GTVGYMAP 170

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           E   + + +   D +  G ++ E++ G+ P   R+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPN 240
           F    V+G G    V+K +       VAIK +D  ++++E  K    E  I     +HPN
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPN 64

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKV 292
           I    G  I       +  L+L+ +   GGS   L + L +K K ++      W + Y +
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE----W-IAY-I 118

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-- 350
                  +AYLH   E  V+HRDIK  NILL+     KL DFG+    SA     L +  
Sbjct: 119 LRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV----SAQLDSTLGRRN 171

Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKP 391
           T  GT  ++APE     +  D +     DV++ G+  +EL  G+ P
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 50/242 (20%)

Query: 183 NFSKGRVLGRGALSFVF---------KGKV---GLLRTSVAIKRLDKEDKESSKAFCREL 230
           NF   +VLG GA   VF          GK+    +L+ +  +++    +   ++    E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S    P +V L  +    E  L LI  YVSGG +  HL+++             VR+
Sbjct: 61  VRQS----PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRF 109

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
                I  ++ +LH   +  +V+RDIK  NILL S+    L DFGL       S  FL +
Sbjct: 110 YSG-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL-------SKEFLSE 158

Query: 351 TVK------GTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
             +      GT  Y+APE  +    HGK     D ++ G+++ ELLTG  P     L+GE
Sbjct: 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFT---LEGE 212

Query: 401 EN 402
            N
Sbjct: 213 RN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 34/225 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC----RELMIASSLH 237
             +     +G GA   V           VAIK++   + ++   FC    RE+ I     
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61

Query: 238 HPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRY 290
           H NI+ ++     P       ++++ +      +E  L+   K ++   T   S   ++Y
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY---KLIK---TQHLSNDHIQY 110

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP--FL 348
            +   I   + Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL
Sbjct: 111 FL-YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
            + V  T  Y APE   + K   K  D+++ G +L E+L+ R P+
Sbjct: 167 TEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLHHPNIVPLVG 246
           V+G+G+   V           VAIK+++   +  S A    RE+ +   L HP+IV +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESVAYLHN 305
             + P +  F    YV    +E  LH+    ++ N  L     ++  L  +  ++ Y+H 
Sbjct: 67  IMLPPSRREFKDI-YVVFELMESDLHQV---IKANDDLT-PEHHQFFLYQLLRALKYIHT 121

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPE- 362
                V HRD+KP NIL ++    K+CDFGLA   +   P+  F    V  T  Y APE 
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRAPEL 177

Query: 363 ---YFQHGKVSDKTDVYAFGVVLLELLTGR 389
              +F   K +   D+++ G +  E+LTG+
Sbjct: 178 CGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 20/203 (9%)

Query: 210 VAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           VA+KR+ K         +    E  I ++     +V L+    D E  L+L  +YV GG 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLAMEYVPGGD 87

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
             R L      +  +       R+ +A    E+V  LH   E   +HRD+KP N L+ + 
Sbjct: 88  F-RTLLNNLGVLSEDHA-----RFYMAEMF-EAVDALH---ELGYIHRDLKPENFLIDAS 137

Query: 327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
              KL DFGL+             +V G+  Y+APE  +        D ++ G +L E L
Sbjct: 138 GHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192

Query: 387 TGRKPIEARRLQGE-ENLVLWAK 408
            G  P          ENL  W +
Sbjct: 193 CGFPPFSGSTPNETWENLKYWKE 215

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 47/182 (25%), Positives = 92/182 (50%), Gaps = 14/182 (7%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L  
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLMEFLQGGALTD 107

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            + + +      +T        V   + +++ YLH+   + V+HRDIK  +ILL+     
Sbjct: 108 IVSQTRLNEEQIAT--------VCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRV 156

Query: 330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           KL DFG     S   VP   K++ GT  ++APE         + D+++ G++++E++ G 
Sbjct: 157 KLSDFGFCAQISK-DVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Query: 390 KP 391
            P
Sbjct: 215 PP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 64/235 (27%), Positives = 87/235 (37%), Gaps = 42/235 (17%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD----KEDKESSKAFC----------RELM 231
           KG  LG G    V K    L    VAIK++       D    +             REL 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 232 IASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           I + + H NI+ LV  +    E     +   +    L       KK V     L  S   
Sbjct: 73  IMNEIKHENIMGLVDVYV---EGDFINLVMDIMASDL-------KKVVDRKIRLTESQVK 122

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            + L I   +  LH       +HRD+ P+NI ++SK I K+ DFGLA     P       
Sbjct: 123 CILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 351 TVKG------------TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             +             T  Y APE      K     D+++ G +  ELLTG KP+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +    +  L  + +YV+GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFG 357
           + YLH+G    +V+RD+K  N++L      K+ DFGL     T A ++   C    GT  
Sbjct: 108 LDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC----GTPE 160

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           YLAPE  +        D +  GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 83/343 (24%), Positives = 131/343 (38%), Gaps = 88/343 (25%)

Query: 187 GRVLGRGALSFVFKGKV-GLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+VLG GA   V +    G+ + S    VA+K L KE   +S  KA   EL I   + +H
Sbjct: 12  GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIGNH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV-------------------- 278
            N+V L+G C  P   L +I ++   G+L   L  K++                      
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 279 ----------------------RGNSTLPWSVR---YKVALGIAESVAY---LHNGTE-- 308
                                    ST P       +K  L + + + Y   +  G E  
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 309 --RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
             R  +HRD+   NILLS   + K+CDFGLA             + +    ++APE    
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD--- 423
              + ++DV++FGV+L E+ +                 L A P  + G+   EE      
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS-----------------LGASP--YPGVQINEEFCQRLK 291

Query: 424 --PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
              R++     + +I R++    AC   +   RP    ++ IL
Sbjct: 292 DGTRMRAPENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 9   IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           V L   C     D E  L L++++V    L  +L +          +P      +   + 
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-----EPGVPTETIKDMMFQLL 120

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T  
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLW 174

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           Y APE       +   D+++ G +  E+   RKP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 68/250 (27%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G    V+K +       VA+K++   +++D     A  RE+ I   L HPN+VPL+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKK-------------KGVRGNSTLPWSVRYKVA 293
             ++                 ++   ++               G+  N     SV+   +
Sbjct: 75  MAVERP---------------DKSKRKRGSVYMVTPYMDHDLSGLLENP----SVKLTES 115

Query: 294 ------LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
                 L + E + YLH   E  ++HRDIK +NIL+ ++ I K+ DFGLA  +   P  P
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 347 FLCKTVKGTFG------------YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIE 393
                  G  G            Y  PE     +  +   D++  G V  E+ T R+PI 
Sbjct: 173 ----KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI- 226

Query: 394 ARRLQGEENL 403
              LQG+ ++
Sbjct: 227 ---LQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 24/221 (10%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPL 244
           +V+GRGA   V   +    R   A+K L K +   +  S  F  E  I +  + P +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAY 302
             +    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      AE V  
Sbjct: 109 F-YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYT-----AEVVLA 154

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L        +HRD+KP N+LL      KL DFG     +   +   C T  GT  Y++PE
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPE 213

Query: 363 YFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
             +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++ +HP IV L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-AF 78

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+    T P  ++  +   + E++ YLH+    
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGL----TEP-QIQV-ICRQMLEALQYLHS---M 129

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 367
            ++HRD+K  N+LL+     KL DFG+    SA +V  L +  +  GT  ++APE     
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 368 KVSD-----KTDVYAFGVVLLEL 385
            + D     K D+++ G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 39/281 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 235
           NF   +VLG GA   VF  +       G L     +K+     K  +    R E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    +  L LI  Y++GG L  HL ++++              +V + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----------FKEQEVQIY 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
             E V  L +  +  +++RDIK  NILL S     L DFGL+       V     +  GT
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169

Query: 356 FGYLAPEYFQHGKVS-DKT-DVYAFGVVLLELLTGRKPIEARRLQGEEN-------LVLW 406
             Y+AP+  + G    DK  D ++ GV++ ELLTG  P     + GE+N        +L 
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT---VDGEKNSQAEISRRILK 226

Query: 407 AKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQIAR 438
           ++P   + M+A     ++ LL  DP  RL C   ++ +I +
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 242
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +      P++ L  I   ++GG L  H H  + GV     + +      A  I   + +
Sbjct: 61  CMTYAFHTPDK-LCFILDLMNGGDL--HYHLSQHGVFSEKEMRF-----YATEIILGLEH 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           +HN   R VV+RD+KP+NILL      ++ D GLA   S            GT GY+APE
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 165

Query: 363 YFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 403
             Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 66/256 (25%), Positives = 94/256 (36%), Gaps = 57/256 (22%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKEDKESSKAFCR---ELMIA 233
            +F K ++LG+G +     G+V L+R        A+K LDK++        R   E  I 
Sbjct: 1   KHFKKIKLLGKGDV-----GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL 55

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           ++L HP +  L       E  L L+  Y  GG L R L  +         L   V     
Sbjct: 56  ATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEV---AR 106

Query: 294 LGIAESVA---YLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP--- 346
              AE +    YLH  G    +V+RD+KP NILL       L DF L+  +     P   
Sbjct: 107 FYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 347 ------------------FLCKTVK------GTFGYLAPEYFQHGKVSDKTDVYAFGVVL 382
                             F  +         GT  Y+APE           D +  G++L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222

Query: 383 LELLTGRKPIEARRLQ 398
            E+L G  P +     
Sbjct: 223 YEMLYGTTPFKGSNRD 238

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 19/218 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 240
           F   RVLG+G    V   +V       A K+L+K+  +  K       E  I   ++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L  +  + +  L L+   ++GG L+ H++       GN           A  I   +
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN-----MGNPGFDEERAVFYAAEITCGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF--LCKTVKGTFGY 358
             LH   ER +V+RD+KP NILL      ++ D GLA       +P     +   GT GY
Sbjct: 116 EDLH--RER-IVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGY 167

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           +APE  ++ + +   D +  G ++ E++ G+ P   R+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 9/183 (4%)

Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           VA+K L ++ +K +   F +E+ I S L  PNI+ L+  CI  +  L +I +Y+  G L 
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLN 107

Query: 269 ----RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
               RH  ++        T+ +S    +A  IA  + YL   +    VHRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 384
                K+ DFG++    +     +         +++ E    GK +  +DV+AFGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 385 LLT 387
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 15/219 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS---VAIK--RLDKEDKESSKAFCRELMIASSLHH 238
              G++LG G    V +G++     S   VA+K  +LD       + F  E        H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 239 PNIVPLVGFCIDPE--QGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           PN++ L+G C +    Q +    +I  ++  G L   L   + G      LP     K  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFM 119

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           + IA  + YL N   R  +HRD+   N +L       + DFGL+    +       +  K
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               ++A E       + K+DV+AFGV + E+ T G+ P
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     +PNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 81  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDF 130

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPL 244
           V+G G    V +  +    L+ + AIK L +   E+  + F  EL +   L HHPNI+ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKK---------KGVRGNSTLPWSVRYKVALG 295
           +G C +    L++  +Y   G+L   L + +         K     STL      + A  
Sbjct: 69  LGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +E+  +HRD+   N+L+      K+ DFGL+              VK T
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV--------YVKKT 176

Query: 356 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            G     ++A E   +   + K+DV++FGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 16/206 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+K +        AIK +  E  E      +E+++     H NIV   G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ L++  ++  GGSL+   H    G    S + +  R  +     + + YLH+  + 
Sbjct: 77  RRDK-LWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF---QH 366
             +HRDIK +NILL+     KL DFG++   +A       K+  GT  ++APE     + 
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERK 183

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPI 392
           G  +   D++A G+  +EL   + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 76/258 (29%), Positives = 110/258 (42%), Gaps = 45/258 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS------VAIKRLDK----EDKESSKAFCRELMI 232
           +F+  R LG G+      G+V L          VAIKR +K    + K+    F  E  I
Sbjct: 31  DFNFIRTLGTGSF-----GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
            + ++HP  V L G   D E  L+L+ ++V GG     L       R N   P  V    
Sbjct: 85  LNYINHPFCVNLYGSFKD-ESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFY 136

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A  I     YL +     +V+RD+KP N+LL      K+ DFG A      +      T+
Sbjct: 137 AAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-----TL 188

Query: 353 KGTFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 409
            GT  Y+APE      HGK +   D +  G+ + E+L G  P  A      E L+++ K 
Sbjct: 189 CGTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYA-----NEPLLIYQKI 240

Query: 410 ILHRGMAAVEELLDPRLK 427
           +   G+    + LD   K
Sbjct: 241 L--EGIIYFPKFLDNNCK 256

Length = 340

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G    V + +  G+ +       +VA+K L  +  DK+ +       ++     
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-----------KGVRGNSTLP- 285
           H NI+ L+G C   E  L++I +Y + G+L   L  ++           K      +   
Sbjct: 77  HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   + RC+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 136 LVSCAYQVARGME----YLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLA--RGVHD 186

Query: 345 VPFLCKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FG+++ E+ T
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 30/214 (14%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 242
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +      P++ L  I   ++GG L  H H  + GV   + + +    ++ LG+     +
Sbjct: 61  CMSYAFHTPDK-LSFILDLMNGGDL--HYHLSQHGVFSEAEMRFYAA-EIILGLE----H 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA----PSVPFLCKTVKGTFGY 358
           +HN   R VV+RD+KP+NILL      ++ D GLA   S      SV        GT GY
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------GTHGY 161

Query: 359 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKP 391
           +APE  Q G   D + D ++ G +L +LL G  P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 54/220 (24%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSL-HHPNIVPLVGF 247
           +G G  S V K +        AIK + K  K   +    RE+     L  HPNI+ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 248 CIDPEQG-LFLI--------YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
             D + G L L+        Y+ + G   +R L EK+  V+       S  Y+    + +
Sbjct: 67  LFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKR--VK-------SYMYQ----LLK 111

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--- 354
           S+ ++H NG    + HRDIKP NIL+    I KL DFG             C+ +     
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILI-KDDILKLADFG------------SCRGIYSKPP 154

Query: 355 ------TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLT 387
                 T  Y APE     G    K D++A G V  E+L+
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +GRGA   V   K       VAIK++    +++  +K   RE+ +   L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71

Query: 248 CIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALGIAESVA 301
            + P        ++++Y+      ++  LH+    +R + TL     +Y +   +   + 
Sbjct: 72  IMPPPHREAFNDVYIVYEL-----MDTDLHQI---IRSSQTLSDDHCQYFL-YQLLRGLK 122

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           Y+H+     V+HRD+KPSN+LL++    K+CDFGLA  T++    F+ + V  T  Y AP
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVV-TRWYRAP 177

Query: 362 EYFQHGKVSDKT---DVYAFGVVLLELLTGRKPI 392
           E   +   S+ T   DV++ G +  ELL GRKP+
Sbjct: 178 ELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G+G    VFK +    +  VA+K+  ++ E +       RE+ I   L H N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 248 CIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           C              +L++++     L   L  K      N     S   KV   +   +
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK------NVKFTLSEIKKVMKMLLNGL 132

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----FLCKTVKGTF 356
            Y+H      ++HRD+K +NIL++   I KL DFGLA   S         +  + V  T 
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV--TL 187

Query: 357 GYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            Y  PE       +G      D++  G ++ E+ T R PI
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 19/218 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F   RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       GN         +     AE   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-----MGNPGFD---EQRAIFYAAELCC 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---TFGY 358
            L +     +V+RD+KP NILL  +   ++ D GLA       +P   +TV+G   T GY
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV-----QIP-EGETVRGRVGTVGY 167

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           +APE   + K +   D +  G ++ E++ G+ P   R+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCI--DPEQGLFLIYKYVSGGS 266
           VA+K L  +  K +   F +E+ I S L +PNI+ L+G C+  DP   L +I +Y+  G 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGD 103

Query: 267 LERHLHEKK---KGVRGNSTLPWSVRYK----VALGIAESVAYLHNGTERCVVHRDIKPS 319
           L + L +++        N+ +P SV       +A+ IA  + YL +      VHRD+   
Sbjct: 104 LNQFLSQREIESTFTHANN-IP-SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158

Query: 320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFG 379
           N L+ +    K+ DFG++    +     +         ++A E    GK +  +DV+AFG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 380 VVLLELLT 387
           V L E+ T
Sbjct: 219 VTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     V+HRDIK  NILL      KL DFG     + P        V GT  ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-GTPYWMAPE 186

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    K D+++ G++ +E++ G  P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 12/209 (5%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPNIVPLVG 246
           LG+G    V   ++       A K+L+K+  +  K +     E  I + +H   IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           +    +  L L+   ++GG L  H++   +   G    P +  Y     I   + +LH  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFY--TAQIISGLEHLH-- 114

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
            +R +++RD+KP N+LL +    ++ D GLA            K   GT G++APE  Q 
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQG 171

Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
            +     D +A GV L E++  R P  AR
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 37/230 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHH 238
           +F   +++  GA   V+  +    R   A+K+++K++     +  + F  E  I +   +
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAEN 60

Query: 239 PNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           P +V +  FC  + ++ L ++ +YV GG     L  K  G      LP  +     +  A
Sbjct: 61  PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIG-----ALPVDM---ARMYFA 108

Query: 298 ESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------WTS 341
           E+V    YLHN     +VHRD+KP N+L++S    KL DFGL+                 
Sbjct: 109 ETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +  FL K V GT  Y+APE           D +A G++L E L G  P
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 15/202 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G+ + V+KG   +    VA+K +  + +E       RE  +   L H NIV L+   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           I  ++ L  +++Y+    L +++ +   G+      P++VR      +   +AY+H    
Sbjct: 72  IHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-----PYNVRL-FMFQLLRGLAYIHG--- 121

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG- 367
           + ++HRD+KP N+L+S     KL DFGLA   S PS  +  + V  T  Y  P+      
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179

Query: 368 KVSDKTDVYAFGVVLLELLTGR 389
             S   D++  G + +E+L G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 39/219 (17%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +VLG+G+   V   ++       A+K L K+    D +       + ++A +  +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 244 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L  +C    ++ LF + ++++GG L  H+ +K     G   L     Y+     AE V  
Sbjct: 61  L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDL-----YRATFYAAEIVCG 108

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK----------TV 352
           L     + +++RD+K  N++L      K+ DFG+            CK          T 
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM------------CKENVFGDNRASTF 156

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GT  Y+APE  Q  K +   D ++FGV+L E+L G+ P
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    +G+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 290
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         +        + + 
Sbjct: 80  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 291 KVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            V+    +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 139 LVSCTYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDVNNIDYY 193

Query: 349 CKTVKGTF--GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH---HPNIVPL 244
           +G GA   V+K +       VA+K +  +  E        RE+ +   L    HPNIV L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 245 VGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +  C     D E  + L++++V    L  +L +          LP      +       +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP-----PGLPAETIKDLMRQFLRGL 121

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH     C+VHRD+KP NIL++S    KL DFGLA      S       V  T  Y A
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA---RIYSCQMALTPVVVTLWYRA 175

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE       +   D+++ G +  E+   RKP+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 17/211 (8%)

Query: 188 RVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +    +  ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIAE 298
           V L+G  +   Q   +I + ++ G L+ +L   +  +  N            ++A  IA+
Sbjct: 72  VRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG- 357
            +AYL+       VHRD+   N +++     K+ DFG+          +  K  KG    
Sbjct: 131 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 185

Query: 358 -YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 85/343 (24%), Positives = 129/343 (37%), Gaps = 89/343 (25%)

Query: 187 GRVLGRGALSFVFKG------KVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HH 238
           G+ LGRGA   V +       K    RT VA+K L +    S  +A   EL I   + HH
Sbjct: 12  GKPLGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------------KGVRGNSTL 284
            N+V L+G C  P   L +I ++   G+L  +L  K+              +G  G   +
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130

Query: 285 PWSVR------------------------------------YKVALGIAESVAY---LHN 305
              ++                                    YK  L + + + Y   +  
Sbjct: 131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAK 190

Query: 306 GTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           G E    R  +HRD+   NILLS   + K+CDFGLA               +    ++AP
Sbjct: 191 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E       + ++DV++FGV+L E+ +                 L A P  + G+   EE 
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASP--YPGVKIDEEF 291

Query: 422 LDPRLKCTSRNSA---QIARVIQAAAACISSEESRRPGIEEII 461
              RLK  +R  A       + Q    C   E S+RP   E++
Sbjct: 292 CR-RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFG 357
           + YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   C    GT  
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPE 160

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           YLAPE  +        D +  GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 16/214 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           H++   + +G G    V+K +        A+K +  E  +      +E+ +     H NI
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G  +  E+ L++  +Y  GGSL+   H    G      + +  R  +     + +A
Sbjct: 69  VAYFGSYLSREK-LWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETL-----QGLA 120

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YLH+   +  +HRDIK +NILL+     KL DFG+A   +A       K+  GT  ++AP
Sbjct: 121 YLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAP 175

Query: 362 EYF---QHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           E     ++G  +   D++A G+  +EL   + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 42/222 (18%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIAS-----SLHHPNIV 242
           +G GA   V+K +       VA+K++     E     +  RE  IA      S  HPNIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNIV 64

Query: 243 PLVGFC----IDPEQGLFLIYKYVSGGSLERHLH---EK--KKGVRGNSTLPWSVRYKVA 293
            L+  C     D E  L L++++V     ++ L     K  K G+      P +++  + 
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLP-----PETIK-DLM 113

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCK 350
             +   V +LH+     +VHRD+KP NIL++S    K+ DFGLA   ++  A     L  
Sbjct: 114 RQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LTS 165

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            V  T  Y APE       +   D+++ G +  EL   R+P+
Sbjct: 166 VVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 28/198 (14%)

Query: 206 LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS 263
           LR   AIKR+ +   +   + F  EL +   L HHPNI+ L+G C +    L+L  +Y  
Sbjct: 21  LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAP 79

Query: 264 GGSL------ERHLHEKKKGVRGN---STLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
            G+L       R L         N   STL        A  +A  + YL   +++  +HR
Sbjct: 80  HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 136

Query: 315 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG-----YLAPEYFQHGKV 369
           D+   NIL+    + K+ DFGL+              VK T G     ++A E   +   
Sbjct: 137 DLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMGRLPVRWMAIESLNYSVY 188

Query: 370 SDKTDVYAFGVVLLELLT 387
           +  +DV+++GV+L E+++
Sbjct: 189 TTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 29/222 (13%)

Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +   ++  G ++G G+   V++         VAIK++ ++ +  +    REL+I  +L+H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNH 118

Query: 239 PNIVPLVGF----CIDP-EQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            NI+ L  +    C    E+ +FL  + +++   ++ +++   K   R N  LP  +   
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYM---KHYARNNHALPLFLVKL 174

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT--WTSAPSVPFL 348
            +  +  ++AY+H+   + + HRD+KP N+L+       KLCDFG A        SV ++
Sbjct: 175 YSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT--DVYAFGVVLLELLTG 388
           C        Y APE    G  +  T  D+++ G ++ E++ G
Sbjct: 232 CSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 190 LGRGALSFV--FKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 244
           LG+GA   V   +        +VAIK++      K  +K   REL +      H NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 245 VGFCI---DPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESV 300
               I        L+L Y+ +    +E  LH+  + G         S  Y++  G+    
Sbjct: 68  YDMDIVFPGNFNELYL-YEEL----MEADLHQIIRSGQPLTDAHFQSFIYQILCGLK--- 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV---PFLCKTVKGTFG 357
            Y+H+     V+HRD+KP N+L+++    K+CDFGLA   S        F+ + V  T  
Sbjct: 120 -YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRW 174

Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           Y APE    FQ    +   DV++ G +L ELL GRKP+
Sbjct: 175 YRAPEIMLSFQ--SYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 15/219 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESS--KAFCRELMIASSLHH 238
           F+ GR+LG+G    V + ++     S   VA+K L  +   SS  + F RE        H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 239 PNIVPLVGFCID--PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           PN++ L+G  +    +  L    +I  ++  G L   L   + G     TLP     +  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFM 119

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           + IA  + YL +   +  +HRD+   N +L+      + DFGL+    +          K
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               +LA E       +  +DV+AFGV + E++T G+ P
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L++        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YL
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYL 163

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE  +        D +  GVV+ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 23/194 (11%)

Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VA+K++    ++  S K   REL +     H N++  +     P    F    YV    +
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE-EIYVVTELM 86

Query: 268 ERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
           +  LH  K  V         V+   Y++  G    + YLH+     ++HRDIKP N+L++
Sbjct: 87  QSDLH--KIIVSPQPLSSDHVKVFLYQILRG----LKYLHSAG---ILHRDIKPGNLLVN 137

Query: 325 SKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPEYF---QHGKVSDKTDVYAFGV 380
           S  + K+CDFGLA       S     + V  T  Y APE     +H   +   D+++ G 
Sbjct: 138 SNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRH--YTSAVDIWSVGC 193

Query: 381 VLLELLTGRKPIEA 394
           +  ELL  R   +A
Sbjct: 194 IFAELLGRRILFQA 207

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.0 bits (142), Expect = 1e-09
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 44/291 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F    ++G G    V+KG+        AIK +D    E  +      M+    HH NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 244 LVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
             G  I  +P   +  L+L+ ++   GS+   +    K  +GN+     + Y +   I  
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAY-ICREILR 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---TSAPSVPFLCKTVKGT 355
            +++LH   +  V+HRDIK  N+LL+     KL DFG++     T      F+     GT
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GT 174

Query: 356 FGYLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
             ++APE     +  D     K+D+++ G+  +E+  G  P+                P+
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------------PM 222

Query: 411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
             R +  +     PRLK + + S +    I+   +C+    S+RP  E+++
Sbjct: 223 --RALFLIPRNPAPRLK-SKKWSKKFQSFIE---SCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 18/209 (8%)

Query: 190 LGRGALSFVFKGKV--GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G    V  G+   G+ +  V +K L      +    F +E+     L+HPN++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            CI+      L+ ++   G L+ +L   +  V   +     V  ++A  +A  + +LH  
Sbjct: 63  QCIESIP-YLLVLEFCPLGDLKNYLRSNRGMVAQMAQK--DVLQRMACEVASGLLWLHQA 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT-FGYLAPE--- 362
                +H D+   N  L++    K+ D+GLA     P   ++ K        +LAPE   
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 363 -YFQHGKVSDKT---DVYAFGVVLLELLT 387
              Q     D+T   ++++ GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 63/245 (25%), Positives = 96/245 (39%), Gaps = 47/245 (19%)

Query: 183 NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V +  +    ++ L+LI +++ GG +   L +K        TL           IAE+
Sbjct: 62  WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLS---EEATQFYIAET 110

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-------------WTSAPSVP 346
           V  +    +   +HRDIKP N+LL +K   KL DFGL T              T  P   
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 347 F--------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
           F                    L  +  GT  Y+APE F     +   D ++ GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 387 TGRKP 391
            G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 32/188 (17%)

Query: 229 ELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E+ +   L H NIV  +  F     Q L+++ ++   G L R++   +K  +    +   
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEH 118

Query: 288 VRYKVALGIAESVAYLHN-----GTERCVVHRDIKPSNILLSS----------------- 325
               +   +  ++AY HN       ER V+HRD+KP NI LS+                 
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS--DKTDVYAFGVVLL 383
           + I K+ DFGL+      S+   C    GT  Y +PE   H   S  DK+D++A G ++ 
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSC---VGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 384 ELLTGRKP 391
           EL +G+ P
Sbjct: 235 ELCSGKTP 242

Length = 1021

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL   ++ V          R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED----RARFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH      VV+RD+K  N++L      K+ DFGL       S     KT  GT  YL
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE  +        D +  GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 71/295 (24%), Positives = 128/295 (43%), Gaps = 66/295 (22%)

Query: 190 LGRGALSFVFKGK---VG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG    VG    L +T V +K LDK  +  S++F     + S L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C+  ++ + ++ +YV  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 63  LNYGVCVCGDESI-MVQEYVKFGSLDTYLKKNKNLI----NISWK------LEVAKQLAW 111

Query: 303 -LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV- 352
            LH   ++ + H ++   N+LL         +    KL D G+       S+  L K + 
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI-------SITVLPKEIL 164

Query: 353 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTG-RKPIEA----RRLQGEENLVLW 406
                ++ PE  ++ + +S   D ++FG  L E+ +G  KP+ A    ++LQ  E+    
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---- 220

Query: 407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
                             R +  +    ++A +I     C+  E   RP    II
Sbjct: 221 ------------------RHQLPAPKWTELANLIN---QCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 31/173 (17%)

Query: 229 ELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGN 281
           E M+   +  +PN + L  + +   +G  LI  Y+  G L      E  L E +      
Sbjct: 58  EPMVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE------ 110

Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWT 340
                 V+ K+   + E++  LH      ++H DIK  N+L    K    LCD+GL    
Sbjct: 111 ------VK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
             PS         GT  Y +PE  +        D +A GV+  ELLTG+ P +
Sbjct: 161 GTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 38/228 (16%)

Query: 184 FSKGRVLGRGALSFVFKG---KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F    V+G G    V+KG   K G L    AIK +D  + E  +      M+    HH N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQL---AAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           I    G  I       +  L+L+ ++   GS+     +  K  +GN+     + Y +   
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGNALKEDWIAY-ICRE 129

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-- 353
           I   +A+LH      V+HRDIK  N+LL+     KL DFG++          L +TV   
Sbjct: 130 ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--------LDRTVGRR 178

Query: 354 ----GTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPI 392
               GT  ++APE     +  D T     D+++ G+  +E+  G  P+
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 64/257 (24%), Positives = 119/257 (46%), Gaps = 30/257 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++++ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGIK----H 141

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPE 195

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL- 421
                   +  D+++ G ++ E++ G          G +++  W K I   G    E + 
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGV-----LFPGTDHIDQWNKVIEQLGTPCPEFMK 250

Query: 422 -LDPRLKCTSRNSAQIA 437
            L P ++    N  + A
Sbjct: 251 KLQPTVRTYVENRPKYA 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK++    +    +K   REL I     H NI+ + 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALG-IAESVAYL 303
              + P    F    YV    +E  LH     +  +  L    +RY   L  +   + Y+
Sbjct: 71  DI-LRPPGADF-KDVYVVMDLMESDLHHI---IHSDQPLTEEHIRY--FLYQLLRGLKYI 123

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLA 360
           H+     V+HRD+KPSN+L++     ++ DFG+A   S+       F+ + V  T  Y A
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRA 179

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE      + +   D+++ G +  E+L GR+ +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 34/252 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 85  FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLL-----YQMLCGI----KH 134

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLA 360
           LH+     ++HRD+KPSNI++ S    K+ DFGLA    TS    P++      T  Y A
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TRYYRA 186

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           PE        +  D+++ G ++ E++  R  I      G + +  W K I   G    E 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV--RHKI---LFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 421 LLDPRLKCTSRN 432
           +   +L+ T RN
Sbjct: 242 M--KKLQPTVRN 251

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 30/167 (17%)

Query: 229 ELMIASSLHHPNIVPLVG-------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG---V 278
           E  + S L HP IV           FCI        I +Y  G  L+  L E K     +
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCI--------ITEYCEGRDLDCKLEELKHTGKTL 103

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
             N    W +  ++ LG    V Y+H   +R ++HRD+K  NI L    + K+ DFG++ 
Sbjct: 104 SENQVCEWFI--QLLLG----VHYMH---QRRILHRDLKAKNIFLK-NNLLKIGDFGVSR 153

Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
                    L  T  GT  Y++PE  +H     K+D+++ G +L E+
Sbjct: 154 LLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPNIVPLVG 246
           +G+G    V+K       +  A+K LD   +  E  +A   E  I  SL +HPN+V   G
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPNHPNVVKFYG 86

Query: 247 FCIDPEQ----GLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESVA 301
                ++     L+L+ +  +GGS+   +      G R +  +   + Y   LG+     
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ---- 142

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           +LHN     ++HRD+K +NILL+++   KL DFG++   +  S      T  GT  ++AP
Sbjct: 143 HLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 197

Query: 362 EYF----QHGKVSD-KTDVYAFGVVLLELLTGRKPI 392
           E      Q+    D + DV++ G+  +EL  G  P+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 65/245 (26%), Positives = 98/245 (40%), Gaps = 47/245 (19%)

Query: 183 NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V +  +    +  L+LI +++ GG +   L +K        TL      +    IAE+
Sbjct: 62  WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTL---TEEETQFYIAET 110

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--------------SAPS- 344
           V  + +  +   +HRDIKP N+LL SK   KL DFGL T                S PS 
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 345 VPF------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
             F                  L  +  GT  Y+APE F     +   D ++ GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 387 TGRKP 391
            G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 65/229 (28%), Positives = 94/229 (41%), Gaps = 31/229 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       IAE V
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDM---ARFYIAEMV 112

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL-------ATWTSAPSVPFLCKTVK 353
             +H+  +   VHRDIKP N+LL      +L DFG         T  S+ +V        
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------- 164

Query: 354 GTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
           GT  Y++PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 42/234 (17%)

Query: 190 LGRGALSFVFKG----------KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           LG+G  + ++KG                 SV +K L   D   S AF     + S L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           ++V L G C+  E    ++ +YV  G L+  LH +K  V    +L W  +  VA  +A +
Sbjct: 62  HLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNV----SLHW--KLDVAKQLASA 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT------SAPSVPFLCKTVK 353
           + YL +     +VH ++   NIL        +  +GL          S P +P    + +
Sbjct: 114 LHYLEDKK---LVHGNVCGKNIL--------VARYGLNEGYVPFIKLSDPGIPITVLSRE 162

Query: 354 ---GTFGYLAPEYFQHGKVSDKT--DVYAFGVVLLELLT-GRKPIEARRLQGEE 401
                  ++APE  ++G+ S     D ++FG  LLE+ + G +P+       +E
Sbjct: 163 ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 25/210 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK+L +  +    +K   REL +   + H N++ L+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 246 G-FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             F         Q ++L+   + G  L   +  +K            +++ V   I   +
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD-------HIQFLV-YQILRGL 131

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     ++HRD+KPSNI ++     K+ DFGLA  T      ++      T  Y A
Sbjct: 132 KYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRA 183

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE        +   D+++ G ++ ELLTG+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 40/226 (17%)

Query: 187 GRVLGRG--ALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIV 242
             ++G+    L  V   K     T VA+K+  LD   KE  K   +E++ +  L HPNI+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P V      +  L+++   ++ GS    L+ H             LP      +   +  
Sbjct: 63  PYV-TSFIVDSELYVVSPLMAYGSCEDLLKTHF---------PEGLPELAIAFILKDVLN 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV--------PFLCK 350
           ++ Y+H+  +   +HR +K S+ILLS      L          + S+             
Sbjct: 113 ALDYIHS--KGF-IHRSVKASHILLSGDGKVVLSGL-----RYSVSMIKHGKRQRVVHDF 164

Query: 351 TVKGTF--GYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
                    +L+PE  Q    G  ++K+D+Y+ G+   EL  G  P
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 76/325 (23%), Positives = 126/325 (38%), Gaps = 97/325 (29%)

Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGK- 202
           E++W+ I++ E +    I P      +L Y E       N   G+ LG GA   V +   
Sbjct: 5   EIRWKIIEAAEGNNYTFIDPT-----QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATA 59

Query: 203 VGLLR----TSVAIKRLD-KEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG-- 254
            GL +      VA+K L      +  +A   EL I S L  H NIV L+G C     G  
Sbjct: 60  FGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---HGGP 116

Query: 255 LFLIYKYVSGGSL---------------------------ERHLHEKKKGVRGNSTL--- 284
           + +I +Y   G L                            +++  +KK +R +S     
Sbjct: 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176

Query: 285 ---------PWSVRYKVALG------------------------IAESVAYLHNGTERCV 311
                    P S     +                          +A+ + +L   ++ C+
Sbjct: 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCI 234

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT----FGYLAPEYFQHG 367
            HRD+   N+LL+  ++ K+CDFGLA      S       VKG       ++APE     
Sbjct: 235 -HRDVAARNVLLTDGRVAKICDFGLARDIMNDS----NYVVKGNARLPVKWMAPESIFDC 289

Query: 368 KVSDKTDVYAFGVVLLELLT-GRKP 391
             + ++DV+++G++L E+ + G+ P
Sbjct: 290 VYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 14/215 (6%)

Query: 187 GRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           G+ LG G    V +G++     +L+ +V   ++    +   + F  E +      HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 243 PLVGFCIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L+G C+   +        +I  ++  G L   L   + G      LP  +  K    IA
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIA 122

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             + YL   + +  +HRD+   N +L+      + DFGL+            +  K    
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           ++A E       + K+DV++FGV + E+ T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD-----KEDKESSKAFCRELMIASSLHHPNIVPL 244
           +G+G    VFK       +  A+K LD      E+ E+     + L       HPN+V  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80

Query: 245 VG--FCIDPEQG--LFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 299
            G  +  D + G  L+L+ +  +GGS+   +    K+G R    +   + ++  +G+   
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ-- 138

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
             +LH       +HRD+K +NILL+++   KL DFG++   +  S      T  GT  ++
Sbjct: 139 --HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWM 191

Query: 360 APEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPI 392
           APE     +  D T     DV++ G+  +EL  G  P+
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V      +   +VAIK+L +  ++   +K   REL++   ++H NI+ L+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 246 GFCIDPE------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
                P+      Q ++L+ +      ++ +L +  +    +  + + + Y++  GI   
Sbjct: 82  N-VFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLL-YQMLCGIK-- 132

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFG 357
             +LH+     ++HRD+KPSNI++ S    K+ DFGLA    TS    P++      T  
Sbjct: 133 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TRY 182

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           Y APE        +  D+++ G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 63/227 (27%), Positives = 94/227 (41%), Gaps = 27/227 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L + +  +  +    +     +A+   +SV
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI---DSV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKTVKGT 355
             LH       VHRDIKP NIL+      +L DFG     +   T   SV        GT
Sbjct: 119 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV------GT 166

Query: 356 FGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
             Y++PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 35/105 (33%), Positives = 49/105 (46%), Gaps = 7/105 (6%)

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +AE V  +H+  +   VHRDIKP N+L+      KL DFG A   +A  +    K   GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166

Query: 356 FGYLAPEYFQHGKVSDKT------DVYAFGVVLLELLTGRKPIEA 394
             Y+APE         K       D ++ GV+  E++ GR P   
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 70

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVR--YKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N    P +++   ++A  I
Sbjct: 71  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 183

Query: 357 --GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
              ++APE  + G  +  +D+++FGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 3/115 (2%)

Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           V  +  LP      +   + E++AYLH    R ++HRD+K  NI L   +   L DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               A      C    GT    +PE         KTD+++ G+VL E+      +
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 9e-08
 Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 45/231 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRE----LMIASS-----L 236
           +V+GRGA   V   K+       A+K L+K +  K +  A  RE    L+         L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H         +    E  L+L+  Y  GG L   L       +    LP  +       +
Sbjct: 67  H---------YAFQDENNLYLVMDYYVGGDLLTLLS------KFEDRLPEDM---ARFYL 108

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKT 351
           AE V  + +  +   VHRDIKP N+LL      +L DFG     LA  T   +V      
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV---- 164

Query: 352 VKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
             GT  Y++PE  Q      G+   + D ++ GV + E+L G  P  A  L
Sbjct: 165 --GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 63/261 (24%), Positives = 98/261 (37%), Gaps = 67/261 (25%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED--KESSKAFCR-ELMIASS 235
           F K + +G GA      G+V L+R        A+K L K D    +  A  + E  I + 
Sbjct: 3   FVKIKTIGIGAF-----GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             +  +V L  +    +  L+ +  Y+ GG +   L   + G+          R+ +A  
Sbjct: 58  ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDL----ARFYIA-E 109

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WT------------ 340
           +  ++  +H       +HRDIKP NIL+      KL DFGL T   WT            
Sbjct: 110 LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 341 -----------SAPSVPFLCKTVK----------------GTFGYLAPEYFQHGKVSDKT 373
                      S        K ++                GT  Y+APE       +   
Sbjct: 167 RQDSMEPSEEWSEID-RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 374 DVYAFGVVLLELLTGRKPIEA 394
           D ++ GV+L E+L G+ P  A
Sbjct: 226 DWWSVGVILYEMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 14/103 (13%)

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
                VP V    + +   +L+ +++ G +L+    E+K+               +A  +
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKE--------------DIAEQL 95

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           AE +A LH      + H D+ P NIL+   KI  + D+  A +
Sbjct: 96  AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 24/159 (15%)

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PN+V L  + +  E  +FL+ ++  GG L  H+  K   +       W+    VAL    
Sbjct: 45  PNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDA-- 100

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS-APSVPFLCKTVKGTFG 357
               LH      +V RD+ P+NILL  +   +L  F    W+    S    C        
Sbjct: 101 ----LH---REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS----CDGEAVENM 147

Query: 358 YLAPEYFQHGKVSDKT---DVYAFGVVLLELLTGRKPIE 393
           Y APE    G +S++T   D ++ G +L ELLTG+  +E
Sbjct: 148 YCAPEV---GGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 25/219 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH-P 239
            + K   +G G    V+K +       VA+K  RL+ +++       RE+ +   L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 240 NIVPLVGFCID------PEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYK 291
            IV L+   ++       +  L+L+++Y+    L++ +  + +  G    +    S  Y+
Sbjct: 62  YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCK 350
           +  G    VA+ H   +  V+HRD+KP N+L+   K + K+ D GL    S P   +  +
Sbjct: 119 LLKG----VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171

Query: 351 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTG 388
            V  T  Y APE        S   D+++ G +  E+   
Sbjct: 172 IV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 188 RVLGRGALSFVFKGKVGL---LRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           R+LG G    + +G + L       VAI  L      +  + F  E +      H NIV 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  I     + ++ +Y+S G+L+  L       +    L       +  G+A  + YL
Sbjct: 71  LEG-VITRGNTMMIVTEYMSNGALDSFLR------KHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
              +E   VH+ +    +L++S  + K+  F       + ++ +   + K    + APE 
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEA 179

Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            Q+   S  +DV++FG+V+ E+++ G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKG 354
           I E + YLH    + ++HRD+K  NI ++      + D G A +   AP+  FL   + G
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--FL--GLAG 218

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
           T    APE     K + K D+++ G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 8/106 (7%)

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           S  Y+VA G++    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA      S  
Sbjct: 218 SFSYQVAKGMS----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            +    +    ++APE   +   + ++DV+++G++L E+ + G  P
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 61/275 (22%), Positives = 108/275 (39%), Gaps = 46/275 (16%)

Query: 197 FVFKGKVGLLRTSVAIKRLDKEDKESSKA----FCRELMIASSLHHPNIVPLVGFCIDPE 252
            ++KG        V I+   K+  +  K        E+     +   NI+ + GF ID  
Sbjct: 35  SIYKGIFN--NKEVIIRTF-KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91

Query: 253 QGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             L    LI +Y + G L   L ++K        L +  +  +A+   + +  L+  T +
Sbjct: 92  DDLPRLSLILEYCTRGYLREVLDKEKD-------LSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--G 367
              ++++   + L++     K+   GL    S+P  PF  K V     Y + +       
Sbjct: 145 --PYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PF--KNVN-FMVYFSYKMLNDIFS 197

Query: 368 KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLK 427
           + + K D+Y+ GVVL E+ TG+ P E    +   +L++                L   L 
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII---------NKNNSLKLP--LD 246

Query: 428 CTSRNSAQIARVIQAAA-ACISSEESRRPGIEEII 461
           C           I+    AC S +  +RP I+EI+
Sbjct: 247 C--------PLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I   + Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----AT 180

Query: 356 FGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
             Y APE   +    ++T D+++ G ++ ELLTGR
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 31/233 (13%)

Query: 165 VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK 224
           V + L   ++G+I       S      R  ++   +GK          + + K  K  S+
Sbjct: 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGK------PKCERLIAKRVKAGSR 205

Query: 225 AFCR---ELMIASSLHHPNIVPLVGFCIDPEQGLFL-------IYKYVSGGSLERHLHEK 274
           A  +   E++    L+H NI+ +            +       +Y ++   + +      
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK---- 261

Query: 275 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 334
                 +  L    R  +   +  +V Y+H+   + ++HRDIK  NI L+      L DF
Sbjct: 262 ------DRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           G A         F    V GT    +PE        + TD+++ G++LL++L+
Sbjct: 312 GTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 21/109 (19%)

Query: 290 YKVALGIAESVAYLHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA-------T 338
           Y   +G +  VA   NG E    +  VHRD+   N+L+   K+ K+CDFGLA        
Sbjct: 238 YMDLVGFSYQVA---NGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294

Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + S  S  FL         ++APE   +   +  +DV++FG++L E+ T
Sbjct: 295 YISKGST-FL------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 38/108 (35%), Positives = 59/108 (54%), Gaps = 21/108 (19%)

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------TW 339
           S  Y+VA G+ E +A     ++ CV HRD+   N+LL+  KI K+CDFGLA        +
Sbjct: 241 SFTYQVARGM-EFLA-----SKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            S  S  FL   VK    ++APE       +  +DV+++G++L E+ +
Sbjct: 294 VSKGST-FL--PVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 32/207 (15%)

Query: 193 GALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLVGF-- 247
           G +      + G     VAIK+L +    +  + +A+ REL +   + H N++ L+    
Sbjct: 29  GTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFT 84

Query: 248 ---CIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
               +D     +L+  ++ G  L + + HEK    R        +++ V   + + + Y+
Sbjct: 85  PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDR--------IQFLV-YQMLKGLKYI 134

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H      ++HRD+KP N+ ++     K+ DFGLA  T +    ++      T  Y APE 
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEV 186

Query: 364 FQHG-KVSDKTDVYAFGVVLLELLTGR 389
             +    +   D+++ G ++ E+LTG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 26/155 (16%)

Query: 192 RGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLV 245
           RGA   V+ G+        A+K + K D          +A    L ++ S   P IV L 
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS---PFIVHLY 70

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA---Y 302
            + +     ++L+ +Y+ GG ++  LH     + G      +V+Y     I+E      Y
Sbjct: 71  -YSLQSANNVYLVMEYLIGGDVKSLLH-----IYGYFDEEMAVKY-----ISEVALALDY 119

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH      ++HRD+KP N+L+S++   KL DFGL+
Sbjct: 120 LH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 46/157 (29%)

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WT------------ 340
           IAE    + +  +   +HRDIKP NIL+      KL DFGL T   WT            
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 341 SAPSVPF------------------------------LCKTVKGTFGYLAPEYFQHGKVS 370
              S+ F                              L  ++ GT  Y+APE       +
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 371 DKTDVYAFGVVLLELLTGRKPIEARR-LQGEENLVLW 406
              D ++ GV+L E+L G+ P  A+  L+ +  ++ W
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 26/188 (13%)

Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV-----GFCIDPEQGLFLIYKYV 262
           VAIK+L +  + +  +K   REL +   + H N++ L+         D  Q  +L+  Y 
Sbjct: 43  VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY- 101

Query: 263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL 322
                   +    + + G+      V+Y V   +   + Y+H+     ++HRD+KP N+ 
Sbjct: 102 --------MQTDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHSAG---IIHRDLKPGNLA 149

Query: 323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVV 381
           ++     K+ DFGLA    A    ++      T  Y APE   +    ++T D+++ G +
Sbjct: 150 VNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILNWMHYNQTVDIWSVGCI 204

Query: 382 LLELLTGR 389
           + E+LTG+
Sbjct: 205 MAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 18/140 (12%)

Query: 149 ELKWRKIQSLERSISPVANSLIRLSYGEI-LAATHNFSK-----GRVLGRGALSFVFKGK 202
           E++WR I+S    ISP  +  I +   ++   +   F +     GR+LG GA   V +G 
Sbjct: 2   EIRWRVIES----ISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGT 57

Query: 203 V-GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGL 255
             GL R+     VA+K L    + S K A   EL I + L  H NIV L+G C      +
Sbjct: 58  AYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SGPI 116

Query: 256 FLIYKYVSGGSLERHLHEKK 275
           ++I +Y   G L  +LH+ +
Sbjct: 117 YIITEYCFYGDLVNYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 63/269 (23%), Positives = 99/269 (36%), Gaps = 83/269 (30%)

Query: 183 NFSKGRVLGRGA---LSFVFK---GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           +F   +V+G+GA   +  V K   GK+  ++T +  +   K+     KA  R+++  S  
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE-RDVLAESD- 59

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 292
             P +V L  +     Q L+LI +++ GG L   L                ++Y      
Sbjct: 60  -SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----------------IKYDTFSED 101

Query: 293 --ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL-------------- 336
                +AE V  +    +   +HRDIKP NIL+      KL DFGL              
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 337 ---------------------------------ATWTSAPSVPFLCKTVKGTFGYLAPEY 363
                                            ATW     +  +  +  GT  Y+APE 
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEI 219

Query: 364 F-QHGKVSDKTDVYAFGVVLLELLTGRKP 391
           F Q G    + D ++ G ++ E L G  P
Sbjct: 220 FLQQG-YGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 17/213 (7%)

Query: 190 LGRGALSFVFKGKV--GLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G    V  G+V  G     V +K L      +    F  E     SL H N++  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C +    L L+ ++   G L+ +L   +K      T   +   ++A  IA  + +LH  
Sbjct: 63  QCTEVTPYL-LVMEFCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ- 365
                +H D+   N LL++    K+ D+GL+              +     ++APE    
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 366 -HGK--VSDKT---DVYAFGVVLLELLT-GRKP 391
            HG   V D+T   +V++ GV + EL   G +P
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V       LR  VA+K+L +  +    ++   REL +   + H N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                        Y+    +   L+   K  + +      + Y++  G+     Y+H+  
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK----YIHSAG 138

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
              ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y APE   + 
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV-----ATRWYRAPEIMLNW 190

Query: 368 KVSDKT-DVYAFGVVLLELLTGR 389
              ++T D+++ G ++ ELL G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 36/128 (28%), Positives = 48/128 (37%), Gaps = 45/128 (35%)

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLAT---WTS----------------APSVPF----- 347
           +HRDIKP NIL+      KL DFGL T   WT                  PS  +     
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 348 ---------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
                                L  ++ GT  Y+APE       +   D ++ GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 387 TGRKPIEA 394
            G+ P  A
Sbjct: 243 VGQPPFLA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 10/117 (8%)

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSA--PSVPFLCKTVKGTFGY 358
           Y+H+     V+HRD+KP+N+ ++++  + K+ DFGLA           +L + +   + Y
Sbjct: 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-Y 184

Query: 359 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILHR 413
            +P          K  D++A G +  E+LTG KP+ A   + E+  L+L + P++  
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVRE 240

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 23/166 (13%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E  I  +++HP+I+ L G     +    ++ +Y +   L  +L  K+        +    
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRN-------IAICD 183

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
              +   +  ++ YLH      ++HRDIK  NI ++      L DFG A +      P  
Sbjct: 184 ILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF------PVD 234

Query: 349 CKTVK-----GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
               K     GT    APE           D+++ G+VL E+ T  
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 32/200 (16%)

Query: 210 VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGS 266
           V ++R++ E    E       EL ++   +HPNIVP    F  D E  L+++  +++ GS
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGS 85

Query: 267 LE----RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL 322
            +     H  +      G S L  ++ Y +  G+ +++ Y+H+      VHR +K S+IL
Sbjct: 86  AKDLICTHFMD------GMSEL--AIAY-ILQGVLKALDYIHH---MGYVHRSVKASHIL 133

Query: 323 LSSKKIPKLCDFGLATWTS-------APSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKT 373
           +S     K+   GL +  S          V    K       +L+PE  Q        K+
Sbjct: 134 ISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191

Query: 374 DVYAFGVVLLELLTGRKPIE 393
           D+Y+ G+   EL  G  P +
Sbjct: 192 DIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HPNI+  +G C++    L L+++Y   G L+ +L +++   R +  L      ++A  
Sbjct: 52  LQHPNILQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           IA  V ++H   +   +H D+   N  L+S    K+ D+G+                   
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 356 FGYLAPEYFQ--HGKV--SDKT---DVYAFGVVLLELL 386
             +LAPE     HG +  +++T   +V+A GV L EL 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	520
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.12
KOG1243	690	consensus Protein kinase [General function predict	99.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
KOG3087	229	consensus Serine/threonine protein kinase [General	98.93
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.84
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.79
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.45
PRK09902	216	hypothetical protein; Provisional	98.45
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.21
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.15
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.13
PF01636	239	APH: Phosphotransferase enzyme family This family	98.07
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.04
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.99
PLN02876	822	acyl-CoA dehydrogenase	97.95
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.86
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.84
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.5
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.37
PRK05231	319	homoserine kinase; Provisional	97.36
PRK10593	297	hypothetical protein; Provisional	97.34
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.33
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.32
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.19
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.85
PLN02236	344	choline kinase	96.78
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.62
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.58
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.12
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.95
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.88
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.8
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.75
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.69
PLN02756	418	S-methyl-5-thioribose kinase	95.66
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.45
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.16
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.98
KOG2270	520	consensus Serine/threonine protein kinase involved	94.89
PRK06148	1013	hypothetical protein; Provisional	94.72
COG2334	331	Putative homoserine kinase type II (protein kinase	94.5
PRK11768	325	serine/threonine protein kinase; Provisional	94.31
PRK12396	409	5-methylribose kinase; Reviewed	94.29
PTZ00384	383	choline kinase; Provisional	93.96
PTZ00296	442	choline kinase; Provisional	93.77

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-59  Score=486.31  Aligned_cols=292  Identities=43%  Similarity=0.761  Sum_probs=256.3

Q ss_pred             ccccccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEE
Q 010012          168 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF  247 (520)
Q Consensus       168 ~~~~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~  247 (520)
                      ....|+|.||..||++|+..++||+|+||.||+|.+.+ +..||||++........++|.+|++++.+++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            56789999999999999999999999999999999985 58999999877544314569999999999999999999999


Q ss_pred             EEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       248 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      |.+.+...+||||||++|+|.++|+....     .+++|..|++||.++|+||+|||+...++||||||||+|||||+++
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            99876447899999999999999997542     1799999999999999999999999988999999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      .+||+|||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+.+..+++.|+
T Consensus       215 ~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             CEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            9999999999766541 111111117999999999999999999999999999999999999999876666677799999


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNS-AQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~-~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ++.+.++  .+.+++|+++....+.. .++.+++.+|.+|++.+|.+||+|.||+++|+.+.
T Consensus       294 ~~~~~~~--~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  294 KPLLEEG--KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHCc--chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9999887  89999999997433333 68899999999999999999999999999996543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=396.29  Aligned_cols=257  Identities=37%  Similarity=0.588  Sum_probs=207.1

Q ss_pred             cccceEEcccCceEEEEeeecCCCcE-EEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTS-VAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~-vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +...+.||+|+||+||+|.++  |+. ||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+....+++|||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            344456999999999999997  455 99999976532  2256899999999999999999999999876645899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~~  339 (520)
                      ||++|+|.++|+...     ...+++..++.||.|||+||+|||+++.  ||||||||+||||+.++ ++||+|||+++.
T Consensus       121 y~~~GsL~~~l~~~~-----~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKR-----KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             eCCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence            999999999998742     2689999999999999999999998764  99999999999999997 999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcc--cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .....  ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||......+      .+..       .
T Consensus       194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~-------v  258 (362)
T KOG0192|consen  194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASA-------V  258 (362)
T ss_pred             ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHH-------H
Confidence            65432  1234478999999999999  5689999999999999999999999998654311      0100       1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                      +.....+.+.  ..   ....+..++.+||..||..||++.+|+.+|+.+..
T Consensus       259 ~~~~~Rp~~p--~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  259 VVGGLRPPIP--KE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             HhcCCCCCCC--cc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            1122222222  11   23345666777999999999999999999987644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=380.49  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=209.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +.+..+.||+|..|+||+++++.+++.+|+|.+... +....+++.+|+++++..+||+||.++|.|......+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            455667899999999999999999999999999544 4566788999999999999999999999988755348999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |.+|||+.++...       ..+++...-+|+.++++||.|||+ .+   ||||||||+||||+..|.|||||||.++.+
T Consensus       160 MDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             cCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999864       569999999999999999999996 44   999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...    .+.+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... .   ..|+        .-+..
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~---~~~~--------~Ll~~  293 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-Y---LDIF--------ELLCA  293 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-C---CCHH--------HHHHH
Confidence            654    457788999999999999999999999999999999999999999865211 0   1111        12344


Q ss_pred             hhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +++.. -..+..  ....++..++..||++||.+||++.|+++
T Consensus       294 Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            44421 111221  23345667778899999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-47  Score=397.30  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=211.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..|..++.||+|||++||.++...+|..||+|++.+.   .....+...+|++|.++|+|||||+++++|.+. +.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-NNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-CceEEE
Confidence            4699999999999999999999889999999999874   344567788999999999999999999987664 559999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      .|+|+.++|.++++..       .++++.+++.++.||+.||.|||+.+   |||||||..|+||+++.++||+|||||.
T Consensus        97 LELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence            9999999999999853       67999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .+..+..  ...+.+||+.|+|||++....++..+||||+|||+|.||.|++||+.....+                 .+
T Consensus       167 ~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----------------ty  227 (592)
T KOG0575|consen  167 QLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----------------TY  227 (592)
T ss_pred             eecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----------------HH
Confidence            8875432  2356789999999999999999999999999999999999999998764332                 12


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.-.....+..   ....+.+|+..+|+.+|.+|||+++|+.
T Consensus       228 ~~Ik~~~Y~~P~~---ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  228 NKIKLNEYSMPSH---LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcCcccccc---cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2222222222222   2344667788999999999999999997

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=376.40  Aligned_cols=204  Identities=31%  Similarity=0.581  Sum_probs=184.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..+|...+.||.|+||+||+|+++.++..||||.+.+.  .++..+.+..|+.+|+.++|||||.|++++.. ++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence            35788889999999999999999999999999999876  55667778899999999999999999997655 5579999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC------CceEEe
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK------KIPKLC  332 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~------~~vkL~  332 (520)
                      ||||.||+|.+|++..       ..+++.+.+.++.|||.||++||+++   ||||||||.||||+..      -.+||+
T Consensus        88 MEyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEec
Confidence            9999999999999875       47999999999999999999999998   9999999999999865      468999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                      |||+|+.+....   ...+.+|++-|||||+++..+|+.|+|+||+|+|||||++|+.||......
T Consensus       158 DFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  158 DFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             ccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            999999887543   345778999999999999999999999999999999999999999876554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-46  Score=376.25  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=205.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-------HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-------SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      +.|...+.||+|+||.|-+|..+.+++.||||++.+....       ......+|+++|++|+|||||++++++..++ .
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-s  250 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-S  250 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-c
Confidence            4677889999999999999999999999999999764211       1223469999999999999999999976654 4


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC---CceEE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKL  331 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~---~~vkL  331 (520)
                      .|+||||+.||+|.+++-..       ..+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence            79999999999999999875       45777788899999999999999988   9999999999999765   78999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCC---CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV---SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~---s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      +|||+|+..+...   ...+.+||+.|+|||++.+..+   ..++|+||+||+||-+++|.+||.......  .      
T Consensus       321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s------  389 (475)
T KOG0615|consen  321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S------  389 (475)
T ss_pred             cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c------
Confidence            9999999887443   4577899999999999987653   348899999999999999999998654321  1      


Q ss_pred             hHhhhchhHHHHhhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                              ..+++...++.. +........+.++++.++|..||++|||+.|+++
T Consensus       390 --------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 --------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                    112223333332 2223445567889999999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=371.55  Aligned_cols=242  Identities=27%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|+..++||+|+||.||.++.+++++.+|+|++++..   ....+...+|..||.+++||+||+++..|.+ .+.+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence            368999999999999999999999999999999998752   3345677899999999999999999977655 556999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |+||+.||.|..+|.+.       ..+++..+..++.+|+.||.|||+.+   ||||||||+|||||++|+++|+||||+
T Consensus       103 Vld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             EEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccc
Confidence            99999999999999865       57999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +..-....  .+.+++||+.|||||++....|+..+||||+||++|||++|.+||...+...                 .
T Consensus       173 k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----------------~  233 (357)
T KOG0598|consen  173 KEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----------------M  233 (357)
T ss_pred             hhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----------------H
Confidence            85433322  2356789999999999999999999999999999999999999998754321                 2


Q ss_pred             HHHhhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCC
Q 010012          418 VEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRP  455 (520)
Q Consensus       418 l~~~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RP  455 (520)
                      ++.++..++.. +...+.   ...+++...|+.+|++|-
T Consensus       234 ~~~I~~~k~~~~p~~ls~---~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  234 YDKILKGKLPLPPGYLSE---EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHhcCcCCCCCccCCH---HHHHHHHHHhccCHHHhc
Confidence            22333333221 222333   455677889999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=360.30  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=212.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc-EEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG-LFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~-~~LV  258 (520)
                      .+|.+.+.||.|.||+||+++...++..||.|.+.-+  +....+.+..|+.+|++|+|||||+++++.+..+.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3688889999999999999999999999999998643  456677899999999999999999999854443443 8899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-ceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER-CVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||.+|+|...++..++.   ...+++..+|+++.|++.||..+|+.-.+ .|+||||||.||+|+.+|.+||+||||+
T Consensus        99 mE~c~~GDLsqmIk~~K~q---kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ---KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc---cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999876542   36799999999999999999999984322 3999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.+.....  ...+.+|||.||+||.+...+|+.||||||+||++|||..-++||.+.+.      ...-+        .
T Consensus       176 r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~--------K  239 (375)
T KOG0591|consen  176 RFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCK--------K  239 (375)
T ss_pred             hHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHH--------H
Confidence            98876433  45678899999999999999999999999999999999999999987632      11111        1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      +...--|.+.    ..-....+.+|+..|+..||+.||+...++..++.
T Consensus       240 I~qgd~~~~p----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  240 IEQGDYPPLP----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHcCCCCCCc----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            2211111121    12334567778888999999999996666655544

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=362.87  Aligned_cols=289  Identities=24%  Similarity=0.315  Sum_probs=233.0

Q ss_pred             cchhhHHHHHHHHHhhhhhccCccccccccccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-
Q 010012          142 LCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-  220 (520)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-  220 (520)
                      ..+++..+..|+.++........             ....+.|...+.||.|.-|+||++.++.++..+|+|++++... 
T Consensus        50 ~kph~~~d~~w~a~~~~~~~~~~-------------~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~  116 (459)
T KOG0610|consen   50 NKPHKGNDVRWEAISSIRNSKDG-------------SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA  116 (459)
T ss_pred             CCCCCCCchhhhhhccccccCCC-------------ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh
Confidence            34556667789888765531111             1123578888999999999999999999899999999988643 


Q ss_pred             --HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHH
Q 010012          221 --ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE  298 (520)
Q Consensus       221 --~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~  298 (520)
                        +...+...|-+||+.++||.+++||..+ +.++..|||||||+||+|..+++++..     ..+++..++.++.+++.
T Consensus       117 ~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-et~~~~cl~meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~  190 (459)
T KOG0610|consen  117 SRKKLKRAQTEREILSLLDHPFLPTLYASF-ETDKYSCLVMEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLL  190 (459)
T ss_pred             hhhHHHHHHHHHHHHHhcCCCccchhhhee-eccceeEEEEecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHH
Confidence              3445667899999999999999999975 557789999999999999999988764     78999999999999999


Q ss_pred             HHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC---------------------------------CC
Q 010012          299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP---------------------------------SV  345 (520)
Q Consensus       299 aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~---------------------------------~~  345 (520)
                      ||+|||.+|   ||+|||||+||||.++|+|.|+||.|+......                                 ..
T Consensus       191 ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~  267 (459)
T KOG0610|consen  191 ALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSK  267 (459)
T ss_pred             HHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccc
Confidence            999999999   999999999999999999999999998543210                                 00


Q ss_pred             ---------------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          346 ---------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       346 ---------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                                           ...+.+++||..|+|||++.+..++.++|||+|||+||||+.|..||.+.+..+     
T Consensus       268 ~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----  342 (459)
T KOG0610|consen  268 KRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----  342 (459)
T ss_pred             ccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----
Confidence                                 011235679999999999999999999999999999999999999999866432     


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH--HHhcCcch
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG----IEEIIA--ILRGEEEL  470 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt----m~eVl~--~L~~~~~~  470 (520)
                                  .+..++-..+..+.. +.....+.+|+++.|.+||.+|-.    +.||-+  ..++.+..
T Consensus       343 ------------Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  343 ------------TLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             ------------hHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence                        455566555654432 345567788999999999999998    888876  45665554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=372.55  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=210.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|..++.||+|+|++|++|+.+.+++.||||++.+.-   ....+-...|-++|.+| .||.|++|+-.|.| +..+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~sL  149 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EESL  149 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-ccce
Confidence            3468999999999999999999999999999999997642   22233456788889998 89999999988766 4569


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      |+|+||+++|+|.++|++.       +.+++...+.+|.+|+.||+|||+.|   ||||||||+|||||+||++||+|||
T Consensus       150 YFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999999876       57999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCC---------ccc--ccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          336 LATWTSAPSVP---------FLC--KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       336 la~~~~~~~~~---------~~~--~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      .|+.+......         ..+  .+++||..|++||++..+..+..+|+|+||||||+|+.|.+||.+.+..    + 
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----l-  294 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----L-  294 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----H-
Confidence            99987643211         112  4588999999999999999999999999999999999999999875432    1 


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                                  ...++++-.+..+...++   .+.+|+.+.|..||.+|+|..+|-+.
T Consensus       295 ------------iFqkI~~l~y~fp~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 ------------IFQKIQALDYEFPEGFPE---DARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ------------HHHHHHHhcccCCCCCCH---HHHHHHHHHHccCccccccHHHHhhC
Confidence                        233344444444444443   45667788999999999999888773

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=372.24  Aligned_cols=257  Identities=31%  Similarity=0.466  Sum_probs=209.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..+.+...+.||+|-||.||.|.++. ...||+|.++... ...+.|.+|+++|++|+|+|||+|+|+|...+ .++|||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVt  280 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVT  280 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEE
Confidence            33455667889999999999999985 4589999997653 34578999999999999999999999997754 689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||+.|+|.++|....+     ..+.......++.|||+|++||++++   +|||||.+.||||+++..+||+|||||+.
T Consensus       281 E~m~~GsLl~yLr~~~~-----~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREG-----GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             EecccCcHHHHhhhcCC-----CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence            99999999999987332     67899999999999999999999988   99999999999999999999999999995


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ..++.. .......-...|.|||.+..++++.|||||||||+||||+| |+.|+......+.       ...+.+|    
T Consensus       353 ~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~~le~G----  420 (468)
T KOG0197|consen  353 IGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LELLERG----  420 (468)
T ss_pred             cCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HHHHhcc----
Confidence            544332 12222334567999999999999999999999999999999 9999876543321       1112222    


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                           .++..+..++.+   +-+++..||+.+|++|||+..+...|+..
T Consensus       421 -----yRlp~P~~CP~~---vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  421 -----YRLPRPEGCPDE---VYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             -----CcCCCCCCCCHH---HHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence                 245555556665   44567789999999999999988888754

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-43  Score=365.27  Aligned_cols=267  Identities=25%  Similarity=0.406  Sum_probs=206.2

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ..++|...+.||+|+||.||+|.+.     .++..||||++.... ......+.+|+.++..+ +||||++++++|....
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3468999999999999999999742     335679999997543 33456788999999999 8999999999988766


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCC------------------------------------------------------
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------  278 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~------------------------------------------------------  278 (520)
                      ..+++||||+++|+|.+++.......                                                      
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            67899999999999999997532100                                                      


Q ss_pred             -CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCC
Q 010012          279 -RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG  357 (520)
Q Consensus       279 -~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~  357 (520)
                       ....++++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence             00135888999999999999999999887   99999999999999999999999999986543322112223456788


Q ss_pred             ccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHH
Q 010012          358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQI  436 (520)
Q Consensus       358 Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  436 (520)
                      |+|||++.+..++.++|||||||+||||++ |..||.......  ...    ..       +........  +.   ...
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~-------~~~~~~~~~--~~---~~~  303 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QR-------LKDGTRMRA--PE---NAT  303 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HH-------HhcCCCCCC--CC---CCC
Confidence            999999998899999999999999999997 999997543211  000    00       111011111  11   122


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          437 ARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       437 ~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            3577888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=344.95  Aligned_cols=237  Identities=27%  Similarity=0.390  Sum_probs=206.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||.|+||+|.+++.+.++..+|+|++++..   ....+...+|..+|+.+.||+++++++.|.+.. .+++|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-NLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-eEEEE
Confidence            58999999999999999999999999999999998764   334556778999999999999999999887754 58999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||++||.|..+|++.       .++++..++.+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+
T Consensus       123 meyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EeccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceE
Confidence            9999999999999875       57999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....     +-+.+||+.|+|||++....++.++|+|||||++|||+.|.+||...++-.                 ..
T Consensus       193 ~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----------------iY  250 (355)
T KOG0616|consen  193 RVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----------------IY  250 (355)
T ss_pred             EecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----------------HH
Confidence            87653     346789999999999999999999999999999999999999998765421                 34


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR  454 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~R  454 (520)
                      ..++...+..+......   +.+|+...|+.|-.+|
T Consensus       251 ~KI~~~~v~fP~~fs~~---~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  251 EKILEGKVKFPSYFSSD---AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHhCcccCCcccCHH---HHHHHHHHHhhhhHhh
Confidence            55666677666555554   4455677888898888

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=353.49  Aligned_cols=257  Identities=31%  Similarity=0.462  Sum_probs=201.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-cEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~~LV~E  260 (520)
                      .++..++.||+|+||+||++...+++...|||.+........+.+.+|+.+|++++|||||+++|.....+. .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            357778899999999999999988899999999977643346778999999999999999999996444343 5789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~~  339 (520)
                      |+++|+|.+++....      ..+++..+..++.||++||+|||+++   ||||||||+||||+. ++.+||+|||+++.
T Consensus        97 y~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccc
Confidence            999999999998753      26999999999999999999999888   999999999999999 79999999999987


Q ss_pred             cCC-CCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          340 TSA-PSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       340 ~~~-~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ... ...........||+.|||||++..+. ...++|||||||++.||+||++||... . +   ...+...+..     
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-~---~~~~~~~ig~-----  237 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F-E---EAEALLLIGR-----  237 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c-c---hHHHHHHHhc-----
Confidence            663 11112234578999999999999643 345999999999999999999999753 0 0   0111111100     


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                        +-.-|.+  +...+   ....+++..|++.+|++|||+.++++..
T Consensus       238 --~~~~P~i--p~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  238 --EDSLPEI--PDSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             --cCCCCCC--CcccC---HHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence              0011212  22222   3455667789999999999999999843

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=359.26  Aligned_cols=251  Identities=30%  Similarity=0.437  Sum_probs=207.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc----ch-HHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~  253 (520)
                      ..++|..++.||+|+||+|+.|....++..||+|++++.    .. ...+.+.+|+.+++.++ ||||++++.++.... 
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence            346899999999999999999999988999999987764    12 23456668999999999 999999999976654 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEe
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLC  332 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~  332 (520)
                      .+++||||+.||+|.+++...       .++.+..+..++.|++.|++|||+.+   |+||||||+|||++.+ +++||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEe
Confidence            489999999999999999873       56888999999999999999999988   9999999999999999 999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCC-CC-CcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s-~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |||++......  .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.......           
T Consensus       164 DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----------  230 (370)
T KOG0583|consen  164 DFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----------  230 (370)
T ss_pred             ccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----------
Confidence            99999977411  12346778999999999999877 75 78999999999999999999998633211           


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                            ....+....+..+....  ...+..++.+||..+|.+|+|+.+|+.
T Consensus       231 ------l~~ki~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 ------LYRKIRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------HHHHHhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  11223333344333321  455777889999999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-43  Score=340.72  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +.|....++|+|+||+||+++++++|+.||||++....  +...+-.++|+.+|++|+|+|+|.|+++|.. ...++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            35777889999999999999999999999999986542  3444556899999999999999999999765 45699999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||+..-| +-|....      ..++.....+++.|++.|+.|+|+++   +|||||||+||||+.++.+||||||+|+.
T Consensus        81 E~~dhTvL-~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   81 EYCDHTVL-HELERYP------NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART  150 (396)
T ss_pred             eecchHHH-HHHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence            99977544 4444433      56899999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-hhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-KPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~~~~~~~~~  417 (520)
                      +..+..  ..+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-++..++... ..++.+    
T Consensus       151 L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr----  224 (396)
T KOG0593|consen  151 LSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR----  224 (396)
T ss_pred             hcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH----
Confidence            875432  2356779999999999987 68999999999999999999999999876544333332221 111111    


Q ss_pred             HHHhhCc-------ccCCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDP-------RLKCT-------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~-------~l~~~-------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -.+++..       ++..+       ...+....-+++++..||+.||.+|++-+|++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1122211       11100       112233446889999999999999999998875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.5e-43  Score=359.89  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ..++|....+||+|+||.||+|+-+++|..+|+|++.+..   ....+....|-.+|...+.|+||+|+..|.+ ..++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeE
Confidence            5579999999999999999999999999999999998864   3455667889999999999999999987766 45699


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      |||||+|||++..+|...       ..|++..+..++.+++.|++-||+.|   +|||||||+|+|||..|++||+||||
T Consensus       218 LiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL  287 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL  287 (550)
T ss_pred             EEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence            999999999999999875       67999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCC----------------------CCCC-----c------------------ccccccccCCccCchhcccCCCCC
Q 010012          337 ATWTSA----------------------PSVP-----F------------------LCKTVKGTFGYLAPEYFQHGKVSD  371 (520)
Q Consensus       337 a~~~~~----------------------~~~~-----~------------------~~~~~~Gt~~Y~aPE~~~~~~~s~  371 (520)
                      +.-+..                      ....     .                  ...+.+|||.|+|||++.+..|+.
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~  367 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK  367 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence            852211                      0000     0                  001367999999999999999999


Q ss_pred             cCceeeHHHHHHHHHhCCCCcchhccccc-hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccC
Q 010012          372 KTDVYAFGVVLLELLTGRKPIEARRLQGE-ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSE  450 (520)
Q Consensus       372 ksDVwS~GvvL~ELltG~~Pf~~~~~~~~-~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~d  450 (520)
                      .+|+||+|||+||||.|.+||....+.+. ..++.|...                +..+. ......++.+++.+|+. |
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~----------------l~fP~-~~~~s~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET----------------LKFPE-EVDLSDEAKDLITRLLC-D  429 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh----------------ccCCC-cCcccHHHHHHHHHHhc-C
Confidence            99999999999999999999998776532 233333221                11111 11122556778889999 9


Q ss_pred             CCCCCC
Q 010012          451 ESRRPG  456 (520)
Q Consensus       451 P~~RPt  456 (520)
                      |.+|-.
T Consensus       430 ~~~RLG  435 (550)
T KOG0605|consen  430 PENRLG  435 (550)
T ss_pred             HHHhcC
Confidence            999987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.4e-43  Score=378.15  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=214.3

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      .+.+....+.||+|+||.||+|...     .....||||.++..... ..++|.+|++++..++|||||+|+|+|.+++ 
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-  562 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD-  562 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-
Confidence            4456667788999999999999863     23567999999876544 7889999999999999999999999998865 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGV-------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~-------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      .+++|+|||..|||.+||.......       ....+|+..+.+.||.|||.|++||-++.   +|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence            5899999999999999998643211       11245889999999999999999999888   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHH
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  405 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~  405 (520)
                      ..|||+||||++..-..+.........-.++|||||.|..+++|.+||||||||+|||+++ |+.|+.+-..++.     
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-----  714 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-----  714 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----
Confidence            9999999999986655444333223345679999999999999999999999999999998 9999987554331     


Q ss_pred             hhhhHhhhchhHHHHhhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          406 WAKPILHRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                                  +..+-+.+ |.++...+.+   +..|+..||+.+|++||+++||-..|+..
T Consensus       715 ------------Ie~i~~g~lL~~Pe~CP~~---vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  715 ------------IECIRAGQLLSCPENCPTE---VYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ------------HHHHHcCCcccCCCCCCHH---HHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                        12222222 4455555555   55677899999999999999999999863

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-41  Score=341.74  Aligned_cols=246  Identities=22%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchH---HHHHHHHHHHHHHhCCCCCeecEEEEEEc--C-CCcEEEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLHHPNIVPLVGFCID--P-EQGLFLIYK  260 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~-~~~~~LV~E  260 (520)
                      ...||+|++|.||+|...  ++.||||++......   ..+.|.+|+.++++++|||||+++|++.+  . ...+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            367999999999999984  789999999765322   25678899999999999999999999876  2 235789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+++|+|.+++...       ..++|.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.
T Consensus       103 y~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988        103 YCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             eCCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            99999999999753       4689999999999999999999974 5   88999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .....     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.......   +   ...+...    
T Consensus       173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~---~~~i~~~----  237 (283)
T PHA02988        173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I---YDLIINK----  237 (283)
T ss_pred             hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHhc----
Confidence            64432     23458899999999976  679999999999999999999999997543221   1   0111100    


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                           ..+...+...   ...+.+++.+||+.||++|||+.+|++.|+..
T Consensus       238 -----~~~~~~~~~~---~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        238 -----NNSLKLPLDC---PLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             -----CCCCCCCCcC---cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                 0111111112   23567788899999999999999999998753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-41  Score=339.86  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|+..+.||+|+||.||+|....+++.||+|.+....   ......+.+|+.+++.++|+||+++++++.+. ...++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEE
Confidence            3777899999999999999998889999999986542   22334678899999999999999999987664 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|..++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        80 e~~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EecCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            99999999988865321     46899999999999999999999888   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......   .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+             ..
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------------~~  215 (285)
T cd05631         152 IPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-------------DR  215 (285)
T ss_pred             cCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-------------HH
Confidence            543221   23456999999999999999999999999999999999999999864432111000             00


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      .+.........   .....+.+++.+||+.+|.+||+     +.++++
T Consensus       216 ~~~~~~~~~~~---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         216 RVKEDQEEYSE---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HhhcccccCCc---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11111111111   12235677889999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5e-42  Score=359.22  Aligned_cols=265  Identities=24%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ..++|+..+.||+|+||.||+|....     ++..||+|++.... ......+.+|+++++.+ +|||||+++++|.+..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            34579999999999999999998532     34579999997543 33456788999999999 8999999999987654


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC-------------------------------------------------------
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG-------------------------------------------------------  277 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~-------------------------------------------------------  277 (520)
                       .+++||||+++|+|.+++......                                                       
T Consensus       116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence             589999999999999998653210                                                       


Q ss_pred             --------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCccc
Q 010012          278 --------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC  349 (520)
Q Consensus       278 --------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  349 (520)
                              .....++++..++.|+.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                    001235889999999999999999999887   999999999999999999999999999865433221122


Q ss_pred             ccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCC
Q 010012          350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKC  428 (520)
Q Consensus       350 ~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~  428 (520)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||........  .   . .       .+.....+.  .
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~---~-~-------~~~~~~~~~--~  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F---Y-K-------MVKRGYQMS--R  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H---H-H-------HHHcccCcc--C
Confidence            23345678999999998899999999999999999997 9999975432110  0   0 0       001101111  1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          429 TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       429 ~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      +...   ...+.+++.+||+.+|++|||+.+|+++|+.
T Consensus       337 ~~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         337 PDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111   2457788889999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-41  Score=347.47  Aligned_cols=245  Identities=28%  Similarity=0.405  Sum_probs=201.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEE
Confidence            57899999999999999999999889999999987542   23345688999999999999999999987764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EcCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999999999754       46889999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ..
T Consensus       167 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----------------~~  224 (329)
T PTZ00263        167 KVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----------------IY  224 (329)
T ss_pred             EcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----------------HH
Confidence            664332     23569999999999999899999999999999999999999997533211                 11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ..+....+..+...   ...+.+++.+||+.||.+||+     +.+++.
T Consensus       225 ~~i~~~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        225 EKILAGRLKFPNWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHhcCCcCCCCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11222222222212   234667889999999999997     677764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-41  Score=341.04  Aligned_cols=268  Identities=26%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             CCcccceEEcccCceEEEEeeecC----------------CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL----------------LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPL  244 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~----------------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l  244 (520)
                      ++|...+.||+|+||.||+|.+..                .+..||+|.+.... ......|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                23479999987643 3445679999999999999999999


Q ss_pred             EEEEEcCCCcEEEEEEecCCCChhHHhhhhccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 010012          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  312 (520)
Q Consensus       245 ~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~Ii  312 (520)
                      ++++.+.+ ..++||||+++|+|.+++......            ......++|..++.++.|++.||.|||+.+   |+
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          85 LGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99987754 589999999999999998653211            011235789999999999999999999888   99


Q ss_pred             ecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh--CCC
Q 010012          313 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRK  390 (520)
Q Consensus       313 HrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt--G~~  390 (520)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++  |..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986544332222233446789999999998899999999999999999987  556


Q ss_pred             CcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          391 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       391 Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ||......   .............   ... .  ....+.   .....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       241 p~~~~~~~---~~~~~~~~~~~~~---~~~-~--~~~~~~---~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDE---QVIENAGEFFRDQ---GRQ-V--YLFRPP---PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHH---HHHHHHHHHhhhc---ccc-c--cccCCC---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            77643221   1111111111110   000 0  000011   12245778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=342.97  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ...|.....||.|..++||+|+....+..||||++..+... ..+.+.+|+..++.++||||++++..|... ..+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEee
Confidence            35889999999999999999999988999999999876443 357889999999999999999999877664 5599999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      .||.+||+.+++.....     ..+++..+..|..++++||.|||.+|   -||||||+.||||+++|.|||+|||.+..
T Consensus       104 pfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             hhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999988654     56999999999999999999999988   99999999999999999999999999865


Q ss_pred             cCCCCCCc--ccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          340 TSAPSVPF--LCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       340 ~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +.......  ...+.+||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+-.  -+..    .++.  
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~----tLqn--  247 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLL----TLQN--  247 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHH----HhcC--
Confidence            54322111  1156789999999999654  369999999999999999999999998654321  1110    0100  


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ......-..+. ..........+.+++..||++||.+|||++++++
T Consensus       248 -~pp~~~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 -DPPTLLTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             -CCCCcccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             00000000000 0111222346778889999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-41  Score=348.83  Aligned_cols=270  Identities=21%  Similarity=0.317  Sum_probs=207.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV  258 (520)
                      +.|...++||+|.||.||+|++..+|+.||+|++..+.  .....-..+|+.||++|+||||++|.+...+. ...+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            56888899999999999999999999999999997654  34445567999999999999999999988776 4569999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +|||+. +|.-++....      -.++..++..++.||+.||+|+|..+   |+|||||.+|||||.+|.+||+|||||+
T Consensus       197 FeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             Eecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence            999976 8888886532      57999999999999999999999888   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh--hHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--~~~~~~~  415 (520)
                      ++...... ..+..+-|.+|.|||.+.+. .|+.++|+||.||||.||++|++.|.+...-++...+...-  +-...+.
T Consensus       267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            87654432 24566789999999999876 69999999999999999999999998765433333221100  0000000


Q ss_pred             -hHHH--HhhCcccCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 -AAVE--ELLDPRLKCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 -~~l~--~~~d~~l~~~~~----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..+.  ..+.+.-.....    ........++|+..+|..||.+|.|+.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             0000  111111100000    0011235678888999999999999999886

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-41  Score=353.20  Aligned_cols=263  Identities=24%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             CCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|+..+.||+|+||.||+|..     ..++..||||+++... ....+.+.+|+.++..+ +|||||+++++|.+.+ .
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-~  113 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-P  113 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-c
Confidence            4788899999999999999964     3446689999996542 33456788999999999 8999999999987755 4


Q ss_pred             EEEEEEecCCCChhHHhhhhccCC--------------------------------------------------------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGV--------------------------------------------------------  278 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~--------------------------------------------------------  278 (520)
                      .++||||+++|+|.+++.......                                                        
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            789999999999999997532100                                                        


Q ss_pred             ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          279 ------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       279 ------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                                  .....++|..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                        01135889999999999999999999887   999999999999999999999999999866443221


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  425 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~  425 (520)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....    .+..+       ..+.
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~-------~~~~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEG-------YRML  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhC-------ccCC
Confidence            11222345678999999999999999999999999999998 888986532211  1110    11111       0000


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       426 l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                        .+...   ...+.+++.+||+.+|++||++.+|+++|+.
T Consensus       338 --~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 --SPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence              01111   2357788899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=341.85  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEE
Confidence            36888999999999999999998889999999986532   23445688999999999999999999887654 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          80 MEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcch
Confidence            9999999999999754       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ..
T Consensus       150 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----------------~~  207 (291)
T cd05612         150 KLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----------------IY  207 (291)
T ss_pred             hccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HH
Confidence            664322     23469999999999998889999999999999999999999997543211                 01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ..+....+..+...   ...+.+++.+||+.||.+||+     +.++++
T Consensus       208 ~~i~~~~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         208 EKILAGKLEFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHHHhCCcCCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            11111122211111   234677889999999999995     777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.6e-41  Score=344.52  Aligned_cols=242  Identities=25%  Similarity=0.340  Sum_probs=195.0

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +.||+|+||.||++....+++.||+|++.+..   ......+.+|+.+++.++||||+++++++... ..+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCC
Confidence            46999999999999998889999999997542   23445678899999999999999999987664 568999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            9999998753       56899999999999999999999988   9999999999999999999999999987532221


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              ...+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~--------------~~~~~~~  210 (323)
T cd05571         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L--------------FELILME  210 (323)
T ss_pred             C--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H--------------HHHHHcC
Confidence            1  1234569999999999999999999999999999999999999997533211   0              0111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ....+...   ...+.+++.+||+.||++||     ++.++++
T Consensus       211 ~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 EIRFPRTL---SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCC---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            11111112   23466788899999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=345.96  Aligned_cols=253  Identities=24%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++....   ......+..|+.++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEE
Confidence            36889999999999999999998889999999997542   23445688999999999999999999987664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          80 MEYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            9999999999999753       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+       ...    
T Consensus       150 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i-------~~~----  213 (333)
T cd05600         150 GIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL-------KYW----  213 (333)
T ss_pred             cccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH-------Hhc----
Confidence            6543     123456999999999999989999999999999999999999999764432211100       000    


Q ss_pred             HHhh-CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          419 EELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       419 ~~~~-d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ...+ .+.....  .......+.+++.+||..+|.+||++.+|++.
T Consensus       214 ~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 KETLQRPVYDDP--RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCCCCCcc--ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0001 1111000  01123456778889999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=355.02  Aligned_cols=250  Identities=24%  Similarity=0.418  Sum_probs=209.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ..|.....||+|+.|.||.+....+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+ .+++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-eLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-ELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-eeEEEEee
Confidence            46777788999999999999999899999999998876666667889999999999999999999877764 48999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |+||+|.+.+..        ..+++.++..|..+++.||+|||..+   |+|||||.+|||++.+|.+||+|||++..+.
T Consensus       352 m~ggsLTDvVt~--------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             cCCCchhhhhhc--------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            999999999876        45999999999999999999999888   9999999999999999999999999998876


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  .-.+.+||+.|||||++....|++|+||||||++++||+-|.+||-...+-...       .       .+..-
T Consensus       421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-------y-------LIa~n  484 (550)
T KOG0578|consen  421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------Y-------LIATN  484 (550)
T ss_pred             cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-------H-------HHhhc
Confidence            6543  224577999999999999999999999999999999999999999754332111       1       11122


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -.|.+..+...+.+   +-+++.+||+.|+.+||++.|+|+
T Consensus       485 g~P~lk~~~klS~~---~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 GTPKLKNPEKLSPE---LKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCCCcCCccccCHH---HHHHHHHHhhcchhcCCCHHHHhc
Confidence            23444433333344   556667899999999999999997

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=341.81  Aligned_cols=240  Identities=25%  Similarity=0.375  Sum_probs=191.9

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||.||+|....+++.||+|++...   .......+..|+.++++++||||+++++++.+. ...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCc
Confidence            69999999999999888999999998653   233456678899999999999999999987664 56899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          80 LFHHLQRE-------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            99999753       46899999999999999999999888   99999999999999999999999999985432221 


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .           ...++...+
T Consensus       149 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~-----------~~~~~~~~~  210 (312)
T cd05585         149 -KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------M-----------YRKILQEPL  210 (312)
T ss_pred             -ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------H-----------HHHHHcCCC
Confidence             2234569999999999999899999999999999999999999997533211      1           111111222


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+....   ..+.+++.+||+.+|.+||+..++.+
T Consensus       211 ~~~~~~~---~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         211 RFPDGFD---RDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             CCCCcCC---HHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            2222222   34667788999999999986443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.2e-41  Score=341.05  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.+.... ....+++.+|+.+++.++||||++++|+|...  ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence            479999999999999999998755444    48999987543 34567888999999999999999999998764  357


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence            9999999999999997643      46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.......   +.    .....  
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~--  226 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEK--  226 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhC--
Confidence            987654333222222335678999999999999999999999999999998 999997532211   10    01110  


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                             ...+..+..   ....+.+++.+||+.+|.+||++.+|+..|...
T Consensus       227 -------~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         227 -------GERLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -------CCCCCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   011111111   123567888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-40  Score=342.14  Aligned_cols=202  Identities=30%  Similarity=0.447  Sum_probs=177.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|+..+.||+|+||.||+++...++..||+|.+... .......+.+|++++++++||||+++++++.+. ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEe
Confidence            36899999999999999999999988999999998765 334456799999999999999999999988764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          83 EHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999753       45899999999999999999999742  399999999999999999999999999976


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      .....    .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            54322    234569999999999998899999999999999999999999996543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=357.04  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=202.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...++||+|+||+|+++..+.+++.+|||++++..   .+..+..+.|..|+... +||.|+.|+..+ +..+++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-QT~~~l  444 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-QTKEHL  444 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-ccCCeE
Confidence            4478999999999999999999999999999999998863   45566777888888777 599999999754 556779


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      |+||||+.||++..+.+.        ..+++..+..+|..|+.||.|||+++   |||||||.+|||||.+|++||+|||
T Consensus       445 ~fvmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccc
Confidence            999999999996555443        57999999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      |++..-....  .+.+.+||+.|||||++.+..|+.++|||||||+||||+.|..||.+++.++.               
T Consensus       514 lcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---------------  576 (694)
T KOG0694|consen  514 LCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---------------  576 (694)
T ss_pred             cccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------
Confidence            9986442221  34678899999999999999999999999999999999999999997654321               


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                        ...++......+   .....+.+.|+.+.|.++|++|-.+
T Consensus       577 --FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 --FDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCC
Confidence              111222122112   2334567788899999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=356.05  Aligned_cols=268  Identities=29%  Similarity=0.448  Sum_probs=210.7

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEE
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~  249 (520)
                      .+..++.+..+.+..+..||+|.||+||+|.+-.   .||||++...  ..+..+.|.+|+..+++-+|.||+-+.|||.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            3445555566677788999999999999999863   5999999765  4567789999999999999999999999997


Q ss_pred             cCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       250 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                      .+.  +.||..+|+|-+|..+|+-.+      ..+...+.+.||.||++|+.|||.++   |||||||..||+|.+++.|
T Consensus       459 ~p~--~AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  459 NPP--LAIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             CCc--eeeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence            654  489999999999999999764      56899999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      ||+||||+.....-..........|...|||||+++.   ..|++.+||||||||+|||++|..||.....+.    +.|
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Iif  603 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIF  603 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEE
Confidence            9999999965433222222334558889999999974   368999999999999999999999998433322    111


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                           .-|++    .+.+++...  .....+.+.+|+..||..++++||.+.+|+..|+...
T Consensus       604 -----mVGrG----~l~pd~s~~--~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  604 -----MVGRG----YLMPDLSKI--RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             -----Eeccc----ccCccchhh--hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                 11111    111222111  1223345666777899999999999999999887643

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-40  Score=332.55  Aligned_cols=262  Identities=29%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC-----cEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+.... ......|.+|+.+++.++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-Cce
Confidence            36888899999999999999875443     679999986543 34456789999999999999999999987664 457


Q ss_pred             EEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      +++|||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.+   |+||||||+|||++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            99999999999999997642210         01146889999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHH
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  405 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~  405 (520)
                      +.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||......+   +..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986543332222233457889999999998899999999999999999998 999997543321   111


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .           +.   .....  .........+.+++.+||+.+|.+||++++|++.|++
T Consensus       238 ~-----------i~---~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 M-----------IR---SRQLL--PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H-----------HH---cCCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            0           10   11110  0011223457788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=351.13  Aligned_cols=247  Identities=29%  Similarity=0.486  Sum_probs=209.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|.+.+.||+|+||+||||+.+.+.+.||+|.+.+..  .+..+.+.+|++|++.++|||||.++++|.. ...+++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            47888889999999999999999999999999998763  3456778999999999999999999998654 56699999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+.| +|..+|...       ..++++.++.|+.+++.||.|||+..   |+|||+||.||||+..+.+|+||||+|+-
T Consensus        81 e~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             hhhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh
Confidence            99976 999999874       67999999999999999999999988   99999999999999999999999999997


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .+..  ....+.+.||+-|||||...+..|+..+|.||+|||||||.+|++||......   .+              ++
T Consensus       150 m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~L--------------v~  210 (808)
T KOG0597|consen  150 MSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QL--------------VK  210 (808)
T ss_pred             cccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HH--------------HH
Confidence            7653  33557789999999999999999999999999999999999999999864321   11              11


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .++......   .......+..++...|.+||.+|.|-.+++.
T Consensus       211 ~I~~d~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  211 SILKDPVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHhcCCCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            111111111   1244456778888999999999999999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=375.01  Aligned_cols=266  Identities=28%  Similarity=0.441  Sum_probs=215.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCC-----cEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ..+.+..+.||+|.||.||.|...+..     ..||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|++. ..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-GP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-CC
Confidence            345567789999999999999985432     34999999776 456778999999999999999999999999994 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .+|++|||++|+|..||++.+....+...+.....+.|+.|||+|+.||++++   +|||||..+|+||++...+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            78999999999999999987555555578999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |||+..-..+.......-.-...|||||.+..+.++.|+|||||||+|||++| |..||......+...      .    
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~----  916 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------D----  916 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------H----
Confidence            99995443332211111123458999999999999999999999999999999 999998655432111      0    


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                            -.-..+|..+.++++.   +.+++..||+.+|++||++..|++++..+..
T Consensus       917 ------~~~ggRL~~P~~CP~~---ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  917 ------VLEGGRLDPPSYCPEK---LYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ------HHhCCccCCCCCCChH---HHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                  1122356556555554   5578889999999999999999998876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.9e-41  Score=321.16  Aligned_cols=269  Identities=22%  Similarity=0.316  Sum_probs=208.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .+|...+.||+|.||+||+|++..+++.||||++......  ......+|+..|+.++|+||+.|+++|...+ .+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEEE
Confidence            3677888999999999999999999999999999765322  2345679999999999999999999887655 489999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||+ .+|+..++...      ..++...+..++.++++||+|||.+.   |+||||||.|+|++++|.+||+|||+|+.
T Consensus        81 Efm~-tdLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             Eecc-ccHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence            9995 49999998754      67999999999999999999999988   99999999999999999999999999999


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh--hHhhhch-
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILHRGM-  415 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--~~~~~~~-  415 (520)
                      +.......  +..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.+...-++...+-.+.  +....+. 
T Consensus       151 f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  151 FGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence            88665432  233679999999998875 68999999999999999999888777654433222221111  1111110 


Q ss_pred             -hHHHHhh----CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          416 -AAVEELL----DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       416 -~~l~~~~----d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                       ..+.+.+    -|........+.....+++++..++..||.+|+|++|++++
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             0011110    11111111233445567999999999999999999999874

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=343.68  Aligned_cols=266  Identities=26%  Similarity=0.398  Sum_probs=206.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~  253 (520)
                      .++|...+.||+|+||.||+|....     +++.||+|++.... ....+.+..|+.++.++ +||||++++++|...+.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3578899999999999999997532     34789999987542 33446778899999999 89999999999887777


Q ss_pred             cEEEEEEecCCCChhHHhhhhccC------------------------------------------------------CC
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKG------------------------------------------------------VR  279 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~------------------------------------------------------~~  279 (520)
                      .++++|||+++|+|.+++......                                                      ..
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            789999999999999998653210                                                      00


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCcc
Q 010012          280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL  359 (520)
Q Consensus       280 ~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~  359 (520)
                      ....++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            0136899999999999999999999887   9999999999999999999999999998764332222223345678899


Q ss_pred             CchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHH
Q 010012          360 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIAR  438 (520)
Q Consensus       360 aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~  438 (520)
                      |||++.+..++.++|||||||+||||++ |..||......+  .+    ...       +.....+..  +.   .....
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~-------~~~~~~~~~--~~---~~~~~  304 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRR-------LKEGTRMRA--PE---YATPE  304 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHH-------HhccCCCCC--Cc---cCCHH
Confidence            9999999999999999999999999998 999997533211  00    001       111111111  11   12345


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          439 VIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       439 l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      +.+++.+||+.+|++||++.||+++|+..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            78889999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-40  Score=330.02  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             CCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+|+..+.||+|+||.||+|.+.   ..+..||+|.+.... ......|.+|+.++++++||||+++++++... ...++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcEE
Confidence            57889999999999999999864   345689999987653 33456789999999999999999999988764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+
T Consensus        84 v~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence            999999999999997542      46899999999999999999999887   999999999999999999999999987


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......+   ...           
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~-----------  219 (266)
T cd05064         155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK-----------  219 (266)
T ss_pred             ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-----------
Confidence            65432211 11112335678999999999999999999999999999875 999997543221   100           


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .+.+...  ...+.   .....+.+++..||+.+|.+||++.+|++.|..
T Consensus       220 ~~~~~~~--~~~~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         220 AVEDGFR--LPAPR---NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             HHHCCCC--CCCCC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            0111111  11111   123457778899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-42  Score=347.76  Aligned_cols=269  Identities=22%  Similarity=0.289  Sum_probs=213.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||.|.||.||+|+...++..||||++++.-.. ..-.=++|+..|++|. |||||+|.+++.+.+..+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            35789999999999999999999999999999999765322 2222358999999998 999999999999988679999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||| ..+|.++++.+.      ..++++.++.|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||||+
T Consensus        89 fE~M-d~NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             HHhh-hhhHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence            9999 569999998753      78999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc-cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-----hHhh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PILH  412 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-----~~~~  412 (520)
                      ......   ..+..+.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++.|.+...-++...+..+.     ..+.
T Consensus       159 ev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  159 EVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             ccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            775433   235677999999999975 5678999999999999999999999998766544333322211     1111


Q ss_pred             hchhHHHHhhCcccCCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTS------RNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ++ ..+...+.-++..-.      -.+....++++++.+|+.+||.+|||+.+.++.
T Consensus       236 eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11 123333333322110      112345678899999999999999999999984

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.7e-41  Score=342.49  Aligned_cols=269  Identities=20%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~~  256 (520)
                      +|+..+.||+|+||.||+|....++..||||++...  .......+.+|+.+++.++||||+++++++....    ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999888999999998643  2234456889999999999999999999876433    2379


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+ +++|.+++...       ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecC-CCCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcc
Confidence            999999 47898888653       46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh-------
Q 010012          337 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-------  406 (520)
Q Consensus       337 a~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~-------  406 (520)
                      ++....... ........||..|+|||++.+  ..++.++|||||||++|||++|+.||...........+..       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            986433221 111234569999999999875  6789999999999999999999999975432111111000       


Q ss_pred             --hhhHhhhchhHHHHhhCcccCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 --AKPILHRGMAAVEELLDPRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 --~~~~~~~~~~~l~~~~d~~l~~~--~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ...+...........+.......  ...+.....+.+++.+||+.+|++|||+.||++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              00000000000000011100000  000011234678899999999999999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-40  Score=339.99  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=194.5

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +.||+|+||.||++....+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.. +...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            46999999999999998889999999997542   2345678889999999999999999988765 4568999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          80 GELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            9999888653       46899999999999999999999888   9999999999999999999999999987543221


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ...+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----------------~~~~~~~  210 (328)
T cd05593         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILME  210 (328)
T ss_pred             c--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----------------HHHhccC
Confidence            1  12345699999999999988999999999999999999999999975432110                 0011111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ....+...   ...+.+++.+||+.+|.+||     ++.++++
T Consensus       211 ~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         211 DIKFPRTL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CccCCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            11111112   23466788899999999997     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-40  Score=342.92  Aligned_cols=246  Identities=26%  Similarity=0.360  Sum_probs=199.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC-cEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|.+...+ ..||+|++....   ....+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEEE
Confidence            57999999999999999999876544 689999986532   23445688999999999999999999998664 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       109 v~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCC
Confidence            99999999999999754       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .
T Consensus       179 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----------------~  236 (340)
T PTZ00426        179 KVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----------------I  236 (340)
T ss_pred             eecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----------------H
Confidence            8654321     34569999999999998889999999999999999999999997543211                 0


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  463 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~~  463 (520)
                      ...+.......+....   ..+.+++.+||+.+|++|+     ++.++++.
T Consensus       237 ~~~i~~~~~~~p~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        237 YQKILEGIIYFPKFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHhcCCCCCCCCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1111222222122222   2456788899999999995     88888763

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-40  Score=332.95  Aligned_cols=269  Identities=23%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|+.+.++..||+|++....  ....+.+.+|+++++.++||||+++++++.+ +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            36889999999999999999999889999999987542  2334667899999999999999999998765 45689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++++.|..+....       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          80 EYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            999987776544321       46899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh-hhhHhhhchh--
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-AKPILHRGMA--  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~~~~~~~~--  416 (520)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ..++......  
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07848         150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLF  228 (287)
T ss_pred             ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhh
Confidence            6432211 12345689999999999988899999999999999999999999976433221111110 0000000000  


Q ss_pred             ----HHHHhhCcccCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 ----AVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ----~l~~~~d~~l~~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          .......+.......     .......+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         229 YSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                000000000000000     0012245889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-40  Score=357.60  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             CcccceEEcccCceEEEEeeecCC-CcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++|||||++++++.+. +..+|||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence            488999999999999999988766 678999987666555566788899999999999999999998765 468999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++.....   ...++++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       147 ~~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        147 GSGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999998875321   1256889999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +..+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~--------------~~~~  283 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I--------------MQQV  283 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H--------------HHHH
Confidence            4332222345669999999999999999999999999999999999999997533211   0              1111


Q ss_pred             hCcccC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~-~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +..... .+.   .....+.+++.+||+.+|++||++.+++.
T Consensus       284 ~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGKYDPFPC---PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCCCCCCCc---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            111111 011   12235778889999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=351.44  Aligned_cols=260  Identities=31%  Similarity=0.480  Sum_probs=206.3

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCc---E-EEEEEecC---cchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRT---S-VAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~-vAvK~l~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      ..++....++||+|+||.||+|.+...+.   . ||||....   .......+|.+|++++++++|||||+++|++... 
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-  233 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-  233 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-
Confidence            34455666899999999999999865322   3 89999875   2467788999999999999999999999998774 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ..++||||+|+||+|.++|....      ..++..++..++.++|+||+|||+++   +|||||..+|+|++.++.+||+
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence            56899999999999999998753      35999999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ||||++.......  ......-...|+|||.+..+.++.++|||||||++||+++ |..||.+....+...      .+.
T Consensus       305 DFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~------kI~  376 (474)
T KOG0194|consen  305 DFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA------KIV  376 (474)
T ss_pred             ccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH------HHH
Confidence            9999875541111  0112235678999999999999999999999999999999 899998654321100      000


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                             ..  +.++..+...+.++   ..+...|+..+|++||+|.+|.+.|+....
T Consensus       377 -------~~--~~r~~~~~~~p~~~---~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  377 -------KN--GYRMPIPSKTPKEL---AKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -------hc--CccCCCCCCCHHHH---HHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                   11  12233333344444   445568999999999999999999987543

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.9e-40  Score=345.44  Aligned_cols=253  Identities=25%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|...+.||+|+||+||+|....+++.||+|++....   ......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEE
Confidence            5888999999999999999999899999999996542   23456788999999999999999999988764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          81 DYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             ecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999998754       46899999999999999999999887   99999999999999999999999999864


Q ss_pred             cCCCCC---------------------------------------------CcccccccccCCccCchhcccCCCCCcCc
Q 010012          340 TSAPSV---------------------------------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTD  374 (520)
Q Consensus       340 ~~~~~~---------------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksD  374 (520)
                      ......                                             ........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            321000                                             00012356999999999999888999999


Q ss_pred             eeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHH--ccccCCC
Q 010012          375 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAA--CISSEES  452 (520)
Q Consensus       375 VwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~--Cl~~dP~  452 (520)
                      ||||||++|||++|+.||..........      .+.. .      ..............   .+.+++.+  |+..+|.
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~------~i~~-~------~~~~~~~~~~~~s~---~~~dli~~ll~~~~~~~  294 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQL------KVIN-W------ENTLHIPPQVKLSP---EAVDLITKLCCSAEERL  294 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHH------HHHc-c------ccccCCCCCCCCCH---HHHHHHHHHccCccccc
Confidence            9999999999999999997643321100      0000 0      00001111111222   34445554  6667777


Q ss_pred             CCCCHHHHHH
Q 010012          453 RRPGIEEIIA  462 (520)
Q Consensus       453 ~RPtm~eVl~  462 (520)
                      .||++.+|++
T Consensus       295 ~R~~~~~~l~  304 (381)
T cd05626         295 GRNGADDIKA  304 (381)
T ss_pred             CCCCHHHHhc
Confidence            8999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=343.31  Aligned_cols=252  Identities=27%  Similarity=0.365  Sum_probs=202.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|....+++.||+|++....   ......+..|+.++..++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEE
Confidence            36889999999999999999999889999999997542   23456788999999999999999999987664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            9999999999999764       46899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCC---------------------------CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCC
Q 010012          339 WTSAPS---------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  391 (520)
Q Consensus       339 ~~~~~~---------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~P  391 (520)
                      ......                           .........||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            665432                           00122345699999999999999999999999999999999999999


Q ss_pred             cchhccccchhhHHhhhhHhhhchhHHHHhhC--cccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 010012          392 IEARRLQGEENLVLWAKPILHRGMAAVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIAI  463 (520)
Q Consensus       392 f~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d--~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-m~eVl~~  463 (520)
                      |........                 ...+..  ..+..+... .....+.+++..|++ +|.+||+ +.++++.
T Consensus       230 f~~~~~~~~-----------------~~~i~~~~~~~~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         230 FYSDTLQET-----------------YNKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCHHHH-----------------HHHHhccCCcccCCCCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            976442110                 011111  111111111 123456677788997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.3e-40  Score=324.29  Aligned_cols=249  Identities=25%  Similarity=0.439  Sum_probs=196.2

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      +.||+|+||.||+|.+..+++.||+|.+... ..+....+.+|+++++.++||||++++++|.... ..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCCc
Confidence            3689999999999999888999999987654 3445567899999999999999999999987654 5799999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        80 L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          80 FLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc
Confidence            999986532      46899999999999999999999887   999999999999999999999999998765432111


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  425 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~  425 (520)
                      .......++..|+|||.+.++.++.++|||||||++|||++ |..||........       ..       .+....  .
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~-------~~~~~~--~  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------RE-------AIEQGV--R  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HH-------HHHcCC--C
Confidence            11111223567999999999899999999999999999998 8888864322110       00       011101  1


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       426 l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...+.   .....+.+++.+||+.+|++|||+.+|.++|+
T Consensus       215 ~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPE---LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11111   12346778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-40  Score=325.66  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=203.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|+..+.||+|+||+||+|.....   ...||||.+.... ......|.+|+.+++.++||||+++++++.+. ...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceEE
Confidence            5788999999999999999988543   4579999987543 34456789999999999999999999987664 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          83 ITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence            999999999999997642      46899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   ...           
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~-----------  219 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK-----------  219 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH-----------
Confidence            87753222222223345678999999998899999999999999999998 999986432211   100           


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .+....  ....+.   .....+.+++.+|++.+|++||++.+|+++|+.
T Consensus       220 ~~~~~~--~~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         220 AVEDGY--RLPPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             HHHcCC--CCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            011100  011111   123457788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-40  Score=342.80  Aligned_cols=204  Identities=30%  Similarity=0.366  Sum_probs=175.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|....+++.||+|++.+..   ......+..|+.++..++||||+++++.+.+. ..+++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEE
Confidence            47889999999999999999998889999999997542   23345678899999999999999999987664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          80 MEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EcCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            9999999999999753       56899999999999999999999988   9999999999999999999999999997


Q ss_pred             ccCCCCCC---------------------------------cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHH
Q 010012          339 WTSAPSVP---------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL  385 (520)
Q Consensus       339 ~~~~~~~~---------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~EL  385 (520)
                      ........                                 .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            54321100                                 001235799999999999999999999999999999999


Q ss_pred             HhCCCCcchhc
Q 010012          386 LTGRKPIEARR  396 (520)
Q Consensus       386 ltG~~Pf~~~~  396 (520)
                      ++|+.||....
T Consensus       230 l~G~~Pf~~~~  240 (363)
T cd05628         230 LIGYPPFCSET  240 (363)
T ss_pred             HhCCCCCCCCC
Confidence            99999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.6e-40  Score=330.10  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             CCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||.||++...     .++..+|+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccE
Confidence            57889999999999999999752     34567999999876666677899999999999999999999998764 4579


Q ss_pred             EEEEecCCCChhHHhhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          257 LIYKYVSGGSLERHLHEKKKG------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      +||||+++++|.+++......      ......+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            999999999999999754210      011235999999999999999999999887   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..     
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~-----  232 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI-----  232 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----
Confidence            999999986543322222233446788999999998899999999999999999998 999986543211   10     


Q ss_pred             HhhhchhHHHHhhCccc-CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          410 ILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l-~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                               ..+..... ....   .....+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       233 ---------~~i~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         233 ---------ECITQGRVLQRPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             ---------HHHHcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                     01111111 0011   12235788999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.9e-40  Score=329.18  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=204.2

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      .+++|...+.||+|+||.||+|.+..     .+..||+|.+.... ......|..|+.+++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence            35689999999999999999999876     67789999886543 334567899999999999999999999887754 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---ceE
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPK  330 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vk  330 (520)
                      ..++||||+++++|.+++............++|..+..++.||+.||+|||+.+   ++||||||+|||++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            468999999999999999875432222346899999999999999999999887   99999999999998754   699


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.......   +..   .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~---~  233 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME---F  233 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H
Confidence            999999987643221111112234568999999998999999999999999999997 999997543221   110   0


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      +. .         ......+..   ....+.+++.+|++.+|++||++.+|++.|+
T Consensus       234 ~~-~---------~~~~~~~~~---~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VT-G---------GGRLDPPKG---CPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HH-c---------CCcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            00 0         001111111   1245778889999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-40  Score=350.43  Aligned_cols=247  Identities=29%  Similarity=0.432  Sum_probs=206.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .-|..++.||.|+-|.|-+|++..+|+.+|||++.+..   ......+.+|+.||+.+.|||+++|++++.+ ...+|||
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEE
Confidence            35778899999999999999999999999999997752   2234567899999999999999999999765 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      .||+++|.|.++|..+       +++++..+.+++.||+.|+.|+|..+   |+||||||+|+|||..++|||+|||+|.
T Consensus        91 lEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             EEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence            9999999999999875       67999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +...+.   ...+.+|++.|.+||++++.+| +.++||||.|||||.||||+.||+.++..   .+..            
T Consensus       161 Le~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLl------------  222 (786)
T KOG0588|consen  161 LEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLL------------  222 (786)
T ss_pred             cccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHH------------
Confidence            765543   3456789999999999999987 67999999999999999999999854321   1211            


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ++-...+..+...   ..++.+|+.+|+..||++|.|+.||++
T Consensus       223 --KV~~G~f~MPs~I---s~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  223 --KVQRGVFEMPSNI---SSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --HHHcCcccCCCcC---CHHHHHHHHHHhccCccccccHHHHhh
Confidence              1112222223222   234667788999999999999999998

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-40  Score=334.25  Aligned_cols=268  Identities=24%  Similarity=0.352  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||+||+|....++..||+|++.... ......+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence            47999999999999999999998889999999986543 2234567789999999999999999998765 445899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ |+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          84 YLD-SDLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCC-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            997 49999886532      45889999999999999999999888   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-----hHhhhc
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PILHRG  414 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-----~~~~~~  414 (520)
                      .....  ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+....     ..+...
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         154 SVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             cCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence            43221  1233468999999999865 468999999999999999999999997654332211111000     000000


Q ss_pred             h--hHHHHhhCcccCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 M--AAVEELLDPRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~--~~l~~~~d~~l~~~~---~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .  ........+......   ........+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0  000111111110000   00011235678899999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=343.96  Aligned_cols=251  Identities=27%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|....+++.||||++....   ......+.+|+.++..++||||+++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEE
Confidence            47899999999999999999998889999999997532   23445678899999999999999999987764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          80 MEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             ECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence            9999999999999753       46899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCCCCc------------------------------------ccccccccCCccCchhcccCCCCCcCceeeHHHHH
Q 010012          339 WTSAPSVPF------------------------------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVL  382 (520)
Q Consensus       339 ~~~~~~~~~------------------------------------~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL  382 (520)
                      .+.......                                    ......||+.|+|||++....++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            543211000                                    01124699999999999999999999999999999


Q ss_pred             HHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC--cccCCCCCCHHHHHHHHHHHHHccccCCCCCCC---H
Q 010012          383 LELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPG---I  457 (520)
Q Consensus       383 ~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d--~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt---m  457 (520)
                      |||++|..||........                 ...++.  ..+..+. .......+.+++.+|+. +|.+|++   +
T Consensus       230 ~el~~G~~Pf~~~~~~~~-----------------~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~  290 (364)
T cd05599         230 YEMLVGYPPFCSDNPQET-----------------YRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGV  290 (364)
T ss_pred             HHhhcCCCCCCCCCHHHH-----------------HHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence            999999999975432210                 001111  1111111 00112345566777886 9999998   8


Q ss_pred             HHHHH
Q 010012          458 EEIIA  462 (520)
Q Consensus       458 ~eVl~  462 (520)
                      .++++
T Consensus       291 ~~ll~  295 (364)
T cd05599         291 NEIKS  295 (364)
T ss_pred             HHHhc
Confidence            88876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-40  Score=325.84  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||+|.....++.||+|.+.... .....+.+|+++++.++||||+++++++... ..+++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEe
Confidence            46888899999999999999998889999999987543 3456788999999999999999999987664 457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          84 MTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            999999999975432     56899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......   +   ..        .+..
T Consensus       156 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~---~~--------~~~~  220 (263)
T cd05052         156 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V---YE--------LLEK  220 (263)
T ss_pred             cceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH--------HHHC
Confidence            432111 112234668999999998899999999999999999998 999987543211   1   00        1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...+..  +...   ...+.+++.+||+.+|++||++.+++++|+.
T Consensus       221 ~~~~~~--~~~~---~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         221 GYRMER--PEGC---PPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCC--CCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            111111  1112   2457778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-40  Score=329.76  Aligned_cols=262  Identities=22%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ++++|+..+.||+|+||.||+|...     ..+..||+|.+... ......++.+|+.+++.++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence            4578999999999999999998764     23467999998643 233456788999999999999999999987664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVR---GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ..++||||+++|+|.+++........   ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            57999999999999999976432111   0135688999999999999999999877   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.......   ..     
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~-----  231 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL-----  231 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-----
Confidence            999999976543322111222345788999999998899999999999999999999 788886543211   11     


Q ss_pred             HhhhchhHHHHhhCccc-CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          410 ILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l-~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                               ..+..... ..+.   .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus       232 ---------~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 ---------RFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---------HHHHcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                     01111111 0111   12235778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.3e-40  Score=338.26  Aligned_cols=242  Identities=25%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +.||+|+||.||++....++..||+|++....   ......+.+|+.+++.++||||+++++++... ..+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence            46999999999999998889999999997542   23445677899999999999999999987664 468999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          80 GELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            9999888653       46899999999999999999999887   9999999999999999999999999987532221


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ....+...
T Consensus       150 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----------------~~~~~~~~  210 (323)
T cd05595         150 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----------------LFELILME  210 (323)
T ss_pred             C--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHhcC
Confidence            1  1234569999999999999999999999999999999999999997543211                 01111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ....+....   ..+.+++.+||+.+|.+||     ++.++++
T Consensus       211 ~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 EIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCCC---HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            111111122   3456778899999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-40  Score=358.36  Aligned_cols=262  Identities=26%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             HHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-
Q 010012          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-  253 (520)
Q Consensus       177 i~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-  253 (520)
                      +....++|...+.||+|+||+||+|....+++.||||++...  .......+.+|+.++..++|+||+++.+.+...+. 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            334567999999999999999999999888999999998654  34455678899999999999999999876653321 


Q ss_pred             ------cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          254 ------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       254 ------~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                            .+++||||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.+   |+||||||+||||+.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence                  26799999999999999976432   1257899999999999999999999887   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      .+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~  254 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VM  254 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HH
Confidence            999999999987654322222345679999999999999999999999999999999999999997543211      11


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ....       ....++ +  +.   .....+.+++..||+.+|.+||++.++++.
T Consensus       255 ~~~~-------~~~~~~-~--~~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTL-------AGRYDP-L--PP---SISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHh-------cCCCCC-C--CC---CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1110       001111 1  11   122457778899999999999999999863

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-41  Score=318.75  Aligned_cols=249  Identities=28%  Similarity=0.434  Sum_probs=209.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      -++|..++.||+|-||.||+|+.+.++-.||+|++.+..   .+...++.+|++|-+.|+||||+++++|+.+. .+.||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEE
Confidence            368999999999999999999999999999999997653   23456788999999999999999999998875 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ++||.+.|+|...|.....     ..+++.....+..|+|.||.|+|..+   ||||||||+|+|++..+.+||+|||.+
T Consensus       100 ilEya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EEEecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence            9999999999999986542     56888888899999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ...+...    -.+.+||..|+|||...+..++.++|+|++||+.||++.|.+||+.....+                 .
T Consensus       172 V~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-----------------t  230 (281)
T KOG0580|consen  172 VHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-----------------T  230 (281)
T ss_pred             eecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-----------------H
Confidence            8765332    245679999999999999999999999999999999999999998754211                 1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..++..-++..+..   ....+.+++.+|+..+|.+|.+..||++
T Consensus       231 YkrI~k~~~~~p~~---is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  231 YKRIRKVDLKFPST---ISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHHHHccccCCcc---cChhHHHHHHHHhccCccccccHHHHhh
Confidence            22232233332322   2334667889999999999999999986

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-40  Score=323.85  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=201.6

Q ss_pred             cccceEEcccCceEEEEeeecCC---CcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----  253 (520)
                      |...+.||+|+||.||+|....+   +..||+|++...  .......+.+|+++++.++||||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56678999999999999987643   378999998754  23445678999999999999999999998765443     


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++|+||+++|+|..++...... .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence            368999999999999998664321 11246899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||+++...............++..|+|||++....++.++|||||||++|||++ |..||.......   +.        
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~--------  225 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IY--------  225 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------
Confidence            999986644332211222335678999999988889999999999999999999 889986532211   11        


Q ss_pred             hchhHHHHhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          413 RGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       413 ~~~~~l~~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                            ..+.+. ....+   ......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       226 ------~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         226 ------DYLRHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ------HHHHcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                  111111 11111   1223467888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=330.53  Aligned_cols=250  Identities=35%  Similarity=0.573  Sum_probs=192.9

Q ss_pred             cceEEcccCceEEEEeeec----CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          186 KGRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~----~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+.||.|.||.||+|.+.    ..+..|+||.+... .....+.|.+|++++++++||||++++|+|...+ ..++|+|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-PLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-SEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-ccccccc
Confidence            4578999999999999987    34678999999654 3445788999999999999999999999998544 4899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.++|.....     ..+++..+..|+.||++||.|||+.+   |+|+||+++|||++.++.+||+|||++...
T Consensus        82 ~~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             --TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             cccccccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999999988622     57999999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .............+...|+|||.+....++.++||||||+++|||++ |+.||.......   +.              .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~--------------~  216 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II--------------E  216 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH--------------H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc--------------c
Confidence            33322222334457788999999999999999999999999999999 788886542211   11              1


Q ss_pred             HhhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          420 ELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       420 ~~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      .+.+.. +..+...   ...+.+++..||..+|++||++.+|++.|
T Consensus       217 ~~~~~~~~~~~~~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  217 KLKQGQRLPIPDNC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHTTEETTSBTTS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccccceeccch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111111 1111112   23466788899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-40  Score=328.49  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=201.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|...+.||+|+||+||+|....++.    .|++|.+.... .....++..|+.+++.++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence            478888999999999999999865555    47888875432 2344677888889999999999999998753  3468


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +++||+++|+|.+++....      ..++|..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+
T Consensus        85 ~i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcc
Confidence            9999999999999997643      46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............++..|+|||++.++.++.++|||||||++|||++ |+.||.........       .++..+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~-  227 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKG-  227 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCC-
Confidence            987654332222334557889999999998899999999999999999998 99999754322111       111111 


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                              .....+...   ...+.+++.+|+..+|.+|||+.|+++.|...
T Consensus       228 --------~~~~~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         228 --------ERLAQPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             --------CcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                    011111111   23456778899999999999999999988763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.7e-40  Score=327.98  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=204.9

Q ss_pred             CCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      .+|...+.||+|+||.||+|....     ++..||+|.+...... ..+.+.+|+++++.++||||+++++++... ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCe
Confidence            468888999999999999998743     3578999999765443 567899999999999999999999998775 458


Q ss_pred             EEEEEecCCCChhHHhhhhccC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          256 FLIYKYVSGGSLERHLHEKKKG-------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~-------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      ++||||+++++|.+++......       ......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999999764210       111246899999999999999999999887   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||.......   .+.  
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~--  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE--  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence            99999999976533222112233446788999999999999999999999999999998 999986543221   111  


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                                  .+........  .......+.+++.+||+.+|.+||++.||++.|+
T Consensus       236 ------------~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 ------------CITQGRLLQR--PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------------HHHcCCcCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                        1111111100  1112345778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.7e-40  Score=335.42  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=193.2

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      ++||+|+||.||+|....+++.||+|++.+..   ......+..|.+++..+ +||||+++++++.+. ...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence            36999999999999998889999999997542   23345677888888865 799999999987664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          80 GGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            99999888753       46899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +..+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~--------------~~~i~~  210 (321)
T cd05591         150 GV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---L--------------FESILH  210 (321)
T ss_pred             Cc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---H--------------HHHHHc
Confidence            21  1234569999999999998899999999999999999999999997643221   1              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRP-------GIEEIIA  462 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-------tm~eVl~  462 (520)
                      .....+...   ...+.+++..||+.+|++||       ++.++++
T Consensus       211 ~~~~~p~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         211 DDVLYPVWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            111111111   23567788899999999999       7777775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-40  Score=337.75  Aligned_cols=242  Identities=25%  Similarity=0.331  Sum_probs=193.6

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +.||+|+||.||++....++..||+|++.+..   ......+..|++++..++||||+++++++... ..+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCC
Confidence            46999999999999998889999999997542   23445677899999999999999999887654 568999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      |+|..++...       ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            9999888653       468999999999999999999997 56   999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ...+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-----------------~~~i~~  210 (325)
T cd05594         150 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILM  210 (325)
T ss_pred             Cc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-----------------HHHHhc
Confidence            21  12345699999999999999999999999999999999999999975432111                 011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      .....+....   ..+.+++.+||+.||++|+     ++.++++
T Consensus       211 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         211 EEIRFPRTLS---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCCCCC---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            1111111122   3466788899999999996     8999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.8e-40  Score=330.13  Aligned_cols=269  Identities=22%  Similarity=0.290  Sum_probs=194.6

Q ss_pred             CCcccceEEcccCceEEEEeeecC-CCcEEEEEEecCcc--hHHHHHHHHHHHHHHhC---CCCCeecEEEEEEc----C
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID----P  251 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~----~  251 (520)
                      ++|...+.||+|+||.||+|.... .+..||+|++....  ......+.+|+.+++.+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368889999999999999998743 46789999986532  12234556677776665   69999999998852    2


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      ...+++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEE
Confidence            345899999996 699999875432     45899999999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhhh-h
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAK-P  409 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~-~  409 (520)
                      +|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|++||......+... +..... +
T Consensus       152 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~  228 (290)
T cd07862         152 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  228 (290)
T ss_pred             ccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999998654332   2234568999999999988899999999999999999999999998654322111 110000 0


Q ss_pred             HhhhchhHH---HHhhCcccCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHRGMAAV---EELLDPRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~~~~~l---~~~~d~~l~~~--~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ........+   ...+.+.....  ...+.....+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000000   00000000000  000011234668899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=343.69  Aligned_cols=254  Identities=25%  Similarity=0.310  Sum_probs=195.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||++....+++.||||++.+..   ....+.+.+|+++++.++|||||++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEE
Confidence            37888999999999999999998889999999986532   23446688899999999999999999988764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          80 MEFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999999998753       46899999999999999999999888   9999999999999999999999999996


Q ss_pred             ccCCCCCC---------------------------------------------cccccccccCCccCchhcccCCCCCcC
Q 010012          339 WTSAPSVP---------------------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKT  373 (520)
Q Consensus       339 ~~~~~~~~---------------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~ks  373 (520)
                      .+......                                             .......||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            33210000                                             000124699999999999988999999


Q ss_pred             ceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCC
Q 010012          374 DVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR  453 (520)
Q Consensus       374 DVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~  453 (520)
                      |||||||++|||++|+.||.........      ..+.        .. ...+..+. .......+.+++.+||+ +|.+
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~--------~~-~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETY------RKII--------NW-RETLYFPD-DIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHH------HHHH--------cc-CCccCCCC-CCCCCHHHHHHHHHHhc-CHhh
Confidence            9999999999999999999754321110      0000        00 00111111 00112346677788987 6666


Q ss_pred             C---CCHHHHHHH
Q 010012          454 R---PGIEEIIAI  463 (520)
Q Consensus       454 R---Ptm~eVl~~  463 (520)
                      |   |++.+++..
T Consensus       293 r~~r~~~~~~l~h  305 (377)
T cd05629         293 RLGRGGAHEIKSH  305 (377)
T ss_pred             cCCCCCHHHHhcC
Confidence            5   699998873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.9e-40  Score=329.93  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=207.9

Q ss_pred             CCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||.||+|...     .++..+++|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-CceE
Confidence            46888899999999999999753     23567999999877666667899999999999999999999998764 4589


Q ss_pred             EEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      +||||+++++|.+++......         ......++|..++.++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            999999999999999764210         011235899999999999999999999888   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~  406 (520)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ... 
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-  236 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE-  236 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-
Confidence            999999999976544332222234457888999999998899999999999999999999 999986543211   110 


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                                   .+........  .......+.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       237 -------------~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 -------------CITQGRVLER--PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             -------------HHhCCCCCCC--CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                         0111111100  1112345778899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-40  Score=335.36  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=192.3

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHH---HhCCCCCeecEEEEEEcCCCcEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIA---SSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      |...+.||+|+||.||+|....+++.||||++.+..   ....+.+..|+.++   +.++||||+++++++.+. ...++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEE
Confidence            567789999999999999998889999999997542   22334566666554   567899999999987664 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|..++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        80 v~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          80 VMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            9999999999888753        46999999999999999999999888   999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                 
T Consensus       149 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-----------------  209 (324)
T cd05589         149 KEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-----------------  209 (324)
T ss_pred             ccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            75332211  12345699999999999998999999999999999999999999975432210                 


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      +..+.......+...   ...+.+++.+||+.||.+||     ++.++++
T Consensus       210 ~~~i~~~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         210 FDSIVNDEVRYPRFL---SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhCCCCCCCCC---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            111111111111112   23467788999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.4e-40  Score=345.71  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~  252 (520)
                      ..++|.++++||+|+||.||+|....     .+..||||++.... ....+.+.+|+++++.+. |||||+++++|.+. 
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence            35789999999999999999998632     23469999997543 334567899999999996 99999999998764 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCC------------------------------------------------------
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------  278 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~------------------------------------------------------  278 (520)
                      ...+||||||++|+|.++|.......                                                      
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            45899999999999999987642100                                                      


Q ss_pred             -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          279 -----------------------------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       279 -----------------------------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                                                         .....+++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                               01135889999999999999999999887   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchh
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  402 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~  402 (520)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            9999999999999986543322112233457788999999998899999999999999999997 9999875322110  


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .    ..       .+....  .+..+   ......+.+++.+||+.+|++||++.+|+++|+..
T Consensus       349 ~----~~-------~~~~~~--~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         349 F----YN-------KIKSGY--RMAKP---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             H----HH-------HHhcCC--CCCCC---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            0    00       011111  11111   11234577888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-40  Score=336.30  Aligned_cols=202  Identities=29%  Similarity=0.454  Sum_probs=176.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|+++++.++||||++++++|.+. +.+++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence            36899999999999999999999988999999998764 334456789999999999999999999998774 4689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          83 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999753       45899999999999999999999742  399999999999999999999999999976


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      .....    .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         154 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             hhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            54321    233468999999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-39  Score=326.84  Aligned_cols=262  Identities=27%  Similarity=0.399  Sum_probs=201.8

Q ss_pred             CCcccceEEcccCceEEEEeeec----CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|+..+.||+|+||+||+|...    ..+..||+|.+... .......+.+|+++++.++||||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceE
Confidence            36788899999999999999852    34578999999753 334456788999999999999999999987664 4579


Q ss_pred             EEEEecCCCChhHHhhhhccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKG----------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~----------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      +||||+++++|.+++......          ......+++.....++.|++.||+|||+.+   |+||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            999999999999998643210          001245889999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHH
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  405 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~  405 (520)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   +..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986644332222233446778999999988889999999999999999998 999986532211   110


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                          .       +..  ...+..+...   ...+.+++.+||+.+|.+||++.+|++.|.+
T Consensus       238 ----~-------~~~--~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ----M-------VRK--RQLLPCSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----H-------HHc--CCcCCCCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                0       000  0011111111   2356778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-40  Score=325.01  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=207.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|+..+.||.|+||.||+|.... +..+|+|.+..........+..|+.+++.++||||+++++++.+.+ ..++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEEEe
Confidence            4578899999999999999999987 8899999998776656678899999999999999999999887654 5799999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          83 LMEKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ecccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence            9999999999976432     56899999999999999999999887   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....  ......++..|+|||.+....++.++||||||+++|+|++ |+.||.......   ....           +.
T Consensus       155 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~-----------~~  218 (261)
T cd05148         155 KEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ-----------IT  218 (261)
T ss_pred             CCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH-----------HH
Confidence            43221  1123346778999999988889999999999999999998 899996543211   1110           00


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .-.  +...+.   .....+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       219 ~~~--~~~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 AGY--RMPCPA---KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             hCC--cCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            000  111111   223457788899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=334.19  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=193.3

Q ss_pred             eEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          188 RVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.||+|+||.||++...   .+++.||+|++....    ......+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEe
Confidence            57999999999999863   457899999987532    22345677899999999999999999987664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          81 YLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999998753       46888899999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .+..
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----------------~~~~  211 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----------------TIDK  211 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----------------HHHH
Confidence            32221  1234569999999999998889999999999999999999999997543211                 1122


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      +.......+...   ...+.+++.+||+.+|++||     ++.++++
T Consensus       212 ~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         212 ILKGKLNLPPYL---TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHcCCCCCCCCC---CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            222222222222   23467888999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-39  Score=323.61  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=199.9

Q ss_pred             cccceEEcccCceEEEEeeecCCCc--EEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----Cc
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  254 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~  254 (520)
                      |..++.||+|+||.||+|.....+.  .||+|.++..  .....+.+..|+++++.++||||++++++|....     ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999999876554  6899988654  3445677889999999999999999999886432     23


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++|+|.+++...... .....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCC
Confidence            68999999999999988543211 11245899999999999999999999877   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++...............+++.|+|||++....++.++|||||||++|||++ |+.||.......   +.    .....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~  229 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQ  229 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHc
Confidence            99987654322111223346778999999998899999999999999999999 889986532211   10    00111


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      +         .......   .....+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       230 ~---------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 G---------NRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             C---------CCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0         0111111   122457788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-39  Score=321.76  Aligned_cols=261  Identities=24%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....+++.||||.+...   .......+.+|+++++.++||||+++++++.+. ...++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEE
Confidence            4788999999999999999999888999999987542   334456788999999999999999999988765 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          81 LELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999999998865322   1246889999999999999999999887   9999999999999999999999999988


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......    ..+..        .+
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~--------~~  220 (267)
T cd08228         155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQ--------KI  220 (267)
T ss_pred             eccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHH--------HH
Confidence            6653221  1123458889999999988889999999999999999999999986533211    11111        11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .....+...    .......+.+++.+||+.+|++||++.+|++.|+..
T Consensus       221 ~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         221 EQCDYPPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hcCCCCCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111111111    112235577888999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.5e-40  Score=322.43  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=198.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||++..+. +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEc
Confidence            457888999999999999998864 5689999886543 2346788999999999999999999987664 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++....      ..++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          81 MENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999999987532      35899999999999999999999888   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||++....++.++||||||+++|||++ |+.||.......   ....   +. ++      
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~---i~-~~------  217 (256)
T cd05114         152 DDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEM---IS-RG------  217 (256)
T ss_pred             CCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HH-CC------
Confidence            32211 1122335678999999988889999999999999999999 999997543211   1111   00 00      


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                         .....+...   ...+.+++.+||+.+|.+||++.+|++.|
T Consensus       218 ---~~~~~~~~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ---FRLYRPKLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCCC---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               001111111   23578889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-39  Score=322.17  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||.||+|... .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEec
Confidence            57889999999999999999976 467899999875433 456889999999999999999999987654 457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          83 MAKGSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             CCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence            999999999976432     56899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||++..+.++.++|||||||++|||++ |..||.......   ....           +..
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~-----------~~~  219 (261)
T cd05072         155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA-----------LQR  219 (261)
T ss_pred             CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH-----------HHc
Confidence            43211 1122346778999999998889999999999999999998 999996533211   1110           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...  .....   .....+.+++.+|+..+|++||++.+|++.|+.
T Consensus       220 ~~~--~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 GYR--MPRME---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCC--CCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111  11011   122457788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-39  Score=334.21  Aligned_cols=242  Identities=23%  Similarity=0.345  Sum_probs=192.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCC-CeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~~LV  258 (520)
                      +|+..+.||+|+||.||+|....+++.||||++.+..   ....+.+..|++++..++|+ +|+++++++.+ .+.+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            4788899999999999999998888999999997542   23455678899999999765 57777776655 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          80 MEYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            9999999999998753       46899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~--------------~  210 (324)
T cd05587         150 ENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L--------------F  210 (324)
T ss_pred             ecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            4322111  1234569999999999999899999999999999999999999997543211   1              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                      ..+.......+...   ...+.+++.+||..+|.+||+.
T Consensus       211 ~~i~~~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         211 QSIMEHNVSYPKSL---SKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHcCCCCCCCCC---CHHHHHHHHHHhhcCHHHcCCC
Confidence            11111111111112   2356788899999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.5e-40  Score=342.74  Aligned_cols=203  Identities=28%  Similarity=0.375  Sum_probs=173.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|...+.||+|+||+||+|....+++.||+|++.+..   ......+.+|+.++++++|||||++++.+.+. ..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEE
Confidence            5888999999999999999998889999999997542   23445788999999999999999999988764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          81 DYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999998753       45889999999999999999999988   99999999999999999999999999753


Q ss_pred             cCCCC---------------------------------------------CCcccccccccCCccCchhcccCCCCCcCc
Q 010012          340 TSAPS---------------------------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTD  374 (520)
Q Consensus       340 ~~~~~---------------------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksD  374 (520)
                      +....                                             .........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            21000                                             000112346999999999999999999999


Q ss_pred             eeeHHHHHHHHHhCCCCcchhc
Q 010012          375 VYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       375 VwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      ||||||+||||++|+.||....
T Consensus       231 iwSlGvil~elltG~~Pf~~~~  252 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCC
Confidence            9999999999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-39  Score=326.38  Aligned_cols=274  Identities=26%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             CCcccceEEcccCceEEEEeee----cCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~  256 (520)
                      .+|...+.||+|+||+||+|..    ..++..||+|.+........+.|.+|+++++.++||||+++++++...+ ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788889999999999999974    3457889999998776666778999999999999999999999876433 4578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence            9999999999999997532      45899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +........... .....++..|+|||++.+..++.++|||||||++|||++|..|+......-...... .... ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~  232 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN-DKQG-QMIV  232 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc-cccc-ccch
Confidence            987654322111 111224456999999998889999999999999999999987764322110000000 0000 0000


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..+.+.+......+ ........+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            01111111111101 0111224577888999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-39  Score=333.26  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=192.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      +|...+.||+|+||.||+|....+++.||+|++.+..   ......+..|..++..+ +|++|+++++++.+ .+.+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            4788899999999999999998888999999997542   22334566788888777 58889999887655 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          80 MEYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            9999999999988653       46899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~--------------~  210 (323)
T cd05616         150 ENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L--------------F  210 (323)
T ss_pred             ecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            5432221  2234569999999999999999999999999999999999999997543221   1              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                      ..+.......+..   ....+.+++.+||+.+|.+|++.
T Consensus       211 ~~i~~~~~~~p~~---~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         211 QSIMEHNVAYPKS---MSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHhCCCCCCCc---CCHHHHHHHHHHcccCHHhcCCC
Confidence            1111112221111   22456788899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-40  Score=343.02  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=199.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ..++|+..+.||+|+||.||++....++..||+|++.+..   ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence            4468999999999999999999999889999999996532   2233457789999999999999999988765 45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999999864        34788888899999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccC----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......             
T Consensus       189 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------------  254 (370)
T cd05596         189 CMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------  254 (370)
T ss_pred             eeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------------
Confidence            986543221 122345699999999998653    47899999999999999999999997643211             


Q ss_pred             hchhHHHHhhCc--ccCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 010012          413 RGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  463 (520)
Q Consensus       413 ~~~~~l~~~~d~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~~  463 (520)
                          ....+++.  .+..+. .......+.+++.+||+.+|.+  ||++.++++.
T Consensus       255 ----~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 ----TYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----HHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                11111111  111111 1112345667888999999988  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-39  Score=318.00  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|++|.||+|....+++.|++|.+...  .......+.+|+++++.++||||+++++++.+. ...++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence            477788999999999999999888999999998643  344567788999999999999999999988764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++..
T Consensus        80 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          80 YAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             eCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceec
Confidence            9999999999986432     56899999999999999999999877   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......|+..|+|||++.+..++.++|||||||++|||++|+.||......   ...              ..
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~--------------~~  212 (256)
T cd08529         152 SDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI--------------LK  212 (256)
T ss_pred             cCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH--------------HH
Confidence            54322  123446889999999999989999999999999999999999999754321   111              11


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +......  .........+.+++.+||+.+|++||++.+|++
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         213 IIRGVFP--PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HHcCCCC--CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            1111111  011123346788899999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.8e-40  Score=338.15  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||++....+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence            36889999999999999999998889999999997542   23445688899999999999999999887664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             ECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence            99999999999997642      46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc------cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ........ ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ...+. 
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~-  222 (330)
T cd05601         151 RLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIM-  222 (330)
T ss_pred             ECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHH-
Confidence            76543221 223456999999999986      45678999999999999999999999975432110      01110 


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                             .. ...+..+. .......+.+++..|++ +|.+||++.++++
T Consensus       223 -------~~-~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 -------NF-QRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -------cC-CCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                   00 00011110 11122346677788997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=321.48  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=202.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|+..+.||+|++|.||+|.... ++.||+|.+.... ...+++.+|+.++++++||||+++++++... +..++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeee
Confidence            4578999999999999999999764 5789999987543 2346788999999999999999999987664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++....     ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          82 LMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             cccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            999999999997643     146899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ...... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......   +..           .+.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-----------~~~  218 (261)
T cd05068         154 KEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ-----------QVD  218 (261)
T ss_pred             cCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHH
Confidence            532211 1111223457999999998899999999999999999999 999997533211   000           011


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...  .+...   ......+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       219 ~~~--~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 QGY--RMPCP---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             cCC--CCCCC---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            100  01111   1223467888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-39  Score=327.28  Aligned_cols=266  Identities=23%  Similarity=0.380  Sum_probs=205.7

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCC-----CcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      ...++|+..+.||+|+||.||++.....     ...+|+|.+... .......+.+|++++.++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3456899999999999999999987532     368999998754 234456788999999999 899999999998664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~---------~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ..+++||||+++|+|..++.....         .......+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus        89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence             458999999999999999975321         0012357899999999999999999999887   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987654322212222335678999999988899999999999999999998 99998653321100


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                             ..       +...  .....+   ......+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       245 -------~~-------~~~~--~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         245 -------KL-------LKEG--YRMEKP---QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -------HH-------HHcC--CcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                   00       0000  011111   12234677899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.8e-40  Score=334.36  Aligned_cols=237  Identities=27%  Similarity=0.391  Sum_probs=189.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|....+++.||+|++.+..   ......+..|..++..+ +||||+++++++.+. ..+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCC
Confidence            36999999999999998889999999987532   23345677888888776 699999999987654 56899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          80 GGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            99999988754       46899999999999999999999888   999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +..+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~--------------~~~i~~  210 (320)
T cd05590         150 GK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---L--------------FEAILN  210 (320)
T ss_pred             CC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H--------------HHHHhc
Confidence            11  1234569999999999998899999999999999999999999997543221   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                      .....+..   ....+.+++.+||+.||.+||++
T Consensus       211 ~~~~~~~~---~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         211 DEVVYPTW---LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCC---CCHHHHHHHHHHcccCHHHCCCC
Confidence            11111111   12356778899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=335.81  Aligned_cols=255  Identities=26%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--------------HHHHHHHHHHHHHHhCCCCCeecEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------ESSKAFCRELMIASSLHHPNIVPLV  245 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~l~  245 (520)
                      ..++|...+.||+|.||.|-+|....+++.||||++.+...              ...++..+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            44789999999999999999999999999999999976421              1235678999999999999999999


Q ss_pred             EEEEcCC-CcEEEEEEecCCCChhHHhhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          246 GFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       246 g~~~~~~-~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~-l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ++.-++. +.+|||+|||..|.+...-..        .+ +++.++++|+.+++.||+|||.++   ||||||||+|+||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d--------~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD--------KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC--------cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            9865543 468999999999887543221        34 999999999999999999999988   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCC---CcccccccccCCccCchhcccCC----CCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          324 SSKKIPKLCDFGLATWTSAPSV---PFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      +++|++||+|||.+..+.....   .......+||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||....
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999999999986633211   11123367999999999998743    3568999999999999999999998654


Q ss_pred             cccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       397 ~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..+                 ....++...|..+. .+++-..+-+|+.++|++||+.|.++.+|...
T Consensus       324 ~~~-----------------l~~KIvn~pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  324 ELE-----------------LFDKIVNDPLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHH-----------------HHHHHhcCcccCCC-cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            321                 23455666666543 23455667788999999999999999998764

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-39  Score=324.87  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      .++|...+.||+|+||+||+|....++.    .||+|++... .......+.+|+.+++.++||||+++++++...  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence            3578899999999999999998765554    4899998654 334566788999999999999999999998653  36


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++++||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCC
Confidence            79999999999999997642      46899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   +..+    +..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~  227 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKG  227 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCC
Confidence            9987654332212222345678999999998899999999999999999998 999986533211   1110    1110


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                             .  ....+   ......+.+++..||+.+|++||++.++++.|+..
T Consensus       228 -------~--~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         228 -------E--RLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -------C--cCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                   0  01111   11234567888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-39  Score=330.05  Aligned_cols=267  Identities=22%  Similarity=0.316  Sum_probs=197.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|...+.||+|+||+||+|....+++.||+|++..... .....+.+|+.+++.++||||+++++++.+. ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence            4689999999999999999999988899999999875432 2234577899999999999999999987664 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++ ++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          83 EYVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             ECCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence            9995 68888876532      45889999999999999999999988   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc----
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----  414 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~----  414 (520)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .............    
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  228 (303)
T cd07869         153 KSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDT  228 (303)
T ss_pred             ccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhh
Confidence            433221  1234568999999999865 457889999999999999999999997532211  1111000000000    


Q ss_pred             hhHHHH--hhCc-ccC--CCCCCHH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEE--LLDP-RLK--CTSRNSA------QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~--~~d~-~l~--~~~~~~~------~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......  ..++ .+.  .+.....      ....+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000  0000 000  0000000      1134668889999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-39  Score=326.21  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             CcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +|+..+.||+|+||.||+|....     ....+|+|.+.... ......+.+|+.+++.++||||+++++.|... ...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcE
Confidence            47778899999999999998642     23568999887543 33456788999999999999999999988664 4578


Q ss_pred             EEEEecCCCChhHHhhhhccC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKG-----------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~-----------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      +|+||+++|+|.+++......                 ......+++..++.++.|++.||+|||+.+   |+||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            999999999999998753211                 011245899999999999999999999887   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  398 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~  398 (520)
                      |||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999986543322111223346778999999988889999999999999999998 99999654322


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .   +..    .       +........  +.   .....+.+++..||+.+|++||++.+|++.|+..
T Consensus       237 ~---~~~----~-------~~~~~~~~~--~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 R---LFN----L-------LKTGYRMER--PE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             H---HHH----H-------HhCCCCCCC--CC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            1   111    0       111111111  11   1224577888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=323.34  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCC-----CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++|...+.||+|+||.||+|.....     +..||+|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CC
Confidence            35788999999999999999987543     3789999987543 34456788999999999999999999998765 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~---~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      .++||||+++|+|.+++.......   .....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            799999999999999997643211   01235789999999999999999999887   999999999999999999999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhH
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      +|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||.......   ...     
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~-----  232 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK-----  232 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH-----
Confidence            99999976544322112233446789999999988889999999999999999998 999986533221   110     


Q ss_pred             hhhchhHHHHhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          411 LHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       411 ~~~~~~~l~~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                               .+.+. ....+..   ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       233 ---------~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 ---------FVIDGGHLDLPEN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---------HHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                     01111 1111111   2346778899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=326.11  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +|+..+.||+|+||.||++....+++.||+|++....   ......+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence            4778899999999999999998889999999986542   22234577899999999999999999987664 4689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++..
T Consensus        80 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             eccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999988865321     46899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..........              .+.
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--------------~~~  214 (285)
T cd05605         152 IPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--------------EVE  214 (285)
T ss_pred             cCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--------------HHH
Confidence            543221   123468999999999998889999999999999999999999997543221100              011


Q ss_pred             HhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          420 ELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       420 ~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+.. ....+   ......+.+++.+||+.||.+||     ++.++++
T Consensus       215 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         215 RRVKEDQEEYS---EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHhhhcccccC---cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            11111 11111   11234567888999999999999     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-39  Score=339.74  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=197.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ..++|+..+.||+|+||.||++....+++.||+|++.+.   .......+.+|+.+++.++||||+++++++.+ +..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEE
Confidence            456899999999999999999999988999999998653   22234567889999999999999999998765 45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++..        ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       120 lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999999864        34788999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccC----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      +........ .......||+.|+|||++...    .++.++|||||||++|||++|+.||......+             
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------------  254 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------------  254 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------------
Confidence            987643221 122356799999999998654    37889999999999999999999997543211             


Q ss_pred             hchhHHHHhhCcc--cCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 010012          413 RGMAAVEELLDPR--LKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  463 (520)
Q Consensus       413 ~~~~~l~~~~d~~--l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~~  463 (520)
                          ....+++..  +..+. .......+.+++..|+..++.+  ||++.|+++.
T Consensus       255 ----~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         255 ----TYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----HHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                111122111  11111 1112234556667788755543  8899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-39  Score=333.38  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=194.2

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      ++||+|+||.||+|....+++.||+|++.+..   ......+..|..++..+ +||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCC
Confidence            46999999999999999889999999997542   23345678899999888 799999999987664 56899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            99999888653       46999999999999999999999888   999999999999999999999999998743221


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcccc--chhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG--EENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~--~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..          ..+
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~  217 (329)
T cd05588         150 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF----------QVI  217 (329)
T ss_pred             CC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH----------HHH
Confidence            11  1234569999999999999999999999999999999999999997432211  111111111          111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG------IEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt------m~eVl~  462 (520)
                      .......+...   ...+.+++.+||+.+|.+||+      +.++++
T Consensus       218 ~~~~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         218 LEKQIRIPRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HcCCCCCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            22222222212   234677889999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-39  Score=332.17  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=192.8

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||+|++.+.   .......+..|+.++.++ +||||+++++++.+. ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCC
Confidence            4799999999999999988999999999764   223445677888888776 899999999987664 56899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            99999888653       46999999999999999999999988   999999999999999999999999998753222


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccc--hhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE--ENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~--~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+..          ..+
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~i  217 (329)
T cd05618         150 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF----------QVI  217 (329)
T ss_pred             CC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH----------HHH
Confidence            11  12345699999999999999999999999999999999999999963221110  01111111          111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG------IEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt------m~eVl~  462 (520)
                      .......+..   ....+.+++.+||+.||++||+      +.++++
T Consensus       218 ~~~~~~~p~~---~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         218 LEKQIRIPRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             hcCCCCCCCC---CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            1222221221   2234667889999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-39  Score=317.08  Aligned_cols=261  Identities=23%  Similarity=0.434  Sum_probs=207.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|.+...   .....+.+.+|++++++++|+||+++++++.+. +..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence            5789999999999999999999888999999988642   233456788999999999999999999998775 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++.....   ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          81 LELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999999875321   1256899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||......    +......        +
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~--------~  220 (267)
T cd08224         155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK--------I  220 (267)
T ss_pred             eccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh--------h
Confidence            6543321  123345889999999999888999999999999999999999998653311    1111100        1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .....+..    ........+.+++.+||..+|++|||+.+|+++|+..
T Consensus       221 ~~~~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         221 EKCDYPPL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hcCCCCCC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            10000111    1112334677888999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.1e-39  Score=323.83  Aligned_cols=266  Identities=22%  Similarity=0.352  Sum_probs=208.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC----CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ..++|...+.||+|+||.||+|....    .+..|++|++... .......+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35689999999999999999999865    2578999988754 344566788999999999999999999998876666


Q ss_pred             EEEEEEecCCCChhHHhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .++++||+++|+|.+++...... ......+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999999764321 011246899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.......   +..+      
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~------  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY------  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH------
Confidence            999986644332222233456778999999988889999999999999999999 999997543211   1111      


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                           +....  .+.....   ....+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       232 -----~~~~~--~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         232 -----LKDGY--RLAQPIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             -----HHcCC--CCCCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                 11111  1111111   123567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.5e-40  Score=341.89  Aligned_cols=204  Identities=26%  Similarity=0.345  Sum_probs=173.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|+...+++.||||++.+..   ......+.+|+.+++.++||||+++++.+.+. +.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEE
Confidence            36889999999999999999998889999999986532   22345678899999999999999999987664 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|.
T Consensus        80 ~E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          80 MDYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999999753       46889999999999999999999988   9999999999999999999999999975


Q ss_pred             ccCCCC-----------------------------------------CCcccccccccCCccCchhcccCCCCCcCceee
Q 010012          339 WTSAPS-----------------------------------------VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYA  377 (520)
Q Consensus       339 ~~~~~~-----------------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS  377 (520)
                      .+....                                         .........||+.|+|||++.+..++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            321000                                         000112346999999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCcchhc
Q 010012          378 FGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       378 ~GvvL~ELltG~~Pf~~~~  396 (520)
                      |||++|||++|+.||....
T Consensus       230 lGvilyell~G~~Pf~~~~  248 (376)
T cd05598         230 VGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             ccceeeehhhCCCCCCCCC
Confidence            9999999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-39  Score=320.28  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=202.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCc---EEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|+..+.||+|+||.||+|.+..++.   .+|+|.+... .....+.+..|+++++.++||||+++++++.+. ...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcE
Confidence            3578889999999999999999865443   7999998755 334456789999999999999999999987664 4579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          83 IITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            9999999999999997532      46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          337 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       337 a~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +........... ......+..|+|||++....++.++|||||||++|||++ |+.||.......   ..   ..     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~---~~-----  222 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VM---KA-----  222 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HH-----
Confidence            976643321111 111223457999999998889999999999999999997 999996533211   10   00     


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                         +....  .....   ......+.+++.+|++.+|.+||++.+|++.|+++
T Consensus       223 ---i~~~~--~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         223 ---INDGF--RLPAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---HhcCC--CCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               11000  11111   11234577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-39  Score=318.08  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=200.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|...+.||+|+||.||++...  +..||+|.+....  ..+.+.+|+.++++++|+|++++++++...+...++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888899999999999999875  6789999986543  3467889999999999999999999877666678999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          82 MAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999876432     45899999999999999999999887   9999999999999999999999999987554


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...     ....++..|+|||++....++.++|||||||++|||++ |+.||......   .+...           +..
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~-----------~~~  214 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR-----------VEK  214 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-----------Hhc
Confidence            322     22335678999999998889999999999999999998 99998643221   11110           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...+..  ..   .....+.+++.+|++.+|++|||+.++++.|+.
T Consensus       215 ~~~~~~--~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 GYKMDA--PD---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCC--CC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            011111  11   122456778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-40  Score=340.92  Aligned_cols=253  Identities=27%  Similarity=0.384  Sum_probs=213.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|..++++|+|+||.++..+++.+++.|++|.+....  .........|+.++++++|||||.+.+.+.+.+..++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999999999999999986543  3334467789999999999999999999888777699999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      +||+||+|.+.+.+.++     ..++++.+..++.|++.|+.|||++.   |+|||||+.|||++.++.|||+|||+|+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence            99999999999998763     57999999999999999999999877   99999999999999999999999999998


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      +.....  ...++.||+.||.||.+.+..|+.|+|||||||++|||++-+++|...+..+   ++.              
T Consensus       156 l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~--------------  216 (426)
T KOG0589|consen  156 LNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL--------------  216 (426)
T ss_pred             cCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH--------------
Confidence            876542  3457889999999999999999999999999999999999999998765432   211              


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ++....+  .+........+..++..||+.+|+.||++.+++.+
T Consensus       217 ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1111111  11122334456667788999999999999999985

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-39  Score=320.13  Aligned_cols=260  Identities=24%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||.||+|....++..||||.+...   ......++.+|+.+++.++||||+++++++.+.+ ..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEE
Confidence            4688889999999999999998878999999988643   2334567889999999999999999999887654 57999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          81 LELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999999875321   1256899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......|+..|+|||++.+..++.++||||||+++|||++|..||.......    .....        .+
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~--------~~  220 (267)
T cd08229         155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK--------KI  220 (267)
T ss_pred             ccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhh--------hh
Confidence            6643321  1223468899999999988889999999999999999999999996532211    01000        11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .....+.+.    .......+.+++.+||..+|.+||||.+|+++++.
T Consensus       221 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         221 EQCDYPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             hcCCCCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111112111    11233457788889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.4e-39  Score=333.77  Aligned_cols=266  Identities=21%  Similarity=0.331  Sum_probs=197.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|+..+.||+|+||.||++....++..||+|++...  .......+.+|+.+++.++||||+++++++....     .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999888999999999653  2344567889999999999999999999876433     2


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+.+ +|.+.+.         ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence            46899999965 5666653         34788899999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH-Hhh----h
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWA----K  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv-~~~----~  408 (520)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ...    .
T Consensus       167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         167 FGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             CCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            99997543322   123456899999999999989999999999999999999999999754321110000 000    0


Q ss_pred             hHhhhchhHHHHhhCcccCCCC-----------------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTS-----------------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~-----------------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .........+............                 ........+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000001111111000000                 00011245678899999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.4e-39  Score=331.61  Aligned_cols=238  Identities=28%  Similarity=0.399  Sum_probs=188.0

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHH-HHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|.. +++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence            46999999999999999889999999997542   122344555554 56789999999999987664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            99999998753       46899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ....++.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----------------~~~~i~~  210 (323)
T cd05575         150 SK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----------------MYDNILN  210 (323)
T ss_pred             CC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHHc
Confidence            11  2234569999999999999899999999999999999999999997543211                 0111122


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                      ..+......   ...+.+++.+||+.+|.+||++.
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 KPLRLKPNI---SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence            222211112   34567788899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-39  Score=324.30  Aligned_cols=269  Identities=26%  Similarity=0.369  Sum_probs=204.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCC----------------cEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeec
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLR----------------TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVP  243 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~----------------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~  243 (520)
                      ..+|...+.||+|+||.||+|.....+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357889999999999999998875432                468999987653 345678899999999999999999


Q ss_pred             EEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       244 l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      +++++... ...++|+||+++++|.+++.......    .....+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99998765 45799999999999999997643100    01136899999999999999999999887   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh--CCCCcchhcc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRL  397 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt--G~~Pf~~~~~  397 (520)
                      ||+++.++.++|+|||+++...............++..|+|||++..+.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999986543332222234456789999999988899999999999999999998  6777754321


Q ss_pred             ccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       398 ~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .   .............        +...... ........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       240 ~---~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 Q---QVIENAGHFFRDD--------GRQIYLP-RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHHhccccc--------cccccCC-CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1   1111111110000        0000000 01112246888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-39  Score=329.97  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=188.7

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHh-CCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||+|++....   ....+.+..|..++.. .+||||+++++++... ..+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            36999999999999998889999999997542   2233445567777764 4899999999987654 46899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          80 GGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            99999988753       46899999999999999999999987   999999999999999999999999999754332


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +..+..
T Consensus       150 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~--------------~~~i~~  210 (316)
T cd05592         150 E--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L--------------FDSILN  210 (316)
T ss_pred             C--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H--------------HHHHHc
Confidence            2  12234569999999999998899999999999999999999999997543211   1              011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EII  461 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~-eVl  461 (520)
                      .....+...   ...+.+++.+||+.+|.+||++. +++
T Consensus       211 ~~~~~~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         211 DRPHFPRWI---SKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111111112   23456778899999999999986 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-39  Score=322.79  Aligned_cols=269  Identities=29%  Similarity=0.382  Sum_probs=202.0

Q ss_pred             cccceEEcccCceEEEEeee----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  257 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~L  257 (520)
                      |...+.||+|+||+||++..    ..++..||+|.+.... ......|.+|+++++.++||||+++++++.... ..+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999987653    3457789999997643 234567889999999999999999999876543 45789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        86 v~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          86 IMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence            9999999999999865        35999999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +......... ......++..|+|||.+....++.++||||||+++|||++|..|+...... ......+.....  ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~--~~~  231 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQM--TVV  231 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhccccccc--chh
Confidence            8765432211 112233566799999998888999999999999999999999998643221 011111100000  000


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .+.+.++.....+ ........+.+++..||+.+|++|||+++|+++|+..
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         232 RLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1222222221111 0111234677888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=338.18  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=191.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .+|...+.||+|+||+||+|.+..+++.||||++.... ......+.+|+++++.++|+||+++++++.+ +..+++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEe
Confidence            35667788999999999999998889999999996543 3345678899999999999999999998765 445899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|...           ...++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       153 ~~~~~~L~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        153 FMDGGSLEGT-----------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             cCCCCccccc-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            9999998543           23567778899999999999999888   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+..          
T Consensus       219 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----------  286 (353)
T PLN00034        219 AQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----------  286 (353)
T ss_pred             ccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----------
Confidence            43221  1234569999999998743     234568999999999999999999997432221111100          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .+.  ........   ......+.+++.+||+.+|++|||+.||++
T Consensus       287 -~~~--~~~~~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        287 -AIC--MSQPPEAP---ATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -HHh--ccCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000  00001111   122345778889999999999999999987

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.8e-39  Score=323.19  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||+||++....+++.||+|.+.....   ...+.+..|+.+++.++||||+++.+++.. +...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            6999999999999988899999999865422   233567789999999999999999987655 455899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |..++.....   .+..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        80 L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          80 LRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             HHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9988864321   1256999999999999999999999887   99999999999999999999999999976544322 


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........      .       ....+.....
T Consensus       153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------~-------~~~~~~~~~~  218 (280)
T cd05608         153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------E-------LKQRILNDSV  218 (280)
T ss_pred             -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------H-------HHHhhcccCC
Confidence             1234568999999999999999999999999999999999999997543211000      0       0111111112


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+.   .....+.+++.+||+.+|++||     ++.++++
T Consensus       219 ~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPD---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1111   1234567788899999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.7e-39  Score=327.15  Aligned_cols=259  Identities=26%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             hCCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~  253 (520)
                      .++|...+.||+|+||.||+|..     ..++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++... .
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-G  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-C
Confidence            35789999999999999999975     2345679999987543 34456788999999999 799999999988664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++||||+++|+|.+++.....     ..+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECC
Confidence            58999999999999999975431     34899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||+++...............++..|+|||.+....++.++|||||||++|||++ |..||.......  ..         
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~---------  253 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF---------  253 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH---------
Confidence            999986644322111223346778999999998899999999999999999998 999986533211  00         


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                            .+.++...... ........+.+++.+||..+|++|||+.+|++.|+.
T Consensus       254 ------~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         254 ------YKLIKEGYRMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ------HHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                  01111111100 001122457788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=330.67  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=193.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|.+..++..||+|++.+..   ......+..|.+++..+ +||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999998889999999997542   23345677888888877 799999999987664 46899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          80 GGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            99999888753       46999999999999999999999888   999999999999999999999999998753222


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .              ...+..
T Consensus       150 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~--------------~~~i~~  210 (318)
T cd05570         150 GV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---L--------------FQSILE  210 (318)
T ss_pred             CC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---H--------------HHHHHc
Confidence            11  1234568999999999999999999999999999999999999997543211   1              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  462 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm-----~eVl~  462 (520)
                      .....+..   ....+.+++.+||+.||.+||++     .++++
T Consensus       211 ~~~~~~~~---~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         211 DEVRYPRW---LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCCCCc---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11111111   12356788899999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.8e-39  Score=329.68  Aligned_cols=252  Identities=27%  Similarity=0.302  Sum_probs=194.4

Q ss_pred             CcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      +|+..+.||+|+||+||++...   .++..||+|++.+..    ....+.+..|+.++..+ +||||+++++++.+ +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            4788899999999999998763   467899999986532    22345678899999999 59999999987655 456


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeC
Confidence            89999999999999998753       46899999999999999999999887   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........  ...     
T Consensus       150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--~~~-----  221 (332)
T cd05614         150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE--VSR-----  221 (332)
T ss_pred             cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH--HHH-----
Confidence            999865432221 12345699999999999765 478899999999999999999999975332211110  000     


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                         .+. ..++.+  +..   ....+.+++.+||+.||++||     ++.++++
T Consensus       222 ---~~~-~~~~~~--~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         222 ---RIL-KCDPPF--PSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---HHh-cCCCCC--CCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               000 011211  111   123466788899999999999     6777775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-39  Score=323.86  Aligned_cols=260  Identities=28%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             CcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +|...+.||+|+||.||+|....     .+..||+|++..... .....+.+|+.+++.++||||+++++++.+.. ..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ceE
Confidence            46777889999999999998743     257899999975533 33466889999999999999999999986654 578


Q ss_pred             EEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      +++||+++++|.+++......         ......+++..+..++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998642110         011245899999999999999999999887   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~  406 (520)
                      .+||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..||......+   .   
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence            999999999886543332222233446789999999988899999999999999999998 888886532211   1   


Q ss_pred             hhhHhhhchhHHHHhhCcccC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          407 AKPILHRGMAAVEELLDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                                 +..+.+.... .+...   ...+.+++..||+.+|.+||++++|++.|+.
T Consensus       236 -----------~~~i~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 -----------IEMIRNRQVLPCPDDC---PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHHHcCCcCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       1111111111 11112   2346788899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-39  Score=321.88  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=200.7

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC-----
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-----  252 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~-----  252 (520)
                      .+++.|+..+.||+|+||.||+|....+++.||+|.+.... .....+..|+.++..+ +||||+++++++....     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678999999999999999999998889999999987543 3345678899999998 7999999999987532     


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ...++||||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence            347899999999999999976432     56899999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      |||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||..........     
T Consensus       154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----  226 (272)
T cd06637         154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  226 (272)
T ss_pred             cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence            9999976543221  123456899999999986     3457889999999999999999999996432211000     


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                               .+.....+.+. ..   .....+.+++.+||..+|.+|||+.+|++
T Consensus       227 ---------~~~~~~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 ---------LIPRNPAPRLK-SK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---------HHhcCCCCCCC-CC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                     00010111111 11   12235678889999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-39  Score=329.92  Aligned_cols=242  Identities=26%  Similarity=0.369  Sum_probs=190.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHh-CCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||||++....   ......+..|..++.. ++||||+++++++.+. ..+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            46999999999999998889999999997542   2233456677778875 5999999999987764 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          80 GGDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            99999998753       46899999999999999999999887   999999999999999999999999998753322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...           +. ...
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~-----------i~-~~~  212 (316)
T cd05619         150 DA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS-----------IR-MDN  212 (316)
T ss_pred             CC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH-----------HH-hCC
Confidence            11  1234569999999999998899999999999999999999999997543211   1100           00 011


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EIIA  462 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~-eVl~  462 (520)
                      +.+  +..   ....+.+++.+||+.+|.+||++. ++.+
T Consensus       213 ~~~--~~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PCY--PRW---LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCC--Ccc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111  111   123466788899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=316.16  Aligned_cols=253  Identities=28%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|++|.||+|....++..||+|.+....     ....+.+.+|++++++++||||+++++++.+.+ .++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence            57899999999999999999998889999999986432     223456889999999999999999999987654 689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+
T Consensus        81 ~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999998754       45889999999999999999999888   99999999999999999999999999


Q ss_pred             ccccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++.......... .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......   ...   ..     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~~-----  219 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIF---KI-----  219 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHH---HH-----
Confidence            976543211110 123457889999999999889999999999999999999999996532211   000   00     


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                        ......+.+  +   ......+.+++.+||..+|.+|||+.++++.
T Consensus       220 --~~~~~~~~~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 --ATQPTNPQL--P---SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --hccCCCCCC--C---ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              000001111  1   1123456778899999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-39  Score=333.75  Aligned_cols=265  Identities=26%  Similarity=0.428  Sum_probs=202.9

Q ss_pred             CCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|...+.||+|+||.||+|..     ..+++.||||++.... ......+.+|+.++.++ +||||++++++|...+..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999974     2356789999997543 33456788999999999 689999999998776677


Q ss_pred             EEEEEEecCCCChhHHhhhhccCC--------------------------------------------------------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGV--------------------------------------------------------  278 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~--------------------------------------------------------  278 (520)
                      .++||||+++|+|.+++.......                                                        
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999987532100                                                        


Q ss_pred             ----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccc
Q 010012          279 ----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG  354 (520)
Q Consensus       279 ----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  354 (520)
                          .....++|..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                00134788999999999999999999887   99999999999999999999999999986543222111223346


Q ss_pred             cCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCH
Q 010012          355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNS  433 (520)
Q Consensus       355 t~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  433 (520)
                      +..|+|||.+.+..++.++|||||||++|||++ |..||.......  ...    .       .+....  ....+... 
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~-------~~~~~~--~~~~~~~~-  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----R-------RLKEGT--RMRAPDYT-  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----H-------HHhccC--CCCCCCCC-
Confidence            678999999988899999999999999999997 999986532211  000    0       011100  11111111 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          434 AQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       434 ~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        ...+.+++..||+.+|++||++.+|++.|+..
T Consensus       308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              23577888999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-39  Score=322.63  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=202.9

Q ss_pred             CCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|+..+.||+|+||.||++...     .++..+|+|.+..........+.+|+++++.++||||+++++++.+. ...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceE
Confidence            46778899999999999999642     34668999998877666677899999999999999999999988765 4579


Q ss_pred             EEEEecCCCChhHHhhhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          257 LIYKYVSGGSLERHLHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~--------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      +||||+++|+|.+++......        ......+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            999999999999999764210        001135899999999999999999999887   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||........       
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence            99999999975543221111223345788999999998899999999999999999998 9999864322110       


Q ss_pred             hhHhhhchhHHHHhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          408 KPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                                +...... ....+...   ...+.+++.+||+.+|.+||++.+|++.|+
T Consensus       234 ----------~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 ----------IECITQGRELERPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----------HHHHHcCccCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                      0001110 01111112   234668889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-39  Score=332.59  Aligned_cols=243  Identities=29%  Similarity=0.390  Sum_probs=190.1

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHH-HHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|....+++.||+|++.+..   ......+..|.. +++.++||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCC
Confidence            46999999999999998889999999996542   223345555554 56789999999999987664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            99999888653       56899999999999999999999888   999999999999999999999999998753322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ....++.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----------------~~~~~~~  210 (325)
T cd05604         150 SD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----------------MYDNILH  210 (325)
T ss_pred             CC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----------------HHHHHHc
Confidence            11  1234569999999999999999999999999999999999999997543211                 0111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..+.....   ....+.+++.+|++.+|.+||++++.++.
T Consensus       211 ~~~~~~~~---~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         211 KPLVLRPG---ASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CCccCCCC---CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            12211111   22346678899999999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-40  Score=327.41  Aligned_cols=264  Identities=25%  Similarity=0.372  Sum_probs=202.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC----cEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----~~~LV  258 (520)
                      .|...+++|.|+||.||+|....+++.||||++-.+.+..    .+|+++|+.++|||||+|+.+|....+    ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            5777899999999999999999889999999986654321    269999999999999999987764433    24599


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~DFGla  337 (520)
                      |||||. +|.++++....   .+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|
T Consensus       101 leymP~-tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHhchH-HHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence            999976 89998886321   2367888888899999999999999987   9999999999999966 89999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +.+......   .+...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....  .+++...+.+=....+
T Consensus       174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTRE  248 (364)
T ss_pred             eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHH
Confidence            987655432   344578889999999876 6999999999999999999999999875543  3344333322111111


Q ss_pred             HHH-------HhhCcccCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVE-------ELLDPRLKCTS----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~-------~~~d~~l~~~~----~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.       +...|.+....    .......+.++++.++|+.+|.+|.+..|++.
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            111       11122222111    12233456889999999999999999999886

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5e-39  Score=329.55  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=191.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      +|+..+.||+|+||+||+|....+++.||+|++.+..   ....+.+..|..++..+. |++|+++++++.+ .+.+++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            4777899999999999999998889999999997542   233456778888888886 4677778876655 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          80 MEYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccc
Confidence            9999999999998653       46999999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              +
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~--------------~  210 (323)
T cd05615         150 EHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L--------------F  210 (323)
T ss_pred             ccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            5432221  1234569999999999998889999999999999999999999997643211   1              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                      ..+.......+..   ....+.+++.+||+.+|.+|++.
T Consensus       211 ~~i~~~~~~~p~~---~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         211 QSIMEHNVSYPKS---LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHHhCCCCCCcc---CCHHHHHHHHHHcccCHhhCCCC
Confidence            1111112211111   12356778899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.9e-39  Score=320.32  Aligned_cols=254  Identities=25%  Similarity=0.342  Sum_probs=200.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||+|....+++.||+|++..........+.+|+.++++++||||+++++++... ...++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEeC
Confidence            5799999999999999999999888999999999765545556788999999999999999999998764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          88 CGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999998653       46899999999999999999999887   9999999999999999999999999998664


Q ss_pred             CCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ....  ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||.........  ..+.          .
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~----------~  223 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS----------K  223 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee----------c
Confidence            3221  112345889999999884   345788999999999999999999998643321100  0000          0


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .....+.+..   .......+.+++.+||+.+|++||++.+|++.
T Consensus       224 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         224 SNFQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            0001111111   11123457788899999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.7e-39  Score=322.06  Aligned_cols=248  Identities=24%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||.||++....+++.||+|.+.....   .....+..|++++++++||||+++++++.+ +...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            6999999999999988899999999865321   223455679999999999999999988765 456899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++.......  
T Consensus        80 L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          80 LKYHIYNVGE-----RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             HHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            9988865432     46899999999999999999999887   9999999999999999999999999998664432  


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ....           ....+....
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~-----------~~~~~~~~~  215 (277)
T cd05607         150 -TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEEL-----------KRRTLEDEV  215 (277)
T ss_pred             -eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHH-----------HHHhhcccc
Confidence             12345689999999999988899999999999999999999999975322111  0000           111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      ...  .......+.+++..||+.+|++||++.|+++.+
T Consensus       216 ~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         216 KFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            111  011223467888999999999999998877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-39  Score=348.47  Aligned_cols=271  Identities=14%  Similarity=0.195  Sum_probs=198.6

Q ss_pred             HHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC------CCeecEEEEE
Q 010012          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH------PNIVPLVGFC  248 (520)
Q Consensus       175 ~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~g~~  248 (520)
                      +++...+++|...+.||+|+||+||+|.+..+++.||||++.... .....+..|++++..++|      ++++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344556789999999999999999999998888999999996532 223445567777766654      4589999988


Q ss_pred             EcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCC
Q 010012          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       249 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~  327 (520)
                      ......+++|||++ +++|.+++...       ..+++..+..|+.||+.||.|||+ .+   ||||||||+|||++.++
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSD  269 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCC
Confidence            76666789999988 78898888653       469999999999999999999997 46   99999999999998765


Q ss_pred             ----------------ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCC
Q 010012          328 ----------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  391 (520)
Q Consensus       328 ----------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~P  391 (520)
                                      .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                            4999999988643322     2345799999999999999999999999999999999999999


Q ss_pred             cchhccccchhhHHhhhh-Hhhhc-----hhHHHHhhCc------ccC----------CCCCCHHHHHHHHHHHHHcccc
Q 010012          392 IEARRLQGEENLVLWAKP-ILHRG-----MAAVEELLDP------RLK----------CTSRNSAQIARVIQAAAACISS  449 (520)
Q Consensus       392 f~~~~~~~~~~lv~~~~~-~~~~~-----~~~l~~~~d~------~l~----------~~~~~~~~~~~l~~la~~Cl~~  449 (520)
                      |......+...++..... +....     .....++.+.      ...          ...........+.+|+.+||+.
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            976443222111111100 00000     0000011100      000          0000001124577999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010012          450 EESRRPGIEEIIA  462 (520)
Q Consensus       450 dP~~RPtm~eVl~  462 (520)
                      ||++|||+.|+++
T Consensus       425 dP~~R~ta~e~L~  437 (467)
T PTZ00284        425 DRQKRLNARQMTT  437 (467)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999987

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-39  Score=330.52  Aligned_cols=243  Identities=26%  Similarity=0.381  Sum_probs=188.9

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHH-HHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCREL-MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~-~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|....+++.||+|++....   ......+..|. .+++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence            36999999999999998888999999997532   12223444444 457889999999999987664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++...       ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          80 GGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            99999998753       45788888899999999999999988   999999999999999999999999999754322


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .              +..+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~--------------~~~i~~  210 (325)
T cd05602         150 NG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M--------------YDNILN  210 (325)
T ss_pred             CC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H--------------HHHHHh
Confidence            21  1234569999999999999999999999999999999999999997543211   0              111111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..+......   ...+.+++.+||+.+|.+||++.+.+..
T Consensus       211 ~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         211 KPLQLKPNI---TNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCcCCCCCC---CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            111111112   2346677889999999999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.8e-39  Score=336.31  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=197.6

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ....++|...+.||+|+||.||++....+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+ +..
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~  117 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRY  117 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCE
Confidence            345579999999999999999999999899999999986432   2234557789999999999999999998765 456


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++||||+++|+|.+++..        ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            8999999999999999864        34788889999999999999999888   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |+++....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||........          
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----------  255 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------  255 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH----------
Confidence            99986643221 122345699999999998653    378999999999999999999999976432110          


Q ss_pred             hhhchhHHHHhhCc--ccCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 010012          411 LHRGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIAI  463 (520)
Q Consensus       411 ~~~~~~~l~~~~d~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~~  463 (520)
                             ...+...  .+..+. .......+.+++..||...+.+  ||++.+|++.
T Consensus       256 -------~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         256 -------YSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -------HHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                   1111110  111111 1112234566778899844433  7889988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.5e-39  Score=329.80  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=190.8

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||+|++.+..   ....+.+..|+.++.++ +||||+++++++.+ ...+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999998889999999997642   23345678899998888 69999999998765 456899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          80 GGDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            99999888653       46999999999999999999999988   999999999999999999999999998753222


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+...          .+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~----------~~~~  217 (327)
T cd05617         150 GD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ----------VILE  217 (327)
T ss_pred             CC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH----------HHHh
Confidence            11  12345699999999999999999999999999999999999999964332211111111111          1111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                      .....+...+   ..+.+++.+||+.||.+||++
T Consensus       218 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 KPIRIPRFLS---VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCCC---HHHHHHHHHHhccCHHHcCCC
Confidence            1122122122   346678889999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.3e-39  Score=324.34  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||+|....++..||+|.+..........+.+|+.+++.++||||+++++++... ...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecc
Confidence            5889999999999999999998888999999999876555567788999999999999999999988764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             cCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999864        35889999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........  +..    ...        .
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~~--------~  231 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IAT--------N  231 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----Hhc--------C
Confidence            3221  11234688999999999988899999999999999999999999975432111  100    000        0


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+..+   ......+.+++.+||..+|++||++.+|++
T Consensus       232 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 GTPELQNP---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCCCCCc---cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            01111111   122345778889999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-39  Score=317.38  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=198.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|...+.||+|+||+||+|.... +..+|+|.+..... ....|.+|+.++++++||||+++++++.+. ...++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEc
Confidence            367888999999999999998764 45699999875432 346789999999999999999999998664 457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          81 MSNGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999987532      36899999999999999999999887   9999999999999999999999999988654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...           .+..
T Consensus       152 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  216 (256)
T cd05113         152 DDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE-----------KVSQ  216 (256)
T ss_pred             CCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-----------HHhc
Confidence            33211 1122335678999999988889999999999999999998 999986433211   100           0100


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ..  ......   .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       217 ~~--~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 GL--RLYRPH---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CC--CCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            00  000011   12356788889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=313.83  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=202.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|++|.||++....+++.||+|.+...  .....+.+.+|++++++++|||++++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            478889999999999999999888899999998654  234456788999999999999999999876555556789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             ccCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            9999999999976432     46899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......+++.|+|||++.+..++.++||||||+++|||++|+.||.......      ....+          
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~----------  214 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRI----------  214 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH----------
Confidence            43221  2234568899999999999899999999999999999999999997533211      11111          


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ....+.  .........+.+++.+|++.+|++||++.++++
T Consensus       215 -~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         215 -IEGKLP--PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -HhcCCC--CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             111111  001123346778899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.5e-39  Score=322.44  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             hCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++|...+.||+|+||.||+|...     .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-P   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-c
Confidence            467999999999999999999874     256789999987653 344567889999999999999999999887654 5


Q ss_pred             EEEEEEecCCCChhHHhhhhccC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKG---------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~---------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      .++||||+++|+|.+++......               ......+++..++.++.|++.||+|||+.+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            79999999999999999753210               011235889999999999999999999887   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  398 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~  398 (520)
                      |||+++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543221111222335678999999998899999999999999999998 88888643221


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .   .              +..+.+.... .+.   .....+.+++.+||+.+|.+|||+.||++.|+
T Consensus       240 ~---~--------------~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 E---V--------------IYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H---H--------------HHHHhcCCCCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1   1              1111111111 111   12345778889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-41  Score=338.03  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..|+....||+|.||.||+|.+..+++.||+|+++.+. ......+..|+.+|.+++++||.++++.+..+. .++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-KLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-cHHHHHH
Confidence            46777789999999999999999999999999998763 345678889999999999999999999887754 5899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ||.||++.+.|...       ..+.+..+..|+.+++.||.|||..+   .+|||||+.||||.++|.+||+|||++..+
T Consensus        92 y~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             HhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence            99999999999764       34577778889999999999999888   999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ......  ..+++||+.|||||++....|+.|+||||||++++||.+|.+|+....+-...       -       .+.+
T Consensus       162 ~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------f-------lIpk  225 (467)
T KOG0201|consen  162 TNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------F-------LIPK  225 (467)
T ss_pred             echhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------E-------eccC
Confidence            654432  25678999999999999889999999999999999999999999865542111       1       1222


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -.-|.+..     .....+.+++..||.++|+.||++.++++
T Consensus       226 ~~PP~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  226 SAPPRLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCcccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            22344433     22234566677899999999999999986

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.6e-39  Score=329.06  Aligned_cols=238  Identities=28%  Similarity=0.405  Sum_probs=187.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHH-HHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      ++||+|+||.||+|+...+++.||+|++.+..   ......+..|.. +++.++||||+++++++.+. +..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            36999999999999998889999999987542   122344555554 67889999999999887664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          80 GGELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            99998888653       46888889999999999999999887   999999999999999999999999998753222


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ....+..
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~~i~~  210 (321)
T cd05603         150 EE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----------------MYDNILH  210 (321)
T ss_pred             CC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHhc
Confidence            21  2234569999999999998899999999999999999999999997543211                 0111222


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                      ..+..+..   ....+.+++.+||+.+|.+||+..
T Consensus       211 ~~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 KPLQLPGG---KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCC---CCHHHHHHHHHHccCCHhhcCCCC
Confidence            22222221   234567888999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.6e-39  Score=315.71  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             eEEcccCceEEEEeeecC-CC--cEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-~~--~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+  ...++|+||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            368999999999998754 23  3699999987655 567789999999999999999999999876  56899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++.....     ..++|..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          79 LGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            9999999976431     46899999999999999999999887   999999999999999999999999999876543


Q ss_pred             CCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ...   .        +.. 
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~--------~~~-  215 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---K--------IDK-  215 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H--------HHh-
Confidence            2211 1123457889999999998899999999999999999998 999986432211   100   0        000 


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ....+..+.   .....+.+++.+|++.+|++||++.+|++.|.
T Consensus       216 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGERLERPE---ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCcCCCCc---cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            001111111   12345778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.4e-39  Score=319.77  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=199.2

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      |+..+.||+|+||.||+|....++..+++|.+........+.+.+|+++++.++||||+++++++... ...++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecC
Confidence            56678899999999999999888899999999876666677899999999999999999999988775 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +++|..++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          86 GGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999998886532      56999999999999999999999887   999999999999999999999999998765432


Q ss_pred             CCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ..  ......++..|+|||++.     +..++.++|||||||++|||++|++||.......  ...            .+
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~------------~~  220 (282)
T cd06643         157 IQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLL------------KI  220 (282)
T ss_pred             cc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHH------------HH
Confidence            11  123456899999999984     3457889999999999999999999997533211  000            00


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+.+..+..   ....+.+++.+||+.+|.+||++.+|++
T Consensus       221 ~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         221 AKSEPPTLAQPSR---WSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             hhcCCCCCCCccc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011111111111   1235677889999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.8e-39  Score=322.75  Aligned_cols=265  Identities=21%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      .+++|++.+.||+|+||.||+|..++     .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            45689999999999999999997542     24579999886543 233456888999999999999999999876654 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~---~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ..++||||+++|+|.+++.......   .....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            5799999999999999997643211   11245678888999999999999999887   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+   .      
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~------  230 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V------  230 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H------
Confidence            999999986543322111222345778999999998899999999999999999999 788886532211   0      


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                              ...+.+......  .......+.+++.+||+.+|++|||+.++++.|+..
T Consensus       231 --------~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         231 --------LKFVMDGGYLDQ--PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --------HHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                    111111111100  011124678888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.6e-39  Score=316.09  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=193.9

Q ss_pred             EEcccCceEEEEeee--cCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          189 VLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      .||+|+||.||+|.+  ..++..||+|++....  ....+++.+|+.+++.++||||+++++++..  ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            589999999999965  3457889999986543  3455678999999999999999999998743  346899999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||.|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          80 GPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999998653       45899999999999999999999887   9999999999999999999999999998765433


Q ss_pred             CCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          345 VPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       345 ~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      .... .....++..|+|||.+....++.++|||||||++|||++ |..||.......   +..           .+....
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-----------~i~~~~  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQ-----------MIESGE  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------HHHCCC
Confidence            2111 112234578999999988889999999999999999998 999997543211   111           011110


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .+..  +...   ...+.+++.+||+.+|++||++.+|++.|+.
T Consensus       216 ~~~~--~~~~---~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 RMEC--PQRC---PPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCC--CCCC---CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1111  1112   2346678899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.6e-39  Score=317.58  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=199.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCc---EEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .|...+.||+|+||.||+|....++.   .||||.+... .......|..|+.+++.++||||+++++++.+. ...++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEEE
Confidence            57788999999999999999875554   6999998764 344567899999999999999999999987654 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          84 TEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             EecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence            99999999999987542      46899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcc-ccccc--ccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          339 WTSAPSVPFL-CKTVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       339 ~~~~~~~~~~-~~~~~--Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      .......... .....  .+..|+|||++....++.++|||||||++|||++ |..||.......   ...+        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~--------  223 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA--------  223 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH--------
Confidence            6543221111 11111  2457999999998899999999999999999986 999996533211   1111        


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                         +...  ..+..+..   ....+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       224 ---i~~~--~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         224 ---IEQD--YRLPPPMD---CPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ---HHcC--CcCCCccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence               1110  01111111   12346778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-39  Score=323.20  Aligned_cols=268  Identities=25%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCC--------------CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL--------------RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG  246 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~--------------~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g  246 (520)
                      ++|...+.||+|+||.||++.....              ...||+|.+... .......|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788899999999999999886432              235899998764 3344567899999999999999999999


Q ss_pred             EEEcCCCcEEEEEEecCCCChhHHhhhhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCe
Q 010012          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG-----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (520)
Q Consensus       247 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~-----~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NI  321 (520)
                      ++... ...++||||+++++|.+++......     ......+++..+..++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            98664 4579999999999999999653210     011134789999999999999999999887   99999999999


Q ss_pred             EecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh--CCCCcchhcccc
Q 010012          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQG  399 (520)
Q Consensus       322 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt--G~~Pf~~~~~~~  399 (520)
                      |++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976543322222223345778999999998899999999999999999998  566776432211


Q ss_pred             chhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       400 ~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                         .+..........   .....   ...+.   .....+.+++.+|++.+|++||++.+|++.|+
T Consensus       241 ---~~~~~~~~~~~~---~~~~~---~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIENTGEFFRNQ---GRQIY---LSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHhhhhc---ccccc---CCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               111111111000   00000   00011   12246888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=325.37  Aligned_cols=272  Identities=23%  Similarity=0.310  Sum_probs=210.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecC--cchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc----CCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~  253 (520)
                      ....|...+.||+|+||.|..+....+++.||||++..  ...-..++-.+|+.+|+.++|+||+.+++.+..    .-+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34567778899999999999999999999999999973  344556777899999999999999999998654    224


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+|+|+|+| +.+|...++..       ..|+......++.|+++||.|+|+.+   |+||||||+|+|++.+..+||+|
T Consensus       100 DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence            589999999 77999999864       45999999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||||+...........+..+.|.+|.|||++.. ..|+.+.||||.|||+.||++|++-|.+.+.-.+..++........
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999998764322223456778999999999854 5799999999999999999999999988765544444432221111


Q ss_pred             hc-----h-hHHHHhhCcccCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RG-----M-AAVEELLDPRLKCTS-----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~-----~-~~l~~~~d~~l~~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +.     . ......+......+.     ..+..-..+++++.++|..||.+|+|+.|.++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            10     0 011111111111111     01122246788889999999999999999987

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.2e-39  Score=334.11  Aligned_cols=268  Identities=20%  Similarity=0.295  Sum_probs=199.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~~  256 (520)
                      +|+..+.||+|+||+||++....+++.||+|++...  .....+.+.+|+++++.++||||+++++++....    ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999888999999998653  2334567889999999999999999999876544    2579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+. ++|.+.+...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccc
Confidence            9999996 6888877543       56899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-----hH
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PI  410 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-----~~  410 (520)
                      ++........ ......+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+....     ..
T Consensus       150 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9865433221 12334588999999998764 47899999999999999999999997654322111111000     00


Q ss_pred             hhhchhHHHHhhCcccCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTS-------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~-------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +..........+........       ........+.+++.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00000000111100000000       00111345778899999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-40  Score=328.14  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|.+.+.||+|.||.|-+|.....|+.||||.+.++.   .+..-.+.+|++|++.|+||||+.++.+|.. ...+.|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEE
Confidence            467888899999999999999998889999999997763   3445567899999999999999999998654 556899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||..+|.|.+|+...       ..|++...+.|+.||..|+.|+|.++   ++|||||.+|||||.++++||+||||+
T Consensus       131 vMEYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  131 VMEYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999875       57999999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      -++....   ...+++|++-|.+||++.+..| ++.+|-||+||+||.|+.|..||++.+..   .              
T Consensus       201 Nly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~--------------  260 (668)
T KOG0611|consen  201 NLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R--------------  260 (668)
T ss_pred             hhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H--------------
Confidence            8886654   3467889999999999999887 68899999999999999999999875432   1              


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .++++-...+..+.    ......-|+++||..+|++|.|+.+|...
T Consensus       261 lvrQIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  261 LVRQISRGAYREPE----TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHhhcccccCCC----CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            22333333333222    22334567899999999999999999863

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.9e-39  Score=331.85  Aligned_cols=268  Identities=21%  Similarity=0.324  Sum_probs=199.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----  252 (520)
                      ..++|...+.||+|+||.||++....+++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            346899999999999999999999888999999999754  2334567788999999999999999999875432     


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ...++||||+++ +|.+.+.         ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence            246899999965 6766664         34889999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH-Hhh----
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWA----  407 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv-~~~----  407 (520)
                      |||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+ ...    
T Consensus       162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (355)
T cd07874         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  238 (355)
T ss_pred             eCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998654322   123456899999999999889999999999999999999999999754322111000 000    


Q ss_pred             hhHhhhchhHHHHhhCcc----------------cCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          408 KPILHRGMAAVEELLDPR----------------LKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~----------------l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..........+...++..                .... .........+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000111111100                0000 0011123457789999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.4e-39  Score=317.17  Aligned_cols=253  Identities=28%  Similarity=0.409  Sum_probs=200.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||.||+|.+..+ ..||+|++..... ..+.+.+|+++++.++||||+++++++.+  ...++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEc
Confidence            5789999999999999999988754 5699999975432 34578899999999999999999997643  347899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          82 MSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             CCCCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            999999999975421     46899999999999999999999887   9999999999999999999999999998665


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||+..+..++.++|||||||++|||++ |..||........   .   .        .+..
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~---~--------~~~~  218 (262)
T cd05071         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---D--------QVER  218 (262)
T ss_pred             ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H---H--------HHhc
Confidence            43221 1123346778999999988899999999999999999999 8888865432110   0   0        0000


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ....   .......+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ~~--~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         219 GY--RMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CC--CCCC---ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            00  0111   12233567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-38  Score=331.57  Aligned_cols=267  Identities=21%  Similarity=0.327  Sum_probs=199.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|...+.||+|+||.||++....+++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999999888999999999753  2334567789999999999999999999765422     3


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+++ +|.+.+.         ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEe
Confidence            47999999964 7777764         24788999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-----h
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-----~  408 (520)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+...     .
T Consensus       170 fG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         170 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998654322   123456899999999999999999999999999999999999999764432211111000     0


Q ss_pred             hHhhhchhHHHHhhCcccCC--------------C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKC--------------T---SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~--------------~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .........+...+..+...              +   .........+.+++.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000011111100000              0   0001122457789999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-38  Score=319.10  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=197.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..++||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++... +..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEec
Confidence            677889999999999999999888999999998654 334456788999999999999999999998764 457899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|..+           ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          81 MDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             CCCCChHHh-----------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999654           23788889999999999999999888   9999999999999999999999999997654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~~~~~l~~  420 (520)
                      ...    .....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ......        .+..
T Consensus       147 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~  214 (279)
T cd06619         147 NSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------CIVD  214 (279)
T ss_pred             ccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------HHhc
Confidence            322    233568999999999998889999999999999999999999997533211100 000000        0111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ...+.+...    .....+.+++.+|++.+|++||++.++++.
T Consensus       215 ~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         215 EDPPVLPVG----QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCCCCCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111122111    122356788899999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-38  Score=336.00  Aligned_cols=263  Identities=20%  Similarity=0.233  Sum_probs=196.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|...+.||+|+||.||+|.+..+++.||+|....      ..+.+|++++++++|||||++++++... ...++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEe
Confidence            3579999999999999999999998999999997532      3467899999999999999999987664 45789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ++ .++|..++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus       164 ~~-~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~  232 (391)
T PHA03212        164 RY-KTDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP  232 (391)
T ss_pred             cC-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence            99 47898888653       45899999999999999999999987   999999999999999999999999999754


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcccc-c---hhhHHhhhhHh-----
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG-E---ENLVLWAKPIL-----  411 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~-~---~~lv~~~~~~~-----  411 (520)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .   ...........     
T Consensus       233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~  311 (391)
T PHA03212        233 VDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN  311 (391)
T ss_pred             cccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence            322111 1234579999999999998899999999999999999999998875432110 0   00000000000     


Q ss_pred             ---hhchhHHHHhh----Cc-ccC--CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 ---HRGMAAVEELL----DP-RLK--CTSR---NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ---~~~~~~l~~~~----d~-~l~--~~~~---~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ......+....    .. ...  ....   .......+.+++.+||+.||++|||+.|+++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               00000011110    00 000  0000   0112346778899999999999999999986

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.2e-39  Score=315.80  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.++++++|||++++++++.+  ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence            478888999999999999998764 66799999876433 34578899999999999999999998643  347899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          82 MSKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             cCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            999999999976421     46899999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...... .....++..|+|||++....++.++||||||+++|||++ |..||.......   ...           .+..
T Consensus       154 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  218 (260)
T cd05070         154 DNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE-----------QVER  218 (260)
T ss_pred             Cccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHHc
Confidence            432111 112235678999999988889999999999999999999 899996532211   100           0100


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ....+   ......+.+++.+|+..+|.+|||+.++++.|+.
T Consensus       219 ~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GY--RMPCP---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CC--CCCCC---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00  11111   1223457788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-38  Score=316.01  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             HHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       177 i~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +..+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++... ...+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEE
Confidence            345677887788999999999999998888899999999877666677899999999999999999999988764 4589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l--~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~D  333 (520)
                      +|+||+++++|.+++....      ..+  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEec
Confidence            9999999999999997642      234  78888899999999999999887   999999999999986 67999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCC--CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ||++........  ......|+..|+|||++....  ++.++|||||||++|+|++|+.||.......   ...+.....
T Consensus       153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~  227 (268)
T cd06624         153 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF  227 (268)
T ss_pred             chhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh
Confidence            999876543221  122345889999999986643  7889999999999999999999996432111   111100000


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                               -..+.+.     ......+.+++.+||+.+|.+|||+.+|++
T Consensus       228 ---------~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 ---------KIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---------ccCCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                     0011111     112245677889999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=312.74  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=202.4

Q ss_pred             eEEcccCceEEEEeeecCC---CcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|.....   +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++.+ ....++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            4699999999999999765   789999999765433 36788999999999999999999999877 556899999999


Q ss_pred             CCChhHHhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|.+++......  ......+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999874210  000156999999999999999999999887   9999999999999999999999999998766


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ............++..|+|||.+....++.++|||||||++|||++ |..||.......   +..           .+..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  222 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE-----------YLRK  222 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHHc
Confidence            5432222334567889999999988889999999999999999999 699997643211   100           1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                        ......+.   .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 --~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYRLPKPE---YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11111111   11346778889999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=341.01  Aligned_cols=241  Identities=30%  Similarity=0.486  Sum_probs=195.2

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +..+-||.|+-|.||+|++.  ++.||||++..-.       ..++.-|++|+||||+.+.|+|.... -+|||||||+.
T Consensus       127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~  196 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc-eeEEeeecccc
Confidence            34567999999999999997  6889999874321       25788999999999999999997754 47999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |-|...|+..       .++.-.....+..+||.|+.|||.+.   |||||||.-||||..+..|||+|||.++......
T Consensus       197 GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  197 GQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             ccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999875       56788888899999999999999988   9999999999999999999999999998765542


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                         ....++||..|||||++.+...++|+|||||||||||||||..||..-+...    +.|     .-|.    ..+  
T Consensus       267 ---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----GVGs----NsL--  328 (904)
T KOG4721|consen  267 ---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----GVGS----NSL--  328 (904)
T ss_pred             ---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----eccC----Ccc--
Confidence               2346789999999999999999999999999999999999999997543221    111     1110    011  


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .|..+..+++   -|.-|+.+||+..|..||++++|+..|.-
T Consensus       329 ~LpvPstcP~---GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  329 HLPVPSTCPD---GFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cccCcccCch---HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            1112222333   35556678999999999999999998863

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.7e-39  Score=329.36  Aligned_cols=239  Identities=26%  Similarity=0.324  Sum_probs=190.4

Q ss_pred             eEEcccCceEEEEeee---cCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +.||+|+||.||++..   ..+++.||+|++.....  .....+..|++++++++||||+++++++.+. ...++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCC
Confidence            5799999999999876   34688999999975432  2334567899999999999999999987664 5689999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          81 RGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999998653       46899999999999999999999988   99999999999999999999999999976543


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .+..+.
T Consensus       151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----------------~~~~i~  211 (318)
T cd05582         151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----------------TMTMIL  211 (318)
T ss_pred             CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----------------HHHHHH
Confidence            321  1234569999999999998889999999999999999999999997543211                 111111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE  459 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~e  459 (520)
                      ......+...   ...+.+++.+||+.||++||++.+
T Consensus       212 ~~~~~~p~~~---~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         212 KAKLGMPQFL---SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             cCCCCCCCCC---CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1122212112   234667888999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-39  Score=335.40  Aligned_cols=204  Identities=29%  Similarity=0.375  Sum_probs=175.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||++....+++.||+|++....   ......+..|+.++..++||||+++++++.+. ..+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEE
Confidence            36888999999999999999999889999999996532   23445678899999999999999999987664 558999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          80 MEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            9999999999999753       46899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCC---------------------------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHH
Q 010012          339 WTSAPSV---------------------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL  385 (520)
Q Consensus       339 ~~~~~~~---------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~EL  385 (520)
                      .......                                 ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            5432110                                 0011234699999999999999999999999999999999


Q ss_pred             HhCCCCcchhc
Q 010012          386 LTGRKPIEARR  396 (520)
Q Consensus       386 ltG~~Pf~~~~  396 (520)
                      ++|+.||....
T Consensus       230 ~tG~~Pf~~~~  240 (360)
T cd05627         230 LIGYPPFCSET  240 (360)
T ss_pred             ccCCCCCCCCC
Confidence            99999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7e-39  Score=317.64  Aligned_cols=255  Identities=30%  Similarity=0.471  Sum_probs=197.2

Q ss_pred             eEEcccCceEEEEeeecCCC------cEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGLLR------TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.||+|+||.||+|......      ..||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEEe
Confidence            36999999999999875433      679999886543 234567889999999999999999999987654 5899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-----ceEEeecC
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFG  335 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-----~vkL~DFG  335 (520)
                      |+++++|.+++............+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999764322112345899999999999999999999877   99999999999999877     89999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......   .....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~--------  225 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH--------  225 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH--------
Confidence            9976543322111223346788999999999999999999999999999998 99998643221   11100        


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                         +..  ........   .....+.+++.+||..+|.+||++.+|++.|+
T Consensus       226 ---~~~--~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 ---VTA--GGRLQKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---Hhc--CCccCCcc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               000  01111111   12345678889999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.9e-39  Score=327.09  Aligned_cols=241  Identities=23%  Similarity=0.344  Sum_probs=189.5

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHh-CCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||+|.+....   ......+..|..++.. ++||||+++++++.+. ..+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCC
Confidence            46999999999999999889999999997542   1234456678777765 4899999999987664 46899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          80 GGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            99999998753       46899999999999999999999988   999999999999999999999999998743221


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..           .+. ...
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~-----------~~~-~~~  212 (316)
T cd05620         150 DN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFE-----------SIR-VDT  212 (316)
T ss_pred             CC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH-----------HHH-hCC
Confidence            11  1234569999999999999999999999999999999999999997543211   100           000 001


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EII  461 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~-eVl  461 (520)
                      +.+  +...   ...+.+++.+||+.||.+||++. ++.
T Consensus       213 ~~~--~~~~---~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 PHY--PRWI---TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCC--CCCC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111  1111   23466788899999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-38  Score=319.96  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=201.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +.|+..+.||.|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEec
Confidence            5788999999999999999999888999999999877777778899999999999999999999987664 468999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|..++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          91 CPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999988876542      46899999999999999999999877   9999999999999999999999999987543


Q ss_pred             CCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ...  .......++..|+|||++.     ...++.++|||||||++|||++|..||.......  .    ..        
T Consensus       162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~----~~--------  225 (292)
T cd06644         162 KTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V----LL--------  225 (292)
T ss_pred             ccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--H----HH--------
Confidence            221  1123456889999999985     3456889999999999999999999986533211  0    00        


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.....+.+..+   ......+.+++.+||+.+|++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         226 KIAKSEPPTLSQP---SKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHhcCCCccCCCC---cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0111111111111   122245778889999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.8e-39  Score=324.27  Aligned_cols=266  Identities=22%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             hCCcccceEEcccCceEEEEeeec-------CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      ..+|...+.||+|+||.||+|+..       ..+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457888999999999999999752       234579999987542 34456788999999999 899999999987664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ...++||||+++|+|.+++.......         .....++|..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus        94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          94 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence             45899999999999999998643210         01246889999999999999999999887   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            99999999999999987654332222223346678999999988889999999999999999998 888886432211  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                          .... +...         .....+.   .....+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       248 ----~~~~-~~~~---------~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 ----LFKL-LKEG---------HRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ----HHHH-HHcC---------CcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                1110 0000         0111111   123456778899999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=314.12  Aligned_cols=249  Identities=29%  Similarity=0.468  Sum_probs=196.1

Q ss_pred             eEEcccCceEEEEeeecCCC---cEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|.....+   ..||+|.+..... ...+++.+|+.+++.++||||+++++++..  ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence            46999999999999875443   7899999876543 345678999999999999999999998643  34789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++...       ..+++..+..++.|++.||+|||..+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          79 LGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999764       35899999999999999999999887   999999999999999999999999999866543


Q ss_pred             CCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..+.    ...       
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~-------  214 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESG-------  214 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcC-------
Confidence            32111 111224567999999998899999999999999999998 99999754321   111111    010       


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       . .+..+.   .....+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       215 -~-~~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         215 -E-RLPRPE---ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -C-cCCCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             0 011111   1224567888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-38  Score=318.51  Aligned_cols=270  Identities=26%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             CCcccceEEcccCceEEEEeee----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~  255 (520)
                      ..|...+.||+|+||.||++..    ..++..||+|.+.... ......+.+|+++++.++||||+++.+++.+. ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999974    3457889999987553 44456789999999999999999999988765 3457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++++|.+++....      ..++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence            89999999999999986532      45899999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH-h-hhhHhh
Q 010012          336 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL-W-AKPILH  412 (520)
Q Consensus       336 la~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~-~-~~~~~~  412 (520)
                      +++......... ......++..|+|||++.+..++.++|||||||++|||++++.|.......-. .... . ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL-KMIGPTHGQMTVT  233 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh-hhcccccccccHH
Confidence            998665432211 11234567789999999888899999999999999999998876543211000 0000 0 000000


Q ss_pred             hchhHHHHhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          413 RGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       413 ~~~~~l~~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .   .+..+.+. .....   ......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       234 ~---~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 R---LVRVLEEGKRLPRP---PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             H---HHHHHHcCccCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0   01111111 11111   11234688899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.2e-39  Score=342.35  Aligned_cols=264  Identities=21%  Similarity=0.350  Sum_probs=193.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-------CC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------EQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-------~~  253 (520)
                      ..+|...+.||+|+||+||+|....++..||||++....    ....+|+.+++.++|||||++++++...       ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999998889999999886532    2234799999999999999999876432       12


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEe
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLC  332 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~  332 (520)
                      .+++||||+++ +|.+++.....   ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++ .+||+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence            36789999974 77777754321   1257999999999999999999999988   99999999999999665 79999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      |||+|+.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||........  +..... .+
T Consensus       214 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~  287 (440)
T PTZ00036        214 DFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VL  287 (440)
T ss_pred             ccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-Hh
Confidence            9999986654321   2345689999999998654 689999999999999999999999976443211  111100 00


Q ss_pred             hh-chhHHHHhhCcccC---CCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HR-GMAAVEELLDPRLK---CTSRN---------SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~-~~~~l~~~~d~~l~---~~~~~---------~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .. ....+. ...+.+.   .+...         ......+.+++.+||+.+|.+|||+.|+++
T Consensus       288 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        288 GTPTEDQLK-EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCCHHHHH-HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00 000000 0011000   00000         011245788999999999999999999985

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-38  Score=319.99  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=205.9

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEc
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~  250 (520)
                      ++..++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566667899999999999999999999998889999999986543 2345677899999998 89999999999875


Q ss_pred             CC----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          251 PE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       251 ~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      .+    ...++|+||+++|+|.+++.....   ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~  164 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE  164 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence            43    347899999999999998875321   1256899999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCC-----CCCcCceeeHHHHHHHHHhCCCCcchhccccch
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-----VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  401 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~  401 (520)
                      +.+||+|||++........  ......|+..|+|||++....     ++.++|||||||++|||++|+.||.......  
T Consensus       165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--  240 (291)
T ss_pred             CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--
Confidence            9999999999886543221  123346889999999986443     6889999999999999999999997533211  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+..            +.....+.+...   ......+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~------------~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 TLFK------------IPRNPPPTLLHP---EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHH------------HhcCCCCCCCcc---cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1100            000011111111   122345788899999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-38  Score=314.46  Aligned_cols=247  Identities=28%  Similarity=0.469  Sum_probs=192.9

Q ss_pred             EcccCceEEEEeeec--CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||.||+|.+.  ..+..||+|++.... ....+.+.+|+.++++++||||+++++++..  ...++||||+++|+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~~   80 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGGP   80 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCCC
Confidence            899999999999764  345679999987653 3345678999999999999999999998743  35789999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        81 L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          81 LNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            999987532      46899999999999999999999887   999999999999999999999999999865443221


Q ss_pred             cc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          347 FL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       347 ~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                      .. .....++..|+|||.+....++.++|||||||++|||++ |..||.......   ..    .....+       .  
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~-------~--  215 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQG-------K--  215 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCC-------C--
Confidence            11 111223578999999988889999999999999999996 999997543211   00    011111       0  


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ....+..   ....+.+++.+||..+|++||++.+|.+.|+.
T Consensus       216 ~~~~~~~---~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         216 RLDCPAE---CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            1111111   23456678899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=317.85  Aligned_cols=256  Identities=27%  Similarity=0.406  Sum_probs=203.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|+..+.||+|+||+||+|....++.    .||+|.+.... ......+.+|+.+++.++||||++++++|..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            578888999999999999999865544    58999887654 3455678899999999999999999999876  4578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence            9999999999999997643      45899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............++..|+|||.+....++.++|||||||++|||++ |+.||.......   +..   .      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~------  223 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD---L------  223 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---H------
Confidence            987654332222222234678999999988889999999999999999998 999997643221   110   0      


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        +..  ......+..   ....+.+++.+||..+|.+||++.++++.|...
T Consensus       224 --~~~--~~~~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         224 --LEK--GERLPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             --HhC--CCCCCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              100  001111111   223567888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=351.69  Aligned_cols=262  Identities=25%  Similarity=0.342  Sum_probs=215.5

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEE-EEcC--CC--
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGF-CIDP--EQ--  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~-~~~~--~~--  253 (520)
                      ..+++++.+.|.+|||+.||.|++...+..||+|++...+....+.+.+|+++|++|. |+|||.+++. ....  ++  
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4568889999999999999999998866999999998878888899999999999997 9999999993 2211  11  


Q ss_pred             -cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          254 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       254 -~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                       .++|.||||.||.|-+++..+..     ..|++.++++|+.++++|+.+||... ++|||||||-+||||..+++.|||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence             26799999999999999987543     45999999999999999999999875 789999999999999999999999


Q ss_pred             ecCCccccCCCCCCccc-------ccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh
Q 010012          333 DFGLATWTSAPSVPFLC-------KTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  402 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~-------~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~  402 (520)
                      |||.|.-..........       -...-|+.|.|||.+.   +..+++|+|||+|||+||-|+....||+....     
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----  263 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----  263 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence            99998633222110000       0123789999999874   56789999999999999999999999986422     


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                                      -.|++..+..+. .+.....|.+||..||+.+|.+||++.+|+..+..+..
T Consensus       264 ----------------laIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  264 ----------------LAILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ----------------eeEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                            234555665554 35677888899999999999999999999998776543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=315.90  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=197.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +|+..+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+++++.++||||+++++++.+. ...++||||+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~   81 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYM   81 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecC
Confidence            57788999999999999998864 66899999865432 335688899999999999999999987654 4589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          82 ANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999997542      46899999999999999999999888   99999999999999999999999999976543


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ...           .+...
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~~~  217 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE-----------SVSAG  217 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH-----------HHHcC
Confidence            2211 1112224567999999998899999999999999999999 899987533211   100           11111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      .....  +.   .....+.+++.+||+.+|++|||+.+|++.|
T Consensus       218 ~~~~~--~~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 YRLYR--PK---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CcCCC--CC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            11111  11   1234577889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-38  Score=319.41  Aligned_cols=266  Identities=21%  Similarity=0.330  Sum_probs=205.3

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEc
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~  250 (520)
                      +.+..+..++++|+..+.||+|+||.||++....+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556667889999999999999999999998889999999886532 2335678899999999 79999999998753


Q ss_pred             ----CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          251 ----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       251 ----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                          .+...++||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~  160 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE  160 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence                23457999999999999998864321   1256899999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccch
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  401 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~  401 (520)
                      +.+||+|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||.......  
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--  236 (286)
T ss_pred             CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--
Confidence            9999999999986543221  1234569999999999853     447889999999999999999999997543211  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .+.            .+.....+.+..+..   ....+.+++.+||+.+|++|||+.||++.
T Consensus       237 ~~~------------~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 ALF------------KIPRNPPPTLHQPEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHh------------hccccCCCcccCCCC---cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            000            000001111111111   12357788899999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-38  Score=312.77  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||.||+|....++..|++|.+.....  .+++.+|+++++.++||||+++++++.+. ...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEec
Confidence            578889999999999999999988789999999875432  67899999999999999999999988775 558999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          80 CGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999986532      56899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  .            .+...
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~------------~~~~~  214 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F------------MIPNK  214 (256)
T ss_pred             cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h------------hhccC
Confidence            4321  123345889999999999889999999999999999999999999754322100  0            00000


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+..   .......+.+++.+||+.+|.+|||+.+|++
T Consensus       215 ~~~~~~~---~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPTLSD---PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCc---hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1111111   1112245778889999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-38  Score=322.05  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=199.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc--EEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|+..+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+. ...++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceE
Confidence            478889999999999999999876554  4788888643 334556789999999999 799999999987664 45799


Q ss_pred             EEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      |+||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999997532100         01135899999999999999999999877   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||++........   ......+..|+|||++....++.++|||||||++|||++ |..||.......   ..   
T Consensus       158 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~---  228 (297)
T cd05089         158 SKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LY---  228 (297)
T ss_pred             EEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---
Confidence            99999999864322110   111223567999999988889999999999999999997 999997543211   10   


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .        .+.....+..  +.   .....+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       229 ~--------~~~~~~~~~~--~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         229 E--------KLPQGYRMEK--PR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             H--------HHhcCCCCCC--CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0        0111111111  11   1223567888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6e-39  Score=338.84  Aligned_cols=266  Identities=25%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~  252 (520)
                      ..++|...+.||+|+||.||+|.+.     ..+..||+|++.... ....+.+.+|+.++.++. |||||+++++|....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3356888899999999999999864     234689999997653 233457889999999997 999999999987654


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC-------------------------------------------------------
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG-------------------------------------------------------  277 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~-------------------------------------------------------  277 (520)
                       ..++||||+++|+|.++++.....                                                       
T Consensus       115 -~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         115 -PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             -CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence             589999999999999999764210                                                       


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCe
Q 010012          278 ------------------------------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (520)
Q Consensus       278 ------------------------------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NI  321 (520)
                                                          ......++|..+..|+.|++.||+|||+.+   |+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                                011235788889999999999999999877   99999999999


Q ss_pred             EecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccc
Q 010012          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE  400 (520)
Q Consensus       322 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~  400 (520)
                      |+++++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |..||......+.
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            999999999999999986543221111223457789999999998889999999999999999998 8999864322110


Q ss_pred             hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       401 ~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                            ....       +..-.  ++..+..   ....+.+++.+||+.+|.+||++++|++.|+..
T Consensus       351 ------~~~~-------~~~~~--~~~~p~~---~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 ------FYNA-------IKRGY--RMAKPAH---ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------HHHH-------HHcCC--CCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  0000       00000  1111111   124577888899999999999999999999853

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-38  Score=313.05  Aligned_cols=249  Identities=28%  Similarity=0.495  Sum_probs=202.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||.|+||.||+|...  ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+ ....++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEe
Confidence            57888999999999999999875  68899999976644 56788999999999999999999999876 4568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          82 MAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             cCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            999999999976432     36899999999999999999999888   9999999999999999999999999998664


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...     ....++..|+|||++..+.++.++||||||+++|||++ |+.||.......   +..           .+..
T Consensus       154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-----------~~~~  214 (256)
T cd05039         154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-----------HVEK  214 (256)
T ss_pred             ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-----------HHhc
Confidence            322     12335678999999998899999999999999999997 999986543211   110           0110


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .  .....+.   .....+.+++.+||..+|++||++.+|+++|+.
T Consensus       215 ~--~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 G--YRMEAPE---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             C--CCCCCcc---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0  0111111   123457788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=326.63  Aligned_cols=203  Identities=28%  Similarity=0.375  Sum_probs=173.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||++....+++.||+|++.+.   .....+.+.+|+.++..++||||+++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence            4788999999999999999999888999999999652   223345688899999999999999999987664 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            99999999999997532      46899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      ....... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         151 RLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            6543221 11223469999999999863     45788999999999999999999999754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-38  Score=319.62  Aligned_cols=268  Identities=24%  Similarity=0.349  Sum_probs=201.3

Q ss_pred             CCcccceEEcccCceEEEEeeec----------------CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG----------------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPL  244 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~----------------~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l  244 (520)
                      ++|+..+.||+|+||.||++...                .++..||+|++... .......+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999998543                23457999999754 33445688999999999999999999


Q ss_pred             EEEEEcCCCcEEEEEEecCCCChhHHhhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCC
Q 010012          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (520)
Q Consensus       245 ~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~N  320 (520)
                      ++++...+ ..++||||+++|+|.+++.......    .....+++..+..++.|++.||+|||+.+   |+||||||+|
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99987654 5799999999999999997643211    11235888999999999999999999888   9999999999


Q ss_pred             eEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh--CCCCcchhccc
Q 010012          321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQ  398 (520)
Q Consensus       321 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt--G~~Pf~~~~~~  398 (520)
                      ||++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986543322111222335678999999888899999999999999999998  77888643221


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .   .+..........   ....   .+..+.   .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~~---~~~~---~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 Q---VIENTGEFFRDQ---GRQV---YLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHHhhc---cccc---cCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   111111111000   0000   011111   12246778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-39  Score=314.21  Aligned_cols=253  Identities=32%  Similarity=0.502  Sum_probs=200.3

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHH--HHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      |+..+.||+|+||+||++....+++.||+|++.........  ....|+.++++++||||+++++++.+ ....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            56788999999999999999998999999999877543332  34569999999999999999999877 4558899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++...       ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.++|+|||.+....
T Consensus        80 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   80 CPGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             ETTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999833       56899999999999999999999988   9999999999999999999999999997642


Q ss_pred             CCCCCcccccccccCCccCchhcc-cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...  .......++..|+|||++. +..++.++||||+|+++|+|++|..||.............   ...       ..
T Consensus       150 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~-------~~  217 (260)
T PF00069_consen  150 ENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KIL-------KR  217 (260)
T ss_dssp             STT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHH-------HT
T ss_pred             ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcc-------cc
Confidence            211  1234556899999999998 7889999999999999999999999998652111111111   000       00


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .........   ......+.+++..||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSSQQS---REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHTTSH---TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccccc---chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000001000   011256888889999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-38  Score=315.44  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=189.9

Q ss_pred             eEEcccCceEEEEeeecC--CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          188 RVLGRGALSFVFKGKVGL--LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      +.||+|+||.||+|....  ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.. ..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCCC
Confidence            358999999999997642  34679999987643 334457889999999999999999999886654 57899999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|.+++......  .....++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          80 GDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999764321  1135678888899999999999999887   9999999999999999999999999997544332


Q ss_pred             CCcccccccccCCccCchhcccC-------CCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHG-------KVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~-------~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      .........++..|+|||++...       .++.++|||||||++|||++ |+.||........   ...  . ...   
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~--~-~~~---  225 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY--T-VRE---  225 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH--H-hhc---
Confidence            21122334578889999998642       35789999999999999996 9999965332211   000  0 000   


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ......++.+..  ...   ..+.+++..|+ .+|++|||+.+|++.|+
T Consensus       226 ~~~~~~~~~~~~--~~~---~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRLKL--PLS---DRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCccCC--CCC---hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            011111222211  112   23556777898 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.2e-39  Score=324.43  Aligned_cols=264  Identities=24%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             CCcccceEEcccCceEEEEeeecC-------CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ++|.+.+.||+|+||.||++....       ....||+|.+.... ......+..|+++++.+ +||||++++++|.+..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999997632       23469999997642 34456788899999999 7999999999987654


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                       ..++||||+++|+|.+++.......         .....++|..+..++.|++.||+|||+.+   ++||||||+|||+
T Consensus        98 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          98 -PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence             5899999999999999997643210         01235899999999999999999999887   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchh
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  402 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~  402 (520)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            9999999999999976543221111112234568999999988889999999999999999998 888986432211   


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      +.   . .....         .....+.   .....+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       251 ~~---~-~~~~~---------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 LF---K-LLKEG---------HRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HH---H-HHHcC---------CCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            00   0 00000         0111111   12345677889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-38  Score=327.08  Aligned_cols=253  Identities=27%  Similarity=0.353  Sum_probs=195.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||++....+++.||+|++.+..   ......+.+|..++..++|+||+++++++.+ ++..++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            47889999999999999999998889999999986532   2234457889999999999999999998765 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence            99999999999997642      46899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ....... .......||+.|+|||++.+     +.++.++|||||||+||||++|+.||.......      .       
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~-------  216 (331)
T cd05624         151 KMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T-------  216 (331)
T ss_pred             eccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------H-------
Confidence            6654322 11233569999999999875     467899999999999999999999997543211      0       


Q ss_pred             chhHHHHhhC--cccCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 010012          414 GMAAVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d--~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~  462 (520)
                          ...+..  .++..+.........+.+++.+|++..+.+  |+++.++++
T Consensus       217 ----~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         217 ----YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ----HHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence                011111  111111111112345666777888765544  567888775

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-38  Score=322.49  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|+||.||++....++..||+|.+... ......++.+|++++.+++||||+++++++.+. ..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEee
Confidence            3688999999999999999999888999999998754 233456788999999999999999999988764 46899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+++++|.+++...       ..+++..+..++.|+++||.|||+ .+   ++||||||+|||++.++.+||+|||++..
T Consensus        80 y~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          80 HMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             ccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence            99999999999754       468999999999999999999997 35   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh------
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR------  413 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~------  413 (520)
                      .....    .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.....................      
T Consensus       150 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         150 LIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             ccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence            53321    23456899999999998888999999999999999999999999654322111100000000000      


Q ss_pred             -------------chhHHHHhh---CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          414 -------------GMAAVEELL---DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       414 -------------~~~~l~~~~---d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                                   .......+.   .+.+...    .....+.+++.+||..+|++|||+.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG----AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         000000011   0111100    122347788999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-38  Score=313.86  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=201.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...++||+|+||.||+|.... ++.||+|.+..... ....+.+|+.+++.++||||+++++++.+  ...++||||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ--EPIYIITEY   81 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc--CCcEEEEEc
Confidence            578889999999999999998764 78899999876443 34678899999999999999999987533  457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          82 MENGSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999999875432     56899999999999999999999887   9999999999999999999999999997665


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||++....++.++|||||||++|||++ |+.||.......   ...           .+..
T Consensus       154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~-----------~~~~  218 (260)
T cd05067         154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ-----------NLER  218 (260)
T ss_pred             CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH-----------HHHc
Confidence            32211 1123346778999999998889999999999999999999 999997543211   110           0111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  .......   ....+.+++.+|+..+|++||++++++.+|+.
T Consensus       219 ~~--~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 GY--RMPRPDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC--CCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11  1111111   22357888899999999999999999999873

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=308.79  Aligned_cols=268  Identities=26%  Similarity=0.367  Sum_probs=215.3

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc----CCCc
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PEQG  254 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~  254 (520)
                      ...++|.+.+.||+|||+-||+++...++..||+|++.....+..+..++|++.-++++||||+++++++..    +...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345789999999999999999999888899999999988877888889999999999999999999987653    3345


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .||+++|...|+|.+.+.....   ....+++.....|+.++.+||++||... +++.||||||.|||+.+.+.++|.||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            8999999999999999987543   2257999999999999999999999876 57999999999999999999999999


Q ss_pred             CCccccCCCCCCc-------ccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          335 GLATWTSAPSVPF-------LCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       335 Gla~~~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      |.+....-.-...       .......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.....+. ++ 
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl-  251 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL-  251 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE-
Confidence            9987554211100       011234788999999985   44679999999999999999999999986443221 11 


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                                   --.+..+.+..+.. ......+.+++.+|++.||.+||++.+++..+..
T Consensus       252 -------------aLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  252 -------------ALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -------------EEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                         11122333332221 2245678888999999999999999999998765

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=317.94  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--HHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~LV  258 (520)
                      ++|+..+.|++|.||.||+|+++.+++.||+|+++.+...  -.-.-++|+++|.+.+|||||.+..+....+ +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4788899999999999999999999999999999765321  1223468999999999999999998765432 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||+. +|..++....      .++...++..++.|+++||+|||.+.   |+||||||+|+|+...|.+||+|||||+
T Consensus       156 Me~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             HHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence            999966 8999998764      57999999999999999999999888   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh----hh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL----HR  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~----~~  413 (520)
                      .++.+..+  .+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+...-++.+.+.......    ..
T Consensus       226 ~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            98876443  3556789999999999876 58999999999999999999999998765443332221110000    00


Q ss_pred             chhHHH------------HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVE------------ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~------------~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +...+.            ..+.+.+..    ......-++++...|..||.+|-|+.|.++
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~----~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGA----LSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccc----cccchhHHHHHHHHhccCccccccHHHhhc
Confidence            000000            000001110    001245567888899999999999999886

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-38  Score=313.99  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=193.6

Q ss_pred             eEEcccCceEEEEeeecC---CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....   ....||+|.+... .....+.+.+|+.+++.++||||+++++++...+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998643   3457999998643 344567888999999999999999999988766666789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            999999997542      34678888899999999999999887   999999999999999999999999999755332


Q ss_pred             CCC--cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhC-CCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          344 SVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG-RKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       344 ~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...  .......++..|+|||++....++.++|||||||++|||++| .+||......   .+..              .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~--------------~  214 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITV--------------Y  214 (262)
T ss_pred             cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--------------H
Confidence            110  111233467789999999888999999999999999999995 5566532211   1111              0


Q ss_pred             hhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          421 LLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       421 ~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      +... ....+..   ....+.+++..||+.+|++||++.+|++.|+..
T Consensus       215 ~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         215 LLQGRRLLQPEY---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             HhcCCCCCCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1110 1111111   123577888999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-38  Score=311.14  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=204.3

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||.|+||.||.+....++..+++|.+...  .....+++.+|+.++++++|+||+++++++.+. ..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEE
Confidence            578899999999999999999888999999998654  345566788999999999999999999998774 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          80 YANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             ecCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            9999999999976432     56899999999999999999999887   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......|++.|+|||++.+..++.++||||||+++|||++|..||.......      .           +..
T Consensus       152 ~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~-----------~~~  212 (256)
T cd08221         152 GSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------L-----------VVK  212 (256)
T ss_pred             ccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------H-----------HHH
Confidence            44331  2234568999999999988888999999999999999999999997533211      0           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      +....+..  ........+.+++.+||+.+|.+||++.++++.
T Consensus       213 ~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         213 IVQGNYTP--VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHcCCCCC--CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            11111110  111223457788889999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-38  Score=321.85  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=202.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||.|+||+||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++.+. ..+++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEe
Confidence            4699999999999999999998888999999999766555567788999999999999999999998764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|..++..        ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          98 LAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             cCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            999999998864        45899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........  .    .        +...
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~----~--------~~~~  230 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----L--------IATN  230 (296)
T ss_pred             cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----H--------HHhc
Confidence            3321  122346889999999999888999999999999999999999999764332110  0    0        0000


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+..+.   .....+.+++.+||..+|.+||++.+|+.
T Consensus       231 ~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 GTPELQNPE---KLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCcc---cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            011111111   11234667889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-38  Score=314.81  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+|...+.||+|+||.||+|....+   ...+|+|.++... ....+.+.+|+.++++++||||+++++++... +..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEE
Confidence            4788899999999999999987533   3479999987543 34456789999999999999999999987654 56899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999997542      46899999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ........... .....++..|+|||++.+..++.++|||||||++||+++ |..||......+   ....         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~---------  221 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKA---------  221 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHH---------
Confidence            87654321111 111223568999999998899999999999999999887 999987543221   1110         


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                        +.+..  +.....   .....+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus       222 --~~~~~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         222 --IEEGY--RLPAPM---DCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --HhCCC--cCCCCC---CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              11110  011111   122356788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-38  Score=319.26  Aligned_cols=268  Identities=23%  Similarity=0.289  Sum_probs=194.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhC---CCCCeecEEEEEEcC----CC
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSL---HHPNIVPLVGFCIDP----EQ  253 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~----~~  253 (520)
                      +|+..+.||+|+||+||+|....+++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999999998899999999865321  1223455677666655   799999999987642    23


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence            4789999997 589888875432     45899999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhhh-hHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAK-PIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~-~~~  411 (520)
                      ||+++.......   .....||..|+|||++.+..++.++|||||||++|||++|++||......+... +..... +..
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            999986653321   234568999999999998899999999999999999999999997543321110 000000 000


Q ss_pred             hhchhHH---HHhhCcccCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAV---EELLDPRLKCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l---~~~~d~~l~~~--~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......+   .....+.....  ...+.....+.+++.+||+.||++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000   00000000000  000112245678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.8e-39  Score=325.27  Aligned_cols=268  Identities=24%  Similarity=0.383  Sum_probs=198.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||+||+|....++..||+|.+.... ......+.+|+++++.++||||+++++++... ...++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence            57899999999999999999998888999999987543 22334677899999999999999999988664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++ +|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          85 YLDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CCCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence            9975 8888876542      45889999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh-hhchhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL-HRGMAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-~~~~~~l  418 (520)
                      .....  ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... ......+
T Consensus       155 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (309)
T cd07872         155 SVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI  232 (309)
T ss_pred             CCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence            43221  1123457899999999865 458899999999999999999999997654332221111100000 0000000


Q ss_pred             ---HHhhC---cccCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 ---EELLD---PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ---~~~~d---~~l~~~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ....+   +.....   .........+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence               00000   000000   000011234678889999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-38  Score=311.83  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=201.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..+.||+|+||.||++....++..||+|.+... .....+.+..|+.+++.++||||+++++++.+ +..+++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            477889999999999999999888999999998643 33455678899999999999999999998765 4568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++....
T Consensus        80 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          80 CDGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            999999998875332     46889999999999999999999887   9999999999999999999999999997664


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||.......   .   ...           +
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~~~-----------~  212 (255)
T cd08219         152 SPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---L---ILK-----------V  212 (255)
T ss_pred             cccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---H---HHH-----------H
Confidence            3221  1234568999999999988889999999999999999999999997533211   0   000           0


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ......  .........+.+++.+||+.+|++||++.+|+..
T Consensus       213 ~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            001110  0001122356788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-38  Score=318.27  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=197.9

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      |+..+.||+|+||.||++....+++.||+|.+....   ......+..|+.+++.++|+|++++++.+.+. ...++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEE
Confidence            677789999999999999999899999999986542   22334577899999999999999999987664 46899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        81 ~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             ecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9999999999865432     46899999999999999999999877   999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....   .....|+..|+|||++.+..++.++|||||||++|||++|+.||...........   .......    .. 
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~----~~-  221 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE----VQ-  221 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh----hh-
Confidence            43221   1234689999999999998999999999999999999999999975432111000   0000000    00 


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                         ...  ..   .....+.+++..||+.+|++|||     +.|+++
T Consensus       222 ---~~~--~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ---EEY--SE---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---hhc--Cc---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence               011  11   11234667888999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=318.24  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|++.+.||.|+||.||+|....++..||+|.+........+.|..|++++++++||||+++++++.+. ...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEee
Confidence            35788999999999999999999878899999999877666677899999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          83 FCDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             ccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999987642      46999999999999999999999988   999999999999999999999999998755


Q ss_pred             CCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .....  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||.......  ...           
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~-----------  218 (280)
T cd06611         154 KSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL-----------  218 (280)
T ss_pred             ccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH-----------
Confidence            43221  123456899999999975     3346789999999999999999999997543211  000           


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .+.....+.+..+...   ...+.+++..||+.+|.+||++.+|++
T Consensus       219 -~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         219 -KILKSEPPTLDQPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -HHhcCCCCCcCCcccC---CHHHHHHHHHHhccChhhCcCHHHHhc
Confidence             1111111122111111   234667888999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-38  Score=321.36  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc--EEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|+..+.||+|+||.||+|.+..++.  .+|+|.+... .......+.+|++++.++ +||||+++++++.+. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCceE
Confidence            578888999999999999999876664  4577777643 334556788999999999 899999999987664 45899


Q ss_pred             EEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      ||||+++|+|.+++.......         .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999997643110         11246899999999999999999999887   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||++.......   ......++..|+|||++....++.++|||||||++|||+| |..||.......   ..   
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---  233 (303)
T cd05088         163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---  233 (303)
T ss_pred             EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH---
Confidence            9999999986432111   1111234667999999988889999999999999999998 999996543211   10   


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..        +....  ....+..   ....+.+++.+||+.+|++||++.++++.|+.+
T Consensus       234 ~~--------~~~~~--~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EK--------LPQGY--RLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HH--------HhcCC--cCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00        10000  1111111   123567888999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=309.94  Aligned_cols=248  Identities=25%  Similarity=0.443  Sum_probs=196.7

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ++||+|+||.||++.... ++.||+|.+..... .....+.+|++++++++||||+++++++.+. ...++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCc
Confidence            369999999999999887 89999999876543 3566889999999999999999999988765 45799999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++....      ..+++..+..++.+++.||.|||+++   ++||||||+|||++.++.+||+|||++.........
T Consensus        79 l~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          79 LLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            999987542      45889999999999999999999888   999999999999999999999999999865432211


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  425 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~  425 (520)
                      .......++..|+|||.+.++.++.++|||||||++|||++ |..||..........              .+...  ..
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~--------------~~~~~--~~  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE--------------RIESG--YR  213 (251)
T ss_pred             eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH--------------HHhcC--CC
Confidence            11122234667999999988899999999999999999999 888886543211100              01000  01


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       426 l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      +..+.   .....+.+++.+|++.+|.+|||+.||++.|+
T Consensus       214 ~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQ---LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCc---cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11111   12345778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-38  Score=316.64  Aligned_cols=272  Identities=26%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             CCcccceEEcccCceEEEEeeecC----CCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~  255 (520)
                      +.|...+.||+|+||.||+|....    ++..||||.+...... ..+.|.+|+++++.++||||+++++++... ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            357777899999999999998643    4788999999765443 567899999999999999999999987652 2357


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccc
Confidence            89999999999999997642      35999999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH-hhh
Q 010012          336 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI-LHR  413 (520)
Q Consensus       336 la~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-~~~  413 (520)
                      ++.......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........    +.... ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~  230 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQM  230 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccc
Confidence            998765332211 111234566799999998889999999999999999999999998653221100    00000 000


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ....+.+.+......+. .......+.+++.+||+.+|.+|||+.||+++|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         231 IVTRLLELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cHHHHHHHHHcCCcCCC-CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00011122211111110 111224678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-38  Score=315.68  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||.||+|....+++.||+|.+..........+.+|+.+++.++||||+++++++... ...++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEec
Confidence            5788889999999999999999888999999999776555556788999999999999999999987764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          88 CGGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999998653       46899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ....  ......|+..|+|||++.   ...++.++|||||||++|||++|..||........  +...          ..
T Consensus       158 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~----------~~  223 (267)
T cd06645         158 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM----------TK  223 (267)
T ss_pred             Cccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhh----------hc
Confidence            3221  123446899999999974   45688999999999999999999999864332110  0000          00


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+.+....   .....+.+++.+||+.+|++||++.+|++
T Consensus       224 ~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 SNFQPPKLKDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCCcccccC---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            001111111100   11234678889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=310.60  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||.|+||.||+|....+++.+|+|.+........+.+.+|+++++.++||||+++++++.+. ..++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeC
Confidence            5788999999999999999999888899999999876666678899999999999999999999987664 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          82 CGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence            99999999987642      46899999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccC---CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ....  ......++..|+|||.+...   .++.++|||||||++|||++|+.||........  ...    .      ..
T Consensus       153 ~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~------~~  218 (262)
T cd06613         153 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----I------SK  218 (262)
T ss_pred             hhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----H------Hh
Confidence            3211  11334688899999999776   789999999999999999999999975332111  000    0      00


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+.+.   ........+.+++.+||+.+|.+|||+.+|+.
T Consensus       219 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 SNFPPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccCCCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000111111   11223356788999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.1e-38  Score=316.53  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=196.7

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      |+..+.||+|+||+||+|....+++.||+|.+....   ......+.+|+++++.++|+||+++.+++.+. ...++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEE
Confidence            667789999999999999998889999999986542   22334577899999999999999999887664 46899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             eccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9999999988875421     46999999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....   .....|+..|+|||++.+..++.++|||||||++|||++|..||...........  .           ...
T Consensus       153 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~--~-----------~~~  216 (285)
T cd05632         153 PEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE--V-----------DRR  216 (285)
T ss_pred             CCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--H-----------HHh
Confidence            43221   2345689999999999988999999999999999999999999975432111100  0           001


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ..........   .....+.+++..||+.+|++||+     +.+++.
T Consensus       217 ~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         217 VLETEEVYSA---KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             hhccccccCc---cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1111111111   11234567888999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-38  Score=323.05  Aligned_cols=257  Identities=28%  Similarity=0.454  Sum_probs=201.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|...+.||+|+||.||+|....++.    .||+|.+.... ......+.+|+.+++.++||||++++++|...  ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--Cce
Confidence            578888999999999999999865554    57899887543 23345788999999999999999999998653  357


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +++||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            9999999999999987542      46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...    +...+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~-  227 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD----LLEKG-  227 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHCC-
Confidence            986654332212223346778999999988889999999999999999997 999986532211   111    11110 


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                              ..+....   .....+.+++..||..+|++||++.+|++.|+...
T Consensus       228 --------~~~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         228 --------ERLPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --------CCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    0111111   12245678889999999999999999999988643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3e-38  Score=324.91  Aligned_cols=203  Identities=28%  Similarity=0.381  Sum_probs=172.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||++....+++.||+|++.+..   ......+..|+.++..++|+||+++++++.+. ..+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence            36888999999999999999998889999999986432   22334578899999999999999999987654 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        80 ~ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence            99999999999997642      46899999999999999999999888   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      ....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         151 KLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             ecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            5533221 1123356999999999986     346889999999999999999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=349.75  Aligned_cols=270  Identities=27%  Similarity=0.431  Sum_probs=218.1

Q ss_pred             cccccHHHHHHhhCCc---------ccceEEcccCceEEEEeeecCCC---cEEEEEEecCc-chHHHHHHHHHHHHHHh
Q 010012          169 LIRLSYGEILAATHNF---------SKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASS  235 (520)
Q Consensus       169 ~~~~s~~ei~~at~~f---------~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~E~~il~~  235 (520)
                      ...++|++--.|.+.|         .+.++||.|.||.||+|+++..+   ..||||.++.. ......+|+.|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            3456777655554444         45689999999999999997544   46999999876 34567789999999999


Q ss_pred             CCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 010012          236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (520)
Q Consensus       236 l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrD  315 (520)
                      ++||||++|.|+. .....++||.|||++|+|+.||....      ..+.+.+..-++++||.|+.||-+++   +||||
T Consensus       687 FdHPNIIrLEGVV-Tks~PvMIiTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm~---YVHRD  756 (996)
T KOG0196|consen  687 FDHPNIIRLEGVV-TKSKPVMIITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRD  756 (996)
T ss_pred             CCCCcEEEEEEEE-ecCceeEEEhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhcC---chhhh
Confidence            9999999999985 44566899999999999999998764      45999999999999999999999998   99999


Q ss_pred             cCCCCeEecCCCceEEeecCCccccCCCCCCcccccccc--cCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCc
Q 010012          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI  392 (520)
Q Consensus       316 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf  392 (520)
                      |..+|||++.+...|++||||++.+.++... ..++.-|  ...|.|||.+...+++.+|||||||||+||.++ |.+|+
T Consensus       757 LAARNILVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             hhhhheeeccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence            9999999999999999999999987654421 2222223  468999999999999999999999999999987 99999


Q ss_pred             chhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       393 ~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .....++..+              .+++  +-+|..+..+   ...+-+|++.||++|..+||++.||+.+|.+..
T Consensus       836 WdmSNQdVIk--------------aIe~--gyRLPpPmDC---P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  836 WDMSNQDVIK--------------AIEQ--GYRLPPPMDC---PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             cccchHHHHH--------------HHHh--ccCCCCCCCC---cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            8765443211              1111  2344433333   345778889999999999999999999998743

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-38  Score=317.46  Aligned_cols=240  Identities=23%  Similarity=0.427  Sum_probs=187.0

Q ss_pred             EEcccCceEEEEeeecC------------------------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecE
Q 010012          189 VLGRGALSFVFKGKVGL------------------------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL  244 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~------------------------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l  244 (520)
                      .||+|+||.||+|....                        ....||+|++..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997531                        124589999876655556678899999999999999999


Q ss_pred             EEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec
Q 010012          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (520)
Q Consensus       245 ~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld  324 (520)
                      +++|.+.. ..++||||+++|+|..++....      ..+++..+..++.|+++||+|||+.+   |+||||||+|||++
T Consensus        82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~  151 (274)
T cd05076          82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLA  151 (274)
T ss_pred             EEEEEeCC-ceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEe
Confidence            99988754 4789999999999999986532      56899999999999999999999877   99999999999997


Q ss_pred             CCC-------ceEEeecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHH-hCCCCcchh
Q 010012          325 SKK-------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELL-TGRKPIEAR  395 (520)
Q Consensus       325 ~~~-------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELl-tG~~Pf~~~  395 (520)
                      ..+       .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||...
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             ccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            644       4899999998644322      12347888999998865 56899999999999999995 699998754


Q ss_pred             ccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       396 ~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .......                  .++.....+..   ....+.+++.+||+.+|++||++.+|++.|.
T Consensus       226 ~~~~~~~------------------~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSEKER------------------FYEKKHRLPEP---SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHHHHH------------------HHHhccCCCCC---CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            3221100                  01111111111   1135778889999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-38  Score=321.39  Aligned_cols=264  Identities=22%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             CCcccceEEcccCceEEEEeeec-------CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      .+|...+.||+|+||.||+|+..       .....||+|.+... .......+..|+.+++++ +||||++++++|.+. 
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence            57888999999999999999753       23457999998754 234456788999999999 699999999988664 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ...++||||+++|+|.+++......         ......++|..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            4589999999999999999764210         011246899999999999999999999887   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchh
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  402 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~  402 (520)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999986543221111112234567999999998889999999999999999999 899986533211   


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      +.    .....+         .....+.   .....+.+++.+||..+|++||++.+|++.|+...
T Consensus       245 ~~----~~~~~~---------~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 LF----KLLREG---------HRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HH----HHHHcC---------CCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            10    000000         0011111   11235668889999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-38  Score=321.03  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=202.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeecc
Confidence            5899999999999999999998888999999999766555566788999999999999999999988764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             cCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999864        45889999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||..........  .    ..        ..
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----~~--------~~  230 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IA--------TN  230 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----ec--------cC
Confidence            3321  1223458899999999998889999999999999999999999997543211100  0    00        00


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -.+.+..+   ......+.+++.+||+.+|++||++.+|++
T Consensus       231 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 GTPELQNP---ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111111   112234667889999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.1e-38  Score=311.38  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=199.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|++|.||+|.... +..+|+|.+.... ...+.+.+|+.+++.++|||++++++++.+  ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEc
Confidence            468888999999999999998865 4569999886543 234678899999999999999999988643  347899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          82 MGKGSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            999999999976421     45899999999999999999999887   9999999999999999999999999997654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++..|+|||+..+..++.++|||||||++|||++ |..||.......   ...           .+..
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-----------~~~~  218 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE-----------QVER  218 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------HHHc
Confidence            33211 1122346778999999988899999999999999999999 999997543211   100           0111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ....+   ......+.+++.+||..+|.+||++.+|++.|+.
T Consensus       219 ~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 GY--RMPCP---QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CC--CCCCC---cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            00  11111   1223457788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.7e-38  Score=310.92  Aligned_cols=252  Identities=29%  Similarity=0.407  Sum_probs=195.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~  255 (520)
                      .+|...+.||+|+||.||+|....++..||+|++....     ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999998889999999886432     23345688899999999999999999987653 3557


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++++||+++++|.+++...       ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCC
Confidence            8999999999999999753       45889999999999999999999877   9999999999999999999999999


Q ss_pred             CccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||........      ....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~----  221 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKI----  221 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHH----
Confidence            99765431111 111234588999999999988899999999999999999999999975321110      0000    


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ......+.+.     ......+.+++ +||..+|++||++.||++
T Consensus       222 ---~~~~~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ---ATQPTNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---hcCCCCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               0001111111     11112233343 688899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-38  Score=312.46  Aligned_cols=240  Identities=24%  Similarity=0.429  Sum_probs=187.9

Q ss_pred             eEEcccCceEEEEeeecC------------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          188 RVLGRGALSFVFKGKVGL------------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      +.||+|+||.||+|....            ....||+|.+..........|.+|+.+++.++||||+++++++.+.. ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-EN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence            368999999999998532            12358999987765556668889999999999999999999987654 46


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc-------
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-------  328 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~-------  328 (520)
                      ++||||+++|+|..++....      ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.       
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence            89999999999999886532      46899999999999999999999887   999999999999987664       


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcc-cCCCCCcCceeeHHHHHHHHH-hCCCCcchhccccchhhHHh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL-TGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwS~GvvL~ELl-tG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +|++|||++......      ....++..|+|||++. ...++.++|||||||++|||+ +|..||........      
T Consensus       151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------  218 (262)
T cd05077         151 IKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------  218 (262)
T ss_pred             eEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------
Confidence            899999998755322      2235788999999987 456899999999999999998 58888764322110      


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                                  ..+.........   .....+.+++.+||+.+|.+||++.+|++.|
T Consensus       219 ------------~~~~~~~~~~~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 ------------ERFYEGQCMLVT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ------------HHHHhcCccCCC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                        000111111111   1124567888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-38  Score=313.79  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=186.2

Q ss_pred             EEcccCceEEEEeeecC--CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCC
Q 010012          189 VLGRGALSFVFKGKVGL--LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      .||+|+||.||+|....  ....+|+|.+.... ......|.+|+++++.++||||+++++++.+.. ..++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCCCC
Confidence            58999999999997532  34578999876543 334567889999999999999999999887654 589999999999


Q ss_pred             ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC
Q 010012          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (520)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~  345 (520)
                      +|.+++.......  ....++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        81 ~L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          81 DLKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             cHHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999997653211  134578888999999999999999887   99999999999999999999999999875433221


Q ss_pred             CcccccccccCCccCchhccc-------CCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          346 PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       346 ~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||.......   ..   .......   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~---  226 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ---  226 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc---
Confidence            111223346778999998743       356889999999999999999 788886432211   00   0001110   


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...+.++.+.     ......+.+++..|+ .+|++|||+.+|+++|.
T Consensus       227 ~~~~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0011111111     112233445667788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-38  Score=308.49  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=194.9

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ++||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++.... ..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCc
Confidence            36899999999999876 57889999987653 334457889999999999999999999987654 5799999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        79 L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          79 FLSFLRKKK------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            999986532      45899999999999999999999887   999999999999999999999999998754332111


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR  425 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~  425 (520)
                       ......++..|+|||++..+.++.++||||||+++|||++ |..||.......   ..    .       .+....  .
T Consensus       150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~-------~~~~~~--~  212 (250)
T cd05085         150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----E-------QVEKGY--R  212 (250)
T ss_pred             -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----H-------HHHcCC--C
Confidence             1112235678999999998899999999999999999998 999996543211   00    0       111111  1


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       426 l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...+.   .....+.+++.+|+..+|++||++.+|++.|.
T Consensus       213 ~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQ---KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11111   12346778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=314.70  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=202.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..+.||.|+||.||+|....+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+++|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEe
Confidence            6788889999999999999998889999999987553 34456788999999999999999999987765 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++...
T Consensus        81 ~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          81 CGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             eCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999864        36899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......+++.|+|||++.+..++.++|||||||++|||++|+.||........      ..        .+...
T Consensus       150 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~--------~~~~~  213 (274)
T cd06609         150 STMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LF--------LIPKN  213 (274)
T ss_pred             cccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HH--------Hhhhc
Confidence            4321  12344688899999999988899999999999999999999999975432110      00        11111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+...    .....+.+++.+||..+|++|||+.++++
T Consensus       214 ~~~~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 NPPSLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11222111    02335677889999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.6e-39  Score=315.81  Aligned_cols=240  Identities=25%  Similarity=0.410  Sum_probs=189.1

Q ss_pred             EEcccCceEEEEeeecCCC-------cEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          189 VLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .||+|+||.||+|.....+       ..||+|.+........+.+.+|+.+++.++||||+++++++.... ..++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEEEec
Confidence            6899999999999875433       348999887665556678889999999999999999999987754 47899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc--------eEEee
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--------PKLCD  333 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~--------vkL~D  333 (520)
                      +++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.        ++++|
T Consensus        81 ~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          81 VKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             CCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecc
Confidence            99999999997642      46899999999999999999999887   999999999999987765        69999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCC-CCcchhccccchhhHHhhhhHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ||++......      ....++..|+|||++.+. .++.++|||||||++|||++|. .|+.........          
T Consensus       152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----------  215 (258)
T cd05078         152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----------  215 (258)
T ss_pred             cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH----------
Confidence            9998654322      234588899999999864 5799999999999999999985 555432221100          


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                              .........+.   .....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       216 --------~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 --------QFYEDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------HHHHccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    00111111111   12245778889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-38  Score=315.56  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=204.1

Q ss_pred             cHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       173 s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      ++.++..+.+.|+..+.||+|+||.||+|....+++.||+|++.... ....++..|+.++.++ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555567789999999999999999999998889999999986643 3345678899999988 799999999988632


Q ss_pred             -----CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          252 -----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       252 -----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                           ....+++|||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~  157 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTEN  157 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence                 3457899999999999999976432     45889989999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccch
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  401 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~  401 (520)
                      +.++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||.........
T Consensus       158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            9999999999875542211  123456899999999985     346788999999999999999999999653221100


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .              .+.....+.+..    ......+.+++.+||+.+|.+||++.||++
T Consensus       236 ~--------------~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 F--------------LIPRNPPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h--------------hHhhCCCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0              011111111111    112346788889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-38  Score=311.11  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=198.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      +|..+..||+|+||.||+|....++..||+|.+.....         ...+.+.+|+.++++++||||+++++++.+. .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-D   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-C
Confidence            36677899999999999999987889999998865321         1235678899999999999999999998764 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++|+||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecc
Confidence            578999999999999999753       46899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCc----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          334 FGLATWTSAPSVPF----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       334 FGla~~~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      ||+++.........    ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......  . +     
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~-----  221 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A-I-----  221 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H-H-----
Confidence            99998665321110    1122458889999999998889999999999999999999999997532110  0 0     


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .     .+.....+.+.     ......+.+++.+||+.+|.+||++.+|++
T Consensus       222 -~-----~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 -F-----KIGENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -H-----HHhccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             0     11111112221     112345677888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=367.00  Aligned_cols=269  Identities=28%  Similarity=0.527  Sum_probs=215.7

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~  251 (520)
                      ++++++.   ..|...++||+|+||.||+|....++..||||++......    ...|++++++++|||||+++|+|.+.
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            3444443   4577888999999999999999878999999998654321    12468899999999999999999775


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      + ..++||||+++|+|.++++          .++|..+..|+.|+++||+|||..+.++|+||||||+||+++.++.+++
T Consensus       756 ~-~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        756 K-GAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             C-CCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            5 4789999999999999984          2899999999999999999999766667999999999999999998887


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      . ||.+......      ....||..|+|||++.+..++.++|||||||++|||+||+.||..... ....++.|++...
T Consensus       825 ~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~  896 (968)
T PLN00113        825 R-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY  896 (968)
T ss_pred             E-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc
Confidence            6 6665433221      223588999999999999999999999999999999999999964332 2345666765544


Q ss_pred             hhchhHHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          412 HRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ...  ....++|+.+... .....+...+.+++.+||+.+|++||||.||++.|+...
T Consensus       897 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        897 SDC--HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             Ccc--chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            332  3556677766432 234567778899999999999999999999999998653

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-38  Score=309.57  Aligned_cols=239  Identities=26%  Similarity=0.463  Sum_probs=190.5

Q ss_pred             eEEcccCceEEEEeeecCCC----------cEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          188 RVLGRGALSFVFKGKVGLLR----------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~----------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...|.+|+.+++.++||||+++++++..  ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            36899999999999997655          35888887654433 6788999999999999999999999877  34689


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-------ceE
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-------IPK  330 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-------~vk  330 (520)
                      ||||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++       .+|
T Consensus        78 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence            999999999999998642      36899999999999999999999877   99999999999999888       799


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      |+|||++......      ....++..|+|||++...  .++.++|||||||++|||++ |..||..........   + 
T Consensus       149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~-  218 (259)
T cd05037         149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---F-  218 (259)
T ss_pred             eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---H-
Confidence            9999999865431      233477889999999876  78999999999999999999 577776543211100   0 


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                                ..  ....+..+  .   ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       219 ----------~~--~~~~~~~~--~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 ----------YQ--DQHRLPMP--D---CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----------Hh--cCCCCCCC--C---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      00  00011111  1   156788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.5e-38  Score=307.92  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=204.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV~  259 (520)
                      +|+..+.||.|+||.||++....++..||+|.+...  .....+.+..|+++++.++||||+++++++... ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999999888999999998653  334456788999999999999999999987653 34578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||+++++|.+++.....   ....+++..++.++.|++.||.|||..+  ..+|+|+||||+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999976421   1257999999999999999999999332  334999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........  ......++..|+|||++....++.++||||||+++|+|++|+.||......   .+..            
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~------------  220 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS------------  220 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH------------
Confidence            87654332  123456899999999999888999999999999999999999999764321   1110            


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                        .+......  .........+.+++.+|++.+|++||++.+|++.
T Consensus       221 --~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         221 --KIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --HHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              11111111  1111233567788899999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.8e-38  Score=310.68  Aligned_cols=251  Identities=30%  Similarity=0.513  Sum_probs=196.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +|...+.||+|+||.||+|... ++..+|+|.+....      ......+.+|+++++.++|+||+++++++.+. ...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence            4778899999999999999875 58899999886432      22345688999999999999999999998775 5689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||+
T Consensus        79 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          79 IFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence            999999999999999653       45889999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCC----CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          337 ATWTSAPSV----PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       337 a~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      +........    ........|+..|+|||++.+..++.++|||||||++|||++|..||........  ..     ...
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~-----~~~  221 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF-----YIG  221 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH-----Hhh
Confidence            876532111    1112335689999999999988899999999999999999999999975322110  00     000


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           ......+.+.  .   .....+.+++.+||+.+|.+||++.+|++
T Consensus       222 -----~~~~~~~~~~--~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 -----AHRGLMPRLP--D---SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----hccCCCCCCC--C---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 0000111111  1   12345677889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-37  Score=317.64  Aligned_cols=204  Identities=28%  Similarity=0.482  Sum_probs=163.2

Q ss_pred             ceEEcccCceEEEEeeec--CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEEEEecC
Q 010012          187 GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVS  263 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV~E~~~  263 (520)
                      ++.||+|+||+||+|...  .+++.||+|.+....  ....+.+|+.+++.++||||+++++++... +..+++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865  356789999987543  234567899999999999999999987643 345789999995


Q ss_pred             CCChhHHhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----cCCCceEEeecCCc
Q 010012          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  337 (520)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----d~~~~vkL~DFGla  337 (520)
                       ++|.+++......  ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888887643211  111235899999999999999999999988   9999999999999    45678999999999


Q ss_pred             cccCCCCCC-cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          338 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       338 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      +........ .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543211 112345689999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.4e-38  Score=316.01  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEc
Confidence            4666778999999999999998888999999987543 34456788999999999999999999987664 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        84 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          84 LGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999998853        45899999999999999999999877   9999999999999999999999999997654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ..           .+...
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~-----------~~~~~  216 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF-----------LIPKN  216 (277)
T ss_pred             Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh-----------hhhcC
Confidence            3221  12234588999999999988899999999999999999999999864322110   00           01111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..+.+.     ......+.+++.+||+.+|.+||++.+|++.
T Consensus       217 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 SPPTLE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            111111     1223457788899999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=311.61  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=194.2

Q ss_pred             eEEcccCceEEEEeeecCCCc--EEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      ++||+|+||.||+|.+..++.  .+|+|.+... .....+.+..|++++.++ +||||+++++++... ...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeCC
Confidence            368999999999999876664  4688888743 344556788999999999 899999999988664 45799999999


Q ss_pred             CCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          264 GGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       264 ~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +|+|.+++......         ......+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            99999999764210         011235899999999999999999999877   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |++.......   .......+..|+|||++....++.++|||||||++|||++ |..||.......   ..   .     
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~---~-----  222 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---E-----  222 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH---H-----
Confidence            9986322111   0111224567999999988889999999999999999997 999996533211   00   0     


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                         .+....  .+....   .....+.+++.+|++.+|.+|||+.+++..|+.+
T Consensus       223 ---~~~~~~--~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         223 ---KLPQGY--RLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ---HHhCCC--CCCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence               010000  111111   1223577889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-38  Score=316.19  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|+||+||++....+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..+++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEe
Confidence            57888899999999999999998889999999886543 34457889999999999999999999998775 55899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+++++|.+++...       ..+++..+..++.+++.||.|||+ .+   |+||||||+||+++.++.++|+|||++..
T Consensus        84 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          84 FMDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             cCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999988653       468999999999999999999997 35   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............  ...+.    ..+.
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--~~~~~----~~~~  223 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD--PMGIL----DLLQ  223 (284)
T ss_pred             hhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh--hhHHH----HHHH
Confidence            43222    12346899999999998889999999999999999999999999854432110000  00000    0111


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      .++..... ..........+.+++.+|++.+|.+|||+.||+++.
T Consensus       224 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         224 QIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11111110 000111234577888999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-37  Score=308.21  Aligned_cols=252  Identities=26%  Similarity=0.352  Sum_probs=197.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-----chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~  255 (520)
                      ++|...+.||+|+||.||+|....++..||+|.+...     .....+.+.+|+.+++.++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999999888999999988532     1234567888999999999999999999876643 457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCc
Confidence            8999999999999998753       35788889999999999999999888   9999999999999999999999999


Q ss_pred             CccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ++......... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------  216 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------------  216 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---------------
Confidence            99765422111 01223458899999999988889999999999999999999999996432110               


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .+.+...... .+.........+.+++.+|+. +|++||++.+|++
T Consensus       217 --~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         217 --AIFKIATQPT-NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --HHHHHhcCCC-CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              0001110000 011112233456677788884 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.2e-38  Score=318.63  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||++....+++.||+|.+....   ......+.+|+++++.++||||+++++.+.. +..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            36888999999999999999999889999999987653   2334578899999999999999999998765 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          80 MEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            9999999999999653       46899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCC-------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          339 WTSAPSV-------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       339 ~~~~~~~-------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      .......             ........|+..|+|||++....++.++|||||||++|||++|..||.......      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------  223 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------  223 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence            4211100             001122457889999999988889999999999999999999999997533211      


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ......      ......+...     ......+.+++.+||+.+|++||+..++.++|+.
T Consensus       224 ~~~~~~------~~~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 LFGQVI------SDDIEWPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHH------hcccCCCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            000000      0001111111     1122346788899999999999998777777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-38  Score=325.69  Aligned_cols=193  Identities=23%  Similarity=0.329  Sum_probs=165.5

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ...+|...+.||+|+||.||+|....++..||+|+.....      ...|+.++++++||||+++++++.+.. ..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence            3468999999999999999999998888999999854332      346899999999999999999987754 578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |++ .++|.+++....      ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       137 e~~-~~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             Ecc-CCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence            999 568888886532      56999999999999999999999887   99999999999999999999999999975


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCc
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI  392 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf  392 (520)
                      .....   ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       207 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        207 PVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            43221   123456999999999999999999999999999999999865554

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-37  Score=307.38  Aligned_cols=259  Identities=28%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+.+. +..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEe
Confidence            47889999999999999999988788999999987543 23567789999999999999999999987664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ++++++|.+++.....    ...+++..+..++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          80 YLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             ccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            9999999999976421    146899999999999999999999887   999999999999999999999999999766


Q ss_pred             CCCCCCc--ccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          341 SAPSVPF--LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       341 ~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .......  ......|+..|+|||++... .++.++|||||||++|||++|+.||.......  ....    ..      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~------  220 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TL------  220 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----Hh------
Confidence            5433211  12334689999999999877 78999999999999999999999997543211  0000    00      


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ....+.+............+.+++.+||+.+|++||++.+|++
T Consensus       221 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         221 --QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              0011112111111123356778889999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-37  Score=308.00  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=200.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|...+.||+|+||.||++.... +..+|+|.+.... .....+.+|+.+++.++|+||+++.+++.+  ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEE
Confidence            3578899999999999999998754 5679999887543 345678899999999999999999998765  45789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          81 FMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             eCCCCcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            9999999999976432     56899999999999999999999877   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ...... ......++..|+|||++..+.++.++|||||||++|+|++ |+.||.......   +..+           +.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~-----------~~  217 (260)
T cd05073         153 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA-----------LE  217 (260)
T ss_pred             cCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH-----------Hh
Confidence            432211 1122345678999999998889999999999999999999 999997533211   1100           00


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ..+...   ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       218 ~~--~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 RG--YRMPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CC--CCCCCc---ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00  011111   1222457788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-38  Score=326.00  Aligned_cols=265  Identities=19%  Similarity=0.304  Sum_probs=196.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----  252 (520)
                      ..++|+..+.||+|+||+||+|....++..||||++....  ....+.+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3468999999999999999999998889999999987542  223456778999999999999999998765322     


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ...+++++++ +++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence            2368999988 8899888753        45999999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhhh--
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAK--  408 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~--  408 (520)
                      |||+++......     ....||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.....  
T Consensus       161 Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07878         161 DFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP  235 (343)
T ss_pred             CCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998654322     33468999999999876 468999999999999999999999997543211100 000000  


Q ss_pred             --hHhhhch-hHHHHhhCcccCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 --PILHRGM-AAVEELLDPRLKC-TSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 --~~~~~~~-~~l~~~~d~~l~~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ....... ......+. .+.. +...     ......+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         236 SPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000000 00000010 0000 0000     001124678899999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-38  Score=309.10  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=202.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||.||+|.... +..||||.+..... ..+++.+|+.+++.++||||+++++++.. ....++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEe
Confidence            4689999999999999999999764 57899999875432 34678899999999999999999998765 345899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          82 YMSKGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             ccCCCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence            9999999999976431     46899999999999999999999888   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   ...           .+.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~-----------~~~  218 (261)
T cd05034         154 EDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE-----------QVE  218 (261)
T ss_pred             cchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------HHH
Confidence            532111 1112235678999999998889999999999999999998 999996533211   000           000


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...  ....+...   ...+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ~~~--~~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 RGY--RMPRPPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             cCC--CCCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            000  11111111   3457788899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.8e-38  Score=310.86  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=201.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+|...+.||+|+||.||+|.....   ...||+|...... ....+.+.+|+.+++.++||||+++++++.+  ...++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence            4688889999999999999987543   3569999887654 4556789999999999999999999998765  34689


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          84 VMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence            999999999999997532      45899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +....... .......++..|+|||.+....++.++|||||||++|||++ |..||.......   ...+          
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----------  220 (270)
T cd05056         155 RYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----------  220 (270)
T ss_pred             eecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----------
Confidence            86654321 11122335568999999988889999999999999999996 999997543221   1110          


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       +...  ..+..+...   ...+.+++.+|+..+|.+|||+.++++.|+..
T Consensus       221 -~~~~--~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         221 -IENG--ERLPMPPNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -HHcC--CcCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             1000  011111112   23577788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-37  Score=307.07  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|+||.||++....+++.||+|.+...  .....+++.+|+.+++.++||||+++++++.+ ....++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            478889999999999999999888999999998643  23345678899999999999999999998765 456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          80 YCEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            9999999999875421     45899999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......|++.|+|||++.+..++.++|||||||++++|++|+.||.......      .           +..
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~-----------~~~  212 (256)
T cd08218         152 NSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------L-----------VLK  212 (256)
T ss_pred             Ccchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------H-----------HHH
Confidence            44321  1233458899999999998889999999999999999999999997532211      1           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ++.....  .........+.+++.+||+.+|.+||++.+|++
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         213 IIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111111  001122345778889999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=326.24  Aligned_cols=241  Identities=25%  Similarity=0.325  Sum_probs=184.8

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhC---CCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      ||+|+||+||+|....+++.||||++.+...   .....+..|..++..+   +||||+++++++.+. ...++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence            6999999999999988899999999865321   2233455666776655   799999999987664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          80 GGELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            99999988753       56899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ..  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........                 ...+.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-----------------~~~i~  210 (330)
T cd05586         150 NK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-----------------YRNIA  210 (330)
T ss_pred             CC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-----------------HHHHH
Confidence            21  12345699999999998765 479999999999999999999999975432110                 01111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPG----IEEIIA  462 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt----m~eVl~  462 (520)
                      ......+.  ......+.+++.+||+.+|.+||+    +.++++
T Consensus       211 ~~~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         211 FGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11111111  011234567888999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-38  Score=309.94  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=201.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC-----C
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~-----~  253 (520)
                      ++++|+..+.||+|+||.||+|....++..|++|++..... ....+.+|+.+++++ +||||+++++++.+..     .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            56899999999999999999999988889999999876543 346788999999999 7999999999987533     2


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence            47899999999999999876431   1256899999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      ||++........  ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||.......  .+.    
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----  228 (275)
T cd06608         157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF----  228 (275)
T ss_pred             Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH----
Confidence            999876543221  1234558999999998753     346789999999999999999999996432111  000    


Q ss_pred             hHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                              .+.....+.+..   .......+.+++.+||..||++|||+.+|++
T Consensus       229 --------~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 --------KIPRNPPPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --------HhhccCCCCCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                    011111111111   1112346778889999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-38  Score=322.52  Aligned_cols=264  Identities=22%  Similarity=0.363  Sum_probs=202.2

Q ss_pred             CCcccceEEcccCceEEEEeeecC-------CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      .+|.+++.||+|+||.||+|....       ....||+|.+.... ....+++.+|+++++++ +||||++++++|.+. 
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-
Confidence            468899999999999999997532       12368999887542 34456889999999999 899999999998764 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ...++|+||+++|+|.+++......         ......++|..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            4589999999999999999764210         011246899999999999999999999887   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchh
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  402 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~  402 (520)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999986543221111122334567999999998899999999999999999998 888886533211   


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                         ....+.        ...  .....   ......+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       245 ---~~~~~~--------~~~--~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 ---LFKLLK--------EGH--RMDKP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ---HHHHHH--------cCC--CCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence               111110        000  00111   112245778889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.8e-38  Score=308.51  Aligned_cols=247  Identities=29%  Similarity=0.524  Sum_probs=196.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|...+.||+|+||.||++..  .++.||+|.+....  ....+.+|+.+++.++|||++++++++...  ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEEC
Confidence            3688889999999999999975  47789999986543  345788999999999999999999987653  36899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          80 MSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999999976431     46899999999999999999999877   9999999999999999999999999987643


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...     .....+..|+|||++.++.++.++|||||||++|||++ |+.||........       .....++      
T Consensus       152 ~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~------  213 (254)
T cd05083         152 MGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKG------  213 (254)
T ss_pred             ccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCC------
Confidence            321     12234568999999998899999999999999999998 9999975432210       0001110      


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                       .  +....   ......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       214 -~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -Y--RMEPP---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -C--CCCCC---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             0  01101   1122456788899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.3e-38  Score=318.42  Aligned_cols=265  Identities=23%  Similarity=0.358  Sum_probs=197.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEEe
Confidence            47899999999999999999998888999999986542 22334677899999999999999999997654 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ ++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++...
T Consensus        85 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          85 YLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            996 68988887542      46889999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc-hhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG-MAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~-~~~l  418 (520)
                      .....  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+..   ......+..- ....
T Consensus       155 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~  229 (301)
T cd07873         155 SIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETW  229 (301)
T ss_pred             CCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhc
Confidence            43221  11234578899999998654 5788999999999999999999999765432111   1111000000 0000


Q ss_pred             HHhhC---------cccCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLD---------PRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d---------~~l~~~~---~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+++         +......   ........+.+++.+||+.||.+|||+.||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000         0000000   00011234678889999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-37  Score=310.76  Aligned_cols=248  Identities=26%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEec
Confidence            5777889999999999999998888999999987543 34567788999999999999999999988764 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++..        ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          84 LGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999998864        35888999999999999999999887   9999999999999999999999999997654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......++..|+|||++.+..++.++|||||||++|||++|..||..........              .+...
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~~  216 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--------------LIPKN  216 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------hhhcC
Confidence            3221  1233468889999999988889999999999999999999999997543211000              00000


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..     +.........+.+++.+||+.+|++||++.+|++.
T Consensus       217 ~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NP-----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CC-----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            01     11122344567889999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-38  Score=328.94  Aligned_cols=266  Identities=21%  Similarity=0.271  Sum_probs=197.3

Q ss_pred             hCCcccceEEcccCceEEEEeeec--CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..+|...+.||+|+||.||++...  ..+..||+|.+...     ..+.+|+++++.++|||||++++++... ...++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWK-STVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEE
Confidence            357999999999999999999754  34578999988653     2345799999999999999999987654 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||++. ++|.+++...       ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       165 ~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             ehhcC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            99995 6888888432       56999999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh-----
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR-----  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-----  413 (520)
                      ...............||+.|+|||++....++.++|||||||++|||++|+.||..................+..     
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            665433322233567999999999999889999999999999999999999999765432211111100000000     


Q ss_pred             ---chhH----HHHh---hCcccCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          414 ---GMAA----VEEL---LDPRLKCTSR--NSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       414 ---~~~~----l~~~---~d~~l~~~~~--~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                         ....    ....   ..+....+..  .......+.+++.+||+.+|++|||+.|++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0000    0000   0110100000  00112346678899999999999999999874

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-38  Score=336.69  Aligned_cols=196  Identities=21%  Similarity=0.261  Sum_probs=168.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||....      ..+.+|+++|++++|||||++++++... ...++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence            4589999999999999999999998899999996432      3456899999999999999999988765 45789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ++ .++|..++....      ..++|..+..|+.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       241 ~~-~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        241 KY-RSDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             cc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            99 578988886532      46999999999999999999999888   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      .............||..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            43322222234569999999999999999999999999999999999887653

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-37  Score=312.53  Aligned_cols=252  Identities=24%  Similarity=0.413  Sum_probs=198.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..+.||+|+||.||++....++..||+|.+... .......+.+|++++++++||||+++++++... ...++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEee
Confidence            678889999999999999999888999999988654 334456788999999999999999999987664 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      +++++|..++.....    ...+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          81 MDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             cCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999998875321    14689999999999999999999963 5   999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCC------CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGK------VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ....    .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||.......   ...         
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~---------  217 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFA---------  217 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHH---------
Confidence            4322    23345888999999985543      4889999999999999999999996432211   000         


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .+..+.+....  .........+.+++.+||+.+|++||++.+++.
T Consensus       218 --~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         218 --QLSAIVDGDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --HHHHHhhcCCC--CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              11122221111  011123345678889999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-37  Score=309.39  Aligned_cols=255  Identities=24%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             CcccceEEcccCceEEEEeeecC-CCcEEEEEEecCc----------chHHHHHHHHHHHHHHh-CCCCCeecEEEEEEc
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE----------DKESSKAFCRELMIASS-LHHPNIVPLVGFCID  250 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~----------~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~  250 (520)
                      +|+..+.||+|+||.||+|.+.. .++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999876 5788999987532          22344567788888865 799999999999876


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCce
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                      . ...++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+ .+   |+|+||+|+|||++.++.+
T Consensus        81 ~-~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          81 N-DRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             C-CeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence            4 468999999999999998865321   12568999999999999999999996 45   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      ||+|||++.......   ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......      .   
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~---  221 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------L---  221 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------H---
Confidence            999999998765432   2234568999999999998889999999999999999999999996532211      0   


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                              ...+.+.... +.........+.+++.+||+.+|++||++.||.++|+
T Consensus       222 --------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 --------ATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------HHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    0111111111 0001112245678888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-37  Score=304.78  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=199.7

Q ss_pred             cccceEEcccCceEEEEeeecCCC----cEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      |+..+.||.|+||.||++.....+    ..||+|.+...... ..+.+..|+.++..++||||+++++++.+. ...+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence            356688999999999999997655    88999999765433 567899999999999999999999998775 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        80 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence            999999999999976431     22899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......... .....+++.|+|||.+....++.++||||+|+++|||++ |+.||.......   ....           
T Consensus       152 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-----------  216 (258)
T smart00219      152 DLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY-----------  216 (258)
T ss_pred             ecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------
Confidence            765442211 112337789999999988889999999999999999998 888886532211   1100           


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      +..  ........   .....+.+++.+|+..+|++|||+.++++.|
T Consensus       217 ~~~--~~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      217 LKK--GYRLPKPE---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             Hhc--CCCCCCCC---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            000  00111111   1234577788999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-38  Score=353.23  Aligned_cols=262  Identities=23%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~  256 (520)
                      ..++|.+.+.||+|+||+||+|.+..++..||+|.+...  .......|..|+.+++.|+|||||++++++.+. ...++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            346899999999999999999999988999999998653  334456788999999999999999999987654 34588


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecccCCCCeEecC-------
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE----RCVVHRDIKPSNILLSS-------  325 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~----~~IiHrDLKp~NILld~-------  325 (520)
                      |||||+++|+|.++|......   ...+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.       
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~---~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKM---FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            999999999999999764221   2469999999999999999999998542    45999999999999964       


Q ss_pred             ----------CCceEEeecCCccccCCCCCCcccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          326 ----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       326 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                                .+.+||+|||++........   .....||+.|+|||++.+  ..++.++||||||||||||++|+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      33589999999986643321   234569999999999864  458899999999999999999999996


Q ss_pred             hhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 010012          394 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA--ILRG  466 (520)
Q Consensus       394 ~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~--~L~~  466 (520)
                      ......  .+   .. .       +..  .+.+...    .....+.+|+..||+.+|.+||++.|++.  .+..
T Consensus       245 ~~~~~~--ql---i~-~-------lk~--~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        245 KANNFS--QL---IS-E-------LKR--GPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             cCCcHH--HH---HH-H-------Hhc--CCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            432110  11   00 0       111  0111111    11245677889999999999999999984  4443

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-37  Score=305.47  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=198.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      +|+..+.||+|+||.||+|....++..|++|.+....     .+..+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence            4677789999999999999998788999999986533     33557789999999999999999999987664 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          80 FLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999998753       45889999999999999999999888   999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      .......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||.......  ...    .       
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~----~-------  213 (258)
T cd06632         150 KQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVF----K-------  213 (258)
T ss_pred             eeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHH----H-------
Confidence            7654332   123456899999999987776 8999999999999999999999997543111  000    0       


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       +...  ....  .........+.+++.+||+.+|.+||++.++++
T Consensus       214 -~~~~--~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         214 -IGRS--KELP--PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -HHhc--ccCC--CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             0000  0000  001112245667888999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-37  Score=308.63  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=199.8

Q ss_pred             cccceEEcccCceEEEEeeec---CCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----
Q 010012          184 FSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----  253 (520)
                      |...+.||+|+||.||+|.+.   .++..||||++...  .....+++.+|+++++.++||||+++++++.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556788999999999999864   34688999998654  33456678899999999999999999998765432     


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++++||+++|+|..++...... .....+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence            246889999999999888643211 11135889999999999999999999887   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||+++...............++..|++||.+....++.++|||||||++|||++ |+.||......   .+..+      
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~------  227 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY------  227 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH------
Confidence            999986643322111223345678999999998889999999999999999999 88998654321   11110      


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                           +...  ..+...   ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 -----~~~~--~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 -----LIKG--NRLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----HHcC--CcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0000  011111   11234678889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-37  Score=311.80  Aligned_cols=267  Identities=22%  Similarity=0.332  Sum_probs=196.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|++|.||+|....++..||+|++....  ......+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence            4778899999999999999998889999999986542  22345678899999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ ++|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          80 FLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             cCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            997 689888865332    256899999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH-------hh
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI-------LH  412 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-------~~  412 (520)
                      .....  ......+++.|+|||++.+. .++.++|||||||++|||++|+.||........  +.......       +.
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  227 (285)
T cd07861         152 GIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWP  227 (285)
T ss_pred             CCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhh
Confidence            43221  11233578899999988654 478899999999999999999999975432111  00000000       00


Q ss_pred             hc--hhHHHHhhCcccCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RG--MAAVEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~--~~~l~~~~d~~l~~--~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..  .......++.....  ..........+.+++.+||+.||.+|||+.+|+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00  00000000000000  0000011235668889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-37  Score=314.73  Aligned_cols=203  Identities=29%  Similarity=0.483  Sum_probs=162.6

Q ss_pred             ceEEcccCceEEEEeeecC--CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEEEEecC
Q 010012          187 GRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVS  263 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV~E~~~  263 (520)
                      +..||+|+||+||+|....  ++..||+|.+....  ....+.+|+++++.++||||+++++++... +...++|+||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999998653  45789999987543  234577899999999999999999987643 445789999986


Q ss_pred             CCChhHHhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----cCCCceEEeecCCc
Q 010012          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  337 (520)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----d~~~~vkL~DFGla  337 (520)
                       ++|.+++......  ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5787877543211  111245899999999999999999999887   9999999999999    56679999999999


Q ss_pred             cccCCCCCC-cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          338 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       338 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      +........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221 112345689999999998764 5799999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.7e-39  Score=305.95  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=204.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ..|...++||.|..++|-++.++.++..+|+|++....        ....+.-..|+.||+++ .||+|+.+.+++ +.+
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-es~   95 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-ESD   95 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-cCc
Confidence            46788889999999999999999999999999986421        12233446799999998 699999999986 446


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ..+++|+|.|+.|.|.++|...       -.++++..+.|+.|+.+|++|||..+   ||||||||+|||+|++.++||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            6789999999999999999875       57999999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcc------cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      |||+|+.+.....   .+..+||++|+|||.+.      ...|+..+|.||+|||+|.|+.|.+||.-...     + . 
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m-l-  235 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M-L-  235 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H-H-
Confidence            9999998876553   45678999999999885      34688899999999999999999999975321     1 1 


Q ss_pred             hhhHhhhchhHHHHhhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                .++-+....... .+...+.....-+++.+||+.||.+|.|.+|+++
T Consensus       236 ----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 ----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                      122223333321 1122344456778999999999999999999987

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.8e-38  Score=320.07  Aligned_cols=199  Identities=24%  Similarity=0.326  Sum_probs=165.5

Q ss_pred             ceEEccc--CceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          187 GRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       187 ~~~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      .++||+|  +|++||++..+.+++.||+|++....  ......+.+|+++++.++||||+++++++... +..++||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEecc
Confidence            4679999  78999999999999999999997542  33445677899999999999999999998765 4589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+.....
T Consensus        82 ~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          82 AYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             CCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            99999999975432     45899999999999999999999888   99999999999999999999999987543321


Q ss_pred             CCCC-----cccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          343 PSVP-----FLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       343 ~~~~-----~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      ....     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            1100     01122357788999999976  3589999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-37  Score=308.96  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch----------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      +|...+.||+|+||.||+|....+++.||+|.+.....          ...+.+..|+.+++.++||||+++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            46778899999999999999887899999998854211          1234678899999999999999999987664 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ...++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEe
Confidence            5589999999999999998754       46899999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCC--CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |||+++...............|+..|+|||.+....  ++.++||||||+++|||++|..||.......  .+    ..+
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~  224 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AM----FKL  224 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HH----HHh
Confidence            999997654322222223456889999999987654  7899999999999999999999996432110  00    000


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..       ....+.+. ..........+.+++.+||..+|.+||++.+|++
T Consensus       225 ~~-------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         225 GN-------KRSAPPIP-PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hc-------cccCCcCC-ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00       00001110 0001122346777888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-37  Score=306.60  Aligned_cols=252  Identities=26%  Similarity=0.487  Sum_probs=198.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ....|.+|++++++++|||++++++++... ...++||||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEc
Confidence            467888999999999999998864 67899999875432 345788999999999999999999987654 457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++....      ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          81 MEHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            99999999987542      45899999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......++.+|+|||++.++.++.++||||||+++|||++ |+.||.......   ...   .+ ..+    ..
T Consensus       152 ~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~-~~~----~~  219 (256)
T cd05112         152 DDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TI-NAG----FR  219 (256)
T ss_pred             cCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HH-hCC----CC
Confidence            32211 1122335678999999998899999999999999999998 999997533211   110   00 000    00


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...+..        ....+.+++.+||+.+|++||++.+|++.|.
T Consensus       220 ~~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         220 LYKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            011111        1246788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-38  Score=318.16  Aligned_cols=248  Identities=21%  Similarity=0.356  Sum_probs=197.5

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      |.....||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||+++++++... ...++|+||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCC
Confidence            34445799999999999999878899999999765545556788999999999999999999987764 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +++|..++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       102 ~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659         102 GGALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             CCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            9999988754        45899999999999999999999888   999999999999999999999999998755432


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                      ..  ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......   ...           .+.....
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~-----------~~~~~~~  234 (297)
T cd06659         171 VP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK-----------RLRDSPP  234 (297)
T ss_pred             cc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----------HHhccCC
Confidence            21  1234568999999999998889999999999999999999999997533211   000           0111011


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +......   .....+.+++.+||+.+|.+||++.+|++
T Consensus       235 ~~~~~~~---~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         235 PKLKNAH---KISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCccccC---CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1111111   11234677888999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-37  Score=350.14  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=201.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|.+..+++.||+|++...   .....++|.+|+++++.++||||+++++++.+. +..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence            4789999999999999999999888999999998653   233456789999999999999999999988764 458999


Q ss_pred             EEecCCCChhHHhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          259 YKYVSGGSLERHLHEKKKG----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~----~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      |||++||+|.+++......    ......+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence            9999999999998753210    011235678888999999999999999887   999999999999999999999999


Q ss_pred             CCccccCCCCC----------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          335 GLATWTSAPSV----------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       335 Gla~~~~~~~~----------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                      |+++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99986521110                00112346999999999999999999999999999999999999999753221


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhc
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIAILRG  466 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-m~eVl~~L~~  466 (520)
                      .   .. ..           ..+.++.-..+  .......+.+++.+|++.+|++||+ +.++++.|+.
T Consensus       238 k---i~-~~-----------~~i~~P~~~~p--~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 K---IS-YR-----------DVILSPIEVAP--YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             h---hh-hh-----------hhccChhhccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1   00 00           00111100000  0112234667889999999999964 6666666654

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.8e-38  Score=317.49  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=199.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      .|.....||+|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++++.+... +..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCC
Confidence            344456799999999999999888999999999766556667789999999999999999999987765 4589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus       102 ~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         102 EGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999998853        35889999999999999999999987   99999999999999999999999999875543


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ...  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   .       .    .+...+
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~-------~----~~~~~~  234 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M-------R----RIRDNL  234 (292)
T ss_pred             ccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------H----HHHhcC
Confidence            221  12335689999999999888899999999999999999999999975332110   0       0    111222


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .+.+......   ...+.+++..|+..+|.+|||+.+|++.
T Consensus       235 ~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 PPRVKDSHKV---SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCcccccccc---CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2222211111   2345677788999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=324.75  Aligned_cols=250  Identities=29%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH---HHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~  256 (520)
                      ...|...+.||+|.||+||+++.+.+|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+++.+.. .++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eEE
Confidence            35788889999999999999999999999999999876432   3467889999999998 999999999976654 589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC----CceEEe
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKLC  332 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~----~~vkL~  332 (520)
                      +|||++.||.|.+.+...        .+++..+..++.|++.|+.|||+.+   |+||||||+|+|+...    +.+|++
T Consensus       113 lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             EEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEe
Confidence            999999999999999764        2899999999999999999999988   9999999999999643    479999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |||++......   ......+||+.|+|||++....|+..+||||+||++|.|++|.+||..........          
T Consensus       182 DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------  248 (382)
T KOG0032|consen  182 DFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------  248 (382)
T ss_pred             eCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence            99999987762   23467789999999999999999999999999999999999999998765432111          


Q ss_pred             hchhHHHHhhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGMAAVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                             .+....+.. ..........+-+++..++..||.+|+|+.++++
T Consensus       249 -------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 -------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                   222222211 1112233455667788999999999999999998

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-37  Score=303.80  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=199.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|+||.||++....++..+|+|.+...  .......+.+|+++++.++||||+++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            478889999999999999999888999999998654  23446678899999999999999999998755 456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~DFGla~~  339 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++++ +.+||+|||++..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          80 YAPGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             cCCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            9999999999976432     46899999999999999999999887   9999999999999855 4689999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......   .   .......      
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~~~~~~------  216 (256)
T cd08220         152 LSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VLKIMSG------  216 (256)
T ss_pred             cCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HHHHHhc------
Confidence            654321   123468899999999998889999999999999999999999997543211   1   1111000      


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ....+  ..   .....+.+++.+||+.+|.+|||+.|+++
T Consensus       217 --~~~~~--~~---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 --TFAPI--SD---RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CCCCC--CC---CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              00001  11   12235678889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-37  Score=308.60  Aligned_cols=260  Identities=29%  Similarity=0.416  Sum_probs=203.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~LV~  259 (520)
                      ++|...+.||.|++|.||+|.+..+++.||+|.+..... ....++.+|+++++.++||||++++++|.+.. ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            368888999999999999999988899999999875432 44567899999999999999999999886543 3589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence            99999999998865322   1256899999999999999999999887   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc--cchhhHHhhhhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ--GEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~--~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......    ....++..|+|||.+.+..++.++|||||||++|||++|+.||......  ....+..+.          
T Consensus       155 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  220 (287)
T cd06621         155 LVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----------  220 (287)
T ss_pred             cccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----------
Confidence            543221    2345788999999999889999999999999999999999999865321  111111111          


Q ss_pred             HHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ...-.+.+... .........+.+++.+||+.+|.+|||+.||++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         221 -VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             00000111100 000112346778999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-37  Score=309.17  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             CCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      .+|+..+.||+|+||.||+|+.+.     ....|++|.+...... ..+.+.+|++++++++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence            478889999999999999998643     3467999998765433 457789999999999999999999987664 457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVR--GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~--~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ++||||+++|+|.+++........  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            999999999999999976432110  0126899999999999999999999888   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ..+.       
T Consensus       161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~-------  229 (275)
T cd05046         161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN-------  229 (275)
T ss_pred             cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH-------
Confidence            9998754322211 1223346778999999988889999999999999999999 88898643211   1111       


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                             ......+... ........+.+++.+||+.+|.+||++.++++.|.
T Consensus       230 -------~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 -------RLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------HHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   0110111000 00112235778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=315.32  Aligned_cols=254  Identities=27%  Similarity=0.376  Sum_probs=201.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|....+++.||+|.+.....   ...+.+..|+++++.++||||+++++.+.+ ....++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            368889999999999999999988899999999976532   245678899999999999999999998766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+.+++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        80 ~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          80 MDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             EEecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence            999999999999875422     56899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCC---------------------------cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCC
Q 010012          339 WTSAPSVP---------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  391 (520)
Q Consensus       339 ~~~~~~~~---------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~P  391 (520)
                      ........                           .......||..|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            54321110                           011234688999999999988899999999999999999999999


Q ss_pred             cchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 010012          392 IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG----IEEIIA  462 (520)
Q Consensus       392 f~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt----m~eVl~  462 (520)
                      |.......                 ....+.+.....+.. ......+.+++.+||+.+|++||+    +.+++.
T Consensus       232 f~~~~~~~-----------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         232 FKGSNRDE-----------------TFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCchHH-----------------HHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            97543211                 111222222221111 113456778889999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-37  Score=310.37  Aligned_cols=268  Identities=25%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEE
Confidence            36888899999999999999998889999999986432  22345678999999999999999999988764 4579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++++.|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          80 EYCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             eccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccccee
Confidence            999998888776532       45899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhh-HHhhhhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~l-v~~~~~~~~~~~~~  417 (520)
                      ......  ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ..............
T Consensus       150 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         150 LTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             cCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            654321  1123457889999999876 4578999999999999999999999975443211110 00000000000000


Q ss_pred             ------HHHhhCcccCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 ------VEELLDPRLKCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 ------l~~~~d~~l~~~~~----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                            ......+.......    .......+.+++.+||+.+|++||++.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  00000000000000    0011345778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3e-37  Score=305.46  Aligned_cols=254  Identities=23%  Similarity=0.401  Sum_probs=200.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +|+..+.||+|+||.||+|....+++.||+|.+....      ....+.+.+|+.+++.++||||+++++++.+.+ ..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence            4788899999999999999998889999999986532      223567889999999999999999999987654 579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFG  335 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFG  335 (520)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .+||+|||
T Consensus        80 ~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccc
Confidence            999999999999998753       46899999999999999999999987   99999999999998776 59999999


Q ss_pred             CccccCCCCCC--cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          336 LATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       336 la~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ++.........  .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...........   .....  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~--  224 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIA--  224 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHh--
Confidence            99766543111  112234688999999999888899999999999999999999999964332211110   00000  


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           .....     ..........+.+++.+|+..+|.+||++.++++
T Consensus       225 -----~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 -----SATTA-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----ccCCC-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 00001     1111223356778889999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.6e-37  Score=307.63  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=193.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHH-HHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|++.... .....++..|+.+ ++.++||||+++++++.+.. .+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEh
Confidence            37888999999999999999999889999999987642 2333455566664 66779999999999987644 589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||++ |+|.+++.....   ....+++..++.++.|++.||+|||++ +   ++||||||+|||++.++.+||+|||++.
T Consensus        80 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          80 EVMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9996 789888865322   125789999999999999999999986 5   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ......   ......|+..|+|||.+.+    ..++.++|+|||||++|||++|+.||...... ...+    .      
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~------  218 (283)
T cd06617         153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----K------  218 (283)
T ss_pred             cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----H------
Confidence            654322   1123458899999998864    45688999999999999999999999642211 0000    0      


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .......+.+...    .....+.+++.+||..+|.+||++.+|++
T Consensus       219 --~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 --QVVEEPSPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --HHHhcCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0011111122111    11245778889999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-37  Score=309.89  Aligned_cols=245  Identities=28%  Similarity=0.399  Sum_probs=199.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||.||++....+++.||+|.+....   ......+.+|++++++++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence            36888999999999999999998889999999986532   23456788999999999999999999987764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||+|+|||++.++.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          80 MEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            9999999999998764       46899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.......                 ..
T Consensus       150 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~  207 (290)
T cd05580         150 RVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-----------------IY  207 (290)
T ss_pred             ccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HH
Confidence            765431     23458999999999988888999999999999999999999997543110                 01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+.......+...   ...+.+++.+||..+|.+||     ++.++++
T Consensus       208 ~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         208 EKILEGKVRFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHHhcCCccCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            11112122111111   24566788899999999999     6666664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4e-37  Score=306.19  Aligned_cols=255  Identities=21%  Similarity=0.319  Sum_probs=186.8

Q ss_pred             EEcccCceEEEEeeecCC--CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCC
Q 010012          189 VLGRGALSFVFKGKVGLL--RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~--~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      .||+|+||.||+|.....  ...+++|.+.... ....+.|.+|+.+++.++||||++++++|.+. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCC
Confidence            599999999999975432  3456777776543 34556899999999999999999999998765 4579999999999


Q ss_pred             ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC
Q 010012          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (520)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~  345 (520)
                      +|.+++......   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 ~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          81 DLKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             cHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            999999764321   145677788899999999999999887   99999999999999999999999999864322211


Q ss_pred             CcccccccccCCccCchhccc-------CCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          346 PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       346 ~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||......+   .   ....+..   .
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~---~  225 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---V---LNHVIKD---Q  225 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhh---c
Confidence            111233457889999998743       245789999999999999997 567875432211   1   1111111   1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...+.++.+...  .   ...+.+++..|+ .+|.+||++.+|++.|.
T Consensus       226 ~~~~~~~~~~~~--~---~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 QVKLFKPQLELP--Y---SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccccCCCccCCC--C---cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            122333333211  1   234556777899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.7e-38  Score=313.39  Aligned_cols=268  Identities=25%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+++++.++||||+++++++.+ +...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            36888899999999999999998889999999886532  2234568899999999999999999998765 45689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|..+....       ..++|..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          80 EFVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             ecCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            999999988876542       35899999999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHhhhhHhhhchh-
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILHRGMA-  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~~~~-  416 (520)
                      ......  ......++..|+|||++.+ ..++.++|||||||++|||++|++||......... .+..+.......... 
T Consensus       150 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         150 LAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             ccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence            544321  1233458899999999875 35788999999999999999999999654321110 111100000000000 


Q ss_pred             -----HHHHhhCcccCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 -----AVEELLDPRLKCTS----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 -----~l~~~~d~~l~~~~----~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           .......+......    ........+.+++.+||+.+|++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 00000000000000    00112345788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.9e-37  Score=297.80  Aligned_cols=250  Identities=28%  Similarity=0.431  Sum_probs=203.3

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +|+..+.||+|++|.||++....++..+++|++........+.+.+|+++++.++|||++++++++... ...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence            477788999999999999999878899999999876655667899999999999999999999987665 5589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++++|.+++....      ..+++..+..++.|++.||.|||..+   ++||||+|+||++++++.++|+|||.+.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          80 SGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999987642      46899999999999999999999877   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ...   .....++..|+|||++....++.++||||||+++|+|++|+.||........   ..           ......
T Consensus       151 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~-----------~~~~~~  213 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LF-----------KIATNG  213 (253)
T ss_pred             ccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HH-----------HHHhcC
Confidence            331   2345688999999999888899999999999999999999999975422110   00           000000


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -+.+...   ......+.+++.+||+.+|++|||+.+|++
T Consensus       214 ~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         214 PPGLRNP---EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCcCcc---cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0111111   111345778889999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.1e-37  Score=302.27  Aligned_cols=253  Identities=27%  Similarity=0.460  Sum_probs=200.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|+||.||+|....++..||+|.+.....  ...+.+..|+++++.++|+||+++++++... ...++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence            47788999999999999999887889999999876544  3667899999999999999999999987654 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          80 YCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             cCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999999998753       45889999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCCcc--cccccccCCccCchhcccCC---CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          341 SAPSVPFL--CKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       341 ~~~~~~~~--~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ........  .....++..|+|||++....   ++.++||||||+++|||++|+.||.......  ... +         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~-~---------  217 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM-F---------  217 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH-H---------
Confidence            54332111  11345888999999998766   8899999999999999999999996432110  000 0         


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .+.....+.+...   ......+.+++.+||+.+|.+||++.+++.
T Consensus       218 -~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         218 -HVGAGHKPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -HHhcCCCCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0111111112111   111345667889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-37  Score=312.05  Aligned_cols=268  Identities=21%  Similarity=0.295  Sum_probs=198.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-----HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      +|+..+.||+|+||.||+|....+++.||+|.+......     ....+..|+++++.++|+||+++++++.+ ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            477788999999999999999888999999999765322     34567789999999999999999999877 456899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+ +|+|.+++....      ..+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.+||+|||++
T Consensus        80 v~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceee
Confidence            99999 999999997532      36999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH-HhhhhHhhhch
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv-~~~~~~~~~~~  415 (520)
                      +........  .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||............ ...........
T Consensus       150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         150 RSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             eeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence            876543211  123356888999999865 45789999999999999999998887654321110000 00000000000


Q ss_pred             hH---HHHhhCcccCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          416 AA---VEELLDPRLKCT----SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       416 ~~---l~~~~d~~l~~~----~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..   +...........    .........+.+++.+||+.+|++|||+.||++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00   000000000000    0011223567889999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-37  Score=308.36  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      .|...+.||+|++|.||++....++..|++|++........+.+.+|+.+++.++||||+++++++... +..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEecc
Confidence            455567999999999999998878899999998765555566788999999999999999999987764 4579999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++++|.+++..        ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          99 EGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999865        35889999999999999999999988   99999999999999999999999999875543


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......      ...        .+....
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~--------~~~~~~  231 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMK--------RIRDNL  231 (285)
T ss_pred             CCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHH--------HHHhcC
Confidence            221  1223458999999999988889999999999999999999999996533211      010        111111


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.+...   ......+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 PPKLKNL---HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCccc---ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1111111   112245788889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-37  Score=309.61  Aligned_cols=265  Identities=23%  Similarity=0.317  Sum_probs=200.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|...+.||+|+||.||+|....++..||+|++....  ......+.+|+.++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEec
Confidence            4778899999999999999998889999999987653  33456788999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+ +++|.+++....      ..+++..++.++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          80 YM-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             cc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            99 999999987543      56999999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc----h
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----M  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~----~  415 (520)
                      ..... .......|+..|+|||.+.+. .++.++||||+||++|||++|.+||.......   ...+........    .
T Consensus       150 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         150 SEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETW  225 (286)
T ss_pred             cCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHH
Confidence            54321 112334689999999998654 46899999999999999999988886543211   111111000000    0


Q ss_pred             hHH------HHhhCcccCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAV------EELLDPRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l------~~~~d~~l~~---~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+      ..+..+.-..   ..........+.+++.+||+.+|.+||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000      0000000000   0000112356788999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=306.47  Aligned_cols=248  Identities=27%  Similarity=0.445  Sum_probs=198.3

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .|+..+.||+|+||.||+|....++..||+|.+... ......++.+|+.+++.++   |||++++++++.+. ...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEE
Confidence            477788999999999999999888999999998654 3344567889999999987   99999999988764 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++..        ..+++.....++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          81 MEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            999999999998854        36899999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .......  ......|+..|+|||++..+ .++.++|||||||++|+|++|..||........   ..           .
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~-----------~  213 (277)
T cd06917         150 LLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MM-----------L  213 (277)
T ss_pred             ecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hh-----------c
Confidence            7654332  12334689999999998754 468999999999999999999999975432110   00           0


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +.....+.+...    .....+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 IPKSKPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cccCCCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            001111112111    12345778889999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.7e-37  Score=310.98  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=201.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.+++.++||||+++++++...+ ..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEEec
Confidence            58889999999999999999987778999999987655555677889999999999999999999887654 57999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999999864        35789999999999999999999887   9999999999999999999999999987554


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......|++.|+|||.+....++.++|||||||++|+|++|+.||.........  .    ......       
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~-------  231 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-------  231 (293)
T ss_pred             cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCC-------
Confidence            3321  122345888999999998888999999999999999999999999754321110  0    000000       


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                       .+....   .......+.+++.+||..+|++||++.+++..
T Consensus       232 -~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 -TPELQN---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011110   11122356778899999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-37  Score=310.27  Aligned_cols=273  Identities=23%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--HHHHHHHHHHHHHhCCCCC-eecEEEEEEcCCC-----
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQ-----  253 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~-----  253 (520)
                      ..|...++||+|.||+||+|+...+|+.||+|++.....+  ......+|+.+|+.|+|+| ||+|++++.....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3566777899999999999999999999999999765332  3344578999999999999 9999999876553     


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++|+||+ .-+|..++.......   ..++-..+..++.||++||+|||+++   |+||||||.||||+++|.+||+|
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence            688999999 559999998764211   35677889999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh-
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL-  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-  411 (520)
                      ||+|+-...+...  .+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+....++...+-...... 
T Consensus       164 FGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  164 FGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             cchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            9999966543322  3456799999999999887 68999999999999999999999998765422111111000000 


Q ss_pred             hhchhHHHHhhCcccCCCC-----CCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTS-----RNSA----QIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~-----~~~~----~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      .+.+..+..+.+-......     ....    ......+++.+||+.+|.+|.|+..++++
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0000111111111111000     0001    11367889999999999999999999885

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=304.53  Aligned_cols=251  Identities=28%  Similarity=0.389  Sum_probs=200.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      +++|+..+.||+|.|+.||++..+.+|+.+|+|++...  +....+++.+|+.|-+.|+|||||+|.+.. ..+...|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-cccceeEEE
Confidence            35788888999999999999999999999999988643  334667888999999999999999999875 446678999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC---CceEEeecC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFG  335 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~---~~vkL~DFG  335 (520)
                      +|+|.|++|..-+-..       ..+++..+-.++.||++||.|+|.++   |||||+||+|+||-..   --+||+|||
T Consensus        89 Fe~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             EecccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccc
Confidence            9999999996665543       35788888899999999999999988   9999999999999533   358999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +|..++...   .....+||++|||||++...+|+..+|||+.|||||-|+.|++||.+.....   +            
T Consensus       159 vAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l------------  220 (355)
T KOG0033|consen  159 LAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L------------  220 (355)
T ss_pred             eEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H------------
Confidence            999887332   3456789999999999999999999999999999999999999998743221   1            


Q ss_pred             hHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .+.+.......+. ..+.......+++++||..||.+|.|+.|.++
T Consensus       221 --ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  221 --YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence              1111111111111 11222334567788999999999999998775

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.5e-37  Score=305.05  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=198.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      -|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEe
Confidence            4677889999999999999988788999999986442 34456788999999999999999999988764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          84 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999863        45899999999999999999999887   9999999999999999999999999987654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......++..|+|||++.+..++.++|||||||++|+|++|..||.......      ....        +...
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~--------~~~~  216 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL--------IPKN  216 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH--------HhcC
Confidence            3221  1233468899999999988889999999999999999999999996432210      0000        0000


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..+.+     .......+.+++.+||+.+|.+||++.++++.
T Consensus       217 ~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 NPPTL-----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCC-----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01111     11123456778899999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.5e-37  Score=300.90  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=205.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|++|.||+|....+++.|++|++..... .....+.+|+.++..++||||+++++++... ...++|+|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEE
Confidence            368888999999999999999998899999999876643 4567899999999999999999999988765 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+++++|.+++...       ..+++..+..++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          80 YMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             ecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence            99999999999764       468999999999999999999998 77   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..........+.              .
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--------------~  213 (264)
T cd06623         150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM--------------Q  213 (264)
T ss_pred             cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH--------------H
Confidence            6543321  12456889999999999888999999999999999999999999765421111111              1


Q ss_pred             HhhCcccCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSA-QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~-~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.......  .... ....+.+++.+||..+|++||++.++++
T Consensus       214 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         214 AICDGPPPS--LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHhcCCCCC--CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            111111110  0111 2346778889999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-37  Score=309.41  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=194.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|...+.||+|+||.||+|....+++.||+|.+....  ......+.+|+.++++++||||+++++++.+. ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence            4778899999999999999998889999999986532  22234677899999999999999999987664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+. ++|.+++....      ..+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          80 YCD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            996 58888876532      46899999999999999999999887   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh----hch
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH----RGM  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~----~~~  415 (520)
                      .....  ......++..|+|||++.+.. ++.++|||||||++|||++|..|+....... ..+ ........    ...
T Consensus       150 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~  225 (284)
T cd07839         150 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESW  225 (284)
T ss_pred             CCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHh
Confidence            43221  112345788999999987654 6899999999999999999998864322111 000 00000000    000


Q ss_pred             hHHHHhhCcccCCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCT--------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~--------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+....+......        .........+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00111111100000        000112345678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.3e-37  Score=304.65  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=201.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..+.||+|+||.||++.+..+++.||+|.+.... .....++.+|+++++.++||||+++++++... ...++|+||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEe
Confidence            5777889999999999999998889999999987653 34556789999999999999999999988775 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      +++++|.+++....      ..+++..+..++.|++.||+|||+ .+   ++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          81 MDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             cCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            99999999987642      468999999999999999999998 66   999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....    ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ......           +..
T Consensus       152 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~-----------~~~  215 (265)
T cd06605         152 VNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFEL-----------LQY  215 (265)
T ss_pred             HHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHH-----------HHH
Confidence            43221    12568899999999998899999999999999999999999997542211 111111           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ++....... ........+.+++.+||..+|.+|||+.+++.
T Consensus       216 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 IVNEPPPRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HhcCCCCCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111111000 00112345778889999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.3e-37  Score=302.94  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=199.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|+||.||+|....++..||+|.+....  ....+.+.+|+++++.++||||+++++.+.+ ....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            4788899999999999999999889999999986542  2344578899999999999999999998766 456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~~  339 (520)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||++++++ .+||+|||.+..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          80 YCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchh
Confidence            9999999999976432     46899999999999999999999887   99999999999999885 569999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......  ......|++.|+|||++.+..++.++|||||||++|||++|..||.......      +..           
T Consensus       152 ~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~-----------  212 (257)
T cd08225         152 LNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVL-----------  212 (257)
T ss_pred             ccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHH-----------
Confidence            653221  1233458999999999988889999999999999999999999996532211      111           


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......+..  ........+.+++.+|+..+|++|||+.+|++
T Consensus       213 ~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         213 KICQGYFAP--ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHhcccCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111111110  01112235778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-36  Score=308.83  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=196.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..|+..+.||+|+||+||+|....+++.||+|.+...   .....+.+.+|+++++.++||||++++++|.+.+ ..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEEE
Confidence            4688889999999999999999888999999998643   2334467889999999999999999999987754 57899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +||++ |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.
T Consensus        94 ~e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          94 MEYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             HHhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcce
Confidence            99996 67777775432      46899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .....      ....++..|+|||++.   .+.++.++||||||+++|||++|+.||........      ...      
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~------  225 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH------  225 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHH------
Confidence            65432      2345888999999874   45688999999999999999999999865332110      000      


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                        +.....+.+.    .......+.+++.+||+.+|++||++.+|+..
T Consensus       226 --~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 --IAQNDSPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --HhcCCCCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0000011111    11223457888899999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=318.06  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=214.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .-|+..+.||+|.|++|-+|++.-+|..||||++++...+  ....+..|+..++.++|||||+||++ ++....+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-iDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-IDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-hcccceEEEEE
Confidence            5688889999999999999999999999999999876433  34567899999999999999999997 57778899999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~  338 (520)
                      |.=.+|+|.+|+.+..      ..+.+....+++.||+.|+.|+|+..   +|||||||+||.+- .-|-+||+|||++-
T Consensus        97 ELGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence            9999999999998875      56999999999999999999999998   99999999999765 56899999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCC-CcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .+.....   .++.+|+..|-|||++.+..|. +++||||+|||||-|++|+.||...+..+                 .
T Consensus       168 kf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------T  227 (864)
T KOG4717|consen  168 KFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------T  227 (864)
T ss_pred             cCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------h
Confidence            7665442   3567899999999999998885 68999999999999999999998654332                 3


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCc
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA--ILRGEE  468 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~--~L~~~~  468 (520)
                      +..++|-.+..+..   ...+..+|+..||..||++|.+..+|+.  -|+...
T Consensus       228 LTmImDCKYtvPsh---vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  228 LTMIMDCKYTVPSH---VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhhcccccCchh---hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            45566666654433   3345667788999999999999999986  455443

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=308.03  Aligned_cols=266  Identities=27%  Similarity=0.377  Sum_probs=200.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.+|+++++.++|+||+++++++... ...++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEE
Confidence            3688899999999999999999888999999998653  233456788999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++++.|..++...       ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          80 EYVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            999987776655432       45899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ...... .......++..|+|||++... .++.++||||||+++|+|++|+.||......+..   ......+.......
T Consensus       150 ~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~  225 (288)
T cd07833         150 LRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSH  225 (288)
T ss_pred             cCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence            654432 122345688999999999888 7899999999999999999999999754322111   00000000000000


Q ss_pred             HHhh--CcccCC-----CC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELL--DPRLKC-----TS--------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~--d~~l~~-----~~--------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....  ++....     ..        ........+.+++.+||..+|++||++++|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000  000000     00        00011356788999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.4e-37  Score=305.91  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=203.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++.|+..+.||+|++|.||+|.+..++..||+|++..... ....+.+|+++++.++|+|++++++++... ...++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEE
Confidence            45678888999999999999999987889999999976554 556788999999999999999999988775 5589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        95 e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          95 EYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             eccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999998642      36999999999999999999999877   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||........  .    ..+...      
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~----~~~~~~------  231 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--L----FLITTK------  231 (286)
T ss_pred             hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhc------
Confidence            543221  11234578899999999888899999999999999999999999875332110  0    000000      


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .. +.....   ......+.+++.+||+.+|.+||++.+|++
T Consensus       232 -~~-~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 -GI-PPLKNP---EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -CC-CCCcch---hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             00 111111   112245778889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4e-37  Score=309.35  Aligned_cols=268  Identities=23%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++.+|...+.||+|+||.||+|....++..||+|++..... .....+.+|+.+++.++|+||+++++++.+. ...++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEE
Confidence            45789999999999999999999988899999999865432 2234567899999999999999999987664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             Eeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence            99995 67877765432      45788889999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh---h-
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH---R-  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~---~-  413 (520)
                      .......  ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ..+. .....+.   . 
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~  227 (291)
T cd07870         152 AKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLE-KIWTVLGVPTED  227 (291)
T ss_pred             ccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHH-HHHHHcCCCChh
Confidence            6433221  11234578999999998754 57889999999999999999999997543211 1110 0000000   0 


Q ss_pred             chhHHH-------HhhCc----ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVE-------ELLDP----RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~-------~~~d~----~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....+.       .....    .+............+.+++.+|+..+|.+|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000       00000    00000000011235667889999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=329.79  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=202.0

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCCh
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL  267 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL  267 (520)
                      -+||+|.||+||.|++.++...+|||-+........+-+..|+.+-+.|+|.|||+++|.|.+ ++.+-+.||.+|||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence            369999999999999999999999999987766677788899999999999999999998755 4457799999999999


Q ss_pred             hHHhhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecCCccccCCCC
Q 010012          268 ERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       268 ~~~L~~~~~~~~~~~~l--~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~~~~~~~  344 (520)
                      .++|....      .++  ++.+.-.+..||++||.|||++.   |||||||-.||||+ -.|.+||+|||.++++..-.
T Consensus       660 SsLLrskW------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  660 SSLLRSKW------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             HHHHHhcc------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99998875      455  78888889999999999999988   99999999999997 46899999999999875422


Q ss_pred             CCcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                        ....++.||..|||||++..|  .|+.++|||||||++.||.||++||..-....   -     ..++-|..+    +
T Consensus       731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---A-----AMFkVGmyK----v  796 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---A-----AMFKVGMYK----V  796 (1226)
T ss_pred             --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---H-----hhhhhccee----c
Confidence              234567799999999999876  58999999999999999999999997533211   0     011111100    1


Q ss_pred             CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       423 d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .     +....+...+...++.+|+.++|.+||+++++++
T Consensus       797 H-----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  797 H-----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             C-----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            1     1223345567778889999999999999999986

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=324.95  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=209.8

Q ss_pred             CcccceEEcccCceEEEEeeecC----CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .....++||.|-||.||+|....    ..-.||||..+.+ ..+..+.|+.|..++++++|||||+|+|+|.+.  ..++
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeE
Confidence            34456789999999999998742    2346999998874 566788999999999999999999999999763  5799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||.++-|.|..+|+..+      ..|+......++.||..||.|||+..   .|||||..+|||+....-+||+||||+
T Consensus       468 vmEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             EEecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            999999999999998765      56999999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +.+........ ....-.+.|||||.+.-.+++.+||||.|||.+||++. |.+||.+-...+...       .++.   
T Consensus       539 R~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEn---  607 (974)
T KOG4257|consen  539 RYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIEN---  607 (974)
T ss_pred             hhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecC---
Confidence            98877654333 34445678999999999999999999999999999987 999998755433111       0111   


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                            ..++.+++.++..   +..++.+||..+|.+||++.+|...|..+
T Consensus       608 ------GeRlP~P~nCPp~---LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  608 ------GERLPCPPNCPPA---LYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ------CCCCCCCCCCChH---HHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                  1345555555544   45678899999999999999999988653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-37  Score=306.73  Aligned_cols=266  Identities=24%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|++|.||+|....+++.||+|.+..... .....+.+|+++++.++||||+++++++.+. ...++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEEe
Confidence            578999999999999999999988889999999865432 2234567899999999999999999997664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ ++|.+++....      ..+++.....++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          84 YLD-TDLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             cCC-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            997 49999887542      46899999999999999999999887   999999999999999999999999998754


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc----h
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----M  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~----~  415 (520)
                      .....  ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......  .........+...    .
T Consensus       154 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (291)
T cd07844         154 SVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETW  229 (291)
T ss_pred             CCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhh
Confidence            32221  1122346889999999875 457899999999999999999999996543111  0000000000000    0


Q ss_pred             hHHHH---hhCcccCC--------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEE---LLDPRLKC--------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~---~~d~~l~~--------~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+..   ........        ..........+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000   00000000        0000001145678889999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=317.42  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=199.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+.|+.-++||+||||.||-++.+.+|+.||.|.+.+..   .....-.++|-.||.++..|.||.|-.. ++....+||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-feTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-FETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-ecCCCceEE
Confidence            367888899999999999999999999999999997653   2334456789999999999999998655 455667999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |+..|.||+|.-+|....     ++.+++..++.+|.+|+.||++||+..   ||+||+||+|||||+.|+++|+|.|||
T Consensus       263 VLtlMNGGDLkfHiyn~g-----~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHG-----NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             EEEeecCCceeEEeeccC-----CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence            999999999999998754     368999999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ..+.....   .+..+||.+|||||++.++.|+...||||+||+||||+.|+.||..........              .
T Consensus       335 vei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e--------------E  397 (591)
T KOG0986|consen  335 VEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE--------------E  397 (591)
T ss_pred             EecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH--------------H
Confidence            98876542   244589999999999999999999999999999999999999997643321100              0


Q ss_pred             HHH-hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          418 VEE-LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       418 l~~-~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                      +.. ++......+...+++   +-.+....|++||++|-.-+
T Consensus       398 vdrr~~~~~~ey~~kFS~e---akslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  398 VDRRTLEDPEEYSDKFSEE---AKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHhcchhhcccccCHH---HHHHHHHHHccCHHHhccCC
Confidence            111 111111112223344   44555668999999997644

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.2e-37  Score=306.40  Aligned_cols=268  Identities=22%  Similarity=0.356  Sum_probs=195.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||.|++|.||+|....+++.||||++....  ......+.+|++++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence            4788899999999999999998889999999986542  22345788999999999999999999987654 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+. ++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++...
T Consensus        80 ~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          80 FLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             ccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            995 689888875432     56899999999999999999999887   999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHhhhhHhh---hch
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILH---RGM  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~---~~~  415 (520)
                      ......  .....++..|+|||++.+.. ++.++|||||||++|||+||+.||......... ....+......   ...
T Consensus       151 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         151 GVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence            432211  12334788999999887654 588999999999999999999999754321100 00100000000   000


Q ss_pred             hHHHHhhC--cccCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLD--PRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d--~~l~~~~---~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+...  +......   ........+.+++.+||+.||.+|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000  0000000   00011234567889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.1e-37  Score=302.71  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=200.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +|+..+.||.|+||.||+|....++..||+|.+....   ....+.+.+|++++++++||||+++++++.+ ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            5788899999999999999998889999999997542   2446788999999999999999999988755 45589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++...       ..+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++..
T Consensus        80 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          80 DLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             eCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999999999753       46899999999999999999999887   99999999999999999999999999886


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....   ......|+..|+|||++....++.++||||||+++|+|++|+.||..........+.    .          
T Consensus       150 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~----------  212 (258)
T cd05578         150 VTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----A----------  212 (258)
T ss_pred             cCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----H----------
Confidence            65432   123456888999999998888999999999999999999999999865432111110    0          


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI--EEII  461 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm--~eVl  461 (520)
                      .........+.   .....+.+++.+||+.+|.+||+.  +|++
T Consensus       213 ~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 KQETADVLYPA---TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HhccccccCcc---cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            00001111111   122567788899999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-36  Score=301.43  Aligned_cols=262  Identities=23%  Similarity=0.264  Sum_probs=193.8

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCC-CcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-~~~~LV~E  260 (520)
                      |...+.||+|+||.||+|....++..||+|++.... .........|+.++.++. ||||+++++++.+.. +.+++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999998889999999987542 122234457888888885 999999999987652 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ |+|.+++....      ..++|..+..++.|++.||+|||+.+   |+||||||+||+++. +.+||+|||++...
T Consensus        81 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          81 LMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             cCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            996 58888876532      46899999999999999999999887   999999999999999 99999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....   .....++..|+|||++.. +.++.++|||||||++|||++|..||......+   .+.+...........+.
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence            43321   123457889999997654 457889999999999999999999997643321   11211111111000111


Q ss_pred             HhhCcc----cCCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPR----LKCTS--------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~----l~~~~--------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......    ...+.        ........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111000    00000        00122467889999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=324.96  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=215.9

Q ss_pred             HHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       174 ~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      +.++.-...+....++||-|-||.||.|.++.....||||.++.+. ....+|+.|+.+++.++|||+|+|+|+|.. +.
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-Ep  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EP  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CC
Confidence            3455555667778899999999999999999888999999997654 456899999999999999999999999976 44


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+|||.|||..|+|.+||.+..+     ..++--..+.+|.||+.|++||...+   +|||||...|.|+.++..+||+|
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeec
Confidence            58999999999999999998654     56777788899999999999999888   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |||++++..+...... ...-.+.|.|||-+....++.|+|||+|||+|||+.| |..||.+-+...       +..+++
T Consensus       409 FGLsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLE  480 (1157)
T KOG4278|consen  409 FGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLE  480 (1157)
T ss_pred             cchhhhhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHh
Confidence            9999998765433221 1223567999999999999999999999999999998 999987643221       112222


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ++         .++..+..++.   .+.+|++.||+++|.+||++.||-+.++.
T Consensus       481 kg---------yRM~~PeGCPp---kVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  481 KG---------YRMDGPEGCPP---KVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             cc---------ccccCCCCCCH---HHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            22         23444554544   46677789999999999999999988775

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=322.41  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=208.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .....+++||+|-||.|.++.... +..||||++..... ....+|..|+.+|.+++|||||+|+|+|...+ .+++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~E  615 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITE  615 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHH
Confidence            445667889999999999999874 68999999987754 44589999999999999999999999998754 5899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ||++|+|.+||.....     +.+.-.....|+.||+.|++||.+.+   +|||||.+.|+|+|.++++||+|||+++-+
T Consensus       616 YmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence            9999999999987642     22344455679999999999999988   999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh--CCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT--GRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt--G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      -..+........+-.+.|||||.+..++++.+||||+|||+|||+++  ...||.....+   +.++-+...+.....  
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~--  762 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGR--  762 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCc--
Confidence            66555444445556789999999999999999999999999999875  78888754322   222222222221100  


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       ..   -+..+..++   ..+.+++.+||..+-++||++++|...|+..
T Consensus       763 -~~---~l~~P~~cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 -QV---VLSRPPACP---QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -ce---eccCCCcCc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             00   011122233   3466888999999999999999999988753

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-36  Score=294.62  Aligned_cols=253  Identities=30%  Similarity=0.427  Sum_probs=203.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~LV~  259 (520)
                      +|+..+.||+|++|.||+|....++..|++|++.....  ...+.+.+|+.++++++||||+++++.+.+.. ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47778999999999999999988899999999876542  45678899999999999999999999887652 4578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            999999999998764       36999999999999999999999977   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ..............++..|+|||.+.....+.++||||||+++|+|++|..||......     ...           +.
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~-----------~~  214 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAA-----------LY  214 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHH-----------HH
Confidence            66543211123456889999999998888999999999999999999999999764411     000           01


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+...... ..........+.+++.+|+..+|.+||++.+++.
T Consensus       215 ~~~~~~~~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             hccccCCC-cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11110000 0011112356778888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-36  Score=313.01  Aligned_cols=266  Identities=20%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|+..+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.+++.++||||+++++++....     .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46899999999999999999999888999999998643  3344556778999999999999999999875432     2


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++||||+. ++|.+.+..         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence            4689999995 588887753         3888899999999999999999987   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~----  408 (520)
                      ||+++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......... .+.....    
T Consensus       162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999986644321   23345889999999999999999999999999999999999999754321110 0000000    


Q ss_pred             hHhhhchhHHHHhhCcc---------------cCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPR---------------LKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~---------------l~~---~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .........+....+.+               +..   ..........+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000000000011100               000   0001122445778999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-36  Score=307.79  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=195.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|...+.||+|+||.||+|....++..||+|.+...   .......+..|+++++.++|||++++++++.+.. ..++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence            477788999999999999999888999999998643   2334457889999999999999999999987654 578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++ |+|.+.+....      ..++|..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++..
T Consensus       105 e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         105 EYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eCCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9996 57877775432      56899999999999999999999887   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ....      ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||.......                 
T Consensus       175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----------------  231 (317)
T cd06635         175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------------  231 (317)
T ss_pred             cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----------------
Confidence            4432      2345889999999974   4568999999999999999999999986532111                 


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .+..+...... ..........+.+++.+||+.+|.+||++.+|++.+-
T Consensus       232 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         232 ALYHIAQNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHHHhccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            00111111110 0001122345778889999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-37  Score=315.83  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=198.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----CcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~  255 (520)
                      +++|...+.||+|+||.||+|....+++.||+|.+... .......+.+|+.++++++||||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999888999999998643 2334566888999999999999999998865433    247


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|+||+. ++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccc
Confidence            89999996 588777753        46999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCc-ccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          336 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       336 la~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ++.......... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......   ........+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~  228 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGT  228 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCC
Confidence            998654322111 1123468999999998754 468999999999999999999999996543211   11111110000


Q ss_pred             -chhHHHHhhCcc-------cCC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          414 -GMAAVEELLDPR-------LKC-TSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       414 -~~~~l~~~~d~~-------l~~-~~~-----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                       .......+.+..       ... ...     .+.....+.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000111111100       000 000     01123457889999999999999999999884

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=307.26  Aligned_cols=261  Identities=15%  Similarity=0.195  Sum_probs=186.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCcchHH-----------HHHHHHHHHHHHhCCCCCeecEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKES-----------SKAFCRELMIASSLHHPNIVPLVG  246 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~g  246 (520)
                      .++|.+.++||+|+||+||+|....+   +..+|+|+........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998766   5667777643322111           011223444566789999999998


Q ss_pred             EEEcCCC---cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          247 FCIDPEQ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       247 ~~~~~~~---~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ++.....   ..+++++++. .++.+.+...       ...++..+..|+.|++.||+|||+.+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV  159 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            7654432   2357777763 4666666542       34678889999999999999999887   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                      +.++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999865432111     1112346999999999999999999999999999999999999999765322


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      .  ..+.....      ..+..+..+.+... ..   ...+.+++..|++.+|++||++.+|++.|
T Consensus       240 ~--~~~~~~~~------~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        240 G--NLIHAAKC------DFIKRLHEGKIKIK-NA---NKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             h--HHHHHhHH------HHHHHhhhhhhccC-CC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  11111100      01111222222211 12   24566778889999999999999999876

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-36  Score=306.71  Aligned_cols=269  Identities=23%  Similarity=0.335  Sum_probs=198.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~LV  258 (520)
                      ++|+..+.||.|+||.||+|....+++.+|+|.+.....  .....+.+|+.++++++||||+++++++.... ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            478888999999999999999988899999999975432  22345678999999999999999999887652 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+. ++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            99997 59999887642      36899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhh-------hh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWA-------KP  409 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~-------~~  409 (520)
                      ........  .....+++.|+|||++.+.. ++.++||||||+++|||++|..||.......... +....       ++
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            76543211  23345788999999987654 6899999999999999999999997543321110 00000       00


Q ss_pred             Hhhhch----hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHRGM----AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~~~----~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+....    ..........+............+.+++.+||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000000    00000000000000000002345678889999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=304.96  Aligned_cols=209  Identities=28%  Similarity=0.447  Sum_probs=171.8

Q ss_pred             CcccceEEcccCceEEEEeeecC--CCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~  256 (520)
                      +|+..+.||+|+||.||+|....  .+..||+|.+....   ......+.+|+.+++.++||||+++++++.+.. ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788899999999999999987  78999999997632   333456788999999999999999999987752 4589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC----CCceEEe
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----KKIPKLC  332 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~----~~~vkL~  332 (520)
                      +||||+++ +|.+++......  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.    ++.+||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99999964 777777543221  1136899999999999999999999888   999999999999999    9999999


Q ss_pred             ecCCccccCCCCC-CcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          333 DFGLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       333 DFGla~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      |||++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            9999986644322 1122345688999999988764 578999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-36  Score=306.74  Aligned_cols=267  Identities=22%  Similarity=0.309  Sum_probs=196.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-------  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-------  252 (520)
                      ++|+..+.||+|+||.||+|....+++.||||.+....  ......+.+|+.++++++||||++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999998889999999986432  222345668999999999999999999886543       


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ...++||||+. ++|.+.+....      ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEEC
Confidence            23589999995 58888876532      46899999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCC--cccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          333 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       333 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |||++.........  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...........+.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999865432211  1122345788999999886653 68899999999999999999999976543221111111000


Q ss_pred             -----Hhhhch--hHHH---------HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 -----ILHRGM--AAVE---------ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 -----~~~~~~--~~l~---------~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           ......  ....         ..+...+.    .......+.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLK----PYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcc----cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 000000  0000         00000000    0001234668999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-36  Score=304.87  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|...+.||+|+||.||++....+++.||+|.+.... ......+.+|+.++.++. ||||+++++++... ...+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEEEe
Confidence            5666778999999999999998889999999987543 344567889999999996 99999999988764 45789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+. ++|.++......  .....+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~-~~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          84 LMD-ISLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccc-CCHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            985 466554432110  0125699999999999999999999974 5   99999999999999999999999999976


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC---CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ......   .....|+..|+|||++.+.   .++.++|||||||++|||++|+.||.....     ........      
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~------  223 (288)
T cd06616         158 LVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV------  223 (288)
T ss_pred             hccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh------
Confidence            543221   1234588999999999776   689999999999999999999999975321     10000000      


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .....+.+... ........+.+++.+||+.+|++|||+.+|++
T Consensus       224 --~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         224 --VKGDPPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --cCCCCCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00011122111 11123346778889999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=296.58  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=197.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-----chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~  255 (520)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999999888999999987532     2334567889999999999999999999876653 357


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|+||+++++|.+++...       ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccc
Confidence            8999999999999998753       45889999999999999999999887   9999999999999999999999999


Q ss_pred             CccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------
Confidence            99865321110 11123458999999999988889999999999999999999999997432110               


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .+......... +.........+.+++.+|++ +|.+||+..+++.
T Consensus       217 --~~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         217 --AIFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --HHHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              01111100000 00111223456777889999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-37  Score=318.72  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecC--cchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcE
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  255 (520)
                      ...+.|++.+.||.||.+.||++...+ .+.||+|++..  .+.+...-|.+|+.+|.+|+ |.+||.|++|= -+++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-v~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-VTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-ccCceE
Confidence            345789999999999999999998865 55677776643  24556778999999999995 89999999984 457789


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      |+||||= ..+|...|.....     ....| .++.++.|++.|+.++|..+   |||.||||.|+|+- .|.+||+|||
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~-----~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS-----IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC-----CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeec
Confidence            9999976 6699999987642     23335 67789999999999999988   99999999999885 4789999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccC-----------CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----------KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      +|.....+.+.....+-+||+.||+||.+...           +.+.++||||+|||||+|+.|++||..-..       
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------  577 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------  577 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------
Confidence            99988877766666777899999999998543           257899999999999999999999974221       


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                               ....+..+.||....+......-..+++++..||..||.+||++.++++
T Consensus       578 ---------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 ---------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ---------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                     1125667788855333222223334889999999999999999999987

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-36  Score=308.43  Aligned_cols=270  Identities=23%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~L  257 (520)
                      .++|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+.++++++|+||+++++++.+.. ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            3589999999999999999999988899999999864422  22234668999999999999999999876543 45799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        86 v~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             EEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcccee
Confidence            999996 58888887532      56899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh-hhch
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL-HRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-~~~~  415 (520)
                      .........  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....... ....
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            876543211  122346788999999865 457899999999999999999999997544322111110000000 0000


Q ss_pred             hHHHHhh---CcccCCCC--C----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELL---DPRLKCTS--R----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~---d~~l~~~~--~----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+...-   ...+....  .    .......+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000   00000000  0    0011345678899999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-36  Score=298.83  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=195.9

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||.|+||.||++....+++.||+|.+.....   .....+.+|+++++.++||||+++++.+.. +...++|+||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999988899999999976533   455678899999999999999999987655 456899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC-
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV-  345 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~-  345 (520)
                      |.+++...       ..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          80 LASLLENV-------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             HHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            99999764       36899999999999999999999887   99999999999999999999999999875543311 


Q ss_pred             -----CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          346 -----PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       346 -----~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                           ........++..|+|||.+.....+.++||||||+++|||++|..||.......   .              ...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~--------------~~~  212 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---I--------------FQN  212 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---H--------------HHH
Confidence                 011233458889999999988889999999999999999999999997543221   0              011


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      +.......+... .....+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       213 ~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         213 ILNGKIEWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HhcCCcCCCccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            111111111110 11345678889999999999999977777665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.4e-36  Score=299.32  Aligned_cols=269  Identities=21%  Similarity=0.318  Sum_probs=197.7

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|+..+.||.|++|.||+|....++..||+|.+..... .....+.+|++++++++||||+++++++.+. +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEec
Confidence            57888999999999999999988899999999876532 2345677899999999999999999998775 457999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++ +|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....
T Consensus        80 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          80 MDK-DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             CCc-cHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            975 88888865431    246899999999999999999999887   9999999999999999999999999997554


Q ss_pred             CCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchh-hHHhhhhHhhhchhHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN-LVLWAKPILHRGMAAVE  419 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~~~~~l~  419 (520)
                      ....  ......++..|++||++.+. .++.++|||||||++|||++|+.||......+... ...............+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  11234578899999998654 56889999999999999999999997654322111 00000000000000000


Q ss_pred             Hh--hCcccCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 EL--LDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~--~d~~l~~~------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..  +.......      ...+.....+.+++.+|++.+|.+||++.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00  00000000      000112345678889999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.2e-36  Score=296.20  Aligned_cols=241  Identities=26%  Similarity=0.341  Sum_probs=194.0

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||.|+||.||+|....+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++ ..+++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence            699999999999998889999999987542   23456788999999999999999999987665 45899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          80 LWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             HHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            99999764       45899999999999999999999877   9999999999999999999999999998765432  


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC--c
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD--P  424 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d--~  424 (520)
                       ......|+..|+|||.+....++.++|+||||+++|+|++|..||.......    ..           ....+.+  .
T Consensus       148 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-----------~~~~~~~~~~  211 (262)
T cd05572         148 -KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-----------IYNDILKGNG  211 (262)
T ss_pred             -ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-----------HHHHHhccCC
Confidence             1223468899999999988889999999999999999999999997654211    00           1111111  1


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ....+...   ...+.+++.+||+.+|++||+     +.|+++
T Consensus       212 ~~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 KLEFPNYI---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCccc---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11111111   346788889999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=300.46  Aligned_cols=268  Identities=21%  Similarity=0.316  Sum_probs=198.1

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV~E  260 (520)
                      |...+.||+|+||.||+|....+++.||+|++....  ......+.+|+++++.++|||++++++++.+. ....++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999998889999999997653  33446788999999999999999999998765 256899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++ +|.+++....      ..+++..++.++.|+++||+|||+.+   ++|+||||+|||+++++.+||+|||++...
T Consensus        81 ~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          81 YMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             cccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            9974 8888886532      46899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh-hhhHhhhchhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-AKPILHRGMAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~~~~~~~~~l  418 (520)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. ...........+
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            543311 1233457888999998764 4578999999999999999999999976443211110000 000000000000


Q ss_pred             H-----HhhCcccCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 E-----ELLDPRLKCTS-----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~-----~~~d~~l~~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .     ....+......     ........+++++.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0     00000000000     00001356789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4e-36  Score=294.75  Aligned_cols=250  Identities=25%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|+||.||++....++..+|+|.+...  .......+.+|+.+++.++||||+++++++.+. ...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence            477889999999999999999888899999998754  234456788999999999999999999987765 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....   ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          80 YAPFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             hcCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            9999999999876322   1256899999999999999999999888   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ....    .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......   +..              .
T Consensus       154 ~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~--------------~  212 (256)
T cd08530         154 KKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRY--------------K  212 (256)
T ss_pred             ccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH--------------H
Confidence            5431    223458899999999998889999999999999999999999997543211   100              0


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +......  .........+.+++.+|++.+|++||++.++++
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         213 VQRGKYP--PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HhcCCCC--CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0011111  111233456888999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-36  Score=304.56  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ...||+|+||.||++....++..||+|.+..........+.+|+.+++.++||||+++++++... +..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCc
Confidence            35799999999999999888999999998765555567788999999999999999999988765 45899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++..        ..+++.....++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus       104 L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         104 LTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             HHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            9988753        35899999999999999999999887   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......|+..|+|||++....++.++|||||||++|||++|..||.......   ...           .+...+.+.+
T Consensus       172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~-----------~~~~~~~~~~  236 (292)
T cd06657         172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK-----------MIRDNLPPKL  236 (292)
T ss_pred             -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-----------HHHhhCCccc
Confidence             1233568899999999988889999999999999999999999987532211   000           1111122222


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....   .....+.+++.+||+.+|.+||++.+|++
T Consensus       237 ~~~~---~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 KNLH---KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCcc---cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1111   12234667788999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.2e-36  Score=302.05  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=184.8

Q ss_pred             EEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHH---HhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIA---SSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +||+|+||.||++....+++.||+|.+.+...   .....+.+|..++   ...+||||+.+++++... +..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecC
Confidence            48999999999999988899999998865421   1222334444433   345799999999887664 4589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.....
T Consensus        80 ~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          80 NGGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999988753       46999999999999999999999988   99999999999999999999999999875543


Q ss_pred             CCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ..    .....||..|+|||.+.+ ..++.++|||||||++|||++|..||..........+    .    .    ....
T Consensus       150 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~----~----~~~~  213 (279)
T cd05633         150 KK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----D----R----MTLT  213 (279)
T ss_pred             cC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----H----H----Hhhc
Confidence            22    123468999999999864 4578999999999999999999999975432211110    0    0    0001


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  463 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~~  463 (520)
                      .+..+.  .   .....+.+++.+||+.+|++||     +++++++.
T Consensus       214 ~~~~~~--~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 VNVELP--D---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCcCCc--c---ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            111111  1   1224566778899999999999     59888773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.7e-36  Score=292.03  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=204.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|...+.||.|+||.||++....++..||+|++.....  ...+.+..|+++++.++|||++++++.+... ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence            47788999999999999999988899999999976532  5567788999999999999999999987765 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++.....   ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          80 YADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             ecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence            9999999999986431   1257999999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ....  .......|++.|+|||.+....++.++||||+|+++|+|++|+.||.......   +              ...
T Consensus       154 ~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~--------------~~~  214 (258)
T cd08215         154 SSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L--------------ALK  214 (258)
T ss_pred             ccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H--------------HHH
Confidence            5432  12234568899999999988889999999999999999999999996543211   0              011


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+...  .......+.+++.+||..+|++|||+.++++
T Consensus       215 ~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         215 ILKGQYPPI--PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HhcCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111111100  0112245778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-36  Score=310.86  Aligned_cols=271  Identities=23%  Similarity=0.319  Sum_probs=198.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC-CcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~-~~~~  256 (520)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++++ +||||++++++|...+ ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788999999999999999999878899999988542  233445677899999999 9999999999876543 3579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||++ ++|..++..        ..++|..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        86 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          86 LVFEYME-TDLHAVIRA--------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             EEecccc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence            9999996 599888864        35889999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCC---cccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh-
Q 010012          337 ATWTSAPSVP---FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL-  411 (520)
Q Consensus       337 a~~~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-  411 (520)
                      +.........   .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9866443221   12233468999999998765 457889999999999999999999996543221111000000000 


Q ss_pred             ----hhch-hHHHHhhCcccCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          412 ----HRGM-AAVEELLDPRLKCT-----SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       412 ----~~~~-~~l~~~~d~~l~~~-----~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                          .... .....+++......     .........+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                0000 00011111000000     0001123457888999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-36  Score=319.48  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=205.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-C-----CCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-H-----PNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~g~~~~~~~~~~  256 (520)
                      +|.+.+.||+|.||.|.+|.+..+++.||||+++... .-..+-..|+.+|..|+ |     -|+|++++|+...+ .+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-cee
Confidence            6788999999999999999999999999999998654 34456668999999997 3     48999999987654 589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC--CceEEeec
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDF  334 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~--~~vkL~DF  334 (520)
                      ||+|.+ .-+|.++|+....     ..++...++.|+.||+.||..||+.+   |||+||||+||||.+-  ..|||+||
T Consensus       265 iVfELL-~~NLYellK~n~f-----~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKF-----RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence            999999 6699999998654     67999999999999999999999888   9999999999999754  47999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh-----
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP-----  409 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~-----  409 (520)
                      |.|......-    . +...+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|.+....++...+.-+.-     
T Consensus       336 GSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  336 GSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             ccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            9998765432    2 45578889999999999999999999999999999999988887766544333321110     


Q ss_pred             HhhhchhHHHHhhCc-------------------------------ccCCC-------CC-CHHHHHHHHHHHHHccccC
Q 010012          410 ILHRGMAAVEELLDP-------------------------------RLKCT-------SR-NSAQIARVIQAAAACISSE  450 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~-------------------------------~l~~~-------~~-~~~~~~~l~~la~~Cl~~d  450 (520)
                      ++..+. .....++.                               ....+       .. .......+++++.+||..|
T Consensus       411 mL~~~~-~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  411 MLDTAK-KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHhcc-ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence            011000 00000100                               00001       01 1134467899999999999


Q ss_pred             CCCCCCHHHHHH
Q 010012          451 ESRRPGIEEIIA  462 (520)
Q Consensus       451 P~~RPtm~eVl~  462 (520)
                      |.+|+|..+.++
T Consensus       490 P~~R~tp~qal~  501 (586)
T KOG0667|consen  490 PAERITPAQALN  501 (586)
T ss_pred             chhcCCHHHHhc
Confidence            999999999987

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-36  Score=302.85  Aligned_cols=270  Identities=21%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCC----c
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ----G  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~----~  254 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|.+.....  .....+.+|+.+++.+. ||||+++++++...+.    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368889999999999999999988899999998865422  23356788999999995 6999999998765433    2


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEee
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  333 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~D  333 (520)
                      .++||||+++ +|.+++......  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence            6899999975 898888764321  1246899999999999999999999887   999999999999998 89999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||++.........  .....+++.|+|||++.+ ..++.++|||||||++|||++|..||.......  .+..... .+.
T Consensus       155 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~  229 (295)
T cd07837         155 LGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLG  229 (295)
T ss_pred             cccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhC
Confidence            9998765432211  122347889999998865 457899999999999999999999997533211  0000000 000


Q ss_pred             hch----hHHHHhh----CcccCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGM----AAVEELL----DPRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~----~~l~~~~----d~~l~~~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...    .......    -+.....   ...+.....+.+++.+||..+|.+||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000    0000000    0000000   000112345778889999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=299.55  Aligned_cols=267  Identities=21%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      |+..+.||.|++|.||+|....++..||+|++....  ......+.+|+++++.++|||++++++++.+. ...++||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence            567789999999999999998889999999987543  22335688899999999999999999998765 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      + +++|.+++.....     ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        80 ~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          80 L-DLDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             c-CcCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            9 4689999876431     36899999999999999999999887   9999999999999999999999999997654


Q ss_pred             CCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHhhhhHhhh---chh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPILHR---GMA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~---~~~  416 (520)
                      .....  .....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ............   ...
T Consensus       151 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         151 VPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             CCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence            32211  1223468899999988664 4688999999999999999999999754321110 000000000000   000


Q ss_pred             HHHHhhC--cccCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLD--PRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d--~~l~~---~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.+...  +....   ..........+.+++.+|++.+|.+|||+.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000  00000   0000111245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=291.91  Aligned_cols=248  Identities=30%  Similarity=0.476  Sum_probs=201.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|+..+.||+|++|.||++.....++.||+|.+.....  .....+.+|++++++++|||++++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence            47788999999999999999988889999999977643  4567889999999999999999999987664 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          80 YAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             cCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999999998754       46899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ......  .....++..|+|||......++.++||||+|+++|+|++|+.||.......    ..+.          ...
T Consensus       150 ~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~----------~~~  213 (254)
T cd06627         150 NDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFR----------IVQ  213 (254)
T ss_pred             CCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHH----------Hhc
Confidence            543321  233468899999999988888999999999999999999999997432110    0000          000


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.+  +.   .....+.+++.+||..+|++||++.+++.
T Consensus       214 ~~~~~~--~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 DDHPPL--PE---GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             cCCCCC--CC---CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            001111  11   12345678889999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-36  Score=312.49  Aligned_cols=268  Identities=22%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----Cc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~  254 (520)
                      .++|...+.||+|+||+||+|....+++.||||.+...  .......+.+|+.+++.++||||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999888999999998653  2334456778999999999999999999876443    23


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++|+||+. ++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcC
Confidence            799999995 7898888643       46999999999999999999999887   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH-hhhhHhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL-WAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~-~~~~~~~  412 (520)
                      |++.......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||............. .......
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9998664432  12234458899999998865 468999999999999999999999997543211110000 0000000


Q ss_pred             hc-----hhHHHHhh-------CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          413 RG-----MAAVEELL-------DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       413 ~~-----~~~l~~~~-------d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ..     .......+       ++.+.  .........+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00     00000000       00000  0011123457789999999999999999999974

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-36  Score=303.00  Aligned_cols=269  Identities=20%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|++|+||+|....+++.||+|.+....  ......+.+|+++++.++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence            47888999999999999999998889999999986542  22345688899999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~  338 (520)
                      ||++ ++|.+++.....     ..+++..+..++.||+.||+|||+.+   |+||||+|+||+++. ++.+||+|||++.
T Consensus        81 e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             eccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccc
Confidence            9995 588888754321     34688888899999999999999887   999999999999985 5679999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH-Hhh-hhHhh--h
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-LWA-KPILH--R  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv-~~~-~~~~~--~  413 (520)
                      .......  ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||......+..... ... .+...  .
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  229 (294)
T PLN00009        152 AFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP  229 (294)
T ss_pred             ccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            6543221  12334578899999998664 5789999999999999999999999754322111000 000 00000  0


Q ss_pred             chhHHHHhhC--cccCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLD--PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d--~~l~~~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +...+.....  +.....   .........+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000000  000000   000112234678889999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=296.02  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=188.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHH-HHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||.||+|....+++.||+|.+.+...   .....+..|..+ ....+|||++++++++... ...++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccC
Confidence            468999999999999988899999999875432   222334455444 4456899999999988664 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++......
T Consensus        81 ~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  150 (260)
T cd05611          81 GGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN  150 (260)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc
Confidence            99999999753       46899999999999999999999887   999999999999999999999999998754331


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhC
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLD  423 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d  423 (520)
                            ....|+..|+|||.+.+..++.++||||||+++|||++|..||........      ...+. .      ...+
T Consensus       151 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~------~~~~  211 (260)
T cd05611         151 ------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNIL-S------RRIN  211 (260)
T ss_pred             ------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-h------cccC
Confidence                  234588899999999888889999999999999999999999975432110      00000 0      0000


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       424 ~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                        .. ..........+.+++.+||+.+|++||++.++.+.|.
T Consensus       212 --~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         212 --WP-EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             --CC-CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence              00 0001112345778889999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.4e-36  Score=301.80  Aligned_cols=252  Identities=25%  Similarity=0.437  Sum_probs=193.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||.||+|....+++.||||.+.... ......+..|+.++.+.. ||||++++++|.+. ...++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEEe
Confidence            57888999999999999999998889999999997543 234456677777666664 99999999998774 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||+. ++|.+++....      ..+++..+..++.|++.||.|||+ .+   |+||||+|+||++++++.+||+|||++.
T Consensus        94 e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          94 ELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             eccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccch
Confidence            9984 57777765532      469999999999999999999997 35   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCC----CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      .......   .....++..|+|||.+....    ++.++||||||+++|||++|+.||...... ..             
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~-------------  226 (296)
T cd06618         164 RLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FE-------------  226 (296)
T ss_pred             hccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HH-------------
Confidence            6543221   12335788999999987553    788999999999999999999999642211 00             


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                        .+..+++...............+.+++.+||+.+|.+||++.+|++.
T Consensus       227 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         227 --VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              11111111111000011123457788899999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-36  Score=311.26  Aligned_cols=263  Identities=20%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----Cc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~  254 (520)
                      .+|...+.||+|+||.||+|....+++.||+|++....  ......+.+|+.+++.++||||+++++++....     ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            78999999999999999999988889999999986532  223456789999999999999999999876432     23


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++|+||+. .+|..++.         ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             EEEEecccc-cCHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence            589999996 46766542         35899999999999999999999887   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh----
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP----  409 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~----  409 (520)
                      |+++......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....    
T Consensus       162 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         162 GLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             CCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9987653321     23457889999999876 4688999999999999999999999976432111111000000    


Q ss_pred             -Hhhhchh-HHHHhhC--cccCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 -ILHRGMA-AVEELLD--PRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 -~~~~~~~-~l~~~~d--~~l~~~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ....... .....++  +.....   ...+.....+.+++.+||+.+|.+||++.+|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0000000 0000000  000000   000012245778999999999999999999986

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=304.90  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=206.3

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      -|++..+||+|+||.||++.++.+|..+|+|.+..+  ...+++..|+.|+++.+.|++|++||.++...+ +++|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhhc
Confidence            478888999999999999999999999999999765  356789999999999999999999998877544 89999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      -.|++.+.+..++      .+|++..+..|+...++||+|||...   -||||||..||||+.+|++||+|||.|-.+..
T Consensus       111 GAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  111 GAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             CCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence            9999999998754      68999999999999999999999877   89999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      .-  ..-.++.||+.|||||++..-.|..++||||+|++..||..|++||..-.+                    ++.++
T Consensus       182 TM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--------------------MRAIF  239 (502)
T KOG0574|consen  182 TM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--------------------MRAIF  239 (502)
T ss_pred             hH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--------------------cceeE
Confidence            32  123567899999999999999999999999999999999999999975332                    11111


Q ss_pred             C-cccCCC-CCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          423 D-PRLKCT-SRNSA-QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       423 d-~~l~~~-~~~~~-~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      - |.-..+ ...++ -...+.+++..||-+.|++|-|+.++++
T Consensus       240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            0 100111 11222 2356889999999999999999998876

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=317.25  Aligned_cols=245  Identities=27%  Similarity=0.406  Sum_probs=199.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|+..+.||.|+||.||-|++..+...||||++.-..   .+..++++.|+..|.+++|||+|.+.|+|.. +...+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHH
Confidence            5777889999999999999999889999999986543   4456789999999999999999999998766 44579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||| -||-.++|.-.+      .++.+..+..|..+.+.||.|||+.+   .||||||..||||.+.|.|||+|||.|..
T Consensus       106 EYC-lGSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHH-hccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence            999 568888887654      57889999999999999999999998   99999999999999999999999999977


Q ss_pred             cCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ....      .+++||+.|||||++.   .|.|+-|+||||+||+-.||.-.++|+-..+.       ..+..       
T Consensus       176 ~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALY-------  235 (948)
T KOG0577|consen  176 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALY-------  235 (948)
T ss_pred             cCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHH-------
Confidence            6543      4678999999999985   46899999999999999999999999754321       01111       


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+..--.|.|..    ..-...|..++..||++-|.+|||..++++
T Consensus       236 HIAQNesPtLqs----~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  236 HIAQNESPTLQS----NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHhcCCCCCCC----chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            111112233331    122344666677899999999999988776

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=295.53  Aligned_cols=265  Identities=24%  Similarity=0.289  Sum_probs=194.5

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhC---CCCCeecEEEEEEcCCC----c
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQ----G  254 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~----~  254 (520)
                      |+..+.||+|+||.||+|....+++.||+|++.....  .....+.+|+.+++++   +||||+++++++.+.+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999987889999999974322  2234566777776655   69999999999876543    3


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .+++|||+. ++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEecc
Confidence            789999996 589888875432     35899999999999999999999987   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      |++........   .....++..|+|||++.+..++.++|||||||++|||++|++||......+  .+...........
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~  226 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPS  226 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCC
Confidence            99987654321   123357889999999998899999999999999999999999987543221  1111100000000


Q ss_pred             hhH-------HHHhhCcccCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAA-------VEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~-------l~~~~d~~l~~--~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...       ...........  ..........+.+++.+||+.+|.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000       00000000000  0001122356678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.2e-36  Score=306.14  Aligned_cols=270  Identities=23%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ++...+++|+..+.||.|+||.||+|....++..||+|++.+.  .....+.+..|+.+++.++||||+++.+++.....
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3445778999999999999999999999888999999988643  22345677889999999999999999998877666


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++|+||+ +++|.+++..        ..+++.....++.|+++||.|||+.+   |+||||+|+|||+++++.+||+|
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence            789999998 6789888753        45788888999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHhhhhHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLWAKPIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~  411 (520)
                      ||++.......     ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+........
T Consensus       152 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  226 (328)
T cd07856         152 FGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP  226 (328)
T ss_pred             cccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99987543321     23457889999998866 46899999999999999999999999754321110 0000000000


Q ss_pred             hhch-----hHHHHhhCc-ccCCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGM-----AAVEELLDP-RLKCTSRN----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~-----~~l~~~~d~-~l~~~~~~----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+..     ....+++.. ........    ......+.+++.+||+.+|++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000     000000000 00000000    011246778889999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=300.33  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      -++|...++||+|.||.|-+++.+.+++.||+|+++++   .++....-+.|-.+|+..+||.+..|... ++...++|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-FQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-FQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-hccCceEEE
Confidence            47899999999999999999999999999999999876   33444555678899999999998888654 455677999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||..||.|.-+|.+.       ..+++...+.+-..|+.||.|||+.+   ||+||||.+|+|||.+|++||+||||+
T Consensus       246 VMeyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             EEEEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccc
Confidence            99999999999999764       56888888899999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.--..  .....+.+||+.|+|||++....|+.++|||.+|||+|||++|+.||...+....-.+              
T Consensus       316 KE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL--------------  379 (516)
T KOG0690|consen  316 KEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL--------------  379 (516)
T ss_pred             hhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH--------------
Confidence            843221  1134678899999999999999999999999999999999999999986544321111              


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG  456 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt  456 (520)
                         ++-..+..+.....+.   ..++...|.+||.+|..
T Consensus       380 ---Il~ed~kFPr~ls~eA---ktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  380 ---ILMEDLKFPRTLSPEA---KTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ---HHhhhccCCccCCHHH---HHHHHHHhhcChHhhcC
Confidence               1111222232233443   34556789999999964

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.5e-36  Score=302.87  Aligned_cols=272  Identities=21%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----  253 (520)
                      .++|+..+.||+|+||.||+|....+++.||+|++.....  .....+.+|+++++.++||||+++++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999988899999999864322  123456789999999999999999998765433     


Q ss_pred             --cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          254 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       254 --~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                        .+++|+||+.+ +|...+....      ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence              36899999964 6777775432      46999999999999999999999888   999999999999999999999


Q ss_pred             eecCCccccCCCCCC---------cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccch
Q 010012          332 CDFGLATWTSAPSVP---------FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE  401 (520)
Q Consensus       332 ~DFGla~~~~~~~~~---------~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~  401 (520)
                      +|||++.........         .......+++.|+|||.+.+. .++.++|||||||++|||++|++||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999765432211         111234578899999988654 5789999999999999999999999754432211


Q ss_pred             hhHHhhhhHh-h---hchhHHHHhhCccc--CCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          402 NLVLWAKPIL-H---RGMAAVEELLDPRL--KCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       402 ~lv~~~~~~~-~---~~~~~l~~~~d~~l--~~~~~----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+....... .   .....+....+...  ..+..    .......+.+++.+||+.+|++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1110000000 0   00000000000000  00000    0111246788999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.2e-36  Score=310.98  Aligned_cols=270  Identities=20%  Similarity=0.313  Sum_probs=199.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC---CCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~~~  256 (520)
                      ++|+..+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.+++.++||||+++++++...   ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999999889999999987542  23456677899999999999999999876532   23578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+. |+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccc
Confidence            9999995 6898888643       45899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCC--cccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-h----
Q 010012          337 ATWTSAPSVP--FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-K----  408 (520)
Q Consensus       337 a~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~----  408 (520)
                      +.........  .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...........+... .    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~  233 (334)
T cd07855         154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE  233 (334)
T ss_pred             ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence            9765432211  11223468999999999865 45889999999999999999999999754332111110000 0    


Q ss_pred             hHhhh-chhHHHHhhCcccCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHR-GMAAVEELLDPRLKCTSR-----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~-~~~~l~~~~d~~l~~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.. ....+.+..+..-.....     .......+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00000 000111111100000000     0112456788999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.4e-36  Score=300.82  Aligned_cols=269  Identities=24%  Similarity=0.301  Sum_probs=197.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----  252 (520)
                      ..++|+..+.||+|+||.||+|....+++.||+|++....  ......+.+|+++++.++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999998889999999996542  223356778999999999999999999886543     


Q ss_pred             ----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          253 ----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       253 ----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                          ..+++|+||+++ +|..++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~  154 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence                258999999976 7777776432      46899999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||++........ .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........  +.. .
T Consensus       155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~-~  230 (302)
T cd07864         155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LEL-I  230 (302)
T ss_pred             EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-H
Confidence            99999999986654321 111223467889999988653 578999999999999999999999975432211  100 0


Q ss_pred             hhHhhhc-hhHHHHh--------hCcccCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 KPILHRG-MAAVEEL--------LDPRLKCT----SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 ~~~~~~~-~~~l~~~--------~d~~l~~~----~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....... ......+        .++.-...    .........+.+++..||+.+|.+||++.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000 0000000        00000000    000011245778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-36  Score=308.49  Aligned_cols=272  Identities=21%  Similarity=0.272  Sum_probs=200.4

Q ss_pred             HHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC
Q 010012          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (520)
Q Consensus       174 ~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~  251 (520)
                      ..++...+++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667899999999999999999999988889999999997542  23345678899999999999999999987542


Q ss_pred             C-----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          252 E-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       252 ~-----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      .     ...+++++++ +++|.+++..        ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~  156 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED  156 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence            2     2367888877 8899888754        35899999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH-
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV-  404 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv-  404 (520)
                      +.+||+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+ 
T Consensus       157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (345)
T cd07877         157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  231 (345)
T ss_pred             CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998765332     123458899999999866 46889999999999999999999999653322111100 


Q ss_pred             Hhhh----hHhhhc----hhHHHHhhCcccCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          405 LWAK----PILHRG----MAAVEELLDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       405 ~~~~----~~~~~~----~~~l~~~~d~~l~~--~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....    ......    .......+......  ..........+.+++.+|++.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0000    000000    00000000000000  0000011235778899999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.3e-36  Score=297.82  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=200.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++...   .......+..|++++++++ ||||+++++++.. +...++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            4788899999999999999999888999999998753   2234467888999999998 9999999998755 456899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          80 VLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccc
Confidence            99999999999999763       46999999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCC------------------cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcccc
Q 010012          338 TWTSAPSVP------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  399 (520)
Q Consensus       338 ~~~~~~~~~------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~  399 (520)
                      .........                  .......++..|+|||.+....++.++||||||+++++|++|+.||.......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            866543211                  11223457899999999988889999999999999999999999998543110


Q ss_pred             chhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 010012          400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI----EEIIA  462 (520)
Q Consensus       400 ~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm----~eVl~  462 (520)
                                       ....+.+.....+..   ....+.+++.+||+.+|.+||++    .++++
T Consensus       230 -----------------~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 -----------------TFQKILKLEYSFPPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -----------------HHHHHHhcCCCCCCc---cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                             011111111111111   13457788899999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=298.44  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=198.5

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      |...+.||+|++|.||+|....+++.+++|.+.....  .....+..|+++++.++||||+++++++.+. ...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence            4567889999999999999988899999999875432  2456788899999999999999999987765 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++ +|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||.+....
T Consensus        80 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          80 MDT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             cCC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            965 8888887642      46899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc----hh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----MA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~----~~  416 (520)
                      ....  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....   ....+...    ..
T Consensus       150 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  224 (283)
T cd05118         150 SPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWP  224 (283)
T ss_pred             CCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcc
Confidence            4331  12234578899999998776 789999999999999999999999975443211100   00000000    00


Q ss_pred             HHHH--------hhCccc-CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEE--------LLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~--------~~d~~l-~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.+        ..+... ............+.+++..||+.+|.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000        000000 000001123456889999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-35  Score=296.31  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=188.9

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||+||++....+++.||+|.+....   ......+..|+++++.++||||+++++++... +..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence            689999999999998889999999986532   22345667899999999999999999887654 45899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++.......  
T Consensus        80 L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  149 (277)
T cd05577          80 LKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--  149 (277)
T ss_pred             HHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence            9999976432     46899999999999999999999887   9999999999999999999999999987654322  


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......++..|+|||++.+..++.++|||||||++|+|++|+.||..........      .+.       ........
T Consensus       150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-------~~~~~~~~  215 (277)
T cd05577         150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------ELK-------RRTLEMAV  215 (277)
T ss_pred             -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------HHH-------hccccccc
Confidence             1233458889999999988889999999999999999999999997543211100      000       00000011


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEE  459 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~e  459 (520)
                      ..+.   .....+.+++.+||+.+|.+||+..+
T Consensus       216 ~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         216 EYPD---KFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCc---cCCHHHHHHHHHHccCChhHccCCCc
Confidence            1111   12335678889999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-35  Score=295.37  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=187.9

Q ss_pred             hhCCcccceEE--cccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh-CCCCCeecEEEEEEcCCCcEE
Q 010012          180 ATHNFSKGRVL--GRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~L--G~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      -.++|...+.+  |+|+||.||++....++..+|+|.+........     |+..... .+||||+++++++...+ ..+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~-~~~   85 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK-GHV   85 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC-eeE
Confidence            34566666665  999999999999988899999999865422111     2222222 27999999999887754 589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFG  335 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFG  335 (520)
                      +||||+++|+|.+++...       ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||
T Consensus        86 iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            999999999999999753       36999999999999999999999888   99999999999999998 99999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++.......      ...|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....+.        
T Consensus       156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~--------  220 (267)
T PHA03390        156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL--------  220 (267)
T ss_pred             cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH--------
Confidence            987654322      2358999999999998899999999999999999999999997433221 1111111        


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-m~eVl~  462 (520)
                          ..........   ......+.+++.+||+.+|.+||+ +.++++
T Consensus       221 ----~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 ----KRQQKKLPFI---KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----HhhcccCCcc---cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                1111111111   123345777888999999999996 688874

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-35  Score=300.15  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=194.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..|+..+.||+|+||.||+|....++..||+|.+...   .....+++.+|+++++.++|||++++++++... ...++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEE
Confidence            3577778899999999999999888899999998642   233456788999999999999999999998775 457899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+. |+|.+.+....      ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        94 ~e~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          94 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             EEccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence            99996 68877775432      45899999999999999999999887   9999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .....      ....|+..|+|||++.   .+.++.++|||||||++|||++|..||........  +.           
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~-----------  224 (308)
T cd06634         164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-----------  224 (308)
T ss_pred             eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HH-----------
Confidence            65432      2345888999999974   35678899999999999999999999864321110  00           


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                       .+.....+...    .......+.+++.+||+.+|.+||++.+|++.
T Consensus       225 -~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         225 -HIAQNESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -HHhhcCCCCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             00000111111    11223456788899999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=296.00  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEe
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      |+..+.||+|++|+||+|....+++.||+|++..... .......+|+..+++++ ||||+++++++.+ +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            5667899999999999999988889999999865422 22334557999999999 9999999998877 4558999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      + +|+|.+++.....     ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          80 M-EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             C-CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            9 8899998876431     46899999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhh-HHhhh----hHhhhch
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAK----PILHRGM  415 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~l-v~~~~----~~~~~~~  415 (520)
                      ....   .....++..|+|||++.. ..++.++||||||++++||++|+.||......+.... .....    ..+..+.
T Consensus       151 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07830         151 SRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY  227 (283)
T ss_pred             CCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence            3221   223458889999998854 4578999999999999999999999965433211100 00000    0000000


Q ss_pred             hHHHHhhCcccCCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTS------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .+...++..+....      ........+.+++.+||+.+|++|||+.||+.
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         228 -KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             -hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             00011111110000      00011356889999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-35  Score=295.58  Aligned_cols=242  Identities=26%  Similarity=0.370  Sum_probs=185.5

Q ss_pred             EEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHH---HHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCREL---MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~---~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +||+|+||.||+|....+++.||+|.+.....   .....+..|.   .+++..+||||+++++++.+. ...++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence            48999999999999988889999999865421   1122233443   344556899999999887654 4589999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          80 NGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999999988643       46999999999999999999999887   99999999999999999999999999876543


Q ss_pred             CCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ..    .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||...........    .        .....
T Consensus       150 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~--------~~~~~  213 (278)
T cd05606         150 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----D--------RMTLT  213 (278)
T ss_pred             cC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----H--------HHhhc
Confidence            22    1234689999999999755 589999999999999999999999976432211110    0        00001


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      .++.+.  .   .....+.+++.+|+..+|.+||     ++.++++
T Consensus       214 ~~~~~~--~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 MAVELP--D---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCCCCC--C---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            111121  1   1134577888899999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=319.90  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=198.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecC----cchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-cEEEEEEe
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIYKY  261 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~~LV~E~  261 (520)
                      ..+||+|+|-+||+|.+..+|..||--.++.    ......++|..|+.+|+.|+|||||+++.++.+..+ .+.+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            3579999999999999988898888654432    234556889999999999999999999999887654 36799999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~~~  340 (520)
                      +..|+|..|+.+.       ..++.+....|++||++||.|||++. +||||||||..||+|+. -|.|||+|.|||+..
T Consensus       125 ~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  125 FTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             ccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            9999999999886       45888999999999999999999986 78999999999999985 589999999999987


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ....    ...+.|||.|||||... ..|++.+||||||+.++||+|+.-||..-....+         +..+    +..
T Consensus       197 r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ---------IYKK----V~S  258 (632)
T KOG0584|consen  197 RKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ---------IYKK----VTS  258 (632)
T ss_pred             hccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH---------HHHH----HHc
Confidence            6543    35578999999999986 7899999999999999999999999986543321         1111    111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA--ILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~--~L~~  466 (520)
                      -+.|.--    .......+.+++.+||.. .++|||+.|+|.  .|..
T Consensus       259 GiKP~sl----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  259 GIKPAAL----SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             CCCHHHh----hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            1111100    011112455677899999 999999999997  4444

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=319.13  Aligned_cols=249  Identities=29%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             CcccceEEcccCceEEEEeeecCC---CcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .....++||+|.||+|++|.+...   ...||||.+..+... ...+|++|+.+|-+|+|||+|+|||+..+  ....+|
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV  188 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMV  188 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHH
Confidence            445567899999999999998642   346999999776543 67899999999999999999999999776  347899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +|.++.|+|.+.|++..+     ..|.......++.|||.|+.||..+.   +|||||...||||-....|||+||||.+
T Consensus       189 ~ELaplGSLldrLrka~~-----~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKK-----AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhcccchHHHHHhhccc-----cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence            999999999999988332     67888889999999999999999877   9999999999999999999999999999


Q ss_pred             ccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          339 WTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       339 ~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      -+...+..+. .....-.+.|+|||.+...+++.++|||+|||++|||+| |..||.+.....                 
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------  323 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------  323 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------
Confidence            8876554332 222345678999999999999999999999999999998 899998654322                 


Q ss_pred             HHHHhhC--cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d--~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       +-+.+|  .+|..+..+   .+++.+++..||..+|++|||+..|.+
T Consensus       324 -IL~~iD~~erLpRPk~c---sedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  324 -ILKNIDAGERLPRPKYC---SEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -HHHhccccccCCCCCCC---hHHHHHHHHHhccCCccccccHHHHHH
Confidence             222222  234334433   456778889999999999999999974

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=305.76  Aligned_cols=265  Identities=20%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC----
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----  253 (520)
                      ..++|+..+.||+|+||.||+|....++..||||++...  .......+.+|+.+++.++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456899999999999999999999888999999998643  22334568899999999999999999998765332    


Q ss_pred             -cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          254 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       254 -~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                       ..++||||+ +++|.+++..        ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence             358999999 7899888753        45899999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHH-----
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVL-----  405 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~-----  405 (520)
                      |||++.......     ....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ....     
T Consensus       161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999998654322     23457889999999876 45889999999999999999999999754321110 0000     


Q ss_pred             ---hhhhHhhhchhHHHHhhCcccCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          406 ---WAKPILHRGMAAVEELLDPRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       406 ---~~~~~~~~~~~~l~~~~d~~l~~~~---~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         +...+...........+ +......   ........+.+++.+|++.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               00000000000000000 0000000   00111235778999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.8e-35  Score=298.51  Aligned_cols=244  Identities=25%  Similarity=0.399  Sum_probs=191.9

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      |...+.||+|+||+||+|....++..|++|++...   .......+.+|+++++.++|||++++++++.+. ...++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence            55567899999999999999888999999998643   223445788999999999999999999998775 45799999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++...
T Consensus       102 ~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         102 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            995 57877776432      56899999999999999999999887   999999999999999999999999998643


Q ss_pred             CCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ...      ....|+..|+|||++.   .+.++.++|||||||++|||++|..||........   .   ..        
T Consensus       172 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~---~~--------  231 (313)
T cd06633         172 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YH--------  231 (313)
T ss_pred             CCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---H---HH--------
Confidence            321      2346889999999984   45688899999999999999999999865432110   0   00        


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +.....+.....    .....+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         232 IAQNDSPTLQSN----EWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHhcCCCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000001111111    11234677888999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-36  Score=314.07  Aligned_cols=248  Identities=29%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ...|.+.+.||+|.|+.|.+|.+..++..||||.+++..  ....+.+.+|++++..|.|||||+|+.+... ...+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEE
Confidence            458899999999999999999999999999999998763  3344568899999999999999999998654 4559999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+.+|.+.++|...       ..+....+..++.|+.+|++|||.++   |||||||++||||+.+.++||+|||++.
T Consensus       134 ~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             EEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence            9999999999999875       45666888889999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .+....   ...+.+|++.|.|||++.+.+| ++.+|+||+||+||-|+.|..||++....+..                
T Consensus       204 ~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------  264 (596)
T KOG0586|consen  204 FFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------------  264 (596)
T ss_pred             eecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------------
Confidence            876433   4567889999999999998876 68999999999999999999999875433211                


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ...+...+..+.+-..   +.-+++++.|-.+|.+|+++.+|-+
T Consensus       265 -~rvl~gk~rIp~~ms~---dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 -PRVLRGKYRIPFYMSC---DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -chheeeeecccceeec---hhHHHHHHhhccCccccCCHHHhhh
Confidence             1112222222222222   2445677899999999999999876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-36  Score=305.32  Aligned_cols=269  Identities=23%  Similarity=0.308  Sum_probs=201.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~~  256 (520)
                      +|...+.||.|+||.||+|....++..||+|++....  ....+.+.+|+.+++.++||||+++++++.+..    ..++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999998889999999987643  345567889999999999999999999887654    3579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||++ ++|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999997 5888888643       46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh-hhhHhhh
Q 010012          337 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-AKPILHR  413 (520)
Q Consensus       337 a~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~~~~~  413 (520)
                      +........ ........++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+.- .......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            987654321 0112334588899999999887 789999999999999999999999976543221111000 0000000


Q ss_pred             -----chhHHHHhhCc---ccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 -----GMAAVEELLDP---RLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 -----~~~~l~~~~d~---~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           ........+..   ...  ...........+.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 00000000000   000  00000112345778889999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-35  Score=299.52  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=187.5

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      +.+|.|+++.||  +...+++.||||++...  .....+.+..|+++++.++||||+++++++.+. ...+++|||+++|
T Consensus         8 ~~~~~~~~v~~~--~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLMIVHLA--KHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCceEEEE--EecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCC
Confidence            334444454444  44457899999998754  345567899999999999999999999987764 4579999999999


Q ss_pred             ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC
Q 010012          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (520)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~  345 (520)
                      +|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+........
T Consensus        85 ~l~~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          85 SCEDLLKTHFP-----EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             CHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            99999986532     45889999999999999999999888   99999999999999999999999999875432211


Q ss_pred             -----CcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----hHhhhc
Q 010012          346 -----PFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----PILHRG  414 (520)
Q Consensus       346 -----~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----~~~~~~  414 (520)
                           ........++..|+|||++...  .++.++|||||||++|||++|+.||.......  .+.....    ..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccC
Confidence                 0112334578899999998763  58899999999999999999999997533211  1111000    000000


Q ss_pred             h-----hHHHH----hhCcccCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 M-----AAVEE----LLDPRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~-----~~l~~----~~d~~l~~---~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .     ..+..    ..++....   ..........+.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0     00000    00000000   0011122346778999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.2e-36  Score=308.00  Aligned_cols=269  Identities=21%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC---------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE---------  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---------  252 (520)
                      .+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|+++++.++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            58999999999999999999998889999999997766566677889999999999999999998765432         


Q ss_pred             ----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCC
Q 010012          253 ----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKK  327 (520)
Q Consensus       253 ----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~  327 (520)
                          ...++||||++ ++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++ +++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~  152 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCc
Confidence                23689999996 588888753        45899999999999999999999887   99999999999997 456


Q ss_pred             ceEEeecCCccccCCCCCC-cccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          328 IPKLCDFGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      .+||+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7899999999765332111 01122357889999998754 457889999999999999999999997543322111111


Q ss_pred             hhhhHhh-----hchhHHHHhhCcccCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          406 WAKPILH-----RGMAAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       406 ~~~~~~~-----~~~~~l~~~~d~~l~~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+...     .....+..............     ......+.+++.+||+.+|.+|||+.+|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000000     00000000000000000000     012245778999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=334.95  Aligned_cols=209  Identities=30%  Similarity=0.373  Sum_probs=183.2

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      +++...++|.+.++||+|+||.|..++++.+++.||+|++.+.   ......-|..|-.+|..-+.+-||.|...|.+ +
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~  147 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-E  147 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-c
Confidence            4445568999999999999999999999999999999999873   23445678889999998899999999877655 5


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      .++|+|||||+||+|-.++...       .++|+..++.++..|+.||.-||+.|   +|||||||.|||||.+|++||+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence            6799999999999999999864       36999999999999999999999998   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcc----c-CCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----H-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      |||.+-.+..+. ...+...+|||.|++||++.    + +.|+..+||||+||++|||+.|..||....
T Consensus       218 DFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  218 DFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             cchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            999998776543 33456678999999999985    2 568999999999999999999999998754

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-35  Score=299.97  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=190.7

Q ss_pred             EEccc--CceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          189 VLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       189 ~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      .||+|  +||+||++.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+ ..++|+||+.+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~~   83 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMAY   83 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEecccC
Confidence            46665  9999999999888999999998753  2334567889999999999999999999987754 57999999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      ++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+.......
T Consensus        84 ~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          84 GSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             CCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            999999876432     45899999999999999999999887   9999999999999999999999998654322111


Q ss_pred             CCc-----ccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh--------
Q 010012          345 VPF-----LCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP--------  409 (520)
Q Consensus       345 ~~~-----~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~--------  409 (520)
                      ...     ......++..|+|||++.+.  .++.++|||||||++|||++|+.||.......  ........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccc
Confidence            000     01112356679999999764  47899999999999999999999997543211  00000000        


Q ss_pred             -Hhhhchh-------HHH--------------HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 -ILHRGMA-------AVE--------------ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 -~~~~~~~-------~l~--------------~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .......       ...              ...+..+. ..........+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             0000000       000              00001111 0111234457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-35  Score=302.76  Aligned_cols=269  Identities=23%  Similarity=0.289  Sum_probs=193.7

Q ss_pred             CcccceEEcccCceEEEEeeecCC--CcEEEEEEecCc--chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC---CCc
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLL--RTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP---EQG  254 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~--~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~---~~~  254 (520)
                      +|...+.||+|+||.||++.....  +..||+|++...  .....+.+.+|+++++++ +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  889999998643  223356778899999999 599999999875432   234


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++++||+. ++|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcC
Confidence            688889885 6898888643       56899999999999999999999888   999999999999999999999999


Q ss_pred             CCccccCCCCCC--cccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh----
Q 010012          335 GLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA----  407 (520)
Q Consensus       335 Gla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~----  407 (520)
                      |+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...    
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            999865432211  11123468999999998765 46899999999999999999999999754321111000000    


Q ss_pred             -----hhHhhhch-hHHHHhh-CcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 -----KPILHRGM-AAVEELL-DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 -----~~~~~~~~-~~l~~~~-d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           ..+..... ..+...- .+..............+.+++.+||+.+|.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 00000000 0000000 0000000000111346778999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=316.19  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=203.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +.+.++..||-|+||.||+|..+.++...|.|++.....+....|+-|++||...+||+||+|++.|+- ++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEee
Confidence            346667789999999999999998888889999998888888999999999999999999999986554 3458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |.||-.+..+-...      .+|.+.++.-++.|++.||.|||++.   |||||||..|||++-+|.++|+|||.+....
T Consensus       111 C~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             cCCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence            99999999987754      67999999999999999999999988   9999999999999999999999999986433


Q ss_pred             CCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ...  ..-.++.||+.|||||+.+     ..+|..++||||||++|.||..+.+|-..-++      .....        
T Consensus       182 ~t~--qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVll--------  245 (1187)
T KOG0579|consen  182 STR--QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLL--------  245 (1187)
T ss_pred             hHH--hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHH--------
Confidence            211  1224577999999999875     45789999999999999999999999654321      11000        


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+..--.|.|..+.   .-...+-+++.+||.++|..||+..++++
T Consensus       246 KiaKSePPTLlqPS---~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  246 KIAKSEPPTLLQPS---HWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHhhcCCCcccCcc---hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11111122232222   22345777888999999999999999887

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.5e-35  Score=289.12  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=193.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-----chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      +|...+.||+|+||.||++.....+..+++|.++..     ......++..|+.+++.++||||+++++++.+.. ..++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence            477788999999999999998766666666666432     1223345678999999999999999999876654 4799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++.....   ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||++
T Consensus        80 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence            9999999999999875322   1257999999999999999999999887   999999999999975 56999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......      ....        .
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~--------~  216 (260)
T cd08222         153 RLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVL--------R  216 (260)
T ss_pred             eecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH--------H
Confidence            76643321  123455889999999998888899999999999999999999999643211      0000        0


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +.....+.+     .......+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         217 IVEGPTPSL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHcCCCCCC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            101111111     1123346778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.5e-35  Score=291.67  Aligned_cols=256  Identities=27%  Similarity=0.306  Sum_probs=196.1

Q ss_pred             CcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      +|+..+.||+|+||.||++...   .++..||||.+.+..    ....+.+.+|+.++.++ +||||+++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4777899999999999998853   356789999986532    22345678899999999 59999999987655 456


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++|+|.+++...       ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEEC
Confidence            88999999999999998653       45889999999999999999999877   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCC--CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |+++........ ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||........  ......    
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~----  222 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISR----  222 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHH----
Confidence            998765433211 112345889999999987665  78899999999999999999999964321110  000000    


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                             .+.......+..   ....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       223 -------~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 -------RILKSKPPFPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -------HHHccCCCCCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                   111111111111   12346678889999999999999999887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.1e-35  Score=292.85  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=191.8

Q ss_pred             CcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      +|+..+.||+|+||.||++...   .++..||+|++....    ....+.+.+|+.+++++ +|+||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            4778899999999999999874   367899999986532    22345678899999999 59999999987655 456


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeC
Confidence            88999999999999999753       45889999999999999999999887   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||.......  .......    
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~----  222 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISR----  222 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHH----
Confidence            999865443211 11234589999999998753  46889999999999999999999996432211  1111111    


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                             .+.......+   ......+.+++.+||+.+|++||     ++.+++.
T Consensus       223 -------~~~~~~~~~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 -------RILKSEPPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------HhhccCCCCC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   1111111111   11234567888999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-35  Score=319.74  Aligned_cols=273  Identities=18%  Similarity=0.209  Sum_probs=185.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCC-cEEEEE------------------EecCcchHHHHHHHHHHHHHHhCCCCCe
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIK------------------RLDKEDKESSKAFCRELMIASSLHHPNI  241 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK------------------~l~~~~~~~~~~~~~E~~il~~l~HpnI  241 (520)
                      ..+|.+.+.||+|+||+||+|..+... ..++.|                  .+. ........+.+|++++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            468999999999999999998764322 111212                  111 112334568899999999999999


Q ss_pred             ecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCe
Q 010012          242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (520)
Q Consensus       242 v~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NI  321 (520)
                      |++++++.+.+ ..++|++++ +++|.+++......  ............|+.||+.||.|||+.+   ||||||||+||
T Consensus       226 v~l~~~~~~~~-~~~lv~e~~-~~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI  298 (501)
T PHA03210        226 LKIEEILRSEA-NTYMITQKY-DFDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI  298 (501)
T ss_pred             CcEeEEEEECC-eeEEEEecc-ccCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            99999987654 578999998 56787777543211  0122345667789999999999999887   99999999999


Q ss_pred             EecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCC-cchhccccc
Q 010012          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP-IEARRLQGE  400 (520)
Q Consensus       322 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~P-f~~~~~~~~  400 (520)
                      ||+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ +........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999876543221 12345699999999999999999999999999999999998754 433221111


Q ss_pred             hhhHHhhhhH------hhhchhHHHHhhCcc-cCCC-CCCHH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          401 ENLVLWAKPI------LHRGMAAVEELLDPR-LKCT-SRNSA------QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       401 ~~lv~~~~~~------~~~~~~~l~~~~d~~-l~~~-~~~~~------~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+......+      +......+.+.++.. +... .....      ....+.+++.+||+.||.+|||+.|+++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111111000      000000011111100 0000 00000      1124567788999999999999999987

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=286.37  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=196.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +......||.|..|+|++++.+.++..+|||...+. ..+..++++..+.++..- +.|+||+.+|||..... +++.||
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-V~IcMe  171 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-VFICME  171 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-HHHHHH
Confidence            344456799999999999999999999999999765 456667788888766554 58999999999887544 789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      .| ...++.+|....      .++|+..+-++...++.||.||-.+.  +|||||+||+|||+|+.|++||||||++-++
T Consensus       172 lM-s~C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HH-HHHHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            98 446777776654      67999999999999999999998854  6999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .+...   .+...|-+.|||||.+.-   .+|..++|||||||+|+||.||+.||.....+ ...+.            .
T Consensus       243 vdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~lt------------k  306 (391)
T KOG0983|consen  243 VDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLT------------K  306 (391)
T ss_pred             ecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHH------------H
Confidence            55432   234568999999999853   46889999999999999999999999874432 11111            1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +-+-.-|.|.....   ....+.+++..||++|+.+||...++++
T Consensus       307 vln~ePP~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  307 VLNEEPPLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHhcCCCCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11112244443322   3345777778899999999999999887

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=316.81  Aligned_cols=261  Identities=29%  Similarity=0.429  Sum_probs=197.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~~  256 (520)
                      .+...+.||+||||.||+|+.+.+|..||||.+... .....+...+|+++|++++|||||++++.=.+..     ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            345567899999999999999999999999999764 2345567789999999999999999998622211     1247


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CCC--ceEEe
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKK--IPKLC  332 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~~--~vkL~  332 (520)
                      +|||||++|||...|.+...    ...|++.+.+.+..++..||.|||+++   |+||||||.||++-  ++|  .-||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN----~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN----AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence            99999999999999987543    368999999999999999999999988   99999999999883  444  46999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcc-cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      |||.|+.+..+.   ...+++||..|++||.+. .+.|+..+|.|||||++|+.+||..||..........-+.|.  +.
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~  241 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--II  241 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hh
Confidence            999999887655   467889999999999998 488999999999999999999999999865433211112221  11


Q ss_pred             hhchhHHHHhhCc----------ccCCCC-CCHHHHHHHHHHHHHccccCCCCCC
Q 010012          412 HRGMAAVEELLDP----------RLKCTS-RNSAQIARVIQAAAACISSEESRRP  455 (520)
Q Consensus       412 ~~~~~~l~~~~d~----------~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RP  455 (520)
                      .+....+.-..++          .++.+. -......++......+|..+|++|-
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            1110011111111          111111 1234445666777788888999998

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=290.20  Aligned_cols=263  Identities=24%  Similarity=0.369  Sum_probs=198.1

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      |+..+.||+|++|.||+|+...+++.||+|.+....  ....+.+..|+.+++.++||||+++++++.+. ...++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence            456678999999999999999889999999997653  33346678899999999999999999987665 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      ++ ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++....
T Consensus        80 ~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          80 CD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            97 59999998642      36999999999999999999999987   9999999999999999999999999998665


Q ss_pred             CCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc----hh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG----MA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~----~~  416 (520)
                      .....  .....++..|+|||.+... .++.++|||||||++|||++|+.||......+.   ...........    ..
T Consensus       150 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         150 IPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWP  224 (282)
T ss_pred             CCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHH
Confidence            43221  1233467889999998776 789999999999999999999999976442211   00000000000    00


Q ss_pred             HHHHh--hCcccCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEEL--LDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~--~d~~l~~~------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+..+  .+......      ...+.....+.+++.+||..+|++||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000  01111000      000111346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.4e-35  Score=300.41  Aligned_cols=266  Identities=24%  Similarity=0.283  Sum_probs=193.6

Q ss_pred             CCcc-cceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH--------------HHHHHHHHHHHHhCCCCCeecEEE
Q 010012          182 HNFS-KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--------------SKAFCRELMIASSLHHPNIVPLVG  246 (520)
Q Consensus       182 ~~f~-~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~g  246 (520)
                      ++|. ..+.||.|+||+||+|.+..+++.||||.+.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 3577999999999999998889999999986542211              124678999999999999999999


Q ss_pred             EEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       247 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      ++... ...++||||+. |+|.+++...       ..+++.....++.|++.||.|||+.+   |+||||+|+||+++.+
T Consensus        88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~  155 (335)
T PTZ00024         88 VYVEG-DFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK  155 (335)
T ss_pred             EEecC-CcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence            98664 46899999996 6899988653       46899999999999999999999887   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCC------------CcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          327 KIPKLCDFGLATWTSAPSV------------PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~------------~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      +.+||+|||++........            ........++..|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999976541110            0111223468899999998764 46899999999999999999999997


Q ss_pred             hhccccchhhHHhhhhHhhhchh-HHHHh--------hCcccCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          394 ARRLQGEENLVLWAKPILHRGMA-AVEEL--------LDPRLKC--TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       394 ~~~~~~~~~lv~~~~~~~~~~~~-~l~~~--------~d~~l~~--~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+.   ............. .....        .......  ..........+.+++.+||+.+|++||++.+|+.
T Consensus       236 ~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            6543211   1111000000000 00000        0000000  0000111345778899999999999999999986

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-35  Score=300.14  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC----
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----  253 (520)
                      ..++|...+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.+++.++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999888999999998653  23344667789999999999999999987654332    


Q ss_pred             -cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          254 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       254 -~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                       ..++|+||+ +++|.+++..        ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence             378999998 6799998864        45899999999999999999999887   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhh-HHhhh--
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAK--  408 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~l-v~~~~--  408 (520)
                      |||++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... .....  
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~  235 (343)
T cd07851         161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP  235 (343)
T ss_pred             ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence            99999866433     133457889999999865 3678999999999999999999999975433211100 00000  


Q ss_pred             --hHhhhc-hhHHHHhhCcccCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 --PILHRG-MAAVEELLDPRLKCTS-----RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 --~~~~~~-~~~l~~~~d~~l~~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ....+. .......+........     ........+.+++.+||+.+|.+|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence              000000 0000001100000000     00012356889999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-34  Score=324.14  Aligned_cols=146  Identities=28%  Similarity=0.394  Sum_probs=130.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++....   ......+..|+.++..++||||+++++++.. ...+++|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence            57999999999999999999999889999999986532   3344678899999999999999999987765 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++...       ..+++..++.|+.||+.||.|||..+   ||||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999753       45889999999999999999999887   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=281.79  Aligned_cols=237  Identities=29%  Similarity=0.377  Sum_probs=191.9

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      ||+|+||.||++....+++.||+|.+.....   .....+..|+.+++.++||||+++++.+.. +...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            6999999999999988889999999876432   245678899999999999999999988655 456899999999999


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~  346 (520)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          80 LFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            99999764       36899999999999999999999877   99999999999999999999999999986654321 


Q ss_pred             cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       347 ~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                       ......++..|+|||.+.+...+.++|+||||+++|||++|..||......   .              ....+....+
T Consensus       149 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~--------------~~~~~~~~~~  210 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---E--------------IYEKILKDPL  210 (250)
T ss_pred             -cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---H--------------HHHHHhcCCC
Confidence             123456889999999998888899999999999999999999999654321   1              1111111222


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEE  459 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~e  459 (520)
                      ..+...   ...+.+++.+||..+|++||++.+
T Consensus       211 ~~~~~~---~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFL---SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCC---CHHHHHHHHHHhcCCHhhCCCccc
Confidence            222222   345677889999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-35  Score=327.16  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC--------
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP--------  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--------  251 (520)
                      ..+|.+..+||+||||.||+++.+-+|+.||||++... +......+.+|+..|++|+|||||+++..+++.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            46899999999999999999999999999999999765 344556788999999999999999988322100        


Q ss_pred             --------------------------------------------------------------------------------
Q 010012          252 --------------------------------------------------------------------------------  251 (520)
Q Consensus       252 --------------------------------------------------------------------------------  251 (520)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 010012          252 ----------------------E--------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA  301 (520)
Q Consensus       252 ----------------------~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~  301 (520)
                                            +        ..+||=||||+...|.+++.....      .-.-...++++.+|++||.
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~------~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF------NSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc------chhhHHHHHHHHHHHHHHH
Confidence                                  0        115788999988888777776431      1135667899999999999


Q ss_pred             HHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC------C----------CCCCcccccccccCCccCchhcc
Q 010012          302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS------A----------PSVPFLCKTVKGTFGYLAPEYFQ  365 (520)
Q Consensus       302 yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~------~----------~~~~~~~~~~~Gt~~Y~aPE~~~  365 (520)
                      |+|+++   ||||||||.||+|+++..|||+|||+|+...      .          .......+..+||.-|+|||++.
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999988   9999999999999999999999999998621      0          01111235678999999999997


Q ss_pred             cC---CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCC-CCCHHHHHHHHH
Q 010012          366 HG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQ  441 (520)
Q Consensus       366 ~~---~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~~l~~  441 (520)
                      +.   +|+.|+|+||+||||+||+.   ||.......                ..+..+-++.++.+ .....+...-..
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa----------------~iL~~LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA----------------SILTNLRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHHHH----------------HHHHhcccCCCCCCcccccccchHHHH
Confidence            65   49999999999999999986   565432110                12333334444422 113344455567


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 010012          442 AAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       442 la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ++.++++.||.+|||+.|++.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            889999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=313.53  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             CcccceEEcccCceEEEEeeecCCC----cEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .....++||+|+||+||+|.+-..+    .+||+|++... ..+...+++.|+-+|.+++||||++|+|+|....  +.|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql  774 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL  774 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence            3455678999999999999884333    46899988654 4456788999999999999999999999997654  679


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |.+|||.|+|.++++..+      ..+.-...+.|..|||+||.|||.+.   ++||||..+||||.+-.++||+|||++
T Consensus       775 vtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            999999999999998865      56888888999999999999999766   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +.+..+..........-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+..++       ++.+  
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~g--  916 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKG--  916 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhcc--
Confidence            99887766555555556678999999999999999999999999999999 9999986544332221       1111  


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                             .+|..++..+   .++-.++.+||..|+..||+++++...+..
T Consensus       917 -------eRLsqPpiCt---iDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 -------ERLSQPPICT---IDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             -------ccCCCCCCcc---HHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                   2355554444   345566789999999999999999876654

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=332.27  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+-+++.+..||.|.||.||.|...++|...|||-+....  ....+.+.+|..++..|.|||+|+++|+=.+. +.++|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHHH
Confidence            4457778889999999999999999999999999886543  23345677899999999999999999985553 44789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      .||||.+|+|.+.+...       ...++.....+..|++.|+.|||+.|   ||||||||.||||+.+|.+|++|||.|
T Consensus      1312 FMEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence            99999999999999764       45677777788999999999999988   999999999999999999999999999


Q ss_pred             cccCCCC--CCcccccccccCCccCchhcccC---CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          338 TWTSAPS--VPFLCKTVKGTFGYLAPEYFQHG---KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       338 ~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~---~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      .......  .+.......||+-|||||++.+.   ....+.||||+|||++||+||++||...+.       .|+...  
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy-- 1452 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMY-- 1452 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHh--
Confidence            8776532  12223456799999999999754   467799999999999999999999975432       122211  


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                          .+...-.|.+.  ..   ....-.+++.+||..||++|.++.|+++.
T Consensus      1453 ----~V~~gh~Pq~P--~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 ----HVAAGHKPQIP--ER---LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----HHhccCCCCCc--hh---hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                12222223332  11   22334566789999999999998887764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=290.83  Aligned_cols=272  Identities=23%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh--CCCCCeecEEEEEEcCC---CcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPE---QGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~~---~~~~  256 (520)
                      ...+..++||+|.||.||+|++.  ++.||||++..   +..+.|.+|-+|.+.  ++|+||++++++-..+.   ..++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45566678999999999999997  58999999964   556788899888775  58999999998633222   1478


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecccCCCCeEecCCCceE
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT------ERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~------~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ||++|.+.|+|.++|..        ..++|....+|+.-+++||+|||+.-      +++|+|||||+.||||.+|++..
T Consensus       285 LVt~fh~kGsL~dyL~~--------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHh--------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            99999999999999986        57999999999999999999999743      56799999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCC-CC-----CcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VS-----DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s-----~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      |+|||||..+...........-+||..|||||++.+.- +.     .+.||||+|.|||||++...-+....... ..+.
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~-Yqlp  435 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE-YQLP  435 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc-ccCc
Confidence            99999999887544433344578999999999987542 22     25899999999999999766553211100 0000


Q ss_pred             Hh----hhhHhhhch-hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          405 LW----AKPILHRGM-AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       405 ~~----~~~~~~~~~-~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      --    ..|-+.+.. ..+++-..|.+...-.....+..+.+.+..||..||+.|-|+.=|-+.+...
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            00    000000000 0233444455443222335667788999999999999999988777766543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=290.42  Aligned_cols=242  Identities=24%  Similarity=0.374  Sum_probs=192.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+|....+||+|+||.|.+|..+.+.+.+|||+++++-   .+..+--+.|-++|... +-|.++.|..+ ++.-.++|+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-FQTmDRLyF  427 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-FQTMDRLYF  427 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-hhhhhheee
Confidence            47888999999999999999999999999999998752   22222334566677655 46788888865 455567999


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+.||+|--++++.       ..+-+..+..+|..||-||-+||+.+   ||+||||..|||||.+|++||+|||++
T Consensus       428 VMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             EEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999875       45888889999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.--.+.  ....+.+||+.|+|||++....|+.++|||||||+||||+.|++||++.+.++   +              
T Consensus       498 KEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l--------------  558 (683)
T KOG0696|consen  498 KENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L--------------  558 (683)
T ss_pred             cccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H--------------
Confidence            8533222  23467889999999999999999999999999999999999999999865432   1              


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG  456 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt  456 (520)
                      ...+.+.....+.   ....+.+.+....|.+.|.+|..
T Consensus       559 F~aI~ehnvsyPK---slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  559 FQAIMEHNVSYPK---SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHccCcCcc---cccHHHHHHHHHHhhcCCccccC
Confidence            1223333333222   23345666777788889988853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=291.20  Aligned_cols=258  Identities=27%  Similarity=0.421  Sum_probs=200.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--H-----HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--E-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|-..++||+|||+.||+|.+....+.||||+-.....  +     -.+...+|..|-+.|+||-||++++|+.-..+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            567788899999999999999987788999998643321  1     123456899999999999999999998766667


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec---CCCceEE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKL  331 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld---~~~~vkL  331 (520)
                      +|-|+|||+|-+|+-+|...       ..+++..++.|+.||+.||.||.+.. ++|||-||||.||||-   ..|.+||
T Consensus       543 FCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence            89999999999999999875       56999999999999999999999864 7899999999999994   4578999


Q ss_pred             eecCCccccCCCCCCc-----ccccccccCCccCchhcccC----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchh
Q 010012          332 CDFGLATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHG----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  402 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~  402 (520)
                      +||||++++..+....     ......||.+|++||.+.-+    +++.|+||||.|||+|+.+.|++||.......   
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence            9999999887654332     23346799999999998644    57889999999999999999999997543221   


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          403 LVLWAKPILHRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                            .+++.+     .++... +..+. .+......-.++++||+..-++|....++..
T Consensus       692 ------dILqeN-----TIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 ------DILQEN-----TILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ------HHHhhh-----chhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                  112211     111111 11111 1222334556778999999999988777654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=309.70  Aligned_cols=266  Identities=29%  Similarity=0.482  Sum_probs=204.8

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecC-------CCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEE
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~  248 (520)
                      ....++....+.||+|.||.|++|....       ....||||.++... ....+.+..|+++++.+ +||||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344555666799999999999997531       14579999997653 35567899999999998 599999999999


Q ss_pred             EcCCCcEEEEEEecCCCChhHHhhhhc--cCCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          249 IDPEQGLFLIYKYVSGGSLERHLHEKK--KGVRGN-------STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       249 ~~~~~~~~LV~E~~~~gsL~~~L~~~~--~~~~~~-------~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      .. .+.+++|+||+..|+|.++|...+  ......       ..++....+.++.|||.|++||++..   +|||||..+
T Consensus       372 t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  372 TQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             cc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            87 566899999999999999998865  011111       24889999999999999999999877   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccc--cCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG--TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARR  396 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~  396 (520)
                      |||+.++..+||+|||+|+......... .....|  ...|||||.+....|+.|||||||||+||||+| |..|+.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999998655433221 112222  345999999999999999999999999999999 999997522


Q ss_pred             cccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       397 ~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ..+.    ..+.+|         .++..+.....   ++.+++..||+.+|++||++.++++.++.
T Consensus       527 ~~--~~l~----~~l~~G---------~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 PT--EELL----EFLKEG---------NRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             cH--HHHH----HHHhcC---------CCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            11  1111    122222         12333333444   45577788999999999999999999886

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=277.73  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             hhCCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEc---CCCc
Q 010012          180 ATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID---PEQG  254 (520)
Q Consensus       180 at~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~~~~  254 (520)
                      .|++|++. ++||-|-.|.|-.+..+.+++.+|+|++...     ....+|+++--.. .|||||.+++++..   +...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677654 5799999999999999999999999998543     2334677765443 69999999998743   2334


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  331 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL  331 (520)
                      +++|||.|+||.|.+.+..+..     ..+++.++-.|+.||..|+.|||+.+   |.||||||+|+|...   |-.+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEe
Confidence            7899999999999999987643     67999999999999999999999999   999999999999964   457999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      +|||+|+......   ...+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........           
T Consensus       206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------  271 (400)
T KOG0604|consen  206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------  271 (400)
T ss_pred             cccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------
Confidence            9999999766432   23566789999999999999999999999999999999999999987554211           


Q ss_pred             hhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+  .-..+....+..+. ......+..-++++..|+.+|.+|-|+.++..
T Consensus       272 spg--Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  272 SPG--MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             Chh--HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            111  11222233333222 12334456678889999999999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=294.10  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=197.0

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      .++||+|-||+||-|+++.+|+.||||++++.+  .....++.+|+.||.+++||.||.|.-.| +..+++++|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-ETPERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-cCCceEEEEehhh-c
Confidence            368999999999999999999999999998753  34557889999999999999999998665 4456699999999 5


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEeecCCccccC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLATWTS  341 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~DFGla~~~~  341 (520)
                      |+..+.+-...+     ..|++.....+..||+.||.|||.++   |+|+||||+||||.+   ...+||||||+|++.+
T Consensus       647 GDMLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  647 GDMLEMILSSEK-----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             chHHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            565555554443     67999999999999999999999988   999999999999964   3479999999999998


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      +..   .-++++||+.|+|||++....|+..-|+||.|||+|.-++|..||..+..  ...                 ++
T Consensus       719 Eks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--Ind-----------------QI  776 (888)
T KOG4236|consen  719 EKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--IND-----------------QI  776 (888)
T ss_pred             hhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhH-----------------Hh
Confidence            754   23678999999999999999999999999999999999999999975321  111                 11


Q ss_pred             hCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -+..+..+ ....+.....++++...|+..-.+|-++.+-+.
T Consensus       777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            11112111 113344456788888999999999998876654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=278.02  Aligned_cols=267  Identities=22%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             cHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       173 s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      ++.++-+.|.     +.||+|+|+.|-.+....++..||||++++.......+..+|++++.+. .|+||+.|++||.+ 
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-  147 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-  147 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence            4555544443     5799999999999999889999999999998888888999999999887 59999999998765 


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---c
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I  328 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~  328 (520)
                      +.++|||||-|.||+|..++++.       ..+++..+..+..+|+.||.+||..+   |.||||||+|||-....   -
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCc
Confidence            56689999999999999999876       56999999999999999999999888   99999999999986544   4


Q ss_pred             eEEeecCCccccCC--C---CCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          329 PKLCDFGLATWTSA--P---SVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       329 vkL~DFGla~~~~~--~---~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                      +|||||.|..-...  +   .......+.+|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            89999999753221  1   1111224567999999999863     235788999999999999999999999876653


Q ss_pred             cc-----hhhHHhhhhHhhhchhHHHHhhCcccCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          399 GE-----ENLVLWAKPILHRGMAAVEELLDPRLKCTSRN-SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       399 ~~-----~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~-~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +-     +........+       ...+-+..+..+..+ .......-+++...+..++.+|-++.+++.
T Consensus       298 dCGWdrGe~Cr~CQ~~L-------FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  298 DCGWDRGEVCRVCQNKL-------FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCccCCCccHHHHHHH-------HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            21     1111111111       222333344332211 112234456777788899999999998876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.6e-34  Score=280.80  Aligned_cols=209  Identities=29%  Similarity=0.464  Sum_probs=176.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC----cEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..|.....||+|.||.||+|...+++    +.+|+|+++.+..  .......+|+.+++.++||||+.|..++...+..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888899999999999999664432    3689999976522  23345678999999999999999999988877789


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC----CceEE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKL  331 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~----~~vkL  331 (520)
                      ++++||.+. +|...++..+...  ...++-..+..|+.||+.|+.|||++-   |+||||||.||||..+    |.+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~--~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASK--AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccch--hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            999999966 8999988755432  257999999999999999999999988   9999999999999877    89999


Q ss_pred             eecCCccccCCCCCCc-ccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          332 CDFGLATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      +|||+++.+..+-.+. ....++-|++|.|||.+.+. .||.+.||||.|||+.||+|-.+-|....
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999999887654443 34567789999999999876 48999999999999999999988887543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-33  Score=276.09  Aligned_cols=221  Identities=21%  Similarity=0.267  Sum_probs=175.4

Q ss_pred             cCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhh
Q 010012          193 GALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  272 (520)
Q Consensus       193 G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~  272 (520)
                      |.||.||++.+..+++.||+|++....     .+..|...+....||||+++++++.+. ...++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999997643     233455555666799999999987765 45899999999999999987


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccc
Q 010012          273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  352 (520)
Q Consensus       273 ~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  352 (520)
                      ..       ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||++.......     ...
T Consensus        78 ~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~  142 (237)
T cd05576          78 KF-------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE  142 (237)
T ss_pred             Hh-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence            54       45899999999999999999999887   9999999999999999999999999886554321     233


Q ss_pred             cccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCC
Q 010012          353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN  432 (520)
Q Consensus       353 ~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~  432 (520)
                      .++..|+|||.+....++.++||||+||++|||++|+.|+.......                   ....  .+..+.. 
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~--~~~~~~~-  200 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHT--TLNIPEW-  200 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------cccc--ccCCccc-
Confidence            46778999999988889999999999999999999998875321100                   0000  0011111 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          433 SAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       433 ~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                        ....+.+++.+|++.||++||++.
T Consensus       201 --~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         201 --VSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             --CCHHHHHHHHHHccCCHHHhcCCC
Confidence              123466788899999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.3e-33  Score=267.23  Aligned_cols=239  Identities=30%  Similarity=0.424  Sum_probs=192.3

Q ss_pred             CceEEEEeeecCCCcEEEEEEecCcchHH-HHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhh
Q 010012          194 ALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  272 (520)
Q Consensus       194 ~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~  272 (520)
                      +||.||+|....+++.+|+|++....... .+.+.+|++.+++++|+||+++++++... ...++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence            58999999998788999999997765443 67899999999999999999999988764 45799999999999999987


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccc
Q 010012          273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  352 (520)
Q Consensus       273 ~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  352 (520)
                      ..       ..+++..++.++.+++.++.|||+.+   |+|+||+|+||++++++.++|+|||++.......   .....
T Consensus        80 ~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  146 (244)
T smart00220       80 KR-------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTF  146 (244)
T ss_pred             hc-------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccc
Confidence            64       23899999999999999999999887   9999999999999999999999999998765532   12345


Q ss_pred             cccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCC
Q 010012          353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN  432 (520)
Q Consensus       353 ~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~  432 (520)
                      .++..|++||.+....++.++||||||+++++|++|..||......  ....              ..+...........
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~--------------~~~~~~~~~~~~~~  210 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELF--------------KKIGKPKPPFPPPE  210 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH--------------HHHhccCCCCcccc
Confidence            6888999999999888999999999999999999999999752111  1111              11111111111100


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          433 SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       433 ~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......+.+++.+|+..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            002346788899999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-33  Score=292.82  Aligned_cols=207  Identities=27%  Similarity=0.343  Sum_probs=177.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .-|..++.||-|+||.|.++.-.++...||+|.+.+.+.   ........|..||..-+.+-||+|+..|.+.+ .+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEE
Confidence            568889999999999999999888889999999976542   23345678999999999999999998776654 59999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |+|++||++-.+|-+.       ..+++..++.++.++.+|+++.|.+|   +|||||||.|||||.+|+|||+||||+.
T Consensus       708 MdYIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EeccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence            9999999999999875       57999999999999999999999888   9999999999999999999999999985


Q ss_pred             cc---------CCCCCC-------------------------------cccccccccCCccCchhcccCCCCCcCceeeH
Q 010012          339 WT---------SAPSVP-------------------------------FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAF  378 (520)
Q Consensus       339 ~~---------~~~~~~-------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~  378 (520)
                      -+         ...+-.                               ......+||..|+|||++....|+..+||||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            22         110000                               01124679999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcchhcccc
Q 010012          379 GVVLLELLTGRKPIEARRLQG  399 (520)
Q Consensus       379 GvvL~ELltG~~Pf~~~~~~~  399 (520)
                      |||||||+.|+.||....+.+
T Consensus       858 gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCc
Confidence            999999999999999877654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=278.69  Aligned_cols=255  Identities=23%  Similarity=0.340  Sum_probs=193.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHH-HhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIA-SSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.+....||.|+||+|++-.++.+|+..|||++..... ...++++.|.+.. +.-+.||||+++|.++..+. .++.||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiCME  143 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWICME  143 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeeeHH
Confidence            44556789999999999999999999999999976543 5567788888755 44578999999999887544 789999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      .| ..||+.+...-..  -....+++...-.|+...+.||.||-..  ..||||||||+||||+..|.+||||||++-.+
T Consensus       144 LM-d~SlDklYk~vy~--vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYS--VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HH-hhhHHHHHHHHHH--HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99 5677666543211  0126799999999999999999999874  45999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ...-   ..+.-+|-..|||||.+..  ..|..+|||||||++|||+.||+.|+.....     ..+           .+
T Consensus       219 v~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfe-----------ql  279 (361)
T KOG1006|consen  219 VDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFE-----------QL  279 (361)
T ss_pred             HHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHH-----------HH
Confidence            4321   2234568889999999853  3589999999999999999999999975432     111           11


Q ss_pred             HHhh--C-cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELL--D-PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~--d-~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..++  | |.+..+.........+..++..||.+|...||...++.+
T Consensus       280 ~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  280 CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1111  1 222222222233456777778899999999999999876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=295.86  Aligned_cols=240  Identities=28%  Similarity=0.380  Sum_probs=190.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh-CCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS-LHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +..|.....+|.|+|+.|-.+.+..+++..++|++.+...+    -.+|+.++.. -+||||+++.+.+.++. ..++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~-~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGK-EIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCc-eeeeee
Confidence            56677777899999999999999999999999999876222    2346655544 47999999999987654 489999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe-cCCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl-d~~~~vkL~DFGla~  338 (520)
                      |.+.++-|.+.+...+        .....+..|+.+|+.|+.|||.++   ||||||||+|||+ ++.++++|+|||.++
T Consensus       396 e~l~g~ell~ri~~~~--------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             hhccccHHHHHHHhcc--------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999998888776542        233777789999999999999988   9999999999999 699999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....     ....+-|..|.|||++....|++++||||||++||+|++|+.||.....+  .++              .
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei--------------~  523 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI--------------H  523 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH--------------H
Confidence            77654     23445788999999999889999999999999999999999999864332  111              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+-.+..     .......+.+|+.+||+.||.+||+|.++..
T Consensus       524 ~~i~~~~~-----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  524 TRIQMPKF-----SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HhhcCCcc-----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            11111111     1223345667788999999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=295.11  Aligned_cols=243  Identities=25%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++.....||-||||.|=++........+|+|++++.   +....+.+..|-.||...+.|.||+||-.|.+ +.++|++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence            3455566799999999999998765556899988764   33445667789999999999999999988766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||-|-||.|+..|..+       ..++..+...++..+++|++|||..+   ||+|||||+|.|||.+|-+||.|||+|+
T Consensus       499 mEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             HHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999999875       56888899999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .+.....   +.+++||+.|+|||++.+..+..++|.||+|+++|||++|.+||.+.++-...+++.       +|   +
T Consensus       569 ki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------kG---i  635 (732)
T KOG0614|consen  569 KIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------KG---I  635 (732)
T ss_pred             HhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------hh---h
Confidence            8876653   456789999999999999999999999999999999999999999876533222221       11   1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG  456 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt  456 (520)
                      ..+--|        ....+...+++.+.+..+|.+|..
T Consensus       636 d~i~~P--------r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 DKIEFP--------RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhhhcc--------cccchhHHHHHHHHHhcCcHhhhc
Confidence            111111        122345667788888999999976

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-32  Score=295.66  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=207.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC----CCc
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP----EQG  254 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~----~~~  254 (520)
                      -+.-|.+...||.|.+|.||+++.+.+++.+|+|+...... ..+++..|.++|+.+ +|||++.++|++.-.    ++.
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            35678889999999999999999999999999999877543 345677888999887 699999999988632    345


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      ++||||||.+||..++++...+     ..+.|..+..|+..++.||.+||.+.   ++|||||-.||||+.++.+||+||
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g-----~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKG-----NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcc-----cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence            9999999999999999987652     67999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC-----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |++..+.....  .-.+..||+.|||||++...     .|+..+|+||||++..||--|.+|+....+--         .
T Consensus       168 GvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------a  236 (953)
T KOG0587|consen  168 GVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------A  236 (953)
T ss_pred             eeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------h
Confidence            99987765332  23456799999999998643     47789999999999999999999987654310         0


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ++     .+..--.|.|.   ....-.+++.+++..||.+|-++||++.++++
T Consensus       237 LF-----~IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 LF-----LIPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hc-----cCCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            00     00000111222   13345578999999999999999999999886

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-32  Score=301.06  Aligned_cols=268  Identities=18%  Similarity=0.246  Sum_probs=170.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCC----CcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEE-----Ec
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC-----ID  250 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-----~~  250 (520)
                      ..++|...+.||+|+||.||+|.+..+    +..||+|++......  +.+..+  .+....+.+++.++..+     ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999887    889999998643221  111111  12222222222222111     12


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKG-------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~-------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      .+...++||||+++++|.+++......             ........+..+..|+.|++.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            344579999999999999998753210             000011223446679999999999999887   9999999


Q ss_pred             CCCeEecC-CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC----------------------CCCCcCc
Q 010012          318 PSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG----------------------KVSDKTD  374 (520)
Q Consensus       318 p~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----------------------~~s~ksD  374 (520)
                      |+|||+++ ++.+||+|||+|+.+..... .......+|+.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543221 123456789999999965322                      2345679


Q ss_pred             eeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc--hhHHHHhhCcccCCC-----CCCHHHHHHHHHHHHHcc
Q 010012          375 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG--MAAVEELLDPRLKCT-----SRNSAQIARVIQAAAACI  447 (520)
Q Consensus       375 VwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~--~~~l~~~~d~~l~~~-----~~~~~~~~~l~~la~~Cl  447 (520)
                      ||||||+||||+++..|+.....       .....+...+  .......+.+.....     ...........+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~-------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI-------QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH-------HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999998776543211       1100000000  001111111111000     000001123457889999


Q ss_pred             ccCCCCCCCHHHHHH
Q 010012          448 SSEESRRPGIEEIIA  462 (520)
Q Consensus       448 ~~dP~~RPtm~eVl~  462 (520)
                      +.||++|||+.++++
T Consensus       435 ~~dP~kR~ta~e~L~  449 (566)
T PLN03225        435 RFKGRQRISAKAALA  449 (566)
T ss_pred             cCCcccCCCHHHHhC
Confidence            999999999999987

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-32  Score=277.49  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=201.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh--CCCCCeecEEEEEEcCCC---cE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ---GL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~~~---~~  255 (520)
                      .++....+.||+|.||.||+|.++  |+.||||++...+   .+.+.+|.+|.+.  |+|+||+.+++.-....+   .+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            357778899999999999999997  7899999997543   3456678887764  699999999986433222   38


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecccCCCCeEecCCCceE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-----GTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-----~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      +||.+|.+.|||.+||..        ..++-...++++..+|.||++||.     ++++.|.|||||+.|||+..++..-
T Consensus       285 wLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             EEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence            999999999999999986        468999999999999999999996     5678899999999999999999999


Q ss_pred             EeecCCccccCCCC--CCcccccccccCCccCchhcccC----CC-C-CcCceeeHHHHHHHHHhC----------CCCc
Q 010012          331 LCDFGLATWTSAPS--VPFLCKTVKGTFGYLAPEYFQHG----KV-S-DKTDVYAFGVVLLELLTG----------RKPI  392 (520)
Q Consensus       331 L~DFGla~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~----~~-s-~ksDVwS~GvvL~ELltG----------~~Pf  392 (520)
                      |+|+|||.......  ........+||-.|||||++...    .+ + ..+||||||.|+||+...          +.||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            99999997665432  12234567899999999998543    12 1 258999999999998752          3455


Q ss_pred             chhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       393 ~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....+.+ .+.-+..+-       .-.+-+.|.+...-...+.+..+.+++..||..+|..|-|+-.|-+.|..+.
T Consensus       437 yd~Vp~D-Ps~eeMrkV-------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  437 YDVVPSD-PSFEEMRKV-------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             ccCCCCC-CCHHHHhcc-------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            4322211 111000000       0112233334333345678899999999999999999999988888877543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.6e-33  Score=276.47  Aligned_cols=266  Identities=24%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC--CC----eecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PN----IVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pn----Iv~l~g~~~~~~~~  254 (520)
                      +++|.+...+|+|.||.|-.+.+..++..||||+++...+. .+.-.-|+++|.++.+  |+    +|.+.+|+ +-.+.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccCc
Confidence            67899999999999999999999888899999999765432 3445579999999842  22    66676664 55667


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---------  325 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---------  325 (520)
                      .|+|+|.+ |.|+.++|....     ..+++..+++.++.|+++++++||+..   ++|.||||+|||+.+         
T Consensus       166 iCivfell-G~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence            89999998 779999998754     268999999999999999999999988   999999999999832         


Q ss_pred             -----------CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          326 -----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       326 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                                 +..|+|+|||.|+.-....     ..++.|..|.|||++.+-+++.++||||+||||+||.||...|..
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                       2369999999998655433     456789999999999999999999999999999999999999987


Q ss_pred             hccccchhhHHhh-hhHhhhchhH----------------------HHHhhCccc---CCCCCCHHHHHHHHHHHHHccc
Q 010012          395 RRLQGEENLVLWA-KPILHRGMAA----------------------VEELLDPRL---KCTSRNSAQIARVIQAAAACIS  448 (520)
Q Consensus       395 ~~~~~~~~lv~~~-~~~~~~~~~~----------------------l~~~~d~~l---~~~~~~~~~~~~l~~la~~Cl~  448 (520)
                      ....+...+.+.. .++.......                      .....++..   ..-.....+..++++|+..+|.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            5532211111110 0111000000                      001111110   0111234667789999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 010012          449 SEESRRPGIEEIIA  462 (520)
Q Consensus       449 ~dP~~RPtm~eVl~  462 (520)
                      .||.+|+|++|++.
T Consensus       392 fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  392 FDPARRITLREALS  405 (415)
T ss_pred             cCccccccHHHHhc
Confidence            99999999999986

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=249.81  Aligned_cols=267  Identities=21%  Similarity=0.313  Sum_probs=195.3

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +|...++||+|.||+||+|+.+.+++.||+|++..++  ........+|+.+|+.++|+|||++++.. ..+..+-||+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-hsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-ccCceeEEeHH
Confidence            4666788999999999999999999999999986542  33345677999999999999999999974 55667899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      || .-+|..+.....      ..++....+.++.|+++||.++|+.+   +.|||+||.|+||+.+|++|++|||+++-+
T Consensus        82 ~c-dqdlkkyfdsln------g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             Hh-hHHHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            99 447888876643      56899999999999999999999988   999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh-chhH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR-GMAA  417 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~-~~~~  417 (520)
                      +-+-.  .....+-|.+|.+|.++.+.+ |+...|+||.|||+.|+.. |++.|.+.+..++...+-|......+ .+..
T Consensus       152 gipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             CCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence            64321  112345789999999998876 7889999999999999997 77777766554433333222111110 0111


Q ss_pred             HHHhhCcccCC--C--CCCHHHH----HHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKC--T--SRNSAQI----ARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~--~--~~~~~~~----~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +..+-|...-.  +  ....+..    ..=.++....+.-+|.+|.++.+.++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            22222211100  0  0001111    11235555667779999999887765

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=269.35  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=194.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...++||+|+|+.|.+++++.+.+.||+|+++++   ..+...-...|-.+..+. +||.+|-|.. |+..+.++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs-cfqtesrl  326 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS-CFQTESRL  326 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh-hhcccceE
Confidence            346899999999999999999999999999999999765   223333445566666554 7999999987 45667789


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|.||++||+|--+++++       ..+|++.++.+...|..||.|||+.+   ||+||||..|||||..|++||+|+|
T Consensus       327 ffvieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccc
Confidence            9999999999998888765       56999999999999999999999877   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcccc-chhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG-EENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~~~~  414 (520)
                      +++.--.+..  ...+++||+.|+|||++.+..|+..+|||++||+++||+.|+.||+....+. ..+...+...+    
T Consensus       397 mcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv----  470 (593)
T KOG0695|consen  397 MCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV----  470 (593)
T ss_pred             hhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH----
Confidence            9985332221  2456789999999999999999999999999999999999999998543221 12222222211    


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG  456 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt  456 (520)
                            ++...+..+.   ....+...++..-|.+||.+|..
T Consensus       471 ------ilekqiripr---slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  471 ------ILEKQIRIPR---SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ------Hhhhcccccc---eeehhhHHHHHHhhcCCcHHhcC
Confidence                  1122222111   11233455667788999999853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=7e-34  Score=269.40  Aligned_cols=272  Identities=21%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC---Cc--
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE---QG--  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---~~--  254 (520)
                      ..|....+||+|.||.||+|+.+.+++.||+|++-.+.  ..-....++|+.+|..|+|+|++.+++.|....   .+  
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            35666678999999999999999999999998764422  112234568999999999999999998875322   22  


Q ss_pred             --EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          255 --LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       255 --~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                        +++||.+|+. +|.-+|....      ..++..++.+++.++..||.|+|.+.   |+|||+||.||||+.++.+||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence              7999999965 8888886543      57999999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCC--cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh--
Q 010012          333 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA--  407 (520)
Q Consensus       333 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~--  407 (520)
                      |||+++.+......  ...+..+-|.+|.+||.+.+. .|+++.|||..|||+.||+||.+-+.+........++...  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999766533221  112345569999999998765 6899999999999999999999988876654433332210  


Q ss_pred             ---hhHhhhch-hHHHHhhC-cccCCCCC--CHHHH------HHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          408 ---KPILHRGM-AAVEELLD-PRLKCTSR--NSAQI------ARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       408 ---~~~~~~~~-~~l~~~~d-~~l~~~~~--~~~~~------~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                         +..+.... -.+.+-+. +.+.....  ..+.+      ...++++..++..||.+|++..+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence               00000000 00111110 00110000  01111      256778888999999999999999863

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=280.92  Aligned_cols=272  Identities=21%  Similarity=0.255  Sum_probs=180.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeec----------------CCCcEEEEEEecCcchHHHHHHH--------------HH
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG----------------LLRTSVAIKRLDKEDKESSKAFC--------------RE  229 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~----------------~~~~~vAvK~l~~~~~~~~~~~~--------------~E  229 (520)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||++........++|.              .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999999752                23467999998765433333333              46


Q ss_pred             HHHHHhCCCCCe-----ecEEEEEEcC-------CCcEEEEEEecCCCChhHHhhhhccC-----------------CCC
Q 010012          230 LMIASSLHHPNI-----VPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKG-----------------VRG  280 (520)
Q Consensus       230 ~~il~~l~HpnI-----v~l~g~~~~~-------~~~~~LV~E~~~~gsL~~~L~~~~~~-----------------~~~  280 (520)
                      +.++.+++|.++     +++++||...       +...+|||||+++|+|.++++.....                 ...
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766554     6777776532       23478999999999999999753210                 001


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccC
Q 010012          281 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA  360 (520)
Q Consensus       281 ~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~a  360 (520)
                      ...++|..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            134678889999999999999999887   99999999999999999999999999976543221 11112235789999


Q ss_pred             chhcccCC----------------------CCCcCceeeHHHHHHHHHhCCC-CcchhccccchhhHHhhhhHhhhchhH
Q 010012          361 PEYFQHGK----------------------VSDKTDVYAFGVVLLELLTGRK-PIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       361 PE~~~~~~----------------------~s~ksDVwS~GvvL~ELltG~~-Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ||.+....                      ...+.||||+||++|||++|.. ||........ .+.. .......+   
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~~~~~~~---  453 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YDNDLNRW---  453 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-ccchHHHH---
Confidence            99875432                      1235799999999999999875 6653211100 0000 00000000   


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEE---SRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP---~~RPtm~eVl~  462 (520)
                       +........... .........+++.++|..+|   .+|+|+.|+++
T Consensus       454 -r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 -RMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -HhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             000001111110 11122445677788888765   78999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=263.27  Aligned_cols=271  Identities=21%  Similarity=0.298  Sum_probs=215.3

Q ss_pred             HHHHHHhhCCcccceEEcccCceEEEEeeecCC-----CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEE
Q 010012          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGF  247 (520)
Q Consensus       174 ~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~  247 (520)
                      .+++.....+++...++-+|.||.||.|.+++.     .+.|-+|.++.. +.-....++.|...+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            345556667788888999999999999977542     234666766543 33345678899999999999999999999


Q ss_pred             EEcCCCcEEEEEEecCCCChhHHhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       248 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      +++.....+++|.++.-|+|..||...+.. ....+.+.-.+...++.|++.|++|||+.+   |||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            998777789999999999999999854321 112245667777889999999999999888   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHH
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL  405 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~  405 (520)
                      ..+||+|=.|++.+...+.............||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+....  
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y--  510 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY--  510 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence            9999999999998777666666566667788999999999999999999999999999999 9999976555432221  


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                           +..|         .++..+..++++   +..++.-||...|++||+.+|++.-|.+
T Consensus       511 -----lkdG---------yRlaQP~NCPDe---Lf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  511 -----LKDG---------YRLAQPFNCPDE---LFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -----Hhcc---------ceecCCCCCcHH---HHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                 1111         234444445554   6677788999999999999999987764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=244.49  Aligned_cols=205  Identities=27%  Similarity=0.418  Sum_probs=168.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHH-hCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIAS-SLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .+....+..||+|++|.|-+-++..+|+..|+|.+... ..+..++.++|+.+.. ....|.+|.++|..++. ..+++.
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-gdvwIc  123 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-GDVWIC  123 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-ccEEEe
Confidence            34555567899999999999999999999999999764 3445567788888654 45799999999987664 448999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||.| ..||+.+-.+--+   ....+++...-+||..+..||.|||++  ..|||||+||+||||+.+|++|+||||++-
T Consensus       124 ME~M-~tSldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             HHHh-hhhHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999 5688877665322   237899999999999999999999994  459999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc----CCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH----GKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      .+.+.-   ..+...|-..|||||.+..    ..|+-|+||||||+++.||.+++.|+...
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            765432   1223457788999999853    36899999999999999999999999754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4e-29  Score=234.52  Aligned_cols=211  Identities=36%  Similarity=0.582  Sum_probs=181.9

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChh
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE  268 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~  268 (520)
                      ||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.+.|++|+++++++... ...++++|++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence            68999999999999877899999999766432 346788999999999999999999987664 4578999999999999


Q ss_pred             HHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCccccCCCCCCc
Q 010012          269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPF  347 (520)
Q Consensus       269 ~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~  347 (520)
                      +++....      ..+++..+..++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        80 ~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          80 DLLKENE------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            9987642      35899999999999999999999887   999999999999999 89999999999986654321  


Q ss_pred             ccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc
Q 010012          348 LCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL  426 (520)
Q Consensus       348 ~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l  426 (520)
                      ......+...|++||.+... ..+.++|+|++|+++++|                                         
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            12334578899999999877 788999999999999999                                         


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          427 KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       427 ~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                                ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                      346677889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=280.11  Aligned_cols=248  Identities=26%  Similarity=0.366  Sum_probs=183.2

Q ss_pred             CcccceEEcccCce-EEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEE
Q 010012          183 NFSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       183 ~f~~~~~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      -|...+++|.|+-| .||+|...  ++.||||++-.+.   ..-..+|+..|+.- +|||||++++. ....+..||..|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEeh
Confidence            35556778999987 68999986  6899999986432   23446899999887 59999999754 333456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---C--CceEEeecC
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---K--KIPKLCDFG  335 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~--~~vkL~DFG  335 (520)
                      .| ..+|.+++.......   ....-...+.+..|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||
T Consensus       584 LC-~~sL~dlie~~~~d~---~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDV---EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             Hh-hhhHHHHHhccccch---hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccc
Confidence            99 669999998741111   11111334567899999999999988   999999999999976   3  479999999


Q ss_pred             CccccCCCCCCcc-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          336 LATWTSAPSVPFL-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       336 la~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      +++.+..+..... .....||-||+|||.+....-+.++||||+|||+|+.++ |..||......+ .+++.        
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~--------  727 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT--------  727 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc--------
Confidence            9998876544321 235679999999999998888889999999999999999 599998643321 11110        


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +   ...+.  .+..   ....  ...+|+.+|+..+|..||++.+|+.
T Consensus       728 ~---~~~L~--~L~~---~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  728 G---NYTLV--HLEP---LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             C---cccee--eecc---CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0   00000  1111   1111  6778899999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=249.80  Aligned_cols=271  Identities=22%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~~  256 (520)
                      +.+..+.||-|+||+||.+++..+|+.||+|++..-  +....+.+.+|+.+|..++|.|++..++......    +.+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            556678999999999999999999999999998653  2344567889999999999999999988643222    1257


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|.|.| ..+|+..+-..       ..++-..+.-+..||++||+|||+.+   |.||||||.|+|++.|-.+|||||||
T Consensus       134 V~TELm-QSDLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHH-HhhhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccc
Confidence            888888 55888877653       57888888889999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh--hHhhh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK--PILHR  413 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--~~~~~  413 (520)
                      |+....++..+ .+..+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+-++..++.-..  +-++.
T Consensus       203 ARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            98765544333 3344578899999999986 58999999999999999998888888766544433332111  00000


Q ss_pred             ch----hHHHHhhCcccCCCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          414 GM----AAVEELLDPRLKCTSR--------NSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       414 ~~----~~l~~~~d~~l~~~~~--------~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      .+    +.-..++......+..        ....-...+.+...++..||.+|.+..+.+..+-
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            00    0111222222211110        0011234556677889999999999998887543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.4e-28  Score=235.65  Aligned_cols=200  Identities=40%  Similarity=0.585  Sum_probs=172.5

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      |...+.||+|++|+||++....+++.+|+|.+...... ..+.+.+|++.++.++|+|++++++++... ...++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence            45678999999999999999877899999999876544 567889999999999999999999987664 4578999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++++|.+++....      ..+++..+..++.+++.+|.+||..+   ++|+||+|.||+++.++.++|+|||++.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       80 EGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999999997642      12889999999999999999999887   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccCchhc-ccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      .... ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4211 12344578899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-28  Score=251.86  Aligned_cols=135  Identities=21%  Similarity=0.351  Sum_probs=114.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-----C---CCeecEEEEEEcCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----H---PNIVPLVGFCIDPE  252 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~l~g~~~~~~  252 (520)
                      ..+|.+.++||.|.|++||++.+....+.||+|+.+.. ..-.+.-+.|+++|++++     |   .+||+|+++|....
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36899999999999999999999998999999998643 233455678999999883     3   36999999886432


Q ss_pred             ---CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec
Q 010012          253 ---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (520)
Q Consensus       253 ---~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld  324 (520)
                         ..+|+|+|++ |-+|..++....     .+.++...+.+|+.||+.||.|||..+  +|||.||||+||||.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~-----YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSN-----YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhC-----CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence               3589999999 889999998754     367999999999999999999999966  699999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4e-29  Score=234.29  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=195.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCC-cEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ-GLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~-~~~LV  258 (520)
                      .++|++.+.+|+|-++.||.|....+++.++||+++..   ..+.+.+|+.||..|. ||||++|++...++.. ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46899999999999999999998878899999999754   3467889999999997 9999999998776653 35799


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla  337 (520)
                      +||+.+.+...+.          +.++-..+..++.+++.||.|+|++|   |+|||+||.||+||. .-.++|+|+|||
T Consensus       114 FE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             hhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchH
Confidence            9999998876654          45777778889999999999999998   999999999999994 567999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc--
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG--  414 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~--  414 (520)
                      .++.....   -...+.+..|--||.+... .|...-|+|||||+|..|+..+.||-... +...+++..++-+-...  
T Consensus       181 EFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHH
Confidence            98765432   1234567778899998765 47888999999999999999999985322 12234444333111000  


Q ss_pred             --hhHHHHhhCcccCC---------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 --MAAVEELLDPRLKC---------------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 --~~~l~~~~d~~l~~---------------~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .....-.+||++..               .....-...++++++...|..|-.+|||++|...
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence              00111112332210               0000011245778888999999999999998865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-29  Score=262.74  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=203.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|.....+|.|.+|-|||+++..+++..|+|+++....+..+-+..|+.+++.-+|||||.++|.+...+ +++++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEE
Confidence            358999999999999999999999999999999999887777778889999999999999999999876644 5899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ||.+|+|.+.-+-.       .++++.++..+.+..++||+|||+++   =+|||||-.|||+++.|.+|++|||.+..+
T Consensus        93 ycgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             ecCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence            99999999887653       67999999999999999999999988   899999999999999999999999998766


Q ss_pred             CCCCCCcccccccccCCccCchhc---ccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~---~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +..-.  ....+.||+.|||||+.   ..+.|..++|||+.|+...|+---++|...-.+  ...+....          
T Consensus       163 tati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~LmT----------  228 (829)
T KOG0576|consen  163 TATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFLMT----------  228 (829)
T ss_pred             hhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHHHHhh----------
Confidence            54322  23567899999999987   467899999999999999999887777543221  11111111          


Q ss_pred             HHHhhC-cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLD-PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d-~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ....+ |.+.......   ..|-+++..|+.++|++||+...++.
T Consensus       229 -kS~~qpp~lkDk~kws---~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  229 -KSGFQPPTLKDKTKWS---EFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -ccCCCCCcccCCccch---HHHHHHHHHHhcCCCccCCChhhhee
Confidence             11122 2333333222   34666777899999999999887654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=256.12  Aligned_cols=197  Identities=26%  Similarity=0.348  Sum_probs=169.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH--------HHHHHHHHHHHHhCC---CCCeecEEEEEEc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--------SKAFCRELMIASSLH---HPNIVPLVGFCID  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~--------~~~~~~E~~il~~l~---HpnIv~l~g~~~~  250 (520)
                      .+|+..+.||+|+||.|++|.++.....|+||.+.+++--.        .-..-.|++||..|+   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999999888999999998753211        112446999999997   9999999998766


Q ss_pred             CCCcEEEEEEec-CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          251 PEQGLFLIYKYV-SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       251 ~~~~~~LV~E~~-~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                       ++++||++|-- ++-+|.+++..+       +.+++..+..|+.|++.|+++||+++   |||||||-+||.++.+|-+
T Consensus       641 -dd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  641 -DDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             -CCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeE
Confidence             55678999865 456899999765       56999999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcc
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      ||+|||.|.......    ...++||.+|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999998765543    356789999999999998887 566899999999999999988875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=2.4e-28  Score=250.79  Aligned_cols=275  Identities=23%  Similarity=0.311  Sum_probs=208.1

Q ss_pred             cccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC------CCCeecE
Q 010012          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH------HPNIVPL  244 (520)
Q Consensus       171 ~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~------HpnIv~l  244 (520)
                      ++.++|+.  ..+|.+....|+|-|++|.+|.+...+..||||+|.....- .+.=+.|++||++|.      --|+++|
T Consensus       423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            33444443  45788888899999999999999888899999999765322 234457999999995      2478888


Q ss_pred             EEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec
Q 010012          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (520)
Q Consensus       245 ~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld  324 (520)
                      +-.|.. .+.+|||+|-+ ..+|.++|.....    +-.|....+..++.|+.-||..|-..+   |+|.||||.|||++
T Consensus       500 ~r~F~h-knHLClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  500 FRHFKH-KNHLCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN  570 (752)
T ss_pred             HHHhhh-cceeEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence            877655 45599999988 6799999987643    367899999999999999999999877   99999999999999


Q ss_pred             CCC-ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhh
Q 010012          325 SKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL  403 (520)
Q Consensus       325 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~l  403 (520)
                      +.- .+||||||.|.........    ...-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+........+
T Consensus       571 E~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             cCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            754 6899999999887765532    22245579999999999999999999999999999999999987665544333


Q ss_pred             HHhhh-----hHhhhchhHHHHhhCcc--------------------------------c----CCCCCCHHHHHHHHHH
Q 010012          404 VLWAK-----PILHRGMAAVEELLDPR--------------------------------L----KCTSRNSAQIARVIQA  442 (520)
Q Consensus       404 v~~~~-----~~~~~~~~~l~~~~d~~--------------------------------l----~~~~~~~~~~~~l~~l  442 (520)
                      ..-.+     .++.++. .+.+-+|..                                |    ..+......+..|.+|
T Consensus       647 ~me~KGk~p~KmlRKgq-F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL  725 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQ-FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL  725 (752)
T ss_pred             HHHhcCCCcHHHhhhcc-hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence            32221     1111110 111111111                                0    0122234566788899


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 010012          443 AAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       443 a~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +..||..||++|.|..+.|+
T Consensus       726 Ldkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  726 LDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHhccChhhcCCHHHHhc
Confidence            99999999999999998876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4e-28  Score=237.43  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=195.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----Cc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~  254 (520)
                      .+|...+.+|.|.- .|..+.+.-.+++||+|++...  .....++-.+|..++..+.|+||++++.++....     ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999988 7777877777899999988543  2233456678999999999999999999764322     23


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +|+|||+| ..+|...++.         .++-.+...|..|++.|+.|||+.+   |+||||||+||++..+..+||.||
T Consensus        96 ~y~v~e~m-~~nl~~vi~~---------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM---------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH---------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccc
Confidence            68999999 6699888873         3777888999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh--
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH--  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~--  412 (520)
                      |+|+.....   ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...     +-.|.+-.-.  
T Consensus       163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lg  234 (369)
T KOG0665|consen  163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLG  234 (369)
T ss_pred             hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhc
Confidence            999865433   234556789999999999998899999999999999999999999875433     2233221111  


Q ss_pred             ------------hchh-----------HHHH-hhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 ------------RGMA-----------AVEE-LLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ------------~~~~-----------~l~~-~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                  .+..           ...+ +-|..+.. ..........+.+++.+||-.+|++|-+++++++
T Consensus       235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                        0000           0000 01111110 0111233455678889999999999999999987

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-28  Score=231.77  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.|.+.+.||+|.||.+-++.++.+.+.+++|.+.+.. ...++|.+|...--.| .|.||+.-++..++..+..++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            57999999999999999999999999999999987653 3457899998765445 589999999887787777889999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CCCceEEeecCCcc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLAT  338 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~~~vkL~DFGla~  338 (520)
                      |+|.|+|.+-+..        ..+.+....+++.|++.|+.|+|+.+   +||||||.+||||-  +...+||||||+.+
T Consensus       103 ~aP~gdL~snv~~--------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA--------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             cCccchhhhhcCc--------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999888764        45788888999999999999999998   99999999999994  34589999999987


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc---C--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---G--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ..+..     ......+..|.+||....   +  ...+.+|||.||+++|.++||..||...... ......|  ..+..
T Consensus       172 k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~--~~w~~  243 (378)
T KOG1345|consen  172 KVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEW--EQWLK  243 (378)
T ss_pred             ccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHH--HHHhc
Confidence            55432     233446778999997643   2  3578899999999999999999999843322 2222332  22222


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      +       ..+++...  ......+++.+..+-|..+|++|=.+.++.++-
T Consensus       244 r-------k~~~~P~~--F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  244 R-------KNPALPKK--FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             c-------cCccCchh--hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            2       11122111  111223455566678888899886666666544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.7e-27  Score=272.26  Aligned_cols=197  Identities=21%  Similarity=0.257  Sum_probs=138.1

Q ss_pred             hCCC-CCeecEEEEEEc------CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 010012          235 SLHH-PNIVPLVGFCID------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT  307 (520)
Q Consensus       235 ~l~H-pnIv~l~g~~~~------~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~  307 (520)
                      .++| +||++++++|..      ....+++++|++ +++|.++|....      ..+++..++.|+.||++||.|||+++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            3445 577777777621      123467888887 679999997532      56999999999999999999999888


Q ss_pred             CCceEecccCCCCeEecC-------------------CCceEEeecCCccccCCCCC--------------Ccccccccc
Q 010012          308 ERCVVHRDIKPSNILLSS-------------------KKIPKLCDFGLATWTSAPSV--------------PFLCKTVKG  354 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~G  354 (520)
                         |+||||||+||||+.                   ++.+||+|||+++.......              ........|
T Consensus       101 ---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181        101 ---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             ---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence               999999999999954                   44566666666653211000              000112358


Q ss_pred             cCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHH
Q 010012          355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSA  434 (520)
Q Consensus       355 t~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  434 (520)
                      |+.|+|||++.+..++.++|||||||+||||++|..|+.....     .   ...+       ....+.+..      ..
T Consensus       178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~---~~~~-------~~~~~~~~~------~~  236 (793)
T PLN00181        178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T---MSSL-------RHRVLPPQI------LL  236 (793)
T ss_pred             CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H---HHHH-------HHhhcChhh------hh
Confidence            8999999999999999999999999999999999988753211     0   0000       001111111      11


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          435 QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       435 ~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .......++.+||+++|.+||+|.||++
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            1233457778999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=5.5e-26  Score=211.57  Aligned_cols=166  Identities=24%  Similarity=0.296  Sum_probs=124.6

Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|.+++....      ..++|..++.|+.|++.||.|||+.+         ||+|||++.++.+|+  ||+++......
T Consensus         1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~   63 (176)
T smart00750        1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ   63 (176)
T ss_pred             CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc
Confidence            78999997642      56999999999999999999999865         999999999999999  99998664422


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                             ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..   ...+..    .... .++
T Consensus        64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~---~~~~~~----~~~~-~~~  126 (176)
T smart00750       64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AI---LEILLN----GMPA-DDP  126 (176)
T ss_pred             -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HH---HHHHHH----Hhcc-CCc
Confidence                   258999999999999999999999999999999999999996532211  00   001100    0000 000


Q ss_pred             ccCCCCCCHHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          425 RLKCTSRNSAQI--ARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       425 ~l~~~~~~~~~~--~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .-  ........  ..+.+++.+||..+|.+||++.++++.+..
T Consensus       127 ~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      127 RD--RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cc--cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            00  00011111  258899999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.8e-26  Score=233.23  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=162.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  255 (520)
                      ..+.|...++||+|.|++||++.+..   .+..||+|.+...+  ....+.+|+++|..+. +.||+++.+++ ..++.+
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~-rnnd~v  110 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF-RNNDQV  110 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh-ccCCee
Confidence            34578889999999999999999876   67889999997643  3356889999999985 88999999865 445568


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeec
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDF  334 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DF  334 (520)
                      ++|+||++.....+++.          .++...+..++..++.||.++|.+|   ||||||||+|+|.+. -+.-.|.||
T Consensus       111 ~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             EEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence            99999999999888875          3778888999999999999999988   999999999999984 456789999


Q ss_pred             CCccccCCCC-------------CC-------------------c----------ccccccccCCccCchhcccC-CCCC
Q 010012          335 GLATWTSAPS-------------VP-------------------F----------LCKTVKGTFGYLAPEYFQHG-KVSD  371 (520)
Q Consensus       335 Gla~~~~~~~-------------~~-------------------~----------~~~~~~Gt~~Y~aPE~~~~~-~~s~  371 (520)
                      |||.......             .+                   .          .--..+||+||.|||++... ..++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9996221000             00                   0          00135699999999998654 5789


Q ss_pred             cCceeeHHHHHHHHHhCCCCcchh
Q 010012          372 KTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       372 ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      ++||||.|||++-+++++.||-..
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             ccceeeccceeehhhccccccccC
Confidence            999999999999999999998643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.4e-24  Score=223.02  Aligned_cols=167  Identities=19%  Similarity=0.181  Sum_probs=130.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC-CCcEEEEEEecCc-----chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ..++|...+.||+|+||+||+|.+.. +++.||||++...     .......|.+|+++|++++|+|+++.+..+   . 
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~-   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G-   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence            44689999999999999999998865 5777899987533     223456689999999999999999644321   2 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCCeEecCCCceEEe
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPKLC  332 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDL-Kp~NILld~~~~vkL~  332 (520)
                      ..+|||||++|++|... ..          ..   ...++.|+++||.|||+.+   |+|||| ||+|||++.++.+||+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence            36899999999999622 10          00   1357889999999999987   999999 9999999999999999


Q ss_pred             ecCCccccCCCCCCcc------cccccccCCccCchhcccC
Q 010012          333 DFGLATWTSAPSVPFL------CKTVKGTFGYLAPEYFQHG  367 (520)
Q Consensus       333 DFGla~~~~~~~~~~~------~~~~~Gt~~Y~aPE~~~~~  367 (520)
                      |||+|+.+........      .+...+++.|+|||++...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999987654321111      1356789999999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.7e-23  Score=211.64  Aligned_cols=261  Identities=21%  Similarity=0.255  Sum_probs=190.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCC-cEEEEEEecCcchHHHHHHHHHHHHHHhCCC----CCeecEEEEEEcCCCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHH----PNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~g~~~~~~~~~~L  257 (520)
                      +|.+.+.||+|+||.||++.....+ ..+|+|............+..|+.++..+..    +++..+++.....+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999987653 5789998766433322267788888888863    5788888765334455689


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-----CceEEe
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLC  332 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-----~~vkL~  332 (520)
                      ||+.+ |.+|.++.....     ...++..+...|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.
T Consensus        99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEE
Confidence            99988 999999886543     267999999999999999999999888   9999999999999854     469999


Q ss_pred             ecCCcc--ccCCCCCC----c-c-cccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          333 DFGLAT--WTSAPSVP----F-L-CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       333 DFGla~--~~~~~~~~----~-~-~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      |||+++  .+......    . . .....||..|.++....+...+.+.|+||++.++.|++.|..||............
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence            999998  43222211    0 1 12355999999999999999999999999999999999999999654322111100


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                         ...      ........   .....+.+...+.   ..+-..+...+|....+...|+..
T Consensus       250 ---~~~------~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  250 ---EKD------PRKLLTDR---FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             ---HHH------hhhhcccc---ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHH
Confidence               000      00111111   1112334444444   445558999999999999887653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=8.1e-23  Score=202.30  Aligned_cols=258  Identities=33%  Similarity=0.478  Sum_probs=194.2

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH---HHHHHHHHHHHHHhCCCC-CeecEEEEEEcCCCcEEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~~LV~  259 (520)
                      |.....||.|+||.||++...   ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++.. ....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence            566788999999999999987   67899998765332   467899999999999988 79999998744 34468999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~  338 (520)
                      +++.+++|.+++......    ..++......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||+++
T Consensus        78 ~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             ecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999999666543210    26888999999999999999999988   99999999999999988 79999999998


Q ss_pred             ccCCCCCCc----ccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccc-cchhhHHhhhhH
Q 010012          339 WTSAPSVPF----LCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ-GEENLVLWAKPI  410 (520)
Q Consensus       339 ~~~~~~~~~----~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~  410 (520)
                      .........    ......||..|+|||.+..   ..++...|+||+|++++++++|..||...... ......    . 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~----~-  225 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----K-  225 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH----H-
Confidence            655433221    2356679999999999987   57889999999999999999999997654321 000000    0 


Q ss_pred             hhhchhHHHHhhCcccCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSRN---SAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~---~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                            .+.....+........   ......+.+++..|+..+|..|.++.+....
T Consensus       226 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 ------IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ------HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                  1111111101000000   1122456778889999999999999987763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.5e-23  Score=228.48  Aligned_cols=254  Identities=23%  Similarity=0.241  Sum_probs=185.3

Q ss_pred             cceEEcccCceEEEEeeecCCCcEEEEEEec-----CcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-----KEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~-----~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..+++|.|++|.|+..........++.|...     ..... ....+..|+.+-..+.|||++..+..+.+.... .-+|
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~m  400 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQSM  400 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhhh
Confidence            4678999999988887776555555555432     11111 112266788888889999998887766665543 3449


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||++ +|..++...       ..+.-..+..++.|++.||.|+|..+   |.|||||++|+++..++.+||+|||.+..
T Consensus       401 E~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             hcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCccee
Confidence            99999 999999763       35778888899999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCC--cccccccccCCccCchhcccCCCCC-cCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~-ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +..+...  .......|+..|+|||.+....|.+ ..||||.||++..|++|+.||......+... ...      ..  
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~------~~--  540 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN------NY--  540 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh------cc--
Confidence            6544333  4556678999999999999999876 5899999999999999999998765543221 000      00  


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ....+-.................++.++|+.+|.+|-||.+|++
T Consensus       541 --~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 --SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              00000000000001122334567788999999999999999987

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=7.7e-21  Score=187.19  Aligned_cols=202  Identities=23%  Similarity=0.323  Sum_probs=167.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEe
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +|.++++||+|+||..+.|..--+++.||||.-...+  ...++..|....+.|. .+.|...+.|-.++. .-.||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-YNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc-hhhhhhhh
Confidence            7999999999999999999988889999999765443  2245667777777774 578887775544433 34699999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-----ceEEeecCC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFGL  336 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-----~vkL~DFGl  336 (520)
                      + |.||++++.-..      ..++.+++.-||.|++.-++|+|+..   +|+|||||+|+||...+     .|.|+|||+
T Consensus       106 L-GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             h-CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence            8 999999987653      67999999999999999999999988   99999999999996433     589999999


Q ss_pred             ccccCCCCCCc-----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          337 ATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      |+.+.++.+..     ...+..||..||+-....+...+.+.|.-|+|-++...|-|..||.+-..
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            99887654322     12456799999999888888999999999999999999999999986443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.9e-21  Score=188.67  Aligned_cols=172  Identities=16%  Similarity=0.153  Sum_probs=132.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH---HHH------HHHHHHHHHhCCCCCeecEEEEEEc
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES---SKA------FCRELMIASSLHHPNIVPLVGFCID  250 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~---~~~------~~~E~~il~~l~HpnIv~l~g~~~~  250 (520)
                      ..++|...++||.|+||.||++..  ++..+|+|.+.......   ...      +.+|+..+.++.||+|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            457999999999999999999655  36689999996543222   122      5789999999999999999988664


Q ss_pred             CC-------CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          251 PE-------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       251 ~~-------~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ..       ...+|||||++|.+|.++..           ++.    ....+++.+|..||..+   ++|||+||+||++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili  168 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV  168 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence            32       34689999999999977632           222    24568999999999988   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHH
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL  386 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELl  386 (520)
                      +.++ ++|+|||...........              ..++....+..++|+|||||++.-+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9988 999999988655322110              11344455678999999999987764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.2e-21  Score=183.27  Aligned_cols=140  Identities=14%  Similarity=0.094  Sum_probs=107.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--H-------HHH-----------------HHHHHHHHHhCCCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--S-------SKA-----------------FCRELMIASSLHHPN  240 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~-------~~~-----------------~~~E~~il~~l~Hpn  240 (520)
                      ...||+|+||.||+|.+. +|+.||||++......  .       ...                 ...|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999997 7999999999654211  0       012                 234999999998877


Q ss_pred             eecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCC
Q 010012          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCVVHRDIKPS  319 (520)
Q Consensus       241 Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~IiHrDLKp~  319 (520)
                      +.....+. . .. .+|||||+++++|...+...       ..+++.....++.|++.+|.|| |+.+   |+||||||+
T Consensus        81 v~~p~~~~-~-~~-~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~  147 (190)
T cd05147          81 IPCPEPIL-L-KS-HVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY  147 (190)
T ss_pred             CCCCcEEE-e-cC-CEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence            64433221 1 22 37999999988776553221       4688999999999999999999 6777   999999999


Q ss_pred             CeEecCCCceEEeecCCccccC
Q 010012          320 NILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~  341 (520)
                      |||++ ++.++|+|||+|....
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCC
Confidence            99998 4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-21  Score=183.02  Aligned_cols=203  Identities=22%  Similarity=0.238  Sum_probs=165.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC-CCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..|...+.||.|+||-+|.|....+|..||||+-.....  ..++..|..+.+.|++ ..|..+..|. .....-.+||+
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~-~e~~ynvlVMd   91 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYG-TEKDYNVLVMD   91 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhc-cccccceeeee
Confidence            689999999999999999999998999999998755432  2456788999998876 3444454443 33445679999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~DFGla  337 (520)
                      .+ |.||++++.-..      ..++..+..-+|-|++.-++|+|..+   .|||||||+|+|..-   ...+.++|||||
T Consensus        92 LL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             cc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence            99 999999987654      56899999999999999999999888   999999999999864   346899999999


Q ss_pred             cccCCCCCCc-----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          338 TWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       338 ~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      +.+-+..+..     ..+...||..|.+--...+...+...|+-|+|.+|..+.-|..||.+-..
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            9775533221     13456799999998877777788899999999999999999999986544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1e-21  Score=188.54  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=180.9

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      ..+|.+...|..|+|++.  |..+++|++...  .....+.|..|.-.|+-+.||||++++|.|..+.+ +.++..||+-
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~isq~mp~  271 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVIISQYMPF  271 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEeeeeccc
Confidence            345778889999999997  445666777543  33445678899999999999999999999987654 7899999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      |+|...|+....     -..+..++.+++.++|+|++|||+.. +-|.---|.+..|+||++.+++|+= +-+++     
T Consensus       272 gslynvlhe~t~-----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----  339 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----  339 (448)
T ss_pred             hHHHHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----
Confidence            999999998643     56788889999999999999999975 3344446899999999999888752 11111     


Q ss_pred             CCcccccccccCCccCchhcccCCC---CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKV---SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~---s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                       +.......-.+.||+||.+...+-   -.++|+|||.++||||.|...||..-.+-+.      ...+       --+-
T Consensus       340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmki-------aleg  405 (448)
T KOG0195|consen  340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKI-------ALEG  405 (448)
T ss_pred             -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhh-------hhcc
Confidence             111223345788999999976653   3479999999999999999999975433111      0000       1111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      +...+  ++.....   +.+++.-|+..||.+||.+..|+-+|+..
T Consensus       406 lrv~i--ppgis~h---m~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  406 LRVHI--PPGISRH---MNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccC--CCCccHH---HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            22222  3333334   44555669999999999999999998863

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=3.4e-20  Score=176.04  Aligned_cols=141  Identities=14%  Similarity=0.127  Sum_probs=110.5

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--------------------------HHHHHHHHHHHHHhCCCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--------------------------SSKAFCRELMIASSLHHPN  240 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--------------------------~~~~~~~E~~il~~l~Hpn  240 (520)
                      .+.||+|+||.||+|.+. +|+.||||++......                          ....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 7999999998754210                          0122357889999999998


Q ss_pred             eecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCC
Q 010012          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPS  319 (520)
Q Consensus       241 Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~  319 (520)
                      +.....+...  . .+|||||++++++.......       ..++......++.|++.+|.+||+ .+   |+||||||+
T Consensus        81 i~~p~~~~~~--~-~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~  147 (190)
T cd05145          81 VPVPEPILLK--K-NVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY  147 (190)
T ss_pred             CCCceEEEec--C-CEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence            7554443322  2 37999999988654432221       357788889999999999999999 77   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCC
Q 010012          320 NILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~  342 (520)
                      |||++ ++.++|+|||++.....
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCC
Confidence            99999 88999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7e-22  Score=209.12  Aligned_cols=186  Identities=28%  Similarity=0.364  Sum_probs=152.9

Q ss_pred             EcccCceEEEEeee---cCCCcEEEEEEecCcchH--HHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          190 LGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       190 LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +|+|.||.|+++.-   .+.+..+|+|++.+....  .......|..++...+ ||.+|++.. +++.+..++++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhy-afqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHY-AFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeee-eeccccchhHhhhhcc
Confidence            79999999997643   345778999988764321  1124456778888887 999999975 5566777899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|.|...+...       ..+.+.....+...++-|++.+|..+   |+|||+|++||+++.+|++++.|||+++..-..
T Consensus        81 gg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   81 GGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             cchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            99998888754       44666666677788999999999888   999999999999999999999999999876544


Q ss_pred             CCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       344 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      ..      .+||..|||||++.  .+...+|+||||++++||+||..||..
T Consensus       151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            32      16999999999998  678899999999999999999999976

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.5e-20  Score=175.23  Aligned_cols=189  Identities=17%  Similarity=0.096  Sum_probs=140.8

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH----HHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEE
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES----SKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      +.+...|++|+||+||.+..  .+..++.+.+.......    ...+.+|+++|++|. |+++++++++     ...+++
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lv   76 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLD   76 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEE
Confidence            34567899999999997765  36778877776543311    225789999999995 5889999886     235899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDL-Kp~NILld~~~~vkL~DFGla  337 (520)
                      |||+.|.+|...+..        .      ...++.|++.+|+++|..+   |+|||| ||+|||++.++.++|+|||+|
T Consensus        77 meyI~G~~L~~~~~~--------~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A  139 (218)
T PRK12274         77 RSYLAGAAMYQRPPR--------G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLA  139 (218)
T ss_pred             EeeecCccHHhhhhh--------h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCc
Confidence            999999998654321        1      1247789999999999988   999999 799999999999999999999


Q ss_pred             cccCCCCCC----c-------ccccccccCCccCchhcccC-CCC-CcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          338 TWTSAPSVP----F-------LCKTVKGTFGYLAPEYFQHG-KVS-DKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       338 ~~~~~~~~~----~-------~~~~~~Gt~~Y~aPE~~~~~-~~s-~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      .........    .       .......++.|++|+-..-- ..+ ...++++-|.-+|.++||+.|...+.
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            855432210    0       01123478889999754322 233 56799999999999999999876544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=3.1e-20  Score=185.31  Aligned_cols=239  Identities=21%  Similarity=0.266  Sum_probs=152.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCC-----------CCeecEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHH-----------PNIVPLVGFC  248 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~H-----------pnIv~l~g~~  248 (520)
                      ....++.||.|+++.||.+++..+++.+|||+.....   ....+++.+|.-....+.+           .-++++--.-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566789999999999999999999999999885432   2345666666655544332           2233322111


Q ss_pred             EcCC----------C-----cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 010012          249 IDPE----------Q-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  313 (520)
Q Consensus       249 ~~~~----------~-----~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiH  313 (520)
                      +.+.          .     ..+++|+-+ .++|.+++..-.........+....+..+..|+++.+++||..+   |+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence            1110          0     136778777 67898886643221111234556677788899999999999988   999


Q ss_pred             cccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC--------CCCCcCceeeHHHHHHHH
Q 010012          314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--------KVSDKTDVYAFGVVLLEL  385 (520)
Q Consensus       314 rDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--------~~s~ksDVwS~GvvL~EL  385 (520)
                      +||||+|+|++.+|.++|+||+.....+...     .....+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999876554321     112345779999977432        478899999999999999


Q ss_pred             HhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 010012          386 LTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR  454 (520)
Q Consensus       386 ltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~R  454 (520)
                      ++|+.||...........                     .+. .  +....+.+..|+...|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~---------------------~f~-~--C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW---------------------DFS-R--CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG---------------------GGT-T--SS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc---------------------cch-h--cCCcCHHHHHHHHHHccCCcccC
Confidence            999999986543321110                     111 1  11334456677789999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=2e-19  Score=173.28  Aligned_cols=137  Identities=20%  Similarity=0.209  Sum_probs=106.9

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-----CCCCeecEEEEEEcCCC--cEE-
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLVGFCIDPEQ--GLF-  256 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~~~~--~~~-  256 (520)
                      ....+||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     +||||++++|++.+..+  .++ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4457899999999996  5555554 69988765444567789999999999     67999999999876532  223 


Q ss_pred             EEEEe--cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecccCCCCeEecC----CCce
Q 010012          257 LIYKY--VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV-AYLHNGTERCVVHRDIKPSNILLSS----KKIP  329 (520)
Q Consensus       257 LV~E~--~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL-~yLH~~~~~~IiHrDLKp~NILld~----~~~v  329 (520)
                      +|+||  +++|+|.+++...        .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcE
Confidence            78999  6689999999642        35555  25577888787 9999988   999999999999974    3479


Q ss_pred             EEeecCCc
Q 010012          330 KLCDFGLA  337 (520)
Q Consensus       330 kL~DFGla  337 (520)
                      +|+||+.+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.5e-20  Score=207.90  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=179.4

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHH---HHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAF---CRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~---~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++...+.||.+.|=.|.+|+++. |. |.||++-+.. .-....|   +.|++ ...++|||.+++.-+ ...+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHH
Confidence            56777889999999999999975 54 8999986553 2223333   34444 556799999998765 3445556788


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      -+|..+ +|.+.|..+       +-+..-+.+.|+.|++.||.-+|..+   |+|+|||.+||||+.=.-+.|+||...+
T Consensus       100 Rqyvkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHHHhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence            888854 888888654       55777888899999999999999988   9999999999999999999999998876


Q ss_pred             cc--CCCCC---CcccccccccCCccCchhcccC----------C-CCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          339 WT--SAPSV---PFLCKTVKGTFGYLAPEYFQHG----------K-VSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       339 ~~--~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~----------~-~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ..  +.++.   .....+...-.+|+|||.+...          . .+++.||||+||++.||++ |++||.....    
T Consensus       169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----  244 (1431)
T KOG1240|consen  169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----  244 (1431)
T ss_pred             CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----
Confidence            32  22221   1122233344579999988542          2 6789999999999999998 8999975432    


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        ..+-..--......++++-|.             .+..+++.|++.||++|-++.+.++.-.|.
T Consensus       245 --~aYr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  245 --LAYRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             --HhHhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence              111100000000012222222             345677889999999999999999986664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.7e-19  Score=189.24  Aligned_cols=217  Identities=26%  Similarity=0.456  Sum_probs=161.6

Q ss_pred             HHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 010012          233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  312 (520)
Q Consensus       233 l~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~Ii  312 (520)
                      |+.+.|.|+.+++|.+.++. ..++|.+||..|+|.+.+....      ..++|.....+..+|+.||+|||+..  .-.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-EMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHNSP--IGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecCC-ceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhcCc--cee
Confidence            45789999999999999974 4789999999999999998742      67999999999999999999999854  239


Q ss_pred             ecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC---C----CCCcCceeeHHHHHHHH
Q 010012          313 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG---K----VSDKTDVYAFGVVLLEL  385 (520)
Q Consensus       313 HrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~----~s~ksDVwS~GvvL~EL  385 (520)
                      |+.+++.|.++|....+||+|||+.................-..-|.|||.+...   .    .+.+.||||||++++|+
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            9999999999999999999999998766431111111222345579999998763   1    46789999999999999


Q ss_pred             HhCCCCcchhccccc-hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          386 LTGRKPIEARRLQGE-ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       386 ltG~~Pf~~~~~~~~-~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      ++.+.||........ ..++.+++.    +   -...+.|.+....   +....++.++..||..+|.+||++.+|-..+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~----~---~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKK----G---GSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHh----c---CCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            999999986443222 122222111    0   1112223322111   2222688899999999999999999999888


Q ss_pred             hcCc
Q 010012          465 RGEE  468 (520)
Q Consensus       465 ~~~~  468 (520)
                      +...
T Consensus       222 ~~~~  225 (484)
T KOG1023|consen  222 LTIN  225 (484)
T ss_pred             hhhc
Confidence            7643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=1.9e-19  Score=199.05  Aligned_cols=217  Identities=26%  Similarity=0.380  Sum_probs=148.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ..+|..+++|-.|++|.||..+++.+.+++|+| +.++..     +.+-  ++.....|                ++|  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~np----------------fvv--  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNP----------------FVV--  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCc----------------cee--
Confidence            368999999999999999999999889999995 433221     0000  22222222                233  


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                          |+-...+...       ..++-.        ++.+++|||+.+   |+|||+||+|+||..-|++|++|||+++..
T Consensus       136 ----gDc~tllk~~-------g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----GDCATLLKNI-------GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----chhhhhcccC-------CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence                4444444432       234332        277999999888   999999999999999999999999998743


Q ss_pred             CCCCC-------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          341 SAPSV-------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       341 ~~~~~-------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      .....             ....+.++||+.|.|||++....|+..+|||++|+|+||.+-|..||.++.+++....+   
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---  270 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---  270 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---
Confidence            21110             11234578999999999999999999999999999999999999999987664321110   


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                +.+.+    .-+..+.....++.+++.+.|+.+|..|---...++
T Consensus       271 ----------isd~i----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  271 ----------ISDDI----EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             ----------hhhhc----cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence                      11111    001111122234556677899999999965443333

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.5e-17  Score=163.48  Aligned_cols=146  Identities=14%  Similarity=0.105  Sum_probs=111.1

Q ss_pred             CCcccceEEcccCceEEEEee-ecCCCcEEEEEEecCcchH------------------------HHHHHHHHHHHHHhC
Q 010012          182 HNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKE------------------------SSKAFCRELMIASSL  236 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~-~~~~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~il~~l  236 (520)
                      ..|...+.||+|+||.||+|. ...+++.||+|++......                        ....+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998 5557899999998753210                        112356899999999


Q ss_pred             CCC--CeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 010012          237 HHP--NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR  314 (520)
Q Consensus       237 ~Hp--nIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHr  314 (520)
                      .+.  .+.+++++    .. .++||||+++++|.......       ..+.......++.|++.+|.+||..+  .|+||
T Consensus       108 ~~~~i~~p~~~~~----~~-~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      108 YEAGVPVPKPIAW----RR-NVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HhcCCCCCeeeEe----cC-ceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            763  33444443    12 47999999998887654321       33555566789999999999999754  39999


Q ss_pred             ccCCCCeEecCCCceEEeecCCccccCC
Q 010012          315 DIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       315 DLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ||||+||+++ ++.++|+|||++.....
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            9999999999 88999999999875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.3e-17  Score=158.29  Aligned_cols=134  Identities=25%  Similarity=0.388  Sum_probs=110.1

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcch--------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +.||+|++|.||+|..  .+..|++|+......        .....+.+|+.++..+.|++++....++.+.. ..++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEE
Confidence            5799999999999987  367799997653221        11245778999999999999887776665544 468999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++|++|.+++...          .+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998642          12 77889999999999999888   99999999999999 78899999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3.5e-17  Score=156.15  Aligned_cols=145  Identities=19%  Similarity=0.125  Sum_probs=111.0

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch----------------------HHHHHHHHHHHHH
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------------------ESSKAFCRELMIA  233 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~il  233 (520)
                      ++......|...+.||+|+||.||++... +++.||||++.....                      .....+..|..++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            44444445888899999999999999886 689999998754320                      0112356788889


Q ss_pred             HhCCCC--CeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 010012          234 SSLHHP--NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV  311 (520)
Q Consensus       234 ~~l~Hp--nIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~I  311 (520)
                      ..+.|+  .++..++.     ...++||||+++++|......             .....++.+++.++.++|+.+   |
T Consensus        88 ~~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~g---i  146 (198)
T cd05144          88 KALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKHG---I  146 (198)
T ss_pred             HHHHHcCCCCCceeec-----CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHCC---C
Confidence            988887  44444432     235899999999998765321             224568899999999999877   9


Q ss_pred             EecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       312 iHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      +||||||+||++++++.++|+|||++.....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999999965544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=6.9e-18  Score=189.96  Aligned_cols=199  Identities=20%  Similarity=0.197  Sum_probs=153.6

Q ss_pred             HHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCC
Q 010012          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       177 i~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~  253 (520)
                      +......|.+.+.||+|+||+||+|...+ ++.||+|+-+.....   +|.--.+++.+|+   -+-|..+...+.- .+
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~  767 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF-QN  767 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc-CC
Confidence            33455788889999999999999999987 999999987654432   2222333444444   1123333322222 23


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-------CC
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-------SK  326 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-------~~  326 (520)
                      ..+||+||.+.|+|.+++..       +..++|...+.|+.|++..++.||..+   |||+||||.|.||.       +.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~-------~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINT-------NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             cceeeeeccccccHHHhhcc-------CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence            35899999999999999983       267999999999999999999999988   99999999999994       23


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCC
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK  390 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~  390 (520)
                      .-++|+|||-+-.+.--........+.+|-.+--+|...+..++...|.|.|+-+++-||.|+.
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            4699999999865432222223456778999999999999999999999999999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.3e-17  Score=167.75  Aligned_cols=198  Identities=26%  Similarity=0.330  Sum_probs=133.3

Q ss_pred             CCCCeecEEEEEEcC--------------------------CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHH
Q 010012          237 HHPNIVPLVGFCIDP--------------------------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY  290 (520)
Q Consensus       237 ~HpnIv~l~g~~~~~--------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~  290 (520)
                      +|||||++.++|.+.                          ...+||||.-.+ .+|.+++-..        ..+...+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--------~~s~r~~~  344 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--------HRSYRTGR  344 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--------CCchHHHH
Confidence            599999999876531                          112688988774 4899998753        35555666


Q ss_pred             HHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CC--CceEEeecCCccccCC--CCCCcc--cccccccCCccCch
Q 010012          291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SK--KIPKLCDFGLATWTSA--PSVPFL--CKTVKGTFGYLAPE  362 (520)
Q Consensus       291 ~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~--~~vkL~DFGla~~~~~--~~~~~~--~~~~~Gt~~Y~aPE  362 (520)
                      -|+.|+++|+.|||.++   |.|||+|+.||||.  +|  ..+.|+|||.+--...  -..+..  ....-|...-||||
T Consensus       345 ~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE  421 (598)
T KOG4158|consen  345 VILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE  421 (598)
T ss_pred             HHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence            78899999999999988   99999999999993  33  3689999998742211  011111  12234778899999


Q ss_pred             hcccCC-----C-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHH
Q 010012          363 YFQHGK-----V-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQI  436 (520)
Q Consensus       363 ~~~~~~-----~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  436 (520)
                      ++....     . -.|+|.|+.|.+.||+++...||....   +..+...          ..++--=|.+.  ...+.  
T Consensus       422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~~r----------~Yqe~qLPalp--~~vpp--  484 (598)
T KOG4158|consen  422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLDTR----------TYQESQLPALP--SRVPP--  484 (598)
T ss_pred             hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheechh----------hhhhhhCCCCc--ccCCh--
Confidence            986432     1 358999999999999999999998622   1111100          11111112222  11222  


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          437 ARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       437 ~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                       .+.+++...|+.||++||+..-....|
T Consensus       485 -~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  485 -VARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -HHHHHHHHHhcCCccccCCccHHHhHH
Confidence             345667789999999999976554443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=5.5e-17  Score=177.87  Aligned_cols=139  Identities=24%  Similarity=0.339  Sum_probs=109.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEe-cCc-c------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL-DKE-D------KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l-~~~-~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~  251 (520)
                      ....|...+.||+|+||+||+|.+...  .+++|+. .+. .      ....+.+.+|++++..++|++++....++.+.
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            344566788999999999999987643  3444432 111 1      11235688999999999999998887776664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      .. .++||||+++++|.+++..               +..++.+++++|.|||+.+   |+||||||+|||+ .++.++|
T Consensus       409 ~~-~~lv~E~~~g~~L~~~l~~---------------~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        409 EE-KTIVMEYIGGKDLKDVLEG---------------NPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             CC-CEEEEEecCCCcHHHHHHH---------------HHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            43 6899999999999988752               3468999999999999988   9999999999999 6789999


Q ss_pred             eecCCcccc
Q 010012          332 CDFGLATWT  340 (520)
Q Consensus       332 ~DFGla~~~  340 (520)
                      +|||+++..
T Consensus       469 iDFGla~~~  477 (535)
T PRK09605        469 IDFGLGKYS  477 (535)
T ss_pred             EeCcccccC
Confidence            999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=7.1e-17  Score=153.63  Aligned_cols=130  Identities=22%  Similarity=0.369  Sum_probs=103.5

Q ss_pred             EEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .||+|+||.||+|...  +..|++|......        .....++.+|++++..++|+++.....++.... ..++|||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-NKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-CCEEEEE
Confidence            3899999999999853  6789999864321        112356778999999999887555444444433 3589999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |++|++|.+++....        .      .++.+++.+|.+||+.+   ++|||++|.||+++ ++.+++.|||++..
T Consensus        78 ~~~g~~l~~~~~~~~--------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN--------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH--------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998875421        1      68999999999999888   99999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=3.4e-18  Score=178.22  Aligned_cols=170  Identities=26%  Similarity=0.403  Sum_probs=127.8

Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++.|++|.-.+|.++|.....+    ...+|.....++.|++.|++|   .+   .+|||+||.||+...+..+||.|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~----e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG----EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc----cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence            378999999999999999865432    568899999999999999999   45   99999999999999999999999


Q ss_pred             cCCccccCCCCC----CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhh
Q 010012          334 FGLATWTSAPSV----PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       334 FGla~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      ||+.........    ....+...||..||+||.+.+..|+.|+||||||+||+||++ =..+++...            
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------------  467 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------------  467 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------------
Confidence            999876654431    112245679999999999999999999999999999999997 333332111            


Q ss_pred             hHhhhchhHHHHhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          409 PILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                              ...++-|..+.  .....+.+    ..++.+++.+.|.+||+.
T Consensus       468 --------t~~d~r~g~ip~~~~~d~p~e----~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  468 --------TLTDIRDGIIPPEFLQDYPEE----YTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             --------hhhhhhcCCCChHHhhcCcHH----HHHHHHhcCCCcccCchH
Confidence                    22222232222  01112222    345678999999999943

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1e-15  Score=144.10  Aligned_cols=137  Identities=19%  Similarity=0.194  Sum_probs=97.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchH--HHHH----------------------HHHHHHHHHhCCCCC--
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKA----------------------FCRELMIASSLHHPN--  240 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~----------------------~~~E~~il~~l~Hpn--  240 (520)
                      .+.||+|+||+||+|... +++.||||++......  ....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 6889999998653211  1111                      134555666654432  


Q ss_pred             eecEEEEEEcCCCcEEEEEEecCCCChhHH-hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCC
Q 010012          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERH-LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKP  318 (520)
Q Consensus       241 Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~~-L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp  318 (520)
                      +.+.+++    . ..++||||++++.+... +...        ... .....++.+++.++.++|. .+   |+||||||
T Consensus        81 ~~~~~~~----~-~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p  143 (187)
T cd05119          81 VPKPIDL----N-RHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSE  143 (187)
T ss_pred             CCceEec----C-CCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence            4444432    1 24899999999654322 2111        011 5567899999999999998 66   99999999


Q ss_pred             CCeEecCCCceEEeecCCccccCC
Q 010012          319 SNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      +||+++ ++.++|+|||.+.....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccC
Confidence            999999 89999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=2.8e-15  Score=147.61  Aligned_cols=136  Identities=17%  Similarity=0.175  Sum_probs=105.4

Q ss_pred             ceEEc-ccCceEEEEeeecCCCcEEEEEEecCcc-------------hHHHHHHHHHHHHHHhCCCCCe--ecEEEEEEc
Q 010012          187 GRVLG-RGALSFVFKGKVGLLRTSVAIKRLDKED-------------KESSKAFCRELMIASSLHHPNI--VPLVGFCID  250 (520)
Q Consensus       187 ~~~LG-~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~  250 (520)
                      ...|| .||.|+||.+...  +..++||++....             ......+.+|++++..|+|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 8999999999875  6789999885321             1223467889999999998875  667766443


Q ss_pred             CCCc---EEEEEEecCC-CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          251 PEQG---LFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       251 ~~~~---~~LV~E~~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      ....   .++|+|+++| .+|.+++..        ..++..    .+.+++.+|.+||..+   |+||||||.|||++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD  178 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence            3322   2599999997 689888754        234443    3578999999999988   9999999999999999


Q ss_pred             CceEEeecCCccc
Q 010012          327 KIPKLCDFGLATW  339 (520)
Q Consensus       327 ~~vkL~DFGla~~  339 (520)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=3.4e-15  Score=133.34  Aligned_cols=135  Identities=21%  Similarity=0.234  Sum_probs=110.9

Q ss_pred             cceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCCCcEEEEEEecC
Q 010012          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.+.||.|.++.||++....  ..+++|.......  ...+..|+.++..++|  +++++++++.... +..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecC
Confidence            35789999999999999863  6799999866543  4578899999999976  5888888876443 45799999998


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ++.+..+              +......++.+++++|.+||.....+++|+|++|.|||+++.+.+++.|||++..
T Consensus        77 g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8877433              4455667899999999999987556799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.6e-16  Score=174.89  Aligned_cols=256  Identities=26%  Similarity=0.309  Sum_probs=184.3

Q ss_pred             CCcccceEEcccCceEEEEeeec-CCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ..|...+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |+|++.+++...+.+ ..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-cccc
Confidence            35677778999999999888763 334567777775543  222334445666666676 999999999765544 4689


Q ss_pred             EEEecCCCChhHHhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecccCCCCeEecCCC-ceEEeec
Q 010012          258 IYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTERCVVHRDIKPSNILLSSKK-IPKLCDF  334 (520)
Q Consensus       258 V~E~~~~gsL~~~L~-~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~~~IiHrDLKp~NILld~~~-~vkL~DF  334 (520)
                      +.+|..++++.+.+. ...      ...+....-.++.|+..++.|+| ..+   +.||||||+|.+++..+ .++++||
T Consensus        99 ~~~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             ccCcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            999999999988883 321      14555566678999999999999 777   99999999999999999 9999999


Q ss_pred             CCccccCC-CCCCcccccccc-cCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          335 GLATWTSA-PSVPFLCKTVKG-TFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       335 Gla~~~~~-~~~~~~~~~~~G-t~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      |+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|.... 
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~-  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK-  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc-
Confidence            99987776 444444555678 9999999999874 557889999999999999999999876543321 111111000 


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        +      .  .....   .........++...++..+|..|.+.+++..
T Consensus       248 --~------~--~~~~~---~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 --G------R--FTQLP---WNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --c------c--cccCc---cccCChhhhhcccccccCCchhccccccccc
Confidence              0      0  00000   1112234556667888899999999888754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=3.7e-13  Score=143.74  Aligned_cols=145  Identities=21%  Similarity=0.221  Sum_probs=100.2

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHH---------------------------------------
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---------------------------------------  223 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~---------------------------------------  223 (520)
                      .|+. +.||.|++|.||+|++. +|+.||||+....-....                                       
T Consensus       119 ~fd~-~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       119 EFEE-KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hCCC-cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            4443 68999999999999987 589999999865421110                                       


Q ss_pred             -HHHHHHHHHHHhC----CCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHH
Q 010012          224 -KAFCRELMIASSL----HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE  298 (520)
Q Consensus       224 -~~~~~E~~il~~l----~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~  298 (520)
                       -+|.+|+..+.++    +|.+-+.+-.++.+.....+|||||++|++|.++.....      ...   .+..++..++.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~------~~~---~~~~ia~~~~~  267 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE------AGL---DRKALAENLAR  267 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh------cCC---CHHHHHHHHHH
Confidence             0234455555444    232223322233332334589999999999988875422      112   23456666666


Q ss_pred             -HHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          299 -SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       299 -aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                       .+..+|..+   ++|+|++|.||+++.++.++++|||++..++
T Consensus       268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             467889877   9999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3.1e-12  Score=118.04  Aligned_cols=131  Identities=18%  Similarity=0.144  Sum_probs=96.1

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      .+.|+.|.++.||++...  +..|++|+...... ....+..|+.+++.+.+.++++-+-++.. .. .++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-~~-~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-ET-GVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-CC-CeEEEEecCCCc
Confidence            357899999999999875  67899998765432 22346688999988876555543333332 22 379999999988


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +....            .   ....++.+++++|..||..+  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            75430            0   01245678999999999876  23469999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=6.5e-12  Score=136.28  Aligned_cols=149  Identities=17%  Similarity=0.153  Sum_probs=95.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH------------------------------H----HH---
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------------------------------S----SK---  224 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~------------------------------~----~~---  224 (520)
                      ..|+. +.||+|++|+||+|+++++|+.||||++.+.-..                              .    .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 7899999999999999877999999999754211                              0    01   


Q ss_pred             ---HHHHHHHHHHhCC----CCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 010012          225 ---AFCRELMIASSLH----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  297 (520)
Q Consensus       225 ---~~~~E~~il~~l~----HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia  297 (520)
                         +|.+|+..+.+++    +.+.+.+-.++.+-....+|||||+.|+.|.++-.-...+. ....+.......++.|+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH-
Confidence               1334554444442    33334333333333334589999999999977532111100 00112222233333333 


Q ss_pred             HHHHHHHhCCCCceEecccCCCCeEecCCC----ceEEeecCCccccCC
Q 010012          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKLCDFGLATWTSA  342 (520)
Q Consensus       298 ~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vkL~DFGla~~~~~  342 (520)
                            ...+   ++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3455   99999999999999888    999999999977654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=1.1e-12  Score=130.03  Aligned_cols=206  Identities=19%  Similarity=0.259  Sum_probs=138.9

Q ss_pred             HHHHhCCCCCeecEEEEEEcCC----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 010012          231 MIASSLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG  306 (520)
Q Consensus       231 ~il~~l~HpnIv~l~g~~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~  306 (520)
                      .-|-++.|.|||++..|+.+..    .+..++.|||..|+|..+|++.++.   ...+......++..||+.||.|||+.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~---~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN---QKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh---hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3455667999999998875533    2467999999999999999986542   25678888889999999999999986


Q ss_pred             CCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC--CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHH
Q 010012          307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE  384 (520)
Q Consensus       307 ~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~E  384 (520)
                      . ++|+|+++...-|++..++-+|+.----...-.....  ........+-++|.+||+-...+.+.++|||+||...+|
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            4 7899999999999999999998853111000000000  000112346789999998877778889999999999999


Q ss_pred             HHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          385 LLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       385 LltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      |.-|..--......-   .+       +.   .+...+- .+...        .-..++..|++..|..||+|++++.
T Consensus       275 mailEiq~tnseS~~---~~-------ee---~ia~~i~-~len~--------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  275 MAILEIQSTNSESKV---EV-------EE---NIANVII-GLENG--------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHheeccCCCccee---eh-------hh---hhhhhee-eccCc--------cccCcCcccccCCCCCCcchhhhhc
Confidence            987765321111000   00       00   0000000 00000        0113456799999999999999876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.9e-12  Score=137.66  Aligned_cols=250  Identities=22%  Similarity=0.265  Sum_probs=177.4

Q ss_pred             CCcccceEEcc--cCceEEEEeee--cCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGR--GALSFVFKGKV--GLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~--G~fG~Vy~~~~--~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~  254 (520)
                      ..|.....+|.  |.+|.||.+..  ..++..+|+|.-+..  .......=.+|+.....++ |+|.++....+.. ...
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence            35667788999  99999999998  778889999984332  2233333345666666664 8999997766544 445


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecccCCCCeEecCC-Cce
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE----SVAYLHNGTERCVVHRDIKPSNILLSSK-KIP  329 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~----aL~yLH~~~~~~IiHrDLKp~NILld~~-~~v  329 (520)
                      .++-.|++ +.+|..+.+...      ..++....+.+..+..+    ||..+|...   |+|-|+||.||++..+ ...
T Consensus       193 lfiqtE~~-~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             ceeeeccc-cchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence            67778877 678888887643      34777777788888888    999999888   9999999999999999 899


Q ss_pred             EEeecCCccccCCCCCCc---ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          330 KLCDFGLATWTSAPSVPF---LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +++|||+...+.......   ......|..-|++||... +-++.++|+|++|.+.++..+|..+...........    
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----
Confidence            999999998877654221   112235778899999874 567899999999999999999888765442222111    


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                 ++....+.    .+.......+...+..+++.+|..|++.+.+..
T Consensus       338 -----------~r~~~ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 -----------LRQGYIPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -----------cccccCch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                       11111110    011111112223667899999999999887665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.24  E-value=1.7e-12  Score=144.65  Aligned_cols=251  Identities=22%  Similarity=0.250  Sum_probs=168.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .-+.|...+.+-+|.++.++.+.-..++...+.|......   ....+....+-.++-..++|-+++...-+ ......+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-PCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-CCCCCcc
Confidence            4466777778889999999988776666555555443221   11122223333333334556666554331 2234478


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      ||++|..+++|...|+..       ...+..........+..+++|||...   ++|||++|.|+|+..+++.+++|||+
T Consensus       881 L~~~~~~~~~~~Skl~~~-------~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS-------GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             hhhHHhccCCchhhhhcC-------CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            999999999999999864       23444445556667889999999866   89999999999999999999999995


Q ss_pred             ccccCCC--------C-C--------------------CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh
Q 010012          337 ATWTSAP--------S-V--------------------PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT  387 (520)
Q Consensus       337 a~~~~~~--------~-~--------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt  387 (520)
                      ....+..        . .                    ........||+.|++||...+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            4322110        0 0                    001124569999999999999999999999999999999999


Q ss_pred             CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          388 GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       388 G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                      |.+||....++..                 .+.++......+.........+.+++...+..+|.+|-.+.
T Consensus      1031 g~pp~na~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999987665431                 12222222221222222333445556667888898888776

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=2.8e-10  Score=109.29  Aligned_cols=143  Identities=23%  Similarity=0.342  Sum_probs=106.8

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCC--CcEEEEEEec
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE--QGLFLIYKYV  262 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~--~~~~LV~E~~  262 (520)
                      +.||.|..+.||++...+ |..+++|....... .....+..|+++++.+.+  .++.+++.+.....  +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            578999999999998754 57899998765432 134567889999999876  34566777654422  2458999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----------------------------------  307 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----------------------------------  307 (520)
                      +|.++...+..        ..++...+..++.+++++|..||+..                                   
T Consensus        83 ~G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          83 DGRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             CCEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            99888765531        23666677777888888888887521                                   


Q ss_pred             ------------------CCceEecccCCCCeEecC--CCceEEeecCCccc
Q 010012          308 ------------------ERCVVHRDIKPSNILLSS--KKIPKLCDFGLATW  339 (520)
Q Consensus       308 ------------------~~~IiHrDLKp~NILld~--~~~vkL~DFGla~~  339 (520)
                                        ...++|+|+.|.|||++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              245899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=2.9e-11  Score=128.71  Aligned_cols=248  Identities=22%  Similarity=0.196  Sum_probs=169.5

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-CCCcEEEEEEecCcchHHHHH--HHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKEDKESSKA--FCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~~~~~~~--~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      -+.+|.....||.|.|+.|+....+ .++..|++|.+.+.......+  -..|+.+...+ .|.+++.+...+.+..+ .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence            3457889999999999999998755 567889999886653222222  13455444444 47777876655444343 5


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEeec
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDF  334 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~DF  334 (520)
                      ++--|||+++++...+.-.       ..+....++.+..|++.++.++|+..   ++|+|+||+||++..+ +.-++.||
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence            7889999999987766322       45778888899999999999999877   9999999999999876 78899999


Q ss_pred             CCccccCCCCCCcccccccccCCcc--CchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYL--APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~--aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |.+..+....     ....+.-++.  +|+......+..+.|++|||..+.|.++|..--...        +.|.     
T Consensus       412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~-----  473 (524)
T KOG0601|consen  412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL-----  473 (524)
T ss_pred             ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccce-----
Confidence            9987533221     1112333444  555556667899999999999999999886543211        1110     


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                          .+..-.-+.+.      .....+..++..+...++..||...++......
T Consensus       474 ----~i~~~~~p~~~------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  474 ----TIRSGDTPNLP------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ----eeecccccCCC------chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                11111111111      111445566667899999999998887765443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.12  E-value=1.2e-09  Score=104.06  Aligned_cols=138  Identities=15%  Similarity=0.173  Sum_probs=97.1

Q ss_pred             eEEcccCceEEEEeeecC------CCcEEEEEEecCcc----------------------hHHHHHHH----HHHHHHHh
Q 010012          188 RVLGRGALSFVFKGKVGL------LRTSVAIKRLDKED----------------------KESSKAFC----RELMIASS  235 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------~~~~vAvK~l~~~~----------------------~~~~~~~~----~E~~il~~  235 (520)
                      ..||.|-=+.||.|...+      .+..+|||+.....                      ....+.+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      24789999874210                      01122233    78888888


Q ss_pred             CCC--CCeecEEEEEEcCCCcEEEEEEecCCCChhH-HhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCce
Q 010012          236 LHH--PNIVPLVGFCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCV  311 (520)
Q Consensus       236 l~H--pnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~I  311 (520)
                      +..  -++...+++   ..  -+|||||+.+..+.. .+..        ..++......+..+++.+|..| |..+   |
T Consensus        83 l~~~Gv~vP~pi~~---~~--~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~g---l  146 (197)
T cd05146          83 MQKAGIPCPEVVVL---KK--HVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKECN---L  146 (197)
T ss_pred             HHHcCCCCCeEEEe---cC--CEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            853  456666654   12  379999997654422 2221        2344455667889999999999 7777   9


Q ss_pred             EecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       312 iHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ||+||++.|||++ ++.+.|+|||.+.....
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999999997 46799999998875544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.11  E-value=5.5e-10  Score=120.33  Aligned_cols=170  Identities=20%  Similarity=0.257  Sum_probs=127.0

Q ss_pred             EeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCC
Q 010012          200 KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR  279 (520)
Q Consensus       200 ~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~  279 (520)
                      .|..+.++.+|.|...+...........+.++.|+.++||||++++.... .+..+|||.|-+.  .|..++...     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV~--Pl~~~lk~l-----  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERVR--PLETVLKEL-----  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeeccc--cHHHHHHHh-----
Confidence            46677788899999988776644556778889999999999999998654 4557899999884  577777653     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCcc
Q 010012          280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL  359 (520)
Q Consensus       280 ~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~  359 (520)
                           ........+.||+.||.+||+.+  .++|++|.-..|+|++.|+-||++|.++........+  .....--..|.
T Consensus       102 -----~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~  172 (690)
T KOG1243|consen  102 -----GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFD  172 (690)
T ss_pred             -----HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhccc
Confidence                 23344456889999999999755  3999999999999999999999999987644332210  11112223466


Q ss_pred             CchhcccCCCCCcCceeeHHHHHHHHHhC
Q 010012          360 APEYFQHGKVSDKTDVYAFGVVLLELLTG  388 (520)
Q Consensus       360 aPE~~~~~~~s~ksDVwS~GvvL~ELltG  388 (520)
                      .|+.+....  -..|.|-||++++|++.|
T Consensus       173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  173 DPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            776553322  346999999999999999

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=5.6e-09  Score=109.59  Aligned_cols=175  Identities=18%  Similarity=0.277  Sum_probs=133.6

Q ss_pred             ceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc---CCCcEEEEEEecCC-CChhHH
Q 010012          195 LSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLFLIYKYVSG-GSLERH  270 (520)
Q Consensus       195 fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~~~LV~E~~~~-gsL~~~  270 (520)
                      -.+.|++....+|..|++|++...+.........-+++++++.|+|+|++.+++..   ++..++|||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35899999998999999999955443333344466889999999999999987652   23348899999997 577666


Q ss_pred             hhhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          271 LHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       271 L~~~~~~--------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      -......        ...+...++...|.++.|+..||.++|+.|   +.-+-|.|.+||++.+..++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5443221        123456889999999999999999999988   88899999999999999999998888766654


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCC
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP  391 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~P  391 (520)
                      +...              |  +..   -.+-|.=.||.+++.|.||..-
T Consensus       446 d~~~--------------~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE--------------P--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc--------------c--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4310              1  111   1256788899999999999654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.93  E-value=2.1e-08  Score=92.92  Aligned_cols=143  Identities=23%  Similarity=0.283  Sum_probs=100.5

Q ss_pred             cceEEcccCceEEEEeeecCCCcEEEEEEecCc--------chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--------DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--------~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ...+|-+|+-+.|+++...  |+...||.-...        ..-..++..+|+.+|.+++--.|.--.-++.+.... .|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~-~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG-QI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC-eE
Confidence            5578899999999999886  677677743221        112234567899988887543333222234455443 69


Q ss_pred             EEEecCC-CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---ceEEee
Q 010012          258 IYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCD  333 (520)
Q Consensus       258 V~E~~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vkL~D  333 (520)
                      +|||++| .++.+++...-.     ..........++..|-+.+.-||.+.   |||+||..+||+|..++   .+.+.|
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EEEeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence            9999977 478888876432     22222233678888999999999988   99999999999997665   458999


Q ss_pred             cCCccc
Q 010012          334 FGLATW  339 (520)
Q Consensus       334 FGla~~  339 (520)
                      ||++..
T Consensus       160 fgls~~  165 (229)
T KOG3087|consen  160 FGLSSV  165 (229)
T ss_pred             ecchhc
Confidence            999753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.90  E-value=1.9e-08  Score=93.56  Aligned_cols=130  Identities=23%  Similarity=0.381  Sum_probs=93.4

Q ss_pred             EEcccCceEEEEeeecCCCcEEEEEEecCc---chH-----HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .+++|+=+.+|.+...  +..+.+|.-.+.   .+.     ....-.+|+.++.+++--.|..-+=|.+++.. ..|+||
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~me   79 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVME   79 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEEE
Confidence            5788999999999664  444666643222   111     12344678999988764333333333456555 469999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |++|-.|.+.+...              +..++..+-.-+.-||..+   |+|+||.++||++.... +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998888652              2356777778888999988   99999999999998766 99999999874

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=8.6e-08  Score=95.91  Aligned_cols=142  Identities=18%  Similarity=0.081  Sum_probs=98.0

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcchH-HHH----------HHHHHHHHHHhCCCC--CeecEEEEEEcC---
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSK----------AFCRELMIASSLHHP--NIVPLVGFCIDP---  251 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~----------~~~~E~~il~~l~Hp--nIv~l~g~~~~~---  251 (520)
                      +.+-......|+++...  |+.|.||........ ..+          .+.+|...+..+...  ..++++++....   
T Consensus        28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            34444444456676654  678999977443311 111          367888887777422  234445554332   


Q ss_pred             -CCcEEEEEEecCCC-ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC----
Q 010012          252 -EQGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----  325 (520)
Q Consensus       252 -~~~~~LV~E~~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~----  325 (520)
                       ...-+||+|++++. +|.+++.....     ...+...+..++.+++..+.-||..+   |+|+|++++|||++.    
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence             12367999999886 89998854211     34556677789999999999999988   999999999999975    


Q ss_pred             ---CCceEEeecCCccc
Q 010012          326 ---KKIPKLCDFGLATW  339 (520)
Q Consensus       326 ---~~~vkL~DFGla~~  339 (520)
                         ++.+.|+||+.+..
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               46899999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.84  E-value=4.6e-08  Score=100.56  Aligned_cols=200  Identities=20%  Similarity=0.226  Sum_probs=131.4

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEE------EcCCCcEEEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC------IDPEQGLFLI  258 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~------~~~~~~~~LV  258 (520)
                      ..++.||+|+-+.+|-.-.-  +..|| |++.........+...|  +...-.||-+-.-+.|=      .+.....-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhh-eeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            45678999999999965332  23344 77765544333322222  22233566433312211      1112224577


Q ss_pred             EEecCCCC-hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGS-LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gs-L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |..+++.. +..++.. ...........|.....++..++.+.+-||+.|   -+-+|+.++|+|+.+++.+.|.|=..-
T Consensus        89 mP~v~g~~pI~~~y~p-~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          89 MPKVSGKEPIHMIYSP-ATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             cccCCCccchhhhcCc-hhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            77776642 2233222 111223356789999999999999999999988   899999999999999999999985544


Q ss_pred             cccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhC-CCCcchhc
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTG-RKPIEARR  396 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG-~~Pf~~~~  396 (520)
                      ..... ..  .....+|...|.+||.-.     +-.-+..+|.|.+||++++|+.| +.||.+-.
T Consensus       165 qi~~n-g~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         165 QINAN-GT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             eeccC-Cc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            33322 11  223467999999999754     33457789999999999999985 99997543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=8e-08  Score=91.03  Aligned_cols=125  Identities=21%  Similarity=0.217  Sum_probs=80.9

Q ss_pred             EEEeeecCCCcEEEEEEecCcc--------------------------hHHHHHHHHHHHHHHhCCCC--CeecEEEEEE
Q 010012          198 VFKGKVGLLRTSVAIKRLDKED--------------------------KESSKAFCRELMIASSLHHP--NIVPLVGFCI  249 (520)
Q Consensus       198 Vy~~~~~~~~~~vAvK~l~~~~--------------------------~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~  249 (520)
                      ||.|...+ +..+|||+.....                          ........+|.+.|.++..-  ++.+++++  
T Consensus         2 Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            89998864 7799999874310                          00123456899999999765  46666654  


Q ss_pred             cCCCcEEEEEEecC--CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceEecccCCCCeEecCC
Q 010012          250 DPEQGLFLIYKYVS--GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY-LHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       250 ~~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~y-LH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      . .+  +|||||++  |..+..+....         ++......++.+++..+.. +|..+   |+|+||.+.|||++++
T Consensus        79 ~-~~--~ivME~I~~~G~~~~~l~~~~---------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   79 N-RN--VIVMEYIGEDGVPLPRLKDVD---------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG  143 (188)
T ss_dssp             E-TT--EEEEE--EETTEEGGCHHHCG---------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT
T ss_pred             e-CC--EEEEEecCCCccchhhHHhcc---------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc
Confidence            2 22  79999998  65554443321         2233455677888886655 56777   9999999999999988


Q ss_pred             CceEEeecCCccccC
Q 010012          327 KIPKLCDFGLATWTS  341 (520)
Q Consensus       327 ~~vkL~DFGla~~~~  341 (520)
                       .+.|+|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             89999999886554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=1.1e-06  Score=84.52  Aligned_cols=107  Identities=23%  Similarity=0.258  Sum_probs=80.7

Q ss_pred             HHHHHHHHHHHhCCC--CCeecEEEEEEcCCC---cEEEEEEecCCC-ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 010012          224 KAFCRELMIASSLHH--PNIVPLVGFCIDPEQ---GLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  297 (520)
Q Consensus       224 ~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~---~~~LV~E~~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia  297 (520)
                      ....+|...+..|..  -...+.+++......   ..+||+|++++. +|.+++....       .++......++.+++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRALA  128 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHHH
Confidence            356677777666642  234555555444222   347999999984 7999987632       255566778999999


Q ss_pred             HHHHHHHhCCCCceEecccCCCCeEecCCC---ceEEeecCCcccc
Q 010012          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWT  340 (520)
Q Consensus       298 ~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vkL~DFGla~~~  340 (520)
                      ..+.-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       129 ~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999988   99999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=2e-06  Score=84.75  Aligned_cols=136  Identities=21%  Similarity=0.124  Sum_probs=94.8

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcch----------------------HHHHHHHHHHHHHHhCCCC--
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------------------ESSKAFCRELMIASSLHHP--  239 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~il~~l~Hp--  239 (520)
                      ..++..||.|-=+.||.|.... +.++|||.-.....                      -......+|.++|..|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3456889999999999999974 88999997532110                      0122346799999998654  


Q ss_pred             CeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       240 nIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      .+.+.+++    + +-.+|||++.|-.|...--            .-+..-.|+..|++-+.-+-..|   |||+|+.+-
T Consensus       172 ~VP~P~~~----n-RHaVvMe~ieG~eL~~~r~------------~~en~~~il~~il~~~~~~~~~G---iVHGDlSef  231 (304)
T COG0478         172 KVPKPIAW----N-RHAVVMEYIEGVELYRLRL------------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEF  231 (304)
T ss_pred             CCCCcccc----c-cceeeeehcccceeecccC------------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence            67776664    2 3479999998876644321            11222234444555554444555   999999999


Q ss_pred             CeEecCCCceEEeecCCcccc
Q 010012          320 NILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~  340 (520)
                      |||++++|.+.++||--+...
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             eEEEecCCCEEEEeCcccccC
Confidence            999999999999999765543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=6.4e-08  Score=105.02  Aligned_cols=151  Identities=23%  Similarity=0.405  Sum_probs=99.6

Q ss_pred             HHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC-CC------cccccccccCCccCchhcccC
Q 010012          295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS-VP------FLCKTVKGTFGYLAPEYFQHG  367 (520)
Q Consensus       295 qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~-~~------~~~~~~~Gt~~Y~aPE~~~~~  367 (520)
                      +++.||.|+|...  .+||++|.|++|.++.++..||+.|+.+.....+. .+      .......-...|.|||++...
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558999999854  59999999999999999999999999875443311 11      111123355689999999998


Q ss_pred             CCCCcCceeeHHHHHHHHHhCCCC-cchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHc
Q 010012          368 KVSDKTDVYAFGVVLLELLTGRKP-IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAAC  446 (520)
Q Consensus       368 ~~s~ksDVwS~GvvL~ELltG~~P-f~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~C  446 (520)
                      ..+.++|+||+||++|-+..|..+ +............              ....+....  ........++.+-+.+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~--~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAF--GYSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccc--cccccCcHHHHHHHHHH
Confidence            889999999999999999955544 4433221111100              001111111  01112223455555678


Q ss_pred             cccCCCCCCCHHHHHHH
Q 010012          447 ISSEESRRPGIEEIIAI  463 (520)
Q Consensus       447 l~~dP~~RPtm~eVl~~  463 (520)
                      +..++.-||++.++...
T Consensus       249 l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             hcCCcccCcchhhhhcc
Confidence            99999999988877664

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=3.1e-06  Score=81.17  Aligned_cols=138  Identities=15%  Similarity=0.132  Sum_probs=101.0

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCc---c---hHHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCC----CcEEE
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---D---KESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE----QGLFL  257 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~---~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~----~~~~L  257 (520)
                      -|+||-+.|++....  |..+-+|+-...   +   +-....|.+|+..|..|..  -.+.+.+ ++....    ..-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            467899999998775  446888876521   0   3356789999999888853  2244444 332111    12579


Q ss_pred             EEEecCC-CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc--eEEeec
Q 010012          258 IYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDF  334 (520)
Q Consensus       258 V~E~~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~--vkL~DF  334 (520)
                      |+|-+.+ -+|.+++.....     .+.+...+..++.+++..+.-||..+   +.|+|+.+.|||++.++.  ++++||
T Consensus       103 VTe~L~g~~~L~~~l~~~~~-----~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV-----SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc-----CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence            9998754 588888865321     34677778899999999999999988   999999999999986666  999999


Q ss_pred             CCcc
Q 010012          335 GLAT  338 (520)
Q Consensus       335 Gla~  338 (520)
                      --++
T Consensus       175 Ek~r  178 (216)
T PRK09902        175 EKSR  178 (216)
T ss_pred             hccc
Confidence            7664

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.32  E-value=3.8e-06  Score=91.08  Aligned_cols=146  Identities=18%  Similarity=0.230  Sum_probs=92.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH------------------------------HH-------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES------------------------------SK-------  224 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~------------------------------~~-------  224 (520)
                      ..|+. ..|+.++-|.||+|++.+ |+.||||+....-...                              .+       
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            34544 689999999999999985 9999999975431110                              01       


Q ss_pred             ---HHHHHHHHHHhCC-----CCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHH
Q 010012          225 ---AFCRELMIASSLH-----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI  296 (520)
Q Consensus       225 ---~~~~E~~il~~l~-----HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qi  296 (520)
                         ++.+|...+.+++     .|++ .+=.++.+-.....|+|||++|-.+.+...-..      ..++-+   .++..+
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k---~ia~~~  273 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRK---ELAELL  273 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCCHH---HHHHHH
Confidence               1234444444432     2322 222223332334589999999999988854332      234422   333333


Q ss_pred             HHH-HHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          297 AES-VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       297 a~a-L~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      +++ +.-+-..+   ++|.|..|.||+++.++.+.+.|||+...+..
T Consensus       274 ~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         274 VRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            332 22222345   99999999999999999999999999876654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.27  E-value=4.2e-06  Score=79.39  Aligned_cols=104  Identities=25%  Similarity=0.322  Sum_probs=82.8

Q ss_pred             HHHHHHHhCCC-CCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 010012          228 RELMIASSLHH-PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG  306 (520)
Q Consensus       228 ~E~~il~~l~H-pnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~  306 (520)
                      .|.-+++.+++ +++++++|+|.     .++|.||...+++...-..    .......+|..|.+||.++++.+++|++.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~----l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRP----LSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccc----cccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            57888888876 68999999982     2689999988776532100    00013479999999999999999999987


Q ss_pred             CCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       307 ~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ....+.-.|++|+|+-+++++.+|+.|.+.+...
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6566899999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.21  E-value=2.5e-05  Score=76.37  Aligned_cols=141  Identities=17%  Similarity=0.177  Sum_probs=80.4

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEEEEEcCCCcEEEEEEecCCC
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      ..||+|..+.||+..    +..+++|......  ......+|.++++.+..-.  +.+.++++.+ .+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCc
Confidence            578999999999842    3457788876533  2234578888888875433  3555655434 34467899999886


Q ss_pred             C-hhHHh--------------hh----hccCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCceEe
Q 010012          266 S-LERHL--------------HE----KKKGVRGNSTLPWSVRYK-VAL----------GIAE-SVAYLHNG-TERCVVH  313 (520)
Q Consensus       266 s-L~~~L--------------~~----~~~~~~~~~~l~~~~~~~-ia~----------qia~-aL~yLH~~-~~~~IiH  313 (520)
                      + +...+              ..    -.....  ...+...... +..          .+.+ ...+|... ....++|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            3 21111              11    000000  0111111100 000          0111 12223221 2345799


Q ss_pred             cccCCCCeEecCCCceEEeecCCcc
Q 010012          314 RDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       314 rDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      +|+.|.||++++++ +.|.||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.15  E-value=5.2e-07  Score=97.15  Aligned_cols=187  Identities=22%  Similarity=0.176  Sum_probs=130.8

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC-eecEEEEEEcCCCcEEEEEEec
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      +..-+-+++|+++.++|.+...+. ....+.+...     ....-++++|.+++||| .++.++-+ +.+...+++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccC-Ccccccchhhhhh
Confidence            333445789999999998876433 3336665432     23445889999999999 55555543 4456678999999


Q ss_pred             CCC-ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          263 SGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       263 ~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      .++ +-.......      ...+...+...+...-+++|+|||+..   =+|||    ||+..+ +..|..||+....+.
T Consensus       317 s~~rs~~~~~~~s------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  317 STGRSSALEMTVS------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             cCCccccccCChh------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence            877 211111100      022333344455666778899999754   48998    777665 678999999987766


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      ...   ..+...+|+.++|||+...+.+..+.|+|+.|+-..+|--|-+|-..
T Consensus       383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            543   23456799999999999999999999999999988888878777543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.13  E-value=2.4e-05  Score=75.46  Aligned_cols=138  Identities=17%  Similarity=0.210  Sum_probs=89.3

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHH---------HHHHHHHhCCC---CCeecEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---------RELMIASSLHH---PNIVPLVGF  247 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~---------~E~~il~~l~H---pnIv~l~g~  247 (520)
                      ...+|...+++-......|.+....  +..+.+|..........+.|.         +++..+..++.   -..+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4468888888887777777776654  678999987654433322222         23333333321   222222222


Q ss_pred             EEcC----CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          248 CIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       248 ~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ....    ....+|||||++|..|.+...           ++.    .++..+++++.-||..|   ++|+|..|.|+++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv  168 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV  168 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence            1111    122468999999988866532           222    25566778899999988   9999999999999


Q ss_pred             cCCCceEEeecCCcc
Q 010012          324 SSKKIPKLCDFGLAT  338 (520)
Q Consensus       324 d~~~~vkL~DFGla~  338 (520)
                      .+++ +++.||+..+
T Consensus       169 ~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  169 SNNG-IRIIDTQGKR  182 (229)
T ss_pred             ECCc-EEEEECcccc
Confidence            8655 8999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.07  E-value=4.4e-05  Score=73.36  Aligned_cols=148  Identities=18%  Similarity=0.205  Sum_probs=84.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC--CeecEEEEEEcC--CCcEEEEEEec
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP--NIVPLVGFCIDP--EQGLFLIYKYV  262 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~~~--~~~~~LV~E~~  262 (520)
                      .+.|+.|..+.||+....+  ..+++|.....  .....+..|..+++.+...  -+.+++.++...  ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4679999999999999875  48999987654  4456677888888777433  245666543322  22368999999


Q ss_pred             CCCChhH----------------HhhhhccCCCCCCCCCHHHHH---------HH------------HHHHHH-HHHHHH
Q 010012          263 SGGSLER----------------HLHEKKKGVRGNSTLPWSVRY---------KV------------ALGIAE-SVAYLH  304 (520)
Q Consensus       263 ~~gsL~~----------------~L~~~~~~~~~~~~l~~~~~~---------~i------------a~qia~-aL~yLH  304 (520)
                      +|..+..                .+............+.+....         ..            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                222111110001112211100         00            011222 233333


Q ss_pred             h----CCCCceEecccCCCCeEec-CCCceEEeecCCcc
Q 010012          305 N----GTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  338 (520)
Q Consensus       305 ~----~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~  338 (520)
                      .    .....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    2356699999999999999 66666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.04  E-value=3.5e-05  Score=83.53  Aligned_cols=144  Identities=20%  Similarity=0.216  Sum_probs=89.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH-------------------------------------HHH
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-------------------------------------SKA  225 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-------------------------------------~~~  225 (520)
                      .|+. +.||.-+.|.||+|++++ |+.||||+-.+.-...                                     +-+
T Consensus       163 ~f~~-~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD  240 (538)
T KOG1235|consen  163 EFDE-EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD  240 (538)
T ss_pred             hcCc-chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence            4443 589999999999999986 9999999865431111                                     011


Q ss_pred             HHHHHHHH----HhCCCCC------eecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHH
Q 010012          226 FCRELMIA----SSLHHPN------IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG  295 (520)
Q Consensus       226 ~~~E~~il----~~l~Hpn------Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~q  295 (520)
                      |.+|++-.    +.+.|-+      |.+++   .+-....+|+||||+|..+.+.-.-..      ..++-..   |+..
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy---~~~st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~---i~~~  308 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVY---WDLSTKRVLTMEYVDGIKINDLDAIDK------RGISPHD---ILNK  308 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeeh---hhcCcceEEEEEecCCccCCCHHHHHH------cCCCHHH---HHHH
Confidence            33444332    2234444      33333   232334689999999998876644332      2344433   3322


Q ss_pred             HHHHHHHHHhCCCCceEecccCCCCeEecC----CCceEEeecCCccccCC
Q 010012          296 IAESVAYLHNGTERCVVHRDIKPSNILLSS----KKIPKLCDFGLATWTSA  342 (520)
Q Consensus       296 ia~aL~yLH~~~~~~IiHrDLKp~NILld~----~~~vkL~DFGla~~~~~  342 (520)
                      +.++  |+++.-..+++|.|-.|.||+++.    ++.+.+-|||+......
T Consensus       309 l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  309 LVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2222  222222334999999999999984    67899999999876653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.99  E-value=0.00015  Score=71.01  Aligned_cols=154  Identities=16%  Similarity=0.163  Sum_probs=96.7

Q ss_pred             cccHHHHHHhhCCcccceE---EcccCceEEEEeeecCCCcEEEEEEecCcchHHH-------------------HH---
Q 010012          171 RLSYGEILAATHNFSKGRV---LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------------------KA---  225 (520)
Q Consensus       171 ~~s~~ei~~at~~f~~~~~---LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~-------------------~~---  225 (520)
                      ..++..|.....+..+...   |.+|--+.||+|... ++..+|||++........                   .+   
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            3344455444444444444   556777799999875 478999999864321110                   11   


Q ss_pred             --HHHHHHHHHhCC--CCCeecEEEEEEcCCCcEEEEEEecCCCCh-hHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 010012          226 --FCRELMIASSLH--HPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV  300 (520)
Q Consensus       226 --~~~E~~il~~l~--HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL-~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL  300 (520)
                        ...|+.-|.++.  +-.+.+-+++.   +  -.|||||+....+ .-.|..        -++.......+..++++.+
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~---~--nVLvMEfIg~~g~pAP~LkD--------v~~e~~e~~~~~~~~v~~~  179 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR---N--NVLVMEFIGDDGLPAPRLKD--------VPLELEEAEGLYEDVVEYM  179 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec---C--CeEEEEeccCCCCCCCCccc--------CCcCchhHHHHHHHHHHHH
Confidence              235666666663  34455555542   2  2699999965311 111111        2223335666777888888


Q ss_pred             HHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          301 AYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       301 ~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      .-|-. .+   +||+||..-|||+. ++.+.|+|||-|.....
T Consensus       180 ~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         180 RRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             HHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence            87776 44   99999999999999 88999999998865543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.95  E-value=0.00012  Score=84.70  Aligned_cols=81  Identities=21%  Similarity=0.323  Sum_probs=56.3

Q ss_pred             ceEEcccCceEEEEeeecCCC--cEEEEEEecCcc-hHHHHHHHHHHHHHHhCC-CCCe--ecEEEEEEcCC--CcEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNI--VPLVGFCIDPE--QGLFLI  258 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~--~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~-HpnI--v~l~g~~~~~~--~~~~LV  258 (520)
                      .+.|+.|.+..+|+......+  ..+++|+..... ......+.+|+.+++.+. |+++  .+++.+|.+..  +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467899999999998765422  367777764432 122346789999999985 6654  77777776532  346899


Q ss_pred             EEecCCCCh
Q 010012          259 YKYVSGGSL  267 (520)
Q Consensus       259 ~E~~~~gsL  267 (520)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.86  E-value=0.00022  Score=69.97  Aligned_cols=144  Identities=16%  Similarity=0.123  Sum_probs=81.6

Q ss_pred             EEcccCc-eEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          189 VLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       189 ~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      .|-.|.. ..||+....  +..+.||+.....   ...+.+|+++++.+. +--+.+++++.... +..++|||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCcc
Confidence            3445555 789998764  3578888876543   234567888887774 33355666655443 34689999999987


Q ss_pred             hhHHhh----------------hhccCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHh---
Q 010012          267 LERHLH----------------EKKKGVRGNSTLP--WSVRYKVAL--------------------GIAESVAYLHN---  305 (520)
Q Consensus       267 L~~~L~----------------~~~~~~~~~~~l~--~~~~~~ia~--------------------qia~aL~yLH~---  305 (520)
                      |.....                .-........++.  +..+.....                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            764321                0000000001111  000000000                    01111222211   


Q ss_pred             -CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          306 -GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       306 -~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                       ...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             123559999999999999998888899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.84  E-value=0.00019  Score=70.21  Aligned_cols=74  Identities=11%  Similarity=0.134  Sum_probs=44.8

Q ss_pred             eEEcccCce-EEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC---CeecEEEEEEcCC--CcEEEEEEe
Q 010012          188 RVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPE--QGLFLIYKY  261 (520)
Q Consensus       188 ~~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~~~~--~~~~LV~E~  261 (520)
                      +.|+.||.. .||+..     ..+.+|.....  .....+.+|.+++..+...   -+...++.....+  ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            567877776 599752     24677865432  2334678899988877531   2334443322211  134789999


Q ss_pred             cCCCChh
Q 010012          262 VSGGSLE  268 (520)
Q Consensus       262 ~~~gsL~  268 (520)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9997663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00011  Score=68.30  Aligned_cols=131  Identities=23%  Similarity=0.311  Sum_probs=90.0

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCC
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~  264 (520)
                      ...+.||+|.+|.||+|.+.  +..+|+|+-..++  ....+..|+++|..+.--++.+=+-.+ . ..  ++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y-g-~~--~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY-G-ED--FIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe-c-hh--hhhhhhhcC
Confidence            44567999999999999987  5689999876554  346788899999988876665543222 1 22  466999999


Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC-CCCeEecCCCceEEeecCCcccc
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK-PSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK-p~NILld~~~~vkL~DFGla~~~  340 (520)
                      -.|.+.-...          .-    +-...++++---|...+   |-|..|. |...+|-.+..+.|+||.-|+..
T Consensus        97 ~~L~~~~~~~----------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIGG----------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhcc----------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8887665421          11    22334555544566556   9999986 44444445558999999988743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00036  Score=67.97  Aligned_cols=145  Identities=19%  Similarity=0.224  Sum_probs=80.2

Q ss_pred             eEEcccCceEEEEeeecC-CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeec-EEEEEEcCCCcEEEEEEecCCC
Q 010012          188 RVLGRGALSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP-LVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~-l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      +.|..|-...+|+..... .+..|.+|+....... .....+|+.++..+....+++ +++. .+  .  .+||||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~-~~--~--~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYAT-FQ--N--GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEE-eC--C--cEEEEeeCCC
Confidence            567778888999987653 2467888976543221 122336888888875434443 3332 22  2  3799999987


Q ss_pred             ChhHH--------------hhhhccCCCC--------CCCCCHHHHHHHHH----------------------HHH---H
Q 010012          266 SLERH--------------LHEKKKGVRG--------NSTLPWSVRYKVAL----------------------GIA---E  298 (520)
Q Consensus       266 sL~~~--------------L~~~~~~~~~--------~~~l~~~~~~~ia~----------------------qia---~  298 (520)
                      ++...              +.+-......        ...-.|..+..+..                      .+.   .
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65321              1110000000        01111222212211                      111   1


Q ss_pred             HH-HHHHhC-CCCceEecccCCCCeEecC-CCceEEeecCCcc
Q 010012          299 SV-AYLHNG-TERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  338 (520)
Q Consensus       299 aL-~yLH~~-~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~  338 (520)
                      .| +.+-.. ....++|+|+.+.|||+++ ++.+.|.||..|.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            11 112221 2346999999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.76  E-value=0.00062  Score=65.12  Aligned_cols=129  Identities=23%  Similarity=0.324  Sum_probs=87.4

Q ss_pred             cceEEcccCceEEEEeeecCCCcEEEEEEecCcc----------------hHHHHHHHHHHHHHHhCC------CCCeec
Q 010012          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----------------KESSKAFCRELMIASSLH------HPNIVP  243 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~E~~il~~l~------HpnIv~  243 (520)
                      ....||+|+.-.||.--.   .....||+.....                ....++..+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            346799999999997543   3346788887654                122355566666555544      788999


Q ss_pred             EEEEEEcCCCcEEEEEEecCC------CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          244 LVGFCIDPEQGLFLIYKYVSG------GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       244 l~g~~~~~~~~~~LV~E~~~~------gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      ++|+. +++.++-+|+|.+.+      .+|.+++..        ..++. ..   ...+-+-..||-...   |+.+|++
T Consensus        82 ~~G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--------~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~  145 (199)
T PF10707_consen   82 FYGFV-ETNLGLGLVVELIRDADGNISPTLEDYLKE--------GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLN  145 (199)
T ss_pred             EeEEE-ecCCceEEEEEEEECCCCCcCccHHHHHHc--------CCccH-HH---HHHHHHHHHHHHHcC---CeecCCC
Confidence            99985 556667899998764      357777743        33555 22   233334456777766   9999999


Q ss_pred             CCCeEecCCC----ceEEee
Q 010012          318 PSNILLSSKK----IPKLCD  333 (520)
Q Consensus       318 p~NILld~~~----~vkL~D  333 (520)
                      |.||++....    .+.|+|
T Consensus       146 ~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  146 PHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cccEEEEecCCCceEEEEEe
Confidence            9999996332    577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.50  E-value=0.00028  Score=81.27  Aligned_cols=196  Identities=18%  Similarity=0.201  Sum_probs=136.4

Q ss_pred             HHHHHHHHHhCCCCCeecEEEEEEcCCCc---EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010012          226 FCRELMIASSLHHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY  302 (520)
Q Consensus       226 ~~~E~~il~~l~HpnIv~l~g~~~~~~~~---~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~y  302 (520)
                      ...|.+.+.++.|+|++.++.|-.+....   ..+..+++..-++...+...       ..++..+.+.+..++.+||.|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-------~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-------GSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-------cccCHHHHHHHHHHHhhhHHH
Confidence            34577788899999999999987654322   23456888888888888764       568888888999999999999


Q ss_pred             HHhCCCCceEecccCCC---CeEecCCCceEEe--ecCCccccCCCCCCcccccccccCCccCchhcccCCCCC--cCce
Q 010012          303 LHNGTERCVVHRDIKPS---NILLSSKKIPKLC--DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDV  375 (520)
Q Consensus       303 LH~~~~~~IiHrDLKp~---NILld~~~~vkL~--DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~--ksDV  375 (520)
                      +|...   ..|.-+..+   +.-.+..+...++  ||+.++.+......   ....-+..+.+||......+..  ..|+
T Consensus       302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHH
Confidence            99875   566555554   4445666677777  99988776654322   2223455678888776655444  4799


Q ss_pred             eeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 010012          376 YAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP  455 (520)
Q Consensus       376 wS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP  455 (520)
                      |.+|..+..+..|..+-....                    .+..+++...      ..   .+.+....|+..++++|+
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~--------------------~~~~~l~~~~------~~---~~~d~~~~~~~~~~~~Rl  426 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSA--------------------VPVSLLDVLS------TS---ELLDALPKCLDEDSEERL  426 (1351)
T ss_pred             HHHHHHHhhhhhcCccccccc--------------------chhhhhcccc------ch---hhhhhhhhhcchhhhhcc
Confidence            999999999998766532211                    1111121111      01   345566789999999999


Q ss_pred             CHHHHHHH
Q 010012          456 GIEEIIAI  463 (520)
Q Consensus       456 tm~eVl~~  463 (520)
                      +..+++..
T Consensus       427 ~~~~ll~~  434 (1351)
T KOG1035|consen  427 SALELLTH  434 (1351)
T ss_pred             chhhhhhc
Confidence            99999984

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.46  E-value=0.0017  Score=62.06  Aligned_cols=126  Identities=22%  Similarity=0.294  Sum_probs=88.1

Q ss_pred             CCcccceEEcccCc-eEEEEeeecCCCcEEEEEEecC---cch------------------HHHHHHHHHHHHHHhCC--
Q 010012          182 HNFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDK---EDK------------------ESSKAFCRELMIASSLH--  237 (520)
Q Consensus       182 ~~f~~~~~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~---~~~------------------~~~~~~~~E~~il~~l~--  237 (520)
                      .+++..+.||.|.- |.||++...  |..||+|+...   ...                  .-...|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68888999999999 999999986  67999999321   100                  11234777887766664  


Q ss_pred             -CCCe--ecEEEEEEcCC-----------------CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 010012          238 -HPNI--VPLVGFCIDPE-----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  297 (520)
Q Consensus       238 -HpnI--v~l~g~~~~~~-----------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia  297 (520)
                       +.++  |+.+||..-..                 ....||.||++...                .+.    ..-+.++.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~----~~~~~~~~  174 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQ----IRDIPQML  174 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccc----hhHHHHHH
Confidence             4566  89999874221                 11357777776543                011    12345677


Q ss_pred             HHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       298 ~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      +-|.-+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       175 ~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  175 RDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            8888999888   999999999986     3489999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.37  E-value=0.0014  Score=66.47  Aligned_cols=145  Identities=21%  Similarity=0.232  Sum_probs=81.8

Q ss_pred             eEEcccCceEEEEeeecC------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCee-cEEEEEEcCCCcEEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGL------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~LV~E  260 (520)
                      +.|..|-...||+.....      .+..+++|+...... ......+|.+++..+....+. ++++++ . +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIF-P-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cchhh
Confidence            456666667899887643      247888998755432 223445788787777543333 444443 2 2   36899


Q ss_pred             ecCCCChhHH-----------------hhhhccC--CCC--CCCCCHHHHHH--------------------------HH
Q 010012          261 YVSGGSLERH-----------------LHEKKKG--VRG--NSTLPWSVRYK--------------------------VA  293 (520)
Q Consensus       261 ~~~~gsL~~~-----------------L~~~~~~--~~~--~~~l~~~~~~~--------------------------ia  293 (520)
                      |++|..+...                 +|.....  ...  ..+.-|.....                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9998776431                 1111100  000  00111211111                          11


Q ss_pred             HHHHHHHHHHHh------CCCCceEecccCCCCeEecCC----CceEEeecCCcc
Q 010012          294 LGIAESVAYLHN------GTERCVVHRDIKPSNILLSSK----KIPKLCDFGLAT  338 (520)
Q Consensus       294 ~qia~aL~yLH~------~~~~~IiHrDLKp~NILld~~----~~vkL~DFGla~  338 (520)
                      ..+...+..|-.      .....++|+|+.|.|||++++    +.++++||..|.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223344432      234579999999999999985    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.36  E-value=0.0051  Score=62.91  Aligned_cols=31  Identities=29%  Similarity=0.530  Sum_probs=26.5

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ..++||+|+.|.|||++.+...-|.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3469999999999999977666899999875

>PRK10593 hypothetical protein; Provisional

Probab=97.34  E-value=0.0035  Score=63.86  Aligned_cols=79  Identities=10%  Similarity=-0.008  Sum_probs=55.4

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC---CCeecEEEEEEcC--CCcEEEEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH---PNIVPLVGFCIDP--EQGLFLIY  259 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~g~~~~~--~~~~~LV~  259 (520)
                      ...+.||.|..+.||+....+ + .+.+|..+..  .....|..|...|+.|.-   ..+.+++++|...  .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            344679999999999987643 3 4666764331  122478889999988853   3577888876543  24478999


Q ss_pred             EecCCCCh
Q 010012          260 KYVSGGSL  267 (520)
Q Consensus       260 E~~~~gsL  267 (520)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.33  E-value=0.0026  Score=62.96  Aligned_cols=141  Identities=18%  Similarity=0.190  Sum_probs=77.2

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCee-cEEEEEEcCCCcEEEEEEecCCCChh
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVSGGSLE  268 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~LV~E~~~~gsL~  268 (520)
                      +..|-.+.+|+...  ++..+++|+.........-...+|..+++.+....++ +++..  . .+  .+||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~-~~--~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV--N-EH--WLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE--e-CC--EEEEEeccCcccc
Confidence            45577788998874  3567888876543222111346788888888644343 33433  2 22  5899999987653


Q ss_pred             HH--------------hhhhccCCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCceEecccCCC
Q 010012          269 RH--------------LHEKKKGVRGNSTLPWSVR-YKVALGI---------AESVAYLHNG-----TERCVVHRDIKPS  319 (520)
Q Consensus       269 ~~--------------L~~~~~~~~~~~~l~~~~~-~~ia~qi---------a~aL~yLH~~-----~~~~IiHrDLKp~  319 (520)
                      ..              +.+-........+++...+ ..+..++         ...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              1111110001112222211 1111111         1112222221     1235899999999


Q ss_pred             CeEecCCCceEEeecCCcc
Q 010012          320 NILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~  338 (520)
                      ||++++++ +.|.||..|.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999877 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.32  E-value=0.0056  Score=61.82  Aligned_cols=147  Identities=16%  Similarity=0.175  Sum_probs=84.2

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEEE-----EEcCCCcEEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  259 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~-----~~~~~~~~~LV~  259 (520)
                      .+.|..|....+|+....  +..+++|+....   ....+..|+.++..+.+..  +.+++..     .....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            456777877899998654  346888987642   2244556777777764322  4444331     112223467999


Q ss_pred             EecCCCChhH-----------H---hhhhccCCC----CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CC
Q 010012          260 KYVSGGSLER-----------H---LHEKKKGVR----GNSTLPWSVRYK----------VALGIAESVAYLHN----GT  307 (520)
Q Consensus       260 E~~~~gsL~~-----------~---L~~~~~~~~----~~~~l~~~~~~~----------ia~qia~aL~yLH~----~~  307 (520)
                      +|++|..+..           .   ++.......    ......|.....          ....+..++.++..    .-
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876532           1   111100000    001123332210          11223344555553    12


Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ..+++|+|+.|.|||++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3459999999999999998778899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.19  E-value=0.0099  Score=62.92  Aligned_cols=77  Identities=17%  Similarity=0.087  Sum_probs=52.3

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCc------c-hHHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCCcEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------D-KESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~------~-~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+.||.|.+..||++...+.++.|.||.-...      . +....++..|.+.|..+.   ..++.+++.+  +.+. .+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CE
Confidence            35799999999999998753358999985321      1 123456667888887753   2456667655  3333 57


Q ss_pred             EEEEecCCCC
Q 010012          257 LIYKYVSGGS  266 (520)
Q Consensus       257 LV~E~~~~gs  266 (520)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998744

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.85  E-value=0.04  Score=56.10  Aligned_cols=148  Identities=16%  Similarity=0.200  Sum_probs=80.3

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEEE-----EEcCCCcEEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  259 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~-----~~~~~~~~~LV~  259 (520)
                      .+.++.|....+|+....  +..+.+|+......  ......|++++..|....  +.+++..     +....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            455677777899988654  33577887754321  223445666666663211  3343331     111234468999


Q ss_pred             EecCCCChh-----------HH---hhhhccCCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHHh---
Q 010012          260 KYVSGGSLE-----------RH---LHEKKKGVRGN-----STLPWSVRYK------------VALGIAESVAYLHN---  305 (520)
Q Consensus       260 E~~~~gsL~-----------~~---L~~~~~~~~~~-----~~l~~~~~~~------------ia~qia~aL~yLH~---  305 (520)
                      +|++|..+.           ..   ++....+....     ..-.|.....            ....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885532           11   11111110000     0112221110            01123344555543   


Q ss_pred             -CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          306 -GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       306 -~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                       ....+++|+|+.+.||++++++.+.|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             224569999999999999998877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.78  E-value=0.013  Score=61.08  Aligned_cols=144  Identities=15%  Similarity=0.150  Sum_probs=79.8

Q ss_pred             eEEcccCceEEEEeeecC----CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCee-cEEEEEEcCCCcEEEEEEec
Q 010012          188 RVLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~LV~E~~  262 (520)
                      ..|-.|-.-.+|+.....    .++.|.+|+......... .-.+|..++..+..-++. ++++.+ . ..   .|++|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~-~-~g---~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRF-P-NG---RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEE-C-Cc---eEEEee
Confidence            345457777899886532    236788998765432221 224688888777544444 344443 2 22   589999


Q ss_pred             CCCChhHH-----------------hhhhccCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 010012          263 SGGSLERH-----------------LHEKKKGVRGNSTLPWSVRYKVALGI-----------------AESVAYL----H  304 (520)
Q Consensus       263 ~~gsL~~~-----------------L~~~~~~~~~~~~l~~~~~~~ia~qi-----------------a~aL~yL----H  304 (520)
                      ++.+|...                 +|.... ........|.....+..++                 ...+..|    .
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~-~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDM-PGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            88776421                 111110 0001122344433332221                 1112222    2


Q ss_pred             h-CCCCceEecccCCCCeEecC-CCceEEeecCCcc
Q 010012          305 N-GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  338 (520)
Q Consensus       305 ~-~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~  338 (520)
                      . .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            2 22346999999999999986 4689999998875

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.77  E-value=0.00018  Score=84.46  Aligned_cols=163  Identities=12%  Similarity=-0.066  Sum_probs=115.4

Q ss_pred             HHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010012          226 FCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH  304 (520)
Q Consensus       226 ~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH  304 (520)
                      ...|..-++...|++++....-.... ....+.+++|+.+|.+.+.+-+.-..   .+.+..........+...+..-+|
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee---~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE---SPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc---CCcchhchHHHHHHHHHhccchhh
Confidence            34455556667898887765432221 12357899999999999998764322   244444444444444355555544


Q ss_pred             hCC--CCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHH
Q 010012          305 NGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVL  382 (520)
Q Consensus       305 ~~~--~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL  382 (520)
                      ...  ....+|+++|+-|.+|..+..+|++++|+.+.......  ......+++-|+.|+....-.++.++|+|..|+-+
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence            432  34489999999999999999999999999984433221  23445678889999999988999999999999999


Q ss_pred             HHHHhCCCCcc
Q 010012          383 LELLTGRKPIE  393 (520)
Q Consensus       383 ~ELltG~~Pf~  393 (520)
                      |++-.|..+|-
T Consensus      1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred             HHHhcccHHHH
Confidence            99988887764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.62  E-value=0.024  Score=57.10  Aligned_cols=32  Identities=28%  Similarity=0.450  Sum_probs=26.1

Q ss_pred             CCceEecccCCCCeEecCCCc-eEEeecCCccc
Q 010012          308 ERCVVHRDIKPSNILLSSKKI-PKLCDFGLATW  339 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~-vkL~DFGla~~  339 (520)
                      ...++|+|+.|.|||+++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            345999999999999997555 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.58  E-value=0.0024  Score=64.84  Aligned_cols=138  Identities=18%  Similarity=0.132  Sum_probs=91.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---------h----------H---HHHHHHHHHHHHHhCC-CC
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------K----------E---SSKAFCRELMIASSLH-HP  239 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---------~----------~---~~~~~~~E~~il~~l~-Hp  239 (520)
                      -++.++.||-|--+-||.+.... |.+.++|.-....         .          .   ..-...+|+..|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            46788999999999999998874 7888888542110         0          0   0112346888888874 32


Q ss_pred             C-eecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 010012          240 N-IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (520)
Q Consensus       240 n-Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp  318 (520)
                      . +.+.+++    . +-++|||++.+-.|...-+          ..+..+++.-+   ..-+--|-..|   +||+|..-
T Consensus       172 fpVPkpiD~----~-RH~Vvmelv~g~Pl~~v~~----------v~d~~~ly~~l---m~~Iv~la~~G---lIHgDFNE  230 (465)
T KOG2268|consen  172 FPVPKPIDH----N-RHCVVMELVDGYPLRQVRH----------VEDPPTLYDDL---MGLIVRLANHG---LIHGDFNE  230 (465)
T ss_pred             CCCCCcccc----c-ceeeHHHhhcccceeeeee----------cCChHHHHHHH---HHHHHHHHHcC---ceecccch
Confidence            2 4444443    2 3489999999888765542          22333333333   33334455555   99999999


Q ss_pred             CCeEecCCCceEEeecCCccccCC
Q 010012          319 SNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      =||++++++.++++||--....+.
T Consensus       231 FNimv~dd~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  231 FNIMVKDDDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             heeEEecCCCEEEeechHhhccCC
Confidence            999999999999999976544443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.58  E-value=0.032  Score=57.24  Aligned_cols=133  Identities=20%  Similarity=0.308  Sum_probs=74.7

Q ss_pred             CcEEEEEEecC--cchHHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCC-CcEEEEEEecCCCChhH------------
Q 010012          207 RTSVAIKRLDK--EDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE-QGLFLIYKYVSGGSLER------------  269 (520)
Q Consensus       207 ~~~vAvK~l~~--~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~-~~~~LV~E~~~~gsL~~------------  269 (520)
                      ++.+.+. ...  ..........+|..+++.+.-  .-+...+++|.+.. ...+.||+|++|..+.+            
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            5667777 321  222334455678888877643  12445567776655 45689999998832222            


Q ss_pred             ------HhhhhccCC-------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHhCC-----CCceEecccC
Q 010012          270 ------HLHEKKKGV-------------RGNSTLPWSVRYKVA--------LGIAESVAYLHNGT-----ERCVVHRDIK  317 (520)
Q Consensus       270 ------~L~~~~~~~-------------~~~~~l~~~~~~~ia--------~qia~aL~yLH~~~-----~~~IiHrDLK  317 (520)
                            +|..-..-.             ...+.-.|...+..+        -....-..+|+...     ...++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                  111110000             001111222222111        11122244555433     4579999999


Q ss_pred             CCCeEecCCCceEEeecCCcccc
Q 010012          318 PSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       318 p~NILld~~~~vkL~DFGla~~~  340 (520)
                      +.||+++....+=|.||+++..-
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccC
Confidence            99999999888999999998753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.12  E-value=0.059  Score=56.18  Aligned_cols=74  Identities=16%  Similarity=0.062  Sum_probs=46.2

Q ss_pred             EEcccCceEEEEeeecCCCcEEEEEEecCc-------chHHHHHHHHHHHHHHhCC--CCC-eecEEEEEEcCCCcEEEE
Q 010012          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-------DKESSKAFCRELMIASSLH--HPN-IVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~E~~il~~l~--Hpn-Iv~l~g~~~~~~~~~~LV  258 (520)
                      .||-|....||++.....++.|+||.-...       -+-...+...|.+.|+...  -|. +.+++.|  +.+. ..+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~-~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM-AVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc-ceeh
Confidence            478999999999998643368999975321       1222334446777776653  354 4445443  4443 4699


Q ss_pred             EEecCCC
Q 010012          259 YKYVSGG  265 (520)
Q Consensus       259 ~E~~~~g  265 (520)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.09  E-value=0.035  Score=56.66  Aligned_cols=32  Identities=19%  Similarity=0.313  Sum_probs=28.4

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ..+++|+|+.+.|||+++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44699999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.95  E-value=0.13  Score=52.17  Aligned_cols=30  Identities=33%  Similarity=0.379  Sum_probs=25.7

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            356999999999999988 678999999754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.88  E-value=0.012  Score=63.06  Aligned_cols=50  Identities=18%  Similarity=0.226  Sum_probs=40.4

Q ss_pred             HHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhh
Q 010012          224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK  274 (520)
Q Consensus       224 ~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~  274 (520)
                      .++.-...+++.+.|+|+...+.+......+..+|+|++ +.||++.+...
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            455667789999999999999987655555678999999 77999998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.80  E-value=0.026  Score=54.14  Aligned_cols=30  Identities=37%  Similarity=0.548  Sum_probs=21.5

Q ss_pred             CceEecccCCCCeEe-cCCCceEEeecCCcc
Q 010012          309 RCVVHRDIKPSNILL-SSKKIPKLCDFGLAT  338 (520)
Q Consensus       309 ~~IiHrDLKp~NILl-d~~~~vkL~DFGla~  338 (520)
                      ..++|.|+.|.|||+ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            458999999999999 889999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.75  E-value=0.13  Score=52.06  Aligned_cols=75  Identities=12%  Similarity=0.133  Sum_probs=44.5

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCCcEEEEEEe
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +..+.|+.|....+|+..  .++..+-||+-..   .....|..|.+-|+.|.   --.+.+.+++....+. .+||+||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEEe
Confidence            445678989999999987  3477899998762   23346778888777773   3446677776544333 5899999


Q ss_pred             cCCC
Q 010012          262 VSGG  265 (520)
Q Consensus       262 ~~~g  265 (520)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.69  E-value=0.094  Score=54.20  Aligned_cols=145  Identities=17%  Similarity=0.253  Sum_probs=78.1

Q ss_pred             eEEcccCceEEEEeeecCC---CcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCee-cEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.|..|=...+|+......   +..|.+|+....... .-.-.+|..+++.+..-++- ++++++ .  ++  +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~--~G--~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-G--NG--MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-C--Cc--Eeehhhc
Confidence            3454466678888865432   237888887554321 12224688888877654454 445443 2  22  5899998


Q ss_pred             CCChhH--------------HhhhhccC-CCCC-CCCCHHHHHHHHHHH----------------------HHHHHH---
Q 010012          264 GGSLER--------------HLHEKKKG-VRGN-STLPWSVRYKVALGI----------------------AESVAY---  302 (520)
Q Consensus       264 ~gsL~~--------------~L~~~~~~-~~~~-~~l~~~~~~~ia~qi----------------------a~aL~y---  302 (520)
                      +-.|..              .+..-... .... .+-.|....++..++                      ..-+..   
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765522              11111110 0001 122344433332222                      111111   


Q ss_pred             -HHh-CCCCceEecccCCCCeEecC-CCceEEeecCCcc
Q 010012          303 -LHN-GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  338 (520)
Q Consensus       303 -LH~-~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~  338 (520)
                       +.. ......+|.|+.+.|||+++ ++.++++||..|.
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence             111 12335899999999999975 5789999999874

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.66  E-value=0.14  Score=54.21  Aligned_cols=73  Identities=15%  Similarity=0.112  Sum_probs=47.9

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcch-------HHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCCcEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+.||-|....||+....  +..|.||+-.....       ....+-..|.+.|+.+.   ..++.+++.++.+  . -+
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~-~v  111 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M-AL  111 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C-CE
Confidence            467899999999998764  45688997652110       12233334566666553   3467788877643  2 47


Q ss_pred             EEEEecCC
Q 010012          257 LIYKYVSG  264 (520)
Q Consensus       257 LV~E~~~~  264 (520)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999977

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.45  E-value=0.073  Score=51.59  Aligned_cols=152  Identities=16%  Similarity=0.171  Sum_probs=91.6

Q ss_pred             CceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhh
Q 010012          194 ALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  272 (520)
Q Consensus       194 ~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~  272 (520)
                      |-++.-.+..+- | +..+|++..-... ...-|..+..++++++-  |++|..   +....+-++.|+|-....     
T Consensus        74 gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~N---Dn~~~yGvIlE~Cy~~~i-----  141 (308)
T PF07387_consen   74 GNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKN---DNNYKYGVILERCYKIKI-----  141 (308)
T ss_pred             CceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeec---CCCceeEEEEeeccCccc-----
Confidence            444444444332 2 3456666544333 34556788889988864  788873   333445689999843211     


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccc
Q 010012          273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  352 (520)
Q Consensus       273 ~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  352 (520)
                                 .+   . .++..=+.+|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+....             
T Consensus       142 -----------~~---~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------  192 (308)
T PF07387_consen  142 -----------NF---S-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------  192 (308)
T ss_pred             -----------ch---h-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh-------------
Confidence                       11   1 12222257788899654 5699999999999999999999999764310             


Q ss_pred             cccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCC
Q 010012          353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK  390 (520)
Q Consensus       353 ~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~  390 (520)
                       .+.-|.--||   ...++++.+-+|=.-++++....+
T Consensus       193 -~~V~~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  193 -NQVNMVNIEY---ESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             -heeeEEeeec---cccChHHHHHHHHHHHHHHHHHHh
Confidence             1111222222   235667777777777777765433

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.16  E-value=0.066  Score=55.45  Aligned_cols=87  Identities=18%  Similarity=0.169  Sum_probs=62.4

Q ss_pred             CCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 010012          239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (520)
Q Consensus       239 pnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp  318 (520)
                      +++.+++-+-.+...+.|++|++- |++|...           ....|++...|+.+.+.-+.-|..  .-+.-|||+.-
T Consensus       285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-----------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~  350 (488)
T COG5072         285 VFLETLKVVSLDETLYLYLHFKDH-GTPISII-----------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTL  350 (488)
T ss_pred             hhhhcceEEecCCceEEEEEEecC-Cceeeee-----------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccc
Confidence            344444333224344566777765 5555321           345688899999998888887776  34589999999


Q ss_pred             CCeEecCCCceEEeecCCcccc
Q 010012          319 SNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~  340 (520)
                      .||||+ +|+|.|+||-+++.-
T Consensus       351 ~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         351 DNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             cceeee-cCceEEEEeeeeecc
Confidence            999999 999999999999843

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.98  E-value=0.077  Score=55.71  Aligned_cols=61  Identities=28%  Similarity=0.328  Sum_probs=44.4

Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCCeEecCC
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~IiHrDLKp~NILld~~  326 (520)
                      ..|+-+|++|-++..++...        ..++..+.+++.-.+.||--+ --.+   .+|.|+.|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~--------~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK--------SQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhcc--------cChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence            46888899999999999763        356666777776556665422 2233   9999999999999643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.89  E-value=0.31  Score=50.77  Aligned_cols=139  Identities=14%  Similarity=0.112  Sum_probs=90.1

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCc-----c-------------------hHH--HHHHHHHHHHHHhCCCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----D-------------------KES--SKAFCRELMIASSLHHPN  240 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~-------------------~~~--~~~~~~E~~il~~l~Hpn  240 (520)
                      ...|..|--+.||.+... +|..+|||+++..     +                   +..  .--...|+.-|.+|+...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            356788889999999876 4888999987531     0                   000  011234666677765433


Q ss_pred             eecEEEEEEcCCCcEEEEEEecCCCChhH--HhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 010012          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLER--HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (520)
Q Consensus       241 Iv~l~g~~~~~~~~~~LV~E~~~~gsL~~--~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp  318 (520)
                      |.----.... .  -+|||+|+- ++=+-  .|.        ...++...+..+..|++.-+.-|.+.+  ++||.||.-
T Consensus       228 IP~PePIlLk-~--hVLVM~FlG-rdgw~aPkLK--------d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE  293 (520)
T KOG2270|consen  228 IPCPEPILLK-N--HVLVMEFLG-RDGWAAPKLK--------DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE  293 (520)
T ss_pred             CCCCCceeee-c--ceEeeeecc-CCCCcCcccc--------cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence            2211111111 1  269999994 32211  111        145777778888899999999888866  499999999


Q ss_pred             CCeEecCCCceEEeecCCccccC
Q 010012          319 SNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~~  341 (520)
                      -|+|+- +|.+.|+|.+-+....
T Consensus       294 fN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  294 FNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hhheEE-CCEEEEEEccccccCC
Confidence            999985 4679999988765443

>PRK06148 hypothetical protein; Provisional

Probab=94.72  E-value=0.67  Score=55.16  Aligned_cols=32  Identities=34%  Similarity=0.433  Sum_probs=26.5

Q ss_pred             CCceEecccCCCCeEecCCC--ceE-EeecCCccc
Q 010012          308 ERCVVHRDIKPSNILLSSKK--IPK-LCDFGLATW  339 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~--~vk-L~DFGla~~  339 (520)
                      ..++||.|+.+.|||++.++  .+. |.|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            35699999999999999875  555 999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.50  E-value=0.91  Score=46.96  Aligned_cols=141  Identities=18%  Similarity=0.245  Sum_probs=77.5

Q ss_pred             CceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC---CCC---eecEEEEEE-cCC--CcEEEEEEecCC
Q 010012          194 ALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPN---IVPLVGFCI-DPE--QGLFLIYKYVSG  264 (520)
Q Consensus       194 ~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---Hpn---Iv~l~g~~~-~~~--~~~~LV~E~~~~  264 (520)
                      .-..||+....+ +. +++|+....  ....++..|...+..|.   .+=   |..+=|-.. .-.  .+.+-|++|++|
T Consensus        37 ~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            455788888764 33 488988765  23345555666666653   221   222212111 111  256889999999


Q ss_pred             CChhH---------------Hhhhhcc-----CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC----C
Q 010012          265 GSLER---------------HLHEKKK-----GVRGNSTLPWSV-------------RYKVALGIAESVAYLHNG----T  307 (520)
Q Consensus       265 gsL~~---------------~L~~~~~-----~~~~~~~l~~~~-------------~~~ia~qia~aL~yLH~~----~  307 (520)
                      ..+..               .|+...+     .........|..             ......++...+..+...    -
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            88773               1111101     011112344541             011223333444444332    1


Q ss_pred             CC---ceEecccCCCCeEecCCCc-eEEeecCCcc
Q 010012          308 ER---CVVHRDIKPSNILLSSKKI-PKLCDFGLAT  338 (520)
Q Consensus       308 ~~---~IiHrDLKp~NILld~~~~-vkL~DFGla~  338 (520)
                      ..   .|||+|+.|.|||++.+.. +.+.|||-+.
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            22   2999999999999998884 8999999764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.31  E-value=0.74  Score=47.42  Aligned_cols=29  Identities=31%  Similarity=0.413  Sum_probs=24.3

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ..++||+|+.+.|||++ + .+.|.||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            34589999999999995 4 57899999865

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.29  E-value=0.2  Score=52.87  Aligned_cols=75  Identities=20%  Similarity=0.214  Sum_probs=47.9

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCc-----c-hHHHHHHHHHHHHHHhCC--CCC-eecEEEEEEcCCCcEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----D-KESSKAFCRELMIASSLH--HPN-IVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~-~~~~~~~~~E~~il~~l~--Hpn-Iv~l~g~~~~~~~~~~L  257 (520)
                      .+.||-|....||++.+...+..|+||.-...     + +-...+...|.+.|+.+.  -|. +.+++.|  +.+. ..+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~-~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM-NCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH-hhH
Confidence            46789999999999987533567999975321     1 223345556777776653  344 4445543  4443 469


Q ss_pred             EEEecCC
Q 010012          258 IYKYVSG  264 (520)
Q Consensus       258 V~E~~~~  264 (520)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999865

>PTZ00384 choline kinase; Provisional

Probab=93.96  E-value=0.63  Score=49.15  Aligned_cols=76  Identities=20%  Similarity=0.184  Sum_probs=44.3

Q ss_pred             eEEcccCceEEEEeeecCCC-c-----EEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          188 RVLGRGALSFVFKGKVGLLR-T-----SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~-~-----~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +.|..|-...+|++...... .     .|.+....... ...-.-.+|+++++.+...++-+-+-.+..  +  .+|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~--g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--D--FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC--C--EEEEEE
Confidence            45555778899998754321 1     24444332211 111122468888888876666655543333  2  599999


Q ss_pred             cCCCChh
Q 010012          262 VSGGSLE  268 (520)
Q Consensus       262 ~~~gsL~  268 (520)
                      ++|-+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987764

>PTZ00296 choline kinase; Provisional

Probab=93.77  E-value=0.66  Score=49.99  Aligned_cols=76  Identities=16%  Similarity=0.132  Sum_probs=44.5

Q ss_pred             cceEEcccCceEEEEeeecCC--------CcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCee-cEEEEEEcCCCcEE
Q 010012          186 KGRVLGRGALSFVFKGKVGLL--------RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLF  256 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~  256 (520)
                      ..+.|..|-.-.+|++.....        ++.|.+++......... .-..|..++..+....|- ++++.+ .  +  .
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f-~--g--g  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTF-S--G--G  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEe-C--C--C
Confidence            345666666778888875421        45788888755432222 234577776666544444 344432 2  2  4


Q ss_pred             EEEEecCCCCh
Q 010012          257 LIYKYVSGGSL  267 (520)
Q Consensus       257 LV~E~~~~gsL  267 (520)
                      .|.||++|-+|
T Consensus       183 ~I~efi~g~~l  193 (442)
T PTZ00296        183 RIEEWLYGDPL  193 (442)
T ss_pred             EEEEeeCCccC
Confidence            68999998744

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	520
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-37
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-30
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-30
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-30
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-13
3soa_A	444	Full-Length Human Camkii Length = 444		7e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/303 (34%), Positives = 165/303 (54%), Gaps = 12/303 (3%)
Query: 168 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AF 226
            L R S  E+  A+ NFS   +LGRG    V+KG++    T VA+KRL +E  +  +  F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQF 82
Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
             E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDW 138
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
             R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA         
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX- 197
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL- 405
            +   V+GT G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  +++++L 
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 406 -WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 464
            W K +L      +E L+D  L+   ++             C  S    RP + E++ +L
Sbjct: 258 DWVKGLLKE--KKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVRML 314
Query: 465 RGE 467
            G+
Sbjct: 315 EGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  161 bits (408), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 103/306 (33%), Positives = 164/306 (53%), Gaps = 16/306 (5%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSK 224
             L R S  E+  A+ NF    +LGRG    V+KG++  G L   VA+KRL +E  +  +
Sbjct: 15  GQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL---VAVKRLKEERTQGGE 71
Query: 225 -AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             F  E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPP 127
Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L W  R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA      
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
               +   V+G  G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  ++++
Sbjct: 188 DX-HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 404 VL--WAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
           +L  W K +L      +E L+D  L+   ++             C  S    RP + E++
Sbjct: 247 MLLDWVKGLLKE--KKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 462 AILRGE 467
            +L G+
Sbjct: 304 RMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 152/298 (51%), Gaps = 25/298 (8%)
Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 228
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 285
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 286 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
               L   VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I     +   NL
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
             WA    + G   +E+++DP L    R              C++     RP + +++
Sbjct: 253 AEWAVESHNNGQ--LEQIVDPNLADKIR-PESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 152/298 (51%), Gaps = 25/298 (8%)
Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 228
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 285
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 286 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
               L   VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I     +   NL
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
             WA    + G   +E+++DP L    R              C++     RP + +++
Sbjct: 253 AEWAVESHNNGQ--LEQIVDPNLADKIR-PESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 240
Query: 402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 462 AILR 465
            +L+
Sbjct: 299 QLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 240
Query: 402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 462 AILR 465
            +L+
Sbjct: 299 QLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/304 (30%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 66
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 121
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
             +   +   + GT  Y+APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 234
Query: 402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
            L+L  K  +      +E+ +D ++     +S            C+  ++++RP I+++ 
Sbjct: 235 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 462 AILR 465
            +L+
Sbjct: 293 QLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 96/304 (31%), Positives = 151/304 (49%), Gaps = 26/304 (8%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G   G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 63
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y   GSL   L      + G 
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDD-LCLVYVYXPNGSLLDRL----SCLDGT 118
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W  R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
             +       + GT  Y APE  + G+++ K+D+Y+FGVVLLE++TG   ++  R   E 
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR---EP 231
Query: 402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEII 461
            L+L  K  +      +E+ +D   K    +S            C+  ++++RP I+++ 
Sbjct: 232 QLLLDIKEEIEDEEKTIEDYIDK--KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 462 AILR 465
            +L+
Sbjct: 290 QLLQ 293

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 143/282 (50%), Gaps = 44/282 (15%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 16  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 305
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 72  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 306 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
              + ++HRD+KP N+LL +   + K+CDFG A       +       KG+  ++APE F
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 176
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM--AAVEELL 422
           +    S+K DV+++G++L E++T RKP +   + G    ++WA   +H G     ++ L 
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTRPPLIKNLP 231
Query: 423 DPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 464
            P     +R              C S + S+RP +EEI+ I+
Sbjct: 232 KPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 143/282 (50%), Gaps = 44/282 (15%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 15  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 305
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 71  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 306 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
              + ++HRD+KP N+LL +   + K+CDFG A       +       KG+  ++APE F
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 175
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM--AAVEELL 422
           +    S+K DV+++G++L E++T RKP +   + G    ++WA   +H G     ++ L 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTRPPLIKNLP 230
Query: 423 DPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 464
            P     +R              C S + S+RP +EEI+ I+
Sbjct: 231 KPIESLMTR--------------CWSKDPSQRPSMEEIVKIM 258

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/201 (37%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 250
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           +VHRD+K  N+L+  K   K+CDFGL+   +  S     K   GT  ++APE  +    +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 371 DKTDVYAFGVVLLELLTGRKP 391
           +K+DVY+FGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 250
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           +VHR++K  N+L+  K   K+CDFGL+   +  S     K+  GT  ++APE  +    +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 371 DKTDVYAFGVVLLELLTGRKP 391
           +K+DVY+FGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 27/211 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G +S V+  +  +L   VAIK +    +E +E+ K F RE+  +S L H NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 247 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAYL 303
             +D E    +L+ +Y+ G +L  ++          S  P SV   +     I + + + 
Sbjct: 79  --VDEEDDCYYLVMEYIEGPTLSEYIE---------SHGPLSVDTAINFTNQILDGIKHA 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFGYLAP 361
           H   +  +VHRDIKP NIL+ S K  K+ DFG+A   S  S   L +T  V GT  Y +P
Sbjct: 128 H---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS---LTQTNHVLGTVQYFSP 181
Query: 362 EYFQHGKVSDK-TDVYAFGVVLLELLTGRKP 391
           E  + G+ +D+ TD+Y+ G+VL E+L G  P
Sbjct: 182 EQAK-GEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 111/218 (50%), Gaps = 29/218 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L   D E         + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + N     +VHRD++  NI L S  +  P   K+ DFGL+   S  SV  L     G F 
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLL----GNFQ 191
Query: 358 YLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
           ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 83  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 134
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 135 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 187
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 111/218 (50%), Gaps = 29/218 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L   D E         + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + N     +VHRD++  NI L S  +  P   K+ DFG    TS  SV  +   + G F 
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----TSQQSVHSVSGLL-GNFQ 191
Query: 358 YLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
           ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 172
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 143
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 196
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTL 171
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 63  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 114
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 115 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 167
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 209

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 171
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 143
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTL 196
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 111/218 (50%), Gaps = 29/218 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESSKAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L       + E  E  + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + N     +VHRD++  NI L S  +  P   K+ DF L+   S  SV  L     G F 
Sbjct: 138 MQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-QSVHSVSGLL----GNFQ 191
Query: 358 YLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
           ++APE    +    ++K D Y+F ++L  +LTG  P +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGT 355
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG   W+  APS      T+ GT
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFG---WSCHAPSS--RRTTLSGT 170
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
             YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTL 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 65  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 116
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 117 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 169
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 211

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 70  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 121
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 174
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 17  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 73
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 74  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 125
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 126 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 118 ANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTL 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)
Query: 188 RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 81  RLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 133 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC    GT 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTL 172
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC    GT 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTL 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 17/213 (7%)
Query: 188 RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 104 RLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 155
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L    ER +VHRD+   N+L+ S    K+ DFGLA         +     K    ++A E
Sbjct: 156 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
              + K + ++DV+++GV + EL+T G KP + 
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           ++G G    V++     +   VA+K      D++  ++ +   +E  + + L HPNI+ L
Sbjct: 14  IIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G C+  E  L L+ ++  GG L R L  K+        +P  +    A+ IA  + YLH
Sbjct: 72  RGVCLK-EPNLCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIARGMNYLH 122
Query: 305 NGTERCVVHRDIKPSNILLSSK--------KIPKLCDFGLA-TWTSAPSVPFLCKTVKGT 355
           +     ++HRD+K SNIL+  K        KI K+ DFGLA  W     +     +  G 
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-----SAAGA 177
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           + ++APE  +    S  +DV+++GV+L ELLTG  P
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYL 177
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            PE  +     +K D+++ GV+  E L G  P EA   Q
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYL 177
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            PE  +     +K D+++ GV+  E L G  P EA   Q
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 12  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 122
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 174
Query: 368 KVSDKTDVYAFGVVLLELLT-GRKP 391
           K S K+DV++FG++L E+ + GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 27  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 137
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 189
Query: 368 KVSDKTDVYAFGVVLLELLT-GRKP 391
           K S K+DV++FG++L E+ + GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 18/222 (8%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    APS       + GT 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSS--RRXXLXGTL 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            YL PE  +     +K D+++ GV+  E L G+ P EA   Q
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 199 QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 309
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 361
Query: 368 KVSDKTDVYAFGVVLLELLT-GRKP 391
           K S K+DV++FG++L E+ + GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 40  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 97  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 148
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 149 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 33  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 90  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 141
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 142 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 15  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 71
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 72  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 123
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 365 Q---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           +       S ++DVYAFG+VL EL+TG+ P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 18  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 128
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
               VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE  +  
Sbjct: 129 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREA 180
Query: 368 KVSDKTDVYAFGVVLLELLT-GRKP 391
             S K+DV++FG++L E+ + GR P
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GS 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GS 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 73  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 122
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 357
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+  
Sbjct: 123 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPP 175
Query: 358 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 112/235 (47%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G 
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC----GA 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 242 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 294
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP---SVPFLCKT 351
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +     +   + KT
Sbjct: 130 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 352 VKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
             GT  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 112/235 (47%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G 
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC----GA 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 76  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 125
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFG 357
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G   
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPP 178
Query: 358 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 179 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GS 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 68  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----------QI 115
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 116 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GS 168
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 169 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 242 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 294
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 71  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 124
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP---SVPFLCKT 351
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +     +   + KT
Sbjct: 125 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 352 VKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
             GT  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 112/235 (47%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 76  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 123
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL      K+ DFG +  +T    +   C    G+
Sbjct: 124 VSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GS 176
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 177 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 140
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 199
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
             K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL H
Sbjct: 33  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA+
Sbjct: 93  AHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAK 144
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL    E  +VHR++   N+LL S    ++ DFG+A          L    K    +
Sbjct: 145 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLV 404
           +A E    GK + ++DV+++GV + EL+T G +P    RL    +L+
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 113/235 (48%), Gaps = 29/235 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGT 355
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +  +T    +   C    G+
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC----GS 175
Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
             Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+     VL  K
Sbjct: 176 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 35/226 (15%)
Query: 187 GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK 350
            E +AYL    E CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K
Sbjct: 113 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
                  + +PE F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 170 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             +  ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH+ 
Sbjct: 75  -VLYKDKRLNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-----TSAPSVPFLCK-------TVKG 354
               ++HRD+   N L+   K   + DFGLA       T    +  L K       TV G
Sbjct: 128 N---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
              ++APE        +K DV++FG+VL E++
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 17/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
              K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA
Sbjct: 74  HAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + + YL    E  +VHR++   N+LL S    ++ DFG+A          L    K    
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLV 404
           ++A E    GK + ++DV+++GV + EL+T G +P    RL    +L+
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 103/190 (54%), Gaps = 24/190 (12%)
Query: 226 FCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 284
             REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------I 111
Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           P  +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQL 165
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQGEE 401
           +  +  +  GT  Y+APE  Q    S ++D+++ G+ L+EL  GR PI   +A+ L+   
Sbjct: 166 IDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEA-- 223
Query: 402 NLVLWAKPIL 411
              ++ +P++
Sbjct: 224 ---IFGRPVV 230

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G+   V+KGK       VA+K L   D   E  +AF  E+ +     H NI+  +G+
Sbjct: 44  IGSGSFGTVYKGK---WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               +  L ++ ++  G SL +HLH ++   +    +       +A   A+ + YLH   
Sbjct: 101 MT--KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI------DIARQTAQGMDYLH--- 149
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-- 365
            + ++HRD+K +NI L      K+ DFGLAT  S  S     +   G+  ++APE  +  
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 366 -HGKVSDKTDVYAFGVVLLELLTGRKP 391
            +   S ++DVY++G+VL EL+TG  P
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +       VA+K L K   E         RE+ I + LHHP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L  +  D  + ++LI +Y   G L + L +       + T        +   +A++
Sbjct: 84  NILRLYNYFYD-RRRIYLILEYAPRGELYKELQK-------SCTFDEQRTATIMEELADA 135
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGY 358
           + Y H    + V+HRDIKP N+LL  K   K+ DFG   W+  APS+    KT+ GT  Y
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFG---WSVHAPSL--RRKTMCGTLDY 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           L PE  +    ++K D++  GV+  ELL G  P E+
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 18  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 76  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 125
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 178
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 179 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + KE   S   F  E  +   L HP +V L G C+
Sbjct: 35  IGSGQFGLVHLG-YWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 93  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 142
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 195
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 196 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 228

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 13  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 71  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 120
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 173
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NIL+S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV-XQTAAVIGT 182
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL--ATWTSAPSVPFLCKTVKGT 355
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+  A   S  SV      V GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 182
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 300
           V L+   I  E+ L L+++++    L++ L E K G++ +       + K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T  Y A
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 361 PEYFQHG-KVSDKTDVYAFGVVLLELLTGR 389
           P+      K S   D+++ G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 300
           V L+   I  E+ L L+++++    L++ L E K G++ +       + K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T  Y A
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRA 187
Query: 361 PEYFQHG-KVSDKTDVYAFGVVLLELLTGR 389
           P+      K S   D+++ G +  E++TG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 16  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+ +++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 74  E-QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
           CV+HRD+   N L+   ++ K+ DFG+        +TS+    F  K       + +PE 
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------WASPEV 176
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
           F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 304
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL----ATWTSAPSVPFLCKTVKGTFGYLA 360
               +C +HRD+   N L++ K + K+ DFG+    A    A S       VK T    A
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT----A 283
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT 387
           PE   +G+ S ++DV++FG++L E  +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 17/218 (7%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 73  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           E + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    
Sbjct: 125 EGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           ++A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 304
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL----ATWTSAPSVPFLCKTVKGTFGYLA 360
               +C +HRD+   N L++ K + K+ DFG+    A    A S       VK T    A
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----A 283
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT 387
           PE   +G+ S ++DV++FG++L E  +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA               
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 142
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 196
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 163
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P       T  GT  
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPN 218
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
           Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 187 GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK 350
            E +AYL    E  V+HRD+   N L+   ++ K+ DFG+        +TS+    F  K
Sbjct: 113 CEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 169
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
                  + +PE F   + S K+DV++FGV++ E+ + G+ P E R
Sbjct: 170 -------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 86  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 136
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 190
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-------WTAPES 185
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-------WTAPES 184
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 76  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
              LH   ER V+HRDIKP N+L+  K   K+ DFG +    +     +C    GT  YL
Sbjct: 125 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 180
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
            PE  +     +K D++  GV+  E L G  P ++
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 78  PHVCRLLGICLT--STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 115 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 165
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 166 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 219
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 220 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 78  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 129
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 111
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 112 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 353 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 353 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 116 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 166
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 167 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 220
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 221 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 93  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 143
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 196
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 185
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 185
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 355
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 132 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 184
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 81  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 102 PHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 153
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 154 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 71  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 122
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 80  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 131
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 109/218 (50%), Gaps = 12/218 (5%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 93  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPERTVWKYFVQLCSA 148
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 203
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
           +PE       + K+D+++ G +L E+   + P    ++
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 83  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 134
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 135 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 87  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 138
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 139 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 188
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 84  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 187
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 15/228 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHP 239
           +F  G +LG+G+ + V++ +       VAIK +DK+    +    R   E+ I   L HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +I+ L  +  D    ++L+ +    G + R+L  + K    N    +  +      I   
Sbjct: 72  SILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ------IITG 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH+     ++HRD+  SN+LL+     K+ DFGLAT    P       T+ GT  Y+
Sbjct: 125 MLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYI 179
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA 407
           +PE         ++DV++ G +   LL GR P +   ++   N V+ A
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 94  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 198
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 98  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 148
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 149 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIA 202
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 203 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 398
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 398
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L+++         H+H+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFE---------HVHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 398
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI---EARRLQ 398
           PE  Q    S ++D+++ G+ L+E+  GR PI   +A+ L+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 129 VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 179
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 233
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L    NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 353 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 116
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 355
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 117 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 169
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 128/294 (43%), Gaps = 50/294 (17%)
Query: 185 SKGRVLGRGALSFVFKGKVGLLRTS-------VAIKRLDKEDKESSKA-FCRELMIASSL 236
           ++ +V+G G    V+KG   +L+TS       VAIK L     E  +  F  E  I    
Sbjct: 47  TRQKVIGAGEFGEVYKG---MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-- 294
            H NI+ L G  I   + + +I +Y+  G+L++ L EK           +SV   V +  
Sbjct: 104 SHHNIIRLEG-VISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLR 154
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVK 353
           GIA  + YL N      VHRD+   NIL++S  + K+ DFGL+      P   +     K
Sbjct: 155 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH 412
               + APE   + K +  +DV++FG+V+ E++T G +P              W     H
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------YWELSN-H 257
Query: 413 RGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAIL 464
             M A+ +   L   + C S               C   E +RRP   +I++IL
Sbjct: 258 EVMKAINDGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 17/212 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMS 171
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  Q    S ++D+++ G+ L+E+  GR PI
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-------WTAPES 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 65  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 115 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 169
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S         +K       + +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQ 114
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 356 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 166
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH- 138
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
             +  +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             + G   +K DV++ GV+L  LL+G  P 
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 166
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 167 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 168
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGT 355
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+      P  +    C    GT
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC----GT 173
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
             Y+APE  +        D +A GV++ E++ GR P +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V 
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV- 167
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  FC   ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 149
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 150 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 248

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 175
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 21/198 (10%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           + I R+  +++E S+   RE+ + +++ HPNIV       +    L+++  Y  GG L +
Sbjct: 57  INISRMSSKEREESR---REVAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFK 112
Query: 270 HLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            ++ +K GV  + +  L W V+  +AL       ++H   +R ++HRDIK  NI L+   
Sbjct: 113 RINAQK-GVLFQEDQILDWFVQICLAL------KHVH---DRKILHRDIKSQNIFLTKDG 162
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
             +L DFG+A   +  S   L +   GT  YL+PE  ++   ++K+D++A G VL EL T
Sbjct: 163 TVQLGDFGIARVLN--STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 388 GRKPIEARRLQGEENLVL 405
            +   EA  ++   NLVL
Sbjct: 221 LKHAFEAGSMK---NLVL 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 64  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 115
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 116 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 168
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 184
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 188
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 139
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA   +            G
Sbjct: 140 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 192
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T GYL+PE  +    S   D++A GV+L  LL G  P 
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T T+     F  K       + APE 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-------WTAPES 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 287 R-EPPFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLE---KK 337
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HR++   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 390
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             + K S K+DV+AFGV+L E+ T G  P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI  L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYX 142
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A       K   GT  Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---XKDKIGTAYYIA 196
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE   HG   +K DV++ GV+L  LL+G  P 
Sbjct: 197 PEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 61  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 113
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 114 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 168
Query: 356 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 183
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 114
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 169
Query: 356 FGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
             Y APE     K  S   D+++ G +  E++T R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +++ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKVALGIA 297
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+     YK  L + 
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKPEDLYKDFLTLE 148
Query: 298 ESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA             
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
             +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 23/232 (9%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGI 296
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+      YK  L +
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKTPEDLYKDFLTL 147
Query: 297 AESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
              + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA            
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
              +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 37/246 (15%)
Query: 161 SISPV--ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE 218
           S+ PV   N  +   + EIL         R +G+G+   V   +    +   A+K ++K+
Sbjct: 1   SMPPVFDENEDVNFDHFEIL---------RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 219 ---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
              ++   +   +EL I   L HP +V L  +    E+ +F++   + GG L  HL +  
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-- 108
Query: 276 KGVRGNSTLPWSVRYK---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
                      +V +K   V L I E V  L     + ++HRD+KP NILL       + 
Sbjct: 109 -----------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGR 389
           DF +A      +      T+ GT  Y+APE F   K    S   D ++ GV   ELL GR
Sbjct: 158 DFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 390 KPIEAR 395
           +P   R
Sbjct: 215 RPYHIR 220

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 24/233 (10%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA           
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
               +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 250

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 81  PHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 132
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 326 R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 376
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HR++   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 429
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT 387
             + K S K+DV+AFGV+L E+ T
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL          F  K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           +HPNIV L+   I  E  L+L+++++S         +K       + +P  +       +
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQL 113
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T 
Sbjct: 114 LQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 168
Query: 357 GYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
            Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 243
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 301
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 136
Query: 302 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           YLH   E  ++HRD+KP NI+L     + I K+ D G A          LC    GT  Y
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 190
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           LAPE  +  K +   D ++FG +  E +TG +P 
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAI  L +    +++K    E  + +S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 110 NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    
Sbjct: 162 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           ++A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 243
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 301
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 135
Query: 302 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           YLH   E  ++HRD+KP NI+L     + I K+ D G A          LC    GT  Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           LAPE  +  K +   D ++FG +  E +TG +P 
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 77  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
             + G   +K DV++ GV+L  LL+G  P   +
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 122/260 (46%), Gaps = 24/260 (9%)
Query: 144 DSRAQELKWRKIQSLERSISPVANSLIR---LSYGEILAATHNFSKGRVLGRGALSFVFK 200
           D   + L ++ + S+  S +P   SL+    +      A +  F     LGRGA S V++
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 201 GKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY 259
            K    +   A+K L K  DK+  +    E+ +   L HPNI+ L      P + + L+ 
Sbjct: 72  CKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIFETPTE-ISLVL 127
Query: 260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS 319
           + V+GG L   + EK  G         +V+      I E+VAYLH   E  +VHRD+KP 
Sbjct: 128 ELVTGGELFDRIVEK--GYYSERDAADAVKQ-----ILEAVAYLH---ENGIVHRDLKPE 177
Query: 320 NILLSSK--KIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVY 376
           N+L ++     P K+ DFGL+          L KTV GT GY APE  +      + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 377 AFGVVLLELLTGRKPIEARR 396
           + G++   LL G +P    R
Sbjct: 235 SVGIITYILLCGFEPFYDER 254

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 79  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A    +  +  K    +
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT  Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE 193
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
             + G   +K DV++ GV+L  LL+G  P   +
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
           F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA+
Sbjct: 84  PHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           +A E   H   + ++DV+++GV + EL+T G KP + 
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST--LPWSVRYKVAL 294
           +HPNIV L+   I  E  L+L++++V          + KK +  ++   +P  +      
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEHVD--------QDLKKFMDASALTGIPLPLIKSYLF 113
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 355 TFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           T  Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 89  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 141
Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
               +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 366 HGK--VSDKTDVYAFGVVLLELLTGRKPI 392
            G        D+++ G  ++E+ TG+ P 
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE       S  +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  IKR+    K +++   RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67
Query: 243 PL----VGFCIDPEQG-----------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
                  GF  DPE             LF+  ++   G+LE+ + EK++G + +  L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           +  ++  G    V Y+H+   + +++RD+KPSNI L   K  K+ DFGL T         
Sbjct: 127 LFEQITKG----VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
                KGT  Y++PE         + D+YA G++L ELL
Sbjct: 180 RS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 17/216 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           NF   RVLG+G+   V   +V       A+K L K+    D +       + +++ + +H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      LF + ++V+GG L  H+ + ++     +          A  I  
Sbjct: 84  PFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEIIS 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
           ++ +LH+   + +++RD+K  N+LL  +   KL DFG+        V     T  GT  Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPDY 190
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           +APE  Q        D +A GV+L E+L G  P EA
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 70  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 120
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +     GT  Y++
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDEMANEFVGTRSYMS 174
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE  Q    S ++D+++ G+ L+E+  GR P
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F   R LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 75  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 123
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGY 358
              LH   ER V+HRDIKP N+L+  K   K+ DFG   W+  APS+    + + GT  Y
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSL--RRRXMCGTLDY 178
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           L PE  +     +K D++  GV+  E L G  P ++
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 168
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P   +  + V  T  
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 167
Query: 358 YLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGR 389
           Y APE     K  S   D+++ G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           + Y   +  G E    R  +HRD+   NILLS K + K+ DFGLA               
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 16/229 (6%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+         P  + YK  L +   
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL-YKDFLTLEHL 152
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA               
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
           +    ++APE       + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 261

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 75  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 127
Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
               +VHRDIK  N+L+++   + K+ DFG  T      +    +T  GT  Y+APE   
Sbjct: 128 Q---IVHRDIKGDNVLINTYSGVLKISDFG--TSKRLAGINPCTETFTGTLQYMAPEIID 182
Query: 366 HGK--VSDKTDVYAFGVVLLELLTGRKPI 392
            G        D+++ G  ++E+ TG+ P 
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAF---CRELMIA 233
            +F   R LG G+      G+V L+R+       A+K L KE     K       E ++ 
Sbjct: 6   QDFQILRTLGTGSF-----GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           S + HP I+ + G   D +Q +F+I  Y+ GG L   L       R +   P  V    A
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYA 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             +  ++ YLH+   + +++RD+KP NILL      K+ DFG A +     VP +   + 
Sbjct: 113 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLC 164
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  Y+APE       +   D ++FG+++ E+L G  P 
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 240

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                +VHRD+KP N+L   L       + DFGL+      SV     T  GT GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                  S   D ++ GV+   LL G  P 
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       WT+     F  K       + APE
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-------WTAPE 182
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIF 243

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                +VHRD+KP N+L   L       + DFGL+      SV     T  GT GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                  S   D ++ GV+   LL G  P 
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   +++ +Y+  G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 99  -LEPPFYIVTEYMPYGNLLDYLRECNR-----EEVTAVVLLYMATQISSAMEYLE---KK 149
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K       + APE 
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-------WTAPES 202
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +   S K+DV+AFGV+L E+ T G  P
Sbjct: 203 LAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                +VHRD+KP N+L   L       + DFGL+      SV     T  GT GY+APE
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                  S   D ++ GV+   LL G  P 
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 244

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 240

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 126
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 127 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           R LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 244 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             G C     + L LI +++  GSL  +L + K+ +     L ++ +      I + + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEY 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAP 361
           L  GT+R  +HRD+   NIL+ ++   K+ DFGL             K   +    + AP
Sbjct: 133 L--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT 387
           E     K S  +DV++FGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 101 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 151
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 107 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 157
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIF 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 106 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 156
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGLA      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 105 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 155
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 100 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 150
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 109 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 159
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 108 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 158
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 351
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 183
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 244

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 243

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 119
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 120 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 218

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+    E
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYV----E 380
Query: 309 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAP 361
           R   VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + AP
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAP 433
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E   +G+ + K+DV++FG++L EL T GR P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 69  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 120
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 219

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 70  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 121
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 122 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HR++   NIL+ ++  
Sbjct: 103 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRNLATRNILVENENR 153
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL          +  K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 122
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 123 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  I+R+    K +++   RE+   + L H NIV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV----KYNNEKAEREVKALAKLDHVNIV 68
Query: 243 PL----VGFCIDPEQG------------------------LFLIYKYVSGGSLERHLHEK 274
                  GF  DPE                          LF+  ++   G+LE+ + EK
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 275 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 334
           ++G + +  L   +  ++  G    V Y+H+   + ++HRD+KPSNI L   K  K+ DF
Sbjct: 128 RRGEKLDKVLALELFEQITKG----VDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
           GL T              KGT  Y++PE         + D+YA G++L ELL
Sbjct: 181 GLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 147
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 148 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 246

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 207 RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG 265
           +  VAIK L +  +K  ++   RE  I   L +P IV L+G C    + L L+ +   GG
Sbjct: 37  QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGG 94
Query: 266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 325
            L + L  K++ +  ++     + ++V++G+     YL    E+  VHRD+   N+LL +
Sbjct: 95  PLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE---EKNFVHRDLAARNVLLVN 145
Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 384
           +   K+ DFGL+    A    +  ++  K    + APE     K S ++DV+++GV + E
Sbjct: 146 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205
Query: 385 LLT-GRKPIEARRLQGEENLVL 405
            L+ G+KP   ++++G E +  
Sbjct: 206 ALSYGQKPY--KKMKGPEVMAF 225

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 127
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 128 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 178
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 125
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 126 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 176
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 16  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 71
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 72  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 176
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 26  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 82  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 133
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 186
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 118
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 230
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 231 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 464 L 464
           L
Sbjct: 275 L 275

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 187
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 123
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 124 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 174
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 36  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 95  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 145
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 146 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 257
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 258 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 464 L 464
           L
Sbjct: 302 L 302

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 31  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 86
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 87  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 138
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 191
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 28/234 (11%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIK---RLDKEDKESSK--AFCRELMIASS 235
            N   G+VLG GA   V      G+ +T V+I+   ++ KE  +SS+  A   EL + + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN------------- 281
           L  H NIV L+G C      ++LI++Y   G L  +L  K++    +             
Sbjct: 105 LGSHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 282 ---STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              + S   +    +    ++APE    G  + K+DV+++G++L E+ + G  P
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 85  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 135
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 136 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 247
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 248 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 291
Query: 464 L 464
           L
Sbjct: 292 L 292

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 301
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGL        +T+     F  K       + APE
Sbjct: 302 --YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-------WTAPE 352
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL       P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           VLG GA S V   +    +  VAIK + K   E KE S     E+ +   + HPNIV L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHKIKHPNIVALD 82
Query: 246 GFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                 E G  L+LI + VSGG L   + EK      +++       ++   + ++V YL
Sbjct: 83  DIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYL 132
Query: 304 HNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H+     +VHRD+KP N+L   L       + DFGL+      SV     T  GT GY+A
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVA 186
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE       S   D ++ GV+   LL G  P 
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F   + LGRG    VF+ K  +   + AIKR+   ++E + +   RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 242 VPLVGFCIDPEQGLFL------IYKYVSGGSLERHLHEKKKGVRGNSTLP---WSVRYKV 292
           V      ++      L      +Y Y+      +     K  + G  T+     SV   +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE--NLKDWMNGRCTIEERERSVCLHI 123
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-----------WTS 341
            L IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T            T 
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
            P+       V GT  Y++PE       S K D+++ G++L ELL
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           T ++     LG+GA S V +   K      +  I    K      +   RE  I   L H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 90  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIHQILE 141
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           SV ++H   +  +VHRD+KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 142 SVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF--GFAGT 196
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            GYL+PE  +        D++A GV+L  LL G  P 
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   + H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S     +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S         GT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           +PE          +D++A G ++ +L+ G  P  A    G E L+ 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIF 241

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD+  +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 290
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 73  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++    +     +  
Sbjct: 132 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                  ++ PE   + K + ++DV++ GVVL E+ T G++P
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 243
           RV+G+G    V+ G+       R   AIK L +  + +  +AF RE ++   L+HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+G  + PE    ++  Y+  G L + +   ++    N T+   + +   L +A  + YL
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISF--GLQVARGMEYL 140
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFG 357
               E+  VHRD+   N +L      K+ DFGLA       + S          VK T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             A E  Q  + + K+DV++FGV+L ELLT   P
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 21  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ +++I +Y++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 129
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +N+L+S   + K+ DFGLA       +T+     F  K       + APE 
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 182
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
              G  + K+DV++FG++L E++T G+ P   R
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGR 215

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK 368
              VHRD++ +NIL+    + K+ DFGLA            +  K    + APE   +G+
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGR 191
Query: 369 VSDKTDVYAFGVVLLELLT-GRKP 391
            + K+DV++FG++L EL T GR P
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 102 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 152
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 17/209 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V           VA+K++D   ++  +    E++I    HH N+V
Sbjct: 49  NFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVV 105
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +    +  ++ L+++ +++ GG+L   +   +      +T        V L +  +++Y
Sbjct: 106 DMYSSYLVGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAT--------VCLSVLRALSY 156
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LHN   + V+HRDIK  +ILL+S    KL DFG     S   VP   K + GT  ++APE
Sbjct: 157 LHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVP-KRKXLVGTPYWMAPE 211
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    + D+++ G++++E++ G  P
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 115 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 165
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 12/215 (5%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKE 59
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV L    I  E  L L+++++    L++++  +  G          V+Y     
Sbjct: 60  LKHENIVRLYD-VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY-FQWQ 116
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F  + V  T
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171
Query: 356 FGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGR 389
             Y AP+     +  S   D+++ G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 22  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 78  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 129
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 182
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 102
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 103 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 153
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGLA         ++ +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 29  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 85  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 136
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 189
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
           A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S   
Sbjct: 8   APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDE 65
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLL- 123
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW------ 339
                ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+ +      
Sbjct: 124 -----EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE 175
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
           TS+    F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 176 TSSVGSKFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 23  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 79  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 183
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 17  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 73  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HR+++ +NIL+S     K+ DFGLA       +T+     F  K       + APE 
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-------WTAPEA 177
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L    + +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 105 DYLQAHAERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 155
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGL             K   +    + APE     K S  +DV++FGVVL EL T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
           A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S   
Sbjct: 8   APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDE 65
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLL- 123
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TW 339
                ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+       +
Sbjct: 124 -----EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
           TS+    F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 176 TSSVGSKFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 187
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 30  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 85
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 86  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 137
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +NIL+S     K+ DFGLA        T+     F  K       + APE 
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-------WTAPEA 190
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +G  + K+DV++FG++L E++T GR P
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPE 362
              VHRD++ +NIL+    + K+ DFGLA       +T+     F  K       + APE
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-------WTAPE 182
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +G+ + K+DV++FG++L EL T GR P
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQAGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
             +HRD++ +NIL+S     K+ DFGLA            +  K    + APE   +G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTF 187
Query: 370 SDKTDVYAFGVVLLELLT-GRKP 391
           + K+DV++FG++L E++T GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 184 FSKGRVLGRGALSFVF--KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           + + + LG GA   V   + KV  +  ++ I R       S+     E+ +   L HPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L  F  D ++  +L+ +   GG L   +  + K    ++ +       +   +   V 
Sbjct: 99  MKLYDFFED-KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------IIKQVLSGVT 150
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGL-ATWTSAPSVPFLCKTVKGTFG 357
           YLH   +  +VHRD+KP N+LL SK+   + K+ DFGL A + +   +    K   GT  
Sbjct: 151 YLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAY 203
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 204 YIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 26/229 (11%)
Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
           L YG       + +  + LG G    V  GK    +  VAIK + KE   S   F  E  
Sbjct: 5   LGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAK 62
Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L      +
Sbjct: 63  VMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------E 115
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSV 345
           +   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+       +TS+   
Sbjct: 116 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
            F  +       +  PE   + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 KFPVR-------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG+GA S V +    L     A K ++  K      +   RE  I   L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E   +LI+  V+GG L   +  ++     +++            I E+V + H   
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH--- 138
Query: 308 ERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
           +  VVHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+PE  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPEVL 196
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           +        D++A GV+L  LL G  P 
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 25/191 (13%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 213 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 269
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 270 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 328 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 381
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 374
Query: 382 LLELLT-GRKP 391
           L+E++T GR P
Sbjct: 375 LMEIVTYGRIP 385

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 73  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 124
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +     K +
Sbjct: 125 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 178
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFC-RELMIASSLHHPNIVPLVGF 247
           +G G+   VFK +       VAIK+ L+ ED    K    RE+ +   L HPN+V L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE- 69
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               ++ L L+++Y     L    HE  +  RG   +P  +   +     ++V + H   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL----HELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN 122
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF--- 364
               +HRD+KP NIL++   + KLCDFG A   + PS  +  +    T  Y +PE     
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELLVGD 177
Query: 365 -QHGKVSDKTDVYAFGVVLLELLTG 388
            Q+G      DV+A G V  ELL+G
Sbjct: 178 TQYGP---PVDVWAIGCVFAELLSG 199

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 87  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 138
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +     K +
Sbjct: 139 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 192
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 118
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 230
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 231 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 464 L 464
           L
Sbjct: 275 L 275

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ + ++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 124
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK 368
              VHRD++ +NIL+    + K+ DFGLA            +  K    + APE   +G+
Sbjct: 125 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGR 181
Query: 369 VSDKTDVYAFGVVLLELLT-GRKP 391
            + K+DV++FG++L EL T GR P
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 66  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +     K +
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    +  I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 305 -NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            NG    +VHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLS 174
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  +        D++A GV+L  LL G  P 
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 231
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 232 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 72  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 123
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+              
Sbjct: 124 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TN 177
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
              GT  Y+APE     K +   D ++FGV+L E+L G+ P      Q EE L
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEEL 227

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVP 346
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+      P   
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
           +  +  K    + +PE   + K +  +DV+++G+VL E+++ G +P      Q       
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV----- 259
Query: 406 WAKPILHRGMAAVEE--LLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAI 463
                    + AV+E   L P + C +               C   + + RP  E+I++I
Sbjct: 260 ---------IKAVDEGYRLPPPMDCPA-------ALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 464 L 464
           L
Sbjct: 304 L 304

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 16  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 74  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 176
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 177
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    +  I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 305 -NGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            NG    +VHRD+KP N+LL+SK      KL DFGLA         +      GT GYL+
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF--GFAGTPGYLS 174
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  +        D++A GV+L  LL G  P 
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 176
Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 82/171 (47%), Gaps = 14/171 (8%)
Query: 228 RELMIASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE   A  L  P++VP+  F  ID +  L++  + ++G  L   L  +     G    P 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQ--LYVDXRLINGVDLAAXLRRQ-----GPLAPPR 135
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           +V     +G A   A+    T     HRD+KP NIL+S+     L DFG+A+ T+   + 
Sbjct: 136 AVAIVRQIGSALDAAHAAGAT-----HRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
            L  TV GT  Y APE F     + + D+YA   VL E LTG  P +  +L
Sbjct: 191 QLGNTV-GTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VA+K + KE   S   F +E      L HP +V   G C 
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC- 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E  ++++ +Y+S G L  +L    KG+  +  L      ++   + E +A+L +    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL------EMCYDVCEGMAFLESHQ-- 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
             +HRD+   N L+      K+ DFG+  +           T K    + APE F + K 
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFKY 182
Query: 370 SDKTDVYAFGVVLLELLT-GRKPIE 393
           S K+DV+AFG+++ E+ + G+ P +
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 25/191 (13%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 40  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 96
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 97  LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 148
Query: 328 IPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVV 381
           + K+ DFGLA       +T+     F  K       + APE    G  + K+DV++FG++
Sbjct: 149 VCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEAINFGSFTIKSDVWSFGIL 201
Query: 382 LLELLT-GRKP 391
           L+E++T GR P
Sbjct: 202 LMEIVTYGRIP 212

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 108 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 165 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 269

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 26/235 (11%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 231
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 232 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 71  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 122
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFL 348
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+              
Sbjct: 123 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
           C    GT  Y+APE     K +   D ++FGV+L E+L G+ P      Q EE L
Sbjct: 179 C----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEEL 226

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 253

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 118 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 175 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
                 ++ PE F  G  + KTD ++FGV+L E+ +
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 20  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ +++I ++++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD++ +N+L+S   + K+ DFGLA       +T+     F  K       + APE 
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------WTAPEA 181
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
              G  + K++V++FG++L E++T G+ P   R
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGR 214

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 190 LGRGALSFVFKG--KVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G    V +G  ++   +  VAIK L +  +K  ++   RE  I   L +P IV L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C    + L L+ +   GG L + L  K++ +  ++     + ++V++G+     YL   
Sbjct: 404 VCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE-- 453
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQ 365
            E+  VHR++   N+LL ++   K+ DFGL+    A    +  ++  K    + APE   
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 366 HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
             K S ++DV+++GV + E L+ G+KP   ++++G E +  
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAF 551

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASS 235
           +N    R +G GA   VF+ +  GLL     T VA+K L +E     +A F RE  + + 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH-----------------EKKKGV 278
             +PNIV L+G C    + + L+++Y++ G L   L                    +   
Sbjct: 107 FDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            G   L  + +  +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+ 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +               ++ PE   + + + ++DV+A+GVVL E+ + G +P
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 70  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 119
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-------WSPPEV 172
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLAPEY 363
             +HRD+   N L++ + + K+ DFGL+       +TS+    F  +       +  PE 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-------WSPPEV 177
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIE 393
             + K S K+D++AFGV++ E+ + G+ P E
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 98  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 155 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VAIK L K    S ++F  E  I   L H  +V L  + +
Sbjct: 17  LGNGQFGEVWMGTWNG-NTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +Y++ GSL   L   K G      LP  V   +A  +A  +AY+      
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYIERMN-- 125
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
             +HRD++ +NIL+ +  I K+ DFGLA            +  K    + APE   +G+ 
Sbjct: 126 -YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRF 183
Query: 370 SDKTDVYAFGVVLLELLT-GRKP 391
           + K+DV++FG++L EL+T GR P
Sbjct: 184 TIKSDVWSFGILLTELVTKGRVP 206

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V K +       VAIK+     +DK   K   RE+ +   L H N+V L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C   ++  +L++++V    L+  L     G      L + V  K    I   + + H+ 
Sbjct: 92  VC-KKKKRWYLVFEFVDHTILD-DLELFPNG------LDYQVVQKYLFQIINGIGFCHSH 143
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF-- 364
               ++HRDIKP NIL+S   + KLCDFG A   +AP   +  +    T  Y APE    
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVG 198
Query: 365 --QHGKVSDKTDVYAFGVVLLELLTG 388
             ++GK     DV+A G ++ E+  G
Sbjct: 199 DVKYGKA---VDVWAIGCLVTEMFMG 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
            VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             +     +L+ + VSGG L   + E+      +++L       V   +  +V YLH   
Sbjct: 75  -YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLH--- 123
Query: 308 ERCVVHRDIKPSNIL-LSSKKIPKL--CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
           E  +VHRD+KP N+L L+ ++  K+   DFGL+       +   C    GT GY+APE  
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGYVAPEVL 179
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                S   D ++ GV+   LL G  P 
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 23/185 (12%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 207 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 263
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 264 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 315
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + K+ DFGLA               K    + APE    G  + K+DV++FG++L+E++T
Sbjct: 316 VCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364
Query: 388 -GRKP 391
            GR P
Sbjct: 365 YGRIP 369

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 187 GRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESSKAFCRE-----LMIASSLHH 238
           G  LG G  + V K +    GL   +  IK+  ++ + S +  CRE     + I   + H
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKK--RQSRASRRGVCREEIEREVSILRQVLH 74
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNI+ L     +    + LI + VSGG L   L +K+      +T            I +
Sbjct: 75  PNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILD 126
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKG 354
            V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIFG 180
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAFCRELM--- 231
           + K R LG GA   V   K     +  AIK + K         +D ++ + F  E+    
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 232 -IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  SL HPNI+ L     + ++  +L+ ++  GG L   +  + K    ++        
Sbjct: 98  SLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA------- 149
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGLATWTSAPSVPF 347
            +   I   + YLH   +  +VHRDIKP NILL +K      K+ DFGL+++ S     +
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DY 203
Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
             +   GT  Y+APE  +  K ++K DV++ GV++  LL G  P   +  Q
Sbjct: 204 KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 164
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+     GT  
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV-----GTPY 215
Query: 358 YLAPEY---FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           ++APE       G+   K DV++ G+  +EL   + P+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 83  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A      S       
Sbjct: 140 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 244

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIAS 234
           A   +F   +V+G+G+   V   +        A+K L K+     KE         ++  
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           ++ HP +V L  F       L+ +  Y++GG L  HL       R    L    R+  A 
Sbjct: 95  NVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA- 146
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            IA ++ YLH+     +V+RD+KP NILL S+    L DFGL       +      T  G
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCG 201
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           T  YLAPE           D +  G VL E+L G  P  +R
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 66  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 117
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 118 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 173
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 392
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 174 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 293
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 94  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL     A     L     
Sbjct: 153 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               ++APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 25/234 (10%)
Query: 173 SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 220
           +Y +   A H F+K          RV+G G    V  G++   G     VAIK L     
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 221 ESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           E  +  F  E  I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +K  G  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEG-VVTKSKPVMIVTEYMENGSLDTFL-KKNDGQF 121
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-T 338
               L   +R     GI+  + YL   ++   VHRD+   NIL++S  + K+ DFGL+  
Sbjct: 122 TVIQLVGMLR-----GISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               P   +  +  K    + APE     K +  +DV+++G+V+ E+++ G +P
Sbjct: 174 LEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    ++ I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 75
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +LI+  V+GG L   +  ++     +++            I E+V + H
Sbjct: 76  HD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH 127
Query: 305 NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
              +  VVHR++KP N+LL+SK      KL DFGLA         +      GT GYL+P
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSP 182
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           E  +        D++A GV+L  LL G  P 
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 70  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 121
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 392
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-- 285
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           + +R    L +A    +  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  + 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               KT  GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 82  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 133
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +       +     +  
Sbjct: 134 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLP 189
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPI 392
             +++PE     + +  +DV+ F V + E+L+ G++P 
Sbjct: 190 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 189 VLGRGALSFVFK-------GKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HP 239
           V+GRG  S V +        +  +    V  +RL  E  +E  +A  RE  I   +  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +I+ L+    +    +FL++  +  G L  +L EK         L       +   + E+
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEA 212
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGY 358
           V++LH      +VHRD+KP NILL      +L DFG +        +  LC    GT GY
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----GTPGY 265
Query: 359 LAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           LAPE  +      H     + D++A GV+L  LL G  P   RR
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 293
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 77  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL     A     L     
Sbjct: 136 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               ++APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G  + V+KGK  L    VA+K +  E +E +     RE+ +   L H NIV L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI- 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           I  E+ L L+++Y+    L+++L +      GN     +V+      +   +AY H    
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNIINMHNVKL-FLFQLLRGLAYCHR--- 118
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-YFQHG 367
           + V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  P+      
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGST 176
Query: 368 KVSDKTDVYAFGVVLLELLTGR 389
             S + D++  G +  E+ TGR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 237
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K     S +  +V  K  L   
Sbjct: 63  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVIMKQVLS-- 115
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
               YLH      +VHRD+KP N+LL SK    + K+ DFGL   ++   V    K   G
Sbjct: 116 -GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLG 168
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T  Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 169 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 132 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A              
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 188 RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 15  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 123
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG-- 354
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL   T A        TVK   
Sbjct: 124 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL---TKAIETDKEXXTVKDDR 177
Query: 355 ---TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
               F Y APE     K    +DV++FGV L ELLT
Sbjct: 178 DSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 109 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKT 351
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A              
Sbjct: 166 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ 398
                 ++ PE F  G  + KTD ++FGV+L E+ + G  P  ++  Q
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 270

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 188 RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 27  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 135
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG-- 354
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL   T A        TVK   
Sbjct: 136 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL---TKAIETDKEXXTVKDDR 189
Query: 355 ---TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
               F Y APE     K    +DV++FGV L ELLT
Sbjct: 190 DSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 72  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 130 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           KT+
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKTL 202
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
            GT  Y+APE       S + D+++ G +L  LL G+ P E 
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 80  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 138 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 187
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 221
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 1   NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 58
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 59  R-RDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GR 112
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWT 340
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++    
Sbjct: 113 FTVIQLV--GMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 167
Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             P   +  +  K    + APE   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 168 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 11/180 (6%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P +  L L+ +Y+  G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 99  DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 149
Query: 329 PKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            K+ DFGLA          + +   +    + APE       S ++DV++FGVVL EL T
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 77  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 135 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 184
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 78  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 135
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 136 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 185
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 221
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 16  NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 74  R-RDFLSEASIMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFLRKND----GR 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWT 340
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++    
Sbjct: 128 FTVIQLV--GMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             P   +  +  K    + APE   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 103 KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 160
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 161 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 210
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 14/215 (6%)
Query: 187 GRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           G++LG G    V +G +       L+ +V   +LD   +   + F  E        HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 242 VPLVGFCID-PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           + L+G CI+   QG+    +I  ++  G L  +L   +    G   +P     K  + IA
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET-GPKHIPLQTLLKFMVDIA 157
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             + YL N   R  +HRD+   N +L       + DFGL+    +       +  K    
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           ++A E       + K+DV+AFGV + E+ T G  P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 82  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 141 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 191
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F+   VLG+G+   V            AIK L K+     +  +    E  + + L  P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y   + I   
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISIG-- 132
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + +LH   +R +++RD+K  N++L S+   K+ DFG+        V    +   GT  Y+
Sbjct: 133 LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYI 187
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           APE   +       D +A+GV+L E+L G+ P + 
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHPNIVP 243
           G  LG G    V  GK  L    VA+K L+++   S        RE+       HP+I+ 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L      P   +F++ +YVSGG L  ++ +       N  L      ++   I   V Y 
Sbjct: 81  LYQVISTPSD-IFMVMEYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYC 132
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H      VVHRD+KP N+LL +    K+ DFGL+   S     FL  +  G+  Y APE 
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSC-GSPNYAAPEV 186
Query: 364 FQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
              G++    + D+++ GV+L  LL G  P +
Sbjct: 187 IS-GRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 137/337 (40%), Gaps = 54/337 (16%)
Query: 72  DDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASA 131
           DD  K+ G NL  N         G +L    P+ + ++     C+Q              
Sbjct: 95  DDKRKACGRNLTQN----FLSHTGPDLIPEVPRQLVTN-----CTQ-------------- 131
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATH 182
                 LE G C    QEL     + L  S++P A+ L  + +   L            +
Sbjct: 132 -----RLEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKN 184
Query: 183 NFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
            F + RVLG+G    V   +V   G +     +++   + ++       E  I   ++  
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V L  +  + +  L L+   ++GG L+ H++       G +  P +     A  I   
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCG 298
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           +  LH   ER +V+RD+KP NILL      ++ D GLA            K   GT GY+
Sbjct: 299 LEDLHR--ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 352
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           APE  ++ + +   D +A G +L E++ G+ P + R+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I + L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 173 SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 220
           +Y +   A H F+K          RV+G G    V  G++   G    +VAIK L     
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 221 ESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           E  +  F  E  I     HPN+V L G  +   + + ++ +++  G+L+  L +      
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEG-VVTRGKPVMIVIEFMENGALDAFLRKHD---- 139
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-T 338
           G  T+   V   +  GIA  + YL    +   VHRD+   NIL++S  + K+ DFGL+  
Sbjct: 140 GQFTVIQLV--GMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194
Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               P   +     K    + APE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 195 IEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 237
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K    ++ +       +   + 
Sbjct: 80  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVL 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
               YLH      +VHRD+KP N+LL SK    + K+ DFGL   ++   V    K   G
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGL---SAHFEVGGKMKERLG 185
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           T  Y+APE  +  K  +K DV++ GV+L  LL G  P 
Sbjct: 186 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 86  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 145 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 195
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 85  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 144 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 194
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+SS    KL DFGL+ +    S  +     K    ++APE
Sbjct: 513 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 26/271 (9%)
Query: 138 LENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATHNFSKGR 188
           LE G C    QEL     + L  S++P A+ L  + +   L            + F + R
Sbjct: 133 LEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           VLG+G    V   +V   G +     +++   + ++       E  I   ++   +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
            +  + +  L L+   ++GG L+ H++       G +  P +     A  I   +  LH 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
             ER +V+RD+KP NILL      ++ D GLA            K   GT GY+APE  +
Sbjct: 305 --ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVK 358
Query: 366 HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
           + + +   D +A G +L E++ G+ P + R+
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 243 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 295
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 296 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 347
Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
              GT GY+APE  Q G   D + D ++ G +L +LL G  P 
Sbjct: 348 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 30/217 (13%)
Query: 188 RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T  + +       
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE----- 129
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I+ ++ +LH   ++ +++RD+KP NI+L+ +   KL DFGL   +       +  T  GT
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGT 184
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             Y+APE       +   D ++ G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH   +R +++RD+KP N+LL      ++ D GLA    A       K   GT G++A
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMA 357
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           PE     +     D +A GV L E++  R P  AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
              GT GY+APE  Q G   D + D ++ G +L +LL G  P 
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIV 242
           +V+G G    V  G++   G     VAIK L     DK+  + F  E  I     HPNI+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 72
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G  +   + + +I +Y+  GSL+  L +      G  T+   V   +  GI   + Y
Sbjct: 73  HLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GRFTVIQLV--GMLRGIGSGMKY 125
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAP 361
           L   ++   VHRD+   NIL++S  + K+ DFG++      P   +  +  K    + AP
Sbjct: 126 L---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E   + K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 134 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 193 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 243
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYLA 360
                    VHRDI   N+L+SS    KL DFGL+ +    +     K  KG     ++A
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTX---XKASKGKLPIKWMA 180
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
           PE     + +  +DV+ FGV + E+L  G KP + 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           + +  KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVA 293
              G C D +  L ++++Y+  G L + L                +    L  S    +A
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++    +     +     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               ++ PE   + K + ++DV++FGV+L E+ T G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 403
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA   S         
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----H 348
Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 403
              GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 36  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 145
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 8/169 (4%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-- 285
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           + +R    L +A    +  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  + 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               K   GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 71  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 42  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 156
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 157 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 383
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 206 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 264
Query: 384 ELLTGRKPIEARRLQG 399
           E+L G  P  A  L G
Sbjct: 265 EMLVGDTPFYADSLVG 280

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 383
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 211 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 384 ELLTGRKPIEARRLQG 399
           E+L G  P  A  L G
Sbjct: 270 EMLVGDTPFYADSLVG 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 26/256 (10%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLL 383
             KL DFG     +   +   C T  GT  Y++PE  +     G    + D ++ GV L 
Sbjct: 211 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 269
Query: 384 ELLTGRKPIEARRLQG 399
           E+L G  P  A  L G
Sbjct: 270 EMLVGDTPFYADSLVG 285

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 183 NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA 
Sbjct: 81  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFY--AAEIAI 132
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGT 355
            + +L +   + +++RD+K  N++L S+   K+ DFG+     W    +  F      GT
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-----GT 184
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYL 359
           LH+     ++HRD+K  NIL +     KL DFG++   T T      F+     GT  ++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWM 202
Query: 360 APEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           APE        D     K DV++ G+ L+E+     P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+APE  +
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 366 HGKV-SDKTDVYAFGVVLLELLTGRKP 391
             +  ++  DV++ G+VL  +L G  P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 55  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 164
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRLDK-EDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 92  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 199
Query: 356 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 35  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     ++HRD+K  NIL +     KL DFG+    SA +   + +  +  GT  ++A
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDSFIGTPYWMA 203
Query: 361 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           PE        D     K DV++ G+ L+E+     P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 82  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 189
Query: 356 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 188 RVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLV 245
           RVL  G  +FV++ + VG  R   A+KRL   ++E ++A  +E+     L  HPNIV   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGR-EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 246 GFCI---------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            FC          D  Q  FL+   +  G L   L  KK   RG   L      K+    
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRG--PLSCDTVLKIFYQT 145
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS-APSVPFLCK----- 350
             +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT  S  P   +  +     
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 351 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
               T   T  Y  PE    + +  + +K D++A G +L  L   + P E
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 183 NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A     
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA 
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFY--AAEIAI 453
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGT 355
            + +L +   + +++RD+K  N++L S+   K+ DFG+     W    +  F      GT
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-----GT 505
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
             Y+APE   +       D +AFGV+L E+L G+ P E 
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 32  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 141
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 290
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++            N     S + 
Sbjct: 78  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 291 KV--ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            V  A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 137 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 191
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 36  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 145
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+S+    KL DFGL+ +    S  +     K    ++APE
Sbjct: 513 ---------VHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 562
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHH 238
             K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + + +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L+G C+     + L+ + +  G L  H+ E +  +     L W ++      IA+
Sbjct: 79  PYVSRLLGICL--TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAK 130
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            ++YL +     +VHRD+   N+L+ S    K+ DFGLA         +     K    +
Sbjct: 131 GMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 187
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP---IEARRL 397
           +A E     + + ++DV+++GV + EL+T G KP   I AR +
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                    VHRDI   N+L+S+    KL DFGL+ +    S  +     K    ++APE
Sbjct: 133 ---------VHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 182
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA 394
                + +  +DV+ FGV + E+L  G KP + 
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 106/224 (47%), Gaps = 36/224 (16%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPSVPFLCK 350
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           LC 
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC- 203
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              GT  Y+APE       S + D+++ G +L  LL G+ P E 
Sbjct: 204 ---GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 34  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 143
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 79
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 80  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 132
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           K +
Sbjct: 133 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 186
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
            GT  Y+APE       S + D+++ G +L  LL G+ P E 
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 290
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++            N     S + 
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 291 KV--ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            V  A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA       + + 
Sbjct: 152 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHHIDYY 206
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +     T  GT  ++APE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPE 174
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMIASSLHHP 239
           +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I +  + P
Sbjct: 81  KVIGRGAF-----GEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 240 NIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGI 296
            +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      
Sbjct: 136 WVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFY-----T 180
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AE V  L       ++HRD+KP N+LL      KL DFG         +   C T  GT 
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VHCDTAVGTP 239
Query: 357 GYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
            Y++PE  +     G    + D ++ GV L E+L G  P  A  L G
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 286

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 56  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 165
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT           K +
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE--RKKDL 202
Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
            GT  Y+APE       S + D+++ G +L  LL G+ P E 
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 29  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 138
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKT-VKGTFGY 358
            YL     +  VHRD+   N +L  K   K+ DFGLA             KT  K    +
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 184
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 33/236 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF- 247
           +  RG    V+K +  L+   VA+K    +DK+S ++  RE+     + H N++  +   
Sbjct: 22  IKARGRFGCVWKAQ--LMNDFVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIAAE 78
Query: 248 --CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               + E  L+LI  +   GSL  +L       +GN  + W+    VA  ++  ++YLH 
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL-------KGN-IITWNELCHVAETMSRGLSYLHE 130
Query: 306 GTERC--------VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
               C        + HRD K  N+LL S     L DFGLA        P       GT  
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 358 YLAPEYFQHGKVSD------KTDVYAFGVVLLELLTGRK----PIEARRLQGEENL 403
           Y+APE  + G ++       + D+YA G+VL EL++  K    P++   L  EE +
Sbjct: 191 YMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEI 245

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     ++HRD+K  NIL +     KL DFG+    SA +   + +     GT  ++A
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDXFIGTPYWMA 203
Query: 361 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           PE        D     K DV++ G+ L+E+     P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 8/169 (4%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-- 285
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           + +R    L +A    +  +     V+HRD+KP+N+ L  K+  KL DFGLA   +    
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               K   GT  Y++PE       ++K+D+++ G +L EL     P  A
Sbjct: 172 --FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 89  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 139
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +     T  GT  ++APE
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPE 194
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLH-HPNIVPLVG 246
           LG+GA   V+K         VA+K++    + S+ A    RE+MI + L  H NIV L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 247 FC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D ++ ++L++ Y     +E  LH     +R N   P   +Y V   + + + YLH+
Sbjct: 77  VLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQY-VVYQLIKVIKYLHS 127
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------------------TWTSAPSV 345
           G    ++HRD+KPSNILL+++   K+ DFGL+                    T       
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 346 PFLCKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           P L   V  T  Y APE      K +   D+++ G +L E+L G KPI
Sbjct: 185 PILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 9   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 68
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K    E  I   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 69  RDRVRTKM---ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 124
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL 
Sbjct: 125 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL- 173
Query: 338 TWTSAPSVPFLCKTVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
              S  S+    K     GT  Y+APE       +   D ++FGV++ E+LTG  P + +
Sbjct: 174 ---SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230
Query: 396 RLQGEENLVLWAK 408
             +    ++L AK
Sbjct: 231 DRKETMTMILKAK 243

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 8   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K    E  I   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 68  RDRVRTKM---ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL 
Sbjct: 124 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL- 172
Query: 338 TWTSAPSVPFLCKTVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
              S  S+    K     GT  Y+APE       +   D ++FGV++ E+LTG  P + +
Sbjct: 173 ---SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 396 RLQGEENLVLWAK 408
             +    ++L AK
Sbjct: 230 DRKETMTMILKAK 242

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 8   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K    E  I   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 68  RDRVRTKM---ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL 
Sbjct: 124 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL- 172
Query: 338 TWTSAPSVPFLCKTVK--GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
              S  S+    K     GT  Y+APE       +   D ++FGV++ E+LTG  P + +
Sbjct: 173 ---SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 396 RLQGEENLVLWAK 408
             +    ++L AK
Sbjct: 230 DRKETMTMILKAK 242

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 117/252 (46%), Gaps = 30/252 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              P++ L       I   +   +L + +  +    R +  L     Y++ +GI     +
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL-----YQMLVGIK----H 141
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPE 195
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL- 421
                   +  D+++ GV++ E++ G          G +++  W K I   G  + E + 
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMK 250
Query: 422 -LDPRLKCTSRN 432
            L P ++    N
Sbjct: 251 KLQPTVRTYVEN 262

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 243
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 99  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 151
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLA 360
               +   VHRD+   NIL++S  + K+ DFGL+ +     S P     + G     + A
Sbjct: 152 ---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 209 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 86  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 188 RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T  + +       
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE----- 129
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I+ ++ +LH   ++ +++RD+KP NI+L+ +   KL DFGL   +       +     GT
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             Y+APE       +   D ++ G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 30/256 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 137
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA      S  F+      T 
Sbjct: 138 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTR 187
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y APE        +  D+++ G ++ EL+ G     +   QG +++  W K I   G  
Sbjct: 188 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQWNKVIEQLGTP 242
Query: 417 AVEELLDPRLKCTSRN 432
           + E +    L+ T RN
Sbjct: 243 SAEFM--AALQPTVRN 256

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 109 FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 34/225 (15%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA       
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA--RDIHH 202
Query: 345 VPFLCKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           +    KT  G     ++APE       + ++DV++FGV+L E+ T
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 149 ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 206
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 6   EVQWKVVEEINGN-NXVXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 64
Query: 207 RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 260
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 65  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 123
Query: 261 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 305
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 124 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 177
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
            ++ C+ HRD+   NILL+  +I K+CDFGLA      S   +    +    ++APE   
Sbjct: 178 ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 236
Query: 366 HGKVSDKTDVYAFGVVLLELLT-GRKP 391
           +   + ++DV+++G+ L EL + G  P
Sbjct: 237 NCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 80  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A    YL        VHRD+   N L+    + K+ DFG++    +     +        
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            ++ PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 114/243 (46%), Gaps = 34/243 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-----EDKESSKA 225
           A   +F   +VLG+G+      GKV L+R           A+K L K      D+  +K 
Sbjct: 25  ADPSHFELLKVLGQGSF-----GKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM 79
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
              E  I + ++HP +V L  +    E  L+LI  ++ GG L   L ++      +    
Sbjct: 80  ---ERDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---- 131
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
             V++ +A  +A  + +LH+     +++RD+KP NILL  +   KL DFGL+    A   
Sbjct: 132 --VKFYLA-ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDH 183
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
                +  GT  Y+APE       S   D +++GV++ E+LTG  P + +  +    L+L
Sbjct: 184 EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243
Query: 406 WAK 408
            AK
Sbjct: 244 KAK 246

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 38  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 147
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 30/230 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + E +  LH      +VHRD+KP NILL      KL DFG +            ++V
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRSV 183
Query: 353 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 297
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T  G+  
Sbjct: 122 SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPN 175
Query: 358 YLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           Y APE    G++    + D+++ GV+L  LL G  P +
Sbjct: 176 YAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 42  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 151
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 152 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 35  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 145 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 89
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 145
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 201 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 235

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 190 LGRGALSFV-----------FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +G+GA S V           +  K+      +  K+L   D +  +   RE  I   L H
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKI------INTKKLSARDHQKLE---REARICRLLKH 62
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 63  SNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILE 114
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +V + H   +  VVHRD+KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 115 AVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF--GFAGT 169
Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            GYL+PE  +        D++A GV+L  LL G  P 
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 96  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 205
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA   +             K    +
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 81
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 137
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 227

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 38  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 147
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV--KGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA          +      K    +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 167
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL------ATWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG       ATWT    
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT---- 218
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 219 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 104
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 160
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 250

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 31/233 (13%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 101 LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA  
Sbjct: 160 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARD 212
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               S   +    +    ++APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH+   +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDR 154
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 213
Query: 386 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 437
           LT          K +E   +   +  VL    +L RG    E L  P  KC         
Sbjct: 214 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPCE------ 262
Query: 438 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 469
                   C  +E S RP  E +I IL+   E
Sbjct: 263 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 31/233 (13%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 106 LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA  
Sbjct: 165 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARH 217
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               S   +    +    ++APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 166
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGY 358
            +L     +  VHRD+   N +L  K   K+ DFGLA   +             K    +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +A E  Q  K + K+DV++FGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRLDK-EDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 89  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HR++   NIL+    + K+ DFGL+              VK T
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 196
Query: 356 FG-----YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            G     ++A E   +   +  +DV+++GV+L E+++
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           F     LG GA S V   +        A+K + K+    KESS     E+ +   + H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L      P   L+L+ + VSGG L   + EK  G          +R      + ++V
Sbjct: 82  IVALEDIYESPNH-LYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIR-----QVLDAV 133
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            YLH      +VHRD+KP N+L  S+    KI  + DFGL+       V     T  GT 
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKI-MISDFGLSKMEGKGDV---MSTACGTP 186
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GY+APE       S   D ++ GV+   LL G  P 
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 31/233 (13%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 83  LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA  
Sbjct: 142 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARD 194
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               S   +    +    ++APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 259
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 260 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 310
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 311 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 369 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 411

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 22/235 (9%)
Query: 163 SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFK---GKVGLLRTSVAIKRLDKED 219
           +P  + ++    G +  + +  SK  +LG G    V K      GL   +  IK    +D
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 220 KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           KE  K    E+ + + L H N++ L     + +  + L+ +YV GG L   + ++   + 
Sbjct: 130 KEEVK---NEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLA 337
              T+ +  +      I E + ++H   +  ++H D+KP NIL  ++  K  K+ DFGLA
Sbjct: 186 ELDTILFMKQ------ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                       K   GT  +LAPE   +  VS  TD+++ GV+   LL+G  P 
Sbjct: 237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 245
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 246 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 297 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 355 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 397

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIITLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 30/230 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 65  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 116
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + E +  LH      +VHRD+KP NILL      KL DFG +            + V
Sbjct: 117 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 170
Query: 353 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 31/233 (13%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 106 LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA  
Sbjct: 165 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARD 217
Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               S   +    +    ++APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 114
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 260

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 112
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 168
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 258

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 122/261 (46%), Gaps = 33/261 (12%)
Query: 188 RVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVP 243
           R LG GA      V +   GL R    IK ++K+  +   +    E+ +  SL HPNI+ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           +     D    ++++ +   GG L ER +  + +G      L      ++   +  ++AY
Sbjct: 85  IFEVFED-YHNMYIVMETCEGGELLERIVSAQARG----KALSEGYVAELMKQMMNALAY 139
Query: 303 LHNGTERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
            H+   + VVH+D+KP NIL   +S   P K+ DFGLA    +           GT  Y+
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYM 193
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ--------GEENLVLWAKPIL 411
           APE F+   V+ K D+++ GVV+  LLTG  P     L+         E N  +  +P+ 
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 412 HRGMAAVEELL--DPRLKCTS 430
            + +  ++++L  DP  + ++
Sbjct: 253 PQAVDLLKQMLTKDPERRPSA 273

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 155
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C     
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 301

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HR+IK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 133 LHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 185
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 30/230 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + E +  LH      +VHRD+KP NILL      KL DFG +            + V
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREV 183
Query: 353 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     V+HRDIK  NILL      KL DFG     + P      + V GT  ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSEMV-GTPYWMAPE 186
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    K D+++ G++ +E++ G  P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 183 NFSKGRVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 235
           NF   +VLG GA   VF  +       G L     +K+     K  +    R E  +   
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    E  L LI  Y++GG L  HL ++++             ++V + 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------FTEHEVQIY 164
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E V  L +  +  +++RDIK  NILL S     L DFGL+    A           GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 356 FGYLAPEYFQHGKVS-DK-TDVYAFGVVLLELLTGRKPIEARRLQGEEN-------LVLW 406
             Y+AP+  + G    DK  D ++ GV++ ELLTG  P     + GE+N        +L 
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF---TVDGEKNSQAEISRRILK 280
Query: 407 AKPILHRGMAA-----VEELL--DP--RLKCTSRNS 433
           ++P   + M+A     ++ LL  DP  RL C  R++
Sbjct: 281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 353
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 354 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 353
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 354 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 117/252 (46%), Gaps = 30/252 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              P++ L       I   +   +L + +  +    R +  L     Y++ +GI     +
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLL-----YQMLVGIK----H 141
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPE 195
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL- 421
                   +  D+++ GV++ E++ G          G +++  W K I   G  + E + 
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMK 250
Query: 422 -LDPRLKCTSRN 432
            L P ++    N
Sbjct: 251 KLQPTVRTYVEN 262

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 171
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 172 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 230 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 272

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 123/254 (48%), Gaps = 23/254 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 247
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 119 LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 171
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGYLAPEYF-- 364
           +  V+HRD+KPSN+L+++    K+CDFG++ +     V  + KT+  G   Y+APE    
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDAGCKPYMAPERINP 227
Query: 365 ---QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVE 419
              Q G  S K+D+++ G+ ++EL   R P ++     Q  + +V    P L     +  
Sbjct: 228 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA- 285
Query: 420 ELLDPRLKCTSRNS 433
           E +D   +C  +NS
Sbjct: 286 EFVDFTSQCLKKNS 299

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 84  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR-----EILKGLDY 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +        GT  ++APE
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 189
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT       LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 119
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 120 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 170
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 171 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 228
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 229 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 271

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HRDIK  NILL      KL DFG      A   P   K   + GT  ++A
Sbjct: 133 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMA 185
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +        GT  ++APE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 174
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HRDIK  NILL      KL DFG      A   P   K   + GT  ++A
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMA 184
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIIHLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 243 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
                         P+    +  +  LF+  +Y   G+L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----- 118
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-------- 340
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 341 ----SAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 386
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 299
              G  +   + L++I +Y+ GGS    L             P+   +++A  + E    
Sbjct: 85  KYYGSYLKGSK-LWIIMEYLGGGSALDLLRAG----------PFD-EFQIATMLKEILKG 132
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A   +   +     T  GT  ++
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWM 187
Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE  Q      K D+++ G+  +EL  G  P
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D     L L+ +YV  GSL
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH    +  +HRD+   N+LL + +
Sbjct: 123 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDR 171
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 230
Query: 386 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 437
           LT          K +E   +   +  VL    +L RG    E L  P  KC +       
Sbjct: 231 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPAE------ 279
Query: 438 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 469
                   C  +E S RP  E +I IL+   E
Sbjct: 280 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 209 SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
            VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L 
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLMEFLQGGALT 130
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             + + +      +T        V   + +++AYLH    + V+HRDIK  +ILL+    
Sbjct: 131 DIVSQVRLNEEQIAT--------VCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGR 179
Query: 329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 388
            KL DFG     S   VP   K + GT  ++APE       + + D+++ G++++E++ G
Sbjct: 180 VKLSDFGFCAQISK-DVPKR-KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
Query: 389 RKP 391
             P
Sbjct: 238 EPP 240

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 126
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSV 345
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG +      S 
Sbjct: 127 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 177
Query: 346 PFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ---- 398
             L +T+ GT  YLAPE          +   D ++ GV+L   L+G  P    R Q    
Sbjct: 178 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235
Query: 399 -----GEENLV--LWAKPILHRGMAAVEELL--DPRLKCTSRNS 433
                G+ N +  +WA+ +  + +  V++LL  DP+ + T+  +
Sbjct: 236 DQITSGKYNFIPEVWAE-VSEKALDLVKKLLVVDPKARFTTEEA 278

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 117/258 (45%), Gaps = 28/258 (10%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +I +Y   G L   L  K + +         NSTL        +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
           C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 370 SDKTDVYAFGVVLLELLT 387
           + ++DV+++G++L E+ +
Sbjct: 244 TVQSDVWSYGILLWEIFS 261

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 84  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 135
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT       LC
Sbjct: 136 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LC 185
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-LQGEENLV 404
               GT  YLAPE       +   D +A GV++ E+  G  P  A + +Q  E +V
Sbjct: 186 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 237

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           K + LG G+ S   K        + A+K + K  + +++     L +     HPNIV L 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLH 72
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D +   FL+ + ++GG L   + +KK      ++        +   +  +V+++H+
Sbjct: 73  EVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAVSHMHD 124
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
                VVHRD+KP N+L + +      K+ DFG A      + P   KT   T  Y APE
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPE 179
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                   +  D+++ GV+L  +L+G+ P ++
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 368 -KVSDKTDVYAFGVVLLELLTG 388
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL---HHPN 240
           F   R+ G+G    V  GK      SVAIK++ ++ +  +    REL I   L   HHPN
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLAVLHHPN 80
Query: 241 IVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAE 298
           IV L   F    E+    IY  V    +   LH   +        P  +  KV L  +  
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSA--PSVPFLCKTVKGT 355
           S+  LH  +   V HRDIKP N+L++ +    KLCDFG A   S   P+V ++C      
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--- 196
Query: 356 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             Y APE  F +   +   D+++ G +  E++ G +PI
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 118/272 (43%), Gaps = 36/272 (13%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH    +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDR 154
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
           + K+ DFGLA         +  +    +  F Y APE  +  K    +DV++FGV L EL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYEL 213
Query: 386 LT--------GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXX 437
           LT          K +E   +   +  VL    +L RG    E L  P  KC         
Sbjct: 214 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERLPRPD-KCPCE------ 262
Query: 438 XXXXXXXXCISSEESRRPGIEEIIAILRGEEE 469
                   C  +E S RP  E +I IL+   E
Sbjct: 263 -VYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 159 ERSISP--VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
           +R I P  +  +L   S+G++  ATH  ++ +V    AL F+ +    LL+ S    R++
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKV----ALKFISRQ---LLKKSDMHMRVE 57
Query: 217 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
                      RE+     L HP+I+ L      P   + ++ +Y +GG L  ++ EKK+
Sbjct: 58  -----------REISYLKLLRHPHIIKLYDVITTPTD-IVMVIEY-AGGELFDYIVEKKR 104
Query: 277 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                         +    I  ++ Y H      +VHRD+KP N+LL      K+ DFGL
Sbjct: 105 MTEDEGR-------RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154
Query: 337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           +   +  +     KT  G+  Y APE   +GK+    + DV++ G+VL  +L GR P +
Sbjct: 155 SNIMTDGN---FLKTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 368 -KVSDKTDVYAFGVVLLELLTG 388
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + ++ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H   
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCH--- 117
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T  Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGS 175
Query: 368 -KVSDKTDVYAFGVVLLELLTG 388
            K S   D+++ G +  E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVK 353
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C    
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 354 GTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 222

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + R LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 75  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 124
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 73  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 123 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 216

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 39  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 94  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 147
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 148 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 198
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 199 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK----LCDFGLATWTSAPSVPFLCKTVK 353
             V YLH+     + H D+KP NI+L  + +PK    + DFGLA      +     K + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  ++APE   +  +  + D+++ GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 297
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S     FL  +  G+  
Sbjct: 122 SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSC-GSPN 175
Query: 358 YLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           Y APE    G++    + D+++ GV+L  LL G  P +
Sbjct: 176 YAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+GA S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H+     ++HRD+KP N+LL+SK+   P KL DFG+A       +  +     GT  ++A
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRG----NSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+      N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++   
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDXX 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-LQGEENL 403
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A + +Q  E +
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 404 V 404
           V
Sbjct: 251 V 251

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 42/241 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 25  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 80  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 133
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 134 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWX---- 184
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-LQGEENL 403
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A + +Q  E +
Sbjct: 185 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 237
Query: 404 V 404
           V
Sbjct: 238 V 238

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 93  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 142
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 143 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 236

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 112/246 (45%), Gaps = 33/246 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 35  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 91
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L   +   +      +         V L + ++++
Sbjct: 92  EMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALS 141
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
            LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + GT  ++AP
Sbjct: 142 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVGTPYWMAP 196
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E         + D+++ G++++E++ G  P              + +P L + M  + + 
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDN 242
Query: 422 LDPRLK 427
           L PRLK
Sbjct: 243 LPPRLK 248

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 85  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 134
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 95
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 151
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 206
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 207 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 243
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 73  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 125
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGTFG--YLA 360
               +   VHR +   NIL++S  + K+ DFGL+ +     S P     + G     + A
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE  Q+ K +  +DV+++G+V+ E+++ G +P
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +++ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 222

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 84
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 140
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 195
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 196 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 230

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           ++  +V+G G+   VF+ K+ +    VAIK++ ++ +  +    REL I   + HPN+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKL-VESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNVVD 96
Query: 244 LVGFCI---DPEQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           L  F     D +  +FL  + +YV         H  K       T+P  +       +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL----KQTMPMLLIKLYMYQLLR 152
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSA--PSVPFLCKTVKGT 355
           S+AY+H+     + HRDIKP N+LL     + KL DFG A    A  P+V  +C      
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 356 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 389
             Y APE  F     +   D+++ G V+ EL+ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 166
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 221
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 112/245 (45%), Gaps = 31/245 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 28  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 84
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +    +  ++ L+++ +++ GG+L   +   +      +         V L + ++++ 
Sbjct: 85  EMYNSYLVGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSV 135
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + GT  ++APE
Sbjct: 136 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVGTPYWMAPE 190
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
                    + D+++ G++++E++ G  P              + +P L + M  + + L
Sbjct: 191 LISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDNL 236
Query: 423 DPRLK 427
            PRLK
Sbjct: 237 PPRLK 241

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 112/245 (45%), Gaps = 31/245 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 24  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +    +  ++ L+++ +++ GG+L   +   +      +         V L + ++++ 
Sbjct: 81  EMYNSYLVGDE-LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSV 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + GT  ++APE
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVGTPYWMAPE 186
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
                    + D+++ G++++E++ G  P              + +P L + M  + + L
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDNL 232
Query: 423 DPRLK 427
            PRLK
Sbjct: 233 PPRLK 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  F + APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW  A  
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA-- 199
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ---------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 80
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 136
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 191
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 192 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 226

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 77
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 133
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 188
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 189 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 223

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 112/246 (45%), Gaps = 33/246 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 33  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 89
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L   +   +      +         V L + ++++
Sbjct: 90  EMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALS 139
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
            LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + GT  ++AP
Sbjct: 140 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLVGTPYWMAP 194
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E         + D+++ G++++E++ G  P              + +P L + M  + + 
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-KAMKMIRDN 240
Query: 422 LDPRLK 427
           L PRLK
Sbjct: 241 LPPRLK 246

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 120/256 (46%), Gaps = 30/256 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA         F+      T 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTR 189
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y APE       +   D+++ G ++ EL+ G         QG +++  W K I   G  
Sbjct: 190 YYRAPEVILGMGYAANVDIWSVGCIMGELVKG-----CVIFQGTDHIDQWNKVIEQLGTP 244
Query: 417 AVEELLDPRLKCTSRN 432
           + E +    L+ T RN
Sbjct: 245 SAEFM--AALQPTVRN 258

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++   
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDXX 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 213
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
             T  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 199
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 200 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   V+KG     +  VAIK +D +E ++  +   +E+ + S    P I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 81  RYFGSYLKSTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILR-----EILKGLDY 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH  +ER + HRDIK +N+LLS +   KL DFG+A   +   +        GT  ++APE
Sbjct: 132 LH--SERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPE 186
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             +      K D+++ G+  +EL  G  P
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 211 AIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL----FLIYKYVS 263
           A+KR+   +++D+E ++   RE  +    +HPNI+ LV +C+  E+G     +L+  +  
Sbjct: 58  ALKRILCHEQQDREEAQ---READMHRLFNHPNILRLVAYCLR-ERGAKHEAWLLLPFFK 113
Query: 264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL 323
            G+L   +   K   +GN      + + + LGI   +  +H    +   HRD+KP+NILL
Sbjct: 114 RGTLWNEIERLKD--KGNFLTEDQILW-LLLGICRGLEAIH---AKGYAHRDLKPTNILL 167
Query: 324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKG---------------TFGYLAPEYF---Q 365
             +  P L D G        S+   C  V+G               T  Y APE F    
Sbjct: 168 GDEGQPVLMDLG--------SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219
Query: 366 HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
           H  + ++TDV++ G VL  ++ G  P +    +G+
Sbjct: 220 HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFAEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 33  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 88  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 141
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 142 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 192
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 193 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 235

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 291
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 87  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 292 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 146 LVSCTYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLA--RDINNIDYY 200
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 142
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 192
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-LQGEENLV 404
               GT  YLAPE       +   D +A GV++ E+  G  P  A + +Q  E +V
Sbjct: 193 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 233
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 8   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 63  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 114
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 115 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 169
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 115/254 (45%), Gaps = 33/254 (12%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 234
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 70  GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 126
Query: 235 SLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
              H N+V +   + +  E  L+++ +++ GG+L   +   +      +         V 
Sbjct: 127 DYQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VC 176
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           L + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + 
Sbjct: 177 LAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLV 231
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 413
           GT  ++APE         + D+++ G++++E++ G  P              + +P L +
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-K 277
Query: 414 GMAAVEELLDPRLK 427
            M  + + L PRLK
Sbjct: 278 AMKMIRDNLPPRLK 291

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 92  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 151 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 205
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ + + GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELMKGGELLDK 106
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
            +  ++CDFG A    A +   L  T   T  ++APE  +        D+++ GV+L  +
Sbjct: 156 PESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 386 LTGRKPI 392
           LTG  P 
Sbjct: 214 LTGYTPF 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 233
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 81  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 132
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA-PSVPFLCKTVKGTFG--YLAP 361
              E   VHRD+   NIL++S  + K+ DFGL+ +     S P    ++ G     + AP
Sbjct: 133 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E     K +  +D +++G+V+ E+++ G +P
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYK- 291
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 89  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 292 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 148 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 202
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ ++  G  P  A
Sbjct: 198 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 33/254 (12%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 234
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 147 GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 203
Query: 235 SLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
              H N+V +   + +  E  L+++ +++ GG+L          +  ++ +       V 
Sbjct: 204 DYQHENVVEMYNSYLVGDE--LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVC 253
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           L + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S   VP   K + 
Sbjct: 254 LAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVP-RRKXLV 308
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 413
           GT  ++APE         + D+++ G++++E++ G  P              + +P L +
Sbjct: 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPL-K 354
Query: 414 GMAAVEELLDPRLK 427
            M  + + L PRLK
Sbjct: 355 AMKMIRDNLPPRLK 368

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 118/248 (47%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 233
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 5   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 60  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL       S     KT  
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL            + +  K  F + APE
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----- 196
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                  + GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 197 ------XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
            +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L    
Sbjct: 33  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 91
Query: 249 IDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H   
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN 143
Query: 308 ERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
              V HRD+KP N L    S   P KL DFGLA          + +T  GT  Y++P+  
Sbjct: 144 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVL 197
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           + G    + D ++ GV++  LL G  P  A
Sbjct: 198 E-GLYGPECDEWSAGVMMYVLLCGYPPFSA 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 348
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 166 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
            +   +  +HRD+   N+LL+++ + K+ DFGL            + +  K  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +    S  +D + FGV L E+ T G++P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 167
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 218
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 219 ---LC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 146 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA      ++ + 
Sbjct: 205 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA--RDINNIDYY 259
Query: 349 CKTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
            KT  G     ++APE       + ++DV++FGV++ E+ T
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 28/258 (10%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +I +Y   G L   L  K + +         NST         +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
           C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 370 SDKTDVYAFGVVLLELLT 387
           + ++DV+++G++L E+ +
Sbjct: 244 TVQSDVWSYGILLWEIFS 261

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLCKTVKG 354
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C     
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-- 187
Query: 355 TFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
              Y APE  F     +   DV++ G VL ELL G +PI
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFGLA      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 247
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 308 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLATW------TSAPSVPFLCKTVKGTFGY 358
            + + HRD+KP NIL    ++  P K+CDFGL +        S  S P L  T  G+  Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-TPCGSAEY 187
Query: 359 LAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEAR 395
           +APE    + +   + DK  D+++ GV+L  LL+G  P   R
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFXEPHARFY--AAQ 142
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 192
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-LQGEENLV 404
               GT  YLAPE       +   D +A GV++ E+  G  P  A + +Q  E +V
Sbjct: 193 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 244

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 170
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 220
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 221 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 7   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 62  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 114
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 348
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   
Sbjct: 115 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 170
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 171 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 83  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 134
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA-PSVPFLCKTVKGTFG--YLAP 361
              E   VHRD+   NIL++S  + K+ DFGL+ +     S P    ++ G     + AP
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           E     K +  +D +++G+V+ E+++ G +P
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
            +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 74
Query: 249 IDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H   
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN 126
Query: 308 ERCVVHRDIKPSNILL--SSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
              V HRD+KP N L    S   P KL DFGLA          + +T  GT  Y++P+  
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVL 180
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
           + G    + D ++ GV++  LL G  P  A
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
            +  ++CDFG A    A +   L  T   T  ++APE  +     +  D+++ G++L  +
Sbjct: 161 PECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTM 218
Query: 386 LTGRKPI 392
           L G  P 
Sbjct: 219 LAGYTPF 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFL 186
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 122/254 (48%), Gaps = 23/254 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 247
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 75  LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 127
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGYLAPEYF-- 364
           +  V+HRD+KPSN+L+++    K+CDFG++ +     V  + K +  G   Y+APE    
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINP 183
Query: 365 ---QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVE 419
              Q G  S K+D+++ G+ ++EL   R P ++     Q  + +V    P L     +  
Sbjct: 184 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA- 241
Query: 420 ELLDPRLKCTSRNS 433
           E +D   +C  +NS
Sbjct: 242 EFVDFTSQCLKKNS 255

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--KNIF 179
Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 18/187 (9%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K ++    RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEKIAANV-KREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+CDFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 387 TGRKPIE 393
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 117/250 (46%), Gaps = 26/250 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 92
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 93  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 147
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPEYF 364
               ++HRD+KPSNI++ S    K+ DFGLA    TS   VPF+      T  Y APE  
Sbjct: 148 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-----TRYYRAPEVI 199
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--L 422
                 +  D+++ G ++ E++ G          G +++  W K I   G    E +  L
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 254
Query: 423 DPRLKCTSRN 432
            P ++    N
Sbjct: 255 QPTVRTYVEN 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 348
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 166 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 79  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 367
            ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++APE     
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCE 184
Query: 368 KVSD-----KTDVYAFGVVLLELLTGRKP 391
            + D     K D+++ G+ L+E+     P
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
            +  ++CDFG A    A +   L  T   T  ++APE  +     +  D+++ G++L  +
Sbjct: 161 PECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTM 218
Query: 386 LTGRKPI 392
           L G  P 
Sbjct: 219 LAGYTPF 225

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           +            S   +P     ++  F ++          + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 247

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 438 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 487
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 488 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 581

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 87  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 136
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 367
            ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++APE     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 368 KVSD-----KTDVYAFGVVLLELLTGRKP 391
            + D     K D+++ G+ L+E+     P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 437 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 486
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPEYF 364
             E   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE  
Sbjct: 487 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 365 QHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE 401
            + K S K+DV++FGV++ E  + G+KP   R ++G E
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSE 580

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 182
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 183 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 182
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 183 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 XEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 189
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 186
           T  +  + +GL    A E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 213 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 264
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YLAPE 
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEV 320
Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            +        D +  GVV+ E++ GR P 
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 22  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 81
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 82  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 138
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 139 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 190
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 191 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 13  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 72
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 73  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 129
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 130 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 181
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 182 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 189
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 190 XEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 243 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
                         P+    +  +  LF+  +Y    +L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY----- 118
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-------- 340
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 341 ----SAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 386
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 30/224 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 348
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL     +   ++   
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF 165
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 166 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
              ++   VHRD+   N+L+ S  + K+ DFGL+      P   +     K    + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                  S  +DV++FGVV+ E+L  G +P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALG--IAESVAYLHNGTERCVVH 313
           +I +Y   G L   L  K +  +      P  +R  +     +A+ +A+L   ++ C+ H
Sbjct: 127 VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-H 183
Query: 314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT 373
           RD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       + ++
Sbjct: 184 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 243
Query: 374 DVYAFGVVLLELLT 387
           DV+++G++L E+ +
Sbjct: 244 DVWSYGILLWEIFS 257

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           ++F K   +G G        +  L +  VA+K +++      +   RE++   SL HPNI
Sbjct: 22  YDFVKD--IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNI 78
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V      + P   L +I +Y SGG L   +    +     +   +         +   V+
Sbjct: 79  VRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQ-------QLLSGVS 130
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  GT  Y+
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI 184
Query: 360 APEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIE 393
           APE     +   K  DV++ GV L  +L G  P E
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 186
           T  +  + +GL     +E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 103 TTAIQTVADGLKKQEEEEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 155
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 216 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 267
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H  +E+ VV+RD+K  N++L      K+ DFGL             KT  GT  YLAPE 
Sbjct: 268 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEV 323
Query: 364 FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            +        D +  GVV+ E++ GR P 
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFL 184
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 5   QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 59
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 60  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 118
Query: 257 LIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALG--IAESVAYLHNGTERCVVH 313
           +I +Y   G L   L  K +  +      P  +R  +     +A+ +A+L   ++ C+ H
Sbjct: 119 VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-H 175
Query: 314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT 373
           RD+   N+LL++  + K+ DFGLA      S   +    +    ++APE       + ++
Sbjct: 176 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 235
Query: 374 DVYAFGVVLLELLT 387
           DV+++G++L E+ +
Sbjct: 236 DVWSYGILLWEIFS 249

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 11/219 (5%)
Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           +G  +GRG    V+K K    +          E    S + CRE+ +   L HPN++ L 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 246 G-FCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F    ++ ++L++ Y           H   K  +    LP  +   +   I + + YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 304 HNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFL-CKTVKGTFGY 358
           H      V+HRD+KP+NIL+      +   K+ D G A   ++P  P      V  TF Y
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 359 LAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARR 396
            APE     +   K  D++A G +  ELLT       R+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 186
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  YLAP        +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFL 184
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 36/237 (15%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-- 246
           V  RG    V+K +  LL   VA+K    +DK+S +    E+     + H NI+  +G  
Sbjct: 31  VKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNE-YEVYSLPGMKHENILQFIGAE 87
Query: 247 ---FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +D +  L+LI  +   GSL   L          + + W+    +A  +A  +AYL
Sbjct: 88  KRGTSVDVD--LWLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYL 137
Query: 304 H-------NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           H       +G +  + HRDIK  N+LL +     + DFGLA    A           GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 357 GYLAPEYFQHGKVSD------KTDVYAFGVVLLELLT----GRKPIEARRLQGEENL 403
            Y+APE  + G ++       + D+YA G+VL EL +       P++   L  EE +
Sbjct: 198 RYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 189 VLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVG 246
           +LG GA + V +G V L      A+K ++K+   S     RE+  +     + NI+ L+ 
Sbjct: 20  LLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F  D +   +L+++ + GGS+  H+ ++K      ++       +V   +A ++ +LH  
Sbjct: 79  FFED-DTRFYLVFEKLQGGSILAHIQKQKHFNEREAS-------RVVRDVAAALDFLHT- 129
Query: 307 TERCVVHRDIKPSNILLSS--KKIP-KLCDFGLA---------TWTSAPSVPFLCKTVKG 354
             + + HRD+KP NIL  S  K  P K+CDF L          T  + P +   C    G
Sbjct: 130 --KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC----G 183
Query: 355 TFGYLAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPI 392
           +  Y+APE    +       DK  D+++ GVVL  +L+G  P 
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 210 VAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VA+K +++ +K  E+ K   RE++   SL HPNIV      + P   L ++ +Y SGG L
Sbjct: 46  VAVKYIERGEKIDENVK---REIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL 101
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              +    +     +   +         +   V+Y H      V HRD+K  N LL    
Sbjct: 102 FERICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSP 151
Query: 328 IP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLE 384
            P  K+CDFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  
Sbjct: 152 APRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 208
Query: 385 LLTGRKPIE 393
           +L G  P E
Sbjct: 209 MLVGAYPFE 217

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   ++ DFGLA      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           +            S   +P     ++  F ++          + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 247

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA----FCRELMIASSLHHPNIVPLV 245
           +GRG+   V+KG      T+V +   + +D++ +K+    F  E      L HPNIV   
Sbjct: 34  IGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 246 GF---CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 +  ++ + L+ +  + G+L+ +L ++ K  +      W  +      I + + +
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIKVLRSWCRQ------ILKGLQF 144
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           LH  T   ++HRD+K  NI ++      K+ D GLAT   A       K V GT  + AP
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFXAP 199
Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           E ++  K  +  DVYAFG   LE  T   P
Sbjct: 200 EXYEE-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 51/240 (21%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A---------TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           +            S   +P     ++  F ++          + ++DV++FGV+L E++T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 247

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 20/177 (11%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I + LHHP ++ L     + +  + LI +++SGG L   +  +   +     + +  
Sbjct: 98  EISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVP 346
           +        E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT  +   + 
Sbjct: 157 Q------ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
              K    T  + APE      V   TD++A GV+   LL+G  P       GE++L
Sbjct: 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDL 256

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHH 238
           + K   LG G  + V+K +       VAIK++    +  +K        RE+ +   L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTL--PWSVRYKVAL 294
           PNI+           GL   + + S  SL     E    V  + NS +  P  ++  + +
Sbjct: 72  PNII-----------GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            + + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +  + V  
Sbjct: 121 TL-QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-- 174
Query: 355 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELL 386
           T  Y APE     ++     D++A G +L ELL
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 151
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 152 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 211
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 212 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 271
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 272 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 309

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-- 283
           F  EL I + + +   +   G   + ++ +++IY+Y+   S+ +   E    +  N T  
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILK-FDEYFFVLDKNYTCF 147
Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG + +    
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEAR 395
            +    K  +GT+ ++ PE+F +    +  K D+++ G+ L  +     P   +
Sbjct: 206 KI----KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ +   GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELXKGGELLDK 106
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
            +  ++CDFG A    A +   L  T   T  ++APE  +        D+++ GV+L   
Sbjct: 156 PESIRICDFGFAKQLRAEN--GLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTX 213
Query: 386 LTGRKPI 392
           LTG  P 
Sbjct: 214 LTGYTPF 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 25  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 84
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 85  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 144
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 145 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 204
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 205 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 264
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 265 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 302

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAI+++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 188
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 184
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 153
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 154 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 213
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 214 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 273
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 274 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 311

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 64/278 (23%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           E    R  +HRD+   NILLS K + K+CDFGLA               +    ++APE 
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
                 + ++DV++FGV+L E+ + G  P    ++  E
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 186
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 187 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 21/239 (8%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 234 SSLHHPNIVPLVGF----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               H NI+ +        I+  + ++L+  ++ G  L + L   K     N  + + + 
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLL---KTQHLSNDHICYFL- 150
Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPF 347
           Y++  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           F
Sbjct: 151 YQILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           L + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 204 LTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 37/254 (14%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 110
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA         
Sbjct: 111 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 347 FLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL- 403
           +  +    +  F Y APE  +  K    +DV++FGV L ELLT     ++   +  E + 
Sbjct: 168 YRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIG 226
Query: 404 -------VLWAKPILHRGMAAVEELLDP-RLKCTSRNSXXXXXXXXXXXXCISSEESRRP 455
                  VL    +L RG    E L  P R  C   +             C  +E S RP
Sbjct: 227 HTQGQMTVLRLTELLERG----ERLPRPDRCPCEIYH---------LMKNCWETEASFRP 273
Query: 456 GIEEIIAILRGEEE 469
             + ++ IL+  +E
Sbjct: 274 TFQNLVPILQTAQE 287

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 111/254 (43%), Gaps = 37/254 (14%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 111
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA         
Sbjct: 112 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 347 FLCKTVKGT--FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL- 403
           +  +    +  F Y APE  +  K    +DV++FGV L ELLT     ++   +  E + 
Sbjct: 169 YRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIG 227
Query: 404 -------VLWAKPILHRGMAAVEELLDP-RLKCTSRNSXXXXXXXXXXXXCISSEESRRP 455
                  VL    +L RG    E L  P R  C   +             C  +E S RP
Sbjct: 228 HTQGQMTVLRLTELLERG----ERLPRPDRCPCEIYH---------LMKNCWETEASFRP 274
Query: 456 GIEEIIAILRGEEE 469
             + ++ IL+  +E
Sbjct: 275 TFQNLVPILQTAQE 288

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 24  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 83
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 140
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 141 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 192
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 193 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 184
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW     
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX---- 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT   LAPE       +   D +A GV++ E+  G  P  A
Sbjct: 198 ---LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G ++G+G    V+ G+       VAI+ +D  +++++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C+ P   L +I     G +L   + + K  +  N T       ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKT------RQIAQEIVKGMGYLH 147
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT---SAPSVPFLCKTVKGTFGYLAP 361
               + ++H+D+K  N+   + K+  + DFGL + +    A       +   G   +LAP
Sbjct: 148 ---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 362 EYFQHGK---------VSDKTDVYAFGVVLLELLTGRKPIEAR 395
           E  +             S  +DV+A G +  EL     P + +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW        LC
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWX-------LC 199
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G  + E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA   S     F   
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF--- 169
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH-PNIVPLVGF 247
           +G G    V+K +       +A+K++ +  +KE +K    +L +    H  P IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I     +F+  + +  G+    L ++ +G      +P  +  K+ + I +++ YL    
Sbjct: 93  FIT-NTDVFIAMELM--GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKE-- 142
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           +  V+HRD+KPSNILL  +   KLCDFG++                G   Y+APE     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPP 199
Query: 368 KVSD-----KTDVYAFGVVLLELLTGRKP 391
             +      + DV++ G+ L+EL TG+ P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 17/237 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 152
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA--PSVPFLC 349
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL 
Sbjct: 153 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
           + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 206 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 72  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 131 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 185
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 27/222 (12%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 247
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 308 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLATW------TSAPSVPFLCKTVKGTFGY 358
            + + HRD+KP NIL    ++  P K+CDF L +        S  S P L  T  G+  Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEY 187
Query: 359 LAPE----YFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEAR 395
           +APE    + +   + DK  D+++ GV+L  LL+G  P   R
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              + +LH+     VVHRD+KP NIL++S    KL DFGLA      S      +V  T 
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            Y APE       +   D+++ G +  E+   RKP+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFGYLAPE 362
              ++   VHRD+   N+L+ S  + K+ DFGL+      P         K    + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                  S  +DV++FGVV+ E+L  G +P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGY 358
           + + H+   R V+HRD+KP N+L++     KL DFGLA    A  +P  C + +  T  Y
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLA---RAFGIPVRCYSAEVVTLWY 167
Query: 359 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 392
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 82  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 141 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 195
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 75  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 134 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 188
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 75  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 134 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 188
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 23/177 (12%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           +E+ I   L HPN+V LV    DP E  L+++++ V+ G +          +   +  P 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------MEVPTLKPL 134
Query: 287 S---VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           S    R+     + + + YLH    + ++HRDIKPSN+L+      K+ DFG++      
Sbjct: 135 SEDQARFYFQ-DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGK--VSDKT-DVYAFGVVLLELLTGRKPIEARRL 397
           S   L  TV GT  ++APE     +   S K  DV+A GV L   + G+ P    R+
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 91
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 146
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 147 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 200
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G    E +  L P
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 256 TVRTYVEN 263

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALD 169
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 17/251 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIAS-SLHHPNIVPLVGF 247
           LGRGA   V K +        A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 102 LF--REGDVWICXELXDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 154
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---TSAPSVPFLCKTVKGTFGYLAPEYF 364
           +  V+HRD+KPSN+L+++    K CDFG++ +     A  +   CK        + PE  
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP-ERINPELN 213
Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEA--RRLQGEENLVLWAKPILHRGMAAVEELL 422
           Q G  S K+D+++ G+  +EL   R P ++     Q  + +V    P L     +  E +
Sbjct: 214 QKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA-EFV 271
Query: 423 DPRLKCTSRNS 433
           D   +C  +NS
Sbjct: 272 DFTSQCLKKNS 282

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 76  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 135 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 189
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 73  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 132 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 186
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 182
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 82  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 141 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 195
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G    E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 117
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 168
Query: 310 CVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
             VH D+KP NI+ ++K+    KL DFGL             K   GT  + APE  +  
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK 225
Query: 368 KVSDKTDVYAFGVVLLELLTGRKPI 392
            V   TD+++ GV+   LL+G  P 
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW        LC
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX-------LC 200
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
               GT  YLAPE       +   D +A GV++ E+  G  P  A
Sbjct: 201 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 104 MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+          +  
Sbjct: 163 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR 217
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALA 169
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 117/250 (46%), Gaps = 30/250 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLL-----YQMLXGIK----H 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPE 188
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
                   +  D+++ G ++ E++  +         G + +  W K I   G    E + 
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTPCPEFM- 242
Query: 423 DPRLKCTSRN 432
             +L+ T RN
Sbjct: 243 -KKLQPTVRN 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 223
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 274
Query: 310 CVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
             VH D+KP NI+ ++K+    KL DFGL             K   GT  + APE  +  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGK 331
Query: 368 KVSDKTDVYAFGVVLLELLTGRKPI 392
            V   TD+++ GV+   LL+G  P 
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 37/264 (14%)
Query: 152 WRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GL 205
           W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +    GL
Sbjct: 1   WKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 55
Query: 206 LRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY 259
            +      VA+K L        K A   EL I S L  H NIV L+G C      + +I 
Sbjct: 56  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVIT 114
Query: 260 KYVSGGSLERHLHEKKKGVRGNSTLP--------------WSVRYKVALG--IAESVAYL 303
           +Y   G L   L  K + + G S  P                +R  +     +A+ +A+L
Sbjct: 115 EYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL 174
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
              ++ C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE 
Sbjct: 175 --ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES 231
Query: 364 FQHGKVSDKTDVYAFGVVLLELLT 387
                 + ++DV+++G++L E+ +
Sbjct: 232 IFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 255 LFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH 313
           + LI +Y +GG +    L E  + V  N  +      ++   I E V YLH      +VH
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQILEGVYYLHQNN---IVH 154
Query: 314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC--KTVKGTFGYLAPEYFQHGKVSD 371
            D+KP NILLSS  I  L D  +  +  +  +   C  + + GT  YLAPE   +  ++ 
Sbjct: 155 LDLKPQNILLSS--IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 372 KTDVYAFGVVLLELLTGRKPIEARRLQGEEN 402
            TD++  G++   LLT   P       GE+N
Sbjct: 213 ATDMWNIGIIAYMLLTHTSP-----FVGEDN 238

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPEVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++ G          G +++  W K I   G    E +  L P
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-----GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 255 TVRTYVEN 262

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 28/199 (14%)
Query: 281 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
           +  +P  +  K+ L   +++ +L    +  ++HRDIKPSNILL      KLCDFG+    
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI---- 172
Query: 341 SAPSVPFLCKTVK-GTFGYLAPEYFQHGKVSD----KTDVYAFGVVLLELLTGRKPIEAR 395
           S   V  + KT   G   Y+APE             ++DV++ G+ L EL TGR P    
Sbjct: 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP-- 230
Query: 396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRP 455
               + N V      + +G        DP     S               C++ +ES+RP
Sbjct: 231 ----KWNSVFDQLTQVVKG--------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
Query: 456 GIEEIIA---ILRGEEELI 471
             +E++    IL  EE  +
Sbjct: 279 KYKELLKHPFILMYEERAV 297

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-----------WT 340
           + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T            T
Sbjct: 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELL 386
             P+       V GT  Y++PE       S K D+++ G++L ELL
Sbjct: 226 PMPAYATHXGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 67  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+             
Sbjct: 126 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR 180
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 175
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 176 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 233 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 169
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 227 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 76  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+             
Sbjct: 135 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR 189
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 114/252 (45%), Gaps = 21/252 (8%)
Query: 162 ISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDK 220
           + P     + +  G+       +++ + +G GA   V      + +T VAIK++   E +
Sbjct: 23  VGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQ 82
Query: 221 ESSKAFCRELMIASSLHHPNIVP----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
              +   RE+ I     H N++     L    ++  + ++++        +E  L++  K
Sbjct: 83  TYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDL-----METDLYKLLK 137
Query: 277 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             + ++       Y++  G+     Y+H+     V+HRD+KPSN+L+++    K+CDFGL
Sbjct: 138 SQQLSNDHICYFLYQILRGLK----YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGL 190
Query: 337 ATWTSA--PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIE 393
           A           FL + V  T  Y APE   + K   K+ D+++ G +L E+L+ R    
Sbjct: 191 ARIADPEHDHTGFLTEXV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 394 ARRLQGEENLVL 405
            +    + N +L
Sbjct: 250 GKHYLDQLNHIL 261

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 35/282 (12%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 333 DFGLA--TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK 390
           DFGLA    TS    P++      T  Y APE        +  D+++ G ++ E++  + 
Sbjct: 207 DFGLARTAGTSFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
Query: 391 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                   G + +  W K I   G    E +   +L+ T RN
Sbjct: 262 -----LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 296

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 183 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 82  LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 133
Query: 315 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 371
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T      Y+APE     K   
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKYDK 189
Query: 372 KTDVYAFGVVLLELLTGRKPI 392
             D+++ GV++  LL G  P 
Sbjct: 190 SCDMWSLGVIMYILLCGFPPF 210

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           + +   IA+ +AYL+       VHRD+   N  ++     K+ DFG+          +  
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYR 182
Query: 350 KTVKGTFG--YLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
           K  KG     +++PE  + G  +  +DV++FGVVL E+ T
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 101 LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 152
Query: 315 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 371
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T      Y+APE     K   
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKYDK 208
Query: 372 KTDVYAFGVVLLELLTGRKPI 392
             D+++ GV++  LL G  P 
Sbjct: 209 SCDMWSLGVIMYILLCGFPPF 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 95  LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 146
Query: 315 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 202
Query: 371 DKTDVYAFGVVLLELLTGRKPI 392
              D+++ GV++  LL G  P 
Sbjct: 203 KSCDMWSLGVIMYILLCGYPPF 224

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 183 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 170 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 224
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 225 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 85/368 (23%), Positives = 143/368 (38%), Gaps = 57/368 (15%)
Query: 161 SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK 220
           S SP A SL  +    +      F    ++G G    V+KG+        AIK +D    
Sbjct: 4   SDSP-ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 221 ESSKAFCRELMIASSLHHPNIVPLVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKK 275
           E  +      M+    HH NI    G  I  +P   +  L+L+ ++   GS+   +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---- 118
Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           K  +GN+     + Y +   I   +++LH   +  V+HRDIK  N+LL+     KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRK 390
           ++             T  GT  ++APE     +  D     K+D+++ G+  +E+  G  
Sbjct: 175 VS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 391 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSE 450
           P+                P+  R +  +     PRLK    +             C+   
Sbjct: 233 PL------------CDMHPM--RALFLIPRNPAPRLKSKKWSK----KFQSFIESCLVKN 274
Query: 451 ESRRPGIEEIIAILRGEEELIYCTWKKHNFSGIIDCYPQLQQTKSEMKSHLALAMVGVSE 510
            S+RP  E+++               KH F   I   P  +Q + ++K H+        E
Sbjct: 275 HSQRPATEQLM---------------KHPF---IRDQPNERQVRIQLKDHIDRTKKKRGE 316
Query: 511 FEEDDHLY 518
            +E ++ Y
Sbjct: 317 KDETEYEY 324

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAP 154
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+ DFG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKIADFGYSKASVLHSQP---KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 387 TGRKPIE 393
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 104 LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 155
Query: 315 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 211
Query: 371 DKTDVYAFGVVLLELLTGRKPI 392
              D+++ GV++  LL G  P 
Sbjct: 212 KSCDMWSLGVIMYILLCGYPPF 233

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 94  LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 145
Query: 315 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 201
Query: 371 DKTDVYAFGVVLLELLTGRKPI 392
              D+++ GV++  LL G  P 
Sbjct: 202 KSCDMWSLGVIMYILLCGYPPF 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 16/142 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L ++ + + GG L   + +     RG+         ++   I E++ YLH+     + HR
Sbjct: 96  LLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHR 147
Query: 315 DIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS 370
           D+KP N+L +SK+   I KL DFG A   TS  S+   C T      Y+APE     K  
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYD 203
Query: 371 DKTDVYAFGVVLLELLTGRKPI 392
              D+++ GV++  LL G  P 
Sbjct: 204 KSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 124
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 125 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 182 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 181 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 207 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--- 260
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 261 --ILFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 296

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 83/187 (44%), Gaps = 18/187 (9%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+C FG +  +   S P   K+  GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICAFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 387 TGRKPIE 393
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 116/235 (49%), Gaps = 39/235 (16%)
Query: 190 LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C+  ++ + L+ ++V  GSL+ +L + K  +     + W  + +VA  +A ++ +
Sbjct: 76  LNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILW--KLEVAKQLAAAMHF 128
Query: 303 LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV-K 353
           L   T   ++H ++   NILL         +    KL D G+       S+  L K + +
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKDILQ 178
Query: 354 GTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEA----RRLQGEEN 402
               ++ PE  ++ K ++  TD ++FG  L E+ + G KP+ A    R+LQ  E+
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 60
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 61  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 119
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 120 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 167
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 168 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 222
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 223 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 257

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVRGNSTLP-------WSVRYKVALG--IAESVAYLHNGT 307
           +I +Y   G L   L  K+      S  P        S R  +     +A+ +A+L   +
Sbjct: 127 VITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--AS 184
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG 367
           + C+ HRD+   N+LL++  + K+ DFGLA      S   +    +    ++APE     
Sbjct: 185 KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 243
Query: 368 KVSDKTDVYAFGVVLLELLT 387
             + ++DV+++G++L E+ +
Sbjct: 244 VYTVQSDVWSYGILLWEIFS 263

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 170 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 224
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 225 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 259

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 31/280 (11%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           DFGLA  T+  S  F+      T  Y APE        +  D+++ G ++ E++  +   
Sbjct: 169 DFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-- 223
Query: 393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
                 G + +  W K I   G    E +   +L+ T RN
Sbjct: 224 ---LFPGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 258

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 20/224 (8%)
Query: 175 GEILAATHN-FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCREL 230
           G +   T N F   ++LG+G    V   K        A+K L KE    K+       E 
Sbjct: 1   GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 61  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF------ 113
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFL 348
                I  ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   
Sbjct: 114 -YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF 170
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           C    GT  YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 171 C----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D+++ GV++  LL G  P 
Sbjct: 181 PY----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 19/216 (8%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHH 238
           + F   ++LG+G    V   K        A+K L KE    K+       E  +  +  H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L  +       L  + +Y +GG L  HL  ++      +             I  
Sbjct: 68  PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVS 119
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTF 356
           ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   C    GT 
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC----GTP 173
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 166 ANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKES 222
           AN    +  G+        +   + +G GA   V      +L  +VAIK+L +  +++  
Sbjct: 1   ANQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 60
Query: 223 SKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
           +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + +  +   
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH 119
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 120 ERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 167
Query: 338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
             T+  S  F+      T  Y APE        +  D+++ G ++ E++  +        
Sbjct: 168 R-TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LF 219
Query: 398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRN 432
            G + +  W K I   G    E +   +L+ T RN
Sbjct: 220 PGRDYIDQWNKVIEQLGTPCPEFM--KKLQPTVRN 252

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFGY 358
           + + H+   R V+HRD+KP N+L++     KL +FGLA    A  +P  C + +  T  Y
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEVVTLWY 167
Query: 359 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 392
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+C FG +  +   S P   K   GT  Y+APE     +   K  DV++ GV L  +L
Sbjct: 155 RLKICAFGYSKSSVLHSQP---KDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 387 TGRKPIE 393
            G  P E
Sbjct: 212 VGAYPFE 218

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 19/216 (8%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHH 238
           + F   ++LG+G    V   K        A+K L KE    K+       E  +  +  H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L  +       L  + +Y +GG L  HL  ++      +             I  
Sbjct: 70  PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVS 121
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKTVKGTF 356
           ++ YLH  +E+ VV+RD+K  N++L      K+ DFGL         ++   C    GT 
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC----GTP 175
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            YLAPE  +        D +  GVV+ E++ GR P 
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 120
Query: 289 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 121 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 172
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              KT+ GT  Y+APE       S + DV++ G ++  LL G+ P E 
Sbjct: 173 -RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 198 VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL 257
           VF GK+  +  S+ +K   +E          E+ I  SL H ++V   GF  D    +F+
Sbjct: 44  VFAGKI--VPKSLLLKPHQRE------KMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV 94
Query: 258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRD 315
           + +     SL   LH+++K +    T P +  Y  ++ LG      YLH      V+HRD
Sbjct: 95  VLELCRRRSL-LELHKRRKAL----TEPEARYYLRQIVLG----CQYLHRNR---VIHRD 142
Query: 316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDV 375
           +K  N+ L+     K+ DFGLAT           KT+ GT  Y+APE       S + DV
Sbjct: 143 LKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 376 YAFGVVLLELLTGRKPIEARRLQ 398
           ++ G ++  LL G+ P E   L+
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLK 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 19/238 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS---VPFL 348
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+ DFGLA   + P      FL
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFL 184
Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
            + V  T  Y APE   + K   K+ D+++ G +L E+L+ R     +    + N +L
Sbjct: 185 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 71  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 124
Query: 289 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 125 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 176
Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
              KT+ GT  Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 177 -RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 15/227 (6%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKAFCREL 230
           ++L     F+ GR+LG+G    V + ++       ++ +V + + D       + F RE 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 231 MIASSLHHPNIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
                  HP++  LVG  +            +I  ++  G L   L   + G      LP
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLP 135
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
                +  + IA  + YL   + R  +HRD+   N +L+      + DFGL+    +   
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                  K    +LA E       +  +DV+AFGV + E++T G+ P
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGI 133
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T 
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTR 183
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y APE        +  D+++ G ++ E++  +         G + +  W K I   G  
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTP 238
Query: 417 AVEELLDPRLKCTSRN 432
             E +   +L+ T RN
Sbjct: 239 CPEFM--KKLQPTVRN 252

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGI 132
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T 
Sbjct: 133 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTR 182
Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            Y APE        +  D+++ G ++ E++  +         G + +  W K I   G  
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-----LFPGRDYIDQWNKVIEQLGTP 237
Query: 417 AVEELLDPRLKCTSRN 432
             E +   +L+ T RN
Sbjct: 238 CPEFM--KKLQPTVRN 251

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 41/236 (17%)
Query: 190 LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C   ++ + L+ ++V  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 76  LNYGVCFCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILWK------LEVAKQLAW 124
Query: 303 -LHNGTERCVVHRDIKPSNILL--------SSKKIPKLCDFGLATWTSAPSVPFLCKTV- 352
            +H   E  ++H ++   NILL         +    KL D G+       S+  L K + 
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------SITVLPKDIL 177
Query: 353 KGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLT-GRKPIEA----RRLQGEEN 402
           +    ++ PE  ++ K ++  TD ++FG  L E+ + G KP+ A    R+LQ  E+
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 66/273 (24%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS--KAFCRELMI 232
           A      G+ LGRGA   V +     ++ S     VA+K L KE   +S  KA   EL I
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKML-KEGATASEYKALMTELKI 83
Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER-----------------HLHEK 274
            + + HH N+V L+G C      L +I +Y   G+L                   H+  K
Sbjct: 84  LTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPK 143
Query: 275 KKGV-----RGNSTLPWSVR----------------------------YKVALGIAESVA 301
           K+ +     +G      SV                             YK  + + + ++
Sbjct: 144 KEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLIS 203
Query: 302 Y---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           Y   +  G E    R  +HRD+   NILLS   + K+CDFGLA               + 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT 387
              ++APE       S K+DV+++GV+L E+ +
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+ +    T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMEPEVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELL 386
               +  D+++ G ++ E++
Sbjct: 200 MGYKENVDIWSVGCIMGEMV 219

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQD-----RGDQAFTEREASEIXKS 169
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT-WTSAPSVPFLCKT 351
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A   TS  S+   C T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                 Y+APE     K     D ++ GV+   LL G  P 
Sbjct: 227 PY----YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 235 SLHHPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 123
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA      S      
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    +  L+L+  Y  GG L   L + +  +       +     +A+   +SV
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI---DSV 191
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG-----LATWTSAPSVPFLCKTVKGT 355
             LH       VHRDIKP NIL+      +L DFG     +   T   SV        GT
Sbjct: 192 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV------GT 239
Query: 356 FGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
             Y++PE  Q      G+   + D ++ GV + E+L G  P  A  L
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 65  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 118
Query: 289 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 344
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 119 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E 
Sbjct: 172 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H+     ++HRD+KP  +LL+SK+   P KL  FG+A       +  +     GT  ++A
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 201
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 89  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 142
Query: 289 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 344
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 143 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 195
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E 
Sbjct: 196 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+ +    T  Y APE    
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMEPEVVTRYYRAPEVILG 199
Query: 367 GKVSDKTDVYAFGVVLLELL 386
               +  D+++ G ++ E++
Sbjct: 200 MGYKENVDLWSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 115/248 (46%), Gaps = 22/248 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 84
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 85  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 139
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 140 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 193
Query: 367 GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL--LDP 424
               +  D+++ G ++ E++  +         G + +  W K I   G    E +  L P
Sbjct: 194 MGYKENVDLWSVGCIMGEMVCHKI-----LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 425 RLKCTSRN 432
            ++    N
Sbjct: 249 TVRTYVEN 256

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 93  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           H+     ++HRD+KP  +LL+SK+   P KL  FG+A       +  +     GT  ++A
Sbjct: 149 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 203
Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           PE  +        DV+  GV+L  LL+G  P 
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I  SL H ++V   GF  D    +F++ +     SL   LH+++K +    T P + 
Sbjct: 91  EISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSL-LELHKRRKAL----TEPEAR 144
Query: 289 RY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT--SAPS 344
            Y  ++ LG      YLH      V+HRD+K  N+ L+     K+ DFGLAT        
Sbjct: 145 YYLRQIVLG----CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              LC    GT  Y+APE       S + DV++ G ++  LL G+ P E 
Sbjct: 198 KKVLC----GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 95
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 96  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 150
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH 366
               ++HRD+KPSNI++ S    K+ DFGLA  T+  S  F+      T  Y APE    
Sbjct: 151 G---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTS--FMMTPYVVTRYYRAPEVILG 204
Query: 367 GKVSDKTDVYAFGVVLLELL 386
               +  D+++ G ++ E++
Sbjct: 205 MGYKENVDLWSVGCIMGEMV 224

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 17/222 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 201
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
             + +  +   VHRDIKP N+LL      +L DFG     +            GT  Y++
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYIS 260
Query: 361 PEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
           PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 302

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLL 194
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 80
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 81  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 193
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 17/222 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 185
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
             + +  +   VHRDIKP N+LL      +L DFG     +            GT  Y++
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSVAVGTPDYIS 244
Query: 361 PEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRL 397
           PE  Q      GK   + D ++ GV + E+L G  P  A  L
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAG 122
Query: 236 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 172
Query: 295 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWTSAPSVP---FLC 349
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A       +       
Sbjct: 173 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             + GT  ++APE         K DV++   ++L +L G  P
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+ + +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 243 PLVG------------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                             +  +  LF+  +Y    +L   +H +    + +        +
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY------W 119
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT---------- 340
           ++   I E+++Y+H+   + ++HR++KP NI +   +  K+ DFGLA             
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 341 --SAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELL 386
             + P       +  GT  Y+A E     G  ++K D Y+ G++  E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRA-----EELMACAG 141
Query: 236 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 191
Query: 295 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWTSAPSVP---FLC 349
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A       +       
Sbjct: 192 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             + GT  ++APE         K DV++   ++L +L G  P
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G+   V+K         VAIK++  E     +   +E+ I      P++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
                L+++ +Y   GS+   +  +      N TL       +     + + YLH   + 
Sbjct: 95  K-NTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLAPEYFQHG 367
             +HRDIK  NILL+++   KL DFG+A   +      + K   V GT  ++APE  Q  
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVAGQLTD----XMAKRNXVIGTPFWMAPEVIQEI 200
Query: 368 KVSDKTDVYAFGVVLLELLTGRKP 391
             +   D+++ G+  +E+  G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 78
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 79  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 137 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 191
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+             K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLL 194
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G    V+K    +   +VAIKR  L+ E++       RE+ +   L H NI+ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS- 100
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I     L LI++Y          ++ KK +  N  +   V       +   V + H  +
Sbjct: 101 VIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--S 150
Query: 308 ERCVVHRDIKPSNILL-----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
            RC+ HRD+KP N+LL     S   + K+ DFGLA     P   F  + +  T  Y  PE
Sbjct: 151 RRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPE 207
Query: 363 YFQHGK-VSDKTDVYAFGVVLLELL 386
                +  S   D+++   +  E+L
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 83  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHR++   N +++     K+ DFG+          +  K  KG  
Sbjct: 141 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 195
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+    +  VHR++   N +++     K+ DFG+          +  K  KG  
Sbjct: 140 ADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 194
Query: 357 G--YLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
              ++APE  + G  +  +D+++FGVVL E+
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 12  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 65
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 117
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 11  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 64
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 116
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 17  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 70
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 122
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 37  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 90
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 142
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 37/247 (14%)
Query: 177 ILAATHNFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCREL 230
           ++    +F    VLG GA  + V++G        VA+KR+  E     D+E         
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFADREVQ------- 69
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++  S  HPN++    FC + ++    I   +   +L+ ++ +K     G    P ++  
Sbjct: 70  LLRESDEHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE--PITLLQ 125
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-----SKKIPKLCDFGLATWTSAPSV 345
           +   G+A    +LH+     +VHRD+KP NIL+S      K    + DFGL    +    
Sbjct: 126 QTTSGLA----HLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 346 PFLCKT-VKGTFGYLAPEYFQHGKVSDKT---DVYAFGVVLLELLT-GRKPIEARRLQGE 400
            F  ++ V GT G++APE        + T   D+++ G V   +++ G  P   + LQ +
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQ 237
Query: 401 ENLVLWA 407
            N++L A
Sbjct: 238 ANILLGA 244

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 14  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 67
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 119
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++GK       VA+K     ++ S   + RE  I  +  L H NI+  +  
Sbjct: 50  IGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA- 103
Query: 248 CIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             + + G    L+L+  Y   GSL  +L+     V G          K+AL  A  +A+L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG--------MIKLALSTASGLAHL 155
Query: 304 HN---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTF 356
           H    GT+    + HRD+K  NIL+       + D GLA    ++  ++        GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 357 GYLAPEYF------QHGKVSDKTDVYAFGVVLLEL 385
            Y+APE        +H +   + D+YA G+V  E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)
Query: 179 AATHNFSKGRVLGRGALSFV---FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
            ++  +S G+ LG G+   V   F  + G      A+K++ ++ +  +    REL I   
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPRYKN----RELDIMKV 56
Query: 236 LHHPNIVPLVGF-----------------------------------CIDPEQGLFL--I 258
           L H NI+ LV +                                    ++P Q  +L  I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP 318
            +YV   +L + L   K  +R   ++P ++       +  +V ++H+     + HRDIKP
Sbjct: 117 MEYVPD-TLHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 319 SNILLSSK-KIPKLCDFGLAT--WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTD 374
            N+L++SK    KLCDFG A     S PSV  +C        Y APE      + +   D
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-----YRAPELMLGATEYTPSID 224
Query: 375 VYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
           +++ G V  EL+ G KP+      GE ++    + I   G    E+++
Sbjct: 225 LWSIGCVFGELILG-KPL----FSGETSIDQLVRIIQIMGTPTKEQMI 267

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLER--HLHEKKKGVRGNSTL 284
           +E+ +   L H N++ LV    + E Q ++++ +Y   G  E    + EK+         
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------F 106
Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           P    +     + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRL 397
               C+T +G+  +  PE           K D+++ GV L  + TG  P E   +
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L K  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 47  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 102
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 103 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 155 AD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIML 206
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           LGRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 133
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 134 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 182
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 362
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 183 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    K D+++   ++L +L G  P
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 230
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 11  AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 65
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 66  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 116
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 117 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 170
Query: 351 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 171 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T+     ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIML 202
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQ--------ILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGL   T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VAIK+L +  + +  +K   REL++   + H N++ L+     P   L   Y +      
Sbjct: 52  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPF 110
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            +   +K  G++ +      + Y++  G+     Y+H+     VVHRD+KP N+ ++   
Sbjct: 111 MQTDLQKIMGLKFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDC 163
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+ DFGLA    A    ++      T  Y APE        ++T D+++ G ++ E+L
Sbjct: 164 ELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 387 TGR 389
           TG+
Sbjct: 219 TGK 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 230
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 10  AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 64
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 65  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 116 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 169
Query: 351 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 170 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 230
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 1   AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 55
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 56  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 106
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 107 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 160
Query: 351 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 161 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCREL 230
           A   N+   + LG G+      GKV L   +     VA+K ++K+    S       RE+
Sbjct: 5   AHIGNYQIVKTLGEGSF-----GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREI 59
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                L HP+I+ L    I  +  + ++ +Y +G  L  ++ ++ K     +        
Sbjct: 60  SYLRLLRHPHIIKLYD-VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEAR------- 110
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           +    I  +V Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     K
Sbjct: 111 RFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLK 164
Query: 351 TVKGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKPIE 393
           T  G+  Y APE    GK+    + DV++ GV+L  +L  R P +
Sbjct: 165 TSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 43  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 98
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 99  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 150
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 202
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 85  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 135
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 35  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 90
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 91  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 142
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 143 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 194
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 41  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 96
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 97  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 148
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 149 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 200
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 66  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 116
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 117 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 47  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 102
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 103 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 154
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 155 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 206
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 48  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 103
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 104 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 155
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 156 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 207
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 59  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 114
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 115 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 218
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 38  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 93
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 94  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 145
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 146 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 197
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 55  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 110
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 111 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 214
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 215
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 33  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 88
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 89  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 192
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 10  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 68
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 69  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 119
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 120 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 175
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 59  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 114
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 115 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 166
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 167 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV-----ATRWYRAPEIML 218
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 119
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 120 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 168
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 362
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    K D+++   ++L +L G  P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 191
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 33  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 88
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 89  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 140
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 141 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 192
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 34  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 89
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L   +  +K        L +         I   + Y+H+
Sbjct: 90  PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYIHS 141
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 142 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 193
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 135
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 136 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 184
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVP---FLCKTVKGTFGYLAPE 362
             R ++H D+K  N+LLSS      LCDFG A       +         + GT  ++APE
Sbjct: 185 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                    K D+++   ++L +L G  P
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 6   KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 64
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 65  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 115
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 116 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 171
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VAIK+L +  + +  +K   REL++   + H N++ L+     P   L   Y +      
Sbjct: 70  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPF 128
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            +   +K  G+  +      + Y++  G+     Y+H+     VVHRD+KP N+ ++   
Sbjct: 129 MQTDLQKIMGMEFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDC 181
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELL 386
             K+ DFGLA    A    ++      T  Y APE        ++T D+++ G ++ E+L
Sbjct: 182 ELKILDFGLARHADAEMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236
Query: 387 TGR 389
           TG+
Sbjct: 237 TGK 239

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--L 236
              H  +    +G+G    V++G       +VA+K     D+   K++ RE  + ++  L
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVML 59
Query: 237 HHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            H NI+  +   +        L+LI  Y   GSL  +L          +TL      ++ 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIV 111
Query: 294 LGIAESVAYLH---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           L IA  +A+LH    GT+    + HRD+K  NIL+       + D GLA   S  +    
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 349 CKTVK--GTFGYLAPEYFQHGKVSD------KTDVYAFGVVLLEL 385
                  GT  Y+APE        D      + D++AFG+VL E+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ D+GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      F+      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-----ATRWYRAPEIML 191
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 26  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 85  QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 135
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A          +  +  GT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------------TWTSAPSV 345
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA             T   +  V
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 346 PFLCKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
            F+      T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 181 EFV-----ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 42  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 97
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 98  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 149
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 150 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 201
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 245
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 246 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKSQALSDEHVQFLV-YQLLRGL 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA-----TRWYRA 196
Query: 361 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 46  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 101
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 102 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 153
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 154 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 205
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++G       SVA+K     D++S   + RE  I ++  L H NI+  +  
Sbjct: 16  VGKGRYGEVWRGL--WHGESVAVKIFSSRDEQS---WFRETEIYNTVLLRHDNILGFIAS 70
Query: 248 CI---DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            +   +    L+LI  Y   GSL   L  +        TL   +  ++A+  A  +A+LH
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQ--------TLEPHLALRLAVSAACGLAHLH 122
Query: 305 N---GTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS--VPFLCKTVKGTFG 357
               GT+    + HRD K  N+L+ S     + D GLA   S  S  +        GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 358 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 385
           Y+APE       +D       TD++AFG+VL E+
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 31/231 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGF 247
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 248 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 305 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +  E  +VHR+IKP NI+       + + KL DFG A         F+  ++ GT  YL 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFV--SLYGTEEYLH 183
Query: 361 PEYFQHG--------KVSDKTDVYAFGVVLLELLTGR---KPIEARRLQGE 400
           P+ ++          K     D+++ GV      TG    +P E  R   E
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)
Query: 186 KGRV------LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL- 236
           KGR+      +G G  S VF+  +   +   AIK   L++ D ++  ++  E+   + L 
Sbjct: 54  KGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            H   I+ L  + I  +     IY  +  G+++ +   KKK     S  PW  R      
Sbjct: 113 QHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKK----KSIDPWE-RKSYWKN 163
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  G 
Sbjct: 164 MLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 356 FGYLAPEYFQHGKVSDKT-----------DVYAFGVVLLELLTGRKPIE 393
             Y+ PE  +    S +            DV++ G +L  +  G+ P +
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T       +      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++G       +VA+K     D+   K++ RE  + ++  L H NI+  +  
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 248 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            +        L+LI  Y   GSL  +L          +TL      ++ L IA  +A+LH
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLH 122
Query: 305 ---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS--VPFLCKTVKGTFG 357
               GT+    + HRD+K  NIL+       + D GLA   S  +  +        GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 358 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 385
           Y+APE        D      + D++AFG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 96/235 (40%), Gaps = 21/235 (8%)
Query: 169 LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF 226
           ++RL   E+     +F   +V+GRGA S V   K+       A+K ++K D  K    + 
Sbjct: 50  VVRLK--EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
            RE            +  + F    E  L+L+ +Y  GG L   L   K G R  + +  
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-- 163
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
             R+     +AE V  + +      VHRDIKP NILL      +L DFG      A    
Sbjct: 164 -ARFY----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 347 FLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                V GT  YL+PE  Q        G    + D +A GV   E+  G+ P  A
Sbjct: 219 RSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK----- 353
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T +     
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 354 ---GTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 39/240 (16%)
Query: 238 HPNIVPLVGFC------IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           HP+IV +  F        DP    +++ +YV G SL+R   +K         LP +    
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVG--YIVMEYVGGQSLKRSKGQK---------LPVAEAIA 186
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
             L I  +++YLH+     +V+ D+KP NI+L+ +++ KL D G  +  ++         
Sbjct: 187 YLLEILPALSYLHS---IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGY 236
Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG--EENLVLWAKP 409
           + GT G+ APE  + G     TD+Y  G  L  L         R + G  E++ VL    
Sbjct: 237 LYGTPGFQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD 295
Query: 410 ----ILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEEIIAILR 465
               +L R +       DPR + T+                       RPG+  I +  R
Sbjct: 296 SYGRLLRRAIDP-----DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSR 350

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 215
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGF 247
           +G+G    V++G       +VA+K     D+   K++ RE  + ++  L H NI+  +  
Sbjct: 45  VGKGRYGEVWRG--SWQGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 248 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            +        L+LI  Y   GSL  +L          +TL      ++ L IA  +A+LH
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLH 151
Query: 305 ---NGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK--GTFG 357
               GT+    + HRD+K  NIL+       + D GLA   S  +           GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 358 YLAPEYFQHGKVSD------KTDVYAFGVVLLEL 385
           Y+APE        D      + D++AFG+VL E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLIYKYVSGGSLERHLHEKKKGVR 279
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 340 TSAPSVPFLCKTVKGTFG-YLAPEYFQHGKVSDK-TDVYAFGVVLLELL 386
            +A +     KT   T   Y APE     K   K  D+++ G V+ E+ 
Sbjct: 184 DTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 299
           I+ L    I PE  L     Y+     +  L +  K  +        ++ Y + LG    
Sbjct: 89  IIRLHDLII-PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG---- 143
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 144 EKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 212 IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 271
           I++++ +D E  K    E+ +   LHHPNI  L     D EQ + L+ +   GG L   L
Sbjct: 64  IRQINPKDVERIKT---EVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKL 119
Query: 272 HE------------------------KKKGVRGN-----STLPWSVRYKVALGIAESV-- 300
           +                          ++ + G+      +L +  R K+   I   +  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 301 --AYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLAT-WTSAPSVPFLCKTVK-G 354
              YLHN   + + HRDIKP N L S+ K    KL DFGL+  +    +  +   T K G
Sbjct: 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 355 TFGYLAPEYFQHGKVS--DKTDVYAFGVVLLELLTGRKPI 392
           T  ++APE       S   K D ++ GV+L  LL G  P 
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK----- 353
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T +     
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 354 ---GTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y APE      K S   DV++ G +L EL   R+PI
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 55  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 110
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 111 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 162
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 163 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 214
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLIYKYVSGGSLERHLHEKKKGVR 279
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 340 TSAPSVPFLCKTVKGTFG-YLAPEYFQHGKVSDK-TDVYAFGVVLLELL 386
            +A +     KT   T   Y APE     K   K  D+++ G V+ E+ 
Sbjct: 184 DTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 31/231 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGF 247
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 248 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 305 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +  E  +VHR+IKP NI+       + + KL DFG A         F+   + GT  YL 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFV--XLYGTEEYLH 183
Query: 361 PEYFQHG--------KVSDKTDVYAFGVVLLELLTGR---KPIEARRLQGE 400
           P+ ++          K     D+++ GV      TG    +P E  R   E
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 191
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 245
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 246 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHVQFLV-YQLLRGL 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 145 KYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA-----TRWYRA 196
Query: 361 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+  FGLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 32  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 87
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L   +    K  +        + Y++  G+     Y+H+
Sbjct: 88  PARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTDDHVQFLIYQILRGLK----YIHS 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T  Y APE   
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIML 191
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 311
           E G+  +   + G SL++H           ++LP +  +        ++A+LH+   + +
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW------GASLPEAQVWGYLRDTLLALAHLHS---QGL 178
Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD 371
           VH D+KP+NI L  +   KL DFGL             +  +G   Y+APE  Q G    
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQ-GSYGT 234
Query: 372 KTDVYAFGVVLLEL 385
             DV++ G+ +LE+
Sbjct: 235 AADVFSLGLTILEV 248

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 40/161 (24%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTV 352
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T+           
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------- 171
Query: 353 KGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
                         G+  DK+ D+++ GV++  LL G  P 
Sbjct: 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 350
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 351 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K GL    VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ D GLA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 350
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 351 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 350
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 351 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW----SVRYKVALGI 296
           I+ L    I P+  L     Y+    LE    + KK  +    L      ++ Y + LG 
Sbjct: 87  IIRLYDLII-PDDLLKFDELYIV---LEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG- 141
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 142 ---ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCK 350
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S    S P    
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 351 TVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPI 392
               T  Y  PE     +      D++  G ++ E+ T R PI
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I   + Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T      ++      T
Sbjct: 163 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----AT 214
Query: 356 FGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
             Y APE   +    + T D+++ G ++ ELLTGR
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLV 245
           R +G GA   V       LR  VA+K+L +  +    ++   REL +   L H N++ L+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 246 GF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   I+    ++L+   + G  L          V+  +     V++ V   +   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHVQFLV-YQLLRGL 136
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     ++HRD+KPSN+ ++     ++ DFGLA         ++      T  Y A
Sbjct: 137 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV-----ATRWYRA 188
Query: 361 PEYFQHGKVSDKT-DVYAFGVVLLELLTGR 389
           PE   +    ++T D+++ G ++ ELL G+
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V     G     VAIK+L +  + +  +K   REL +   + H N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 +D     +L+  ++     +   HEK     G   + + V Y++  G+     Y
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLV-YQMLKGLR----Y 143
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           +H      ++HRD+KP N+ ++     K+ DFGLA    +     +      T  Y APE
Sbjct: 144 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV-----TRWYRAPE 195
Query: 363 YFQHG-KVSDKTDVYAFGVVLLELLTGR 389
              +  + +   D+++ G ++ E++TG+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 56  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 111
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 112 PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 163
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DFGLA  T              T  Y APE   
Sbjct: 164 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIML 215
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 28/224 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELM-----I 232
            +  G +LG+G    VF G     R  VAIK + +         S    C   +     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
            +   HP ++ L+ +    E  + ++ + +    L  ++ EK     G S        + 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS--------RC 143
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGL-ATWTSAPSVPFLCK 350
             G  + VA + +   R VVHRDIK  NIL+  ++   KL DFG  A     P   F   
Sbjct: 144 FFG--QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198
Query: 351 TVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
              GT  Y  PE+  +H   +    V++ G++L +++ G  P E
Sbjct: 199 --DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 40/224 (17%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI--ASSLHHPNIVPLV- 245
           ++GRG    V+KG   L    VA+K     ++++   F  E  I     + H NI   + 
Sbjct: 20  LIGRGRYGAVYKG--SLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV 74
Query: 246 ---GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                  D      L+ +Y   GSL ++L           T  W    ++A  +   +AY
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL--------SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 303 LHNGTER------CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV------PFLCK 350
           LH    R       + HRD+   N+L+ +     + DFGL+   +   +           
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 351 TVKGTFGYLAPEYFQHGKVS--------DKTDVYAFGVVLLELL 386
           +  GT  Y+APE  + G V+         + D+YA G++  E+ 
Sbjct: 187 SEVGTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 19/171 (11%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           +E+ I +   H NI+ L     +  + L +I++++SG  +   +          S    +
Sbjct: 50  KEISILNIARHRNILHLHE-SFESMEELVMIFEFISGLDIFERI--------NTSAFELN 100
Query: 288 VRYKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAP 343
            R  V+    + E++ +LH+     + H DI+P NI+  +++    K+ +FG A     P
Sbjct: 101 EREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-P 156
Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
              F  + +     Y APE  QH  VS  TD+++ G ++  LL+G  P  A
Sbjct: 157 GDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V   +  L    VAIK++    +   ++K   REL I     H NI+ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAESVAYLH 304
                        YV    +E  LH+       +S+ P +   VRY +   +   + Y+H
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQII-----HSSQPLTLEHVRYFL-YQLLRGLKYMH 175
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKGTFGYLAPE 362
           +     V+HRD+KPSN+L++     K+ DFG+A    TS     +       T  Y APE
Sbjct: 176 SAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 363 -YFQHGKVSDKTDVYAFGVVLLELLTGRK 390
                 + +   D+++ G +  E+L  R+
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 24/222 (10%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---------DKESSKAFCRELM 231
           +  +S    LG GA  FV+          V +K + KE         D +  K    E+ 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV-TLEIA 81
Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I S + H NI+ ++   I   QG F +     G  L+      +          +  R  
Sbjct: 82  ILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           V+     +V YL     + ++HRDIK  NI+++     KL DFG A +        L  T
Sbjct: 140 VS-----AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYT 188
Query: 352 VKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 392
             GT  Y APE          + ++++ GV L  L+    P 
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIV---- 242
            +G GA   V   +  L    VAIK++    +   ++K   REL I     H NI+    
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 243 ---PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGI 296
              P V +      G F    YV    +E  LH+       +S+ P +   VRY +   +
Sbjct: 122 ILRPTVPY------GEFKSV-YVVLDLMESDLHQII-----HSSQPLTLEHVRYFL-YQL 168
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 354
              + Y+H+     V+HRD+KPSN+L++     K+ DFG+A    TS     +       
Sbjct: 169 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 355 TFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGRK 390
           T  Y APE      + +   D+++ G +  E+L  R+
Sbjct: 226 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKAFCRELMIASSLHHPNIVPLVGFCID 250
           G++   F  K G     VA+K+L +  +    +K   REL +   + H N++ L+     
Sbjct: 36  GSVCAAFDTKTG---HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD-VFT 91
Query: 251 PEQGL-----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           P + L       +  ++ G  L          V+        V++ +   I   + Y+H+
Sbjct: 92  PARSLEEFNDVYLVTHLMGADL-------NNIVKCQKLTDDHVQFLI-YQILRGLKYIHS 143
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                ++HRD+KPSN+ ++     K+ DF LA  T      ++      T  Y APE   
Sbjct: 144 AD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV-----ATRWYRAPEIML 195
Query: 366 HGKVSDKT-DVYAFGVVLLELLTGR 389
           +    ++T D+++ G ++ ELLTGR
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 30/251 (11%)
Query: 182 HNFSKG------RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           H F  G      + LG G    VF          VAIK++   D +S K   RE+ I   
Sbjct: 5   HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVR 289
           L H NIV +  F I    G  L     S   L      + ++      V     L     
Sbjct: 65  LDHDNIVKV--FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122
Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAP----- 343
                 +   + Y+H+     V+HRD+KP+N+ ++++  + K+ DFGLA           
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 344 --SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
             S   + K  +     L+P  +     +   D++A G +  E+LTG+          + 
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 402 NLVLWAKPILH 412
            L+L + P++H
Sbjct: 235 QLILESIPVVH 245

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H ++V ++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             I  +   F     V    LE    + KK  R    L       +   +   V Y+H+ 
Sbjct: 120 IVIPKDVEKFDELYVV----LEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA 175
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
               ++HRD+KP+N L++     K+CDFGLA     P
Sbjct: 176 G---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 59/134 (44%), Gaps = 36/134 (26%)
Query: 311 VVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFL-----------CKTVK----- 353
           +VHRD+KPSN L + + K   L DFGLA  T    +  L           C   K     
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 354 ----------GTFGYLAPEYFQHGKVSDKT---DVYAFGVVLLELLTGRKPIEARRLQGE 400
                     GT G+ APE     K  ++T   D+++ GV+ L LL+GR P      +  
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLT--KCPNQTTAIDMWSAGVIFLSLLSGRYPF----YKAS 251
Query: 401 ENLVLWAKPILHRG 414
           ++L   A+ +  RG
Sbjct: 252 DDLTALAQIMTIRG 265

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 97/250 (38%), Gaps = 44/250 (17%)
Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           C  L I S   HPN++P++G C  P      LI  ++  GSL   LHE    V   S   
Sbjct: 58  CPRLRIFS---HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA- 113
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
                K AL +A  +A+LH        H         L+S+ +  + D  +    S   V
Sbjct: 114 ----VKFALDMARGMAFLHTLEPLIPRH--------ALNSRSV--MIDEDMTARISMADV 159
Query: 346 PFLCKTVKGTF--GYLAPEYFQHGKVSD----KTDVYAFGVVLLELLTGRKPIEARRLQG 399
            F  ++    +   ++APE  Q  K  D      D+++F V+L EL+T   P        
Sbjct: 160 KFSFQSPGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVP-----FAD 213
Query: 400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSXXXXXXXXXXXXCISSEESRRPGIEE 459
             N+ +        GM    E L P +                   C++ + ++RP  + 
Sbjct: 214 LSNMEI--------GMKVALEGLRPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDM 260
Query: 460 IIAILRGEEE 469
           I+ IL   ++
Sbjct: 261 IVPILEKMQD 270
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	520
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-104
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-100
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-100
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-43
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-43
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-41
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-40
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-37
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-32
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-28
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-27
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  314 bits (808), Expect = e-104
 Identities = 108/307 (35%), Positives = 168/307 (54%), Gaps = 26/307 (8%)

Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKA-FC 227
           R S  E+  A+ NFS   +LGRG    V+KG+   L   T VA+KRL +E  +  +  F 
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGR---LADGTLVAVKRLKEERTQGGELQFQ 75

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
            E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W 
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDWP 131

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA          
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----- 186

Query: 348 LCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE- 401
              T     V+GT G++APEY   GK S+KTDV+ +GV+LLEL+TG++  +  RL  ++ 
Sbjct: 187 -KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 402 -NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
             L+ W K +L      +E L+D  L+  +    ++ ++IQ A  C  S    RP + E+
Sbjct: 246 VMLLDWVKGLLKEKK--LEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 461 IAILRGE 467
           + +L G+
Sbjct: 303 VRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  305 bits (783), Expect = e-100
 Identities = 99/317 (31%), Positives = 157/317 (49%), Gaps = 25/317 (7%)

Query: 161 SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKE 218
           S   V     R+   ++  AT+NF    ++G G    V+KG +  G     VA+KR   E
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPE 74

Query: 219 DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV 278
             +  + F  E+   S   HP++V L+GFC +  + + LIYKY+  G+L+RHL+      
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILIYKYMENGNLKRHLYGSDLPT 133

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               ++ W  R ++ +G A  + YLH      ++HRD+K  NILL    +PK+ DFG++ 
Sbjct: 134 ---MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 339 WTSAPSVPFLCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE 393
                    L +T     VKGT GY+ PEYF  G++++K+DVY+FGVVL E+L  R  I 
Sbjct: 188 -----KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

Query: 394 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR 453
               +   NL  WA    + G   +E+++DP L         + +    A  C++     
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQ--LEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSED 299

Query: 454 RPGIEEIIAILRGEEEL 470
           RP + +++  L     L
Sbjct: 300 RPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  302 bits (777), Expect = e-100
 Identities = 92/321 (28%), Positives = 156/321 (48%), Gaps = 36/321 (11%)

Query: 159 ERSISPVANSLIRLSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAI 212
            +S+          S+ E+   T+NF +      G  +G G    V+KG V    T+VA+
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAV 59

Query: 213 KRLDKEDKESS----KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           K+L      ++    + F +E+ + +   H N+V L+GF  D +    L+Y Y+  GSL 
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLL 118

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L      + G   L W +R K+A G A  + +LH   E   +HRDIK +NILL     
Sbjct: 119 DRLS----CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFT 171

Query: 329 PKLCDFGLATWTSAPSVPFLCKT-----VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLL 383
            K+ DFGLA            +T     + GT  Y+APE    G+++ K+D+Y+FGVVLL
Sbjct: 172 AKISDFGLARA-----SEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225

Query: 384 ELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAA 443
           E++TG   ++  R    + L+   + I       +E+ +D ++      S +   +   A
Sbjct: 226 EIITGLPAVDEHR--EPQLLLDIKEEIEDEEK-TIEDYIDKKMNDADSTSVE--AMYSVA 280

Query: 444 AACISSEESRRPGIEEIIAIL 464
           + C+  ++++RP I+++  +L
Sbjct: 281 SQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  218 bits (556), Expect = 6e-67
 Identities = 68/316 (21%), Positives = 112/316 (35%), Gaps = 29/316 (9%)

Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF 226
           +S + L    +   +       V  RG    V+K ++      VA+K    +D + S   
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQN 65

Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             E+     + H NI+  +G           L+LI  +   GSL   L          + 
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--------ANV 117

Query: 284 LPWSVRYKVALGIAESVAYLHNGTER-------CVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + W+    +A  +A  +AYLH             + HRDIK  N+LL +     + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----KVSDKTDVYAFGVVLLELLTGRKP 391
           A    A           GT  Y+APE  +           + D+YA G+VL EL +    
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 392 IEARRLQGEENL--VLWAKPILHRGMAAV-EELLDPRLKCTSRNSAQIARVIQAAAACIS 448
            +    +        +   P L      V  +   P L+   +  A +A + +    C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 449 SEESRRPGIEEIIAIL 464
            +   R     +   +
Sbjct: 298 HDAEARLSAGCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (526), Expect = 9e-63
 Identities = 89/280 (31%), Positives = 135/280 (48%), Gaps = 34/280 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
             V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G
Sbjct: 13  EEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C++P   + L+ +Y  GGSL   LH  +           +      L  ++ VAYLH+ 
Sbjct: 69  ACLNP---VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
             + ++HRD+KP N+LL +   + K+CDFG A               KG+  ++APE F+
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFE 176

Query: 366 HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPR 425
               S+K DV+++G++L E++T RKP         + +   A  I    M AV      R
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPF--------DEIGGPAFRI----MWAVHN--GTR 222

Query: 426 LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                     I  ++     C S + S+RP +EEI+ I+ 
Sbjct: 223 PPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  198 bits (505), Expect = 8e-60
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 47/294 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMIASSLHHP 239
            + +G+G    V KG++   ++ VAIK L   D E         + F RE+ I S+L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L G   +P     ++ ++V  G L   L +K         + WSV+ ++ L IA  
Sbjct: 84  NIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALG 134

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           + Y+ N     +VHRD++  NI L S         K+ DFGL+  +           + G
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLG 188

Query: 355 TFGYLAPEYF--QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPIL 411
            F ++APE    +    ++K D Y+F ++L  +LTG  P +           + +   I 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIR 243

Query: 412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
             G+         R         ++  VI+    C S +  +RP    I+  L 
Sbjct: 244 EEGL---------RPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (504), Expect = 2e-59
 Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 32/282 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
              +G G+   V + +     + VA+K L ++D   E    F RE+ I   L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G    P   L ++ +Y+S GSL R LH+          L    R  +A  +A+ + YLH
Sbjct: 100 MGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH 154

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
           N     +VHR++K  N+L+  K   K+CDFGL+   +  S     K+  GT  ++APE  
Sbjct: 155 NRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVL 211

Query: 365 QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPILHRGMAAVEELLD 423
           +    ++K+DVY+FGV+L EL T ++P             V+ A  +  +          
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWG-----NLNPAQVVAA--VGFKCK-------- 256

Query: 424 PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            RL+     + Q+A +I+    C ++E  +RP    I+ +LR
Sbjct: 257 -RLEIPRNLNPQVAAIIEG---CWTNEPWKRPSFATIMDLLR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  194 bits (496), Expect = 1e-58
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 47/292 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKESSKAFCRELMIASSLHHPNIV 242
             ++G G    V++     +   VA+K      D++  ++ +   +E  + + L HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G C+     L L+ ++  GG L R L  K+        +P  +    A+ IA  + Y
Sbjct: 70  ALRGVCLKEPN-LCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIARGMNY 120

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLATWTSAPSVPFLCKTVKG 354
           LH+     ++HRD+K SNIL+  K           K+ DFGLA      +      +  G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAG 176

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPILHR 413
            + ++APE  +    S  +DV+++GV+L ELLTG  P       G + L V +   +   
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-----GIDGLAVAYG--VAMN 229

Query: 414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            +          L   S      A++++    C + +   RP    I+  L 
Sbjct: 230 KL---------ALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  191 bits (488), Expect = 1e-57
 Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 41/286 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
              L       ++KG+       + +K L   D     S+ F  E        HPN++P+
Sbjct: 15  LTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 245 VGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           +G C  P      LI  ++  GSL   LHE       N  +  S   K AL +A  +A+L
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFL 127

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEY 363
           H   E  +    +   ++++      ++    +          F          ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 364 FQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-PILHRGMAAVE 419
            Q           D+++F V+L EL+T   P              +A    +  GM    
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--------------FADLSNMEIGMKVAL 225

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           E L  R       S  ++++++    C++ + ++RP  + I+ IL 
Sbjct: 226 EGL--RPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (481), Expect = 6e-56
 Identities = 65/294 (22%), Positives = 121/294 (41%), Gaps = 48/294 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
           G ++G+G    V+ G+       VAI+ +D E   ++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C+ P   L +I     G +L   + + K        L  +   ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQIAQEIVKGMGYLH 147

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WTSAPSVPFLCKTVKGTFGYLAP 361
               + ++H+D+K  N+   + K+  + DFGL +      A       +   G   +LAP
Sbjct: 148 A---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 362 EYFQHGKV---------SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL-VLWAKPIL 411
           E  +             S  +DV+A G +  EL     P +      +    ++W    +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-----TQPAEAIIWQ---M 255

Query: 412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
             GM    +    ++        +I+ ++     C + E+  RP   +++ +L 
Sbjct: 256 GTGM----KPNLSQIGM----GKEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 7e-56
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 37/286 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L       +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +                +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLH 137

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE-- 362
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++APE  
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 363 -YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL--VLWAKPILHRGMAAVE 419
                   S ++DVYAFG+VL EL+TG+ P          N   ++     + RG     
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIEM---VGRG----- 241

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            L     K  S    ++ R++     C+  +   RP    I+A + 
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  183 bits (467), Expect = 4e-54
 Identities = 72/327 (22%), Positives = 118/327 (36%), Gaps = 48/327 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH  
Sbjct: 75  VLYKDKR-LNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLH-- 125

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------------TWTSAPSVPFLCKTVKG 354
               ++HRD+   N L+   K   + DFGLA              +          TV G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG 414
              ++APE        +K DV++FG+VL E++                       +    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------DPDYLPRTM 230

Query: 415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCT 474
              +         C          +      C   +  +RP   ++   L   E L    
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITV---RCCDLDPEKRPSFVKLEHWL---ETLR--- 281

Query: 475 WKKHNFSGIIDCYPQLQQTKSEMKSHL 501
               + +G +   PQL+Q         
Sbjct: 282 ---MHLAGHLPLGPQLEQLDRGFWETY 305

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (445), Expect = 2e-50
 Identities = 60/326 (18%), Positives = 107/326 (32%), Gaps = 44/326 (13%)

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           +  +  E      N     ++GRG    V+KG   L    VA+K     ++++   F  E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQN---FINE 55

Query: 230 LMIA--SSLHHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             I     + H NI   +               L+ +Y   GSL ++L           T
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------T 107

Query: 284 LPWSVRYKVALGIAESVAYLHN------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             W    ++A  +   +AYLH         +  + HRD+   N+L+ +     + DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 338 ------TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLE 384
                              +  GT  Y+APE  +             + D+YA G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 385 LLTGRKPIEARRLQGEENL----VLWAKPILHRGMAAV-EELLDPRL-KCTSRNSAQIAR 438
           +      +       E  +     +   P        V  E   P+  +    NS  +  
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 439 VIQAAAACISSEESRRPGIEEIIAIL 464
           + +    C   +   R   +     +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERM 313

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 1e-47
 Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 33/299 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 244
            + +G+G    V+ GK       VA+K     ++ S   + RE  I     + H NI+  
Sbjct: 42  VKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGF 96

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +   I        L+LI  Y   GSL  +L         ++TL      K+A      + 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLC 148

Query: 302 YLHNGTER-----CVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVK-G 354
           +LH           + HRD+K  NIL+       + D GLA  + S  +   +    + G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 355 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIE-ARRLQGEENLVLWA 407
           T  Y+ PE         H +     D+Y+FG++L E+             Q   + ++ +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268

Query: 408 KPILHRGMAAV-EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            P        V  + L P       +   + ++ +    C +   + R     +   L 
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  160 bits (407), Expect = 2e-45
 Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 31/223 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE--LMIASSLHHPNIVPL 244
              +G+G    V++G       +VA+K     D++S   + RE  L     L H NI+  
Sbjct: 13  LECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGF 67

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +   +        L+LI  Y   GSL  +L           TL      ++ L IA  +A
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--------TLDTVSCLRIVLSIASGLA 119

Query: 302 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 354
           +LH           + HRD+K  NIL+       + D GLA     S   +        G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 355 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  Y+APE               + D++AFG+VL E+      
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (397), Expect = 1e-43
 Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 31/223 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 244
              +G+G    V++GK       VA+K     ++ S   + RE  I     L H NI+  
Sbjct: 47  QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGF 101

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +            L+L+  Y   GSL  +L+          T+      K+AL  A  +A
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLA 153

Query: 302 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 354
           +LH           + HRD+K  NIL+       + D GLA    ++  ++        G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 355 TFGYLAPE------YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  Y+APE        +H +   + D+YA G+V  E+      
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  154 bits (390), Expect = 8e-43
 Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 19/232 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            ++   + LG G  S+V   +        A+KR+   +++  +   RE  +    +HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 242 VPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           + LV +C+         +L+  +   G+L   +   ++     + L       + LGI  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICR 145

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVK---- 353
            +  +H    +   HRD+KP+NILL  +  P L D G                T++    
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 354 --GTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
              T  Y APE F    H  + ++TDV++ G VL  ++ G  P +    +G+
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (376), Expect = 6e-41
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            R++GRG +  V++ +  +    VA+K + +    D        RE   A  L  P++VP
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 244 L--VGFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +   G     E    L++  + ++G  L   L       +G    P +V   +   I  +
Sbjct: 99  IHDFG-----EIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVA--IVRQIGSA 146

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT----VKGT 355
           +   H        HRD+KP NIL+S+     L DFG+A+ T+   +     T      GT
Sbjct: 147 LDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNTVGT 198

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             Y+APE F     + + D+YA   VL E LTG  P
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  153 bits (387), Expect = 5e-40
 Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 47/285 (16%)

Query: 187 GRVLGRGALSFVFKGK-VGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 244
              +  G L +++      +    V +K L    D E+      E    + + HP+IV +
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 245 VGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             F    ++      +++ +YV G SL+R   +K         LP +      L I  ++
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---------LPVAEAIAYLLEILPAL 195

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +YLH      +V+ D+KP NI+L+ +++ KL D G  +  ++         + GT G+ A
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFG------YLYGTPGFQA 245

Query: 361 PEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG--EENLVLWAKPILHRGMAA 417
           PE        +  TD+Y  G  L  L         R + G  E++ VL           +
Sbjct: 246 PE--IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD-------S 296

Query: 418 VEELLDPRLKCTSRN------SAQ-IARVIQAAAACISSEESRRP 455
              LL    +    +      +A+ ++  +      + ++++  P
Sbjct: 297 YGRLL---RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  144 bits (366), Expect = 1e-39
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
              LG G +S V+  +  +L   VAIK +       +E+ K F RE+  +S L H NIV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 244 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +  V      E    +L+ +Y+ G +L  ++            L           I + +
Sbjct: 76  MIDVDE----EDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGI 124

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            + H   +  +VHRDIKP NIL+ S K  K+ DFG+A   S  S+      V GT  Y +
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFS 180

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE  +     + TD+Y+ G+VL E+L G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (363), Expect = 2e-39
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 12/223 (5%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++     +G G+     K +       +  K LD     + E       E+ +   L HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHP 65

Query: 240 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           NIV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 299 SVAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           ++   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +     KT  GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTP 180

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
            Y++PE       ++K+D+++ G +L EL     P  A   + 
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  143 bits (364), Expect = 4e-39
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 244 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +   G    P   L +++ +YV G +L   +H +         +      +V     +++
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 301 AYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFG 357
            + H NG    ++HRD+KP+NI++S+    K+ DFG+A   +      + +T  V GT  
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS-VTQTAAVIGTAQ 184

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           YL+PE  +   V  ++DVY+ G VL E+LTG  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (362), Expect = 6e-39
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 12/212 (5%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+  + L ++ +    G L R +   KK       +P    +K  + +  +
Sbjct: 93  NVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSA 148

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + ++H    R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT  Y+
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 203

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +PE       + K+D+++ G +L E+   + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (363), Expect = 1e-38
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 15/220 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
            + + + +G G+       K         IK ++      KE  ++  RE+ + +++ HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHP 83

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV       +    L+++  Y  GG L + ++ +K                  + I  +
Sbjct: 84  NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLA 137

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + ++H   +R ++HRDIK  NI L+     +L DFG+A   ++     L +   GT  YL
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYL 192

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
           +PE  ++   ++K+D++A G VL EL T +   EA  ++ 
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  142 bits (359), Expect = 2e-38
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 87  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 137

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT  
Sbjct: 138 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 358 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 391
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (354), Expect = 2e-37
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 68  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 118

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT  
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 358 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 391
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  138 bits (349), Expect = 2e-37
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 25/224 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  G +LG+G  SF     V           VAIK +DK+    +        E+ I  
Sbjct: 12  DFKVGNLLGKG--SF---AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HP+I+ L  +  D    ++L+ +    G + R+L  + K            R+ +  
Sbjct: 67  QLKHPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFS-----ENEARHFMH- 119

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I   + YLH      ++HRD+  SN+LL+     K+ DFGLAT    P       T+ G
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCG 174

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
           T  Y++PE         ++DV++ G +   LL GR P +   ++
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (348), Expect = 3e-37
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 30/224 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  IKR+   ++++     RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67

Query: 243 PLVGFCIDPEQG---------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
              G     +                 LF+  ++   G+LE+ + +++        L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKV 122

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           +  ++   I + V Y+H    + +++RD+KPSNI L   K  K+ DFGL T         
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--- 176

Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                KGT  Y++PE         + D+YA G++L ELL     
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (352), Expect = 7e-37
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 29/225 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 115 SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 165

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  G   
Sbjct: 166 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 358 YLAPEYFQ-----------HGKVSDKTDVYAFGVVLLELLTGRKP 391
           Y+ PE  +             K+S K+DV++ G +L  +  G+ P
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (345), Expect = 1e-36
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 35/233 (15%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
             +F +  VLG+GA   V K +  L     AIK++   +++ S     E+M+ +SL+H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQY 63

Query: 241 IVPLVGFCIDPEQG------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           +V      ++                LF+  +Y   G+L   +H +    + +       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---------- 338
           +      I E+++Y+H    + ++HRD+KP NI +   +  K+ DFGLA           
Sbjct: 124 Q------ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174

Query: 339 --WTSAPSVPFLCKTVKGTFGYLAPEYFQ-HGKVSDKTDVYAFGVVLLELLTG 388
               + P       +  GT  Y+A E     G  ++K D+Y+ G++  E++  
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  137 bits (347), Expect = 1e-36
 Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 25/233 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPN 240
                 RVL  G  +FV++ +        A+KRL   ++E ++A  +E+     L  HPN
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 241 IVPLVGFCI------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           IV             D  Q  FL+   +  G L   L + +        L      K+  
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP----LSCDTVLKIFY 143

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK---- 350
               +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT  S             
Sbjct: 144 QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 351 ------TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                 T   T  Y  PE    + +  + +K D++A G +L  L   + P E 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (344), Expect = 2e-36
 Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 50/302 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 241
           +F   + LGRG    VF+ K  +   + AIKR+   ++E ++    RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 242 VPLVGFCID-----------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           V      ++           P+  L++  +     +L+  ++ +            SV  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCL 121

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---------WTS 341
            + L IAE+V +LH    + ++HRD+KPSNI  +   + K+ DFGL T            
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 342 APSVPFLCKTVK-GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
            P   +   T + GT  Y++PE       S K D+++ G++L ELL    P         
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QM 231

Query: 401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
           E +              V  L  P L   ++       ++Q     +S     RP    I
Sbjct: 232 ERVRTLTD---------VRNLKFPPLF--TQKYPCEYVMVQ---DMLSPSPMERPEAINI 277

Query: 461 IA 462
           I 
Sbjct: 278 IE 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (341), Expect = 3e-36
 Identities = 70/221 (31%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRT-----SVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  GR LG+G   F   G V L R       +A+K L K   E +       RE+ I S
Sbjct: 10  DFEIGRPLGKG--KF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HPNI+ L G+  D  + ++LI +Y   G++ R L +  K                  
Sbjct: 65  HLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYIT 116

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            +A +++Y H    + V+HRDIKP N+LL S    K+ DFG     S  +       + G
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCG 169

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           T  YL PE  +     +K D+++ GV+  E L G+ P EA 
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  136 bits (344), Expect = 3e-36
 Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 18/221 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHH 238
             + +GR LG+G  +  F+      +   A K + K              E+ I  SL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIA 297
            ++V   G   +    +F++ +     SL      +K        L     RY +   I 
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIV 151

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
               YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT  
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPN 206

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
           Y+APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  141 bits (357), Expect = 3e-36
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 24/237 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 241
            +     LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V           + P     L  +Y  GG L ++L++ +        L       +   I
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDI 130

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 353
           + ++ YLH   E  ++HRD+KP NI+L       I K+ D G A          LC    
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
           GT  YLAPE  +  K +   D ++FG +  E +TG +P            V W   +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHGKV 236

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  135 bits (341), Expect = 4e-36
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 18/220 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 239
            + +GR LG+G  +  F+      +   A K + K              E+ I  SL H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAE 298
           ++V   G   +    +F++ +     SL      +K        L     RY +   I  
Sbjct: 76  HVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIVL 126

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
              YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT  Y
Sbjct: 127 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNY 181

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
           +APE       S + DV++ G ++  LL G+ P E   L+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 9e-36
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 19/212 (8%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVP 243
               +GRG+   V+KG        VA    +  K  K   + F  E  +   L HPNIV 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 244 LVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                    +G   + L+ + ++ G+L+ +L   K        +   V       I + +
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGL 142

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
            +LH      ++HRD+K  NI ++      K+ D GLAT   A       K V GT  ++
Sbjct: 143 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFM 197

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           APE ++     +  DVYAFG+ +LE+ T   P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 1e-35
 Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 23/242 (9%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
            + ++ E   SP  +     S+ +      +F +   LG G+   VFK +        A+
Sbjct: 33  FRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87

Query: 213 KRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           KR        K+ ++             HP  V L     +    L+L  +   G SL++
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQTEL-CGPSLQQ 145

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
           H   +  G      LP +  +        ++A+LH    + +VH D+KP+NI L  +   
Sbjct: 146 HC--EAWGAS----LPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRC 196

Query: 330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           KL DFGL             +  +G   Y+APE  Q G      DV++ G+ +LE+    
Sbjct: 197 KLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252

Query: 390 KP 391
           + 
Sbjct: 253 EL 254

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (339), Expect = 1e-35
 Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 24/224 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 240
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 241 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

Query: 356 FGYLAPEYFQHGKVSD--------KTDVYAFGVVLLELLTGRKP 391
             YL P+ ++   +            D+++ GV      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  133 bits (336), Expect = 2e-35
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 30/222 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  GR LG+G   F   G V L R       +A+K L K   E         RE+ I S
Sbjct: 15  DFDIGRPLGKG--KF---GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVA 293
            L HPNI+ +  +  D ++ ++L+ ++   G L + L +  +                + 
Sbjct: 70  HLRHPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGR-------FDEQRSATFME 121

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
             +A+++ Y H   ER V+HRDIKP N+L+  K   K+ DFG     S  +     +T+ 
Sbjct: 122 E-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRRTMC 173

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           GT  YL PE  +     +K D++  GV+  E L G  P ++ 
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (339), Expect = 2e-35
 Identities = 51/232 (21%), Positives = 96/232 (41%), Gaps = 35/232 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKAFC------------ 227
           ++   R L +G   F    K+ L        A+K+ +K   E  + F             
Sbjct: 32  DYRIIRTLNQG--KF---NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 228 -----RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRGN 281
                 EL I + + +   +   G   + ++ +++IY+Y+   S+ +             
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG + +  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
                   K  +GT+ ++ PE+F +    +  K D+++ G+ L  +     P
Sbjct: 204 DK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  134 bits (337), Expect = 5e-35
 Identities = 40/365 (10%), Positives = 81/365 (22%), Gaps = 55/365 (15%)

Query: 139 ENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 198
             G C   A +     ++++  ++ P        S   +            L  G  S V
Sbjct: 21  LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVV 78

Query: 199 FKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPNIV------------- 242
           F  +        A+K      + S    +        A+ L   +               
Sbjct: 79  FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138

Query: 243 -------PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                  P        +         L+    S   LE                     +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFRGDEGILALH 197

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +   +    A L     + +VH    P N+ +       L D                 
Sbjct: 198 ILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGP 249

Query: 351 TVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
                  Y   E+        +   + +  G+ +  +     P        +        
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG------- 302

Query: 409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA---ILR 465
               R    V           +     +  +I      ++ +  RR    E +     L+
Sbjct: 303 -SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMETPEFLQ 358

Query: 466 GEEEL 470
            + E+
Sbjct: 359 LQNEI 363

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (336), Expect = 1e-34
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +   G  +GRG    VF G++    T VA+K   +E    +    F +E  I     HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPN 173

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C   +Q ++++ + V GG     L  +         L      ++    A  +
Sbjct: 174 IVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTEGA------RLRVKTLLQMVGDAAAGM 226

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVPFLCKT 351
            YL     +C +HRD+   N L++ K + K+ DFG++                VP     
Sbjct: 227 EYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP----- 278

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           VK T    APE   +G+ S ++DV++FG++L E  + G  P
Sbjct: 279 VKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (332), Expect = 5e-34
 Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 24/224 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 240
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 241 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

Query: 356 FGYLAPEYFQHGKVSD--------KTDVYAFGVVLLELLTGRKP 391
             YL P+ ++   +            D+++ GV      TG  P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  133 bits (336), Expect = 6e-34
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 27/268 (10%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           R+    +  +       I    G +   +  + + + LG GA   V   +  +     AI
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 213 KRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERH 270
           K + K      S+     E+ +   L HPNI+ L  F  D ++  +L+ +   GG L   
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKGGELFDE 126

Query: 271 LHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK- 327
           +  + K         ++      +   +   V YLH   +  +VHRD+KP N+LL SK+ 
Sbjct: 127 IIHRMK---------FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174

Query: 328 --IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
             + K+ DFGL+            K   GT  Y+APE  +  K  +K DV++ GV+L  L
Sbjct: 175 DALIKIVDFGLSAVFE-NQKKM--KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230

Query: 386 LTGRKPIEARRLQGEENLVLWAKPILHR 413
           L G  P   +  Q     V   K     
Sbjct: 231 LAGYPPFGGQTDQEILRKVEKGKYTFDS 258

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (327), Expect = 6e-34
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 37/226 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
             F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + 
Sbjct: 74  VDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVP 346
           IA+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA                VP
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                +K      A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 183 -----IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  132 bits (334), Expect = 1e-33
 Identities = 68/265 (25%), Positives = 111/265 (41%), Gaps = 28/265 (10%)

Query: 157 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
           S+   +       ++ S       +  +   RVLG+G+   V   K  +     A+K + 
Sbjct: 4   SMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60

Query: 217 K---EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE 273
           K   + K   ++  RE+ +   L HPNI+ L  F  D     +L+ +  +GG L   +  
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIIS 119

Query: 274 KKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I 328
           +K+         +S     ++   +   + Y+H   +  +VHRD+KP N+LL SK     
Sbjct: 120 RKR---------FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167

Query: 329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 388
            ++ DFGL+T     S     K   GT  Y+APE    G   +K DV++ GV+L  LL+G
Sbjct: 168 IRIIDFGLSTHFE-ASKKM--KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

Query: 389 RKPIEARRLQGEENLVLWAKPILHR 413
             P            V   K     
Sbjct: 224 CPPFNGANEYDILKKVEKGKYTFEL 248

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (323), Expect = 1e-33
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 13/209 (6%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
              VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G   +    + +  + V GGSL   L  K   ++ N      +       I E + YLH 
Sbjct: 86  GSFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLH- 139

Query: 306 GTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF 364
             +  +VHRDIK  N+L+++   + K+ DFG +   +  +     +T  GT  Y+APE  
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195

Query: 365 QHGKV--SDKTDVYAFGVVLLELLTGRKP 391
             G        D+++ G  ++E+ TG+ P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (318), Expect = 5e-33
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 26  LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGYLAPE 362
                VHRD+   N+L+S   + K+ DFGL     +      +P     VK T    APE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWT----APE 184

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +  K S K+DV++FG++L E+ + GR P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (318), Expect = 1e-32
 Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 20/243 (8%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           R     E +   +    ++    E     H  +    +GRG+   V + K        A+
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 213 KRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 272
           K++  E          EL+  + L  P IVPL G   +    + +  + + GGSL + + 
Sbjct: 89  KKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPW-VNIFMELLEGGSLGQLI- 141

Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KL 331
            K+ G      LP            E + YLH    R ++H D+K  N+LLSS      L
Sbjct: 142 -KQMG-----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAAL 192

Query: 332 CDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG 388
           CDFG A                 + GT  ++APE         K D+++   ++L +L G
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

Query: 389 RKP 391
             P
Sbjct: 253 CHP 255

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  128 bits (323), Expect = 1e-32
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 27/220 (12%)

Query: 183 NFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPN 240
           +F    VLG GA  + V++G        VA+KR+  E    +    RE+ +   S  HPN
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFAD---REVQLLRESDEHPN 79

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           ++       D  Q  ++  +     +L+ ++ +K     G   +       +       +
Sbjct: 80  VIRYFCTEKD-RQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI------TLLQQTTSGL 131

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFGLATWTSAPSVPFLC-KTVKG 354
           A+LH      +VHRD+KP NIL+S           + DFGL    +     F     V G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 355 TFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           T G++APE          +   D+++ G V   +++    
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (320), Expect = 2e-32
 Identities = 32/271 (11%), Positives = 67/271 (24%), Gaps = 45/271 (16%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL---- 236
             +G VLG+       +        S  +      ++  S   K    E++    L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 237 ---------------------HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
                                    ++ +     D               +L+       
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                + +L    R ++ L +   +A LH      +VH  ++P +I+L  +    L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 336 LATWTSAPSVPFLCKTVKGTFGYLAPE-----YFQHGKVSDKTDVYAFGVVLLELLTGRK 390
                 A +V              A             ++   D +  G+ +  +     
Sbjct: 257 HLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 391 PIEARRLQGEENLVL--------WAKPILHR 413
           P       G    +           + +L  
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  123 bits (312), Expect = 2e-32
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
              +  + +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L G C++ +  + L+ +++  G L  +L  +    RG       +     L + E +A
Sbjct: 66  VQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGM--CLDVCEGMA 118

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 353
           YL    E CV+HRD+   N L+   ++ K+ DFG+         T ++    P     VK
Sbjct: 119 YL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VK 170

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                 +PE F   + S K+DV++FGV++ E+ + G+ P
Sbjct: 171 WA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  124 bits (313), Expect = 6e-32
 Identities = 73/300 (24%), Positives = 110/300 (36%), Gaps = 39/300 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +      LG+G    V   +   L       VA+K+L     +  + F RE+ I  +LH
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
              IV   G    P  Q L L+ +Y+  G L   L   +  +  +  L +      +  I
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQI 136

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 346
            + + YL     R  VHRD+   NIL+ S+   K+ DFGLA                  P
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVL 405
                +       APE       S ++DV++FGVVL EL T   K               
Sbjct: 194 -----IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
              P L R +  +EE    RL       A++  +++    C +     RP    +   L 
Sbjct: 245 RDVPALSRLLELLEE--GQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLD 299

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  126 bits (318), Expect = 9e-32
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLE-- 306

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA----TWTSAPSVPFLCKTVKGTFGYLAPE 362
                VHRD+   N+L+S   + K+ DFGL     +      +P     VK T    APE
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWT----APE 356

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +  K S K+DV++FG++L E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (311), Expect = 1e-31
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
            F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S+
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 74

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + I
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 126

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW---------TSAPSVPF 347
           A+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA                VP 
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP- 182

Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               +K      A E   H   + ++DV+++GV + EL+T G KP
Sbjct: 183 ----IKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (312), Expect = 1e-31
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 15/212 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F K   LG G    VFK         +A K +  E K +      REL +    + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G     +  + +  +++ GGSL++ L +          +P  +  KV++ + + + Y
Sbjct: 95  GFYG-AFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTY 146

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT  Y++PE
Sbjct: 147 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPE 200

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
             Q    S ++D+++ G+ L+E+  GR PI  
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  126 bits (318), Expect = 2e-31
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 46/269 (17%)

Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------- 217
              +R   G+I     ++ K R LG GA   V   K     +  AIK + K         
Sbjct: 24  GMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80

Query: 218 ----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER--- 269
                 ++  +    E+ +  SL HPNI+ L     D ++  +L+ ++  GG L E+   
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIIN 139

Query: 270 --HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                E                  +   I   + YLH   +  +VHRDIKP NILL +K 
Sbjct: 140 RHKFDECDAA-------------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKN 183

Query: 328 ---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE 384
                K+ DFGL+++ S        +   GT  Y+APE  +  K ++K DV++ GV++  
Sbjct: 184 SLLNIKIVDFGLSSFFS-KDYKL--RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYI 239

Query: 385 LLTGRKPIEARRLQGEENLVLWAKPILHR 413
           LL G  P   +  Q     V   K     
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  121 bits (306), Expect = 2e-31
 Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 30/236 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 247 FCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
              D    ++L+ +  +GG L ER        E                 ++   +  +V
Sbjct: 74  TFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAA-------------RIMKDVLSAV 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           AY H   +  V HRD+KP N L  +       KL DFGLA     P      +T  GT  
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMM--RTKVGTPY 173

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 413
           Y++P+  + G    + D ++ GV++  LL G  P  A         +         
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  121 bits (306), Expect = 3e-31
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +    LG G    V++G       +VA+K L KED    + F +E  +   + HPN+
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+G C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ 
Sbjct: 72  VQLLGVCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAME 125

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 353
           YL    ++  +HRD+   N L+    + K+ DFGL+        T  +    P     +K
Sbjct: 126 YL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-----IK 177

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            T    APE   + K S K+DV+AFGV+L E+ T G  P
Sbjct: 178 WT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (315), Expect = 4e-31
 Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 32/244 (13%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH 238
              ++   +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 292
           PNI+ L     D     +++ +  +GG L +         E                 ++
Sbjct: 81  PNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RI 126

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLC 349
              +   + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T     +     
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM-- 180

Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 409
           K   GT  Y+APE  + G   +K DV++ GV+L  LL+G  P   +        V   K 
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 410 ILHR 413
               
Sbjct: 240 AFDL 243

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  123 bits (309), Expect = 4e-31
 Identities = 34/264 (12%), Positives = 68/264 (25%), Gaps = 48/264 (18%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--------------- 225
                +G VLG+       +        S  +      ++  S A               
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 226 -------------FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 272
                        F     +        ++ +     D               +L+    
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
                   + +L    R ++ L +   +A LH+     +VH  ++P +I+L  +    L 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVV 381
            F       A            + G+  PE                 ++   D +A G+V
Sbjct: 249 GFEHLVRDGARV------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 382 LLELLTGRKPIEARRLQGEENLVL 405
           +  +     PI      G    + 
Sbjct: 303 IYWIWCADLPITKDAALGGSEWIF 326

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  122 bits (307), Expect = 4e-31
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
               K +VLG G    V KG        ++  V IK + ++   ++S +A    ++   S
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W       + 
Sbjct: 72  LDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQ 123

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVP 346
           IA+ + YL    E  +VHR++   N+LL S    ++ DFG+A            S    P
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                +K      A E    GK + ++DV+++GV + EL+T G +P
Sbjct: 181 -----IKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  121 bits (305), Expect = 5e-31
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 18/213 (8%)

Query: 187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            RV+G+G    V+ G+           AIK L       +  +AF RE ++   L+HPN+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L+G  + PE    ++  Y+  G L + +       + N T+   + +   L +A  + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISF--GLQVARGME 138

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF--GYL 359
           YL    E+  VHRD+   N +L      K+ DFGLA          + +         + 
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           A E  Q  + + K+DV++FGV+L ELLT G  P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (314), Expect = 5e-31
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ YL   
Sbjct: 284 VCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLE-- 335

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 360
            ++  +HR++   N L+    + K+ DFGL+      T+T+     F    +K T    A
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWT----A 387

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE   + K S K+DV+AFGV+L E+ T G  P
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (302), Expect = 6e-31
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 34/221 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
              +  + LG G    V  GK    +    VA+K + KE   S   F +E      L HP
Sbjct: 8   EEITLLKELGSGQFGVVKLGK---WKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHP 63

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V   G C   E  ++++ +Y+S G L  +L    KG+         +       + E 
Sbjct: 64  KLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEM--CYDVCEG 116

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKT 351
           +A+L        +HRD+   N L+      K+ DFG+           +     P     
Sbjct: 117 MAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP----- 168

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           VK +    APE F + K S K+DV+AFG+++ E+ + G+ P
Sbjct: 169 VKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 6e-31
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESS----KAFCRELMIASS 235
           +      LG G+   V +G+         SVA+K L K D  S       F RE+    S
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS 77

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H N++ L G  +     + ++ +    GSL   L + +    G+  L    RY  A+ 
Sbjct: 78  LDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQ 129

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSV 345
           +AE + YL     +  +HRD+   N+LL+++ + K+ DFGL                  V
Sbjct: 130 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           P             APE  +    S  +D + FGV L E+ T G++P
Sbjct: 187 P-----FAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (302), Expect = 9e-31
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +  + LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L G C   ++ +F+I +Y++ G L  +L E     R        +       + E++ 
Sbjct: 82  VQLYGVCTK-QRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEM--CKDVCEAME 134

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVK 353
           YL     +  +HRD+   N L++ + + K+ DFGL+        T +     P     V+
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VR 186

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            +     PE   + K S K+D++AFGV++ E+ + G+ P
Sbjct: 187 WS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  119 bits (302), Expect = 1e-30
 Identities = 65/215 (30%), Positives = 87/215 (40%), Gaps = 32/215 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
             VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 247 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                    +L+ + VSGG L     ER    EK                 V   +  +V
Sbjct: 74  IYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDAS-------------LVIQQVLSAV 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            YLH   E  +VHRD+KP N+L  +     KI  + DFGL+          +  T  GT 
Sbjct: 120 KYLH---ENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKMEQ----NGIMSTACGTP 171

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GY+APE       S   D ++ GV+   LL G  P
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (301), Expect = 1e-30
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 183 NFSKGRVLGRGALSFVFKGK-------VGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           +      LG+G  + +FKG          L  T V +K LDK  +  S++F     + S 
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H ++V   G C+       L+ ++V  GSL+ +L +     +    + W +    A  
Sbjct: 69  LSHKHLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEV--AKQ 121

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLATWTSAPSVPF 347
           +A ++ +L    E  ++H ++   NILL  ++          KL D G++          
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------- 168

Query: 348 LCKTVKGTFGY------LAPEYFQHGKV-SDKTDVYAFGVVLLELLT-GRKP 391
              TV            + PE  ++ K  +  TD ++FG  L E+ + G KP
Sbjct: 169 --ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  120 bits (303), Expect = 1e-30
 Identities = 58/255 (22%), Positives = 88/255 (34%), Gaps = 48/255 (18%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASS 235
              +     +G+G+   V        R   AIK ++K      + +  +    E+ +   
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           LHHPNI  L     D +  + L+ +   GG L   L+       G   +           
Sbjct: 85  LHHPNIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 296 ---------------------------------IAESVAYLHNGTERCVVHRDIKPSNIL 322
                                            I  ++ YLH    + + HRDIKP N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFL 200

Query: 323 LSSKK--IPKLCDFGLATWTSA--PSVPFLCKTVKGTFGYLAPE--YFQHGKVSDKTDVY 376
            S+ K    KL DFGL+           +   T  GT  ++APE     +     K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 377 AFGVVLLELLTGRKP 391
           + GV+L  LL G  P
Sbjct: 261 SAGVLLHLLLMGAVP 275

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  119 bits (301), Expect = 2e-30
 Identities = 73/305 (23%), Positives = 112/305 (36%), Gaps = 50/305 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 235
               + R LG G    V   +           VA+K L K +          +E+ I  +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRN 79

Query: 236 LHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H NIV   G C +    G+ LI +++  GSL+ +L + K  +     L +      A+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AV 133

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPS 344
            I + + YL     R  VHRD+   N+L+ S+   K+ DFGL           T      
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENL 403
            P     V       APE     K    +DV++FGV L ELLT                L
Sbjct: 191 SP-----VFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFL 237

Query: 404 VLWAKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 459
            +      H  M        L    RL C      ++ ++++    C   + S R   + 
Sbjct: 238 KMIGPT--HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQN 292

Query: 460 IIAIL 464
           +I   
Sbjct: 293 LIEGF 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  120 bits (303), Expect = 3e-30
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKF 207

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL--- 359
           L     +  VHRD+   N +L  K   K+ DFGLA                 T   L   
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVK 261

Query: 360 --APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             A E  Q  K + K+DV++FGV+L EL+T G  P
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (298), Expect = 4e-30
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 44/302 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 123

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 346
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL                   P
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 406
                +       APE     K S  +DV++FGVVL EL T  +  ++   +    +   
Sbjct: 181 -----IFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

Query: 407 AKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
            +      M      ELL    RL        +I  ++     C ++  ++RP   ++  
Sbjct: 232 KQG----QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLAL 284

Query: 463 IL 464
            +
Sbjct: 285 RV 286

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  121 bits (306), Expect = 4e-30
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + LG G    V+        T VA+K + K    S +AF  E  +  +L H  +V L  
Sbjct: 193 EKKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ +++I ++++ GSL   L          S  P       +  IAE +A++   
Sbjct: 251 VVT--KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFI--- 300

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 360
            +R  +HRD++ +NIL+S+  + K+ DFGLA       +T+     F    +K T    A
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWT----A 353

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE    G  + K+DV++FG++L+E++T GR P
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  119 bits (300), Expect = 4e-30
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
            + +G+G  +F    KV L R       VAIK +DK   +  S +   RE+ I   L+HP
Sbjct: 20  LKTIGKG--NF---AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 240 NIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           NIV L  V   I+ E+ L+LI +Y SGG +  +L    +       +           I 
Sbjct: 75  NIVKLFEV---IETEKTLYLIMEYASGGEVFDYLVAHGR-------MKEKEARSKFRQIV 124

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            +V Y H    + +VHRD+K  N+LL +    K+ DFG +   +            G   
Sbjct: 125 SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPP 178

Query: 358 YLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKPIEARRLQ 398
           Y APE FQ GK  D  + DV++ GV+L  L++G  P + + L+
Sbjct: 179 YAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  118 bits (298), Expect = 4e-30
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + Y
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKY 143

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-----------TWTSAPSVPFLCKT 351
           L     +  VHRD+   N +L  K   K+ DFGLA              +   +P     
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP----- 195

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           VK      A E  Q  K + K+DV++FGV+L EL+T G  P
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  119 bits (300), Expect = 5e-30
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LGRGA S V++ K    +   A+K L K   +  K    E+ +   L HPNI+ L  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKE 115

Query: 247 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
               P + + L+ + V+GG L     E+ +  E+                     I E+V
Sbjct: 116 IFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAA-------------DAVKQILEAV 161

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AYLH   E  +VHRD+KP N+L ++      + K+ DFGL+       +    KTV GT 
Sbjct: 162 AYLH---ENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVL---MKTVCGTP 214

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           GY APE  +      + D+++ G++   LL G +P
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  117 bits (296), Expect = 6e-30
 Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 21/236 (8%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHP 239
              F   R LG GA   V   +         IK ++K+  +   +    E+ +  SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGI 296
           NI+ +     D    ++++ +   GG L ER +  + +G         S  Y  ++   +
Sbjct: 81  NIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKA------LSEGYVAELMKQM 133

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 353
             ++AY H    + VVH+D+KP NIL          K+ DFGLA                
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHS--TNAA 187

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 409
           GT  Y+APE F+   V+ K D+++ GVV+  LLTG  P     L+  +    + +P
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 7e-30
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 44/302 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 154

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVP 346
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL                   P
Sbjct: 155 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 347 FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 406
                +       APE     K S  +DV++FGVVL EL T  +  ++   +    +   
Sbjct: 212 -----IFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

Query: 407 AKPILHRGMAAVE--ELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
            +      M      ELL    RL        +I  ++     C ++  ++RP   ++  
Sbjct: 263 KQG----QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLAL 315

Query: 463 IL 464
            +
Sbjct: 316 RV 317

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  117 bits (296), Expect = 7e-30
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 36/221 (16%)

Query: 186 KGRVLGRGALSFVFKG--KVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNI 241
           + + LG G    V KG  ++  +  +VA+K L  +  D         E  +   L +P I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V ++G C    +   L+ +    G L ++L       + N  +      ++   ++  + 
Sbjct: 81  VRMIGICE--AESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVSMGMK 131

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKT 351
           YL    E   VHRD+   N+LL ++   K+ DFGL+             +    P     
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP----- 183

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           VK      APE   + K S K+DV++FGV++ E  + G+KP
Sbjct: 184 VKWY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  117 bits (295), Expect = 7e-30
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ +++I +Y+  GSL   L            L  +    +A  IAE +A++   
Sbjct: 76  VVT--QEPIYIITEYMENGSLVDFLKT-----PSGIKLTINKLLDMAAQIAEGMAFI--- 125

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTVKGTFGYLA 360
            ER  +HRD++ +NIL+S     K+ DFGLA       +T+     F    +K T    A
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIKWT----A 178

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           PE   +G  + K+DV++FG++L E++T GR P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  120 bits (303), Expect = 8e-30
 Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 34/232 (14%)

Query: 184 FSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNI 241
               ++LG G+    VF+G        VA+KR+  +  + +     E+ +   S  HPN+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +            L++  +     +L+  +  K                 +   IA  VA
Sbjct: 72  IRYYCSETTDRF-LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIP-------------KLCDFGLAT--WTSAPSVP 346
           +LH      ++HRD+KP NIL+S+                  + DFGL     +   S  
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 347 FLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKP 391
                  GT G+ APE  +         +++   D+++ G V   +L+  K 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  118 bits (298), Expect = 1e-29
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSLHHPNI 241
             V+G+G  S V +          A+K +D          S++   RE  I   L HP+I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGIAE 298
           V L+      +  L+++++++ G  L    +       R ++   +S          I E
Sbjct: 89  VELLETYSS-DGMLYMVFEFMDGADLCFEIVK------RADAGFVYSEAVASHYMRQILE 141

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 355
           ++ Y H   +  ++HRD+KP  +LL+SK+     KL  FG+A       +        GT
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             ++APE  +        DV+  GV+L  LL+G  P
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  119 bits (301), Expect = 1e-29
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 297

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFGY 358
                VHRD++ +NIL+    + K+ DFGLA        T       P     +K T   
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-----IKWT--- 348

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            APE   +G+ + K+DV++FG++L EL T GR P
Sbjct: 349 -APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (292), Expect = 2e-29
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 35/224 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
            +    R+LG G    V++G        + +VA+K   K+D   ++ + F  E +I  +L
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E+  ++I +    G L  +L       + +  +   V Y  +L I
Sbjct: 71  DHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY--SLQI 122

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFL 348
            +++AYL        VHRDI   NIL++S +  KL DFGL+           S   +P  
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-- 177

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +K      +PE     + +  +DV+ F V + E+L+ G++P
Sbjct: 178 ---IKWM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  120 bits (303), Expect = 2e-29
 Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 272 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 330 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 380

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFLCKTVKGTFGY 358
                VHRD++ +NIL+    + K+ DFGLA        T       P     +K T   
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-----IKWT--- 431

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            APE   +G+ + K+DV++FG++L EL T GR P
Sbjct: 432 -APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  116 bits (292), Expect = 2e-29
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 32/234 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
             +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L HPNI+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
                D     +++ +  +GG L       +   E                 ++   +  
Sbjct: 87  FEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RIIKQVFS 132

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T     +     K   GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM--KDRIGT 186

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP 409
             Y+APE  + G   +K DV++ GV+L  LL+G  P   +        V   K 
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (296), Expect = 2e-29
 Identities = 33/227 (14%), Positives = 71/227 (31%), Gaps = 22/227 (9%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASS 235
           +       +LG GA + V++   G L  +       +K     +        + +     
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
                 +      +    G  L+ +  S G+L   ++  K        +P  +    A+ 
Sbjct: 124 SMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMR 180

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----------KLCDFGLATWTSAPS 344
           +   +  +H   +  ++H DIKP N +L +  +             L D G +       
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
              +      T G+   E   +   + + D +     +  +L G   
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  116 bits (293), Expect = 3e-29
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 27/222 (12%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 240
           GR+LG+G    V + ++         VA+K L K D  +S   + F RE        HP+
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPH 86

Query: 241 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +  LVG  +            +I  ++  G L   L   + G    + LP     +  + 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-LPLQTLVRFMVD 145

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           IA  + YL   + R  +HRD+   N +L+      + DFGL+    +          +G 
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-----YRQGC 197

Query: 356 FGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              L     A E       +  +DV+AFGV + E++T G+ P
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  118 bits (299), Expect = 3e-29
 Identities = 64/216 (29%), Positives = 88/216 (40%), Gaps = 30/216 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
              LG+GA S V +    L     A   ++ +       +   RE  I   L HPNIV L
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
                +     +LI+  V+GG L E      +  E                      I E
Sbjct: 76  HDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADAS-------------HCIQQILE 121

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 355
           +V + H   +  VVHR++KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGT 176

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GYL+PE  +        D++A GV+L  LL G  P
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  115 bits (290), Expect = 4e-29
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K          S +   RE+ I   + HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVAL 294
           I+ L     +    + LI + VSGG L +       L E +               +   
Sbjct: 70  IITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT-------------QFLK 115

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 350
            I + V YLH    + + H D+KP NI+L  K +P    KL DFG+A         F  K
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF--K 169

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (290), Expect = 4e-29
 Identities = 55/232 (23%), Positives = 86/232 (37%), Gaps = 36/232 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSL-HHP 239
            F +   +G G    VFK    L     AIKR  K    S   +   RE+   + L  H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           ++V       + +  + +  +Y +GGSL   + E     R  S    +    + L +   
Sbjct: 72  HVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENY---RIMSYFKEAELKDLLLQVGRG 127

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KLCDFGLATWT 340
           + Y+H      +VH DIKPSNI +S   IP                   K+ D G  T  
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
           S+P      +  +G   +LA E  Q       K D++A  + ++        
Sbjct: 185 SSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (289), Expect = 5e-29
 Identities = 68/226 (30%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 181 THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIAS 234
           +  FS        LG+GA S V +          A K ++ +       +   RE  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSV 288
            L HPNIV L     +     +L++  V+GG L      R    E               
Sbjct: 61  KLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS----------- 108

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSV 345
                  I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA   +  S 
Sbjct: 109 --HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSE 162

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            +      GT GYL+PE  +    S   D++A GV+L  LL G  P
Sbjct: 163 AW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  115 bits (289), Expect = 6e-29
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)

Query: 190 LGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLV 245
           LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL  
Sbjct: 77  GVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL-- 126

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKTVKGT 355
             E+  VHRD+   N+LL ++   K+ DFGL+          T  SA   P     +K  
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-----LKWY 180

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
               APE     K S ++DV+++GV + E L+ G+KP
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  115 bits (290), Expect = 6e-29
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 240
           G++LG G    V +G +         VA+K + K D  S +    F  E        HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 241 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           ++ L+G CI+          +I  ++  G L  +L   +        +P     K  + I
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQTLLKFMVDI 156

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A  + YL   + R  +HRD+   N +L       + DFGL+    +          +G  
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-----YRQGRI 208

Query: 357 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +     A E       + K+DV+AFGV + E+ T G  P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  115 bits (291), Expect = 7e-29
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVP 243
            K + LG G+ S   K        + A+K + K  + +++   +E+        HPNIV 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVK 70

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIA 297
           L     D     FL+ + ++GG L   + +KK              +       +   + 
Sbjct: 71  LHEVFHDQLH-TFLVMELLNGGELFERIKKKKH-------------FSETEASYIMRKLV 116

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
            +V+++H   +  VVHRD+KP N+L + +      K+ DFG A      + P   KT   
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCF 171

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  Y APE        +  D+++ GV+L  +L+G+ P
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  114 bits (287), Expect = 8e-29
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 73

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 74  DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILY--AYQL 125

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+ +    +     K  KG  
Sbjct: 126 STALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKL 179

Query: 357 --GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              ++APE     + +  +DV+ FGV + E+L  G KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  114 bits (288), Expect = 1e-28
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE----DKESSKAFCRELMIASSLH 237
           G +LG G  S+   GKV  +         A+K L K+             +E+ +   L 
Sbjct: 10  GDLLGEG--SY---GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE--RHLHEKKKGVRGNSTLPWSVRYKVAL 294
           H N++ LV    +  +Q ++++ +Y   G  E    + EK+                 A 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR------------FPVCQAH 112

Query: 295 G----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           G    + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +    C+
Sbjct: 113 GYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 351 TVKGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
           T +G+  +  PE           K D+++ GV L  + TG  P
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  115 bits (289), Expect = 1e-28
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPL 244
              LGRG    V +      + +   K +     D+   K   +E+ I +   H NI+ L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHL 66

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                  E+ L +I++++SG  +          L+E++                    + 
Sbjct: 67  HESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIV-------------SYVHQVC 112

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGT 355
           E++ +LH      + H DI+P NI+  +++    K+ +FG A     P   F  + +   
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTA 166

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             Y APE  QH  VS  TD+++ G ++  LL+G  P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  116 bits (292), Expect = 2e-28
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 238
            + LG GA   V           VAI+ + K         + + +     E+ I   L+H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKV 292
           P I+ +  F    +   +++ + + GG L       + L E                   
Sbjct: 200 PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 244

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLC 349
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG +      S+    
Sbjct: 245 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 298

Query: 350 KTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +T+ GT  YLAPE          +   D ++ GV+L   L+G  P
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  114 bits (288), Expect = 2e-28
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 27/222 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
              ++ +V+G G    V+KG      G     VAIK L K    ++    F  E  I   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 102

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             H NI+ L G      + + +I +Y+  G+L++ L EK     G  ++   V      G
Sbjct: 103 FSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM--LRG 155

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT---- 351
           IA  + YL        VHRD+   NIL++S  + K+ DFGL+             +    
Sbjct: 156 IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 352 -VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            ++ T    APE   + K +  +DV++FG+V+ E++T G +P
Sbjct: 213 PIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (290), Expect = 2e-28
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 29/220 (13%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
              +     LG GA   V +            K ++            E+ I + LHHP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVA 293
           ++ L     D  + + LI +++SGG L +R       + E +                  
Sbjct: 110 LINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVI-------------NYM 155

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKT 351
               E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT  + P      K 
Sbjct: 156 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIV--KV 209

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
              T  + APE      V   TD++A GV+   LL+G  P
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 2e-28
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 40/231 (17%)

Query: 181 THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCREL 230
             N       G  LG G  + V K +        A K + K          S +   RE+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTL 284
            I   + HPN++ L     +    + LI + V+GG L      +  L E++         
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEAT------- 117

Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWT 340
                 +    I   V YLH      + H D+KP NI+L  + +P    K+ DFGLA   
Sbjct: 118 ------EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                 F  K + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 169 D-FGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  114 bits (288), Expect = 3e-28
 Identities = 63/221 (28%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K            +   RE+ I   + HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           I+ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  IITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 350
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--K 176

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  117 bits (295), Expect = 3e-28
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 29/217 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +     LG GA   V +        + A K +    +   +   +E+   S L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVALGI 296
           L     D  + + +IY+++SGG L E+       + E +               +    +
Sbjct: 219 LHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEA-------------VEYMRQV 264

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKG 354
            + + ++H   E   VH D+KP NI+ ++K+    KL DFGL      P      K   G
Sbjct: 265 CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSV--KVTTG 318

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  + APE  +   V   TD+++ GV+   LL+G  P
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (285), Expect = 4e-28
 Identities = 79/305 (25%), Positives = 119/305 (39%), Gaps = 50/305 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 235
               K R LG G    V               VA+K L K D   +    + +E+ I  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRT 89

Query: 236 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H +I+   G C D     L L+ +YV  GSL  +L            +  +     A 
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQ 141

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I E +AYLH    +  +HRD+   N+LL + ++ K+ DFGLA            K V  
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA------------KAVPE 186

Query: 355 TFGY-------------LAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE 400
              Y              APE  +  K    +DV++FGV L ELLT             E
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
              +   +  + R    +E     RL    +  A++  +++    C  +E S RP  E +
Sbjct: 247 LIGIAQGQMTVLRLTELLER--GERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENL 301

Query: 461 IAILR 465
           I IL+
Sbjct: 302 IPILK 306

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (285), Expect = 4e-28
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 26/216 (12%)

Query: 187 GRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            +++G G    V  G+    G     VAIK L K    +   + F  E  I     HPNI
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L G      +   ++ +Y+  GSL+  L        G  T+   V      G+   + 
Sbjct: 113 IRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGM--LRGVGAGMR 165

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-----VKGTF 356
           YL   ++   VHRD+   N+L+ S  + K+ DFGL+             T     ++ T 
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT- 221

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              APE       S  +DV++FGVV+ E+L  G +P
Sbjct: 222 ---APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (284), Expect = 5e-28
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K          S +   RE+ I   + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           ++ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  VITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCK 350
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA       V F  K
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF--K 176

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            + GT  ++APE   +  +  + D+++ GV+   LL+G  P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (286), Expect = 6e-28
 Identities = 69/230 (30%), Positives = 96/230 (41%), Gaps = 35/230 (15%)

Query: 177 ILAATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCREL 230
           ++ A+  FS        LG+GA S V +          A K ++ +       +   RE 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTL 284
            I   L HPNIV L     +     +L++  V+GG L      R    E           
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS------- 131

Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTS 341
                      I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA   +
Sbjct: 132 ------HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             S  +      GT GYL+PE  +    S   D++A GV+L  LL G  P
Sbjct: 183 -DSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  112 bits (283), Expect = 8e-28
 Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 36/221 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIK-----RLDKEDKESSKAFCRELMIASSL-HHP 239
             + LGRG  + V +          A K     R  ++ +        E+ +       P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCP 89

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVA 293
            ++ L     +  + + LI +Y +GG +      +                      ++ 
Sbjct: 90  RVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAE-----------MVSENDVIRLI 137

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCK 350
             I E V YLH   +  +VH D+KP NILLSS       K+ DFG++      +     +
Sbjct: 138 KQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL--R 191

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            + GT  YLAPE   +  ++  TD++  G++   LLT   P
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  113 bits (285), Expect = 8e-28
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            +V+G G    V  G++        SVAIK L K    ++  + F  E  I     HPNI
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L G      + + ++ +Y+  GSL+  L +         T+   V      GIA  + 
Sbjct: 109 IRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGM--LRGIASGMK 161

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKT 351
           YL   ++   VHRD+   NIL++S  + K+ DFGL             T    +P     
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP----- 213

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           ++ T    +PE   + K +  +DV+++G+VL E+++ G +P
Sbjct: 214 IRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (291), Expect = 1e-27
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 36/218 (16%)

Query: 189 VLGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
            LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL 
Sbjct: 402 IGVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL- 452

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------TWTSAPSVPFLCKTVKG 354
              E+  VHR++   N+LL ++   K+ DFGL+          T  SA   P     +K 
Sbjct: 453 --EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-----LKW 505

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                APE     K S ++DV+++GV + E L+ G+KP
Sbjct: 506 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  111 bits (279), Expect = 1e-27
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 361 PEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
           PE  +  +       DV++ G+VL  +L G  P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (284), Expect = 1e-27
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 30/238 (12%)

Query: 163 SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 222
           +P  + ++    G +  + +  SK  +LG G    V K +       +A K +     + 
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 223 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGN 281
            +    E+ + + L H N++ L          + L+ +YV GG L +R + E        
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDES------- 181

Query: 282 STLPWSVRY--KVALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCD 333
                         +     I E + ++H   +  ++H D+KP NIL  ++     K+ D
Sbjct: 182 ------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232

Query: 334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           FGLA     P      K   GT  +LAPE   +  VS  TD+++ GV+   LL+G  P
Sbjct: 233 FGLARRYK-PREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  112 bits (282), Expect = 2e-27
 Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 42/220 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +G G  +F   G   L+R       VA+K +++          RE++   SL HPNI
Sbjct: 25  VKDIGSG--NF---GVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNI 78

Query: 242 VPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG---- 295
           V    V   I     L +I +Y SGG L   +    +                A      
Sbjct: 79  VRFKEV---ILTPTHLAIIMEYASGGELYERICNAGR-----------FSEDEARFFFQQ 124

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVK 353
           +   V+Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  
Sbjct: 125 LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTV 178

Query: 354 GTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
           GT  Y+APE     +  D    DV++ GV L  +L G  P
Sbjct: 179 GTPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (289), Expect = 2e-27
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 35/224 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQF 448

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 449 DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KFSLDLASLILY--AYQL 500

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWTSAPSVPFL 348
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+           S   +P  
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-- 555

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +K      APE     + +  +DV+ FGV + E+L  G KP
Sbjct: 556 ---IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  110 bits (276), Expect = 3e-27
 Identities = 36/278 (12%), Positives = 77/278 (27%), Gaps = 67/278 (24%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVP 243
               G       ++     L   VA+  +D       +  +      +  S +  P +  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 244 L--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +  V        G  ++ +++ GGSL+            + +   ++R      +A +  
Sbjct: 96  VLDVV---HTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIR--AMQSLAAAAD 143

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
             H      V      PS + +S      L                           +  
Sbjct: 144 AAH---RAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPD 178

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA-----------RRLQGEENLVLWAKPI 410
                   + + D+   G  L  LL  R P+             R   G+          
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231

Query: 411 LHRGMAA-VEELL--DPRLKCTSRNSAQIARVIQAAAA 445
           +   ++A     +  D  +    R+++ +  ++Q A A
Sbjct: 232 IPFQISAVAARSVQGDGGI----RSASTLLNLMQQATA 265

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (280), Expect = 3e-27
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 34/216 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
              +G G+ S   +          A+K +DK  K        E+ I      HPNI+ L 
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPT---EEIEILLRYGQHPNIITLK 82

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAES 299
               D  + ++++ + + GG L   +  +K              +       V   I ++
Sbjct: 83  DVYDD-GKYVYVVTELMKGGELLDKILRQKF-------------FSEREASAVLFTITKT 128

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           V YLH    + VVHRD+KPSNIL   +       ++CDFG A    A +      T   T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYT 183

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             ++APE  +        D+++ GV+L  +LTG  P
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (279), Expect = 3e-27
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 39/230 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+ LG GA   V +     L        VA+K L K    +   +A   EL I S L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQH 109

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------K 291
            NIV L+G C      + +I +Y   G L   L  K + +  +     +           
Sbjct: 110 ENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSA 342
            +  +A+ +A+L     +  +HRD+   N+LL++  + K+ DFGLA              
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             +P     VK      APE       + ++DV+++G++L E+ + G  P
Sbjct: 226 ARLP-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (278), Expect = 4e-27
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG+G+   V++G    +      T VAIK +  E         F  E  +    +  
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCH 88

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---KVALGI 296
           ++V L+G      Q   +I + ++ G L+ +L   +  +  N  L         ++A  I
Sbjct: 89  HVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           A+ +AYL+       VHRD+   N +++     K+ DFG+                KG  
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YRKGGK 199

Query: 357 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           G L     +PE  + G  +  +DV++FGVVL E+ T   +P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  110 bits (278), Expect = 4e-27
 Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG GA   V++G+V           VA+K L  E   ++    F  E +I S  +H 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 93

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 94  NIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             YL    E   +HRDI   N LL+     ++ K+ DFG+A      S        KG  
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGC 204

Query: 357 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             L      PE F  G  + KTD ++FGV+L E+ + G  P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  110 bits (277), Expect = 4e-27
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 361 PEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
           PE  +  +       DV++ G+VL  +L G  P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (279), Expect = 5e-27
 Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 26/221 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG GA   V++G+V  +        VA+K L  E   ++    F  E +I S  +H 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 134

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 135 NIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             YL    E   +HRDI   N LL+     ++ K+ DFG+A               KG  
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-----YRKGGC 245

Query: 357 GYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
             L      PE F  G  + KTD ++FGV+L E+ + G  P
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (275), Expect = 5e-27
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 40/231 (17%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
              LG      V+KG +     G    +VAIK L K+       + F  E M+ + L HP
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHP 72

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---------Y 290
           N+V L+G     +Q L +I+ Y S G L   L  +       ST                
Sbjct: 73  NVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTS 341
            +   IA  + YL   +   VVH+D+   N+L+  K   K+ D GL              
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
              +P     ++      APE   +GK S  +D++++GVVL E+ + G +P
Sbjct: 189 NSLLP-----IRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  109 bits (275), Expect = 6e-27
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 46/238 (19%)

Query: 180 ATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAF 226
           +TH F +      +LGRG  S V +          A+K +D          E +E  +A 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 227 CRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVR 279
            +E+ I   +  HPNI+ L           FL++  +  G L     E+  L EK+    
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                      K+   + E +  LH   +  +VHRD+KP NILL      KL DFG +  
Sbjct: 128 -----------KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKT------DVYAFGVVLLELLTGRKP 391
                     + V GT  YLAPE  +     +        D+++ GV++  LL G  P
Sbjct: 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (276), Expect = 7e-27
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 41/225 (18%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 238
            + LG GA   V           VAIK + K         + + +     E+ I   L+H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 292
           P I+ +  F    +   +++ + + GG L ++      L E                   
Sbjct: 75  PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 119

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLC 349
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG +      S+    
Sbjct: 120 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---M 173

Query: 350 KTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           +T+ GT  YLAPE          +   D ++ GV+L   L+G  P
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (275), Expect = 7e-27
 Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 40/237 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIAS 234
                G+ LGRGA   V +             +VA+K L KE       +A   EL I  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 85

Query: 235 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV- 292
            + HH N+V L+G C  P   L +I ++   G+L  +L  K+         P  +     
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 293 --------ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------- 337
                   +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA       
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 338 --TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                    +P     +K      APE       + ++DV++FGV+L E+ + G  P
Sbjct: 203 DYVRKGDARLP-----LKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  109 bits (274), Expect = 9e-27
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 30/220 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F  G++LG G  SF     V L R   TS   AIK L+K     +       RE  + S
Sbjct: 31  DFKFGKILGEG--SF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HP  V L     D E+ L+    Y   G L +++  +K G    +      R+  A 
Sbjct: 86  RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYI--RKIGSFDETC----TRFYTA- 137

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I  ++ YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 355 TFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           T  Y++PE        K S   D++A G ++ +L+ G  P
Sbjct: 195 TAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGLPP 231

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (273), Expect = 9e-27
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 37/229 (16%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            R LG GA   VF  +         +  VA+K L K+   +++  F RE  + ++L H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--------- 291
           IV   G C D    L ++++Y+  G L + L                             
Sbjct: 79  IVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFL 348
           +A  IA  + YL     +  VHRD+   N L+ +  + K+ DFG++     T        
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY------ 188

Query: 349 CKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                G    L      PE   + K + ++DV++FGV+L E+ T G++P
Sbjct: 189 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  109 bits (275), Expect = 1e-26
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 36/216 (16%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLVGF 247
           VLG G    V +          A+K L       S    +E+     +   P+IV ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 248 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 298
             +   G   L +I + + GG L   + E+               +      ++   I  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERG-----------DQAFTEREAAEIMRDIGT 139

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           ++ +LH      + HRD+KP N+L +SK+   + KL DFG A  T+  ++    +T   T
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             Y+APE     K     D+++ GV++  LL G  P
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (276), Expect = 1e-26
 Identities = 51/221 (23%), Positives = 81/221 (36%), Gaps = 24/221 (10%)

Query: 184 FSKGRVLGRGALSF--VFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
           +    V+G+G      V   +       V ++R  L+    E       EL ++   +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 240 NIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           NIVP    F  D E  L+++  +++ GS  + L         N      +   V   +  
Sbjct: 87  NIVPYRATFIADNE--LWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD- 142

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA-----PSVPFLCKTV 352
              Y+H  G     VHR +K S+IL+S      L          +       V    K  
Sbjct: 143 ---YIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 353 KGTFGYLAPEYFQHGKV--SDKTDVYAFGVVLLELLTGRKP 391
                +L+PE  Q        K+D+Y+ G+   EL  G  P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  108 bits (273), Expect = 2e-26
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 30/225 (13%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
              LG GA   VF  +   LL       VA+K L KE  ES++  F RE  + + L H +
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQH 104

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--------YKV 292
           IV   G C +  + L ++++Y+  G L R L       +  +                 V
Sbjct: 105 IVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A  +A  + YL        VHRD+   N L+    + K+ DFG++    +          
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YR 215

Query: 353 KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            G    L      PE   + K + ++DV++FGVVL E+ T G++P
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 2e-26
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVG 246
            LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   +++  + +   SL++     K+ +    T+P  +  K+A+ I +++ +LH+ 
Sbjct: 74  ALFREGD-VWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPE- 362
            +  V+HRD+KPSN+L+++    K+CDFG++       A           G   Y+APE 
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA------KDIDAGCKPYMAPER 180

Query: 363 ---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA 394
                     S K+D+++ G+ ++EL   R P ++
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  108 bits (272), Expect = 2e-26
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 187 GRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSL-HHPNI 241
             V+G G    V K ++    LR   AIKR+ KE   K+  + F  EL +   L HHPNI
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKV 292
           + L+G C      L+L  +Y   G+L   L + +               STL        
Sbjct: 89  INLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A  +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              V
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YV 196

Query: 353 KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           K T G L     A E   +   +  +DV+++GV+L E+++ G  P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  109 bits (273), Expect = 4e-26
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +       P+IV +V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 121

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 296
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSI 170

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 353
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG A  T+         T  
Sbjct: 171 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSL--TTPC 224

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            T  Y+APE     K     D+++ GV++  LL G  P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  108 bits (271), Expect = 6e-26
 Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 45/272 (16%)

Query: 145 SRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSK----GRVLGRGALSFVFK 200
           +   E K       + + +    S+         AA   F +      V+GRG  S V +
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112

Query: 201 GKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP 251
                     A+K ++         + +E  +A  RE  I   +  HP+I+ L+      
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172

Query: 252 EQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +FL++  +  G L     E+  L EK+                +   + E+V++LH 
Sbjct: 173 SF-MFLVFDLMRKGELFDYLTEKVALSEKETR-------------SIMRSLLEAVSFLH- 217

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ 365
                +VHRD+KP NILL      +L DFG +     P      + + GT GYLAPE  +
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKL--RELCGTPGYLAPEILK 272

Query: 366 HGKVSDKT------DVYAFGVVLLELLTGRKP 391
                         D++A GV+L  LL G  P
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  107 bits (269), Expect = 7e-26
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 26/221 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--------DKESSKAFCRELMIA 233
             +S    LG GA  FV+          V +K + KE        +         E+ I 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           S + H NI+ ++    + +    L+  K+ SG  L   +    +       L   +   +
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYI 135

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              +  +V YL     + ++HRDIK  NI+++     KL DFG A +        L  T 
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTF 189

Query: 353 KGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
            GT  Y APE    G      + ++++ GV L  L+    P
Sbjct: 190 CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  106 bits (268), Expect = 7e-26
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 37/226 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           +  VLG GA + V      +     A+K ++K+         RE+ +      H N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 298
           + F  + ++  +L+++ + GGS+  H+H+++              +       V   +A 
Sbjct: 77  IEFFEEEDR-FYLVFEKMRGGSILSHIHKRRH-------------FNELEASVVVQDVAS 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT-----WTSAPSVPFLCK 350
           ++ +LHN   + + HRD+KP NIL          K+CDF L +        +P       
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 351 TVKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKP 391
           T  G+  Y+APE  +             D+++ GV+L  LL+G  P
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  105 bits (265), Expect = 9e-26
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 34/217 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
           G  LG G  +F   GKV +         VA+K L+++   S        RE+       H
Sbjct: 16  GDTLGVG--TF---GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           P+I+ L  V   I      F++ +YVSGG L  ++ +  +       +      ++   I
Sbjct: 71  PHIIKLYQV---ISTPTDFFMVMEYVSGGELFDYICKHGR-------VEEMEARRLFQQI 120

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T  G+ 
Sbjct: 121 LSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 174

Query: 357 GYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
            Y APE    G++    + D+++ GV+L  LL G  P
Sbjct: 175 NYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLP 210

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (266), Expect = 1e-25
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 43/239 (17%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIAS 234
           +  S G+ LG GA   V +    GL++     +VA+K L K        +A   EL + S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLS 81

Query: 235 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---- 289
            L +H NIV L+G C        +I +Y   G L   L  K+     + T P  +     
Sbjct: 82  YLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 290 -------YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 337
                     +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 338 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                      +P     VK      APE   +   + ++DV+++G+ L EL + G  P
Sbjct: 198 DSNYVVKGNARLP-----VKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (266), Expect = 1e-25
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 34/231 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 235
             +  G +LG+G    VF G     R  VAIK + +           S     E+ +   
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 236 LH----HPNIVPLVGFCIDPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +     HP ++ L+ +  + ++G  L+ +  +    L  ++ EK         L      
Sbjct: 91  VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP-------LGEGPSR 142

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLC 349
                +  ++ + H+   R VVHRDIK  NIL+  ++   KL DFG          P+  
Sbjct: 143 CFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPY-- 195

Query: 350 KTVKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKPIEARR 396
               GT  Y  PE+      H        V++ G++L +++ G  P E  +
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQ 243

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (265), Expect = 1e-25
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 16/218 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           V     F +  E  L+L+ K +SGGS+   +  H   KG   +  L  S    +   + E
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC---KTVKG 354
            + YLH NG     +HRD+K  NILL      ++ DFG++ + +           KT  G
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 355 TFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
           T  ++APE  +  +  D K D+++FG+  +EL TG  P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (263), Expect = 3e-25
 Identities = 48/224 (21%), Positives = 86/224 (38%), Gaps = 32/224 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 235
             +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 236 LHH--PNIVPLVGFCIDPEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           +      ++ L+ +  +      LI +       L   + E+         L   +    
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGA-------LQEELARSF 154

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKT 351
              + E+V + HN     V+HRDIK  NIL+   +   KL DFG           +    
Sbjct: 155 FWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVY--TD 207

Query: 352 VKGTFGYLAPEYFQ----HGKVSDKTDVYAFGVVLLELLTGRKP 391
             GT  Y  PE+ +    HG+      V++ G++L +++ G  P
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP 248

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  105 bits (263), Expect = 3e-25
 Identities = 41/183 (22%), Positives = 75/183 (40%), Gaps = 18/183 (9%)

Query: 216 DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
                    A   ++         N V  +     P+  L++  +     +L+  ++ + 
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQL-QPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                   +       + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFG
Sbjct: 157 SLEDREHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 336 LAT---------WTSAPSVPFLCKTVK-GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLEL 385
           L T             P   +   T + GT  Y++PE       S K D+++ G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 386 LTG 388
           L  
Sbjct: 270 LYS 272

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (263), Expect = 4e-25
 Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 43/239 (17%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 232
              + G+ LG GA   V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 93

Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 282
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 94  MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 283 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 337
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA     
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 338 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                 T+   +P     VK      APE       + ++DV++FGV++ E+ T G  P
Sbjct: 210 IDYYKKTTNGRLP-----VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  105 bits (263), Expect = 5e-25
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 47/227 (20%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CRELMIA 233
             F + + LG G  SF   G+V L++        A+K LDK+     K       E  I 
Sbjct: 41  DQFDRIKTLGTG--SF---GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +++ P +V L     D    L+++ +YV+GG +  HL  ++ G           R+  A
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHL--RRIGRFSEPH----ARFYAA 148

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPF 347
             I  +  YLH      +++RD+KP N+L+  +   ++ DFG A      TWT       
Sbjct: 149 -QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------- 197

Query: 348 LCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
           LC    GT   LAPE      + K     D +A GV++ E+  G  P
Sbjct: 198 LC----GTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPP 237

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (261), Expect = 6e-25
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIA-SSLHHPNIVPLVG 246
            +GRGA   V K         +A+KR+     E   K    +L +   S   P IV   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E   ++  + +   S ++        +     +P  +  K+ L   +++ +L   
Sbjct: 89  ALFR-EGDCWICMELM-STSFDKFYKYVYSVLDD--VIPEEILGKITLATVKALNHLKE- 143

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTVKGTFGYLAPEY 363
               ++HRDIKPSNILL      KLCDFG++     + A       +   G   Y+APE 
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-----TRDA-GCRPYMAPER 196

Query: 364 FQHGKVSD----KTDVYAFGVVLLELLTGRKP 391
                       ++DV++ G+ L EL TGR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (262), Expect = 6e-25
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R +G GA   VF+ +  GLL     T VA+K L KE+   +    F RE  + +   +P
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNP 110

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--------- 290
           NIV L+G C    + + L+++Y++ G L   L         + +                
Sbjct: 111 NIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 291 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
                    +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+     
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS----- 221

Query: 343 PSVPFLCKTV-------KGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GR 389
                  + +             +      PE   + + + ++DV+A+GVVL E+ + G 
Sbjct: 222 -------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274

Query: 390 KP 391
           +P
Sbjct: 275 QP 276

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (260), Expect = 8e-25
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 40/240 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIAS 234
            N   G+ LG G    V K     L+     T+VA+K L KE+   S  +    E  +  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLK 81

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---- 290
            ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G      S       
Sbjct: 82  QVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 291 -------------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                          A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 338 TWTSAPSVPFLCKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                         VK + G +     A E       + ++DV++FGV+L E++T G  P
Sbjct: 198 RDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  104 bits (261), Expect = 1e-24
 Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 232
              + G+ LG G    V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 139

Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 282
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 140 MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 283 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA   + 
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 343 PSVPFLCKTVKGTFGYL-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                     K T G L     APE       + ++DV++FGV++ E+ T G  P
Sbjct: 256 IDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (260), Expect = 2e-24
 Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 44/226 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           R +G+G  SF   GKV +++   T    A+K ++K+   ++   +   +EL I   L HP
Sbjct: 21  RAIGKG--SF---GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-LGIAE 298
            +V L     D E  +F++   + GG L  HL  ++       T    V+  +  L +A 
Sbjct: 76  FLVNLWYSFQDEED-MFMVVDLLLGGDLRYHL--QQNVHFKEET----VKLFICELVMA- 127

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCKTV 352
            + YL     + ++HRD+KP NILL       + DF +A      T  +         T+
Sbjct: 128 -LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT---------TM 174

Query: 353 KGTFGYLAPEYFQHGKVS--DKT-DVYAFGVVLLELLTGRKPIEAR 395
            GT  Y+APE F   K +      D ++ GV   ELL GR+P   R
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  102 bits (256), Expect = 3e-24
 Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 53/230 (23%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE------DKESSKAFCREL 230
            +F   R LG G  SF   G+V L+R        A+K L KE        E +     E 
Sbjct: 6   QDFQILRTLGTG--SF---GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ER 57

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ S + HP I+ + G   D +Q +F+I  Y+ GG L   L  +K     N       ++
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL--RKSQRFPNPV----AKF 110

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  +  ++ YLH    + +++RD+KP NILL      K+ DFG A      T+T    
Sbjct: 111 YAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---- 162

Query: 345 VPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
              LC    GT  Y+APE      + K     D ++FG+++ E+L G  P
Sbjct: 163 ---LC----GTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTP 202

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (254), Expect = 6e-24
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            + K   LG G  + V+KGK  L    VA+K  RL+ E+     A  RE+ +   L H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       E+ L L+++Y+    L+++L +          +           +   +
Sbjct: 62  IVTLHDIIHT-EKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLFLFQLLRGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           AY H    + V+HRD+KP N+L++ +   KL DFGLA   S P+  +  + V  T  Y  
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRP 168

Query: 361 PEYFQHGKV-SDKTDVYAFGVVLLELLTGR 389
           P+        S + D++  G +  E+ TGR
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  104 bits (261), Expect = 8e-24
 Identities = 75/285 (26%), Positives = 115/285 (40%), Gaps = 58/285 (20%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFC--RELM 231
           +FS  R++GRG   F   G+V   R +      A+K LDK+     +  + A      L 
Sbjct: 190 DFSVHRIIGRG--GF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S+   P IV +  +       L  I   ++GG L  HL +      G  +      Y 
Sbjct: 245 LVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFY- 297

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-------TWTSAPS 344
            A  I   + ++H    R VV+RD+KP+NILL      ++ D GLA              
Sbjct: 298 -AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---- 349

Query: 345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPIEARRLQGEENL 403
                    GT GY+APE  Q G   D + D ++ G +L +LL G  P    + + +  +
Sbjct: 350 ---SV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

Query: 404 ---VLWAKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 436
               L     L    +      +E LL  D   RL C  R + ++
Sbjct: 403 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (254), Expect = 8e-24
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 48/239 (20%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+VLG GA   V       +        VA+K L KE  +SS  +A   EL + + L  H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSH 108

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------- 290
            NIV L+G C      ++LI++Y   G L  +L  K++    +     + +         
Sbjct: 109 ENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 291 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----- 337
                     A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA     
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 338 ----TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
                      +P     VK      APE    G  + K+DV+++G++L E+ + G  P
Sbjct: 225 DSNYVVRGNARLP-----VKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  103 bits (259), Expect = 8e-24
 Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 37/277 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 232
             F   RVLGRG   F   G+V   +        A K+L+K+     K    A   E  I
Sbjct: 185 DWFLDFRVLGRG--GF---GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKI 238

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
            + +H   IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y  
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFY-- 294

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              I   + +LH   +R +++RD+KP N+LL      ++ D GLA    A       K  
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGY 349

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR--RLQGEE--NLVLWAK 408
            GT G++APE     +     D +A GV L E++  R P  AR  +++ +E    VL   
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409

Query: 409 PILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 436
                  +       E LL  DP  RL     +   +
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (252), Expect = 1e-23
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 24/221 (10%)

Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV L       E  L L+++++    L++++  +  G          V+      
Sbjct: 60  LKHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F  + V  T
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171

Query: 356 FGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
             Y AP+       Y      S   D+++ G +L E++TG+
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/255 (25%), Positives = 98/255 (38%), Gaps = 69/255 (27%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC-------------- 227
              +G+G  S+   G V L       T  A+K L K+       F               
Sbjct: 18  KDEIGKG--SY---GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 228 ------------RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL-----ER 269
                       +E+ I   L HPN+V LV    DP E  L+++++ V+ G +      +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            L E +           +  Y   L     + YLH    + ++HRDIKPSN+L+      
Sbjct: 133 PLSEDQ-----------ARFYFQDLIKG--IEYLHY---QKIIHRDIKPSNLLVGEDGHI 176

Query: 330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLL 383
           K+ DFG++      S   L     GT  ++APE          GK     DV+A GV L 
Sbjct: 177 KIADFGVSNE-FKGSDALL-SNTVGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLY 231

Query: 384 ELLTGRKPIEARRLQ 398
             + G+ P    R+ 
Sbjct: 232 CFVFGQCPFMDERIM 246

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMI-ASSLHHPNIVPLVG 246
            +G G    V+K +       +A+K++ +  +KE +K    +L +   S   P IV   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   +F+  + +   + +     +         +P  +  K+ + I +++ YL   
Sbjct: 92  -TFITNTDVFIAMELMGTCAEKLKKRMQG-------PIPERILGKMTVAIVKALYYLKE- 142

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK-----GTFGYLAP 361
            +  V+HRD+KPSNILL  +   KLCDFG++          L          G   Y+AP
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISG--------RLVDDKAKDRSAGCAAYMAP 193

Query: 362 EYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           E       +      + DV++ G+ L+EL TG+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  101 bits (253), Expect = 2e-23
 Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 43/234 (18%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR------TSVAIKRLDKEDKESS--KAFCRELMIASSL- 236
           G+ LG GA   V   +  GL +      T VA+K L K D           E+ +   + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 292
            H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P     +     
Sbjct: 133 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 293 -----ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------T 338
                A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA          
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
            T+   +P     VK      APE       + ++DV++FGV+L E+ T G  P
Sbjct: 249 KTTNGRLP-----VKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E       +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
              G     +  L++I +Y+ GGS         L E +            +  ++  G+ 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREILKGLD 133

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 355
               YLH+      +HRDIK +N+LLS     KL DFG+A   +        K  T  GT
Sbjct: 134 ----YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----QIKRNTFVGT 182

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             ++APE  +      K D+++ G+  +EL  G  P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  101 bits (253), Expect = 4e-23
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 42/221 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
           G  LG G  +F   GKV + +       VA+K L+++   S        RE+       H
Sbjct: 21  GDTLGVG--TF---GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG- 295
           P+I+ L  V   I     +F++ +YVSGG L  ++ +  +           +  K +   
Sbjct: 76  PHIIKLYQV---ISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRL 121

Query: 296 ---IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              I   V Y H      VVHRD+KP N+LL +    K+ DFGL+   S        +T 
Sbjct: 122 FQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTS 175

Query: 353 KGTFGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
            G+  Y APE    G++    + D+++ GV+L  LL G  P
Sbjct: 176 CGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLP 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 20/215 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 238
            + K   +G G    VFK K       VA+K  RLD +  E   S A  RE+ +   L H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSAL-REICLLKELKH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NIV L       ++ L L++++     L+++             L   +       + +
Sbjct: 61  KNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSCNGD------LDPEIVKSFLFQLLK 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + + H    R V+HRD+KP N+L++     KL +FGLA     P   +  + V  T  Y
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWY 167

Query: 359 LAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPI 392
             P+     K+ S   D+++ G +  EL    +P+
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (253), Expect = 7e-23
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 44/279 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 232
           + F + RVLG+G   F   G+V   +        A K+L+K+     K  + A   E  I
Sbjct: 184 NTFRQYRVLGKG--GF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQI 237

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              ++   +V L  +  + +  L L+   ++GG L+ H++   +          +V Y  
Sbjct: 238 LEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG---FPEARAVFY-- 291

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCK 350
           A  I   +  LH      +V+RD+KP NILL      ++ D GLA               
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-V- 346

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR--RLQGEE--NLVLW 406
              GT GY+APE  ++ + +   D +A G +L E++ G+ P + R  +++ EE   LV  
Sbjct: 347 ---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403

Query: 407 AKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 436
                    +        +LL  DP  RL C   ++ ++
Sbjct: 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
              LG G  SF   GKV L         VA+K + ++  + S       RE+     L H
Sbjct: 14  RETLGEG--SF---GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           P+I+ L  V   I     + ++ +Y  GG L  ++ EKK+       +      +    I
Sbjct: 69  PHIIKLYDV---ITTPTDIVMVIEYA-GGELFDYIVEKKR-------MTEDEGRRFFQQI 117

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             ++ Y H      +VHRD+KP N+LL      K+ DFGL+   +  +     KT  G+ 
Sbjct: 118 ICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171

Query: 357 GYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
            Y APE    GK+    + DV++ G+VL  +L GR P
Sbjct: 172 NYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 64/234 (27%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F   +V+GRG  +F    +V +++   T    A+K ++K D   +     F  E  +  
Sbjct: 62  DFEILKVIGRG--AF---SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +     I  L  F    E  L+L+ +Y  GG L   L   K G R       +  Y    
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGER--IPAEMARFY---- 167

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
            +AE V     +H       VHRDIKP NILL      +L DFG                
Sbjct: 168 -LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLV 222

Query: 352 VKGTFGYLAPEYFQHGKVSDKTDVY-------AFGVVLLELLTGRKPIEARRLQ 398
             GT  YL+PE  Q       T  Y       A GV   E+  G+ P  A    
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 36/234 (15%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K K    +     A+K+++      S   CRE+ +   L HPN++ 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVIS 82

Query: 244 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALGIAESV 300
           L    +   ++ ++L++ Y     L   +   +        +         +   I + +
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPF--LCKTVKG 354
            YLH      V+HRD+KP+NIL+  +       K+ D G A   ++P  P   L   V  
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 355 TFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE 401
           TF Y APE       Y      +   D++A G +  ELLT  +PI        +
Sbjct: 198 TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-SEPI----FHCRQ 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +  + +  E  L+++ +Y++GGSL   + E        +         V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+     V+HRDIK  NILL      KL DFG      A   P   K  T+ GT  ++A
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF----CAQITPEQSKRSTMVGTPYWMA 184

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
           PE         K D+++ G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 65/234 (27%), Positives = 96/234 (41%), Gaps = 42/234 (17%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIASS 235
           +   +V+GRG  +F   G+V L+R   T    A+K L K +   +  S  F  E  I + 
Sbjct: 71  YEVVKVIGRG--AF---GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            + P +V L     D    L+++ +Y+ GG L   +              W+  Y     
Sbjct: 126 ANSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD------VPEKWARFY----- 173

Query: 296 IAESVA---YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
            AE V     +H       +HRD+KP N+LL      KL DFG             C T 
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTA 229

Query: 353 KGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
            GT  Y++PE  +       +G+     D ++ GV L E+L G  P  A  L G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            + K   +G G+   VFK +       VAIK     ++D    K   RE+ +   L HPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L+      ++ L L+++Y    ++   L   ++G      +P  +   +     ++V
Sbjct: 64  LVNLLE-VFRRKRRLHLVFEYCDH-TVLHELDRYQRG------VPEHLVKSITWQTLQAV 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            + H   +   +HRD+KP NIL++   + KLCDFG A   + PS  +  +    T  Y +
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRS 170

Query: 361 PE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE       Y          DV+A G V  ELL+G 
Sbjct: 171 PELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.7 bits (241), Expect = 8e-22
 Identities = 72/227 (31%), Positives = 102/227 (44%), Gaps = 38/227 (16%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHH 238
             +++  +V+G G+   V++ K+      VAIK+   DK  K       REL I   L H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDH 106

Query: 239 PNIVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----R 289
            NIV L  F         E  L L+  YV   ++ R     +   R   TLP        
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVA---RHYSRAKQTLPVIYVKLYM 162

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSAPSVP 346
           Y++   +A    Y+H+     + HRDIKP N+LL     + KLCDFG A       P+V 
Sbjct: 163 YQLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

Query: 347 FLCKTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           ++C     +  Y APE  F     +   DV++ G VL ELL G+ PI
Sbjct: 216 YIC-----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 55/231 (23%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           ++LG+G  SF   GKV L          AIK L K+    D +       + +++ +  H
Sbjct: 23  KMLGKG--SF---GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALGI 296
           P +  +       ++ LF + +Y++GG L  H+    K       L  +  Y   + LG+
Sbjct: 78  PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGL 131

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVPF 347
                +LH    + +V+RD+K  NILL      K+ DFG+          T T       
Sbjct: 132 Q----FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT------- 177

Query: 348 LCKTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
            C    GT  Y+APE     ++       D ++FGV+L E+L G+ P   +
Sbjct: 178 FC----GTPDYIAPEILLGQKYNHS---VDWWSFGVLLYEMLIGQSPFHGQ 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 68/239 (28%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-------DKESSKAFCRELMI 232
           RVLG+G   +   GKV  +R           A+K L K        D   +KA   E  I
Sbjct: 23  RVLGKG--GY---GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNI 74

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              + HP IV L+ +       L+LI +Y+SGG L   L  +            +  Y  
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI-----FMEDTACFY-- 126

Query: 293 ALGIAE---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
              +AE   ++ +LH   ++ +++RD+KP NI+L+ +   KL DFG            LC
Sbjct: 127 ---LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG------------LC 168

Query: 350 K----------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           K          T  GT  Y+APE      H +     D ++ G ++ ++LTG  P    
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPPFTGE 224

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 58/228 (25%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKE------DKESSKAFCRELMIASSL 236
           ++LG+G  +F   GKV L+R   T    A+K L KE      +   +     E  +  + 
Sbjct: 11  KLLGKG--TF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L  +       L  + +Y +GG L  HL  ++       T   +  Y     I
Sbjct: 63  RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY--GAEI 114

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK------ 350
             ++ YLH    R VV+RDIK  N++L      K+ DFG            LCK      
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG------------LCKEGISDG 159

Query: 351 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
               T  GT  YLAPE      +G+     D +  GVV+ E++ GR P
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 204

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE------DKESSKAFCRELMIASSL 236
           ++LG+G  +F   GKV L++        A+K L KE      +   +     E  +  + 
Sbjct: 154 KLLGKG--TF---GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 205

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L  +       L  + +Y +GG L  HL  ++       +   +  Y     I
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY--GAEI 257

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
             ++ YLH+  E+ VV+RD+K  N++L      K+ DFGL             KT  GT 
Sbjct: 258 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTP 313

Query: 357 GYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKP 391
            YLAPE  +   +G+     D +  GVV+ E++ GR P
Sbjct: 314 EYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLP 348

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 57/232 (24%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 236
            VLG+G  SF   GKV L          A+K L K+      D E +    R L +    
Sbjct: 26  MVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-- 78

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
             P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   + I
Sbjct: 79  KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAI 132

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK------ 350
              + +L     + +++RD+K  N++L S+   K+ DFG            +CK      
Sbjct: 133 G--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG------------MCKENIWDG 175

Query: 351 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
               T  GT  Y+APE   Y  +GK     D +AFGV+L E+L G+ P E  
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAPFEGE 224

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 28/216 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +    ++G G+   V K +       VAIK      +DK   K   RE+ +   L H N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L+  C   ++  +L++++V   ++   L     G      L + V  K    I   +
Sbjct: 86  LVNLLEVCKK-KKRWYLVFEFVDH-TILDDLELFPNG------LDYQVVQKYLFQIINGI 137

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            + H      ++HRDIKP NIL+S   + KLCDFG A   +AP   +  +    T  Y A
Sbjct: 138 GFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRA 192

Query: 361 PE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE       Y          DV+A G ++ E+  G 
Sbjct: 193 PELLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 66/237 (27%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-----DKESSKAFCRELMIAS 234
           +VLG+G  SF   GKV L++           A+K L K      D+  +K    E  I  
Sbjct: 30  KVLGQG--SF---GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILV 81

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            ++HP IV L  +    E  L+LI  ++ GG L   L ++        T      Y    
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFY---- 131

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK- 350
            +AE      +LH      +++RD+KP NILL  +   KL DFG            L K 
Sbjct: 132 -LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG------------LSKE 175

Query: 351 ---------TVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
                    +  GT  Y+APE      H +     D ++FGV++ E+LTG  P + +
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLPFQGK 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 68/232 (29%), Positives = 101/232 (43%), Gaps = 57/232 (24%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 236
           RVLG+G  SF   GKV L R        A+K L K+      D E +    R L +A + 
Sbjct: 29  RVLGKG--SF---GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN- 82

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L   C      LF + ++V+GG L  H+ + ++          +  Y   +  
Sbjct: 83  -HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIIS 135

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK------ 350
           A  + +LH   ++ +++RD+K  N+LL  +   KL DFG            +CK      
Sbjct: 136 A--LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG------------MCKEGICNG 178

Query: 351 ----TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
               T  GT  Y+APE      +G      D +A GV+L E+L G  P EA 
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEAE 227

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 96.6 bits (240), Expect = 2e-21
 Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 62/285 (21%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIA 233
           +F+   VLG+G  SF   GKV L          A+K L K+    D +       + ++A
Sbjct: 342 DFNFLMVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
                P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAE 450

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--- 350
           + I   + +L     + +++RD+K  N++L S+   K+ DFG            +CK   
Sbjct: 451 IAIG--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFG------------MCKENI 493

Query: 351 -------TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
                  T  GT  Y+APE   Y  +GK     D +AFGV+L E+L G+ P E       
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

Query: 401 ENLVLWAKPILHRGMAA-----VEELL--DP--RLKCTSRNSAQI 436
              ++       + M+       + L+   P  RL C       I
Sbjct: 551 FQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 23/216 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +     LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L+G +  D +  L+++ ++  GG+++  + E  +G+         ++  V   + E++ +
Sbjct: 81  LLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQV-VCRQMLEALNF 132

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGTFGYLA 360
           LH+   + ++HRD+K  N+L++ +   +L DFG+    SA ++  L K  +  GT  ++A
Sbjct: 133 LHS---KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMA 185

Query: 361 PEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           PE      + D     K D+++ G+ L+E+     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 70/232 (30%), Positives = 101/232 (43%), Gaps = 57/232 (24%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE------DKESSKAFCRELMI-ASS 235
           +V+G+G  SF   GKV L R     V  A+K L K+      +++   +   E  +   +
Sbjct: 44  KVIGKG--SF---GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVLLKN 95

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP +V L  F       L+ +  Y++GG L  HL  ++         P +  Y  A  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFY--AAE 147

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---------TWTSAPSVP 346
           IA ++ YLH      +V+RD+KP NILL S+    L DFGL          T T      
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST------ 198

Query: 347 FLCKTVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
             C    GT  YLAPE      + +     D +  G VL E+L G  P  +R
Sbjct: 199 -FC----GTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPPFYSR 242

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 50/216 (23%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
                 +G G+   V   +       VA+K +D   ++  +    E++I     H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +   + +  E  L+++ +++ GG+L     +  L+E++                V   + 
Sbjct: 107 MYKSYLVGEE--LWVLMEFLQGGALTDIVSQVRLNEEQIAT-------------VCEAVL 151

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TVKGT 355
           +++AYLH    + V+HRDIK  +ILL+     KL DFG      A     + K  ++ GT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGF----CAQISKDVPKRKSLVGT 204

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             ++APE       + + D+++ G++++E++ G  P
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 40/222 (18%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRT-SVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           ++  +V+G G+   VF+ K  L+ +  VAIK    DK  K       REL I   + HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAK--LVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPN 93

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----RYK 291
           +V L  F         E  L L+ +YV   ++ R      K      T+P  +     Y+
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKL---KQTMPMLLIKLYMYQ 149

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSAPSVPFL 348
           +   +A    Y+H+     + HRDIKP N+LL     + KL DFG A       P+V ++
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 349 CKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           C     +  Y APE  F     +   D+++ G V+ EL+ G+
Sbjct: 203 C-----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 53/226 (23%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE----DKESSKAFCRELMIASSLHH 238
           RV+GRG  S+    KV L+R   T    A+K + KE    D++       + +   + +H
Sbjct: 15  RVIGRG--SY---AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-------- 350
            + YLH   ER +++RD+K  N+LL S+   KL D+G            +CK        
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG------------MCKEGLRPGDT 166

Query: 351 --TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             T  GT  Y+APE      +G      D +A GV++ E++ GR P
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 236
            + K   +G G    V+K K         VA+K  RLD E  E   S A  RE+ +   L
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD---SQGRIVALKRIRLDAE-DEGIPSTAI-REISLLKEL 76

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           HHPNIV L+      E+ L L+++++    L++ L E K G      L  S        +
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKTG------LQDSQIKIYLYQL 128

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              VA+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +  + V  T 
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TL 183

Query: 357 GYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
            Y AP+       Y      S   D+++ G +  E++TG+
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 236
            +     +G G    V+K +          A+K  RL+KED E   S    RE+ I   L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN---NYGETFALKKIRLEKED-EGIPSTTI-REISILKEL 57

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NIV L       ++ L L+++++    L++ L   + G      L         L +
Sbjct: 58  KHSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGG------LESVTAKSFLLQL 109

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              +AY H   +R V+HRD+KP N+L++ +   K+ DFGLA     P   +  + V  T 
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TL 164

Query: 357 GYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
            Y AP+       Y      S   D+++ G +  E++ G 
Sbjct: 165 WYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 92.6 bits (231), Expect = 6e-21
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 27/223 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF----CRELMIASSL 236
            +     +G GA   V+K +       VA+K  R+                RE+ +   L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRL 68

Query: 237 H---HPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               HPN+V L         D E  + L++++V    L  +L +          LP    
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-----APPPGLPAETI 122

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
             +       + +LH     C+VHRD+KP NIL++S    KL DFGLA   S   +    
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTP 178

Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 179 VVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            F     LG G+   V+K         VAIK++  E         +E+ I      P++V
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVV 87

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALG 295
              G        L+++ +Y   GS+        + L E +                +   
Sbjct: 88  KYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------------ILQS 133

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAPSVPFLCKTV 352
             + + YLH       +HRDIK  NILL+++   KL DFG+A   T T A        TV
Sbjct: 134 TLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-----NTV 185

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GT  ++APE  Q    +   D+++ G+  +E+  G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 66/235 (28%), Positives = 98/235 (41%), Gaps = 64/235 (27%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 232
           +VLG G  ++   GKV L+R           A+K L K       +  E ++    E  +
Sbjct: 60  KVLGTG--AY---GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQV 111

Query: 233 -ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
                  P +V L  +    E  L LI  Y++GG L  HL ++++      T      Y 
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY- 164

Query: 292 VALGIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA----------T 338
               + E V    +LH   +  +++RDIK  NILL S     L DFGL+           
Sbjct: 165 ----VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKT-DVYAFGVVLLELLTGRKP 391
           +         C    GT  Y+AP+  + G    DK  D ++ GV++ ELLTG  P
Sbjct: 218 YD-------FC----GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 93.2 bits (232), Expect = 9e-21
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 53/226 (23%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           RV+GRG  S+    KV L+R        A++ + KE    D++       + +   + +H
Sbjct: 58  RVIGRG--SY---AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 165

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK-------- 350
            + YLH   ER +++RD+K  N+LL S+   KL D+G            +CK        
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG------------MCKEGLRPGDT 209

Query: 351 --TVKGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             T  GT  Y+APE      +G      D +A GV++ E++ GR P
Sbjct: 210 TSTFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 252

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 35/232 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F   +V+GRG  +F   G+V +++        A+K L+K +   +  +  F  E  +  
Sbjct: 75  DFEILKVIGRG--AF---GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +     I  L  +    +  L+L+  Y  GG L   L +             +  Y    
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFY---- 180

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
            +AE V     +H       VHRDIKP NIL+      +L DFG                
Sbjct: 181 -LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL-KLMEDGTVQSSV 235

Query: 352 VKGTFGYLAPEYFQHGKVSDKT-----DVYAFGVVLLELLTGRKPIEARRLQ 398
             GT  Y++PE  Q  +          D ++ GV + E+L G  P  A  L 
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 26/225 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES----SKAFCRELMIASSL 236
            + K   LG G  + V+K +       VAIK  +L    +        A  RE+ +   L
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQEL 69

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L+      +  + L++ ++    LE  + +          L  S      L  
Sbjct: 70  SHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDNSLV------LTPSHIKAYMLMT 121

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +  + V  T 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TR 176

Query: 357 GYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGE 400
            Y APE     ++     D++A G +L ELL  R P     L G+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF----LPGD 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 38/223 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 238
            + +   LG G    V+K    +   +VAIK  RL+ E +E     A  RE+ +   L H
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAI-REVSLLKELQH 92

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NI+ L          L LI++Y          ++ KK +  N  +   V       +  
Sbjct: 93  RNIIELKSVIHH-NHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATWTSAPSVPFLCKTVK 353
            V + H    R  +HRD+KP N+LLS          K+ DFGLA     P   F  + + 
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 354 GTFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGR 389
            T  Y  PE       Y      S   D+++   +  E+L   
Sbjct: 200 -TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 40/231 (17%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMI---ASS 235
              F   R+ G+G    V  GK      SVAIK+   D   +       REL I    + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQIMQDLAV 75

Query: 236 LHHPNIVPL------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW--- 286
           LHHPNIV L      +G     +  L ++ +YV   +L R     +   R     P    
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC---RNYYRRQVAPPPILI 131

Query: 287 -SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA--TWTSA 342
               ++    +  S+  LH  +   V HRDIKP N+L++      KLCDFG A     S 
Sbjct: 132 KVFLFQ----LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 343 PSVPFLCKTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
           P+V ++C     +  Y APE  F +   +   D+++ G +  E++ G +PI
Sbjct: 187 PNVAYIC-----SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 56/218 (25%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 77

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 296
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREASEIMKSI 126

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 353
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG                  
Sbjct: 127 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG------------------ 165

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
                 A E     K     D+++ GV++  LL G  P
Sbjct: 166 -----FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 51/242 (21%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES--SKAFCRELMIASSLHH 238
            + K   +G+G    VFK +       VA+K   ++ E KE     A  RE+ I   L H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITAL-REIKILQLLKH 75

Query: 239 PNIVPLVGFCIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY- 290
            N+V L+  C             ++L++ +      E  L     G+  N  + +++   
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDL----AGLLSNVLVKFTLSEI 126

Query: 291 -KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP----SV 345
            +V   +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S        
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 346 PFLCKTVKGTFGYLAPE-------YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
            +  + V  T  Y  PE       Y          D++  G ++ E+ T R PI    +Q
Sbjct: 184 RYTNRVV--TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWT-RSPI----MQ 230

Query: 399 GE 400
           G 
Sbjct: 231 GN 232

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRE---LMIA 233
            +     +G GA   VFK +  L      VA+K  R+    +E        RE   L   
Sbjct: 12  QYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTG-EEGMPLSTI-REVAVLRHL 68

Query: 234 SSLHHPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
            +  HPN+V L         D E  L L++++V    L  +L +  +       +P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-----VPTETI 122

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA   S   +    
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTS 178

Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
             V  T  Y APE       +   D+++ G +  E+   RKP+
Sbjct: 179 VVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 22/219 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIV 242
           F    ++G G    V+KG+        AIK +D    E  +   +E+ +     HH NI 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84

Query: 243 P-----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                 +       +  L+L+ ++   GS+   +   K       TL       +   I 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREIL 139

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             +++LH   +  V+HRDIK  N+LL+     KL DFG++             T  GT  
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPY 194

Query: 358 YLAPEYFQHGKVSD-----KTDVYAFGVVLLELLTGRKP 391
           ++APE     +  D     K+D+++ G+  +E+  G  P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+  E  +   +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            +   G C   E   +L+ +Y  G +       ++ L E +                V  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-------------VTH 161

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK--TV 352
           G  + +AYLH+     ++HRD+K  NILLS   + KL DFG A+         +    + 
Sbjct: 162 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANSF 210

Query: 353 KGTFGYLAPE---YFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            GT  ++APE       G+   K DV++ G+  +EL   + P
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 53/216 (24%), Positives = 104/216 (48%), Gaps = 23/216 (10%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHH 238
              +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 239 PNIVPLV-----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            NI+ L+        ++  Q ++++ + +   +L + +  +    R +  L     Y++ 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL-----YQML 137

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
            GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA   +A +   +   V 
Sbjct: 138 CGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYV- 187

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
            T  Y APE        +  D+++ G ++ E++ G 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 27/216 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 241
           ++   R LGRG  S VF+         V +K L    K+  K   RE+ I  +L   PNI
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNI 93

Query: 242 VPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAES 299
           + L     DP      L++++V+    ++             TL  + +R+ +   I ++
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYM-YEILKA 142

Query: 300 VAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAPSVPFLCKTVK-GTFG 357
           + Y H      ++HRD+KP N+++    +  +L D+GLA +   P   +    V+  +  
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY---NVRVASRY 195

Query: 358 YLAPEYFQHGKVSDKT-DVYAFGVVLLELLTGRKPI 392
           +  PE     ++ D + D+++ G +L  ++  ++P 
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.9 bits (210), Expect = 9e-18
 Identities = 51/209 (24%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 246 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   ++  Q ++L+ +      ++ +L +  +    +  + + + Y++  GI    
Sbjct: 128 NVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL-YQMLCGIK--- 178

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA   +A +   +   V  T  Y A
Sbjct: 179 -HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYV-VTRYYRA 231

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE        +  D+++ G ++ E++  +
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 30/219 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL--- 244
           + LG G    VF          VAIK++   D +S K   RE+ I   L H NIV +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 245 ----------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
                         +     ++++ +Y     +E  L      +     L    R     
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLA---NVLEQGPLLEEHARL-FMY 127

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLA--TWTSAPSVPFLCKT 351
            +   + Y+H+     V+HRD+KP+N+ ++++ +  K+ DFGLA            L + 
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 352 VKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           +  T  Y +P         +   D++A G +  E+LTG+
Sbjct: 185 L-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 57/250 (22%), Positives = 93/250 (37%), Gaps = 56/250 (22%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 241
            +S G+ LG G+   V +          A+K++ ++ +     +  REL I   L H NI
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNI 62

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------------ 289
           + L         G              +   +       + ++  +              
Sbjct: 63  IKL--VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 290 ----YKVALGIAES-------------------VAYLHNGTERCVVHRDIKPSNILLSSK 326
               +KV      S                   V ++H+     + HRDIKP N+L++SK
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177

Query: 327 K-IPKLCDFGLA--TWTSAPSVPFLCKTVKGTFGYLAPE-YFQHGKVSDKTDVYAFGVVL 382
               KLCDFG A     S PSV ++C     +  Y APE      + +   D+++ G V 
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYIC-----SRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 383 LELLTGRKPI 392
            EL+ G KP+
Sbjct: 233 GELILG-KPL 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/279 (21%), Positives = 99/279 (35%), Gaps = 74/279 (26%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRL-DKEDKESSKAFCRELMIASS 235
                G+ LGRGA   V +    G+ +     +VA+K L +       +A   EL I   
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----Y 290
           + HH N+V L+G C  P   L +I ++   G+L  +L  K+       T     R    Y
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141

Query: 291 KVALGI----------------------AESVAYLHNGTERCVVHRDIKPSNIL------ 322
             A+ +                       +S++ +        +++D      L      
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201

Query: 323 -------LSSKKIP-----------------KLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
                  L+S+K                   K+CDFGLA              V+     
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDAR 256

Query: 359 L-----APEYFQHGKVSDKTDVYAFGVVLLELLT-GRKP 391
           L     APE       + ++DV++FGV+L E+ + G  P
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 36/221 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 246
            +LG GA   V           VAIK+++  +    +    RE+ I     H NI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76

Query: 247 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 297
                       +++I +      ++  LH   + +         ++Y +     A+   
Sbjct: 77  IQRPDSFENFNEVYIIQEL-----MQTDLH---RVISTQMLSDDHIQYFIYQTLRAV--- 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
                LH      V+HRD+KPSN+L++S    K+CDFGLA      +      T + +  
Sbjct: 126 ---KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 358 --------YLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 389
                   Y APE      K S   DV++ G +L EL   R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 31/215 (14%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 246
             +G GA   V      L +  VAIK++   E +   +   RE+ I     H NI+ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92

Query: 247 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 297
               P     + ++++        +E  L+   K ++        + Y +      L   
Sbjct: 93  IIRAPTIEQMKDVYIVQDL-----METDLY---KLLKTQHLSNDHICYFLYQILRGL--- 141

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLCKTVKGT 355
               Y+H+     V+HRD+KPSN+LL++    K+CDFGLA           FL + V  T
Sbjct: 142 ---KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-AT 194

Query: 356 FGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 389
             Y APE        +   D+++ G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 26/210 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK+L +  + +  +K   REL++   + H N++ L+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 246 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                          +L+  +     ++  L +          + + V Y++  G+    
Sbjct: 90  DVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLV-YQMLKGLK--- 140

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     VVHRD+KP N+ ++     K+ DFGLA          +   V  T  Y A
Sbjct: 141 -YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYV-VTRWYRA 191

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE        +   D+++ G ++ E+LTG+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 47/210 (22%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V     G     VAIK+L +  + +  +K   REL +   + H N++ L+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 246 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   +D     +L+  +     +   L    K ++        +++ V   + + +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPF-----MGTDLG---KLMKHEKLGEDRIQFLV-YQMLKGL 141

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H      ++HRD+KP N+ ++     K+ DFGLA          +   V  T  Y A
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYV-VTRWYRA 193

Query: 361 PEY-FQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE      + +   D+++ G ++ E++TG+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 25/210 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VA+K+L +  +    +K   REL +   + H N++ L+
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 246 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                         ++L+        +   L+     V+        V++ +   I   +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHL-----MGADLN---NIVKCQKLTDDHVQFLI-YQILRGL 145

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            Y+H+     ++HRD+KPSN+ ++     K+ DFGLA  T+      +   V  T  Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYV-ATRWYRA 197

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTGR 389
           PE        +   D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
            +    ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 241 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW----SVRYKV 292
           +V ++   I  +      L+++ +       +       K  R    L      ++ Y +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFK---KLFRTPVYLTELHIKTLLYNL 165

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +G+     Y+H+     ++HRD+KP+N L++     K+CDFGLA
Sbjct: 166 LVGVK----YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
            ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    I+ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 246 GFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV-----ALG 295
              I  +      L+++ +       +  L    K  +    L    ++  +        
Sbjct: 92  DLIIPDDLLKFDELYIVLEI-----ADSDLK---KLFKTPIFLTEEHIKTILYNLLLGE- 142

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 ++H      ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 143 -----NFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 36/221 (16%)

Query: 188 RVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKE-------SSKAFC----RELMIAS 234
           R +  G+   V  G    G     VAIKR+     +       S    C    RE+ + +
Sbjct: 28  RFISSGSYGAVCAGVDSEG---IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 235 SLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
             HHPNI+ L    +  E      L+L+ +      +   L    + +     +      
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA---QVIHDQRIVISPQHI 136

Query: 291 KVAL-GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           +  +  I   +  LH      VVHRD+ P NILL+      +CDF LA      +     
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA--REDTADANKT 191

Query: 350 KTVKGTFGYLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGR 389
             V     Y APE   Q    +   D+++ G V+ E+   +
Sbjct: 192 HYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 47/234 (20%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 244
           + LG+GA   V+K         VA+K++    ++   ++   RE+MI + L  H NIV L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 245 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIAE 298
           +        + ++L++ Y     +E  LH     +R N   P   +Y V      +    
Sbjct: 75  LNVLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQYVVYQLIKVI---- 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVKGTFG 357
              YLH+G    ++HRD+KPSNILL+++   K+ DFGL+ ++ +   V            
Sbjct: 123 --KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 358 ------------------YLAPEY-FQHGKVSDKTDVYAFGVVLLELLTGRKPI 392
                             Y APE      K +   D+++ G +L E+L   KPI
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI 230

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 44/240 (18%), Positives = 87/240 (36%), Gaps = 59/240 (24%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIK--------------------RLDKEDKESSKAFC 227
            ++G+G+   V K    + +  VAIK                     ++K D E      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE--KKKGVRGNSTLP 285
              +    +   ++      C+  E              L  +L++  +    RG   + 
Sbjct: 120 H--LKRHFMFRNHL------CLVFE-------------MLSYNLYDLLRNTNFRG---VS 155

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAP 343
            ++  K A  +  ++ +L       ++H D+KP NILL + K    K+ DFG +      
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
              ++      +  Y +PE           D+++ G +L+E+ TG +P+      G   +
Sbjct: 215 IYQYIQ-----SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL----FSGANEV 264

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 15/115 (13%)

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFL 348
           K A  I + +  LH   +  ++H D+KP NILL  +     K+ DFG + +       ++
Sbjct: 204 KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
                 +  Y APE     +     D+++ G +L ELLTG  P+    L GE+  
Sbjct: 261 Q-----SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPL----LPGEDEG 305

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 38/224 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---------- 237
           R LG G  S V+  K  +  T VA+K + + DK  ++A   E+ +   ++          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 238 -HPNIVPLVG-FCIDPEQG--LFLIYKYVSGGSLERHLHE--KKKGVRGNSTLPWSVRYK 291
              +I+ L+  F      G  + ++++      L  +L    KK   RG   +P     +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRG---IPLIYVKQ 135

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP------KLCDFGLATWTSAPSV 345
           ++  +   + Y+H      ++H DIKP N+L+     P      K+ D G A W      
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR 389
             +      T  Y +PE           D+++   ++ EL+TG 
Sbjct: 194 NSIQ-----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 57/295 (19%), Positives = 98/295 (33%), Gaps = 82/295 (27%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-----ASSLHHPN---I 241
           LG G  S V+       +  VA+K + K  +  ++    E+ +      S  + PN   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 242 VPLVG-FCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           V L+  F I    G  + ++++ V G  L + + +          LP     K+   + +
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIK-----SNYQGLPLPCVKKIIQQVLQ 157

Query: 299 SVAYLHNGTERCVVHRDIKPSNILL----------------------------------- 323
            + YLH  T+  ++H DIKP NILL                                   
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 324 --------------SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV 369
                         + K   K+ D G A W        +      T  Y + E       
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270

Query: 370 SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP 424
           +   D+++   +  EL TG    E    +       + +   H  +A + ELL  
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEE------YTRDEDH--IALIIELLGK 317

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.8 bits (123), Expect = 2e-07
 Identities = 30/213 (14%), Positives = 52/213 (24%), Gaps = 58/213 (27%)

Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF--------- 226
              T    +   +G G    VF+       T VAIK   ++  D  +             
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 227 ------CRELMIASSLHHPNIVPLVGFCI-----------------------------DP 251
                    L           + L                                    
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 311
           +  LF++ ++  GG     +  K            +    +   +  S+A          
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSS--------LATAKSILHQLTASLAVAEASLR--F 183

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            HRD+   N+LL    + KL        ++ PS
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 35/193 (18%), Positives = 64/193 (33%), Gaps = 31/193 (16%)

Query: 167 NSLIRLSYGEILAAT--HNFSKGRVLGRGALSFVFKG--------KVGLLRTSVAIK--- 213
            SL  L  G +L       +       R     +++           G  +   ++K   
Sbjct: 25  TSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA 84

Query: 214 ---RLDKEDK----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
              RL  E       +      +     S     I   +GF +  ++  FL+   + G S
Sbjct: 85  KDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRS 143

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
           L+  L    K       L      +VA  + +++ +LH   E   VH ++   NI +  +
Sbjct: 144 LQSALDVSPKH-----VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE 195

Query: 327 KIPK--LCDFGLA 337
              +  L  +G A
Sbjct: 196 DQSQVTLAGYGFA 208

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 31/170 (18%), Positives = 63/170 (37%), Gaps = 30/170 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--------------KAFCRELMI 232
           G+ +G G    ++           A   +  E +E+               K   ++ + 
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 233 ASSLHHPNIVPLVGFCIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
              L +  I    G  +   +G    F++ + + G  L++   +             S  
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT-------FKKSTV 153

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 337
            ++ + + + + Y+H   E   VH DIK +N+LL  K   +  L D+GL+
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 5/38 (13%)

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 337
           Y+H   E   VH DIK SN+LL+ K   +  L D+GLA
Sbjct: 167 YIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 25/165 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF  G+ +G G    +  GK       VAIK    + +        E      L   + +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGI 67

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA----E 298
           P V +     +   ++ + + G SLE  L +            +S+  K  L IA     
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRT-------FSL--KTVLMIAIQLIS 116

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT 338
            + Y+H+   + +++RD+KP N L+            + DF LA 
Sbjct: 117 RMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 61/459 (13%), Positives = 126/459 (27%), Gaps = 156/459 (33%)

Query: 9   SKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNN 68
           SK  +  + +   ++  NY ++ + +    E +  +++ +M                 + 
Sbjct: 73  SKQEEMVQKFVEEVLRINY-KF-LMSPIKTEQRQPSMMTRM------------YIEQRDR 118

Query: 69  RINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQS---VH-------SSFRFSLCSQV 118
             ND+   +K +         L ++    L    P     +        +     +C   
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQA----LLELRPAKNVLIDGVLGSGKTWVALDVCLSY 174

Query: 119 ELES--------MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLI 170
           +++         +N+    S   ++  L+  L                + S +      I
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQK-LLYQIDPNWT----SRSDHSSN------I 223

Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAF--- 226
           +L    I              +  L  + K K       + +  L   ++ ++  AF   
Sbjct: 224 KLRIHSI--------------QAELRRLLKSKP--YENCLLV--LLNVQNAKAWNAFNLS 265

Query: 227 CRELMI-----------ASSLHHPNIVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEK 274
           C+ L+            A++  H ++          P++   L+ KY         L  +
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEVKSLLLKY---------LDCR 314

Query: 275 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 334
                    LP                      E    +    P    LS   I +    
Sbjct: 315 P------QDLP---------------------REVLTTN----P--RRLSI--IAESIRD 339

Query: 335 GLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHGKVSDKTDVY-AFGV----VLLELLT 387
           GLATW +   V    L   ++ +   L P  ++         ++    V           
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK--------MFDRLSVFPPSA------ 385

Query: 388 GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL 426
               I    L      ++W   I    M  V +L    L
Sbjct: 386 ---HIPTILLS-----LIWFDVIKSDVMVVVNKLHKYSL 416

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 2e-04
 Identities = 67/496 (13%), Positives = 134/496 (27%), Gaps = 180/496 (36%)

Query: 102 DPQSVHSSFRFSLCSQVELES-MNIGASASATVLMVNLENGLCDSRAQELK--------- 151
           D + V    + S+ S+ E++  +    + S T+ +      L   + + ++         
Sbjct: 34  DCKDVQDMPK-SILSKEEIDHIIMSKDAVSGTLRLFWT---LLSKQEEMVQKFVEEVLRI 89

Query: 152 -----WRKIQSLERSISPVANSLIRLSYGEILAATHN----FSKGRV--------LGRGA 194
                   I+       P   S++   Y E     +N    F+K  V        L R A
Sbjct: 90  NYKFLMSPIK--TEQRQP---SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL-RQA 143

Query: 195 LS-------FVFKGKVGLLRTSVAIKRLDKEDKESSKAF---------CRE----LMIAS 234
           L         +  G +G  +T VA+        +    F         C      L +  
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            L +  I P   +    +    +  +  S    L R L  K               Y+  
Sbjct: 204 KLLY-QIDP--NWTSRSDHSSNIKLRIHSIQAELRRLLKSK--------------PYENC 246

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           L                +V  ++        + K     +               CK + 
Sbjct: 247 L----------------LVLLNV-------QNAKAWNAFNLS-------------CKILL 270

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLE-LLTGRKPIEARRLQGEENLVLWAK---- 408
            T         +  +V+D         + L+       P E + L     L+ +      
Sbjct: 271 TT---------RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-----LLKYLDCRPQ 316

Query: 409 ----------PILHRGMAAVEELLDPRLKCTSRNSAQI-----ARVIQAAAACISSEESR 453
                     P     + A E + D     T  N   +       +I+++   +   E R
Sbjct: 317 DLPREVLTTNP-RRLSIIA-ESIRDG--LATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 454 R--------------PGIEEIIAIL-----RGEEELI------YCTWKKHNFSGII---D 485
           +              P    +++++     + +  ++      Y   +K      I    
Sbjct: 373 KMFDRLSVFPPSAHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS 430

Query: 486 CYPQLQQTKSEMKS-H 500
            Y +L+       + H
Sbjct: 431 IYLELKVKLENEYALH 446

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 44/138 (31%)

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KL 331
            +A  +  ++ +LH   E  + H D+KP NIL  + +                     ++
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFGVVLLEL 385
            DFG AT+        +      T  Y  PE      +      +   DV++ G +L E 
Sbjct: 184 ADFGSATFDHEHHTTIVA-----TRHYRPPEVILELGW------AQPCDVWSIGCILFEY 232

Query: 386 LTGRKPIEARRLQGEENL 403
             G   +     Q  EN 
Sbjct: 233 YRG-FTL----FQTHENR 245

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 32/138 (23%), Positives = 48/138 (34%), Gaps = 44/138 (31%)

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KL 331
           K+A  I +SV +LH      + H D+KP NIL                          K+
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFGVVLLEL 385
            DFG AT+        +      T  Y APE      +      S   DV++ G +L+E 
Sbjct: 179 VDFGSATYDDEHHSTLVS-----TRHYRAPEVILALGW------SQPCDVWSIGCILIEY 227

Query: 386 LTGRKPIEARRLQGEENL 403
             G   +        ++ 
Sbjct: 228 YLG-FTV----FPTHDSK 240

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 34/144 (23%), Positives = 52/144 (36%), Gaps = 50/144 (34%)

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--------------------- 329
              + I +++ YL    +  + H D+KP NILL                           
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 330 ----KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE------YFQHGKVSDKTDVYAFG 379
               KL DFG AT+ S      +      T  Y APE      +         +D+++FG
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIIN-----TRQYRAPEVILNLGW------DVSSDMWSFG 246

Query: 380 VVLLELLTGRKPIEARRLQGEENL 403
            VL EL TG   +     +  E++
Sbjct: 247 CVLAELYTG-SLL----FRTHEHM 265

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 53/224 (23%), Positives = 82/224 (36%), Gaps = 32/224 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---- 298
           P V +         L+   + G SLE  L +     R  S        K     A+    
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCG--RKFSV-------KTVAMAAKQMLA 117

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT-WTSAPS---VPFL- 348
            V  +H   E+ +V+RDIKP N L+            + DFG+   +    +   +P+  
Sbjct: 118 RVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 349 CKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKP 391
            K + GT  Y        G+  S + D+ A G V +  L G  P
Sbjct: 175 KKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	520
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.98
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.71
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.51
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.38
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.13
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.12
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.96
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.93
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.82
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.55
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.86
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.0
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.28
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.58

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3e-56  Score=451.29  Aligned_cols=263  Identities=25%  Similarity=0.395  Sum_probs=211.8

Q ss_pred             CCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||+||+|++.     .++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+ .++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEE
Confidence            57888999999999999999874     347789999998877777889999999999999999999999987754 589


Q ss_pred             EEEEecCCCChhHHhhhhcc------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          257 LIYKYVSGGSLERHLHEKKK------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~------~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ||||||++|+|.++|+....      .......++|..+..|+.||++||+|||+.+   ||||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            99999999999999976421      0112357999999999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhh
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+   +..    
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~----  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence            999999987654433333344679999999999999999999999999999999999 999997643221   111    


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                             .+..-  ..+..+...+   ..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       242 -------~i~~~--~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          242 -------CITQG--RVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             -------HHHHT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHHcC--CCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   11110  1122222233   3466788899999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-55  Score=452.81  Aligned_cols=264  Identities=24%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             CCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+ .++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-PLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence            57888899999999999999864     357889999998877777889999999999999999999999987754 589


Q ss_pred             EEEEecCCCChhHHhhhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          257 LIYKYVSGGSLERHLHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~--------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      ||||||++|+|.++|+.....        .....+++|..++.|+.|||+||+|||+.+   ||||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            999999999999999864321        011256999999999999999999999987   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+   +..  
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~--  271 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID--  271 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH--
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence            99999999987655443333455679999999999999999999999999999999999 999997643221   111  


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                               .+.+-  .++..+...+   ..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       272 ---------~i~~g--~~~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 ---------CITQG--RELERPRACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             ---------HHHHT--CCCCCCTTCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------HHHcC--CCCCCccccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence                     11111  1222222233   34667888999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-55  Score=446.42  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .+++...+.||+|+||+||+|++..   .||||+++..  ..+..+.|.+|+.++++++|||||+++|+|.+  +.++||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEE
Confidence            3578889999999999999998753   5999998643  34566789999999999999999999998754  347999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.++|+...      ..++|..+..|+.|||+||+|||+.+   ||||||||+||||++++.+||+|||+|+
T Consensus       110 mEy~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~  180 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT  180 (307)
T ss_dssp             EECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred             EEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence            99999999999997643      56999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ...............||+.|||||++..   +.|+.++|||||||+||||+||+.||........  +    .....   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~----~~~~~---  251 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--I----IFMVG---  251 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHH---
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--H----HHHHh---
Confidence            7654433333456689999999999964   4689999999999999999999999975432211  1    11111   


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                         .....|.+..  ........+.+++.+||+.||++||||.||++.|+.++
T Consensus       252 ---~~~~~p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          252 ---RGYASPDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ---TTCCCCCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence               1112222221  11122345677889999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.2e-56  Score=449.94  Aligned_cols=262  Identities=28%  Similarity=0.374  Sum_probs=208.3

Q ss_pred             CcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++...+.||+|+||+||+|.+.     .+++.||||++.... ....++|.+|+.++++++|||||+++|+|.+.+ .++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-PLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-EEE
Confidence            4566789999999999999863     356789999997543 344578999999999999999999999987754 579


Q ss_pred             EEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      ||||||++|+|.++|.......         .....++|..+..|+.|||+||+|||+.+   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999997643110         01246999999999999999999999988   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~  406 (520)
                      .+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654433333455679999999999999999999999999999999998 899997643321   1110


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                                 +..  ...+..+...+   ..+.+++.+||+.||++||||.||++.|+..
T Consensus       260 -----------i~~--~~~~~~p~~~~---~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 -----------IRN--RQVLPCPDDCP---AWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------HHT--TCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------HHc--CCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       111  01122222233   3467788999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-54  Score=445.35  Aligned_cols=250  Identities=22%  Similarity=0.360  Sum_probs=208.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ..|+..+.||+|+||+||+|+++.+++.||||++........+.+.+|+.+|+.++|||||++++++.+. +.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeC
Confidence            4699999999999999999999999999999999766555556788999999999999999999998774 468999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |++|+|.+++..        ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus       153 ~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          153 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            999999999875        45999999999999999999999988   9999999999999999999999999998775


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........   .   .        .+...
T Consensus       222 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~--------~i~~~  285 (346)
T 4fih_A          222 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---K--------MIRDN  285 (346)
T ss_dssp             SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---H--------HHHHS
T ss_pred             CCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---H--------HHHcC
Confidence            4322  23567899999999999999999999999999999999999999976432211   0   0        12222


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+....   .....+.+++.+||+.||++|||+.|+++
T Consensus       286 ~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 LPPRLKNLH---KVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCCCCSCGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222332211   12245677889999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-54  Score=445.65  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|++..+++.||||++.+.  .....+.|.+|+.+|++|+|||||++++++.+. +.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEE
Confidence            5899999999999999999999999999999999764  344567899999999999999999999998764 5689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||+||+|.++|.....     ..+++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus       103 Ey~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             eCCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccccee
Confidence            99999999999976432     56899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....  ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||.......   +   .           .
T Consensus       175 ~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~-----------~  235 (350)
T 4b9d_A          175 LNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---L---V-----------L  235 (350)
T ss_dssp             CCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---H-----------H
T ss_pred             ecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---H-----------H
Confidence            64321  12345679999999999999999999999999999999999999997643221   1   1           1


Q ss_pred             HhhCcccC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~-~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .++..... .+...+   ..+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~i~~~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          236 KIISGSFPPVSLHYS---YDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHTCCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCCccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111 111122   34677888999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-53  Score=430.04  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC---CCcEEEEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLIY  259 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~~~LV~  259 (520)
                      ...+.||+|+||+||+|.+..++..||+|++...  .....+.|.+|++++++++|||||++++++.+.   +..++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5567899999999999999999999999999654  344567899999999999999999999988642   34579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~  338 (520)
                      |||++|+|.+++...       ..+++..+..|+.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+
T Consensus       109 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999864       56999999999999999999999865 4599999999999998 48999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....    .....+||+.|||||++. ++|+.++|||||||+||||+||+.||.......  .+.   .        .+
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~---~--------~i  242 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---R--------RV  242 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---H--------HH
T ss_pred             eCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHH---H--------HH
Confidence            65432    235678999999999886 469999999999999999999999997532211  110   0        01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+... +...+   ..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~-~~~~~---~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          243 TSGVKPASF-DKVAI---PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCCCGGG-GGCCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCCCC-CccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111100 11112   24667889999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-54  Score=437.15  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|++..+++.||||++.+..   ....+.+.+|+++|++++|||||++++++.+ ++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            47999999999999999999999999999999997542   2345678999999999999999999998766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||+||+|.+++...       ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus       111 mEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999999865       56999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .+..........+.+||+.|||||++.+..|+.++||||+||+||||++|+.||.......   +              +
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~--------------~  243 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---I--------------F  243 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------H
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H--------------H
Confidence            8765443334456789999999999999999999999999999999999999997643221   1              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII  461 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl  461 (520)
                      ..++...+..+...+   ..+.+++.+||+.||++|||+.|++
T Consensus       244 ~~i~~~~~~~p~~~s---~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          244 AKIIKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHTCCCCCTTCC---HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHcCCCCCCcccC---HHHHHHHHHHccCCHhHCcChHHHc
Confidence            112222222222222   3466788999999999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.7e-54  Score=442.39  Aligned_cols=271  Identities=25%  Similarity=0.402  Sum_probs=216.5

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCC-----CcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCC-CCeecEEEEE
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED-KESSKAFCRELMIASSLHH-PNIVPLVGFC  248 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~H-pnIv~l~g~~  248 (520)
                      ++....++|..++.||+|+||+||+|.+...     ++.||||++.... ....+.|.+|+.+|++++| ||||+++|+|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            3344557899999999999999999987543     3679999997653 3446789999999999965 9999999999


Q ss_pred             EcCCCcEEEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       249 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      .+.+..++||||||++|+|.++|+......         .....++|..+..|+.|||+||+|||+.+   ||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcc
Confidence            876666899999999999999998643210         11246899999999999999999999988   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQ  398 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~  398 (520)
                      ||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997765544334456679999999999999999999999999999999998 99999764322


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .  .+    ..       .+.+-.  ++..+...+.   .+.+++.+||+.||++|||+.||++.|+.+
T Consensus       295 ~--~~----~~-------~i~~g~--~~~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          295 E--EF----CR-------RLKEGT--RMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             H--HH----HH-------HHHHTC--CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--HH----HH-------HHHcCC--CCCCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1  11    11       111111  2222333333   466778899999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-53  Score=437.57  Aligned_cols=253  Identities=24%  Similarity=0.286  Sum_probs=203.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .+.|...+.||+|+||+||+|+++.+++.||||++.....     +.+|+.+++.++|||||++++++.+. +.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEe
Confidence            4578888999999999999999999999999999976432     24699999999999999999998764 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~~  339 (520)
                      ||+||+|.++|...       ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.
T Consensus       131 y~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            99999999999864       46999999999999999999999888   99999999999999987 699999999987


Q ss_pred             cCCCCCC---cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVP---FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +......   ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...........      +....  
T Consensus       201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~--  272 (336)
T 4g3f_A          201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEP--  272 (336)
T ss_dssp             C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHSC--
T ss_pred             ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcCC--
Confidence            6543211   122346799999999999999999999999999999999999999986543321111      11000  


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                            .+....+...+   ..+.+++.+||+.||.+|||+.||++.|..
T Consensus       273 ------~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          273 ------PPIREIPPSCA---PLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ------CGGGGSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCchhcCccCC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                  00001111222   346677889999999999999999988764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.1e-54  Score=434.11  Aligned_cols=273  Identities=22%  Similarity=0.265  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---cEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~~~LV  258 (520)
                      ++|...+.||+|+||+||+|++.  |+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+.   .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            35788899999999999999984  789999999754322 2233456666678999999999999986543   47999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCCeEecCCCceEEee
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ||||++|+|.++|+.        ..++|..+.+|+.|+++||+|||+.+     .++||||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             ecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999975        46999999999999999999999862     33599999999999999999999999


Q ss_pred             cCCccccCCCCCC--cccccccccCCccCchhcccC------CCCCcCceeeHHHHHHHHHhCCCCcchhccccchh--h
Q 010012          334 FGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN--L  403 (520)
Q Consensus       334 FGla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~--l  403 (520)
                      ||+|+........  .......||+.|||||++.+.      .++.++|||||||+||||+||++||..........  .
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            9999876543321  122345799999999999754      46789999999999999999998876433211100  0


Q ss_pred             H--HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          404 V--LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       404 v--~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .  .+....+...  .....++|.+.......+....+.+++.+||+.||++||||.||++.|+.+
T Consensus       232 ~~~~~~~~~~~~~--~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          232 VPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SCSSCCHHHHHHH--HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccchHHHHHHH--HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            0  0000000000  112223343332222345667788999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-53  Score=445.84  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=209.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ..|+..+.||+|+||+||+|.++.+++.||||++........+.+.+|+.+|+.++|||||++++++.+. +.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeC
Confidence            5799999999999999999999999999999999876555556788999999999999999999998775 468999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |+||+|.+++..        ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus       230 ~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          230 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            999999999864        45999999999999999999999988   9999999999999999999999999998775


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........   .   .        .+...
T Consensus       299 ~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~---~--------~i~~~  362 (423)
T 4fie_A          299 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M---K--------MIRDN  362 (423)
T ss_dssp             SSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---H--------HHHHS
T ss_pred             CCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H---H--------HHHcC
Confidence            4332  23567899999999999999999999999999999999999999976432211   0   0        12222


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.+......+   ..+.+|+.+||+.||++|||+.|+++
T Consensus       363 ~~~~~~~~~~~s---~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 LPPRLKNLHKVS---PSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCCCCSCTTSSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCcccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            233333222223   34667888999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-52  Score=418.45  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=190.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++.+..   ......+.+|+.++++++|||||++++++.+ ++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            58999999999999999999999899999999997642   2335678999999999999999999998766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||| +|+|.+++...       ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        92 mEy~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EeCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCe
Confidence            9999 78999999764       56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......   ...+..||+.|||||++.+..+ +.++||||+||+||||+||+.||.......   +              
T Consensus       161 ~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~--------------  220 (275)
T 3hyh_A          161 IMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---L--------------  220 (275)
T ss_dssp             -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------
T ss_pred             ecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---H--------------
Confidence            765433   2345679999999999988776 579999999999999999999997543211   1              


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+...+   ..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          221 FKNISNGVYTLPKFLS---PGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHHTCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111111222222222   34667888999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-52  Score=424.78  Aligned_cols=243  Identities=27%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             CCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|+..+.||+|+||+||+|+..   .+++.||||++.+..  ......+.+|+++|++++|||||++++++.+ ++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence            47999999999999999999863   457899999997642  1223467889999999999999999999876 45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      ||||||+||+|.+++...       ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+
T Consensus       103 ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999865       56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      |+.......  ......||+.|||||++.+..|+.++|||||||+||||+||+.||......+.                
T Consensus       173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------  234 (304)
T 3ubd_A          173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET----------------  234 (304)
T ss_dssp             EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH----------------
Confidence            986543322  23456799999999999999999999999999999999999999976433211                


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                       +..+....+..+...+   ..+.+++.+||+.||++|||.
T Consensus       235 -~~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          235 -MTMILKAKLGMPQFLS---PEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSGGGSTTC
T ss_pred             -HHHHHcCCCCCCCcCC---HHHHHHHHHHcccCHHHCCCC
Confidence             1112222222222223   346678889999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-51  Score=414.72  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=190.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC--------
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ--------  253 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--------  253 (520)
                      +|+..+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.        
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            6899999999999999999999899999999997543 3445678999999999999999999999875443        


Q ss_pred             ---cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          254 ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       254 ---~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                         .+|+|||||++|+|.+++......    ...++..++.|+.||++||+|||+++   ||||||||+||||+.++.+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSG----GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCC----ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence               368999999999999999764321    34567788899999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCc----------ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccc
Q 010012          331 LCDFGLATWTSAPSVPF----------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  400 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~----------~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~  400 (520)
                      |+|||+|+.........          ..+..+||+.|||||++.+..|+.++|||||||+||||++   ||......  
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--  233 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--  233 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--
Confidence            99999998765432111          1234579999999999999999999999999999999996   77542210  


Q ss_pred             hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       401 ~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ..           .+..+.+...  +.........+.+++.+||+.||++|||+.||++
T Consensus       234 ---~~-----------~~~~~~~~~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 ---VR-----------TLTDVRNLKF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ---HH-----------HHHHHHTTCC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HH-----------HHHHHhcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               00           0111111111  1111122234567889999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=408.35  Aligned_cols=270  Identities=19%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-----CCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~  254 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.+.  .....+.+.+|+++|+.++|||||++++++...     .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999754  234456788999999999999999999986532     245


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +|||||||. |+|.+++...       ..+++..+..|+.||+.||+|||+++   ||||||||+|||++.++.+||+||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeec
Confidence            899999995 7899998753       57999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCC--CcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH-
Q 010012          335 GLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI-  410 (520)
Q Consensus       335 Gla~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-  410 (520)
                      |+|+.+.....  .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+...... 
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987643211  1223457899999999998875 5699999999999999999999999865433222211110000 


Q ss_pred             ----hhh-chhHHHHhhCcccCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 ----LHR-GMAAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ----~~~-~~~~l~~~~d~~l~~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          +.. ........+...........     .....+.+|+.+||+.||.+|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                000 00000000000000000000     11245778899999999999999999886

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.7e-48  Score=390.43  Aligned_cols=286  Identities=33%  Similarity=0.616  Sum_probs=235.5

Q ss_pred             cccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc
Q 010012          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (520)
Q Consensus       171 ~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~  250 (520)
                      ++++.++..++++|...+.||+|+||+||+|.+. ++..||||++........+.+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            4455556668899999999999999999999976 588999999987766677889999999999999999999999766


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      . ...++||||+++|+|.+++.....   ....++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       107 ~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          107 R-NEMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             T-TCCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred             C-CeEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence            4 457999999999999999975432   1246999999999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.............|....
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998755433333334556999999999999999999999999999999999999999876655555555555443


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ....  .+...+++.+.. .........+.+++.+||+.||++|||+.||++.|+..
T Consensus       260 ~~~~--~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          260 HNNG--QLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HTTT--CCCSSSSSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccc--cHHHhcChhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            3222  344455555442 23567778899999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-47  Score=396.12  Aligned_cols=200  Identities=25%  Similarity=0.353  Sum_probs=168.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..+.|.+.+.||+|+||+||+|+.+   .+++.||||++....  ...++.+|+++|+.+ +|||||++++++.+ .+.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEE
Confidence            3468999999999999999999864   357889999987653  235678999999998 69999999998766 4568


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEeec
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDF  334 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~DF  334 (520)
                      ++|||||++|+|.+++.          .+++..+..++.||+.||+|||+++   ||||||||+||||+.+ +.+||+||
T Consensus        96 ~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999883          4899999999999999999999988   9999999999999877 79999999


Q ss_pred             CCccccCCCCCC--------------------------cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHh
Q 010012          335 GLATWTSAPSVP--------------------------FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLT  387 (520)
Q Consensus       335 Gla~~~~~~~~~--------------------------~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELlt  387 (520)
                      |+|+........                          ......+||+.|+|||++.+. .++.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999865432211                          012345799999999999875 58999999999999999999


Q ss_pred             CCCCcchh
Q 010012          388 GRKPIEAR  395 (520)
Q Consensus       388 G~~Pf~~~  395 (520)
                      |+.||...
T Consensus       243 G~~Pf~~~  250 (361)
T 4f9c_A          243 GRYPFYKA  250 (361)
T ss_dssp             TCSSSSCC
T ss_pred             CCCCCCCC
Confidence            99999643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-47  Score=418.82  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=208.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|.+.+.||+|+||+||+|.++.+++.||+|++........+.+.+|+.+|+.++|||||++++++.+ +..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEee
Confidence            589999999999999999999999999999999987766667788999999999999999999998766 4568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC--CceEEeecCCccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLATW  339 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~--~~vkL~DFGla~~  339 (520)
                      |+||+|.++|....      ..+++..+..++.||+.||+|||+++   |+||||||+||||+.+  +.+||+|||+|+.
T Consensus       236 ~~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          236 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             CCCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             cCCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999996532      46999999999999999999999988   9999999999999854  8999999999998


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      +....   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........                 +.
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-----------------~~  366 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LR  366 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----------------HH
T ss_pred             ccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----------------HH
Confidence            76443   23456799999999999999999999999999999999999999976443211                 11


Q ss_pred             HhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.......+. ........+.+|+.+||+.||.+|||+.|+++
T Consensus       367 ~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          367 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111000 00111234677889999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5e-47  Score=417.39  Aligned_cols=249  Identities=26%  Similarity=0.337  Sum_probs=200.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|...++||+|+||+||+|+.+.+++.||||++.+...      ........++.+++.++|||||++++++.+ ...+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEE
Confidence            689999999999999999999999999999999975321      112223344677788899999999998766 4569


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      |||||||+||+|.++|...       ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|++||+|||
T Consensus       268 ylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccc
Confidence            9999999999999999865       56999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +|+......    ..+.+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+           
T Consensus       338 lA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i-----------  402 (689)
T 3v5w_A          338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------  402 (689)
T ss_dssp             TCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH-----------
T ss_pred             eeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----------
Confidence            998775443    245679999999999975 4799999999999999999999999976543321111           


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                         ...+....+..+...+   ..+.+|+.+||+.||.+|++     +.||++
T Consensus       403 ---~~~i~~~~~~~p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          403 ---DRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---HHhhcCCCCCCCccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               1111222222222223   34667888999999999998     677765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-47  Score=385.57  Aligned_cols=293  Identities=36%  Similarity=0.652  Sum_probs=237.2

Q ss_pred             cccccccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-HHHHHHHHHHHHHhCCCCCeecEE
Q 010012          167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLV  245 (520)
Q Consensus       167 ~~~~~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~  245 (520)
                      .....|++.++..++++|...+.||+|+||+||+|... +++.||||++...... ....+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            44678999999999999999999999999999999875 4889999999765322 233688999999999999999999


Q ss_pred             EEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC
Q 010012          246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (520)
Q Consensus       246 g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~  325 (520)
                      +++.+.. ..++||||+++|+|.+++.....   ....++|..+..|+.|++.||+|||+....+|+||||||+|||++.
T Consensus        94 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           94 GFCMTPT-ERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             EEECCSS-CCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             EEEecCC-ceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            9987654 46899999999999999986532   2256999999999999999999999983334999999999999999


Q ss_pred             CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc--cchhh
Q 010012          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ--GEENL  403 (520)
Q Consensus       326 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~--~~~~l  403 (520)
                      ++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  248 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML  248 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred             CCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence            999999999999876543322 234456999999999999889999999999999999999999999753322  22234


Q ss_pred             HHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       404 v~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ..|........  .+..+.+..+.. .........+.+++.+||+.+|.+|||+.+|++.|++..
T Consensus       249 ~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          249 LDWVKGLLKEK--KLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHHTTTTSSC--CSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHhhch--hhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            44444443332  344455555542 345677889999999999999999999999999999743

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.8e-45  Score=365.77  Aligned_cols=284  Identities=31%  Similarity=0.566  Sum_probs=230.5

Q ss_pred             ccccccHHHHHHhhCCcccc------eEEcccCceEEEEeeecCCCcEEEEEEecCc----chHHHHHHHHHHHHHHhCC
Q 010012          168 SLIRLSYGEILAATHNFSKG------RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLH  237 (520)
Q Consensus       168 ~~~~~s~~ei~~at~~f~~~------~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~E~~il~~l~  237 (520)
                      ....|++.++..++++|...      +.||+|+||+||+|...  ++.||||++...    .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45679999999999999887      89999999999999874  789999998653    2345678999999999999


Q ss_pred             CCCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       238 HpnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      ||||+++++++.+.+ ..++||||+++|+|.+++.....    ...++|..++.++.|++.||.|||+.+   |+|||||
T Consensus        89 h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk  160 (307)
T 2nru_A           89 HENLVELLGFSSDGD-DLCLVYVYMPNGSLLDRLSCLDG----TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK  160 (307)
T ss_dssp             CTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTGGG----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred             CCCeEEEEEEEecCC-ceEEEEEecCCCcHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence            999999999986654 57999999999999999976432    256999999999999999999999988   9999999


Q ss_pred             CCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       318 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      |+|||++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987654333323344579999999998864 689999999999999999999999986543


Q ss_pred             ccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       398 ~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ....  ..+.... ......+...+++.+.  .........+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       240 ~~~~--~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          240 PQLL--LDIKEEI-EDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             SSBT--THHHHHH-HTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             hHHH--HHHHHHh-hhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            3211  1111111 1111234556666553  23456677889999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-45  Score=370.42  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=207.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEEE
Confidence            358999999999999999999998889999999997665555677899999999999999999999987754 5899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             CCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999975        35899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........      ..        +..
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~--------~~~  230 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YL--------IAT  230 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HH--------HHH
T ss_pred             CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH--------HHh
Confidence            54332  223457999999999999999999999999999999999999999754322110      00        111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.+..+   ......+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          231 NGTPELQNP---EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HCSCCCSCG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCc---cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111122111   112245678889999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=370.97  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=213.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||+||+|.+..++..||+|++........+.|.+|++++++++||||+++++++.+. ...++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEEe
Confidence            5799999999999999999999988999999999877777788999999999999999999999998775 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           89 IKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             CTTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            99999999998643      56999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCc------------ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          342 APSVPF------------LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       342 ~~~~~~------------~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      ......            ......||+.|+|||++.+..++.++|||||||++|||++|..|+............     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-----  234 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----  234 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----
Confidence            432211            011456999999999999999999999999999999999999998754332211000     


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcch
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  470 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~~  470 (520)
                             ......+....  ...+   ..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       235 -------~~~~~~~~~~~--~~~~---~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          235 -------NVRGFLDRYCP--PNCP---PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             -------CHHHHHHHTCC--TTCC---TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------hhhccccccCC--CCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                   01111111111  1111   2467788999999999999999999999976544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5e-45  Score=371.70  Aligned_cols=262  Identities=22%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             ccccHHHHHHhhCC----------cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC
Q 010012          170 IRLSYGEILAATHN----------FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP  239 (520)
Q Consensus       170 ~~~s~~ei~~at~~----------f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp  239 (520)
                      ..++++++..+++.          |...+.||+|+||+||+|....+++.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35677777776654          77778999999999999999888999999999876655667889999999999999


Q ss_pred             CeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 010012          240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (520)
Q Consensus       240 nIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~  319 (520)
                      ||+++++++...+ ..++||||+++|+|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+
T Consensus       103 niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~  170 (321)
T 2c30_A          103 NVVEMYKSYLVGE-ELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD  170 (321)
T ss_dssp             TBCCEEEEEEETT-EEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred             CcceEEEEEEECC-EEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence            9999999987754 58999999999999999864        46999999999999999999999988   999999999


Q ss_pred             CeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcccc
Q 010012          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG  399 (520)
Q Consensus       320 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~  399 (520)
                      |||++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       171 NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~  248 (321)
T 2c30_A          171 SILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ  248 (321)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             HEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999987654322  1244579999999999999999999999999999999999999997543211


Q ss_pred             chhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       400 ~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ..   .        .+.....+.+....   .....+.+++.+||+.||++|||+.+|++
T Consensus       249 ---~~---~--------~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 ---AM---K--------RLRDSPPPKLKNSH---KVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---HH---H--------HHHHSSCCCCTTGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HH---H--------HHhcCCCCCcCccc---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00   0        11222222222111   11234677888999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.9e-46  Score=376.58  Aligned_cols=276  Identities=24%  Similarity=0.294  Sum_probs=209.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---cEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~~~L  257 (520)
                      .++|+..+.||+|+||+||+|+..  ++.||||++..... ....+..|+.++++++|||||++++++.+...   .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            468999999999999999999876  68999999976543 33456679999999999999999999876543   3689


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecccCCCCeEecCCCceE
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-------TERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-------~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ||||+++|+|.+++..        ..++|..++.++.|++.||.|||+.       ..++|+||||||+|||++.++.+|
T Consensus       100 v~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            9999999999999975        3599999999999999999999987       001399999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccC-----CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      |+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.............
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999999876554333233446799999999999763     45678999999999999999999997654322111111


Q ss_pred             hhhhHhhhchhHHHHh-----hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          406 WAKPILHRGMAAVEEL-----LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~-----~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                      ......  ....+.+.     ..+.+............+.+++.+||+.||++|||+.||++.|+.+..
T Consensus       252 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          252 EIGQHP--SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHCSSC--CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccCC--chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            000000  00011111     111121111122455678899999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-44  Score=371.25  Aligned_cols=248  Identities=28%  Similarity=0.400  Sum_probs=206.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence            36899999999999999999999888999999999754  34456778899999999999999999999766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        93 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             EECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999765       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCC-CcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......   ......||+.|+|||++.+..+. .++|||||||++|||++|+.||........                 
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------------  222 (328)
T 3fe3_A          163 EFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-----------------  222 (328)
T ss_dssp             GGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------
T ss_pred             ecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            765432   23456799999999999888765 789999999999999999999976432211                 


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       223 ~~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          223 RERVLRGKYRIPFYMS---TDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHHCCCCCCTTSC---HHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCCCCCCCCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111112222222222   34667888999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-45  Score=377.94  Aligned_cols=275  Identities=26%  Similarity=0.400  Sum_probs=216.9

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEee-----ecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecE
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPL  244 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~-----~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l  244 (520)
                      +...++....++|...+.||+|+||.||+|.     ...+++.||||++.... ....+.+.+|++++.++ +|||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3444555567899999999999999999998     44567899999997643 34456799999999999 79999999


Q ss_pred             EEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCC---------------------------------------------
Q 010012          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------------------------------------------  279 (520)
Q Consensus       245 ~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~---------------------------------------------  279 (520)
                      ++++.+.+...++||||+++|+|.+++........                                             
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988876668999999999999999986532100                                             


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCC
Q 010012          280 --------------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (520)
Q Consensus       280 --------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~  345 (520)
                                    ....+++..++.++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                          0123899999999999999999999988   99999999999999999999999999987654433


Q ss_pred             CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCc
Q 010012          346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDP  424 (520)
Q Consensus       346 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~  424 (520)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||........  ..    .       .+......
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~-------~~~~~~~~  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----R-------RLKEGTRM  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH----H-------HHHHTCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH----H-------HHHcCCCC
Confidence            333445678999999999999999999999999999999998 9999976443211  00    0       11111111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          425 RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       425 ~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..  +...+   ..+.+++..||+.+|.+|||+.||++.|+..
T Consensus       316 ~~--~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          316 RA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC--CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11  11122   3467788899999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.8e-45  Score=367.77  Aligned_cols=260  Identities=32%  Similarity=0.491  Sum_probs=199.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|+..+.||+|+||+||+|...  +..||||++....  ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv  112 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-NLSIV  112 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-CCEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-ceEEE
Confidence            468999999999999999999874  7889999997653  445568899999999999999999999986654 47999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus       113 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGA----REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EECCTTCBHHHHHHSTTH----HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EecCCCCcHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            999999999999976421    124999999999999999999999764 349999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..           .+
T Consensus       188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~-----------~~  251 (309)
T 3p86_A          188 LKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VA-----------AV  251 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HH-----------HH
T ss_pred             ccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-----------HH
Confidence            6543321  22345799999999999999999999999999999999999999975432211   00           00


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      . ........+...+   ..+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       252 ~-~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          252 G-FKCKRLEIPRNLN---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             H-HSCCCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H-hcCCCCCCCccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0 0111111122222   34677888999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.3e-44  Score=373.24  Aligned_cols=265  Identities=21%  Similarity=0.360  Sum_probs=209.9

Q ss_pred             hCCcccceEEcccCceEEEEeeec-------CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      .++|...+.||+|+||+||+|.+.       .++..||||++... .....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            368999999999999999999863       24567999999765 334567899999999999 899999999998664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ..+++||||+++|+|.+++......         ......+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus       160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          160 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             -CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence             4589999999999999999875310         001245899999999999999999999988   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      |+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999987654432222334567889999999999999999999999999999999 999997643221  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       +..           .+.....+..  +...   ...+.+++.+||+.+|.+|||+.||++.|+.+.
T Consensus       314 -~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 -LFK-----------LLKEGHRMDK--PANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             -HHH-----------HHHTTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHH-----------HHhcCCCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             110           0111111111  1112   235677888999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.4e-45  Score=365.24  Aligned_cols=272  Identities=25%  Similarity=0.329  Sum_probs=207.7

Q ss_pred             hCCcccceEEcccCceEEEEee----ecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~  255 (520)
                      .++|+..+.||+|+||+||+|.    ...+++.||||++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            3689999999999999999998    45578999999998877777788999999999999999999999886432 347


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence            89999999999999998653      35999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh--hhhHhh
Q 010012          336 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW--AKPILH  412 (520)
Q Consensus       336 la~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~--~~~~~~  412 (520)
                      +++........ .......+|..|+|||.+.+..++.++||||||+++|||++|..|+..............  ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99876543221 112334577889999999999999999999999999999999999875432110000000  000000


Q ss_pred             hchhHHHHhhCc--ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          413 RGMAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       413 ~~~~~l~~~~d~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                          .+.+.+..  +...+...   ...+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus       240 ----~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          240 ----HLIELLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             ----HHHHHHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHhccCcCCCCcCc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                01111111  11112222   245777889999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=368.84  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=205.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC---cEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||+||+|.+..++   ..||||++... .....+.|.+|+.+++.++||||+++++++.+.. ..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-LAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-CCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-ccEE
Confidence            57889999999999999999986444   45999999765 4455678999999999999999999999986644 4789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       128 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence            999999999999997542      46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........   ..          
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----------  265 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---IS----------  265 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HH----------
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HH----------
Confidence            876543221 12223446788999999998999999999999999999999 9999975432211   00          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       .+....  ....+...   ...+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       266 -~~~~~~--~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          266 -SVEEGY--RLPAPMGC---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             -HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCCCc---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             111111  11111112   245777889999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-44  Score=367.52  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=204.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|+...+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEEE
Confidence            58999999999999999999999889999999997542   23456788999999999999999999988664 468999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchh
Confidence            9999999999999764       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +              .
T Consensus       154 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~--------------~  214 (337)
T 1o6l_A          154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L--------------F  214 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------H
T ss_pred             hcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---H--------------H
Confidence            6433221  2345679999999999999999999999999999999999999997543211   0              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+....+..+...+   ..+.+++.+||+.||.+||     ++.||++
T Consensus       215 ~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          215 ELILMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHcCCCCCCCCCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            111111222222222   3466788899999999999     8999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-44  Score=369.67  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=201.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcE----EEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||+||+|.+..++..    ||+|.+... .....+.|.+|+.++++++||||++++++|.+..  .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eE
Confidence            5799999999999999999998766654    588877543 2345578999999999999999999999987643  68


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|+||+++|+|.+++....      ..+++..++.|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcc
Confidence            9999999999999998643      56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........             
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------------  230 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------------  230 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------------
T ss_pred             eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-------------
Confidence            987765443333344567889999999999999999999999999999999 999997644322111             


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       .+....  ....+   ......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       231 -~~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          231 -ILEKGE--RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -HHHTTC--CCCCC---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCC---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             011100  11111   122345778889999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.7e-45  Score=379.57  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=209.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..++|...+.||+|+||.||+|.+..+++.||||++... .....+.|.+|+.++++++|||||+++++|.+. ...++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEE
Confidence            456899999999999999999999888999999998754 234456788999999999999999999998664 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       191 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             EECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            99999999999998643      45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ...............++..|+|||.+..+.++.++|||||||++|||++ |..||........   .    ..       
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~----~~-------  327 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---R----EF-------  327 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---H----HH-------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HH-------
Confidence            6543221111122346778999999999999999999999999999998 9999976432211   0    01       


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      +...  .++..+...+   ..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       328 ~~~~--~~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          328 VEKG--GRLPCPELCP---DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcC--CCCCCCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1110  1122222223   34667888999999999999999999998643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=376.11  Aligned_cols=264  Identities=27%  Similarity=0.377  Sum_probs=207.9

Q ss_pred             CCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|...+.||+|+||+||+|..     ..++..||||++... .......+.+|+.++++++|||||++++++.+.. ..
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~  149 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-PR  149 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SC
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-CC
Confidence            5799999999999999999994     345678999999654 3455667899999999999999999999986644 47


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---ceEEe
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLC  332 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vkL~  332 (520)
                      ++||||+++|+|.+++............+++..++.++.||+.||+|||+.+   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            8999999999999999876543333356999999999999999999999988   99999999999999555   59999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   +..      
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~------  297 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE------  297 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH------
Confidence            9999975432222222334568999999999999999999999999999999998 999997643221   110      


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                           .+....  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       298 -----~i~~~~--~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          298 -----FVTSGG--RMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             -----HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHcCC--CCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                 011100  11111112   234678889999999999999999999998653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.4e-43  Score=354.46  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||+||+|.+..++..||+|++...   .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence            36899999999999999999999888999999998543   34456788999999999999999999999766 455899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        89 v~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             EEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             EEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999764       46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ...........
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~  231 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDSVPN  231 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSCCCC
T ss_pred             ccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhccCCC
Confidence            876543221 22345699999999999999999999999999999999999999976432110      00111110000


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRGE  467 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-tm~eVl~~L~~~  467 (520)
                      ....+      ..   .....+.+++.+||+.||.+|| ++.++.+.|+..
T Consensus       232 ~~~~~------~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          232 VTTDV------RK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHHS------CT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             cchhc------cc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            00001      11   1123567788999999999998 899999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-44  Score=366.87  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e   85 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   85 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEEE
Confidence            589999999999999999999998899999999965432 3345688999999999999999999998764 45799999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           86 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            99999999998653       46999999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .............||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+             
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-------------  221 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------------  221 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH-------------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH-------------
Confidence            43332222345679999999999987775 7789999999999999999999975433211 11110             


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ........ ........+.+++.+||+.||.+|||+.||++
T Consensus       222 --~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          222 --KEKKTYLN-PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --HTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --hcccccCC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              00000000 01112245678889999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-44  Score=373.10  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=195.7

Q ss_pred             CCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|.+.   ..+..||||++... .....+.|.+|+.++++++||||+++++++.+. ...++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceEE
Confidence            58999999999999999999876   45678999999765 344567899999999999999999999998664 45799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       124 v~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999999997542      46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +..          
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~----------  261 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIK----------  261 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHH----------
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence            876543211 11122346788999999999999999999999999999998 999997543211   100          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       .+....  +...+.   .....+.+++.+||+.+|.+||++.+|+++|+...
T Consensus       262 -~i~~~~--~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          262 -AVDEGY--RLPPPM---DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             -HHHTTE--ECCCCT---TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCc---cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence             011110  111111   12345778889999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=370.39  Aligned_cols=249  Identities=27%  Similarity=0.382  Sum_probs=200.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|...+.||+|+||+||+|+...+++.||||++.+..   ......+.+|..+++.+ +||||+++++++.+. ..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~  100 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLF  100 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEE
Confidence            368999999999999999999999889999999997542   23445678899999988 799999999987664 5689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|..++...       ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence            999999999999999765       46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 
T Consensus       171 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------  231 (353)
T 3txo_A          171 CKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------  231 (353)
T ss_dssp             CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------
T ss_pred             eeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----------------
Confidence            986433221  2345679999999999998899999999999999999999999997643321                 


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI------EEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm------~eVl~  462 (520)
                      ....+....+..+....   ..+.+++.+||+.+|.+||++      .+|++
T Consensus       232 ~~~~i~~~~~~~p~~~~---~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          232 LFEAILNDEVVYPTWLH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHcCCCCCCCCCC---HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11122222222222222   346678889999999999998      67765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5e-44  Score=358.19  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh--CCCCCeecEEEEEEcC---CCcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDP---EQGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~---~~~~  255 (520)
                      .++|...+.||+|+||+||+|..  +++.||||++...   ....+..|.+++..  ++||||+++++++.+.   ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999988  4789999999654   33455667777666  8999999999987653   2347


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCCeEecCCC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      ++||||+++|+|.+++..        ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++
T Consensus        82 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred             EEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence            899999999999999954        46999999999999999999999        666   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCc--ccccccccCCccCchhcccC------CCCCcCceeeHHHHHHHHHhC----------C
Q 010012          328 IPKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTG----------R  389 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwS~GvvL~ELltG----------~  389 (520)
                      .+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            99999999997655433211  12234799999999999876      455799999999999999999          8


Q ss_pred             CCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          390 KPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       390 ~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .||.......... ... ....      ......+.+............+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       231 ~pf~~~~~~~~~~-~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          231 PPFYDVVPNDPSF-EDM-RKVV------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CTTTTTSCSSCCH-HHH-HHHH------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCCCcch-hhh-hHHH------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            8886543322110 000 0000      00011111111111234567788999999999999999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=354.85  Aligned_cols=274  Identities=23%  Similarity=0.296  Sum_probs=212.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-cEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+... ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57999999999999999999999889999999997543 2345678899999999999999999999876543 579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----cCCCceEEeecC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFG  335 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----d~~~~vkL~DFG  335 (520)
                      ||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        89 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             eCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999987542    134999999999999999999999988   9999999999999    788889999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcc--------cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQ--------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.........  ....
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~  236 (319)
T 4euu_A          162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVM  236 (319)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHH
T ss_pred             CceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHH
Confidence            9987654432   23456999999999986        567899999999999999999999999754322111  1111


Q ss_pred             hhHhhhch----hHHHHhh------CcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          408 KPILHRGM----AAVEELL------DPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       408 ~~~~~~~~----~~l~~~~------d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..+.....    ..+....      .+.+.. ..........+.+++.+||+.||++|||+.|+++.....
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111000    0000000      001111 122345666788999999999999999999999987753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.9e-44  Score=369.21  Aligned_cols=251  Identities=26%  Similarity=0.346  Sum_probs=204.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH------HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .+.|...+.||+|+||+||+|....+++.||+|++.+....      ..+.+.+|+.+++.++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CE
Confidence            35899999999999999999999989999999999764321      346788999999999999999999998664 56


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC----ceE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  330 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vk  330 (520)
                      +++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEE
Confidence            89999999999999999653       56999999999999999999999988   99999999999998877    799


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||........          
T Consensus       160 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----------  226 (361)
T 2yab_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------  226 (361)
T ss_dssp             ECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----------
T ss_pred             EEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            999999987654321   2345699999999999988999999999999999999999999976432211          


Q ss_pred             hhhchhHHHHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                             +..+.......+.. .......+.+++.+||..||.+|||+.|+++
T Consensus       227 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          227 -------LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   11111111110000 0011234678889999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=359.92  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=200.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-------  253 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-------  253 (520)
                      ++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++|||||++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            47999999999999999999999889999999997543 3456789999999999999999999999866432       


Q ss_pred             -------------------------------------------------cEEEEEEecCCCChhHHhhhhccCCCCCCCC
Q 010012          254 -------------------------------------------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTL  284 (520)
Q Consensus       254 -------------------------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l  284 (520)
                                                                       ..++||||+++|+|.+++.....    ....
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~  161 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LEDR  161 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GGGS
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----ccch
Confidence                                                             27899999999999999987532    1456


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCC----------cccccccc
Q 010012          285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----------FLCKTVKG  354 (520)
Q Consensus       285 ~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~G  354 (520)
                      ++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77789999999999999999988   999999999999999999999999999876653211          11234569


Q ss_pred             cCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHH
Q 010012          355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSA  434 (520)
Q Consensus       355 t~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  434 (520)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+.....     .              +........  +.....
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----~--------------~~~~~~~~~--~~~~~~  297 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----I--------------ITDVRNLKF--PLLFTQ  297 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----H--------------HHHHHTTCC--CHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----H--------------HHHhhccCC--Cccccc
Confidence            9999999999999999999999999999999999887643211     0              001111111  000122


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          435 QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       435 ~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....+.+++.+||+.||.+|||+.|+++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            3345678899999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-44  Score=357.64  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--------------------------HHHHHHHHHHHHHHh
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------------------ESSKAFCRELMIASS  235 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------------------------~~~~~~~~E~~il~~  235 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            689999999999999999999988899999999965431                          123568899999999


Q ss_pred             CCCCCeecEEEEEEcC-CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 010012          236 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR  314 (520)
Q Consensus       236 l~HpnIv~l~g~~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHr  314 (520)
                      ++||||+++++++.+. ....++||||+++++|.+++..        ..+++..+..++.|++.||+|||+.+   |+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~  161 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHR  161 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence            9999999999998763 4568999999999999886532        56999999999999999999999988   9999


Q ss_pred             ccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCC---CCCcCceeeHHHHHHHHHhCCCC
Q 010012          315 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKP  391 (520)
Q Consensus       315 DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwS~GvvL~ELltG~~P  391 (520)
                      ||||+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.|
T Consensus       162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999987654322  223457999999999997665   37789999999999999999999


Q ss_pred             cchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          392 IEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       392 f~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      |.......      ....        +... ..........   ...+.+++.+||+.||++|||+.||++
T Consensus       240 f~~~~~~~------~~~~--------~~~~-~~~~~~~~~~---~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMC------LHSK--------IKSQ-ALEFPDQPDI---AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHH------HHHH--------HHHC-CCCCCSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHH------HHHH--------Hhcc-cCCCCCcccc---CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            97543211      1000        1000 0011111112   235677889999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-44  Score=363.05  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=205.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEE
Confidence            368999999999999999999999889999999997553 3456788999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC--CCceEEeecCCcc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLAT  338 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~--~~~vkL~DFGla~  338 (520)
                      |+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++
T Consensus        82 ~~~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             eCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999996532      46999999999999999999999988   999999999999987  7899999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........                 +
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------------~  212 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------I  212 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----------------H
Confidence            765433   23456799999999999988899999999999999999999999976432211                 1


Q ss_pred             HHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+......... ........+.+++.+||..||.+|||+.|+++
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111000 00011235778889999999999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-44  Score=361.72  Aligned_cols=266  Identities=24%  Similarity=0.358  Sum_probs=195.2

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCc---EEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ...++|...+.||+|+||+||+|.+..++.   .||||++...  .....+.+.+|+.++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345789999999999999999999876554   7999999764  33456789999999999999999999999876543


Q ss_pred             c-----EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          254 G-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       254 ~-----~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      .     .++||||+++|+|.+++...... .....+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            2     38999999999999999765421 11236999999999999999999999988   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.........      
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------  249 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY------  249 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH------
Confidence            99999999987654433222334557889999999999999999999999999999999 99999764432110      


Q ss_pred             hhHhhhchhHHHHhhCc-ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          408 KPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~-~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                                 ..+... ....+.   .....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       250 -----------~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          250 -----------NYLIGGNRLKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             -----------HHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------HHHhcCCCCCCCC---ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                       111111 111111   12245778889999999999999999999998643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-43  Score=360.08  Aligned_cols=245  Identities=28%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|+...+++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEEE
Confidence            57999999999999999999999889999999997542   12345678899999999999999999988664 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        85 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999999764       46999999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ..
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------------~~  212 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----------------TY  212 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HH
T ss_pred             ecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----------------HH
Confidence            76432     234579999999999999999999999999999999999999997543211                 11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..++...+..+...+   ..+.+++.+||+.||.+||     ++.+|++
T Consensus       213 ~~i~~~~~~~p~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          213 EKILNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHhCCCCCCCCCC---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            122222222222222   3466788899999999999     8888875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-44  Score=381.32  Aligned_cols=264  Identities=25%  Similarity=0.326  Sum_probs=208.6

Q ss_pred             cHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEE
Q 010012          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (520)
Q Consensus       173 s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~  249 (520)
                      .+.++...+++|...++||+|+||+||+|++..+++.||||++.+...   .....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            455666677899999999999999999999998899999999975322   12234788999999999999999999887


Q ss_pred             cCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       250 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                      +. ..+++|||||++|+|.+++....      ..+++..++.++.|++.||+|||+.+   ||||||||+||||+.++.+
T Consensus       145 ~~-~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          145 DD-NNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             CS-SEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             eC-CEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCE
Confidence            64 55899999999999999997632      56999999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      ||+|||+|+....... .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+..   
T Consensus       215 kL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---  290 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---  290 (437)
T ss_dssp             EECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---
T ss_pred             EEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---
Confidence            9999999987654332 2233467999999999997     567899999999999999999999999764332111   


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIA  462 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~  462 (520)
                         ..+...    ...     +..+.........+.+++.+||+.+|++  ||++.||++
T Consensus       291 ---~~i~~~----~~~-----~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          291 ---GKIMNH----KER-----FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---HHHHTH----HHH-----CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---Hhhhhc----ccc-----ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               111100    000     1111110112234667788899888888  999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-43  Score=356.72  Aligned_cols=265  Identities=24%  Similarity=0.331  Sum_probs=209.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ..++|...+.||+|+||.||+|...     .++..||||++... .....+.+.+|+.+++.++||||+++++++.+. .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-G   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-C
Confidence            3468999999999999999999873     34588999999764 345567889999999999999999999998664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  316 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDL  316 (520)
                      ..++||||+++|+|.+++.......                 .....+++..++.++.|++.||.|||+.+   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            5799999999999999998743200                 01134899999999999999999999988   999999


Q ss_pred             CCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchh
Q 010012          317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR  395 (520)
Q Consensus       317 Kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~  395 (520)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654433222334457889999999999899999999999999999999 99999764


Q ss_pred             ccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       396 ~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .......              .+.....+..  +..   ....+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       257 ~~~~~~~--------------~~~~~~~~~~--~~~---~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          257 PPERLFN--------------LLKTGHRMER--PDN---CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CGGGHHH--------------HHHTTCCCCC--CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHH--------------HhhcCCcCCC--Ccc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            4321110              0111111111  111   224577888999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-44  Score=363.70  Aligned_cols=267  Identities=25%  Similarity=0.396  Sum_probs=210.3

Q ss_pred             HhhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      ...++|...+.||+|+||.||+|...     .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+. 
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-
Confidence            34578999999999999999999986     34588999999765 344567899999999999999999999998664 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrD  315 (520)
                      ...++||||+++|+|.+++.......                 .....+++..++.|+.||+.||.|||+.+   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            45799999999999999998642100                 01156999999999999999999999988   99999


Q ss_pred             cCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcch
Q 010012          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEA  394 (520)
Q Consensus       316 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~  394 (520)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999986543322222334568999999999999999999999999999999999 9999975


Q ss_pred             hccccchhhHHhhhhHhhhchhHHHHhhCccc-CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          395 RRLQGEENLVLWAKPILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       395 ~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l-~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                      .....   +              +..+.+... ..+...+   ..+.+++.+||+.+|.+||++.+|++.|+...+
T Consensus       280 ~~~~~---~--------------~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          280 MAHEE---V--------------IYYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SCHHH---H--------------HHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CChHH---H--------------HHHHhCCCcCCCCCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            43211   1              111111111 1111222   356778899999999999999999999997643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-43  Score=347.17  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|.... +..||+|++..... ..+++.+|+.++++++||||+++++++.+ ....++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEE
Confidence            4689999999999999999998874 67899999976543 34678899999999999999999999865 445899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           84 YISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             CCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence            999999999998753      45999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........      .        .+.
T Consensus       155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~--------~~~  219 (268)
T 3sxs_A          155 LDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------L--------KVS  219 (268)
T ss_dssp             CTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------H--------HHH
T ss_pred             chhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------H--------HHH
Confidence            543321 2233456778999999998899999999999999999999 99999754322110      0        011


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ...  ....+...   ...+.+++..||+.+|.+|||+.+|++.|+...
T Consensus       220 ~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          220 QGH--RLYRPHLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             TTC--CCCCCTTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             cCC--CCCCCCcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            100  11111112   235677889999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.3e-44  Score=351.51  Aligned_cols=256  Identities=24%  Similarity=0.433  Sum_probs=206.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|.... +..||+|++..... ..+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   85 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFE   85 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEE
Confidence            3579999999999999999999874 77899999976543 346789999999999999999999998664 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             CCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             eCCCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccc
Confidence            999999999997643      56999999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..   .        .+.
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~---~--------~~~  221 (269)
T 4hcu_A          157 LDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---E--------DIS  221 (269)
T ss_dssp             CCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H--------HHH
T ss_pred             ccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HH---H--------HHh
Confidence            43221 11233457788999999999999999999999999999999 999997543221   10   0        111


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....  ...+...   ...+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       222 ~~~~--~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          222 TGFR--LYKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             TTCC--CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCcc--CCCCCcC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            1111  1111112   235677889999999999999999999998653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-43  Score=356.18  Aligned_cols=266  Identities=25%  Similarity=0.398  Sum_probs=210.9

Q ss_pred             hhCCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ..++|...+.||+|+||+||+|..     ..++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346899999999999999999984     3467899999997653 34557889999999999 9999999999987654


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG-----------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~-----------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NI  321 (520)
                       ..++||||+++|+|.+++......           ......+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus       101 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             -CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence             579999999999999999875321           001135899999999999999999999988   99999999999


Q ss_pred             EecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccc
Q 010012          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGE  400 (520)
Q Consensus       322 Lld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~  400 (520)
                      |++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987765443333344567889999999999999999999999999999999 9999976433211


Q ss_pred             hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       401 ~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        .    ..       .+.....+..  +..   ....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       257 --~----~~-------~~~~~~~~~~--~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 --F----YK-------MIKEGFRMLS--PEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             --H----HH-------HHHHTCCCCC--CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --H----HH-------HhccCCCCCC--ccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence              0    00       1111111111  111   224577788999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=360.97  Aligned_cols=245  Identities=24%  Similarity=0.298  Sum_probs=191.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++...  .......+..|+..+..+ +||||++++++|.+. ..+++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEE
Confidence            5799999999999999999999988999999998653  233344555666555544 999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+ +++|.+++....      ..++|..++.|+.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++.
T Consensus       136 ~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             Eecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999 779999987653      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.......          .+..+    
T Consensus       206 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----------~~~~~----  267 (311)
T 3p1a_A          206 ELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ----------QLRQG----  267 (311)
T ss_dssp             ECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH----------HHTTT----
T ss_pred             ecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----------HHhcc----
Confidence            765432   2234569999999999875 79999999999999999999977765422100          00000    


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ...+.+.  .   .....+.+++.+||+.||++|||+.||++
T Consensus       268 --~~~~~~~--~---~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 --YLPPEFT--A---GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --CCCHHHH--T---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CCCcccc--c---CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              0000110  0   11245778889999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-43  Score=369.37  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=199.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|...++||+|+||+||+|+...+++.||||++.+..   ......+..|..++.++ +|||||++++++.+ ...++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence            358999999999999999999999899999999997642   22334577899999876 89999999998766 45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|..++...       ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       130 lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecce
Confidence            999999999999999865       46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccch--hhHHhhhhHhhhc
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE--NLVLWAKPILHRG  414 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~--~lv~~~~~~~~~~  414 (520)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .....        
T Consensus       200 a~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~--------  269 (396)
T 4dc2_A          200 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--------  269 (396)
T ss_dssp             CBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH--------
T ss_pred             eeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH--------
Confidence            986332221  234567999999999999999999999999999999999999999753322110  00000        


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                        ....+....+..+...+   ..+.+++.+||+.||.+||++
T Consensus       270 --~~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          270 --LFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --HHHHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTSTTC
T ss_pred             --HHHHHhccccCCCCcCC---HHHHHHHHHHhcCCHhHcCCC
Confidence              11122222333222222   346678889999999999995

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.4e-44  Score=364.66  Aligned_cols=257  Identities=28%  Similarity=0.431  Sum_probs=203.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcE----EEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||+||+|.+..++..    ||+|.+.... ......+.+|+.+++.++||||+++++++.+  ...+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccE
Confidence            5899999999999999999998766665    7888775432 2233467789999999999999999998753  3478


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             EEEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence            9999999999999997642      46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++...............||..|+|||++.+..++.++|||||||++|||++ |+.||...........            
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------------  229 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL------------  229 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH------------
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH------------
Confidence            998765544333455678889999999999999999999999999999999 9999986443221111            


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        +....  ....+..   ....+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       230 --~~~~~--~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          230 --LEKGE--RLAQPQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --HHTTC--BCCCCTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --HHcCC--CCCCCCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              11100  1111111   1123667888999999999999999999998754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-43  Score=366.12  Aligned_cols=270  Identities=18%  Similarity=0.239  Sum_probs=207.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCC-----CcEEEEEEecCcchHHH-----------HHHHHHHHHHHhCCCCCeec
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESS-----------KAFCRELMIASSLHHPNIVP  243 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~  243 (520)
                      ..++|...+.||+|+||+||+|.+..+     ++.||||++........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356899999999999999999988653     47899999876542211           12345666778889999999


Q ss_pred             EEEEEEcCC---CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCC
Q 010012          244 LVGFCIDPE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (520)
Q Consensus       244 l~g~~~~~~---~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~N  320 (520)
                      +++++....   ...++||||+ +++|.+++....      ..+++..++.|+.||+.||+|||+.+   |+||||||+|
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence            999987642   3478999999 999999997642      56999999999999999999999988   9999999999


Q ss_pred             eEec--CCCceEEeecCCccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          321 ILLS--SKKIPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       321 ILld--~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      |||+  .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  8899999999999866432211     11133459999999999999999999999999999999999999998


Q ss_pred             hhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          394 ARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       394 ~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ......  ..+........   ..+.+++++.+... ..+   ..+.+++..||+.+|.+||++.+|++.|+...
T Consensus       263 ~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          263 DNLKDP--KYVRDSKIRYR---ENIASLMDKCFPAA-NAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             GGTTCH--HHHHHHHHHHH---HCHHHHHHHHSCTT-CCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccccCH--HHHHHHHHHhh---hhHHHHHHHhcccc-cCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            643221  12222221111   13445555554322 122   34667778899999999999999999998643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=359.74  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH------HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      +.|...+.||+|+||+||+|....++..||+|++......      ..+.+.+|+.+++.++||||+++++++.+. ...
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEE
Confidence            4799999999999999999999988999999999764321      356789999999999999999999998764 458


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC----ceEE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vkL  331 (520)
                      ++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999999653       56999999999999999999999988   99999999999999887    8999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      +|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........      .  
T Consensus       160 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~--  228 (326)
T 2y0a_A          160 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------N--  228 (326)
T ss_dssp             CCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------H--
T ss_pred             EECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------H--
Confidence            99999987654321   234569999999999998899999999999999999999999997543221100      0  


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                            +.. ........ ........+.+++.+||+.||.+|||+.|+++
T Consensus       229 ------~~~-~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 ------VSA-VNYEFEDE-YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ------HHH-TCCCCCHH-HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------HHh-cCCCcCcc-ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  000 00000000 00011234678889999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.7e-43  Score=351.18  Aligned_cols=255  Identities=31%  Similarity=0.532  Sum_probs=202.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH---H----HHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---S----SKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~----~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      .++|...+.||+|+||+||+|.+..+++.||+|++......   .    .+.+.+|+.++++++||||+++++++.+.  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            46899999999999999999999888999999998654221   1    16788999999999999999999987443  


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc-----
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----  328 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~-----  328 (520)
                       .++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.     
T Consensus        96 -~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           96 -PRMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             -TEEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             -CeEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence             279999999999999887542      57999999999999999999999764 34999999999999988776     


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcc--cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ--HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +||+|||+++.....     .....||+.|+|||++.  ...++.++|||||||++|||++|+.||.........    .
T Consensus       168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~  238 (287)
T 4f0f_A          168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F  238 (287)
T ss_dssp             EEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H
T ss_pred             EEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H
Confidence            999999999854432     23456999999999984  456789999999999999999999999754432111    0


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ....       ......+.+  +.   .....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       239 ~~~~-------~~~~~~~~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          239 INMI-------REEGLRPTI--PE---DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHH-------HHSCCCCCC--CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHH-------hccCCCCCC--Cc---ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            0000       011111111  11   122457788889999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-43  Score=348.21  Aligned_cols=251  Identities=27%  Similarity=0.450  Sum_probs=194.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch----HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|+..+.||+|+||+||+|.+.  +..||||++.....    ...+.+.+|+.+++.++||||+++++++.+.+ ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ceE
Confidence            358999999999999999999975  78899999865432    23467889999999999999999999987644 579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC--------CCc
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--------KKI  328 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~--------~~~  328 (520)
                      +||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.
T Consensus        83 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             EEEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999853        46999999999999999999999987556999999999999986        778


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      +||+|||+++.......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........        
T Consensus       155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------  222 (271)
T 3dtc_A          155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------  222 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--------
T ss_pred             eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------
Confidence            99999999986654322    245699999999999999999999999999999999999999975432110        


Q ss_pred             hHhhhchhHHHHhhCcc--cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          409 PILHRGMAAVEELLDPR--LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~--l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                               ........  ...+..   ....+.+++.+||+.+|.+|||+.||++.|+.
T Consensus       223 ---------~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          223 ---------AYGVAMNKLALPIPST---CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---------HHHHHTSCCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---------HHhhhcCCCCCCCCcc---cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                     00111111  111111   22457788899999999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-43  Score=363.24  Aligned_cols=245  Identities=24%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|+...+++.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEE
Confidence            58999999999999999999999889999999996542   23346788999999999999999999987764 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccce
Confidence            9999999999999864       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ..
T Consensus       190 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~  247 (350)
T 1rdq_E          190 RVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----------------IY  247 (350)
T ss_dssp             ECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HH
T ss_pred             eccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----------------HH
Confidence            765432     34569999999999999999999999999999999999999997543211                 11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ..+....+..+...+   ..+.+++.+||+.||.+||+     +.+|++
T Consensus       248 ~~i~~~~~~~p~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          248 EKIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHCCCCCCTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHcCCCCCCCCCC---HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            112222222222222   34677888999999999998     888876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=366.77  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=211.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecC-------CCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      .++|...+.||+|+||+||+|....       .+..||||++... .....+.+.+|+++++.+ +|||||++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4689999999999999999998642       3457999999765 344557889999999999 999999999998664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ...++||||+++|+|.+++......         ......+++..++.|+.||+.||.|||+.+   |+||||||+|||
T Consensus       148 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          148 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             -CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence             4579999999999999999875321         011246999999999999999999999988   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      |+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            99999999999999987655433223344568899999999999999999999999999999999 999997543221  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                       +..           .+........  +...   ...+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus       302 -~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          302 -LFK-----------LLKEGHRMDK--PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -HHH-----------HHHTTCCCCC--CSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHH-----------HHHcCCCCCC--CccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             110           1111111111  1112   2357778899999999999999999999987643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.7e-43  Score=374.70  Aligned_cols=253  Identities=27%  Similarity=0.470  Sum_probs=206.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||.||+|...  ++.||||+++...  ..+.|.+|+.++++++|||||++++++.+....+++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            4468899999999999999999886  6799999997654  45679999999999999999999999888766789999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       267 e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence            99999999999987532     45899999999999999999999988   99999999999999999999999999985


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....     ....++..|+|||++.+..++.++|||||||++|||++ |+.||........   ..           .+
T Consensus       339 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~-----------~i  399 (450)
T 1k9a_A          339 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP-----------RV  399 (450)
T ss_dssp             CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH-----------HH
T ss_pred             ccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-----------HH
Confidence            54321     22357889999999999999999999999999999998 9999976443221   10           11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....  ++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       400 ~~~~--~~~~p~~~~---~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          400 EKGY--KMDAPDGCP---PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             HTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCC--CCCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1111  122222222   35667888999999999999999999998643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-43  Score=358.17  Aligned_cols=273  Identities=26%  Similarity=0.402  Sum_probs=214.6

Q ss_pred             HHHHHHhhCCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEE
Q 010012          174 YGEILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVG  246 (520)
Q Consensus       174 ~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g  246 (520)
                      ..++....++|...+.||+|+||+||+|..     ..+++.||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            334444567999999999999999999984     3457899999997653 34456789999999999 7999999999


Q ss_pred             EEEcCCCcEEEEEEecCCCChhHHhhhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       247 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~---------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      ++...+..+++||||+++|+|.+++........         ....+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence            987766668999999999999999986432100         0123899999999999999999999988   9999999


Q ss_pred             CCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhc
Q 010012          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARR  396 (520)
Q Consensus       318 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~  396 (520)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999999999987655433333345568899999999999999999999999999999998 999997643


Q ss_pred             cccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       397 ~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ....  ..    .       .+........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       256 ~~~~--~~----~-------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          256 IDEE--FC----R-------RLKEGTRMRA--PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CSHH--HH----H-------HHHHTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHH--HH----H-------HhccCccCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2211  10    0       1111111111  1112   23567788899999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-43  Score=365.10  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.+++.++|||||++++++.+. ...++|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            35799999999999999999999988999999999754  334556789999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---ceEEeecC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG  335 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vkL~DFG  335 (520)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||
T Consensus       107 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999998753       46899999999999999999999988   99999999999998654   59999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..          
T Consensus       177 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~----------  240 (362)
T 2bdw_A          177 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA----------  240 (362)
T ss_dssp             TCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----------
T ss_pred             cceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH----------
Confidence            9987654322   234579999999999999899999999999999999999999997543211   110          


Q ss_pred             hHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          .+.......+. ........+.+++.+||+.||.+|||+.++++
T Consensus       241 ----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          241 ----QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ----HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                01111111000 00112245678889999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=361.59  Aligned_cols=266  Identities=24%  Similarity=0.424  Sum_probs=207.0

Q ss_pred             hhCCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~  252 (520)
                      ..++|...+.||+|+||+||+|.+     ..++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+. 
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence            346899999999999999999986     2356789999997542 33456788999999999 899999999998764 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGV----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  316 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~----------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDL  316 (520)
                      ...++||||+++|+|.+++.......                .....+++..++.++.||+.||+|||+.+   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            45799999999999999998643210                00134899999999999999999999988   999999


Q ss_pred             CCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchh
Q 010012          317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR  395 (520)
Q Consensus       317 Kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~  395 (520)
                      ||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987654433333345568889999999999999999999999999999998 99999764


Q ss_pred             ccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       396 ~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .....  ..    .       .+.....+..  +...   ...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       279 ~~~~~--~~----~-------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          279 PVDAN--FY----K-------LIQNGFKMDQ--PFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CCSHH--HH----H-------HHHTTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcHHH--HH----H-------HHhcCCCCCC--CCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            33211  10    0       1111111111  1112   24567788899999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-43  Score=365.38  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...+.||+|+||+||+|+.+.+++.||||++.+..   ......+..|..++..+ +||||+++++++.+. ..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~   93 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENL   93 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEE
Confidence            4579999999999999999999999889999999997542   22345677899998876 999999999988764 468


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence            9999999999999999864       46999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +            
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~------------  226 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L------------  226 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H------------
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---H------------
Confidence            9986433221  2345679999999999999999999999999999999999999997543221   1            


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EII  461 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~-eVl  461 (520)
                        ...+.......+...   ...+.+++.+||+.||.+||++. +|+
T Consensus       227 --~~~i~~~~~~~p~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          227 --FHSIRMDNPFYPRWL---EKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --HHHHHHCCCCCCTTS---CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --HHHHHhCCCCCCccc---CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              011111111111112   23567788999999999999997 665

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-43  Score=353.30  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=202.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC-------cEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|...+.||+|+||+||+|....++       ..||+|++........+.+.+|+.++++++||||+++++++.+.+ .
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-E   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-C
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-C
Confidence            58999999999999999999987655       479999998776667788999999999999999999999987654 4


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI------  328 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~------  328 (520)
                      .++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.      
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             CEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccc
Confidence            789999999999999998643      34899999999999999999999988   999999999999998887      


Q ss_pred             --eEEeecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          329 --PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       329 --vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                        +||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.......  ....
T Consensus       158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~  229 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ  229 (289)
T ss_dssp             CEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH
T ss_pred             ceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH
Confidence              999999998754321      23458999999999987 678999999999999999999655443221111  0000


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcch
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  470 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~~  470 (520)
                                 ....  ...+.  ...   ...+.+++.+||+.||.+|||+.+|++.|+.+..+
T Consensus       230 -----------~~~~--~~~~~--~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          230 -----------FYED--RHQLP--APK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -----------HHHT--TCCCC--CCS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -----------Hhhc--cCCCC--CCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                       0000  11111  111   12466788899999999999999999999976543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-43  Score=363.45  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=202.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-----HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      +.|...+.||+|+||+||+|....+++.||||++.....     ...+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEE
Confidence            479999999999999999999998899999999864321     1356789999999999999999999998764 5689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc---eEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~---vkL~D  333 (520)
                      +||||+++|+|.+++......   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999888764321   246899999999999999999999988   999999999999987654   99999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    +.         
T Consensus       177 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~---------  241 (351)
T 3c0i_A          177 FGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LF---------  241 (351)
T ss_dssp             CTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HH---------
T ss_pred             CcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HH---------
Confidence            999987654322  234457999999999999999999999999999999999999999763211    10         


Q ss_pred             chhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           ..+......... ........+.+++.+||+.||++|||+.++++
T Consensus       242 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          242 -----EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -----HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 011111110000 00011235678889999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-43  Score=359.54  Aligned_cols=274  Identities=25%  Similarity=0.302  Sum_probs=213.3

Q ss_pred             CCcccceEEcccCceEEEEee----ecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~  256 (520)
                      ++|...+.||+|+||.||+|.    ...++..||||++........+.+.+|++++++++||||+++++++... ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            689999999999999999998    4567889999999887777778899999999999999999999988743 44578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++++|.+++....      ..+++..++.|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence            9999999999999998753      35999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++......... ......||..|+|||++.+..++.++|||||||++|||++|+.||..........   +.........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~  250 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM---MGCERDVPAL  250 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---CC----CCHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh---cccccccccH
Confidence            98765433211 2233458888999999999899999999999999999999999997543321000   0000000000


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ..+.+.+....... ........+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       251 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          251 SRLLELLEEGQRLP-APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHHHhhcccCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            01111111111100 11122345778889999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=373.70  Aligned_cols=253  Identities=26%  Similarity=0.319  Sum_probs=203.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||+||+|....+++.||+|++....  ....+.+.+|+.+++.++|||||++++++.+. ...++|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEEE
Confidence            357999999999999999999998899999999997653  34456789999999999999999999998764 558999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec---CCCceEEeecC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFG  335 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld---~~~~vkL~DFG  335 (520)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||
T Consensus        89 ~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             ECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            9999999999999764       56999999999999999999999988   99999999999998   46789999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   +.   ..+.    
T Consensus       159 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~----  226 (444)
T 3soa_A          159 LAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY---QQIK----  226 (444)
T ss_dssp             SCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHH----
T ss_pred             eeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH---HHHH----
Confidence            9987654332  2234679999999999999899999999999999999999999997543211   10   0000    


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ....+......   ......+.+++.+||+.||.+|||+.|+++
T Consensus       227 ---~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          227 ---AGAYDFPSPEW---DTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ---HTCCCCCTTTT---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---hCCCCCCcccc---ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               00111111000   112245677889999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-43  Score=363.84  Aligned_cols=212  Identities=25%  Similarity=0.307  Sum_probs=184.2

Q ss_pred             cccccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-----CCCeec
Q 010012          169 LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----HPNIVP  243 (520)
Q Consensus       169 ~~~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~  243 (520)
                      ...+++.+.....++|...+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44556666666778999999999999999999999888999999999753 344566778999999986     999999


Q ss_pred             EEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       244 l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      +++++... ...++||||+ +++|.+++.....     ..+++..+..++.||+.||+|||+.+   |+||||||+|||+
T Consensus       101 ~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  170 (360)
T 3llt_A          101 YHGKFMYY-DHMCLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILL  170 (360)
T ss_dssp             EEEEEEET-TEEEEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             ccceeeEC-CeeEEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEE
Confidence            99998775 4589999999 9999999986532     46999999999999999999999988   9999999999999


Q ss_pred             cC-------------------------CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeH
Q 010012          324 SS-------------------------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAF  378 (520)
Q Consensus       324 d~-------------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~  378 (520)
                      +.                         ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence            75                         7899999999998654432     34569999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcchhc
Q 010012          379 GVVLLELLTGRKPIEARR  396 (520)
Q Consensus       379 GvvL~ELltG~~Pf~~~~  396 (520)
                      ||++|||++|+.||....
T Consensus       246 G~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHCCCCCCCCc
Confidence            999999999999997644

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-42  Score=347.04  Aligned_cols=263  Identities=19%  Similarity=0.214  Sum_probs=207.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|...+.||+|+||+||+|....+++.||||++....  ..+.+.+|+.+++.+ +|+|++++++++.+. ...++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEE
Confidence            368999999999999999999988889999999986543  234577899999999 799999999987654 4579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc-----eEEeec
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  334 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~-----vkL~DF  334 (520)
                      ||+ +++|.+++....      ..+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        86 e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999 999999998642      46999999999999999999999887   999999999999987776     999999


Q ss_pred             CCccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          335 GLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       335 Gla~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999876543221     112455799999999999999999999999999999999999999986443222211111110


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .....  ..... .+      ..   ...+.+++.+||+.+|++||++.+|++.|+...
T Consensus       236 ~~~~~--~~~~~-~~------~~---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          236 KKQST--PLREL-CA------GF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HHHHS--CHHHH-TT------TS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hccCc--cHHHH-Hh------hC---cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            00000  00000 00      11   235677888999999999999999999998653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-43  Score=382.11  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .....+|...+.||+|+||.||+|.+..++..||||++..... ..+.|.+|+.++++++|||||+++++|.+. ..+++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~l  293 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYI  293 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEE
Confidence            3345678999999999999999999988889999999976543 457899999999999999999999998764 45799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++.....     ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       294 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence            9999999999999986432     56899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +........ ......++..|+|||++....++.++|||||||+||||++ |+.||........   .    .       
T Consensus       366 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~----~-------  430 (495)
T 1opk_A          366 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----E-------  430 (495)
T ss_dssp             ECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----H-------
T ss_pred             eeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----H-------
Confidence            876543211 1223456789999999999999999999999999999999 9999976443211   1    0       


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .+...  .++..+...+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       431 ~~~~~--~~~~~~~~~~---~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          431 LLEKD--YRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             HHHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHcC--CCCCCCCCCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            11111  1111122222   3566788899999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=367.25  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=205.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||+||+|....+++.||+|++..........+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEEc
Confidence            5899999999999999999999988999999999877666667899999999999999999999998764 558999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC--CCceEEeecCCccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLATW  339 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~--~~~vkL~DFGla~~  339 (520)
                      +++|+|.+++....      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.
T Consensus       130 ~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          130 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999999987532      46999999999999999999999988   999999999999974  57899999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..              .
T Consensus       201 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~--------------~  260 (387)
T 1kob_A          201 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL--------------Q  260 (387)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH--------------H
T ss_pred             cCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH--------------H
Confidence            654332   234569999999999999899999999999999999999999997643211   10              0


Q ss_pred             HhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+....+... .........+.+++.+||+.||.+|||+.|+++
T Consensus       261 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0110011000 001112245778889999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.7e-44  Score=362.94  Aligned_cols=268  Identities=25%  Similarity=0.382  Sum_probs=210.9

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCC-----cEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEc
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~  250 (520)
                      ....++|...+.||+|+||+||+|....++     ..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            345678999999999999999999986544     379999997653 34567789999999999 89999999999866


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~-------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      .+ ..++||||+++|+|.+++........       ....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       122 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          122 GG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SS-SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             CC-ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            54 57999999999999999986431100       1246899999999999999999999988   9999999999999


Q ss_pred             cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchh
Q 010012          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEEN  402 (520)
Q Consensus       324 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~  402 (520)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||........  
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--  275 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--  275 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence            9999999999999986654433223344567889999999999999999999999999999999 9999975432211  


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .    ..       .+........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       276 ~----~~-------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 F----YK-------LVKDGYQMAQ--PAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             H----HH-------HHHHTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HH-------HHhcCCCCCC--CCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            0    00       1111111111  1112   23567788999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.6e-43  Score=356.43  Aligned_cols=261  Identities=18%  Similarity=0.182  Sum_probs=207.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|...+.||+|+||+||+|....+++.||||++.....  .+.+.+|+.+++.+ +||||+++++++.+. ...++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEE
Confidence            3689999999999999999999988899999999875432  24578999999999 999999999988764 5579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc-----eEEeec
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  334 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~-----vkL~DF  334 (520)
                      ||+ +++|.+++....      ..+++..++.|+.|++.||+|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             EeC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999 999999998642      57999999999999999999999988   999999999999999887     999999


Q ss_pred             CCccccCCCCCCc-----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          335 GLATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       335 Gla~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9998765433211     12356799999999999999999999999999999999999999986543322111111100


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..      .  ....... ....+    .+.+++..||+.+|.+||++.+|++.|+..
T Consensus       235 ~~------~--~~~~~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          235 TK------R--ATPIEVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HH------H--HSCHHHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hh------c--cCCHHHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            00      0  0000000 01112    677888999999999999999999999854

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-42  Score=358.05  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|+...+++.||+|++.+.   .....+.+.+|+.++.++ +||||+++++++.+ ...+++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEE
Confidence            5799999999999999999999988999999999764   334456788999999987 89999999998766 456899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        88 v~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999764       46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccch--hhHHhhhhHhhhch
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE--NLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~--~lv~~~~~~~~~~~  415 (520)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .....         
T Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------  226 (345)
T 3a8x_A          158 KEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY---------  226 (345)
T ss_dssp             BCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH---------
T ss_pred             ccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH---------
Confidence            86432221  234567999999999999999999999999999999999999999753221110  00000         


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI  457 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm  457 (520)
                       ....+....+..+...+   ..+.+++.+||+.||.+||++
T Consensus       227 -~~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          227 -LFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -HHHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTC
T ss_pred             -HHHHHHcCCCCCCCCCC---HHHHHHHHHHhcCCHhHCCCC
Confidence             01112222222222222   346678889999999999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.8e-43  Score=362.63  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=203.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|...+.||+|+||+||+|+...+++.||||++.+..   ......+..|..++..+ +||||+++++++.+ ...++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEE
Confidence            368999999999999999999999889999999997642   23345678899999887 89999999998766 45689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999864       46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 
T Consensus       168 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------  228 (353)
T 2i0e_A          168 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----------------  228 (353)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------
T ss_pred             ccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----------------
Confidence            986432221  2345679999999999999999999999999999999999999997643221                 


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ....++...+..+...   ...+.+++.+||+.+|.+||+     +.+|++
T Consensus       229 ~~~~i~~~~~~~p~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          229 LFQSIMEHNVAYPKSM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHCCCCCCTTS---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1111222222222222   235677888999999999995     466664

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=366.24  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=198.2

Q ss_pred             cccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      |...+.||+|+||.||+|....++..||+|++........+.+.+|+.++++++||||+++++++.+. ..++|||||++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~  169 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVD  169 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCC
Confidence            34467899999999999999888999999999887666778899999999999999999999998764 45899999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe--cCCCceEEeecCCccccC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL--SSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl--d~~~~vkL~DFGla~~~~  341 (520)
                      +|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++...
T Consensus       170 ~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          170 GGELFDRIIDES------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             TCEEHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            999999987643      45899999999999999999999988   9999999999999  577899999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....   .....||+.|+|||++....++.++|||||||++|||++|+.||........                 +..+
T Consensus       241 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----------------~~~i  300 (373)
T 2x4f_A          241 PREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-----------------LNNI  300 (373)
T ss_dssp             TTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHH
T ss_pred             Cccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHH
Confidence            4332   2345699999999999988999999999999999999999999976432211                 1111


Q ss_pred             hCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +........ ........+.+++.+||+.||.+|||+.|+++
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111111000 00011245778889999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=360.54  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=200.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcE----EEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      .++|...+.||+|+||+||+|.+..+++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.+..  .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence            36899999999999999999998766664    477776543 3345678899999999999999999999987643  7


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|+||+++|+|.+++....      ..+++..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             eEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCc
Confidence            89999999999999998653      56999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..........            
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------------  230 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------  230 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------------
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------------
Confidence            9987654433333334557889999999999999999999999999999999 999997654322111            


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        .+....  ....+..   ....+.+++.+||+.+|.+||++.||++.|+...
T Consensus       231 --~~~~~~--~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          231 --ILEKGE--RLPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             --HHHTTC--CCCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHcCC--CCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              011100  1111111   2235777889999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-43  Score=353.04  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=212.2

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ...++|...+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEE
Confidence            35578999999999999999999999889999999997654 3457889999999999999999999998664 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEcCCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence            999999999999976432     56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..........              .
T Consensus       160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~--------------~  224 (288)
T 3kfa_A          160 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--------------L  224 (288)
T ss_dssp             TSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--------------H
T ss_pred             eccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------H
Confidence            7654332 22334557889999999999999999999999999999999 999997644321110              1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      +......  ..+...   ...+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       225 ~~~~~~~--~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          225 LEKDYRM--ERPEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHTTCCC--CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccCCC--CCCCCC---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            1111111  111112   24577888999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=367.70  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++.+..   ....+.+.+|+.+++.++|||||++++++.+. ..+++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEE
Confidence            57999999999999999999999999999999996542   23346788999999999999999999988764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        94 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999753       56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ......   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.           
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-----------  229 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-----------  229 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-----------
T ss_pred             eccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-----------
Confidence            765432   2345679999999999974   45899999999999999999999999754332211111           


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-m~eVl~  462 (520)
                         ..+.......+...   ...+.+++.+||+.+|.+||+ +.+|.+
T Consensus       230 ---~~~~~~~~~~p~~~---s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          230 ---HTFETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---HHHHHCCCCCCTTS---CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---HHHhhcccCCCCcC---CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               11111112212222   245678889999999999999 777764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=374.32  Aligned_cols=263  Identities=26%  Similarity=0.283  Sum_probs=206.1

Q ss_pred             cHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEE
Q 010012          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (520)
Q Consensus       173 s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~  249 (520)
                      .+.++....++|...+.||+|+||+||+|+.+.+++.||||++.+...   .....+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            344555667899999999999999999999998899999999975321   22345788999999999999999999887


Q ss_pred             cCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       250 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                      +. ..+++||||+++|+|.+++....      ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++++
T Consensus       132 ~~-~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          132 DE-NYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             CS-SEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred             eC-CEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCE
Confidence            64 56899999999999999998642      46999999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcc-------cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  402 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~  402 (520)
                      ||+|||+++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||......... 
T Consensus       202 kL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-  279 (412)
T 2vd5_A          202 RLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-  279 (412)
T ss_dssp             EECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-
T ss_pred             EEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH-
Confidence            9999999987654332 1223457999999999997       356899999999999999999999999764332111 


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR---PGIEEIIA  462 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~R---Ptm~eVl~  462 (520)
                           ..+...    .....-+.+  ....   ...+.+++.+||+ +|.+|   |++.||++
T Consensus       280 -----~~i~~~----~~~~~~p~~--~~~~---s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          280 -----GKIVHY----KEHLSLPLV--DEGV---PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -----HHHHTH----HHHCCCC------CC---CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -----HHHHhc----ccCcCCCcc--ccCC---CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                 111100    000101111  0112   2356778889999 99998   68999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.5e-44  Score=375.52  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=205.1

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      ++....++|...+.||+|+||+||+|+...+++.||+|++.+...   .....+.+|+.+++.++|||||++++++.+ .
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~  141 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-D  141 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-C
Confidence            444566899999999999999999999998899999999965321   122347789999999999999999998876 4


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ..+++||||+++|+|.+++..        ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence            568999999999999999865        35899999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCC----CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK----VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      |||+++....... .......||+.|+|||++....    ++.++|||||||++|||++|+.||........      ..
T Consensus       211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~  283 (410)
T 3v8s_A          211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YS  283 (410)
T ss_dssp             CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH
T ss_pred             ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HH
Confidence            9999987654321 1234567999999999997655    78999999999999999999999976443211      11


Q ss_pred             hHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESR--RPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~--RPtm~eVl~  462 (520)
                      .+...    ...   .........+   ..+.+++.+||+.+|.+  ||++.||++
T Consensus       284 ~i~~~----~~~---~~~p~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          284 KIMNH----KNS---LTFPDDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHTH----HHH---CCCCTTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHhc----ccc---ccCCCccccc---HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            11100    000   1111111122   34667788999999998  999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-42  Score=370.31  Aligned_cols=266  Identities=21%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++|||||++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999988999999999764  3445677889999999999999999999986543     3


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+.+ +|.+.+.         ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEE
Confidence            47999999975 4666663         34899999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-----h
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-----~  408 (520)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+...     .
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          208 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998765432   234567999999999999999999999999999999999999999765432211111000     0


Q ss_pred             hHhhhchhHHHHhhCcccCCCC--------------C---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTS--------------R---NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~--------------~---~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+..........+........              .   .......+.+|+.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000100111111111110000              0   0111456889999999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5e-43  Score=348.82  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=195.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|...+.||+|+||.||+|.+..   .+..||+|++... .....+.+.+|+.++++++||||+++++++.+  +..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--CccE
Confidence            4689999999999999999998854   3457999998764 34456678999999999999999999998743  3478


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence            9999999999999997642      46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++........ ......+|+.|+|||.+....++.++|||||||++|||++ |..||........   ..          
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----------  228 (281)
T 1mp8_A          163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----------  228 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----------
T ss_pred             ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----------
Confidence            9876543221 1233457789999999998899999999999999999997 9999976443211   10          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+....  ....+...   ...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       229 -~i~~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          229 -RIENGE--RLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             011100  11111112   24567788999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-43  Score=361.56  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.....   .....+.+|+.+++.++||||+++++++.+. ...++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            589999999999999999999988899999999965321   2235788999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+ +|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999 78999998764       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........                
T Consensus       157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------  217 (336)
T 3h4j_B          157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------  217 (336)
T ss_dssp             TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------
T ss_pred             eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------
Confidence            765432   1244569999999999987776 78999999999999999999999764322110                


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..+.......+...+   ..+.+++.+||+.||.+|||+.||++
T Consensus       218 -~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 -KKVNSCVYVMPDFLS---PGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCSSCCCCCTTSC---HHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -HHHHcCCCCCcccCC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             001111111122222   34667889999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-42  Score=362.78  Aligned_cols=207  Identities=23%  Similarity=0.312  Sum_probs=178.6

Q ss_pred             hCCcccceEEccc--CceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|...+.||+|  +||+||+|+...+++.||||++....  ....+.+.+|+.+++.++|||||++++++.+. +.++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEE
Confidence            4689999999999  99999999999889999999997542  44557788999999999999999999998764 4589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++.....     ..+++..+..|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccc
Confidence            99999999999999986532     56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCC-----CCcccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          337 ATWTSAPS-----VPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       337 a~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      +.......     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            86442211     0111233468999999999987  578999999999999999999999997643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-42  Score=346.24  Aligned_cols=265  Identities=19%  Similarity=0.226  Sum_probs=206.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||+||+|.+..+++.||||++.....  ...+.+|+.+++.++|++++..++++.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            34789999999999999999999988899999998765432  2357789999999999998888888877777789999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGl  336 (520)
                      ||+ +++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             Ecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999 999999997542      46999999999999999999999988   9999999999999   7889999999999


Q ss_pred             ccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          337 ATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       337 a~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ++........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9876543321     11234579999999999999999999999999999999999999998644332222111110000


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ...  .. ..+.      ...   ...+.+++..||+.+|++|||+.+|++.|+...
T Consensus       235 ~~~--~~-~~~~------~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          235 MST--PI-EVLC------KGY---PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHS--CH-HHHT------TTS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             ccc--hh-hhhh------ccC---CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            000  00 0000      011   135778889999999999999999999998653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.5e-43  Score=351.12  Aligned_cols=269  Identities=26%  Similarity=0.333  Sum_probs=205.5

Q ss_pred             CCcccceEEcccCceEEEEee----ecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~  255 (520)
                      +.|...+.||+|+||.||+|.    ...+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.. ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            468899999999999999998    45678999999997543 234567889999999999999999999987653 457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence            89999999999999997643      56999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ++......... .......||..|+|||.+.+..++.++||||||+++|||++|..|+........    ....+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL----KMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh----hccCCccccc
Confidence            99876544321 122345688899999999999999999999999999999999999754321100    0000000000


Q ss_pred             -hhHHHHhhCc--ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          415 -MAAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       415 -~~~l~~~~d~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                       ...+...+..  ....+.   .....+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCC---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence             0011111111  111111   222457788899999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-42  Score=344.06  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=203.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||+||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEE
Confidence            46899999999999999999999988999999999654  344557788999999999999999999998664 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc---eEEeecC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFG  335 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~---vkL~DFG  335 (520)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        84 ~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999998765       46999999999999999999999988   999999999999986655   9999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ..   .+     
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~---~~-----  219 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YA---QI-----  219 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH-----
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HH---HH-----
Confidence            9987654332   2345699999999999999999999999999999999999999975432211   00   00     


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .............   .....+.+++.+||+.+|++|||+.|+++
T Consensus       220 --~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          220 --KAGAYDYPSPEWD---TVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --HHTCCCCCTTTTT---TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --HhccccCCchhhc---ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              0001111111011   12234678888999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-43  Score=376.08  Aligned_cols=262  Identities=25%  Similarity=0.386  Sum_probs=210.0

Q ss_pred             HHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       175 ~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++....++|...+.||+|+||+||+|.+.. +..||||++.... ...+.|.+|+.++++++|||||++++++.  ...
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~  256 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEP  256 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCc
Confidence            3344566789999999999999999999874 6789999997654 34678999999999999999999999875  345


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++|+|.+++.....     ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECST
T ss_pred             cEEEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeC
Confidence            7999999999999999986432     36899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++....... .......+|..|+|||++..+.++.++|||||||+||||++ |+.||.......   +..        
T Consensus       329 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~--------  396 (454)
T 1qcf_A          329 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR--------  396 (454)
T ss_dssp             TGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH--------
T ss_pred             CCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH--------
Confidence            99987643211 11123346788999999999999999999999999999999 999997543221   110        


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                         .+....  ++..+...   ...+.+++.+||+.||++|||+.+|++.|+...
T Consensus       397 ---~i~~~~--~~~~~~~~---~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          397 ---ALERGY--RMPRPENC---PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ---HHHHTC--CCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---HHHcCC--CCCCCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence               111111  11112222   235677889999999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-43  Score=350.96  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||+||+|... ++..||+|++..... ..+++.+|+.+++.++||||+++++++.+. ...++||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   98 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIIT   98 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-CCeEEEE
Confidence            4468999999999999999999887 477899999976543 346788999999999999999999998654 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        99 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           99 EYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             CCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             eccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            9999999999997643      46999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........      .        .+
T Consensus       170 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~--------~~  234 (283)
T 3gen_A          170 VLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------E--------HI  234 (283)
T ss_dssp             BCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------H--------HH
T ss_pred             cccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------H--------HH
Confidence            643221 11223447788999999998999999999999999999998 99999754322110      0        11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       235 ~~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          235 AQGLRLYR--PHLA---SEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             HTTCCCCC--CTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCC--CCcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11111111  1112   23577788999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.5e-43  Score=348.81  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=193.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||+||+|....   .||+|++...  .....+.|.+|+.++++++||||+++++++..  ...++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEEE
Confidence            4689999999999999999998753   5999998654  34556789999999999999999999997533  347899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        98 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             EECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             EEecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence            99999999999996543      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ...............||+.|+|||.+.   ...++.++||||||+++|||++|+.||.......  .+.    ....   
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~---  239 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----EMVG---  239 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHH----HHHH---
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHH----HHhc---
Confidence            665433222334556999999999986   5678889999999999999999999997543221  111    1110   


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                         .....+.+..  ........+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       240 ---~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          240 ---RGSLSPDLSK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             ---HTSCCCCTTS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---ccccCcchhh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence               1111111110  0112234577888999999999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-42  Score=345.30  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=200.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||+||+|....++..||+|++....   ......+.+|+.+++.++||||+++++++.+. ...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEE
Confidence            468999999999999999999999889999999986542   12345788999999999999999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        87 v~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             EEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccc
Confidence            99999999999999765       45999999999999999999999887   999999999999999999999999998


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........                 
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------  215 (279)
T 3fdn_A          157 VHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----------------  215 (279)
T ss_dssp             SCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------
T ss_pred             ccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-----------------
Confidence            6554332    2345699999999999998999999999999999999999999975432211                 


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+...+   ..+.+++.+||+.+|.+|||+.||++
T Consensus       216 ~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          216 YKRISRVEFTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHHHHTCCCCCTTSC---HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCcCC---HHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0111111111111122   34667888999999999999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-42  Score=354.21  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=192.7

Q ss_pred             CCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|...+.||+|+||.||+|...   .+++.||+|++.+..    ......+.+|+.+++.++||||+++++++.+. ..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~   95 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GK   95 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-SC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-CE
Confidence            58999999999999999999874   578999999997642    23345678899999999999999999998764 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence            89999999999999999764       46899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......               
T Consensus       166 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  228 (327)
T 3a62_A          166 GLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---------------  228 (327)
T ss_dssp             SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------
T ss_pred             CcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence            99975433221  2234579999999999999899999999999999999999999997543211               


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                        .+..++...+..+...+   ..+.+++.+||+.+|.+||     ++.++++
T Consensus       229 --~~~~i~~~~~~~p~~~~---~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          229 --TIDKILKCKLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --HHHHHHHTCCCCCTTSC---HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --HHHHHHhCCCCCCCCCC---HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              11111112222222222   3566788899999999999     7778776

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.4e-43  Score=360.55  Aligned_cols=251  Identities=28%  Similarity=0.372  Sum_probs=188.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||+||+|....+++.||||++....  ..+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEE
Confidence            3468999999999999999999999889999999997643  345688999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~DFGl  336 (520)
                      ||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       128 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             CCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             EeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999998753       46899999999999999999999988   999999999999975   88999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .+             
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~-------------  259 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM-------------  259 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH-------------
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH-------------
Confidence            98664432   1234569999999999999899999999999999999999999997543221  00             


Q ss_pred             HHHHhhCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       +..+....... ..........+.+++.+||+.||++|||+.|+++
T Consensus       260 -~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          260 -FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11111111110 0001122345778889999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.6e-43  Score=373.93  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=195.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||.||+|....+++.||||++...   .......+.+|+.+++.++||||+++++++.+. +.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEE
Confidence            46799999999999999999999989999999999753   233445678899999999999999999998765 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      ||||+++|+|.+++...       ..+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+
T Consensus       226 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             EEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCC
Confidence            99999999999999764       469999999999999999999997 77   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++.......  ......||+.|+|||++.+..++.++|||||||+||||++|+.||........                
T Consensus       296 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----------------  357 (446)
T 4ejn_A          296 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----------------  357 (446)
T ss_dssp             CCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred             ceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----------------
Confidence            986443221  23456799999999999999999999999999999999999999975432211                


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                       ...+....+..+...+   ..+.+++.+||+.||.+||     ++.|+++
T Consensus       358 -~~~i~~~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          358 -FELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -HHHHHHCCCCCCTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -HHHHHhCCCCCCccCC---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             1111111122122222   3567788999999999999     9999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-42  Score=350.44  Aligned_cols=265  Identities=23%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|+..+.||+|+||+||+|.+.. ++.||+|++....  ......+.+|+.++++++||||+++++++.+. ...++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEE
Confidence            3689999999999999999999864 8899999997543  22346788999999999999999999997654 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||++ |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        98 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           98 FEFME-KDLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             EECCS-EEHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EcCCC-CCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence            99997 58888886542      46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc---
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG---  414 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~---  414 (520)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+   .......   
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~  242 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPR  242 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTT
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChH
Confidence            7654322  1234568999999999876 56899999999999999999999999765433221111   0000000   


Q ss_pred             -h---hHHHHhhCcccCCCC-CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 -M---AAVEELLDPRLKCTS-RN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 -~---~~l~~~~d~~l~~~~-~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .   ..+....+....... ..     ......+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             0   000000010000000 00     011235778899999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.2e-42  Score=344.27  Aligned_cols=263  Identities=19%  Similarity=0.237  Sum_probs=208.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.+++.++|++++..+.++.......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4689999999999999999999988899999999865432  24588999999999999988888887776777899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGla  337 (520)
                      |+ +++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus        86 ~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             ec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99 999999997542      56999999999999999999999988   9999999999999   48889999999999


Q ss_pred             cccCCCCCCc-----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          338 TWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       338 ~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      +.........     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            8765433211     12345799999999999999999999999999999999999999986443222111111110000


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..  .. ..+.      ...+   ..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus       236 ~~--~~-~~~~------~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          236 ST--PI-EVLC------KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HS--CH-HHHT------TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CC--ch-HHHH------hhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            00  00 0000      1111   3477788999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.5e-43  Score=361.01  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=194.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||++....+++.||||++..... ..+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEE
Confidence            4689999999999999999999998899999999976432 235678999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc--eEEeecCCcc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLAT  338 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~--vkL~DFGla~  338 (520)
                      |+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||+++
T Consensus        97 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           97 YASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             eCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            99999999999764       46999999999999999999999988   999999999999987765  9999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCc-CceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-sDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......   ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.........  ..           .
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~-----------~  230 (361)
T 3uc3_A          167 SSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RK-----------T  230 (361)
T ss_dssp             -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HH-----------H
T ss_pred             cccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HH-----------H
Confidence            543222   1234569999999999988887665 89999999999999999999864432211  10           1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +..+.......+. .......+.+++.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          231 IQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1222222222111 0011235678889999999999999999987

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-42  Score=345.12  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|....++..||+|++........+.+.+|+++++.++||||+++++++.+. ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEEe
Confidence            35799999999999999999999988999999999876555667899999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGla  337 (520)
                      |+++++|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           87 LCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             CCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999998764       46999999999999999999999988   9999999999999   78899999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........   .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........                 
T Consensus       157 ~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------------  215 (277)
T 3f3z_A          157 ARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-----------------  215 (277)
T ss_dssp             EECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------
T ss_pred             eeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-----------------
Confidence            87654332   234569999999999865 489999999999999999999999976432211                 


Q ss_pred             HHHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+.. .......+.+++.+||+.+|.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111111110000 0011245778889999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=346.51  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             CcccceEEcccCceEEEEeeecCCC---cEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .|...+.||+|+||+||+|.+..++   ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+...++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5667799999999999999865433   379999997643 345678899999999999999999999987766656899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+.+|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       102 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             EecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            99999999999997632      56899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCC--CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCc-chhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSV--PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI-EARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf-~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .......  ........+|..|+|||.+.+..++.++||||||+++|||++|..|+ .......   +..          
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~----------  239 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH----------  239 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH----------
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH----------
Confidence            6543221  11223456889999999999999999999999999999999965554 3322211   110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                       .+....  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       240 -~~~~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          240 -FLAQGR--RLPQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             -HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhhcCC--CCCCCccc---hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             011111  11111112   2357788899999999999999999999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.1e-43  Score=357.21  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=195.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---c
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~  254 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++...   .......+.+|+.++++++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36899999999999999999999888999999999764   33445678899999999999999999998765433   2


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCC
T ss_pred             cEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeec
Confidence            48999999999999999764       46999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      .......
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~  234 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRE  234 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcC
Confidence            999866543211 122345699999999999999999999999999999999999999976433211      0001100


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .      ...+... ...   ....+.+++.+||+.||.+||+..+++.
T Consensus       235 ~------~~~~~~~-~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          235 D------PIPPSAR-HEG---LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             C------CCCHHHH-STT---CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             C------CCCcccc-cCC---CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            0      0000000 001   1235677889999999999998776654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.8e-43  Score=355.08  Aligned_cols=271  Identities=22%  Similarity=0.317  Sum_probs=212.5

Q ss_pred             HHHHHHhhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEE
Q 010012          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGF  247 (520)
Q Consensus       174 ~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~  247 (520)
                      ..++....++|...+.||+|+||.||+|...     .+++.||+|++.... ......+.+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3344456689999999999999999999875     346789999997543 3455678999999999999999999999


Q ss_pred             EEcCCCcEEEEEEecCCCChhHHhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec
Q 010012          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKG---VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (520)
Q Consensus       248 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~---~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld  324 (520)
                      +.+. ...++||||+++|+|.+++......   ......+++..++.++.|++.||.|||+.+   |+||||||+|||++
T Consensus        97 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           97 VSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             ECSS-SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EccC-CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            8664 4579999999999999999864310   011145799999999999999999999988   99999999999999


Q ss_pred             CCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhh
Q 010012          325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENL  403 (520)
Q Consensus       325 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~l  403 (520)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.......   .
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---H
Confidence            999999999999986544322222234457889999999999999999999999999999999 899987543211   1


Q ss_pred             HHhhhhHhhhchhHHHHhhCccc-CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          404 VLWAKPILHRGMAAVEELLDPRL-KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       404 v~~~~~~~~~~~~~l~~~~d~~l-~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                                    ...+..... ..+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       250 --------------~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          250 --------------LRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             --------------HHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             --------------HHHHHcCCcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                          111111111 111112   234677888999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-42  Score=347.87  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .+|...+.||+|+||+||+|.+...   ...||+|.+... .....+.+.+|+.++++++||||++++++|.+.+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4688899999999999999986532   346899998764 344567899999999999999999999998877777899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence            999999999999997532      56899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCC--CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          338 TWTSAPSV--PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       338 ~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +.......  ........||+.|+|||.+.+..++.++||||||+++|||++ |.+||........   ..         
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~---------  243 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---------  243 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH---------
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH---------
Confidence            86643221  111234557889999999999999999999999999999999 5556654332211   00         


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        .+...  .....+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       244 --~~~~~--~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          244 --YLLQG--RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             --HHHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHhcC--CCCCCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              00000  0111111122   35777889999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.8e-42  Score=345.31  Aligned_cols=266  Identities=21%  Similarity=0.298  Sum_probs=199.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....  ......+.+|+.++++++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence            47999999999999999999999889999999997542  33456788999999999999999999998764 5689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++ +|.+.+....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            99975 6666665432      56999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh----c
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR----G  414 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~----~  414 (520)
                      ......  ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.......  ............    .
T Consensus       151 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          151 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             cCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhh
Confidence            654322  223456899999999998766 7999999999999999999888864322111  111110000000    0


Q ss_pred             hhHHHHhhCcc----c----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPR----L----KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~----l----~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ........+..    .    ............+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00000000000    0    000001112345678889999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=352.27  Aligned_cols=267  Identities=23%  Similarity=0.359  Sum_probs=208.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc---CCCcEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLF  256 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~~~  256 (520)
                      ..++|...+.||+|+||.||++....+++.||||++........+.+.+|+.+++.++||||+++++++..   .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            34689999999999999999999988899999999977666777889999999999999999999999863   233578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            99999999999999987432   1267999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-------ccccccccCCccCchhcccCC---CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          337 ATWTSAPSVPF-------LCKTVKGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       337 a~~~~~~~~~~-------~~~~~~Gt~~Y~aPE~~~~~~---~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +..........       ......||+.|+|||++....   ++.++|||||||++|||++|+.||......... ... 
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~-  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL-  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH-
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH-
Confidence            87653211100       012345799999999987554   689999999999999999999999753222111 000 


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                                .+...  ..+....   .....+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       259 ----------~~~~~--~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 ----------AVQNQ--LSIPQSP---RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----------HHHCC----CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----------Hhhcc--CCCCccc---cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                      01110  0111111   122457788899999999999999999999997654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-42  Score=342.59  Aligned_cols=254  Identities=21%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|.+.  +..||||++...  .....+.+.+|+.++++++||||+++++++.+.. ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            57999999999999999999985  788999999764  3455678999999999999999999999987652 457999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.++|+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999986431     46999999999999999999999754 449999999999999999999999999875


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCC---cCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSD---KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~---ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ....       ....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||........      ...      
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~------  222 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMK------  222 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHH------
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHH------
Confidence            4322       2345899999999998765554   79999999999999999999975432211      000      


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       .......+.+  +...   ...+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       223 -~~~~~~~~~~--~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          223 -VALEGLRPTI--PPGI---SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -HHHSCCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -HHhcCCCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence             0111111222  1112   235677888999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-43  Score=358.68  Aligned_cols=265  Identities=24%  Similarity=0.299  Sum_probs=201.1

Q ss_pred             HHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-----chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC
Q 010012          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (520)
Q Consensus       177 i~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~  251 (520)
                      +....++|...+.||+|+||+||+|....++..||+|++...     .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345567899999999999999999999888999999998653     234557889999999999999999999998764


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCC---------------------------------CCCCCCHHHHHHHHHHHHH
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVR---------------------------------GNSTLPWSVRYKVALGIAE  298 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~---------------------------------~~~~l~~~~~~~ia~qia~  298 (520)
                       ...++||||+++|+|.+++........                                 ....+++..++.|+.|++.
T Consensus       101 -~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          101 -QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             -SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence             558999999999999999863211000                                 0123467788899999999


Q ss_pred             HHHHHHhCCCCceEecccCCCCeEecCCC--ceEEeecCCccccCCCCC--CcccccccccCCccCchhccc--CCCCCc
Q 010012          299 SVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQH--GKVSDK  372 (520)
Q Consensus       299 aL~yLH~~~~~~IiHrDLKp~NILld~~~--~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k  372 (520)
                      ||+|||+.+   |+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999988   99999999999998776  899999999986543211  112245569999999999975  678999


Q ss_pred             CceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCC
Q 010012          373 TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEE  451 (520)
Q Consensus       373 sDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP  451 (520)
                      +|||||||++|||++|+.||........                 +..++....... .........+.+++.+||+.+|
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT-----------------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH-----------------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999999975432211                 111111111100 0001122457788899999999


Q ss_pred             CCCCCHHHHHH
Q 010012          452 SRRPGIEEIIA  462 (520)
Q Consensus       452 ~~RPtm~eVl~  462 (520)
                      .+||++.++++
T Consensus       320 ~~Rps~~~~l~  330 (345)
T 3hko_A          320 DERFDAMRALQ  330 (345)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCCCHHHHhc
Confidence            99999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=348.05  Aligned_cols=268  Identities=23%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEE
Confidence            57999999999999999999999889999999986543  33456788999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        82 e~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             ECCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999887653       46999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-hhHhhhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-KPILHRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~~~~~~~~~  417 (520)
                      ......  ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ..........
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            654322  1234568999999999976 56899999999999999999999999765433221111110 0000000000


Q ss_pred             HH--H-hhCcccCCCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VE--E-LLDPRLKCTSR-------NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~--~-~~d~~l~~~~~-------~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..  . .....+.....       .......+.+++.+||+.||.+|||+.||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00  0 00000000000       0112235778899999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-42  Score=352.59  Aligned_cols=269  Identities=21%  Similarity=0.339  Sum_probs=190.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|...+.||+|+||+||+|....+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            4689999999999999999999988899999999975432 234678899999999999999999998765 45689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||++ |+|.+++...... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9997 6999998765321 11246899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh-----Hhhh
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP-----ILHR  413 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~-----~~~~  413 (520)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.....     .+..
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            653322  12345689999999999764 689999999999999999999999976543221111100000     0000


Q ss_pred             c--------------hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 G--------------MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~--------------~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .              ...+.+.+.+....     .....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKE-----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSS-----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccc-----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0              00000111111110     11235778899999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.9e-43  Score=363.67  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=194.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHH-HHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|+...+++.||||++.+..   ......+..|..+ ++.++||||+++++++.+. ..+++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~l  116 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYF  116 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEEE
Confidence            58999999999999999999999889999999997643   2334456677776 5778999999999988764 56899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++++||+|||++
T Consensus       117 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccc
Confidence            99999999999999764       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .
T Consensus       187 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~  247 (373)
T 2r5t_A          187 KENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----------------M  247 (373)
T ss_dssp             GGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----------------H
T ss_pred             cccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----------------H
Confidence            86433221  2345679999999999999999999999999999999999999997543221                 1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL  464 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L  464 (520)
                      ...++...+..+...+   ..+.+++.+||+.||.+||++.+.++.+
T Consensus       248 ~~~i~~~~~~~~~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          248 YDNILNKPLQLKPNIT---NSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             HHHHHHSCCCCCSSSC---HHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             HHHHHhcccCCCCCCC---HHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            1122222222222222   3466788899999999999986444333

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-42  Score=351.04  Aligned_cols=267  Identities=21%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~  253 (520)
                      ...++|...+.||+|+||+||+|....   ++..||+|++...  .....+.+.+|+.++++++||||+++++++.+...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            455789999999999999999998754   4568999998754  34456778999999999999999999999876543


Q ss_pred             ----cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          254 ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       254 ----~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                          ..++||||+++|+|.+++...... .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence                358999999999999999653211 12357999999999999999999999887   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||........   ..   
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~---  260 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD---  260 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH---
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH---
Confidence            9999999987654332222334557889999999999999999999999999999999 8999976433211   00   


Q ss_pred             hHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                              .+.....+..  +..   ....+.+++.+||..+|.+|||+.+|++.|+...
T Consensus       261 --------~~~~~~~~~~--~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          261 --------YLLHGHRLKQ--PED---CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             --------HHHTTCCCCC--BTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------HHHcCCCCCC--Ccc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    0111011111  111   2245778889999999999999999999998653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=348.92  Aligned_cols=268  Identities=22%  Similarity=0.280  Sum_probs=198.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-----hHHHHHHHHHHHHHHhC---CCCCeecEEEEEEcC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSL---HHPNIVPLVGFCIDP  251 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~  251 (520)
                      .+++|...+.||+|+||+||+|.+..+++.||||++....     ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3579999999999999999999998889999999986432     11123455677766665   599999999998765


Q ss_pred             CC----cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          252 EQ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       252 ~~----~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      ..    ..++||||+. |+|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC
Confidence            43    4789999996 699999986432     45999999999999999999999988   99999999999999999


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      .+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   
T Consensus       158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---  231 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---  231 (308)
T ss_dssp             CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH---
T ss_pred             CEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            999999999987654332   24567999999999999999999999999999999999999999764432211110   


Q ss_pred             hhHhhhch-hHHH---HhhCcccCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 KPILHRGM-AAVE---ELLDPRLKC-TSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 ~~~~~~~~-~~l~---~~~d~~l~~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ........ ....   ......+.. ....     ......+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000000 0000   000000000 0000     011245778889999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=343.93  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=183.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....+++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEEE
Confidence            579999999999999999999988899999999965422   2246788999999999999999999998764 558999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        90 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            99999999999997542      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........                 +
T Consensus       161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~  221 (278)
T 3cok_A          161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------L  221 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------H
Confidence            7653322  12345699999999999988899999999999999999999999975432211                 1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.......+...   ...+.+++.+||+.||++|||+.+|++
T Consensus       222 ~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 NKVVLADYEMPSFL---SIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCSSCCCCCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhhcccCCcccc---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11111111112112   235677889999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-42  Score=362.49  Aligned_cols=205  Identities=27%  Similarity=0.412  Sum_probs=166.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCC-CcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-~~~~  256 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.++..+. ||||+++++++...+ ..++
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999999989999999998643  3445667889999999997 999999999987543 3589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|||||+ |+|..++..        ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        88 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             EEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            9999997 689999875        45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCC-------------------CCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          337 ATWTSAPS-------------------VPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       337 a~~~~~~~-------------------~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      |+......                   .........||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98653211                   0111234579999999999976 578999999999999999999999997654


Q ss_pred             c
Q 010012          397 L  397 (520)
Q Consensus       397 ~  397 (520)
                      .
T Consensus       236 ~  236 (388)
T 3oz6_A          236 T  236 (388)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=356.97  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...+.||+|+||+||+|... +++.||||++...  .....+.+.+|+.++..++|  |||+++++++.+. ...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEE
Confidence            3467999999999999999999886 4889999998654  34455788999999999986  9999999998764 468


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||| +.+|+|.+++...       ..+++..+..|+.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus        85 ~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             EEEEe-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecc
Confidence            99999 5688999999864       56999999999999999999999988   99999999999997 6789999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhccc-----------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      +++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~  227 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I  227 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H
Confidence            9987755433333345679999999999865           67899999999999999999999999643211     0


Q ss_pred             HhhhhHhhhchhHHHHhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .           .+..++++...  .+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~-----------~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          228 S-----------KLHAIIDPNHEIEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             H-----------HHHHHHCTTSCCCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-----------HHHHHhcCCcccCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            0           12233333222  111122   35678889999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-42  Score=353.99  Aligned_cols=266  Identities=21%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             hCCcccceEEcccCceEEEEeeec-------CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      .++|...+.||+|+||+||+|.+.       .++..||||++... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999874       34678999999765 334567789999999999 899999999998664


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ...++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       114 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 -GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             -CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence             45799999999999999998643200         01135899999999999999999999988   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence            99999999999999987654432222234457889999999998889999999999999999999 999997543221  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                       +..           .+........  +...   ...+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       268 -~~~-----------~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 -LFK-----------LLKEGHRMDK--PANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -HHH-----------HHHHTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHH-----------HHhcCCCCCC--CccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             110           1111111111  1112   2356778889999999999999999999987543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-42  Score=348.46  Aligned_cols=264  Identities=23%  Similarity=0.415  Sum_probs=199.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .+|...+.||+|+||.||+|....+++.||||++...   .......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv  110 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIV  110 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEEE
Confidence            5799999999999999999999888999999999753   345567889999999999999999999998774 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++......   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       111 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             EecCCCCCHHHHHHHhccc---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            9999999999999764321   256999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||.......    .....        .+
T Consensus       185 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~--------~~  250 (310)
T 2wqm_A          185 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK--------KI  250 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHH--------HH
T ss_pred             eecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHH--------Hh
Confidence            6654321  1234568999999999999999999999999999999999999997543211    11111        11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcch
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  470 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~~  470 (520)
                      .....+.+. ....   ...+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       251 ~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          251 EQCDYPPLP-SDHY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HTTCSCCCC-TTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcccCCCCc-cccc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            111111111 1111   23567788899999999999999999999876544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-42  Score=347.55  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=197.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||+||+|....++..||+|++.... ....+.+.+|+++++.++||||+++++++.+. ...++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEEE
Confidence            47999999999999999999998889999999987643 23457788999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGla  337 (520)
                      |+++|+|.+++......   ...+++..+..|+.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus       101 ~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          101 TCEGGELLERIVSAQAR---GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CCSCCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             eCCCCcHHHHHHhhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999998764221   257999999999999999999999988   9999999999999   45678999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......   .....||+.|+|||++. +.++.++|||||||++|||++|+.||...........              
T Consensus       175 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~--------------  236 (285)
T 3is5_A          175 ELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK--------------  236 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------
T ss_pred             eecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh--------------
Confidence            86654321   24456999999999985 5789999999999999999999999976432211000              


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      . ....+.....  .......+.+++.+||+.||++|||+.||++
T Consensus       237 ~-~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          237 A-TYKEPNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             H-HHCCCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             h-ccCCcccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0111111100  0011235668889999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-42  Score=370.04  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=204.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|.+..+++.||||++.....   .....+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence            589999999999999999999988899999999975422   2346788999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        95 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999999753       56999999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......                 .
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----------------~  224 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----------------L  224 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----------------H
T ss_pred             hccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----------------H
Confidence            765432   2244579999999999988765 689999999999999999999997543211                 1


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.+.....+...+   ..+.+++.+||+.||.+|||+.||++
T Consensus       225 ~~~i~~~~~~~p~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          225 FKKICDGIFYTPQYLN---PSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHTTCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCcCCCccCC---HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            1122222222222222   34677889999999999999999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-42  Score=343.23  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC---CCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~~~  256 (520)
                      +.|...+.||+|+||+||+|.+..++..||+|++...  .....+.+.+|+.+++.++||||+++++++...   ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4578888999999999999999988999999998654  345567889999999999999999999987652   34578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  335 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFG  335 (520)
                      +||||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||
T Consensus       106 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            999999999999999764       46899999999999999999999764 3599999999999998 88999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++.......    .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......  ..   ...      
T Consensus       178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~---~~~------  241 (290)
T 1t4h_A          178 LATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QI---YRR------  241 (290)
T ss_dssp             GGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HH---HHH------
T ss_pred             Ccccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HH---HHH------
Confidence            997654332    23456999999999886 569999999999999999999999997533211  11   000      


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        +.....+... ....   ...+.+++..||+.+|.+|||+.+|++
T Consensus       242 --~~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 --VTSGVKPASF-DKVA---IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --HTTTCCCGGG-GGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --HhccCCcccc-CCCC---CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              0000011000 0111   135778889999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.9e-43  Score=346.50  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=198.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||+||+|...  ++.||||++....  ..+.+.+|+.++++++||||+++++++.+.....++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            358999999999999999999875  7899999997653  456789999999999999999999998776666899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        96 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CCTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             cCCCCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            9999999999986532     34899999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ....     ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...           .+.
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~-----------~~~  228 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-----------RVE  228 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH-----------HHT
T ss_pred             cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------HHh
Confidence            4322     23357889999999999999999999999999999998 999997543221   100           011


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....+..  +...   ...+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       229 ~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          229 KGYKMDA--PDGC---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             TTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCC--cccC---CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            1111111  1112   235677888999999999999999999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.9e-42  Score=344.23  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=203.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...+.||+|+||+||+|....   .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CC
Confidence            34689999999999999999998643   3456999999765 345567899999999999999999999987543  35


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence            89999999999999997643      46899999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..........            
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~------------  225 (281)
T 3cc6_A          159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG------------  225 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH------------
T ss_pred             CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH------------
Confidence            99876543221 1233457889999999998899999999999999999998 999997543321110            


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        .+....  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       226 --~~~~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          226 --VLEKGD--RLPKPDLC---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             --HHHHTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHhcCC--CCCCCCCC---CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence              011111  11111112   234677889999999999999999999998643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-42  Score=370.74  Aligned_cols=259  Identities=28%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ....++|...+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.++++++||||+++++++.+  ...++
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~i  255 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYI  255 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEE
Confidence            3455789999999999999999999975 56799999976542 34679999999999999999999999755  45789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       256 v~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EehhhcCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence            9999999999999976432     46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +........ ......+|..|+|||++..+.++.++|||||||++|||++ |+.||......+   ...           
T Consensus       328 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~-----------  392 (452)
T 1fmk_A          328 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD-----------  392 (452)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-----------
T ss_pred             eecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------
Confidence            876543211 1223457889999999999999999999999999999999 999997543221   100           


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .+...  .++..+...+   ..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       393 ~i~~~--~~~~~~~~~~---~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          393 QVERG--YRMPCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHHTT--CCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHcC--CCCCCCCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            11111  1111122222   35677889999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-42  Score=351.62  Aligned_cols=273  Identities=28%  Similarity=0.347  Sum_probs=207.8

Q ss_pred             CcccceEEcccCceEEEEee----ecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEE
Q 010012          183 NFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~  256 (520)
                      .|...+.||+|+||+||++.    ...+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            34899999999999997765    34568899999997653 345677999999999999999999999988653 5678


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       112 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR--------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEECCCTTCBHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEecccCCcHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            99999999999999965        34999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +......... .......||..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.......  
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~--  257 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTV--  257 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHH--
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhH--
Confidence            9877543321 12234558888999999999899999999999999999999999997543211 0000000000000  


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcch
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  470 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~~  470 (520)
                      ..+.+.++...... ........+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       258 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          258 LRLTELLERGERLP-RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCC-CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            01222222221111 1112234577888999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-42  Score=355.84  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..|...+.||+|+||+||+|....+++.||||++....   ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEE
Confidence            45889999999999999999998889999999997542   33456789999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       133 ~e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             EECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            99996 68888886543      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .....      ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.......      ....      
T Consensus       203 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~------  264 (348)
T 1u5q_A          203 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH------  264 (348)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH------
T ss_pred             ecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHH------
Confidence            66432      2356999999999984   5678999999999999999999999997543211      0011      


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        +.....+.+. ....+   ..+.+++.+||+.+|++|||+.+|++
T Consensus       265 --~~~~~~~~~~-~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          265 --IAQNESPALQ-SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --HHHSCCCCCC-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHhcCCCCCC-CCCCC---HHHHHHHHHHcccChhhCcCHHHHhh
Confidence              1111112221 11122   34667888999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=346.76  Aligned_cols=267  Identities=22%  Similarity=0.302  Sum_probs=198.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC--CCCCeecEEEEEEcCC---CcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL--HHPNIVPLVGFCIDPE---QGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~~~---~~~  255 (520)
                      .++|...+.||+|+||.||+|...  ++.||||++....   ...+..|.+++..+  +||||+++++++.+..   ..+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            468999999999999999999886  7899999986532   23445566666554  9999999999987753   458


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCCeEecCCCceE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ++||||+++|+|.+++..        ..+++..++.++.|++.||.|||+.+     .++|+||||||+|||++.++.+|
T Consensus       111 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             EEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            999999999999999965        45999999999999999999999871     11399999999999999999999


Q ss_pred             EeecCCccccCCCCCCc--ccccccccCCccCchhcccCCCCCc------CceeeHHHHHHHHHhC----------CCCc
Q 010012          331 LCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHGKVSDK------TDVYAFGVVLLELLTG----------RKPI  392 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k------sDVwS~GvvL~ELltG----------~~Pf  392 (520)
                      |+|||+++.........  ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997665432211  1224569999999999988776665      9999999999999999          5565


Q ss_pred             chhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          393 EARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       393 ~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .......... .. .....      ......+.+............+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       263 ~~~~~~~~~~-~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          263 HDLVPSDPSY-ED-MREIV------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTSCSSCCH-HH-HHHHH------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhcCCCCch-hh-hHHHH------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            4432211100 00 00000      001111111111111255677889999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-42  Score=346.30  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=196.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|.. .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEE
Confidence            4789999999999999999998 4688999999965432  2346788999999999999999999998765 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++ +|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        80 e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             ECCSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EecCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            99975 9999887542      56899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh----c
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR----G  414 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~----~  414 (520)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  +.. .......    .
T Consensus       150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~  224 (288)
T 1ob3_A          150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKN  224 (288)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTT
T ss_pred             cCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHHCCCChhh
Confidence            643221  12345689999999999764 589999999999999999999999976432211  110 0000000    0


Q ss_pred             hhHHHH--hhCcccCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEE--LLDPRLKCT------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~--~~d~~l~~~------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.+  ..++.+...      .........+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000  011111100      000112245678889999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-42  Score=351.22  Aligned_cols=251  Identities=26%  Similarity=0.332  Sum_probs=203.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH------HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++|...+.||+|+||.||+|....+++.||+|++......      ..+.+.+|+.++++++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CE
Confidence            35799999999999999999999888999999999754321      356789999999999999999999998764 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC----ceE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  330 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vk  330 (520)
                      .++||||+++++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence            89999999999999999753       46899999999999999999999988   99999999999999888    799


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   .      
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~------  227 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L------  227 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H------
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---H------
Confidence            999999987654321   2345699999999999999999999999999999999999999975432211   0      


Q ss_pred             hhhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                              ..+.......+. ........+.+++.+||+.||.+|||+.|+++
T Consensus       228 --------~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          228 --------ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --------HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    011111100000 00001234678889999999999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-42  Score=342.23  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEEE
Confidence            57999999999999999999998889999999986542 34457788999999999999999999998764 45799999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        86 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           86 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999998643       46999999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .............||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.            
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~------------  222 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK------------  222 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH------------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh------------
Confidence            43322222344569999999999987665 7789999999999999999999976433211 111110            


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ....... ........+.+++.+||+.||.+|||+.||++
T Consensus       223 ---~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          223 ---EKKTYLN-PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---TTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hcccccC-chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               0000000 00112235677889999999999999999976

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-42  Score=346.91  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             hhCCcccce-EEcccCceEEEEeee--cCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          180 ATHNFSKGR-VLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       180 at~~f~~~~-~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ..++|...+ .||+|+||+||+|.+  ..+++.||||++....  ....+.+.+|+.+++.++||||+++++++ + ...
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~~~   91 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-AES   91 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-SSS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-CCC
Confidence            345788887 999999999999954  5567899999997643  23457799999999999999999999998 3 345


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence            78999999999999999763       46999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          335 GLATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |++.......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +..       
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~-------  231 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA-------  231 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-------
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH-------
Confidence            9998765433211 1122346788999999998889999999999999999999 999997643321   100       


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                          .+.....+..  +...   ...+.+++.+||+.||.+||++.+|++.|+..-
T Consensus       232 ----~~~~~~~~~~--~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          232 ----MLEKGERMGC--PAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ----HHHTTCCCCC--CTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----HHHcCCCCCC--CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1111111111  1112   245777889999999999999999999998643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=353.72  Aligned_cols=274  Identities=25%  Similarity=0.336  Sum_probs=210.1

Q ss_pred             CCcccceEEcccCceEEEEee----ecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-CcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~  256 (520)
                      ++|...+.||+|+||.||+|.    ...+++.||||++........+.+.+|+.++++++||||+++++++...+ ...+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            578999999999999999998    35578899999998777677788999999999999999999999876543 3578


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       121 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence            9999999999999997643      46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......-. ........ .....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~~-~~~~~  269 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQ-GQMIV  269 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTCC-THHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-Hhhccccc-hhhhH
Confidence            98765433211 12234577889999999988899999999999999999999999874321100 00000000 00000


Q ss_pred             hHHHHhhCc--ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          416 AAVEELLDP--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       416 ~~l~~~~d~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                      ..+.+.+..  ....+...   ...+.+++.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcc---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            011111111  11111122   2457778899999999999999999999987543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-42  Score=350.84  Aligned_cols=268  Identities=22%  Similarity=0.313  Sum_probs=197.8

Q ss_pred             CCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      +.|.+. +.||+|+||+||+|....+++.||||++..........+.+|+.++.++ +||||+++++++.+. +..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEE
Confidence            467774 7899999999999999888999999999776555667889999999884 799999999998764 4689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc---eEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~---vkL~DFGl  336 (520)
                      ||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        91 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999865       46899999999999999999999988   999999999999998776   99999999


Q ss_pred             ccccCCCCC-----CcccccccccCCccCchhccc-----CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          337 ATWTSAPSV-----PFLCKTVKGTFGYLAPEYFQH-----GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       337 a~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +........     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            976542211     011223459999999999875     4589999999999999999999999976543221000000


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+....  .....+.......+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQN--MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHH--HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHH--HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000000  0011111111111100 0011245778889999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=353.55  Aligned_cols=275  Identities=21%  Similarity=0.326  Sum_probs=197.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHH--HHhCCCCCeecEEEEEEc----CCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI--ASSLHHPNIVPLVGFCID----PEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~g~~~~----~~~~  254 (520)
                      .++|...+.||+|+||+||+|..  +++.||||++.....   ..+..|.++  +..++||||+++++++..    ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36899999999999999999977  478999999975432   344445444  455899999999975532    2234


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecccCCCCeEecCCCc
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT------ERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~------~~~IiHrDLKp~NILld~~~~  328 (520)
                      +++||||+++|+|.+++..        ...++..+..|+.|++.||.|||+..      .++|+||||||+||||+.++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL--------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             EEEEEecCCCCcHHHHHhh--------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence            6899999999999999975        34689999999999999999999871      013999999999999999999


Q ss_pred             eEEeecCCccccCCCCC------CcccccccccCCccCchhccc-------CCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          329 PKLCDFGLATWTSAPSV------PFLCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~------~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      +||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999987653221      111234569999999999976       35677899999999999999998876543


Q ss_pred             ccccchhhHHhhhhHhhhchhHHHHh-----hCcccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          396 RLQGEENLVLWAKPILHRGMAAVEEL-----LDPRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       396 ~~~~~~~lv~~~~~~~~~~~~~l~~~-----~d~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ......................+...     ..+.+.. ..........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            32111100000000000000011111     1111211 1112345567889999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-42  Score=362.23  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=195.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCC--CCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||+||+|.... ++.||||++...  .....+.+.+|+.+++.++  ||||+++++++... ..+++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEE
Confidence            469999999999999999999875 889999998654  3455678999999999996  59999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||| +.+++|.+++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||++
T Consensus       134 v~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             EEe-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999 5689999999764       46899999999999999999999887   99999999999995 588999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhccc-----------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +...............||+.|+|||++.+           ..++.++|||||||+||||++|+.||......     .. 
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~-  275 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS-  275 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HH-
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HH-
Confidence            87654433223345679999999999865           36889999999999999999999999643211     00 


Q ss_pred             hhhHhhhchhHHHHhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                .+..++++...  .+...   ...+.+++.+||+.||.+|||+.||++
T Consensus       276 ----------~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 ----------KLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ----------HHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------HHHHHhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                      12233333322  11112   235678889999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.2e-42  Score=342.33  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEE
Confidence            35899999999999999999999988999999998654   334567788999999999999999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        93 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             EEECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCc
Confidence            99999999999998764       46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........                 
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------------  223 (294)
T 2rku_A          163 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----------------  223 (294)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------
T ss_pred             eecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------
Confidence            87653322  12345699999999999988899999999999999999999999975432210                 


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+....   ..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          224 YLRIKKNEYSIPKHIN---PVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHHHTTCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHhhccCCCccccC---HHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1111111121121222   34667888999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=352.75  Aligned_cols=268  Identities=18%  Similarity=0.234  Sum_probs=199.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCcchHH-----------HHHHHHHHHHHHhCCCCCeecEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKES-----------SKAFCRELMIASSLHHPNIVPLVG  246 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~g  246 (520)
                      .++|...+.||+|+||+||+|....   ++..||+|++.......           ...+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3689999999999999999999976   67899999987653211           123667889999999999999999


Q ss_pred             EEEcC---CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe
Q 010012          247 FCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (520)
Q Consensus       247 ~~~~~---~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl  323 (520)
                      ++.+.   ....++||||+ +++|.+++...       ..+++..++.|+.||+.||+|||+.+   |+||||||+|||+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence            98762   45589999999 99999999764       36999999999999999999999988   9999999999999


Q ss_pred             cCCC--ceEEeecCCccccCCCCC-----CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          324 SSKK--IPKLCDFGLATWTSAPSV-----PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       324 d~~~--~vkL~DFGla~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      +.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9887  999999999986643211     111234579999999999999899999999999999999999999996532


Q ss_pred             cccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       397 ~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .... ............    +...+..... ....   ...+.+++..||+.+|.+||++.+|++.|+...
T Consensus       265 ~~~~-~~~~~~~~~~~~----~~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          265 KDPV-AVQTAKTNLLDE----LPQSVLKWAP-SGSS---CCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TCHH-HHHHHHHHHHHT----TTHHHHHHSC-TTSC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccH-HHHHHHHhhccc----ccHHHHhhcc-cccc---HHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2111 111111111110    1111111111 0011   235677888999999999999999999998743

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.3e-42  Score=340.19  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|....++..||+|++....   ......+.+|+++++.++||||+++++++.+. ...++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEEE
Confidence            57999999999999999999998889999999986542   12346788999999999999999999998764 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        93 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999999764       45899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||........                 .
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------------~  221 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----------------H  221 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----------------H
Confidence            654322    2345699999999999999999999999999999999999999975432110                 1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.......+...+   ..+.+++.+||+.+|.+||++.+|++
T Consensus       222 ~~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          222 RRIVNVDLKFPPFLS---DGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHTTCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccccCCCCcCC---HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            111222222222222   34667888999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-42  Score=352.71  Aligned_cols=265  Identities=27%  Similarity=0.381  Sum_probs=203.3

Q ss_pred             hCCcccceEEcccCceEEEEeee-----cCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++|...+.||+|+||.||+|..     ..++..||||++... ......++.+|+.++++++||||+++++++.+.. .
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-C
Confidence            35899999999999999999984     456778999999654 3455667899999999999999999999987654 4


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEE
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  331 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL  331 (520)
                      .++||||+++|+|.+++............+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            79999999999999999875432222356999999999999999999999988   999999999999984   446999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhH
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      +|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||.......   ...     
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~-----  256 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE-----  256 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH-----
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH-----
Confidence            99999976543332222334568999999999999999999999999999999998 999997543211   110     


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                            .+....  ....+...   ...+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       257 ------~~~~~~--~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          257 ------FVTSGG--RMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ------HHHTTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHhcCC--CCCCCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                  011100  11111112   235677889999999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-42  Score=344.27  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=206.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEc-CCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|....+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            5899999999999999999999888999999999754  34456778999999999999999999998764 34568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCeEecCCCceEEeecCC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      |||+++|+|.+++......   ...+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999865321   256999999999999999999999865  23499999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   +..           
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-----------  226 (279)
T 2w5a_A          163 ARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG-----------  226 (279)
T ss_dssp             HHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-----------
T ss_pred             heeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH-----------
Confidence            987654321  1234568999999999998899999999999999999999999997543211   110           


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .+.....+.+  +...   ...+.+++.+||+.+|.+||++.||++.+...
T Consensus       227 ~i~~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          227 KIREGKFRRI--PYRY---SDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             HHHHTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             HHhhcccccC--Cccc---CHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            1111111111  1112   23567788999999999999999999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-42  Score=341.16  Aligned_cols=256  Identities=24%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+++++.++||||+++++++.+. ...++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTE   83 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEEC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEe
Confidence            357999999999999999999987 477899999976543 346789999999999999999999998664 45799999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  154 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV  154 (267)
T ss_dssp             CCTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccc
Confidence            999999999997643      46899999999999999999999988   999999999999999999999999999866


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..   .        .+.
T Consensus       155 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~--------~i~  219 (267)
T 3t9t_A          155 LDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---E--------DIS  219 (267)
T ss_dssp             CCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---H--------HHH
T ss_pred             ccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH---H--------HHh
Confidence            43211 11223457889999999998899999999999999999999 899997543211   10   0        111


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....  ...+...   ...+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       220 ~~~~--~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          220 TGFR--LYKPRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             TTCC--CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCc--CCCCccC---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111  1111111   235677889999999999999999999998643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=361.15  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=196.0

Q ss_pred             CcccceEEcccCceEEEEeeecCC---CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .|...+.||+|+||+||+|.....   ...||+|.+... .....+.|.+|+.++++++||||++++++|.+.+...++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            577788999999999999987532   346899998654 3355678999999999999999999999987766678999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++|+|.+++....      ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence            99999999999997542      56899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCC--cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ........  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.........   ..         
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~---------  308 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VY---------  308 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HH---------
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HH---------
Confidence            65433211  11233457889999999999999999999999999999999 67777654332211   00         


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        +...  .....+...+   ..+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       309 --~~~~--~~~~~p~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          309 --LLQG--RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             --HHTT--CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHcC--CCCCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              0000  1111122222   34677888999999999999999999998753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.3e-42  Score=339.72  Aligned_cols=248  Identities=26%  Similarity=0.387  Sum_probs=204.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc-----------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-----------  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----------  250 (520)
                      .+|...+.||+|+||.||+|.+..+++.||+|++....    ..+.+|+++++.++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            47999999999999999999998889999999997654    246689999999999999999998753           


Q ss_pred             ----CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          251 ----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       251 ----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                          ....+++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                12347899999999999999986532     56999999999999999999999988   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|||++|..|+.....         
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------  226 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---------  226 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---------
Confidence            9999999999987654322   2345699999999999998999999999999999999999998753211         


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                                ....+.+..+.  ...+   ..+.+++.+||+.||.+|||+.|+++.|....
T Consensus       227 ----------~~~~~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          227 ----------FFTDLRDGIIS--DIFD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------HHHHHHTTCCC--TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------HHHHhhccccc--ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                      00111111111  1112   34667888999999999999999999998643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=348.90  Aligned_cols=256  Identities=34%  Similarity=0.541  Sum_probs=197.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||+||+|...  ++.||||++...  ...+.|.+|+.++++++||||+++++++.+   ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEc
Confidence            57889999999999999999885  678999999754  345688999999999999999999998643   36899999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc-eEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~-vkL~DFGla~~~  340 (520)
                      +++|+|.+++.....    ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++...
T Consensus        81 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             CTTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             CCCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999976431    135789999999999999999999943345999999999999998886 799999999765


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ....     ....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+.          +..
T Consensus       157 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----------~~~  219 (307)
T 2eva_A          157 QTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWA----------VHN  219 (307)
T ss_dssp             -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHH----------HHT
T ss_pred             cccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHH----------Hhc
Confidence            4321     234599999999999999999999999999999999999999975332210  01110          111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcch
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEEL  470 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~~  470 (520)
                      ...+.+.  ...   ...+.+++.+||+.+|.+|||+.+|++.|+.+...
T Consensus       220 ~~~~~~~--~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          220 GTRPPLI--KNL---PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             TCCCCCB--TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             CCCCCcc--ccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111  112   23467788999999999999999999999876543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-42  Score=350.59  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=198.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCC----CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~----~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ++|...+.||+|+||+||+|....+    +..||||++... .......+.+|+.+++.++||||+++++++.+ ....+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcE
Confidence            5788889999999999999987643    345999999764 33455678999999999999999999999765 45589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       123 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence            9999999999999997642      56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          337 ATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       337 a~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      ++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +..         
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~---------  261 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK---------  261 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH---------
Confidence            9876543211 11223346788999999998999999999999999999999 999997543211   100         


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        .+....  ....+...   ...+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       262 --~~~~~~--~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          262 --AINDGF--RLPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             --HHHTTC--CCCCCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --HHHCCC--cCCCcccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              111111  11111112   235677889999999999999999999998654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=355.72  Aligned_cols=243  Identities=22%  Similarity=0.320  Sum_probs=201.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++.....        .....+.+|+.+++.++||||+++++++.+. 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-
Confidence            3589999999999999999999988899999999976431        1234567899999999999999999998664 


Q ss_pred             CcEEEEEEecCCC-ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          253 QGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       253 ~~~~LV~E~~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      ...++||||+.+| +|.+++...       ..+++..+..|+.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEE
Confidence            5589999999777 999998753       46999999999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      +|||+++.......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....             
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------  235 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------  235 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------
Confidence            99999987654432   234569999999999988776 7899999999999999999999964211             


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                                ........+...+   ..+.+++.+||+.||++|||+.+|++.
T Consensus       236 ----------~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ----------TVEAAIHPPYLVS---KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------GTTTCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------HHhhccCCCcccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0111111111122   346778889999999999999999883

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-43  Score=366.40  Aligned_cols=248  Identities=16%  Similarity=0.184  Sum_probs=192.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHH---HHHHhCCCCCeecEE-------EE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCREL---MIASSLHHPNIVPLV-------GF  247 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~---~il~~l~HpnIv~l~-------g~  247 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...   .....+.+.+|+   .+++.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46899999999999999999999888999999999743   344567888999   556666899999998       66


Q ss_pred             EEcCCC----------------cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 010012          248 CIDPEQ----------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV  311 (520)
Q Consensus       248 ~~~~~~----------------~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~I  311 (520)
                      +.+.+.                ..++||||+ +|+|.+++............+++..++.|+.||+.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            554321                278999999 68999999875332211234557899999999999999999988   9


Q ss_pred             EecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC-----------CCCCcCceeeHHH
Q 010012          312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-----------KVSDKTDVYAFGV  380 (520)
Q Consensus       312 iHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~s~ksDVwS~Gv  380 (520)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986433     2234567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 010012          381 VLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI  460 (520)
Q Consensus       381 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eV  460 (520)
                      ++|||++|+.||.........                 ..+...    ....+   ..+.+++.+||+.||.+|||+.++
T Consensus       302 il~elltg~~Pf~~~~~~~~~-----------------~~~~~~----~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS-----------------EWIFRS----CKNIP---QPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHSSCCC------CCS-----------------GGGGSS----CCCCC---HHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHCCCCCcccccccch-----------------hhhhhh----ccCCC---HHHHHHHHHHcCCCchhCCCHHHH
Confidence            999999999999754432111                 011110    11122   346778889999999999999999


Q ss_pred             HH
Q 010012          461 IA  462 (520)
Q Consensus       461 l~  462 (520)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            86

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-42  Score=343.06  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||.||+|... .+..||+|.+..... ..+.+.+|+++++.++||||+++++++.+  +..++||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~   86 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIIT   86 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEE
Confidence            3468999999999999999999986 467899999976532 35678999999999999999999998753  3478999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..
T Consensus        87 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            99999999999976432     36999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   +..           .+
T Consensus       159 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~-----------~~  223 (279)
T 1qpc_A          159 IEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ-----------NL  223 (279)
T ss_dssp             CSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH-----------HH
T ss_pred             ccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH-----------HH
Confidence            6543211 1233457889999999998899999999999999999999 999997543211   110           11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ........  +...   ...+.+++..||+.+|++|||+.+|++.|+..
T Consensus       224 ~~~~~~~~--~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          224 ERGYRMVR--PDNC---PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             HTTCCCCC--CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCC--cccc---cHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            11111111  1112   24567788899999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-42  Score=354.16  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=178.7

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEecCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      .+.||+|+||+||+|.+..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+. ...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCC
Confidence            47899999999999999988999999999653   3456778999999997 99999999998764 4589999999999


Q ss_pred             ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---ceEEeecCCccccCC
Q 010012          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA  342 (520)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~vkL~DFGla~~~~~  342 (520)
                      +|.+++...       ..+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++....
T Consensus        92 ~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           92 ELFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             BHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            999999764       56999999999999999999999988   99999999999998765   899999999986654


Q ss_pred             CCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhh
Q 010012          343 PSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL  422 (520)
Q Consensus       343 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~  422 (520)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............          .+..+.
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----------~~~~i~  229 (325)
T 3kn6_A          162 DNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE----------IMKKIK  229 (325)
T ss_dssp             ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH----------HHHHHT
T ss_pred             CCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH----------HHHHHH
Confidence            322  22445689999999999999999999999999999999999999976443211000000          111222


Q ss_pred             CcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          423 DPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       423 d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ......... .......+.+++.+||+.||.+|||+.||++
T Consensus       230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            222211100 0112345778889999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=350.94  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=192.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEE-------cC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCI-------DP  251 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~-------~~  251 (520)
                      ...+|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++.++. ||||+++++++.       ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3458999999999999999999998889999999997776677788999999999996 999999999985       22


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      ...+++||||+. |+|.+++.....    ...+++..++.|+.||+.||.|||+.+ ++|+||||||+|||++.++.+||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMES----RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHT----TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence            334789999995 799999876432    256999999999999999999999754 34999999999999999999999


Q ss_pred             eecCCccccCCCCCCc----------ccccccccCCccCchhc---ccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          332 CDFGLATWTSAPSVPF----------LCKTVKGTFGYLAPEYF---QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~----------~~~~~~Gt~~Y~aPE~~---~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                      +|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998765432110          01134589999999998   5667899999999999999999999999753221


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                      .   .              +........  ....   ...+.+++.+||+.+|.+|||+.||++.|+....
T Consensus       260 ~---~--------------~~~~~~~~~--~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 R---I--------------VNGKYSIPP--HDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             -----------------------CCCCT--TCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---h--------------hcCcccCCc--cccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1   0              000010000  1111   1236678899999999999999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.3e-42  Score=360.45  Aligned_cols=253  Identities=24%  Similarity=0.326  Sum_probs=190.8

Q ss_pred             CCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHH-HhCCCCCeecEEEEEEc---CCCcEE
Q 010012          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA-SSLHHPNIVPLVGFCID---PEQGLF  256 (520)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~---~~~~~~  256 (520)
                      ++|... +.||+|+||+||+|.+..+++.||||++...     ..+.+|+.++ +..+||||+++++++..   ....++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            467665 6899999999999999989999999999643     3456788876 55689999999998754   234589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~D  333 (520)
                      ||||||++|+|.+++.....     ..+++..+..|+.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|
T Consensus       136 lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEe
Confidence            99999999999999976421     46999999999999999999999988   999999999999997   78999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ....+..
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~  281 (400)
T 1nxk_A          208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRM  281 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHH
T ss_pred             cccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHc
Confidence            99998665332   12456799999999999999999999999999999999999999976443211000   0000000


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +      ..  .+... ........+.+++.+||+.||.+|||+.||++
T Consensus       282 ~------~~--~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          282 G------QY--EFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             T------CC--CCCTT-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C------cc--cCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0      00  01000 00112245778889999999999999999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-42  Score=365.51  Aligned_cols=196  Identities=24%  Similarity=0.395  Sum_probs=157.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----Cc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~  254 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+|+.++|||||++++++....    ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36899999999999999999999988999999999653  3445678899999999999999999999885432    45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++||||+ +|+|.+++...       ..+++..+..|+.||+.||+|||+.+   ||||||||+||||+.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccc
Confidence            89999998 67999998653       56999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCC-------------------------cccccccccCCccCchhc-ccCCCCCcCceeeHHHHHHHHHh
Q 010012          335 GLATWTSAPSVP-------------------------FLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLT  387 (520)
Q Consensus       335 Gla~~~~~~~~~-------------------------~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwS~GvvL~ELlt  387 (520)
                      |+|+........                         ......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            999876432110                         112345789999999986 45679999999999999999999

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.7e-42  Score=345.62  Aligned_cols=258  Identities=23%  Similarity=0.333  Sum_probs=198.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  112 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYVD  112 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEEE
Confidence            68999999999999999999998889999999997542   33457788999999999999999999998764 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       113 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             EECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             EEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            9999999999999864       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....       +
T Consensus       183 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~-------~  247 (309)
T 2h34_A          183 ATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAH-------I  247 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHH-------H
T ss_pred             cccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHH-------h
Confidence            66543221 1234569999999999999899999999999999999999999997543211       0000       1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCc
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRGEE  468 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-tm~eVl~~L~~~~  468 (520)
                      ..............+   ..+.+++.+||+.||++|| ++.++++.|+...
T Consensus       248 ~~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          248 NQAIPRPSTVRPGIP---VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             HSCCCCGGGTSTTCC---THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ccCCCCccccCCCCC---HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            110000000011111   2466788899999999999 9999999998643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.5e-42  Score=345.13  Aligned_cols=249  Identities=26%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||+||+|....+++.||+|++..........+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEEEc
Confidence            5799999999999999999999888999999999876555556788999999999999999999998764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCCcc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLAT  338 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGla~  338 (520)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus        88 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           88 VSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             CCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999998764       46899999999999999999999988   9999999999999   788999999999997


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.              
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~--------------  216 (304)
T 2jam_A          158 MEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LF--------------  216 (304)
T ss_dssp             CCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH--------------
T ss_pred             ecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH--------------
Confidence            654321    234569999999999999999999999999999999999999997543211   10              


Q ss_pred             HHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+........ .........+.+++.+||+.||.+|||+.++++
T Consensus       217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00111110000 001112245778889999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-42  Score=341.75  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             CCcccce-EEcccCceEEEEeeec--CCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGR-VLGRGALSFVFKGKVG--LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~-~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+ .||+|+||+||+|...  ..+..||||++... .....+.+.+|+++++.++||||+++++++..  +..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--CCcEE
Confidence            4666666 9999999999999863  35778999999765 34556789999999999999999999999833  34899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             EEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence            999999999999997532      56999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      .......... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||.......   +..          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----------  224 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----------  224 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----------
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----------
Confidence            8765432211 1223457889999999998889999999999999999998 999997643221   110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       .+.....+  ..+...   ...+.+++..||+.+|.+||++.+|++.|+...
T Consensus       225 -~i~~~~~~--~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          225 -FIEQGKRM--ECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             -HHHTTCCC--CCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHhcCCcC--CCCCCc---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             11111111  111122   245677889999999999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=359.27  Aligned_cols=274  Identities=23%  Similarity=0.297  Sum_probs=211.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-cEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+... ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57999999999999999999999889999999997543 2345677899999999999999999999876543 579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----cCCCceEEeecC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFG  335 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----d~~~~vkL~DFG  335 (520)
                      ||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        89 e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             ecCCCCCHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999986532    134999999999999999999999988   9999999999999    788889999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhccc--------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +++......   ......||+.|+|||++..        ..++.++|||||||++|||++|+.||.........  ....
T Consensus       162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~  236 (396)
T 4eut_A          162 AARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVM  236 (396)
T ss_dssp             GCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHH
T ss_pred             CceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHH
Confidence            998765432   1234569999999999865        56788999999999999999999999754322111  1111


Q ss_pred             hhHhhhch----hHHHHhhC------cccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          408 KPILHRGM----AAVEELLD------PRLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       408 ~~~~~~~~----~~l~~~~d------~~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..+.....    ..+....+      ..+.. ..........+.+++.+||+.||++||++.++++.|+.+
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            11111000    00000000      01111 112345666788999999999999999999999988764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=339.91  Aligned_cols=252  Identities=22%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~  256 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++....    ......+.+|+.+++.++||||+++++++... ....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            68999999999999999999998889999999997542    23456789999999999999999999988543 34689


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||++++ |.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTT-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEehhccCC-HHHHHHhCcc-----cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence            999999876 7777765432     56999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCC--CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +................||+.|+|||++.+..  ++.++||||||+++|||++|+.||.......   .           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-----------  221 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---L-----------  221 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H-----------
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---H-----------
Confidence            98765433333334567999999999997644  3779999999999999999999997543211   0           


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ...+.......+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       222 ---~~~i~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          222 ---FENIGKGSYAIPGDCG---PPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ---HHHHHHCCCCCCSSSC---HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---HHHHhcCCCCCCCccC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence               0111111111111122   34667888999999999999999997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=353.62  Aligned_cols=256  Identities=14%  Similarity=0.146  Sum_probs=201.8

Q ss_pred             HHhhCCcccceEEcccCceEEEEee-----ecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC---CCCeecEEEEEE
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCI  249 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~-----~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~  249 (520)
                      ....++|...+.||+|+||+||+|.     ...+++.||||++....   ..++..|++++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3456789999999999999999994     45568899999997654   346777888888887   999999999987


Q ss_pred             cCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC----
Q 010012          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----  325 (520)
Q Consensus       250 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~----  325 (520)
                      ..+ ..++||||+++|+|.+++......  ....++|..++.|+.||+.||+|||+.+   ||||||||+||||+.    
T Consensus       138 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          138 FQN-GSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             CSS-CEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             cCC-CcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            755 479999999999999999864321  1257999999999999999999999887   999999999999998    


Q ss_pred             -------CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccc
Q 010012          326 -------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ  398 (520)
Q Consensus       326 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~  398 (520)
                             ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999997654322223345567999999999999999999999999999999999999999654321


Q ss_pred             cchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhc
Q 010012          399 GEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRR-PGIEEIIAILRG  466 (520)
Q Consensus       399 ~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~R-Ptm~eVl~~L~~  466 (520)
                      ..                .    +...+. .....+   .+.+++..|+..+|.+| |++.++.+.|+.
T Consensus       292 ~~----------------~----~~~~~~-~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          292 EC----------------K----PEGLFR-RLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             EE----------------E----ECSCCT-TCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ce----------------e----echhcc-ccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            10                0    011111 111233   34466678999999998 678888888775

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=357.05  Aligned_cols=265  Identities=15%  Similarity=0.201  Sum_probs=204.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecC--------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeec---------
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP---------  243 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~---------  243 (520)
                      .++|...+.||+|+||.||+|....        .++.||||++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999876        3789999999754     35778999999999999887         


Q ss_pred             ------EEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          244 ------LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       244 ------l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                            +++++...+...++||||+ +++|.+++.....     ..+++..++.|+.||+.||.|||+.+   |+|||||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik  186 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-----HVLSERSVLQVACRLLDALEFLHENE---YVHGNVT  186 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence                  6777776567789999999 9999999986532     56999999999999999999999988   9999999


Q ss_pred             CCCeEecCCC--ceEEeecCCccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCC
Q 010012          318 PSNILLSSKK--IPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK  390 (520)
Q Consensus       318 p~NILld~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~  390 (520)
                      |+|||++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  9999999999866532211     11133479999999999999899999999999999999999999


Q ss_pred             CcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          391 PIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       391 Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ||....... ..+........ .   ....+.+.... ....   ...+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       267 pf~~~~~~~-~~~~~~~~~~~-~---~~~~~~~~~~~-~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          267 PWTNCLPNT-EDIMKQKQKFV-D---KPGPFVGPCGH-WIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTGGGTTCH-HHHHHHHHHHH-H---SCCCEECTTSC-EECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcccCCcCH-HHHHHHHHhcc-C---Chhhhhhhccc-cCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            998654221 11111110000 0   00111111100 0011   245777888999999999999999999998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-41  Score=348.81  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=205.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEE
Confidence            36899999999999999999999988999999998654   334567788999999999999999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       119 v~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             EECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCc
Confidence            99999999999998764       46999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......  ......||..|+|||++.+..++.++|||||||++|||++|+.||........                 
T Consensus       189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------------  249 (335)
T 2owb_A          189 TKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----------------  249 (335)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------
T ss_pred             eecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-----------------
Confidence            87653322  12345699999999999998999999999999999999999999975432110                 


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+....   ..+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          250 YLRIKKNEYSIPKHIN---PVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHHTCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHhcCCCCCCccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0001111111111122   34667888999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.7e-42  Score=340.03  Aligned_cols=250  Identities=27%  Similarity=0.355  Sum_probs=199.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|...+.||+|+||+||+|....+++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeE
Confidence            468999999999999999999998899999999875421      1357789999999999999999999998764 458


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC----ceEE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vkL  331 (520)
                      ++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999999764       46999999999999999999999988   99999999999998877    8999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      +|||++........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .       
T Consensus       154 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------  220 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---L-------  220 (283)
T ss_dssp             CCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-------
T ss_pred             EecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---H-------
Confidence            99999987654321   2345699999999999989999999999999999999999999975432211   0       


Q ss_pred             hhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                             ..+......... ........+.+++.+||+.||.+|||+.++++
T Consensus       221 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          221 -------TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -------HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                   000000000000 00011235678889999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-42  Score=346.78  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=198.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||.||+|....++..||+|++........+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEEE
Confidence            46899999999999999999999988999999999876666677899999999999999999999998775 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             CCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             eCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            999999999987643      56999999999999999999999988   999999999999999999999999997543


Q ss_pred             CCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ....  .......||+.|+|||++.     ...++.++||||||+++|||++|+.||.......   .   ..       
T Consensus       168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~-------  232 (302)
T 2j7t_A          168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V---LL-------  232 (302)
T ss_dssp             HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HH-------
T ss_pred             cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HH-------
Confidence            2110  0112346899999999983     6678999999999999999999999997543211   0   00       


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       .+.....+.+..+   ......+.+++.+||+.+|.+|||+.+|++
T Consensus       233 -~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          233 -KIAKSDPPTLLTP---SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -HHHHSCCCCCSSG---GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -HHhccCCcccCCc---cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             0111111111111   111235778889999999999999999876

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-42  Score=354.59  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=203.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||+||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  111 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICME  111 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEEE
Confidence            5899999999999999999999988999999999765 344567889999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |+++|+|.+++...       ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++..
T Consensus       112 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             CCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            99999999999764       4689999999999999999999985 6   99999999999999999999999999975


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-----hHh---
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----PIL---  411 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-----~~~---  411 (520)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||................     ...   
T Consensus       182 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          182 LIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            43221    234569999999999999999999999999999999999999997544322111000000     000   


Q ss_pred             -----------------hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 -----------------HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 -----------------~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                       ......+..+....... .........+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCC-CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCC-CCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                             00000011111111110 000112235778889999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9e-42  Score=338.28  Aligned_cols=247  Identities=24%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||+||+|....+++.||+|++...  .......+.+|+.++..+ +||||+++++++.+. ...++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence            35799999999999999999999888999999999754  234556788999999999 999999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-----------
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----------  326 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-----------  326 (520)
                      ||||+++|+|.+++......   ...+++..++.|+.|++.||.|||+.+   |+||||||+|||++.+           
T Consensus        89 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRI---MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred             EEEecCCCcHHHHHHhhccc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999999875321   156899999999999999999999988   9999999999999844           


Q ss_pred             --------CceEEeecCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          327 --------KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       327 --------~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                              ..+||+|||++.......      ...||+.|+|||.+.+. .++.++|||||||++|||++|.+|+.....
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred             cccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence                    479999999998765432      23499999999999766 567899999999999999999987643211


Q ss_pred             ccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       398 ~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           .    .        .+.....+.+.  ...+   ..+.+++.+||+.||.+|||+.++++
T Consensus       237 -----~----~--------~~~~~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -----W----H--------EIRQGRLPRIP--QVLS---QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----H----H--------HHHTTCCCCCS--SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----H----H--------HHHcCCCCCCC--cccC---HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 0    0        01111111111  1122   35677888999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.8e-41  Score=349.81  Aligned_cols=266  Identities=21%  Similarity=0.329  Sum_probs=194.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|...+.||+|+||+||+|....+++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999999888999999999753  3445567889999999999999999999986543     2


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++||||++ |+|.+++.         ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEcCC-CCHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEE
Confidence            5799999996 57888874         34899999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh-----h
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----K  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~-----~  408 (520)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...     .
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998664322   123456999999999999999999999999999999999999999764432111100000     0


Q ss_pred             hHhhhchhHHHHhhCcc--------------cCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPR--------------LKCTSR---NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~--------------l~~~~~---~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .........+...+...              ...+..   .......+.+++.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00000000111111000              000000   0122456889999999999999999999987

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-41  Score=346.57  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=205.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHh--CCCCCeecEEEEEEcCCC---c
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ---G  254 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~~~---~  254 (520)
                      ..++|...+.||+|+||+||+|...  ++.||||++...   ....+.+|++++..  ++||||+++++++.....   .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3468999999999999999999984  789999999653   34567788888887  799999999999877552   5


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCCeEecCC
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~IiHrDLKp~NILld~~  326 (520)
                      .++||||+++|+|.+++..        ..+++..++.++.|++.||.|||        +.+   |+||||||+||||+.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN  183 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred             eEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence            8999999999999999975        35899999999999999999999        656   9999999999999999


Q ss_pred             CceEEeecCCccccCCCCCCc--ccccccccCCccCchhcccC------CCCCcCceeeHHHHHHHHHhC----------
Q 010012          327 KIPKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQHG------KVSDKTDVYAFGVVLLELLTG----------  388 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~------~~s~ksDVwS~GvvL~ELltG----------  388 (520)
                      +.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999998765433211  12345699999999999765      234689999999999999999          


Q ss_pred             CCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          389 RKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       389 ~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ..||........ ....+...+       ......+.+............+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       264 ~~p~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          264 QLPYYDLVPSDP-SVEEMRKVV-------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCTTTTTSCSSC-CHHHHHHHH-------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCccccCcCcc-cHHHHHHHH-------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            677765432211 111111100       011122222211112356677889999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=339.70  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=199.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++++.+. ...++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEe
Confidence            3455667999999999999999888999999999876666667899999999999999999999998764 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEEeecCCcccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  340 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL~DFGla~~~  340 (520)
                      +++++|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++. ++.+||+|||++...
T Consensus       101 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A          101 VPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             CSEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             CCCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            999999999986432    245779999999999999999999988   999999999999987 899999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCC--CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGK--VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .....  ......||+.|+|||++.+..  ++.++||||||+++|||++|+.||........   ..+.         ..
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~---------~~  239 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFK---------VG  239 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHH---------HH
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHh---------hc
Confidence            54221  123456999999999997653  78999999999999999999999975332110   0000         00


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+.+.  ...   ...+.+++.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~--~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          240 MFKVHPEIP--ESM---SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHCCCCCCC--TTS---CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccccc--ccC---CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            001112221  112   235667888999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=349.17  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             ccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEc
Q 010012          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (520)
Q Consensus       172 ~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~  250 (520)
                      +++.++....++|...+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            3444455567899999999999999999999988899999999875432 346788999999998 89999999999876


Q ss_pred             C-----CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC
Q 010012          251 P-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (520)
Q Consensus       251 ~-----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~  325 (520)
                      .     ....++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE  164 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcC
Confidence            4     3468999999999999999986432     46899999999999999999999988   999999999999999


Q ss_pred             CCceEEeecCCccccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccc
Q 010012          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  400 (520)
Q Consensus       326 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~  400 (520)
                      ++.+||+|||++........  ......||+.|+|||++.     ...++.++|||||||++|||++|+.||........
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  242 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  242 (326)
T ss_dssp             TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             CCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence            99999999999986643221  123456999999999987     56789999999999999999999999965432110


Q ss_pred             hhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       401 ~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        +    .        .+.....+.+... ..   ...+.+++.+||..||.+||++.+|++
T Consensus       243 --~----~--------~~~~~~~~~~~~~-~~---~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 --L----F--------LIPRNPAPRLKSK-KW---SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             --H----H--------HHHHSCCCCCSCS-CS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --H----H--------HhhcCccccCCcc-cc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              0    0        0111111122111 11   235677888999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-42  Score=372.94  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=205.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||.||+|....+++.||||++.+..   ......+.+|+.+|+.++|||||++++++.+. ..+++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEE
Confidence            468999999999999999999999899999999996542   22345688999999999999999999987664 56899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++.....     ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       262 VmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccc
Confidence            9999999999999976431     45999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.            
T Consensus       334 ~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------  398 (576)
T 2acx_A          334 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------  398 (576)
T ss_dssp             EECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------
T ss_pred             eecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------
Confidence            87654332   234579999999999999899999999999999999999999998643321111000            


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                       ..+.......+...   ...+.+++.+||+.||.+||     ++.||++
T Consensus       399 -~~i~~~~~~~p~~~---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          399 -RLVKEVPEEYSERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -HHHHHCCCCCCTTS---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -HHhhcccccCCccC---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             00111111111112   23567788899999999999     7888875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-41  Score=358.04  Aligned_cols=202  Identities=23%  Similarity=0.366  Sum_probs=170.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----Cc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~  254 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999989999999999753  3445678899999999999999999999986653    45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +++||||+. |+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccC
Confidence            899999985 6999999753       56999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCC--------------------cccccccccCCccCchhc-ccCCCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          335 GLATWTSAPSVP--------------------FLCKTVKGTFGYLAPEYF-QHGKVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       335 Gla~~~~~~~~~--------------------~~~~~~~Gt~~Y~aPE~~-~~~~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      |+++........                    .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999876543211                    112456799999999986 45669999999999999999998655543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-41  Score=369.21  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      .++|...+.||+|+||+||+|+...+++.||||++.+...   .....+.+|+.+++.++||||+++++++.+ ...+++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEE
Confidence            3689999999999999999999998899999999975422   234678899999999999999999998766 456899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++.....   ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       263 VmE~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EECCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999976431   1256999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ...           
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~-----------  401 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL-----------  401 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHH-----------
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHH-----------
Confidence            87654332  123457999999999999999999999999999999999999999765322111  001           


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm-----~eVl~  462 (520)
                      ...++......+...+   ..+.+++.+||+.||.+||++     .+|++
T Consensus       402 ~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          402 KQRVLEQAVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHCCCCCCTTSC---HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHhhcccCCCcccC---HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1111222222222222   346677889999999999975     55654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=353.37  Aligned_cols=265  Identities=20%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----C
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~  253 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999999888999999999653  3344567889999999999999999999986543     2


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+ +++|.+++..        ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEe
Confidence            358999999 8899999875        35899999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----  408 (520)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....    
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999876532     234568999999999887 679999999999999999999999998654322111110000    


Q ss_pred             -hHhhhch-hHHHHhhC--cccCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 -PILHRGM-AAVEELLD--PRLKC---TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 -~~~~~~~-~~l~~~~d--~~l~~---~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..+.... ......+.  +....   ..........+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             0000000 00000000  00000   0001112345778889999999999999999988

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=349.68  Aligned_cols=268  Identities=23%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH-HHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|...+.||+|+||+||+|....+++.||||++....... ...+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEec
Confidence            47999999999999999999998889999999997543221 12455799999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |++ |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             CCS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            997 59999987643      56999999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH-----hhhc
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI-----LHRG  414 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-----~~~~  414 (520)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......     +...
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          151 SIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             --------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence            53322  1234568999999999876 56899999999999999999999999865433211111100000     0000


Q ss_pred             h--hHHHHhhCcccCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 M--AAVEELLDPRLKCTS---RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~--~~l~~~~d~~l~~~~---~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .  ........+......   ........+.+++.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0  000000000000000   00011235678899999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-41  Score=341.11  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=204.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e  100 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIME  100 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEE
Confidence            57999999999999999999998889999999997543 34467889999999999999999999998764 45899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A          101 YLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             CCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999864        46999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ...           .+..
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-----------~~~~  233 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLF-----------LIPK  233 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH-----------HHHH
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHH-----------Hhhc
Confidence            54321  1234569999999999999999999999999999999999999997543211   000           1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                      ...+.+.  ...   ...+.+++.+||+.+|.+|||+.+|++.
T Consensus       234 ~~~~~~~--~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 NNPPTLE--GNY---SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCCCCC--SSC---CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCc--ccc---CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111121  112   2346778889999999999999999873

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.5e-42  Score=362.37  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=191.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~  251 (520)
                      ..++|...+.||+|+||+||+|....+++.||||++....        ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3578999999999999999999999899999999987532        1122357899999999999999999998743 


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC---c
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I  328 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~---~  328 (520)
                      + ..++||||+++|+|.+++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred             C-ceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence            3 478999999999999988653       56999999999999999999999988   99999999999997544   5


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      +||+|||+++......   ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........  +..
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~  355 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD  355 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH
Confidence            9999999998765432   2345679999999999853   5678899999999999999999999975432211  110


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          .          +......... ........+.+++.+||+.||.+|||+.|+++
T Consensus       356 ----~----------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 ----Q----------ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----H----------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----H----------HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                0          0000000000 00011245778889999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-41  Score=379.94  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  255 (520)
                      ..++|...+.||+|+||.||+|....+++.||||++.+..   ....+.+..|..++..+ +||||+++++++.+ ...+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence            4468999999999999999999999899999999997532   23345677899999887 79999999987654 5568


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      +|||||+++|+|..++...       ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence            9999999999999999865       46999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +|+.......  ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......                
T Consensus       488 la~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----------------  549 (674)
T 3pfq_A          488 MCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----------------  549 (674)
T ss_dssp             TCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred             eeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----------------
Confidence            9986433222  2345679999999999999999999999999999999999999997643221                


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGI-----EEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm-----~eVl~  462 (520)
                       .+..++...+..+...+   ..+.+|+..||+.||.+||++     .||++
T Consensus       550 -~~~~i~~~~~~~p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          550 -LFQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -HHHHHHSSCCCCCTTSC---HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -HHHHHHhCCCCCCccCC---HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             12223333333332222   356778889999999999997     66654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=376.03  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             CCcccce-EEcccCceEEEEeeec--CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGR-VLGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~-~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      +++...+ .||+|+||.||+|.+.  ..+..||||++.... ....+.|.+|++++++++|||||+++++|.+  +.+++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEE
Confidence            3444444 7999999999999875  345679999997653 3456789999999999999999999999865  34899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      ||||+++|+|.+++....      ..+++..+..|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       413 v~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             EEECCTTCBHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             EEEeCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence            999999999999997542      56999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +......... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+   +..          
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~----------  550 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----------  550 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH----------
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----------
Confidence            8765432211 1122346789999999999999999999999999999998 999997644321   110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+...  .++..+...+   ..+.+++..||+.+|++||++.+|++.|+..
T Consensus       551 -~i~~~--~~~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          551 -FIEQG--KRMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -HHHTT--CCCCCCTTCC---HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -HHHcC--CCCCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             11111  1122222222   4567788999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-41  Score=353.01  Aligned_cols=266  Identities=19%  Similarity=0.228  Sum_probs=203.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC--------CCCeecEEEEEEc---
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH--------HPNIVPLVGFCID---  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~g~~~~---  250 (520)
                      ++|...+.||+|+||+||+|....+++.||||++... ....+.+.+|+.+++.++        ||||+++++++..   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            6899999999999999999999888999999999754 345567889999999885        7889999998762   


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCC--
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKK--  327 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~--  327 (520)
                      ....+++||||+ +++|.+.+.....     ..+++..++.|+.||+.||.|||+. +   |+||||||+||||+.++  
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNY-----QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence            234589999999 6677777765421     5699999999999999999999997 7   99999999999999775  


Q ss_pred             -----------------------------------------------ceEEeecCCccccCCCCCCcccccccccCCccC
Q 010012          328 -----------------------------------------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA  360 (520)
Q Consensus       328 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~a  360 (520)
                                                                     .+||+|||+++......     ....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccC
Confidence                                                           79999999998765332     34469999999


Q ss_pred             chhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH---HhhhhHhhhchhH-------HHHhhCcc--c--
Q 010012          361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV---LWAKPILHRGMAA-------VEELLDPR--L--  426 (520)
Q Consensus       361 PE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv---~~~~~~~~~~~~~-------l~~~~d~~--l--  426 (520)
                      ||++.+..++.++|||||||+||||++|+.||............   .............       ........  +  
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999999764432211111   1110110000000       00000000  0  


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          427 --------------KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       427 --------------~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                    ............+.+|+.+||+.||++|||+.||++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                          001123456677889999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-41  Score=334.82  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=194.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   89 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFMV   89 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEEE
Confidence            68999999999999999999998889999999986542   22345788999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        90 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999999764       45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      .......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......   +.             
T Consensus       160 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~-------------  220 (276)
T 2h6d_A          160 MMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LF-------------  220 (276)
T ss_dssp             CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------
T ss_pred             ccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HH-------------
Confidence            7654321   234568999999999987765 689999999999999999999997533211   00             


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..+.......+...+   ..+.+++.+||+.||.+|||+.+|++
T Consensus       221 -~~~~~~~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          221 -KKIRGGVFYIPEYLN---RSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -HHHHHCCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHhhcCcccCchhcC---HHHHHHHHHHccCChhhCCCHHHHHh
Confidence             001111111111122   34677889999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.5e-42  Score=353.37  Aligned_cols=271  Identities=21%  Similarity=0.302  Sum_probs=203.7

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----Cc
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~  254 (520)
                      ..++|...+.||+|+||.||+|.+..++..||||++.... ....+.+.+|+.++++++||||+++++++....    ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4568999999999999999999998889999999997543 344577899999999999999999999986543    35


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+. |+|.+++..        ..+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       105 ~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeC
Confidence            899999996 599999865        45999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCC-CcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-h--
Q 010012          335 GLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-P--  409 (520)
Q Consensus       335 Gla~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~--  409 (520)
                      |+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .  
T Consensus       173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  252 (364)
T 3qyz_A          173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS  252 (364)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred             cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99986653221 111234579999999998754 458999999999999999999999997654432211111000 0  


Q ss_pred             --Hhhhch-hHHHHhhCcccCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 --ILHRGM-AAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 --~~~~~~-~~l~~~~d~~l~~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        .+.... .................     ......+.+++.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000000 00000000000000000     011245778899999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.4e-42  Score=342.40  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=196.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecC-CC--cEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-~~--~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      .++|...+.||+|+||+||+|.+.. ++  ..||||++...   .....+.+.+|+.++++++||||+++++++.+..  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence            3589999999999999999998642 22  36999998754   2345678899999999999999999999986543  


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++|+||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred             ceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccc
Confidence            689999999999999998653      45899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhh
Q 010012          335 GLATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       335 Gla~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |++.......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   +.   ..+..
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~  239 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDK  239 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHT
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HH---HHHHc
Confidence            9998765433211 1234457889999999998889999999999999999999 999997543221   10   00000


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      .         ........   .....+.+++.+||..+|.+|||+.+|++.|+...
T Consensus       240 ~---------~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          240 E---------GERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             S---------CCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             c---------CCCCCCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            0         01111111   12245778889999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-41  Score=339.16  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=186.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-h-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-K-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|+..+.||+|+||+||+|....+++.||+|++.... . ...+.+..+...++.++||||+++++++.+.+ ..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEEE
Confidence            468999999999999999999998889999999997642 2 22333445555688899999999999987654 58999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||++ |+|.+++.....   ....+++..++.|+.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++
T Consensus        85 ~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVID---KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EECCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             Eehhc-cchHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence            99997 588888865322   126799999999999999999999997 7   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhc----ccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      +.......   .....||+.|+|||++    ....++.++|||||||++|||++|+.||....... ..+    ..    
T Consensus       158 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~----  225 (290)
T 3fme_A          158 GYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL----KQ----  225 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH----HH----
T ss_pred             cccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH----HH----
Confidence            87654322   2334699999999996    45678999999999999999999999997432211 000    00    


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          ......+....    ......+.+++.+||+.+|++|||+.||++
T Consensus       226 ----~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 ----VVEEPSPQLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----HHHSCCCCCCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HhccCCCCccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                00111111111    112245778889999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.1e-41  Score=336.82  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=202.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---------hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------KESSKAFCRELMIASSLH-HPNIVPLVGFCID  250 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---------~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~  250 (520)
                      .++|...+.||+|+||.||+|....+++.||||++....         ....+.+.+|+.+++++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            368999999999999999999999889999999996542         223456889999999995 9999999999866


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                       ....++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        96 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           96 -NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             -CCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEE
Confidence             45689999999999999999764       46999999999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcc------cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      |+|||++........   .....||+.|+|||++.      ...++.++||||||+++|||++|+.||.......   . 
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-  237 (298)
T 1phk_A          165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M-  237 (298)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-
T ss_pred             EecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---H-
Confidence            999999987654321   23456999999999985      4568899999999999999999999997543211   0 


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ..           .+........ .........+.+++.+||+.||.+|||+.++++
T Consensus       238 --~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 --LR-----------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HH-----------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HH-----------HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              00           1111111100 001122345778889999999999999999976

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=341.20  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ..++|...+.||+|+||.||+|....+++.||+|++....  ..+.+.+|+.+++.++||||+++++++.+. ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEe
Confidence            3468999999999999999999998889999999997643  345788999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       104 e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             ECCTTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            9999999999997532      57999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   .   .        .+.
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~--------~~~  238 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---I---F--------MIP  238 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---H--------HHH
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---H---H--------HHh
Confidence            654321  12345699999999999998999999999999999999999999975432110   0   0        011


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....+.+..+.   .....+.+++.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 TNPPPTFRKPE---LWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HSCCCCCSSGG---GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCCcccCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111111   11245778889999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2e-41  Score=348.11  Aligned_cols=271  Identities=21%  Similarity=0.317  Sum_probs=201.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-------C
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-------~  252 (520)
                      ++|...+.||+|+||+||+|....+++.||||++....  ......+.+|+.+++.++||||+++++++.+.       .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            58999999999999999999998889999999986543  22345678999999999999999999998764       2


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      +.+++||||+++ +|.+.+....      ..+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence            357899999974 7877776542      46999999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCC--CcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-
Q 010012          333 DFGLATWTSAPSV--PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-  408 (520)
Q Consensus       333 DFGla~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-  408 (520)
                      |||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... 
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999987653221  112244568999999999876 458999999999999999999999998654332211111000 


Q ss_pred             hHhhhchhHHH--HhhCc-cc-CC-CCCCHHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVE--ELLDP-RL-KC-TSRNSAQ------IARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~--~~~d~-~l-~~-~~~~~~~------~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...........  +..+. .. .. .......      ...+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00000000000  00000 00 00 0000111      134778999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.4e-42  Score=347.23  Aligned_cols=260  Identities=25%  Similarity=0.377  Sum_probs=201.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEE--EEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV--AIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~v--AvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||.||+|....++..+  |+|.+... .....+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEE
Confidence            57999999999999999999998777755  99998753 234456788999999999 999999999998764 45899


Q ss_pred             EEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      ||||+++|+|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            99999999999999764200         001246999999999999999999999988   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......   +..  
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~--  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--  252 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHH--
Confidence            9999999997443211   1223457889999999998889999999999999999998 999997543221   100  


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                               .+.....  ...+.   .....+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       253 ---------~~~~~~~--~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 ---------KLPQGYR--LEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ---------HGGGTCC--CCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HhhcCCC--CCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     0111111  11111   1224577888999999999999999999998864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.5e-42  Score=348.57  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++.....  .....+.+|+.++++++||||+++++++.+. ...++|
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv  111 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLI  111 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEE
Confidence            3589999999999999999999988899999999975532  2345678999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe-----cCCCceEEee
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL-----SSKKIPKLCD  333 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl-----d~~~~vkL~D  333 (520)
                      |||++ |+|.+++...       ..+++..++.|+.||+.||.|||+.+   |+||||||+|||+     +.++.+||+|
T Consensus       112 ~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence            99997 5999999764       46999999999999999999999988   9999999999999     4555699999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ||+++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus       181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          181 FGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            999987653322  12345689999999999875 489999999999999999999999976443211110000000000


Q ss_pred             -hchhHHHHhhC--cccCC-CCCCHH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 -RGMAAVEELLD--PRLKC-TSRNSA------QIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 -~~~~~l~~~~d--~~l~~-~~~~~~------~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..........+  ..+.. ......      ....+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             00000000000  00000 000000      1245678899999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-42  Score=353.36  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|...+.||+|+||+||+|....+++.||||++.+....    +.+|++++.++ +||||+++++++.+ ...+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEE
Confidence            35799999999999999999999988999999999765332    34678888777 79999999999866 45689999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC----CceEEeecC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFG  335 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~----~~vkL~DFG  335 (520)
                      ||+++|+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||+..+    +.+||+|||
T Consensus        96 E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             CCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999753       46999999999999999999999988   9999999999998533    359999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.           
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----------  232 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-----------  232 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-----------
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-----------
Confidence            9987654322  223457999999999998888999999999999999999999999753222111111           


Q ss_pred             hHHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ..+........ .........+.+++.+||+.||++|||+.+|++
T Consensus       233 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          233 ---ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               11111111100 001112245677889999999999999999886

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-41  Score=350.17  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhC-CCCCeecEEEEE
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~  248 (520)
                      ....++|...+.||+|+||.||+|.+..+++.||||++....        ....+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344568999999999999999999998889999999986542        12245678999999999 799999999988


Q ss_pred             EcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       249 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      .. ....++||||+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       170 ~~-~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          170 ES-SSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EB-SSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             ee-CCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            66 45689999999999999999764       46999999999999999999999988   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhccc------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  402 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~  402 (520)
                      +||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.......   
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---  312 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---
Confidence            99999999987654332   234679999999999863      358899999999999999999999997533211   


Q ss_pred             hHHhhhhHhhhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          403 LVLWAKPILHRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       403 lv~~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..              ..+......... ........+.+++.+||+.||++|||+.++++
T Consensus       313 ~~--------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 ML--------------RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH--------------HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH--------------HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00              001001110000 00001234778889999999999999999987

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-41  Score=365.65  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=199.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-------------HHHHHHHHHHHHHHhCCCCCeecEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------------ESSKAFCRELMIASSLHHPNIVPLVGF  247 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l~g~  247 (520)
                      .++|...+.||+|+||+||+|....++..||+|++.....             ...+.+.+|+.++++++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4689999999999999999999998899999999975431             234678899999999999999999999


Q ss_pred             EEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC
Q 010012          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (520)
Q Consensus       248 ~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (520)
                      +.+. ..+++|||||++|+|.+++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       115 ~~~~-~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          115 FEDK-KYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKN  183 (504)
T ss_dssp             EECS-SEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTT
T ss_pred             EEcC-CEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCC
Confidence            8764 5589999999999999999764       46999999999999999999999988   99999999999998776


Q ss_pred             ---ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          328 ---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       328 ---~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                         .+||+|||+++......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||.........   
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---  256 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---  256 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence               69999999998765432   224456999999999986 56999999999999999999999999764432111   


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                    ..+....+.... ........+.+++.+||+.||.+|||+.|+++
T Consensus       257 --------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 --------------KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --------------HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------------HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                          111111110000 00011235778889999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=350.31  Aligned_cols=269  Identities=23%  Similarity=0.288  Sum_probs=195.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH-----HHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ..++|...+.||+|+||.||+|.+..+++.||||++......     ..+.+.+|+.+++.++||||+++++++.+. ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-Cc
Confidence            346899999999999999999999888999999999754221     124678999999999999999999998664 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++ +|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEec
Confidence            7999999975 8988886532      46899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh-
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH-  412 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~-  412 (520)
                      |+++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|.+||........  +......... 
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~  232 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTP  232 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCC
T ss_pred             ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCC
Confidence            99987654322  22345699999999999764 478999999999999999999999976432211  1100000000 


Q ss_pred             --hchhHHHHhhCcc-cC-CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          413 --RGMAAVEELLDPR-LK-CTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       413 --~~~~~l~~~~d~~-l~-~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                        ..........+.. .. .+...     ......+.+++.+||+.||.+|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              0000000000000 00 00000     1112467888999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.6e-41  Score=366.00  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=196.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|....++..||+|++.+..  ......+.+|+.+++.++|||||++++++.+. ...++||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEE
Confidence            47999999999999999999999889999999997643  23356788999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC---CceEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~---~~vkL~DFGl  336 (520)
                      |||++|+|.+++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||+
T Consensus       116 e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            999999999998765       46999999999999999999999988   9999999999999764   4599999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++......   ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.........               
T Consensus       186 a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------  246 (494)
T 3lij_A          186 SAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL---------------  246 (494)
T ss_dssp             CEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------------
T ss_pred             CeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------
Confidence            98765432   224456999999999986 57999999999999999999999999764432110               


Q ss_pred             HHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ..+........ .........+.+++.+||+.+|.+|||+.|+++
T Consensus       247 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          247 --RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence              00111111000 000011235677889999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-41  Score=347.29  Aligned_cols=255  Identities=22%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             hhCCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcE
Q 010012          180 ATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       180 at~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  255 (520)
                      -.+.|... +.||+|+||+||+|....+++.||+|++....  ......+.+|+.++..+. ||||+++++++.+. ...
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-SEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-CeE
Confidence            34467666 88999999999999999889999999997643  233567889999999994 69999999998664 458


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEe
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLC  332 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~  332 (520)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999865322     56999999999999999999999988   999999999999998   7899999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........          
T Consensus       177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------  243 (327)
T 3lm5_A          177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL----------  243 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred             eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----------
Confidence            9999987654321   234569999999999999999999999999999999999999997643221100          


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          .+... ..... ..........+.+++.+||+.||.+|||+.++++
T Consensus       244 ----~i~~~-~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          244 ----NISQV-NVDYS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ----HHHHT-CCCCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----HHHhc-ccccC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                01110 00111 0001122345678889999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-41  Score=364.85  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|....+++.||||++....  ......+.+|+.++++++|||||++++++.+. ..+++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEEE
Confidence            57999999999999999999998889999999986432  23456788999999999999999999998764 5589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec---CCCceEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld---~~~~vkL~DFGl  336 (520)
                      ||+++|+|.+++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+
T Consensus       101 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999998765       46999999999999999999999988   99999999999995   456799999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........   .            
T Consensus       171 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~------------  231 (486)
T 3mwu_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---L------------  231 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H------------
T ss_pred             CeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H------------
Confidence            987654321   234569999999999875 689999999999999999999999976432211   0            


Q ss_pred             HHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ..+........ .........+.+++.+||+.+|.+|||+.++++
T Consensus       232 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          232 --KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             --HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              01111111100 000112245678889999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-42  Score=373.35  Aligned_cols=261  Identities=28%  Similarity=0.387  Sum_probs=208.7

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      .+....++|...+.||+|+||.||+|.+.. +..||||++..... ..+.|.+|+.++++++|||||++++++.+  ...
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~  336 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPI  336 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccc
Confidence            344456789999999999999999999975 56799999976542 34679999999999999999999999755  457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      +|||||+++|+|.++|.....     ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             eEeeehhcCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccc
Confidence            999999999999999976432     46899999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++....... .......++..|+|||++..+.++.++|||||||+||||++ |+.||......+   +..         
T Consensus       409 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~---------  475 (535)
T 2h8h_A          409 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---------  475 (535)
T ss_dssp             STTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH---------
T ss_pred             cceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            9986643211 11123447789999999999999999999999999999999 999997543211   100         


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                        .+....  ++..+...+   ..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       476 --~i~~~~--~~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          476 --QVERGY--RMPCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             --HHHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --HHHcCC--CCCCCCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              111111  111122222   35677889999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.4e-42  Score=366.77  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|....+++.||||++....   ......+.+|+.++++++|||||++++++.+ ....++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEE
Confidence            57999999999999999999999889999999986542   3345778999999999999999999999876 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFG  335 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFG  335 (520)
                      |||+.+|+|.+++...       ..+++..+..|+.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||
T Consensus       105 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             ECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            9999999999998754       56999999999999999999999988   9999999999999   567899999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........   .           
T Consensus       175 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~-----------  236 (484)
T 3nyv_A          175 LSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---L-----------  236 (484)
T ss_dssp             HHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-----------
T ss_pred             eeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---H-----------
Confidence            9987654332   244569999999999865 799999999999999999999999976433211   1           


Q ss_pred             hHHHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ..+........ .........+.+++.+||+.+|.+|||+.|+++
T Consensus       237 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          237 ---KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               11111111100 000112245678889999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-41  Score=376.99  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=196.7

Q ss_pred             eEEcccCceEEEEeee--cCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|.+  ...++.||||+++...  ....++|.+|++++++++|||||+++++|.+  ...++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            4799999999999955  4456889999997643  3346789999999999999999999999854  34789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++...       ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       453 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          453 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            99999999753       56999999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.........       .       .+...
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~-------~i~~~  588 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------A-------MLEKG  588 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------H-------HHHTT
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------H-------HHHcC
Confidence            321 11233457889999999999999999999999999999998 99999764432110       0       11111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .  ....+...+   ..+.+++..||+.||++||++.+|++.|+..
T Consensus       589 ~--~~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 E--RMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             C--CCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C--CCCCCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1  111122222   4567788899999999999999999999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=343.07  Aligned_cols=269  Identities=21%  Similarity=0.294  Sum_probs=196.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc-----------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-----------  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----------  250 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            689999999999999999999998899999999987777777889999999999999999999998743           


Q ss_pred             --CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCC
Q 010012          251 --PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKK  327 (520)
Q Consensus       251 --~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~  327 (520)
                        .....++||||++ |+|.+++..        ..+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence              2345789999997 699999864        46899999999999999999999988   99999999999997 567


Q ss_pred             ceEEeecCCccccCCCCC-CcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          328 IPKLCDFGLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      .+||+|||+++....... ........+|..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999987643211 111234457999999998865 678999999999999999999999998654322111111


Q ss_pred             hhhhHhhh-chhHHHH----hhCcccCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          406 WAKPILHR-GMAAVEE----LLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       406 ~~~~~~~~-~~~~l~~----~~d~~l~~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.... ....+..    .+..........     ......+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000000 0000000    000000000000     011245778889999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.5e-41  Score=339.23  Aligned_cols=265  Identities=20%  Similarity=0.261  Sum_probs=202.9

Q ss_pred             CCcccceEEcccCceEEEEeee-cCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC------CeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP------NIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp------nIv~l~g~~~~~~~~  254 (520)
                      ++|...+.||+|+||+||+|.+ ..+++.||||++... ....+.+.+|+.+++.++|+      +++++++++.+. ..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-GH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-TE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-Cc
Confidence            5899999999999999999987 556889999999754 34456788899999888765      499999988764 46


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---------  325 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---------  325 (520)
                      .++||||+ +++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.         
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence            89999999 8999999976432     46899999999999999999999988   999999999999987         


Q ss_pred             ----------CCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          326 ----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       326 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                                ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      6689999999998654332     3456999999999999989999999999999999999999999764


Q ss_pred             ccccchhhHHhhhh-----Hhhhc-------------------hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCC
Q 010012          396 RLQGEENLVLWAKP-----ILHRG-------------------MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEE  451 (520)
Q Consensus       396 ~~~~~~~lv~~~~~-----~~~~~-------------------~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP  451 (520)
                      ........+.....     .....                   ...+.....+..............+.+++.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            43221111110000     00000                   0000111111111111223455678899999999999


Q ss_pred             CCCCCHHHHHH
Q 010012          452 SRRPGIEEIIA  462 (520)
Q Consensus       452 ~~RPtm~eVl~  462 (520)
                      .+|||+.||++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-41  Score=347.05  Aligned_cols=267  Identities=25%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|....+++.||||++...  .....+.+.+|+.+++.++||||+++++++.+. ...++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEEE
Confidence            5899999999999999999999988999999998654  234456688999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+++++|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       104 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             ECCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             ecCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            999999998876543       46999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH-hhh-------hH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL-WAK-------PI  410 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~-~~~-------~~  410 (520)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+. ...       ..
T Consensus       174 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          174 LAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            654322  22345699999999999875 68999999999999999999999997654322111100 000       00


Q ss_pred             hhhchhHHHHhhCcccCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSR----NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~----~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..... .......+.+.....    .+.....+.+++.+||+.||.+|||+.||++
T Consensus       252 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          252 FNKNP-VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHCG-GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhcc-ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000 000001111110000    0012346788899999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-40  Score=337.47  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcC-CCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~~~~LV~  259 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....   .+.+.+|+.+++.++ ||||+++++++.+. ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            58999999999999999999998889999999997543   356889999999997 99999999998764 34578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~  338 (520)
                      ||+++++|.+++.          .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++
T Consensus       113 e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             ECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            9999999999874          3889999999999999999999988   99999999999999776 89999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc---
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG---  414 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~---  414 (520)
                      .......   .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+.......-...   
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhh
Confidence            7654332   234568999999999977 668999999999999999999999995432211 11111110000000   


Q ss_pred             ---------hhHHHHhhCccc-------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 ---------MAAVEELLDPRL-------KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ---------~~~l~~~~d~~l-------~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                               .....+.+....       ............+.+++.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     000001110000       000001112356788899999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-41  Score=350.91  Aligned_cols=267  Identities=23%  Similarity=0.313  Sum_probs=197.7

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC------
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE------  252 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------  252 (520)
                      ...++|...+.||+|+||+||+|.+..+++.||||++......    ..+|+.+++.++|||||++++++....      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567999999999999999999999888999999998654322    237999999999999999999885432      


Q ss_pred             -------------------------------CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 010012          253 -------------------------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA  301 (520)
Q Consensus       253 -------------------------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~  301 (520)
                                                     ..+++||||++ |+|.+.+.....   ....+++..+..++.||++||.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---SGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Confidence                                           23789999997 588888875322   1267999999999999999999


Q ss_pred             HHHhCCCCceEecccCCCCeEec-CCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHH
Q 010012          302 YLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFG  379 (520)
Q Consensus       302 yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~G  379 (520)
                      |||+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||..|+|||++.+. .++.++||||||
T Consensus       156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            999887   99999999999998 688999999999987654332   2345689999999998765 489999999999


Q ss_pred             HHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCccc--------CCCC----CCHHHHHHHHHHHHHcc
Q 010012          380 VVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRL--------KCTS----RNSAQIARVIQAAAACI  447 (520)
Q Consensus       380 vvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l--------~~~~----~~~~~~~~l~~la~~Cl  447 (520)
                      |++|||++|+.||......+.  +.......-......+.. .++..        ....    ........+.+++.+||
T Consensus       230 ~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIR-MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH-HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHH-hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            999999999999986543221  111111000000000000 01110        0000    00011234778899999


Q ss_pred             ccCCCCCCCHHHHHH
Q 010012          448 SSEESRRPGIEEIIA  462 (520)
Q Consensus       448 ~~dP~~RPtm~eVl~  462 (520)
                      +.||.+|||+.|+++
T Consensus       307 ~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          307 RYEPDLRINPYEAMA  321 (383)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCChhhCCCHHHHhc
Confidence            999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.7e-42  Score=343.20  Aligned_cols=268  Identities=25%  Similarity=0.388  Sum_probs=185.0

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ..++|...+.||+|+||+||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv   91 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLV   91 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEE
Confidence            4578999999999999999999998789999999986543 234567889999999999999999999987755 48999


Q ss_pred             EEecCCCChhHHhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||+++++|.+++...... ......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999999753211 111256999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCC---CcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          338 TWTSAPSV---PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       338 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ........   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .    .....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--M----LTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--H----HHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--H----HHhcc
Confidence            76543211   111234569999999999876 56899999999999999999999999764432111  0    00000


Q ss_pred             chhHHH-HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVE-ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~-~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....+. ...++...  ...   ...+.+++.+||+.||.+|||+.+|++
T Consensus       243 ~~~~~~~~~~~~~~~--~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEML--KKY---GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCC--CCC---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhh--hhh---hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000 00011110  111   235677889999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.5e-41  Score=359.25  Aligned_cols=263  Identities=22%  Similarity=0.234  Sum_probs=205.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++......  .++..|+++++.++|++.+..+.++.......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36899999999999999999999888999999988654322  3577899999999886555555555555666899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe---cCCCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl---d~~~~vkL~DFGla  337 (520)
                      |+ +++|.+++....      ..+++..++.|+.||+.||+|||+.+   ||||||||+||||   +.++.+||+|||++
T Consensus        84 ~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99 999999997542      56999999999999999999999988   9999999999999   68899999999999


Q ss_pred             cccCCCCCCc-----ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          338 TWTSAPSVPF-----LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       338 ~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      +.........     ......||+.|+|||++.+..++.++|||||||+||||++|+.||....................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            8765433211     12356799999999999999999999999999999999999999986544322222111111000


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ..  .+..+..       ..   ...+.+++..||+.+|++||++.+|+++|+.+
T Consensus       234 ~~--~~~~l~~-------~~---p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 AT--SIEALCR-------GY---PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HS--CHHHHHT-------TS---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cc--cHHHHhc-------CC---cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00  0111110       11   13577888999999999999999999998864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.1e-41  Score=347.92  Aligned_cols=265  Identities=21%  Similarity=0.297  Sum_probs=186.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-----CC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~  253 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999999888999999999653  344567788999999999999999999988643     13


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++|+|++ +++|.+++..        ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             CCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEee
Confidence            478999999 7899998864        46999999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----  408 (520)
                      ||+++.....     .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....    
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     234569999999999877 678999999999999999999999997654322111111000    


Q ss_pred             -hHhhhch-hHHHHhhCcccCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 -PILHRGM-AAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 -~~~~~~~-~~l~~~~d~~l~~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ..+.... ......+......+....     .....+.+|+.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             0000000 001111110000000010     11245778899999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-40  Score=343.85  Aligned_cols=276  Identities=22%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             cHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHHHhCCCCCe
Q 010012          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----------KESSKAFCRELMIASSLHHPNI  241 (520)
Q Consensus       173 s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----------~~~~~~~~~E~~il~~l~HpnI  241 (520)
                      ...++....++|...+.||+|+||.||+|.... +..||||++....           ....+.+.+|+.++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345666778899999999999999999999875 8999999985432           2234788999999999999999


Q ss_pred             ecEEEEEEcCC----CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          242 VPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       242 v~l~g~~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      +++++++...+    ..+++||||+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+|||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  161 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH  161 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence            99999886433    35799999997 68888887532      56999999999999999999999988   9999999


Q ss_pred             CCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       318 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      |+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997554332   1234568999999999877 678999999999999999999999998654


Q ss_pred             cccchhhH-Hhhhh-----HhhhchhHHHHhhCcccCCC-CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          397 LQGEENLV-LWAKP-----ILHRGMAAVEELLDPRLKCT-SRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       397 ~~~~~~lv-~~~~~-----~~~~~~~~l~~~~d~~l~~~-~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .......+ .....     ..........+.+...+... ...     ......+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            32211110 00000     00000001111111111100 000     011245778899999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5e-41  Score=356.17  Aligned_cols=201  Identities=23%  Similarity=0.329  Sum_probs=174.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC------CCCCeecEEEEEEcCCCc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL------HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~g~~~~~~~~  254 (520)
                      ..+|...+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+      .|+||+++++++... ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-Ce
Confidence            35799999999999999999999988999999999764 33446677888888776      577999999998764 45


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc--eEEe
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLC  332 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~--vkL~  332 (520)
                      +++||||+. ++|.+++.....     ..+++..+..|+.||+.||+|||+.+   |+||||||+||||+.++.  +||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             EEEEEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence            899999995 699999986532     45999999999999999999999988   999999999999999887  9999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      |||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       245 DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          245 DFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999997654332     345699999999999999999999999999999999999999976543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-41  Score=342.55  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--------HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++.....        .....+.+|+++++.++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            3579999999999999999999988899999999865421        2234578999999999999999999987553 


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc---e
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---P  329 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~---v  329 (520)
                      . .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCE
T ss_pred             c-eEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeE
Confidence            3 79999999999999998653       56999999999999999999999988   999999999999987664   9


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      ||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|||++|+.||........  +.. 
T Consensus       157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-  230 (322)
T 2ycf_A          157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD-  230 (322)
T ss_dssp             EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH-
T ss_pred             EEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH-
Confidence            999999998765432   223456999999999974   46789999999999999999999999975433211  110 


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         .+..+...    ..+...  .   .....+.+++.+||+.||.+|||+.++++
T Consensus       231 ---~~~~~~~~----~~~~~~--~---~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 ---QITSGKYN----FIPEVW--A---EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ---HHHHTCCC----CCHHHH--T---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHhCccc----cCchhh--h---hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence               00000000    000000  0   11245778889999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=349.09  Aligned_cols=254  Identities=25%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             CCcccceEEcccCceEEEEeeec---CCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~  253 (520)
                      ++|...+.||+|+||+||+|...   .+++.||||++....    ......+.+|+++++.+ +||||+++++++.+. .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  132 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-T  132 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-T
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-c
Confidence            58999999999999999999883   468999999986532    12334567899999999 699999999987664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             eEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEee
Confidence            589999999999999999764       46999999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ||+++....... .......||+.|+|||++.+.  .++.++|||||||+||||++|+.||.........  .....   
T Consensus       203 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~---  276 (355)
T 1vzo_A          203 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR---  276 (355)
T ss_dssp             SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH---
T ss_pred             CCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHH---
Confidence            999986543222 122345799999999999853  4789999999999999999999999754332211  11111   


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIAI  463 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~~  463 (520)
                              .+.......+..   ....+.+++.+||..||.+||     ++.|+++.
T Consensus       277 --------~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          277 --------RILKSEPPYPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             --------HHHHCCCCCCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --------HHhccCCCCCcc---cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                    111111111111   223567788999999999999     99999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-40  Score=344.29  Aligned_cols=263  Identities=18%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-----------CCCeecEEEEEEc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCID  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~~  250 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++... ......+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            6899999999999999999999888999999999754 334567888999998876           8999999998875


Q ss_pred             CC---CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEec--
Q 010012          251 PE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLS--  324 (520)
Q Consensus       251 ~~---~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld--  324 (520)
                      ..   ..+++||||+ +++|.+++.....     ..+++..+..++.||+.||+|||+. +   |+||||||+||||+  
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEecc
Confidence            43   2578999999 9999999986432     4699999999999999999999997 7   99999999999994  


Q ss_pred             ----CCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccc
Q 010012          325 ----SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE  400 (520)
Q Consensus       325 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~  400 (520)
                          ..+.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                44589999999998765432     334689999999999999999999999999999999999999986542211


Q ss_pred             h---hhHHhhhhHhh--------hchh--------------------HHHHhhCcccCCCCCCHHHHHHHHHHHHHcccc
Q 010012          401 E---NLVLWAKPILH--------RGMA--------------------AVEELLDPRLKCTSRNSAQIARVIQAAAACISS  449 (520)
Q Consensus       401 ~---~lv~~~~~~~~--------~~~~--------------------~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~  449 (520)
                      .   .........+.        .+..                    .+...+....   .........+.+++.+||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY---KFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT---CCCHHHHHHHHHHHGGGGCS
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc---cCCcchHHHHHHHHHHHhcc
Confidence            1   00000000000        0000                    0000111111   12345667888999999999


Q ss_pred             CCCCCCCHHHHHH
Q 010012          450 EESRRPGIEEIIA  462 (520)
Q Consensus       450 dP~~RPtm~eVl~  462 (520)
                      ||.+|||+.||++
T Consensus       321 dP~~Rpt~~ell~  333 (373)
T 1q8y_A          321 DPRKRADAGGLVN  333 (373)
T ss_dssp             STTTCBCHHHHHT
T ss_pred             CccccCCHHHHhh
Confidence            9999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-41  Score=353.26  Aligned_cols=255  Identities=13%  Similarity=0.080  Sum_probs=183.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHH---HHHHhCCCCCeecEE-------EE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCREL---MIASSLHHPNIVPLV-------GF  247 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~---~il~~l~HpnIv~l~-------g~  247 (520)
                      ..+|...+.||+|+||+||+|.+..+++.||||++....   ....+.+.+|+   .+|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            346899999999999999999998889999999998753   23455677775   45555 799988755       44


Q ss_pred             EEcCC----------------CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHh
Q 010012          248 CIDPE----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------YKVALGIAESVAYLHN  305 (520)
Q Consensus       248 ~~~~~----------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~------~~ia~qia~aL~yLH~  305 (520)
                      +....                ..+++||||++ |+|.+++....      ..+++..+      ..++.||+.||+|||+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            33221                23799999998 89999998753      34566667      7888999999999999


Q ss_pred             CCCCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhccc--CCCCCcCceeeHHHHHH
Q 010012          306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLL  383 (520)
Q Consensus       306 ~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~  383 (520)
                      .+   |+||||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||+||
T Consensus       213 ~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          213 KG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             TT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             CC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            88   9999999999999999999999999998664321     13457799999999987  67999999999999999


Q ss_pred             HHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          384 ELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       384 ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ||++|+.||..........   +...       .........+..+. .......+.+++.+||+.||++|||+.++++
T Consensus       285 elltg~~Pf~~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGS---WKRP-------SLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTC---CCBC-------CTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHhCCCCCCCcCcccccc---hhhh-------hhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999998654321110   0000       00000011111110 0112245677888999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.6e-41  Score=333.88  Aligned_cols=253  Identities=23%  Similarity=0.407  Sum_probs=192.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC----------
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP----------  251 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----------  251 (520)
                      ++|...+.||+|+||+||+|....+++.||||++... ....+.+.+|+.+++.++||||+++++++.+.          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            5799999999999999999999888999999999653 34557889999999999999999999988653          


Q ss_pred             --CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          252 --EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       252 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                        ....++||||+++|+|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCE
Confidence              235789999999999999998642      45788999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCC------------CcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          330 KLCDFGLATWTSAPSV------------PFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       330 kL~DFGla~~~~~~~~------------~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      ||+|||+++.......            ........||+.|+|||++.+. .++.++|||||||++|||++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            9999999986543210            1112345699999999999764 68999999999999999998   554221


Q ss_pred             cccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          397 LQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       397 ~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..  ...   ..        .+.. ....+. ..........+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~--~~~---~~--------~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 ER--VNI---LK--------KLRS-VSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH--HHH---HH--------HHHS-TTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hH--HHH---HH--------hccc-cccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            10  000   00        0110 011111 1111222345678889999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.7e-40  Score=339.13  Aligned_cols=267  Identities=23%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC----CCcE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP----EQGL  255 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----~~~~  255 (520)
                      .++|...+.||+|+||+||+|....+++.||||++... .......+.+|+.+++.++||||+++++++...    ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46899999999999999999999888999999999754 334556788999999999999999999987653    2558


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+. |+|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecc
Confidence            99999996 699998875        45999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCc--------ccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          336 LATWTSAPSVPF--------LCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       336 la~~~~~~~~~~--------~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      +++.........        ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+  
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--  235 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI--  235 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--
Confidence            998765322110        1123468999999998765 67899999999999999999999999765432111110  


Q ss_pred             hhhHhhh----------chhHHHHhhCcccCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHR----------GMAAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~----------~~~~l~~~~d~~l~~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ......          ......+.+..........     ......+.+++.+||+.||++|||+.||++
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          236 -FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             -HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000000          0000111110000000000     011245678889999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.9e-41  Score=352.85  Aligned_cols=264  Identities=27%  Similarity=0.320  Sum_probs=196.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC-----CcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~~  256 (520)
                      .+|...+.||+|+||+||+|.+..+++.||||++.....    .+.+|+++++.++|||||++++++....     ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468999999999999999999988899999999865432    2346999999999999999999876422     2367


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-CceEEeecC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFG  335 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-~~vkL~DFG  335 (520)
                      +||||+++ +|.+.+.....   ....+++..++.++.||++||+|||+.+   |+||||||+||||+.+ +.+||+|||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccch
Confidence            99999975 67666654221   1267999999999999999999999887   9999999999999965 678999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++.......   .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+  .+......+-...
T Consensus       203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~  277 (420)
T 1j1b_A          203 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPT  277 (420)
T ss_dssp             TCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCC
T ss_pred             hhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            9987654322   2345689999999999765 78999999999999999999999998644321  1221111110000


Q ss_pred             hhHHHHhhCcccCC---CC---------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDPRLKC---TS---------RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~---~~---------~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+... ++....   +.         ........+.+|+.+||+.||.+|||+.|+++
T Consensus       278 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          278 REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0111111 111110   00         00011246788999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-40  Score=343.19  Aligned_cols=271  Identities=23%  Similarity=0.293  Sum_probs=190.3

Q ss_pred             HHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC----
Q 010012          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  253 (520)
Q Consensus       178 ~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----  253 (520)
                      ....++|...+.||+|+||+||+|.+..+++.||||++..... ....+.++++.++.++||||+++++++.....    
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3456799999999999999999999988899999999865432 23456678888999999999999999865332    


Q ss_pred             --cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecccCCCCeEecC-CCc
Q 010012          254 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--NGTERCVVHRDIKPSNILLSS-KKI  328 (520)
Q Consensus       254 --~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--~~~~~~IiHrDLKp~NILld~-~~~  328 (520)
                        .+++||||+++ +|...+.....   ....+++..+..++.|++.||.|||  +.+   |+||||||+||||+. ++.
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYR---RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence              27899999976 55555543211   1267899999999999999999999  777   999999999999996 899


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........  ..
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~--~~  245 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE--IV  245 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH--HH
Confidence            99999999987654332   23456899999999986654 89999999999999999999999986543221111  11


Q ss_pred             hhHhhhchhHHHHhhCcccC---------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          408 KPILHRGMAAVEELLDPRLK---------------CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~---------------~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      . ............+++...               ...........+.+++.+||+.||.+|||+.||++
T Consensus       246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 R-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             H-HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             H-HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1 000000001111111100               00001113456888999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.9e-41  Score=340.26  Aligned_cols=259  Identities=23%  Similarity=0.375  Sum_probs=196.9

Q ss_pred             cccHHHHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCC--CCCeecEEE
Q 010012          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLVG  246 (520)
Q Consensus       171 ~~s~~ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~--HpnIv~l~g  246 (520)
                      .+.+..+....++|...+.||+|+||.||+|.... ++.||||++...  .....+.+.+|+.++.+++  ||||+++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            34444444566789999999999999999999864 889999999654  3455678899999999997  599999999


Q ss_pred             EEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       247 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      ++.+. ...++||| +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++ 
T Consensus        96 ~~~~~-~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           96 YEITD-QYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-  162 (313)
T ss_dssp             EEECS-SEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred             EeecC-CEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence            98764 45899999 5689999999764       46899999999999999999999988   999999999999965 


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccCchhccc-----------CCCCCcCceeeHHHHHHHHHhCCCCcchh
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-----------GKVSDKTDVYAFGVVLLELLTGRKPIEAR  395 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~  395 (520)
                      +.+||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            8999999999987654432222344569999999999875           46888999999999999999999999653


Q ss_pred             ccccchhhHHhhhhHhhhchhHHHHhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       396 ~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ....     .           .+...+++...  .+...   ...+.+++.+||+.||.+||++.||++
T Consensus       243 ~~~~-----~-----------~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          243 INQI-----S-----------KLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CSHH-----H-----------HHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHH-----H-----------HHHHHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2110     0           12222332221  11112   235677888999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-40  Score=336.72  Aligned_cols=266  Identities=18%  Similarity=0.251  Sum_probs=201.2

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCC-cEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC------eecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPN------IVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~~~~~~  253 (520)
                      .++|...+.||+|+||+||+|....++ ..||+|++... ....+.+.+|+.+++.++|++      ++.+++++... .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-G   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-C
Confidence            368999999999999999999987666 68999999754 344567888999999987765      89999887664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----------
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----------  323 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----------  323 (520)
                      ..++||||+ +++|.+++.....     ..+++..++.++.||+.||+|||+.+   |+||||||+|||+          
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eEEEEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence            689999999 7778777765432     46999999999999999999999887   9999999999999          


Q ss_pred             ---------cCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          324 ---------SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       324 ---------d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                               +.++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                     567899999999998654332     345699999999999999999999999999999999999999976


Q ss_pred             hccccchhhHHhhh-hHhh----hc-------------------hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccC
Q 010012          395 RRLQGEENLVLWAK-PILH----RG-------------------MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSE  450 (520)
Q Consensus       395 ~~~~~~~~lv~~~~-~~~~----~~-------------------~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~d  450 (520)
                      .........+.... +...    ..                   ...+.+...+..............+.+++.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            44322111111000 0000    00                   000000111100111122344567889999999999


Q ss_pred             CCCCCCHHHHHH
Q 010012          451 ESRRPGIEEIIA  462 (520)
Q Consensus       451 P~~RPtm~eVl~  462 (520)
                      |++|||+.||++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.2e-41  Score=343.22  Aligned_cols=251  Identities=21%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH-----------------HHHHHHHHHHHHhCCCCCeec
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-----------------SKAFCRELMIASSLHHPNIVP  243 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-----------------~~~~~~E~~il~~l~HpnIv~  243 (520)
                      .++|...+.||+|+||.||+|..  +++.||||++.......                 .+.+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36899999999999999999998  68999999986542211                 178899999999999999999


Q ss_pred             EEEEEEcCCCcEEEEEEecCCCChhHH------hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeccc
Q 010012          244 LVGFCIDPEQGLFLIYKYVSGGSLERH------LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDI  316 (520)
Q Consensus       244 l~g~~~~~~~~~~LV~E~~~~gsL~~~------L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDL  316 (520)
                      +++++.+. +..++||||+++|+|.++      +....     ...+++..++.++.|++.||.|||+ .+   |+||||
T Consensus       108 ~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl  178 (348)
T 2pml_X          108 CEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV  178 (348)
T ss_dssp             CSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred             EEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence            99998775 468999999999999998      44321     2679999999999999999999998 77   999999


Q ss_pred             CCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccC-CCCC-cCceeeHHHHHHHHHhCCCCcch
Q 010012          317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSD-KTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       317 Kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~-ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      ||+|||++.++.+||+|||++......    ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||..
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999876443    22445699999999999877 5666 99999999999999999999976


Q ss_pred             hccccchhhHHhhhhHhhhchhHHHHhhCcccCCCC----------------CCHHHHHHHHHHHHHccccCCCCCCCHH
Q 010012          395 RRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTS----------------RNSAQIARVIQAAAACISSEESRRPGIE  458 (520)
Q Consensus       395 ~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~----------------~~~~~~~~l~~la~~Cl~~dP~~RPtm~  458 (520)
                      .....  .+..              .+.......+.                ........+.+++.+||+.||.+|||+.
T Consensus       255 ~~~~~--~~~~--------------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~  318 (348)
T 2pml_X          255 KISLV--ELFN--------------NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE  318 (348)
T ss_dssp             SSCSH--HHHH--------------HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCcHH--HHHH--------------HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence            43311  1111              11111110000                0011224577888999999999999999


Q ss_pred             HHHH
Q 010012          459 EIIA  462 (520)
Q Consensus       459 eVl~  462 (520)
                      |+++
T Consensus       319 e~l~  322 (348)
T 2pml_X          319 DALK  322 (348)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=340.45  Aligned_cols=264  Identities=19%  Similarity=0.301  Sum_probs=197.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----  253 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36899999999999999999999888999999999654  33445678899999999999999999999866443     


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ..++||||+. |+|.+++.         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECS
T ss_pred             eEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEee
Confidence            2489999996 68887763         34899999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----  408 (520)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....    
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999865432     234568999999999877 678999999999999999999999998654322111100000    


Q ss_pred             -hHhhhch-hHHHHhhC---c--ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 -PILHRGM-AAVEELLD---P--RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 -~~~~~~~-~~l~~~~d---~--~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ....... ......+.   .  ..............+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000000 00000000   0  00000111122346778889999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.2e-40  Score=339.73  Aligned_cols=264  Identities=19%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~----  254 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36899999999999999999999988999999999764  334467788999999999999999999998664431    


Q ss_pred             -EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          255 -LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       255 -~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                       .++||||+. ++|.+++.         ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEe
Confidence             389999996 68887773         35999999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----  408 (520)
                      ||+++......     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+....    
T Consensus       188 fg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          188 FGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            99998654332     34568999999999987 678999999999999999999999997644322111100000    


Q ss_pred             -hHhhhch-hHHHHhhCcccCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 -PILHRGM-AAVEELLDPRLKCTSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 -~~~~~~~-~~l~~~~d~~l~~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       ....... ......+..........     ......+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             0000000 00000000000000000     011346778889999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.2e-40  Score=341.77  Aligned_cols=204  Identities=22%  Similarity=0.279  Sum_probs=172.8

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CC-----CeecEEEEEEcCCC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HP-----NIVPLVGFCIDPEQ  253 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~g~~~~~~~  253 (520)
                      ..++|...+.||+|+||+||+|.+..+++.||||++... .....++..|+.+++.++ |+     +|+++++++... .
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-N  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-T
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-C
Confidence            457999999999999999999999888999999999754 334566778888888875 44     499999988764 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CCCceEE
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKL  331 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~~~vkL  331 (520)
                      ..++||||+. |+|.+++.....     ..+++..+..++.|++.||.|||.. ..+|+||||||+||||+  .++.+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence            5899999995 599999986532     4599999999999999999999953 13499999999999995  5788999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhcc
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRL  397 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~  397 (520)
                      +|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999998765432     345699999999999999999999999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-40  Score=330.66  Aligned_cols=250  Identities=25%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+. ...++|+
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEEEEE
Confidence            57999999999999999999998889999999986542  23456788999999999999999999998764 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC---CceEEeecCC
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  336 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~---~~vkL~DFGl  336 (520)
                      ||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.+   +.+||+|||+
T Consensus       101 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A          101 ELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999998764       46899999999999999999999988   9999999999999764   4799999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      +........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......   ..   ..+ ..+  
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~-~~~--  237 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRV-ETG--  237 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHC--
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HH---HHH-HcC--
Confidence            987654321   233458999999999865 58999999999999999999999997643221   10   000 000  


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          .....+....   .....+.+++.+||+.+|.+|||+.++++
T Consensus       238 ----~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 ----KYAFDLPQWR---TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----CCCCCSGGGT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCchhhh---hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                0000111001   11235678889999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-40  Score=336.30  Aligned_cols=268  Identities=22%  Similarity=0.302  Sum_probs=197.6

Q ss_pred             hhCCcccceEEcccCceEEEEeeec-CCCcEEEEEEecCcch--HHHHHHHHHHHHHHhC---CCCCeecEEEEEEc---
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKEDK--ESSKAFCRELMIASSL---HHPNIVPLVGFCID---  250 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~---  250 (520)
                      +.++|...+.||+|+||+||+|.+. .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984 5688999999864321  1123455677666655   89999999999862   


Q ss_pred             -CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCce
Q 010012          251 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (520)
Q Consensus       251 -~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~v  329 (520)
                       .....++||||+. |+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCE
Confidence             3345789999997 699999976432     45999999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      ||+|||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+   ..
T Consensus       160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~  233 (326)
T 1blx_A          160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LD  233 (326)
T ss_dssp             EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH
T ss_pred             EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HH
Confidence            999999998654322   223456899999999999999999999999999999999999999764432111100   00


Q ss_pred             Hhhh-chhHHH-------HhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHR-GMAAVE-------ELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~-~~~~l~-------~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .... ......       ........  ...........+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000 000000       00000000  00000112235677889999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=342.53  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=197.6

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ...++|...+.||+|+||+||+|....   .||+|++....  ....+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-HLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-CEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-ceE
Confidence            345789999999999999999998863   49999986542  223355778999999999999999999987754 489


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++++|.+++....      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+
T Consensus       106 iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999997532      46999999999999999999999988   99999999999998 67999999999


Q ss_pred             ccccCCCC---CCcccccccccCCccCchhccc---------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhH
Q 010012          337 ATWTSAPS---VPFLCKTVKGTFGYLAPEYFQH---------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLV  404 (520)
Q Consensus       337 a~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~---------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv  404 (520)
                      ++......   .........||+.|+|||++..         ..++.++|||||||++|||++|+.||.......   ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~  252 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---II  252 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence            87653211   1112234469999999999864         357889999999999999999999997543221   10


Q ss_pred             HhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          405 LWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       405 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                         .        .+.....+.+... ..   ...+.+++..||..+|.+|||+.+|+++|+....
T Consensus       253 ---~--------~~~~~~~~~~~~~-~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          253 ---W--------QMGTGMKPNLSQI-GM---GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             ---H--------HHHTTCCCCCCCS-SC---CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             ---H--------HhccCCCCCCCcC-CC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               0        1111122222111 11   1246778899999999999999999999997653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-40  Score=346.38  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=192.2

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----cEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----GLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----~~~  256 (520)
                      .+|...+.||+|+||+||+|.+..++. ||+|++......    ..+|+++++.++||||+++++++.....     .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999999999976554 888888654321    2369999999999999999999865432     278


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  335 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFG  335 (520)
                      +||||++++.+.........    ...+++..+..++.||++||+|||+.+   |+||||||+||||+ .++.+||+|||
T Consensus       115 lv~e~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKL----KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEeeccCccHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            99999977544433322211    257999999999999999999999988   99999999999999 79999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .+......+-...
T Consensus       188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~  262 (394)
T 4e7w_A          188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPS  262 (394)
T ss_dssp             TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            9987654332   2345689999999998765 58999999999999999999999998654322  1111111000000


Q ss_pred             hhHHHH----hhCcccCCC-CC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEE----LLDPRLKCT-SR------NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~----~~d~~l~~~-~~------~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+..    .....+... ..      .......+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            000110    001111000 00      0012246788899999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=347.37  Aligned_cols=208  Identities=28%  Similarity=0.479  Sum_probs=156.7

Q ss_pred             Cccc-ceEEcccCceEEEEeeec--CCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEc-CCCcEEEE
Q 010012          183 NFSK-GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFLI  258 (520)
Q Consensus       183 ~f~~-~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~~LV  258 (520)
                      .|.. +++||+|+||+||+|...  .+++.||||++.....  ...+.+|+.+++.++|||||++++++.. ....+++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4554 568999999999999965  4578899999976432  2467899999999999999999999864 34568999


Q ss_pred             EEecCCCChhHHhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEe----cCCCceEEe
Q 010012          259 YKYVSGGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLC  332 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~--~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILl----d~~~~vkL~  332 (520)
                      |||+. |+|.+++......  ......+++..++.|+.||+.||.|||+.+   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 5888887643211  011135999999999999999999999988   9999999999999    778899999


Q ss_pred             ecCCccccCCCCCC-cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          333 DFGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       333 DFGla~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      |||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999876543211 122446799999999999874 58999999999999999999999997543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.1e-40  Score=366.21  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=203.3

Q ss_pred             HhhCCcccceEEcccCceEEEEeeecC---CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~  254 (520)
                      ...++|...+.||+|+||+||+|.+..   .+..||+|++... .....+.|.+|+.++++++||||+++++++.+  +.
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~  464 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP  464 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cc
Confidence            345678899999999999999998753   3467999998764 34455789999999999999999999998743  34


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence            789999999999999997642      46999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   ...        
T Consensus       536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~--------  603 (656)
T 2j0j_A          536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG--------  603 (656)
T ss_dssp             CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--------
T ss_pred             CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH--------
Confidence            999876543221 2233457889999999998999999999999999999997 999997543221   110        


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                         .+....  ....+...   ...+.+++.+||..||.+|||+.+|++.|+.+
T Consensus       604 ---~i~~~~--~~~~~~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          604 ---RIENGE--RLPMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---HHHHTC--CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHcCC--CCCCCccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               111111  11111112   24567788999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=332.76  Aligned_cols=242  Identities=25%  Similarity=0.396  Sum_probs=192.2

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch------HHHHHHHHHHHHHHhC----CCCCeecEEEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSL----HHPNIVPLVGFCI  249 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l----~HpnIv~l~g~~~  249 (520)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.....      .....+.+|+.++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            34689999999999999999999988899999999976532      1223456789999888    8999999999876


Q ss_pred             cCCCcEEEEEEe-cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCC
Q 010012          250 DPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKK  327 (520)
Q Consensus       250 ~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~  327 (520)
                      +.+ ..++|+|+ +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++ .++
T Consensus       109 ~~~-~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          109 TQE-GFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred             cCC-eEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence            644 47899999 7899999999864       46999999999999999999999988   99999999999999 889


Q ss_pred             ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCC-CcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh
Q 010012          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVS-DKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW  406 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~  406 (520)
                      .+||+|||+++......    .....||..|+|||++.+..+. .++|||||||++|||++|+.||.....         
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------  244 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------  244 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence            99999999998765432    2345699999999999877664 589999999999999999999964311         


Q ss_pred             hhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       407 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                    +.+.........   ...+.+++.+||+.+|++|||+.||++
T Consensus       245 --------------~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 --------------ILEAELHFPAHV---SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --------------HHHTCCCCCTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------HhhhccCCcccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          001111111112   234677889999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.2e-40  Score=337.43  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=173.2

Q ss_pred             hCCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC---CCcEE
Q 010012          181 THNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  256 (520)
Q Consensus       181 t~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~~~  256 (520)
                      .++|... ++||+|+||+||+|.+..+++.||||++.... ...+   .....++.+.||||+++++++...   ...++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4689885 46999999999999999889999999996542 2222   223346778999999999987652   33478


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~D  333 (520)
                      +||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       103 lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C-----CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEeccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEec
Confidence            99999999999999986432     57999999999999999999999988   999999999999986   45599999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ||+++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ...... 
T Consensus       175 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~-  246 (336)
T 3fhr_A          175 FGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIR-  246 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhh-
Confidence            99998665332    2345689999999999888899999999999999999999999976443211000   000000 


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          ...   ..+... ........+.+++.+||+.||.+|||+.|+++
T Consensus       247 ----~~~---~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          247 ----LGQ---YGFPNP-EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------CCCTT-TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----ccc---cccCch-hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                000   000000 01112345677889999999999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=331.52  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=178.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HH-HHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||.||+|.+..+++.||||++..... .. .+.+..+..+++.++||||+++++++.+. ...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEE
Confidence            3578999999999999999999988899999999976532 22 23344555678889999999999998765 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||+ ++.+..++....      ..+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             Eecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            9999 556655554332      5699999999999999999999984 7   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      ........   .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.......  ..   ...   
T Consensus       173 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~---  241 (318)
T 2dyl_A          173 GRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTK---  241 (318)
T ss_dssp             -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHH---
T ss_pred             hhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHH---
Confidence            76644321   23456999999999994     4568899999999999999999999997532210  00   001   


Q ss_pred             hchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       413 ~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                           +.....+.+......+   ..+.+++.+||+.||.+||++.+|++
T Consensus       242 -----~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          242 -----VLQEEPPLLPGHMGFS---GDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -----HHHSCCCCCCSSSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----HhccCCCCCCccCCCC---HHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 1111111121111122   34667888999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.4e-40  Score=333.94  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=178.7

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHH-HHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||.||+|....+++.||||++.... .....++..|+. +++.++||||+++++++.+. +..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEE
Confidence            368999999999999999999998889999999997653 334455666665 77888999999999998775 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||+++ +|.+++......  ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EeecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            999975 888887643211  125799999999999999999999997 7   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhc----ccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYF----QHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      +.......   .....||+.|+|||++    .+..++.++|||||||++|||++|+.||.......     .        
T Consensus       174 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~--------  237 (327)
T 3aln_A          174 GQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----D--------  237 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------
T ss_pred             eecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----H--------
Confidence            87654321   2334699999999998    45678999999999999999999999997532110     0        


Q ss_pred             chhHHHHhhC---cccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLD---PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d---~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         .+..++.   +.+... ........+.+++.+||+.||.+|||+.+|++
T Consensus       238 ---~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 ---QLTQVVKGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCCSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHhcCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               0011111   111100 00112245778889999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.5e-40  Score=335.30  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchH------HHHHHHHHHHHHHhCC--CCCeecEEEEEEcC
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE------SSKAFCRELMIASSLH--HPNIVPLVGFCIDP  251 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~  251 (520)
                      ..++|...+.||+|+||+||+|....+++.||||++......      ....+.+|+.++++++  ||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            346899999999999999999999888999999999654211      2245668999999996  59999999998764


Q ss_pred             CCcEEEEEEecCC-CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCce
Q 010012          252 EQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIP  329 (520)
Q Consensus       252 ~~~~~LV~E~~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~v  329 (520)
                       ...++|+|++.+ ++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++.+
T Consensus       121 -~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          121 -DSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred             -CcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence             458999999976 8999999764       46899999999999999999999988   99999999999999 78999


Q ss_pred             EEeecCCccccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh
Q 010012          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       330 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      ||+|||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     .     
T Consensus       190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-----  255 (320)
T 3a99_A          190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-----  255 (320)
T ss_dssp             EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-----
T ss_pred             EEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-----
Confidence            999999998765432    234569999999999987765 6789999999999999999999964321     0     


Q ss_pred             hHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                   ...........+   ..+.+++.+||+.||.+|||+.+|++
T Consensus       256 -------------~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 -------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -------------HHCCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------------hcccccccccCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                         000111111122   34677888999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-39  Score=344.15  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=184.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.|...++||+|+||+||.+.. .+++.||||++....   .+.+.+|+.+++++ +|||||++++++.+ +..+++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEe
Confidence            4556678999999999986544 358999999986532   34677899999876 89999999998765 456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC-------------C
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-------------K  327 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~-------------~  327 (520)
                      ||. |+|.+++.............++..++.|+.||+.||+|||+.+   |+||||||+||||+.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            995 6999999864321111111244456789999999999999988   9999999999999754             4


Q ss_pred             ceEEeecCCccccCCCCCCc--ccccccccCCccCchhccc-------CCCCCcCceeeHHHHHHHHHh-CCCCcchhcc
Q 010012          328 IPKLCDFGLATWTSAPSVPF--LCKTVKGTFGYLAPEYFQH-------GKVSDKTDVYAFGVVLLELLT-GRKPIEARRL  397 (520)
Q Consensus       328 ~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~-------~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~  397 (520)
                      .+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            89999999998776533211  1234579999999999975       568999999999999999999 9999965332


Q ss_pred             ccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       398 ~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .. ..              .+....+...............+.+++.+||+.||.+|||+.+|++
T Consensus       246 ~~-~~--------------i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 RE-SN--------------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH-HH--------------HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hH-HH--------------HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11 00              0111111110011123345567889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-39  Score=339.15  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=183.9

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEE
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ...+|...++||+|+||+|+.... .+++.||||++.....   ..+.+|+.+++.+ +|||||++++++.+ ....++|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEE
Confidence            345799999999999998654333 3588999999965432   2355799999999 79999999998766 4558999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-----CCceEEee
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCD  333 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-----~~~vkL~D  333 (520)
                      ||||. |+|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.     ...+||+|
T Consensus        97 ~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99995 69999997643      34555567789999999999999988   999999999999953     33688999


Q ss_pred             cCCccccCCCCCC-cccccccccCCccCchhcc---cCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhh
Q 010012          334 FGLATWTSAPSVP-FLCKTVKGTFGYLAPEYFQ---HGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAK  408 (520)
Q Consensus       334 FGla~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~---~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~  408 (520)
                      ||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||........       .
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~  239 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------N  239 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------H
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------H
Confidence            9999876543211 1223467999999999997   4567889999999999999999 9999964322110       0


Q ss_pred             hHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...          .................+.+++.+||+.||.+|||+.+|++
T Consensus       240 ~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ILL----------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHT----------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHh----------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000          00011111112233445778999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-38  Score=352.39  Aligned_cols=240  Identities=25%  Similarity=0.350  Sum_probs=193.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecC-CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCc----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~----  254 (520)
                      .++|.+.+.||+|+||+||+|.+.. +++.||||++... .......+.+|+.++++++|||||++++++.+.+..    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999865 6889999998654 345556789999999999999999999998765442    


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .+|||||+++++|.+++.         ..++|..++.|+.||+.||.|||+.+   ||||||||+||||+.+ .+||+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred             eEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence            689999999999988764         35999999999999999999999988   9999999999999986 8999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      |+++.....      ....||+.|+|||++.++. +.++|||||||+||||++|..||..........            
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~------------  286 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------  286 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccc------------
Confidence            999876543      3456999999999987654 889999999999999999999887532211000            


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhc
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-IEEIIAILRG  466 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-m~eVl~~L~~  466 (520)
                                    ..........+.+++.+||+.||.+||+ +.++...|.+
T Consensus       287 --------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 --------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             --------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                          0000111245778889999999999995 5556666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-38  Score=335.95  Aligned_cols=249  Identities=16%  Similarity=0.189  Sum_probs=184.5

Q ss_pred             hhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHHHHHHHHHHhCCC-CC----------eecE-
Q 010012          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHH-PN----------IVPL-  244 (520)
Q Consensus       180 at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~H-pn----------Iv~l-  244 (520)
                      .+++|...++||+|+||+||+|.+..+++.||||++.....   ...+.|.+|+.+++.++| +|          ++.+ 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            44568888999999999999999988899999999874322   235678899999999987 22          1111 


Q ss_pred             ----------EEEEEcC----CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 010012          245 ----------VGFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC  310 (520)
Q Consensus       245 ----------~g~~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~  310 (520)
                                +.++...    ....+++|+++ +++|.+++............+++..++.|+.|+++||+|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                      1111111    11256677765 78999998643211112256889999999999999999999988   


Q ss_pred             eEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhc----------ccCCCCCcCceeeHHH
Q 010012          311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYF----------QHGKVSDKTDVYAFGV  380 (520)
Q Consensus       311 IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~s~ksDVwS~Gv  380 (520)
                      |+||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999999865432     234567 999999999          5556888999999999


Q ss_pred             HHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 010012          381 VLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI  460 (520)
Q Consensus       381 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eV  460 (520)
                      ++|||++|+.||.........                 ..++..    ....+   ..+.+++.+||+.||++||++.++
T Consensus       306 il~elltg~~Pf~~~~~~~~~-----------------~~~~~~----~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGS-----------------EWIFRS----CKNIP---QPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCS-----------------GGGGSS----CCCCC---HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHCCCCCCCcchhhhH-----------------HHHHhh----cccCC---HHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999765432211                 111111    11122   357778889999999999998887


Q ss_pred             HH
Q 010012          461 IA  462 (520)
Q Consensus       461 l~  462 (520)
                      ++
T Consensus       362 l~  363 (413)
T 3dzo_A          362 ME  363 (413)
T ss_dssp             TT
T ss_pred             Hh
Confidence            64

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-38  Score=352.98  Aligned_cols=264  Identities=24%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEc-----CCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCID-----PEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~~~~  255 (520)
                      ++|...+.||+|+||+||+|.+..++..||||++... .....+.+.+|+.+++.++||||+++++++..     .....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999999888999999998764 44556779999999999999999999998643     13457


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc---eEEe
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLC  332 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~---vkL~  332 (520)
                      ++||||+++|+|.+++.....    ...+++..++.|+.|++.||+|||+.+   |+||||||+|||++.++.   +||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence            899999999999999986432    246999999999999999999999988   999999999999997664   9999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH  412 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~  412 (520)
                      |||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...|......
T Consensus       167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~  238 (676)
T 3qa8_A          167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVRE  238 (676)
T ss_dssp             SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-
T ss_pred             ccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhc
Confidence            9999987654332   2446799999999999999999999999999999999999999975321     1122111111


Q ss_pred             hchhH--HHHhhCc------ccCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 010012          413 RGMAA--VEELLDP------RLKC-TSRNSAQIARVIQAAAACISSEESRRPGIEEI  460 (520)
Q Consensus       413 ~~~~~--l~~~~d~------~l~~-~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eV  460 (520)
                      .....  ..+....      .+.. ..........+.+++..||..||++|||+.++
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            10000  0000011      1110 11123345678889999999999999999763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4e-37  Score=309.34  Aligned_cols=231  Identities=23%  Similarity=0.331  Sum_probs=177.1

Q ss_pred             CCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHH-HhCCCCCeecEEEEEEc---CCCcEE
Q 010012          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA-SSLHHPNIVPLVGFCID---PEQGLF  256 (520)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~---~~~~~~  256 (520)
                      ++|... +.||+|+||.||+|....+++.||+|++...     ..+.+|+.++ +.++||||+++++++..   .....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            467776 7899999999999999888999999999643     3456788887 66799999999998764   234579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~D  333 (520)
                      +||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence            99999999999999987432     46999999999999999999999988   999999999999998   78999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ||++....                        +..++.++|||||||++|||++|+.||...........      .   
T Consensus       164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------~---  210 (299)
T 3m2w_A          164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------M---  210 (299)
T ss_dssp             CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC------S---
T ss_pred             cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH------H---
Confidence            99986432                        23467799999999999999999999975432210000      0   


Q ss_pred             chhHHHHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                          ...+.......+.. .......+.+++.+||+.||.+|||+.|+++
T Consensus       211 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ----CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                00000000000000 0011245778889999999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-37  Score=311.74  Aligned_cols=231  Identities=14%  Similarity=0.136  Sum_probs=180.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEE
Confidence            57999999999999999999998889999999997652   34457889999999999999999999998764 558999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+++++|.+++..        . .....+..|+.|++.||+|||+.+   |+||||||+||||+.++.+||+++|   
T Consensus       110 ~e~~~g~~L~~~l~~--------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             EEecCCCCHHHHHhc--------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---
Confidence            999999999999853        2 344567889999999999999988   9999999999999999999998443   


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                                         |++|       ++.++|||||||++|||++|+.||...........   ............
T Consensus       175 -------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~  225 (286)
T 3uqc_A          175 -------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQPIEP  225 (286)
T ss_dssp             -------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTSCBCCH
T ss_pred             -------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhccCCCCh
Confidence                               3333       68899999999999999999999986543221000   000000000000


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                       ..+.+      ..   ...+.+++.+||+.||.+| |+.|+++.|+...
T Consensus       226 -~~~~~------~~---~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 -ADIDR------DI---PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             -HHHCT------TS---CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             -hhccc------CC---CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence             00001      11   1346778899999999999 9999999998743

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-36  Score=310.99  Aligned_cols=242  Identities=14%  Similarity=0.184  Sum_probs=183.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhCC---------CCCeecE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLH---------HPNIVPL  244 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~---------HpnIv~l  244 (520)
                      ++|...+.||+|+||+||+|++  +++.||||++....        ....+.+.+|+.+++.++         |||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5789999999999999999998  47999999997542        223467888999988885         8888888


Q ss_pred             EEEEEc-----------------------------CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHH
Q 010012          245 VGFCID-----------------------------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG  295 (520)
Q Consensus       245 ~g~~~~-----------------------------~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~q  295 (520)
                      .+.+..                             ....+++||||+++|++.+.+..        ..+++..++.|+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHHH
Confidence            876531                             14568999999999987776643        45899999999999


Q ss_pred             HHHHHHHHH-hCCCCceEecccCCCCeEecCCC--------------------ceEEeecCCccccCCCCCCcccccccc
Q 010012          296 IAESVAYLH-NGTERCVVHRDIKPSNILLSSKK--------------------IPKLCDFGLATWTSAPSVPFLCKTVKG  354 (520)
Q Consensus       296 ia~aL~yLH-~~~~~~IiHrDLKp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~G  354 (520)
                      |+.||+||| +.+   |+||||||+||||+.++                    .+||+|||+|+.....       ...|
T Consensus       170 i~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~g  239 (336)
T 2vuw_A          170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVF  239 (336)
T ss_dssp             HHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEEC
T ss_pred             HHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEE
Confidence            999999999 888   99999999999999887                    8999999999876532       3469


Q ss_pred             cCCccCchhcccCCCCCcCceeeHHHH-HHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCH
Q 010012          355 TFGYLAPEYFQHGKVSDKTDVYAFGVV-LLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNS  433 (520)
Q Consensus       355 t~~Y~aPE~~~~~~~s~ksDVwS~Gvv-L~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  433 (520)
                      |+.|+|||++.+.. +.++||||+|++ .+++++|..||....         |.......   .+.....+.........
T Consensus       240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHYLTDK---MLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHHHHHH---HHHTCCCSSCCCSHHHH
T ss_pred             eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhHHHHh---hhhhhccCcccchhhhh
Confidence            99999999998665 889999998777 778899999986421         11111100   00000000000011112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 010012          434 AQIARVIQAAAACISSEESRRPGIEEII  461 (520)
Q Consensus       434 ~~~~~l~~la~~Cl~~dP~~RPtm~eVl  461 (520)
                      .....+.+++.+||+.|     |+.|++
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHH
Confidence            34567889999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.1e-31  Score=291.92  Aligned_cols=186  Identities=15%  Similarity=0.112  Sum_probs=131.8

Q ss_pred             EcccCceEEEEeeecCCCcEEEEEEecCcc----------hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEEE
Q 010012          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED----------KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++.|++|.+..++..-.|+.||+|++.+..          ....++|.+|+++|+++ .|+||+++++++.+ ++.+|||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLV  320 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLV  320 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEE
Confidence            466777777777666678899999996541          23346799999999999 79999999998765 5568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||++|++|.++|...       .+++..   +|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus       321 MEyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCe
Confidence            9999999999999764       456553   58999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCc
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPI  392 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf  392 (520)
                      .......  ......||++|+|||++.+ .+..++|+||+|+++++|.+|..|+
T Consensus       388 ~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          388 TTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             SCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             eCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            7654332  2345679999999999864 5678899999999999887766554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.1e-27  Score=261.11  Aligned_cols=186  Identities=19%  Similarity=0.215  Sum_probs=144.0

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ...++||+|+||+||+|...  +..+++|+.....        ....+.+.+|++++++++||||+++..++...+. .+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KR  415 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cE
Confidence            45678999999999999554  6789999864421        1123568999999999999999965555555444 58


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      |||||+++++|.+++..               +..|+.|+++||+|||+.+   |+||||||+|||++.  .+||+|||+
T Consensus       416 lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred             EEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence            99999999999999864               3479999999999999988   999999999999999  999999999


Q ss_pred             ccccCCCCCCc-----ccccccccCCccCchhccc--CCCCCcCceeeHHHHHHHHHhCCCCcc
Q 010012          337 ATWTSAPSVPF-----LCKTVKGTFGYLAPEYFQH--GKVSDKTDVYAFGVVLLELLTGRKPIE  393 (520)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~--~~~s~ksDVwS~GvvL~ELltG~~Pf~  393 (520)
                      ++.........     ......||+.|+|||++..  ..|+..+|+||..+-.++.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99875432111     1235679999999999986  568888999999999999888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.5e-24  Score=213.69  Aligned_cols=151  Identities=18%  Similarity=0.123  Sum_probs=119.9

Q ss_pred             HHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch------------------HHHHHHHHHHHHHHhCCC
Q 010012          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------------------ESSKAFCRELMIASSLHH  238 (520)
Q Consensus       177 i~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------------------~~~~~~~~E~~il~~l~H  238 (520)
                      +......|..++.||+|+||.||+|.. .+++.||||++.....                  .....+.+|+.+++.++|
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            344556777889999999999999999 6789999999964321                  135678899999999994


Q ss_pred             CCeecEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 010012          239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (520)
Q Consensus       239 pnIv~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp  318 (520)
                         +++.+++.. + ..++||||+++|+|.+ +..             .....++.|++.||.|||+.+   |+||||||
T Consensus       164 ---~~v~~~~~~-~-~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp  221 (282)
T 1zar_A          164 ---LAVPKVYAW-E-GNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQ  221 (282)
T ss_dssp             ---SSSCCEEEE-E-TTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             ---CCcCeEEec-c-ceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCH
Confidence               555554433 2 3589999999999988 421             123469999999999999988   99999999


Q ss_pred             CCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhccc
Q 010012          319 SNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH  366 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  366 (520)
                      +|||++ ++.+||+|||+|+.               +..+.|||++..
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            999999 99999999999863               345788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1.9e-20  Score=184.57  Aligned_cols=139  Identities=17%  Similarity=0.111  Sum_probs=107.0

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcE--EEEEEecCcch------------------------HHHHHHHHHHHHHHhC
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDK------------------------ESSKAFCRELMIASSL  236 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~--vAvK~l~~~~~------------------------~~~~~~~~E~~il~~l  236 (520)
                      -|...+.||+|+||.||+|....+++.  ||||++.....                        .....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367788999999999999998556888  99998754311                        1123678899999999


Q ss_pred             CCCCe--ecEEEEEEcCCCcEEEEEEecCC-C----ChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCC
Q 010012          237 HHPNI--VPLVGFCIDPEQGLFLIYKYVSG-G----SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTE  308 (520)
Q Consensus       237 ~HpnI--v~l~g~~~~~~~~~~LV~E~~~~-g----sL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~  308 (520)
                      .|+++  ..++++  .   ..+|||||+.+ |    +|.++...          .++..+..++.|++.||.||| +.+ 
T Consensus       128 ~~~~i~~p~~~~~--~---~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~g-  191 (258)
T 1zth_A          128 KEAGVSVPQPYTY--M---KNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQEAE-  191 (258)
T ss_dssp             HHTTCCCCCEEEE--E---TTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred             HhCCCCCCeEEEc--C---CCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence            88754  444432  1   25899999942 4    56555422          234567789999999999999 887 


Q ss_pred             CceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                        |+||||||+|||++.  .++|+|||+|....
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence              999999999999998  99999999997553

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=5.6e-17  Score=168.39  Aligned_cols=138  Identities=14%  Similarity=0.127  Sum_probs=99.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--------------HHH--------HHHHHHHHHHHhCCCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------ESS--------KAFCRELMIASSLHHP  239 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------------~~~--------~~~~~E~~il~~l~Hp  239 (520)
                      .-|.+++.||+|+||.||+|... +|+.||||++.....              ...        .....|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34899999999999999999986 489999998753210              000        0123466677777554


Q ss_pred             Cee--cEEEEEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 010012          240 NIV--PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (520)
Q Consensus       240 nIv--~l~g~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLK  317 (520)
                      ++.  ..+++  . .  .+|||||++|++|.++..           .  .....++.|++.+|.|||+.+   |||||||
T Consensus       174 gv~vp~p~~~--~-~--~~LVME~i~G~~L~~l~~-----------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLK  232 (397)
T 4gyi_A          174 GFPVPEPIAQ--S-R--HTIVMSLVDALPMRQVSS-----------V--PDPASLYADLIALILRLAKHG---LIHGDFN  232 (397)
T ss_dssp             TCSCCCEEEE--E-T--TEEEEECCSCEEGGGCCC-----------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             CCCCCeeeec--c-C--ceEEEEecCCccHhhhcc-----------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence            432  22222  1 2  279999999988865432           1  123468899999999999988   9999999


Q ss_pred             CCCeEecCCC----------ceEEeecCCccccC
Q 010012          318 PSNILLSSKK----------IPKLCDFGLATWTS  341 (520)
Q Consensus       318 p~NILld~~~----------~vkL~DFGla~~~~  341 (520)
                      |.||||++++          .+.|+||+-+....
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999998876          38999999776443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=1.1e-11  Score=121.03  Aligned_cols=143  Identities=17%  Similarity=0.114  Sum_probs=108.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ...|.....+|.|+.+.||++...  +..+++|+...........+.+|+.+++.+. +..+.++++++.+ .+..++||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEE
Confidence            356877788888889999999754  5789999986532122235778999998884 6678889888765 45579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG---------------------------------  306 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~---------------------------------  306 (520)
                      ||++|.+|.+.+..            ......++.+++++|..||+.                                 
T Consensus        90 e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           90 SEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             ECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999998776321            112346888999999999981                                 


Q ss_pred             -----------------------CCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          307 -----------------------TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       307 -----------------------~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                                             ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   11459999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=5.5e-11  Score=115.15  Aligned_cols=135  Identities=16%  Similarity=0.122  Sum_probs=94.8

Q ss_pred             CcccceEEc-ccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLG-RGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG-~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~~LV~  259 (520)
                      ++... .++ .|..+.||++... ++..+++|+....   ....+..|+.+++.+.+.+  +.+++++.... +..++||
T Consensus        21 ~~~~~-~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~   94 (264)
T 1nd4_A           21 GYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLL   94 (264)
T ss_dssp             TCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEE
T ss_pred             CCceE-ecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEE
Confidence            45443 444 5556999999764 4678999997654   2245678888888886544  45578776554 4579999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--------------------------------  307 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------  307 (520)
                      ||++|.+|.  ..          ...   ...++.++++.|..||+..                                
T Consensus        95 e~i~G~~l~--~~----------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           95 GEVPGQDLL--SS----------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             ECCSSEETT--TS----------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             EecCCcccC--cC----------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            999998884  21          111   1246677777777777643                                


Q ss_pred             -----------------------CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 -----------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 -----------------------~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                                             ...++|+|++|.|||++++..+.|.|||.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   1239999999999999887667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=4.7e-10  Score=114.95  Aligned_cols=143  Identities=19%  Similarity=0.236  Sum_probs=105.6

Q ss_pred             cceEEcccCceEEEEeeecCCCcEEEEEEec--Ccc-hHHHHHHHHHHHHHHhCC--CCCeecEEEEEEcCC--CcEEEE
Q 010012          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KED-KESSKAFCRELMIASSLH--HPNIVPLVGFCIDPE--QGLFLI  258 (520)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~--~~~~LV  258 (520)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+..  +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998875  4578888775  322 122346778999999887  455788888875542  236899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-------------------------------  307 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-------------------------------  307 (520)
                      |||++|..+.+...         ..++...+..++.++++.|..||...                               
T Consensus       120 me~v~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL---------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EECCCCBCCCCTTC---------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEecCCeecCCCcc---------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            99999988744211         34778888899999999999999831                               


Q ss_pred             ------------------------CCceEecccCCCCeEecCCCc--eEEeecCCccc
Q 010012          308 ------------------------ERCVVHRDIKPSNILLSSKKI--PKLCDFGLATW  339 (520)
Q Consensus       308 ------------------------~~~IiHrDLKp~NILld~~~~--vkL~DFGla~~  339 (520)
                                              ...++|+|++|.|||++.++.  +.|.||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    256999999999999997753  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.98  E-value=4e-10  Score=112.88  Aligned_cols=190  Identities=19%  Similarity=0.231  Sum_probs=122.0

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCC--eecEEEEEEcCC--CcEEEEEEe
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPN--IVPLVGFCIDPE--QGLFLIYKY  261 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~g~~~~~~--~~~~LV~E~  261 (520)
                      .+.++.|....||+..     ..+++|+....  .....+.+|+.+++.+. +..  +.+++.+.....  ...++||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4569999999999874     35888986532  34567889999998873 322  344444322222  123789999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT----------------------------------  307 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~----------------------------------  307 (520)
                      ++|.+|.....         ..++...+..++.++++.|..||...                                  
T Consensus        98 i~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           98 IKGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             CCCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             cCCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            99988865432         23667777788888888888888621                                  


Q ss_pred             ---------------------CCceEecccCCCCeEecC--CCceEEeecCCccccCCCCCC-ccc-----------ccc
Q 010012          308 ---------------------ERCVVHRDIKPSNILLSS--KKIPKLCDFGLATWTSAPSVP-FLC-----------KTV  352 (520)
Q Consensus       308 ---------------------~~~IiHrDLKp~NILld~--~~~vkL~DFGla~~~~~~~~~-~~~-----------~~~  352 (520)
                                           ...++|+|++|.|||+++  ...+.|.||+.+......... ...           ...
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence                                 245899999999999998  556889999998653221000 000           000


Q ss_pred             cccCCccC-chhcccCCCCCcCceeeHHHHHHHHHhCCCCcch
Q 010012          353 KGTFGYLA-PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEA  394 (520)
Q Consensus       353 ~Gt~~Y~a-PE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~  394 (520)
                      ....+... |+....  .....+.|++|.++|.+.+|..+|..
T Consensus       249 l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            00111122 222111  11125889999999999999988754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=6.2e-07  Score=89.89  Aligned_cols=137  Identities=20%  Similarity=0.242  Sum_probs=92.5

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC---CeecEEEEEEcCCCcEEEEEEecC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      .+.++.|....||+.     +..+++|+-.  .......+..|+.+|+.+.+.   .+.+.+.++....+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456888888999987     3568888853  234456788999999998752   355666666544555789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-------------------------------------  306 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-------------------------------------  306 (520)
                      |.+|.....         ..++...+..++.++++.|..||+.                                     
T Consensus        97 G~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           97 GQILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             SEECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             CeECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            988865321         1233333444444444444444432                                     


Q ss_pred             --------------------CCCceEecccCCCCeEecC---CCc-eEEeecCCccc
Q 010012          307 --------------------TERCVVHRDIKPSNILLSS---KKI-PKLCDFGLATW  339 (520)
Q Consensus       307 --------------------~~~~IiHrDLKp~NILld~---~~~-vkL~DFGla~~  339 (520)
                                          ....++|+|++|.|||++.   ++. +.|.||+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                2345799999999999987   455 48999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=2.9e-06  Score=82.70  Aligned_cols=135  Identities=15%  Similarity=0.133  Sum_probs=93.5

Q ss_pred             EEcccCce-EEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCcEEEEEEecCCCC
Q 010012          189 VLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (520)
Q Consensus       189 ~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~LV~E~~~~gs  266 (520)
                      .+..|..| .||+......+..+.+|+-...   ....+.+|..+|+.+. +--+.++++++.+. +..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCcc
Confidence            45556555 6999877666778999986543   3456778998888774 22366778877665 45789999999988


Q ss_pred             hhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 010012          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG----------------------------------------  306 (520)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~----------------------------------------  306 (520)
                      +.+.....           ......++.+++..|.-||..                                        
T Consensus       107 ~~~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          107 AFQVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             HHHHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             ccccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            77654321           112234555566666666641                                        


Q ss_pred             ---------------CCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          307 ---------------TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       307 ---------------~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                                     ....++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           12248999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=3.7e-06  Score=85.53  Aligned_cols=82  Identities=7%  Similarity=0.011  Sum_probs=53.2

Q ss_pred             ceEE-cccCceEEEEeeec---C---CCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCC---CCeecEEEEEEcCC-
Q 010012          187 GRVL-GRGALSFVFKGKVG---L---LRTSVAIKRLDKED---KESSKAFCRELMIASSLHH---PNIVPLVGFCIDPE-  252 (520)
Q Consensus       187 ~~~L-G~G~fG~Vy~~~~~---~---~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~H---pnIv~l~g~~~~~~-  252 (520)
                      .+.| +.|....+|+....   +   ++..+++|+.....   ......+.+|+.+++.+..   ..+.+++.++.+.. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4677 88888999988653   0   15678888765432   0011346678887777642   34677777765432 


Q ss_pred             -CcEEEEEEecCCCChh
Q 010012          253 -QGLFLIYKYVSGGSLE  268 (520)
Q Consensus       253 -~~~~LV~E~~~~gsL~  268 (520)
                       ...++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             2357999999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.07  E-value=1.2e-05  Score=83.30  Aligned_cols=76  Identities=18%  Similarity=0.097  Sum_probs=48.1

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcch-------HHHHHHHHHHHHHHhCCC--CCee-cEEEEEEcCCCcEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLHH--PNIV-PLVGFCIDPEQGLF  256 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~E~~il~~l~H--pnIv-~l~g~~~~~~~~~~  256 (520)
                      .+.||.|.++.||++.....+..|+||.......       .....+..|.++++.+..  |..+ +++.+  +.+. .+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-cE
Confidence            4679999999999997655567899998653211       112345678888877632  3444 45543  3333 47


Q ss_pred             EEEEecCCC
Q 010012          257 LIYKYVSGG  265 (520)
Q Consensus       257 LV~E~~~~g  265 (520)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.99  E-value=4.9e-05  Score=76.10  Aligned_cols=145  Identities=19%  Similarity=0.308  Sum_probs=78.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhC-----CCCCeecEE-E-EEEcCCCcEEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLV-G-FCIDPEQGLFLIYK  260 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~-g-~~~~~~~~~~LV~E  260 (520)
                      +.|+.|..+.||+....+  ..+++|+.... .   ..+..|+.++..|     ..|.++... | .+....+..++||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS--GAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETT--EEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCC--CCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456667789999987753  35899998753 2   2223344444433     234444311 0 01111344689999


Q ss_pred             ecCCCChh--------------HHhhhhccCC--CC-----CCCCCHHHHH-----------------------------
Q 010012          261 YVSGGSLE--------------RHLHEKKKGV--RG-----NSTLPWSVRY-----------------------------  290 (520)
Q Consensus       261 ~~~~gsL~--------------~~L~~~~~~~--~~-----~~~l~~~~~~-----------------------------  290 (520)
                      |++|..+.              ..+|......  ..     ...-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1222211110  00     0112343211                             


Q ss_pred             --HHHHHHHHHHHHHHh----------CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          291 --KVALGIAESVAYLHN----------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       291 --~ia~qia~aL~yLH~----------~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              011223445667763          124569999999999999888899999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.00032  Score=73.07  Aligned_cols=79  Identities=9%  Similarity=0.144  Sum_probs=46.6

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCccccCCCCCCcccccc-cccCCccCchhcccCC---CCCcCceeeHHHHHH
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV-KGTFGYLAPEYFQHGK---VSDKTDVYAFGVVLL  383 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~---~s~ksDVwS~GvvL~  383 (520)
                      ...++|+|++|.|||++.++ ++|.||+.+..-...- . ..... .-...|++|+......   -....++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45699999999999999876 9999999886432110 0 00000 0113456665543111   111234457777778


Q ss_pred             HHHhCC
Q 010012          384 ELLTGR  389 (520)
Q Consensus       384 ELltG~  389 (520)
                      +.+++.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.51  E-value=0.00057  Score=67.21  Aligned_cols=80  Identities=14%  Similarity=0.162  Sum_probs=56.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC---CCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH---PNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~g~~~~~~~~~~LV  258 (520)
                      ......+.+|.|..+.||+.... +|+.|.+|+...........|..|+..|+.|.-   --+.+++++  + .  -++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~--~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D--RTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T--TEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C--ceEE
Confidence            35666788999999999999986 488999998765443333457789988887742   124555543  2 2  2799


Q ss_pred             EEecCCCCh
Q 010012          259 YKYVSGGSL  267 (520)
Q Consensus       259 ~E~~~~gsL  267 (520)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.38  E-value=0.0022  Score=64.26  Aligned_cols=144  Identities=15%  Similarity=0.179  Sum_probs=90.5

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC---CCCeecEEEEEEcCCCcEEEEEEe
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ...+.|+.|....+|+....  +..+++|+....   ....+..|+..|+.|.   ...+.+++.++... +..++||||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEe
Confidence            34567999999999998763  567889987543   3456788888888773   35577888876553 457999999


Q ss_pred             cCCCChh--------H---Hhhhhcc-C---CC-C----------CCCCCHHHHHH---HH----------------HHH
Q 010012          262 VSGGSLE--------R---HLHEKKK-G---VR-G----------NSTLPWSVRYK---VA----------------LGI  296 (520)
Q Consensus       262 ~~~gsL~--------~---~L~~~~~-~---~~-~----------~~~l~~~~~~~---ia----------------~qi  296 (520)
                      +++..+.        +   .|+.... .   .. .          ...-+|...+.   +.                ..+
T Consensus       113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l  192 (312)
T 3jr1_A          113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI  192 (312)
T ss_dssp             CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred             ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence            9997652        1   2222111 0   00 0          01124654321   11                111


Q ss_pred             HHHH-HHHHh-CCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          297 AESV-AYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       297 a~aL-~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      +..+ ..|.. ...+.+||+|+.+.||+++.++ +.|.||.
T Consensus       193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1122 23421 2356799999999999999887 8899974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.23  E-value=0.001  Score=65.85  Aligned_cols=142  Identities=11%  Similarity=0.113  Sum_probs=73.8

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCe-ecEEEEEEcCCCcEEEEEEec-CC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYV-SG  264 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~LV~E~~-~~  264 (520)
                      .+.|+.|....+|+.      ..+.+|+........ ....+|+.+++.+....+ .+++++  +.+. -++|+||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~-~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPAT-GVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTT-CCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCC-CEEEEeecCCC
Confidence            678999999999998      348888876432111 112356666665532222 455544  3322 26899999 66


Q ss_pred             CChhHH---------------hhhhccCC-CCCCCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCC
Q 010012          265 GSLERH---------------LHEKKKGV-RGNSTLP-WSVRYKVAL--------------GIAESV----AYLHN-GTE  308 (520)
Q Consensus       265 gsL~~~---------------L~~~~~~~-~~~~~l~-~~~~~~ia~--------------qia~aL----~yLH~-~~~  308 (520)
                      .+|...               |..-.... ....... +.....+..              .+...+    ..|.. ...
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            544321               11100000 0000011 111111111              011111    12221 234


Q ss_pred             CceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ..++|+|+.|.||| ..++.+.|.||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            56999999999999 5667789999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.13  E-value=0.00096  Score=69.94  Aligned_cols=74  Identities=14%  Similarity=0.166  Sum_probs=48.3

Q ss_pred             ceEEcccCceEEEEeeecC-------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCe-ecEEEEEEcCCCcEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~LV  258 (520)
                      .+.|+.|....||++....       .+..+.+|+......  ...+..|..+++.|...++ .++++.+ .  +  .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-~--~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIF-S--G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-C--C--CEE
Confidence            3578888889999998652       246789998843211  1345578888877743333 5666653 2  2  389


Q ss_pred             EEecCCCCh
Q 010012          259 YKYVSGGSL  267 (520)
Q Consensus       259 ~E~~~~gsL  267 (520)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.12  E-value=0.0013  Score=65.33  Aligned_cols=148  Identities=16%  Similarity=0.161  Sum_probs=77.2

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEEE-----EEcCCCcEEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  259 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~-----~~~~~~~~~LV~  259 (520)
                      .+.|+.|....+|+....+ + .+++|+.....  ....+..|+.++..|....  +.+++..     +....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3557778889999987653 3 68899886521  1123445666665553111  2222211     001123468999


Q ss_pred             EecCCCChhH--------------HhhhhccCCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC--
Q 010012          260 KYVSGGSLER--------------HLHEKKKGVRGN-----STLPWSVRYK------------VALGIAESVAYLHNG--  306 (520)
Q Consensus       260 E~~~~gsL~~--------------~L~~~~~~~~~~-----~~l~~~~~~~------------ia~qia~aL~yLH~~--  306 (520)
                      +|++|..+..              .++.........     ....|...+.            +...+...++.|...  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9999865421              122211000000     0012332111            011234455666532  


Q ss_pred             --CCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          307 --TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       307 --~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                        ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              23569999999999999987666899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.96  E-value=0.0049  Score=61.63  Aligned_cols=33  Identities=27%  Similarity=0.343  Sum_probs=28.1

Q ss_pred             CCceEecccCCCCeEecCC----CceEEeecCCcccc
Q 010012          308 ERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWT  340 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~----~~vkL~DFGla~~~  340 (520)
                      ...++|+|+.+.|||++.+    +.+.|.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4569999999999999875    67999999988643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.93  E-value=0.0033  Score=66.46  Aligned_cols=75  Identities=20%  Similarity=0.151  Sum_probs=47.0

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCe-ecEEEEEEcCCCcEEEEEEecCCC
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      .+.|+.|-...+|+......+..+.+|+........ -.-.+|..++..|...++ .++++++ .  +  .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-T--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-T--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-C--C--eEEEEeeCCc
Confidence            467888888999999876434778899874432111 111478888888765445 4566654 2  2  2599999875


Q ss_pred             Ch
Q 010012          266 SL  267 (520)
Q Consensus       266 sL  267 (520)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.89  E-value=0.0097  Score=59.12  Aligned_cols=147  Identities=19%  Similarity=0.178  Sum_probs=78.3

Q ss_pred             eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCC--CeecEEEE----EEcCCCcEEEEEEe
Q 010012          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP--NIVPLVGF----CIDPEQGLFLIYKY  261 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~----~~~~~~~~~LV~E~  261 (520)
                      ..|+ |....||+.... +|+.+++|+...... ....+..|..++..+...  .+++++..    ....++..++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4677 888899998764 356799999864311 234555677776665321  13334332    00112345789999


Q ss_pred             cCCCChh-----------HH---hhhhccCC--CCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 010012          262 VSGGSLE-----------RH---LHEKKKGV--RGNSTLPWSVR----YKV---------------ALGIAESVAYLHNG  306 (520)
Q Consensus       262 ~~~gsL~-----------~~---L~~~~~~~--~~~~~l~~~~~----~~i---------------a~qia~aL~yLH~~  306 (520)
                      ++|..+.           ..   ++......  ......++...    ..+               ...+...++.+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885432           11   12111100  00112222211    000               11111223333221


Q ss_pred             ----CCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          307 ----TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       307 ----~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                          ....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                245689999999999999 4 899999988753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.82  E-value=0.0026  Score=65.59  Aligned_cols=145  Identities=16%  Similarity=0.169  Sum_probs=80.5

Q ss_pred             eEEcccCceEEEEeeecC-------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC-eecEEEEEEcCCCcEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~LV~  259 (520)
                      +.|..|-...+|++....       .+..|.+|+.... ......+.+|..+++.|.-.. ..++++++ + +   .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~-~---g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-P-E---GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-T-T---EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-C-C---ccEE
Confidence            467667788899987642       3467889886332 122345568888887774222 35566554 2 2   2899


Q ss_pred             EecCCCChhH--------------HhhhhccC-CCCCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 010012          260 KYVSGGSLER--------------HLHEKKKG-VRGNSTL--PWSVRYKVALGIAE-------------------SVAY-  302 (520)
Q Consensus       260 E~~~~gsL~~--------------~L~~~~~~-~~~~~~l--~~~~~~~ia~qia~-------------------aL~y-  302 (520)
                      ||++|..|..              .|.+-... .......  -|.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999865531              11111100 0001112  24555555443321                   2233 


Q ss_pred             ---HHhC-CCCceEecccCCCCeEecCC----CceEEeecCCcc
Q 010012          303 ---LHNG-TERCVVHRDIKPSNILLSSK----KIPKLCDFGLAT  338 (520)
Q Consensus       303 ---LH~~-~~~~IiHrDLKp~NILld~~----~~vkL~DFGla~  338 (520)
                         |... ....++|+|+.+.|||++.+    +.+.|.||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               3322 23469999999999999876    689999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.55  E-value=0.0057  Score=62.20  Aligned_cols=74  Identities=16%  Similarity=0.151  Sum_probs=42.1

Q ss_pred             eEEcccCceEEEEeeecC--------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC-eecEEEEEEcCCCcEEEE
Q 010012          188 RVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~LV  258 (520)
                      ..|+.|....+|+.....        .+..+.+|+....... ......|..+++.+...+ ..++++..   .+  ++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---NG--GRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---CC--cEE
Confidence            467778888999987653        1257888886543221 112346777777664333 34666542   22  689


Q ss_pred             EEecCCCCh
Q 010012          259 YKYVSGGSL  267 (520)
Q Consensus       259 ~E~~~~gsL  267 (520)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.99  E-value=0.036  Score=52.45  Aligned_cols=99  Identities=14%  Similarity=0.092  Sum_probs=65.5

Q ss_pred             CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCCC
Q 010012          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (520)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~~  344 (520)
                      -+|.+.|....      .+++++++|-++.|.+.+|.-+-....  -..+=+-|..|+|..+|.|.+.+ +.+.      
T Consensus        33 vSL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------   97 (229)
T 2yle_A           33 LSLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------   97 (229)
T ss_dssp             EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred             ccHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------
Confidence            47999998764      789999999999999999876521111  11233456899999999987764 2110      


Q ss_pred             CCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh
Q 010012          345 VPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT  387 (520)
Q Consensus       345 ~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt  387 (520)
                              .....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                    1222466888763 345678899999999999986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.86  E-value=0.032  Score=56.17  Aligned_cols=32  Identities=19%  Similarity=0.347  Sum_probs=27.9

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ...++|+|+.+.|||+++++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.00  E-value=0.16  Score=53.00  Aligned_cols=145  Identities=14%  Similarity=0.138  Sum_probs=81.7

Q ss_pred             ceEEcccCceEEEEeeecCC-------CcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC-eecEEEEEEcCCCcEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~-------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~LV  258 (520)
                      .+.|..|-...+|+......       +..|.+++....... .-...+|..+++.+.-.. ..++++.+ .  +  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~-~--~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF-P--E--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE-T--T--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc-C--C--CEE
Confidence            35677677889999887521       467888886543211 112236777776664222 34555432 2  2  689


Q ss_pred             EEecCCCChhH-----------------Hhhhhcc---CCC---CCCCCCHHHHHHHHHHH-------------------
Q 010012          259 YKYVSGGSLER-----------------HLHEKKK---GVR---GNSTLPWSVRYKVALGI-------------------  296 (520)
Q Consensus       259 ~E~~~~gsL~~-----------------~L~~~~~---~~~---~~~~l~~~~~~~ia~qi-------------------  296 (520)
                      |||++|..|..                 .||....   ...   ...+..|..+.++..++                   
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99999865421                 0111110   000   11222355444443222                   


Q ss_pred             HHHHHHHHh---------------------CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          297 AESVAYLHN---------------------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       297 a~aL~yLH~---------------------~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ...+..|..                     .....++|+|+.+.||+ +.++.+.|.||..|.
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            122333321                     12346999999999999 888899999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.28  E-value=0.65  Score=47.63  Aligned_cols=29  Identities=38%  Similarity=0.517  Sum_probs=24.7

Q ss_pred             ceEecccCCCCeEe------cCCCceEEeecCCcc
Q 010012          310 CVVHRDIKPSNILL------SSKKIPKLCDFGLAT  338 (520)
Q Consensus       310 ~IiHrDLKp~NILl------d~~~~vkL~DFGla~  338 (520)
                      .++|+|+.+.|||+      +++..++++||-.|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456779999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.58  E-value=0.099  Score=55.12  Aligned_cols=60  Identities=8%  Similarity=0.104  Sum_probs=16.8

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEE------EEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAI------KRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAv------K~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~  249 (520)
                      .+.||   ||.||+|.+.....+|||      |.....  ..+....|.+|..+++.++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            34565   999999999754567888      665432  2233456888999999999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	520
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-66
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 33/288 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
             + G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           I+  +G+   P+  L ++ ++  G SL  HLH  +                +A   A+ +
Sbjct: 66  ILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGM 117

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YLH    + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  ++A
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 361 PEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 417
           PE  +       S ++DVYAFG+VL EL+TG+ P          N       ++ RG   
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGY-- 226

Query: 418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
              L     K  S     + R++     C+  +   RP   +I+A + 
Sbjct: 227 ---LSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-60
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G      + + +  +++ GGSL++ L +  +       +P  +  KV++ + + + 
Sbjct: 67  VGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLT 118

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YL    +  ++HRD+KPSNIL++S+   KLCDFG++          +  +  GT  Y++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 172

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR 395
           E  Q    S ++D+++ G+ L+E+  GR PI   
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 35/283 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
                + +G+G    V  G        VA+K +  +   +++AF  E  + + L H N+V
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ Y
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L        VHRD+   N+L+S   + K+ DFGL    S+        T K    + APE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPE 170

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
             +  K S K+DV++FG++L E+ +  +               + +  L   +  VE+  
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVP-------------YPRIPLKDVVPRVEK-- 215

Query: 423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
             ++         +  V++    C   + + RP   ++   L 
Sbjct: 216 GYKMDAPDGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 65/284 (22%), Positives = 113/284 (39%), Gaps = 29/284 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           ++     +G G+     K +       +  K LD     +   +    E+ +   L HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 241 IVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  +
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT---KGTKERQYLDEEFVLRVMTQLTLA 121

Query: 300 VAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           +   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +     K   GT  
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPY 179

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 417
           Y++PE       ++K+D+++ G +L EL     P  A       +    A  I       
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIRE----- 228

Query: 418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
                    +   R S ++  +I      ++ ++  RP +EEI+
Sbjct: 229 -----GKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 9e-56
 Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 31/283 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
                   LG G    V+ G        VA+K L +    S  AF  E  +   L H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRL 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L          +++I +Y+  GSL   L            L  +    +A  IAE +A
Sbjct: 71  VRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMA 123

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           ++    ER  +HRD++ +NIL+S     K+ DFGLA      +     +  K    + AP
Sbjct: 124 FIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E   +G  + K+DV++FG++L E++T  +        G  N  +     L RG       
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQN--LERG------- 226

Query: 422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
              R+        ++ ++++    C       RP  + + ++L
Sbjct: 227 --YRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-55
 Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 29/297 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              +G+G    V++GK       VA+K     ++ S      E+     L H NI+  + 
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 247 FCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                      L+L+  Y   GSL  +L+           +      K+AL  A  +A+L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHL 116

Query: 304 HN-----GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTF 356
           H        +  + HRD+K  NIL+       + D GLA    +   ++        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 357 GYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGE--ENLVLWAK 408
            Y+APE         H +   + D+YA G+V  E+                  +LV    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            +        E+ L P +    ++   +  + +    C  +  + R     I   L 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-55
 Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 34/285 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+         L+++ ++ +GG+++  + E ++       L  S    V     +++ Y
Sbjct: 73  KLLDAFYYENN-LWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNY 125

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH   +  ++HRD+K  NIL +     KL DFG++   +         +  GT  ++APE
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPE 180

Query: 363 YFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 417
                         K DV++ G+ L+E+     P            +  ++P        
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232

Query: 418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
                 P L   SR S+     ++    C+      R    +++ 
Sbjct: 233 ------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 6e-55
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 38/282 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  K                   +A +
Sbjct: 67  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYITELANA 118

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           ++Y H    + V+HRDIKP N+LL S    K+ DFG +    +     LC    GT  YL
Sbjct: 119 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYL 171

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
            PE  +     +K D+++ GV+  E L G+ P EA   Q     +   +      +    
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---- 227

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
                        +     +I      +    S+RP + E++
Sbjct: 228 -------------TEGARDLIS---RLLKHNPSQRPMLREVL 253

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-54
 Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 30/280 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 241
           ++   + LG GA   V      +   +VA+K +D +   +  +   +E+ I   L+H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G   +     +L  +Y SGG L   +            +P     +    +   V 
Sbjct: 66  VKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGVV 117

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 362 EYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           E  +  +      DV++ G+VL  +L G  P +      +E      K            
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------- 223

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
                L    +  +    ++      +    S R  I +I
Sbjct: 224 ---TYLNPWKKIDSAPLALLH---KILVENPSARITIPDI 257

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 6e-54
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 36/281 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
              +GRG+   V+KG        VA   L      K   + F  E  +   L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
                   +G   + L+ + ++ G+L+ +L   K        +   V       I + + 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQ 126

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +LH  T   ++HRD+K  NI ++      K+ D GLAT   A       K V GT  ++A
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA 181

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           PE ++  K  +  DVYAFG+ +LE+ T   P         +N     + +          
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSG------- 228

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
                         ++  +I+    CI   +  R  I++++
Sbjct: 229 --VKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 9e-53
 Identities = 57/279 (20%), Positives = 113/279 (40%), Gaps = 31/279 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             +   +  ++ L+++ +Y++GGSL   + E                  V     +++ +
Sbjct: 81  NYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH      V+HRDIK  NILL      KL DFG     +         T+ GT  ++APE
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
                    K D+++ G++ +E++ G  P                     R +  +    
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------------RALYLIATNG 232

Query: 423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
            P L+   + SA     +     C+  +  +R   +E++
Sbjct: 233 TPELQNPEKLSAIFRDFLN---RCLDMDVEKRGSAKELL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 23/258 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++        E  +   +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +   G  +      +L+ +Y  G + +     KK        L       V  G  + +
Sbjct: 77  TIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAVTHGALQGL 128

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           AYLH      ++HRD+K  NILLS   + KL DFG A+  +         +  GT  ++A
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMA 179

Query: 361 PEYFQ---HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA 417
           PE       G+   K DV++ G+  +EL   + P+           +   +    +    
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239

Query: 418 VEELLDPRLKCTSRNSAQ 435
            E   +    C  +    
Sbjct: 240 SEYFRNFVDSCLQKIPQD 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 3e-52
 Identities = 71/308 (23%), Positives = 131/308 (42%), Gaps = 44/308 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSL 236
           N   G+VLG GA   V      G+ +T     VA+K L ++ D    +A   EL + + L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----------------GVR 279
             H NIV L+G C      ++LI++Y   G L  +L  K++                   
Sbjct: 98  GSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
             + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQG 399
             + S   +    +    ++APE    G  + K+DV+++G++L E+ +           G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----YPG 269

Query: 400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 459
                 + K ++  G          ++      + +I  ++Q   +C + +  +RP    
Sbjct: 270 IPVDANFYK-LIQNG---------FKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPN 316

Query: 460 IIAILRGE 467
           + + L  +
Sbjct: 317 LTSFLGCQ 324

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-52
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 31/283 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
             +  + +G G    V  G   L +  VAIK + +    S + F  E  +   L HP +V
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G C++    + L+++++  G L  +L  +                 + L + E +AY
Sbjct: 64  QLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           L    E CV+HRD+   N L+   ++ K+ DFG+  +             K    + +PE
Sbjct: 117 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPE 172

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
            F   + S K+DV++FGV++ E+ +  K     R   E          +   ++    L 
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------VVEDISTGFRLY 222

Query: 423 DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
            PRL      S  + +++     C       RP    ++  L 
Sbjct: 223 KPRLA-----STHVYQIMN---HCWKERPEDRPAFSRLLRQLA 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 6e-52
 Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 39/304 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCRELMIASS 235
           +  S G+ LG GA   V +     L  S     VA+K L      +  +A   EL + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST----------- 283
           L +H NIV L+G C        +I +Y   G L   L  K+     + T           
Sbjct: 83  LGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L        +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
           S   +    +    ++APE   +   + ++DV+++G+ L EL +               +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-----PV 253

Query: 404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAI 463
                 ++  G          R+       A++  +++    C  ++  +RP  ++I+ +
Sbjct: 254 DSKFYKMIKEG---------FRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQL 301

Query: 464 LRGE 467
           +  +
Sbjct: 302 IEKQ 305

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-52
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 34/295 (11%)

Query: 176 EILAATHNFSKGRV-LGRGALSFVFKGKVGLLRTS--VAIKRLDKE-DKESSKAFCRELM 231
           ++     N     + LG G    V +G   + +    VAIK L +  +K  ++   RE  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I   L +P IV L+G C    + L L+ +   GG L + L  K++       +P S   +
Sbjct: 62  IMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAE 113

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP-SVPFLCK 350
           +   ++  + YL     +  VHRD+   N+LL ++   K+ DFGL+    A  S      
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 351 TVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI 410
             K    + APE     K S ++DV+++GV + E L+  +       +  +   + A   
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAF-- 224

Query: 411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           + +G          R++C      ++  ++     C   +   RP    +   +R
Sbjct: 225 IEQG---------KRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-51
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 34/281 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K     +       RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L     D E+ L+    Y   G L +++ +             +        I  +
Sbjct: 69  FFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGS-------FDETCTRFYTAEIVSA 120

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           +PE          +D++A G ++ +L+ G  P  A                        +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------YLIFQ 220

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
           +++        +   +   +++     +  + ++R G EE+
Sbjct: 221 KIIKLEYDFPEKFFPKARDLVE---KLLVLDATKRLGCEEM 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-51
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 31/283 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            +      LG+G    V+ G        VAIK L      S +AF +E  +   L H  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L     +    ++++ +Y+S GSL   L  +                 +A  IA  +A
Sbjct: 75  VQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMA 127

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           Y+        VHRD++ +NIL+    + K+ DFGLA      +     +  K    + AP
Sbjct: 128 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAP 183

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E   +G+ + K+DV++FG++L EL T  +      +  E              +  VE  
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------------LDQVER- 229

Query: 422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
              R+ C       +  ++     C   E   RP  E + A L
Sbjct: 230 -GYRMPCPPECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (443), Expect = 3e-51
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 173 SYGEILAATHNFSK---------GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-D 219
           ++ +   A   F+K          +V+G G    V  G +   G     VAIK L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 220 KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           ++  + F  E  I     HPN++ L G        + +I +++  GSL+  L +      
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDG--- 123

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                       +  GIA  + YL +      VHRD+   NIL++S  + K+ DFGL+ +
Sbjct: 124 ---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 340 -TSAPSVPFLCKTV--KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEAR 395
                S P     +  K    + APE  Q+ K +  +DV+++G+V+ E+++ G +P    
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 396 RLQGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP 455
             Q   N +                  D RL       + + +++     C   + + RP
Sbjct: 238 TNQDVINAIEQ----------------DYRLPPPMDCPSALHQLML---DCWQKDRNHRP 278

Query: 456 GIEEIIAILR 465
              +I+  L 
Sbjct: 279 KFGQIVNTLD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-51
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 37/286 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           + +  + LG G    V  GK    R    VAIK + +    S   F  E  +  +L H  
Sbjct: 5   DLTFLKELGTGQFGVVKYGK---WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEK 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L G C      +F+I +Y++ G L  +L E +               ++   + E++
Sbjct: 61  LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAM 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            YL +   +  +HRD+   N L++ + + K+ DFGL+ +             K    +  
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSP 169

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           PE   + K S K+D++AFGV++ E+ + G+ P E          +               
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                RL      S ++  ++    +C   +   RP  + +++ + 
Sbjct: 219 -----RLYRPHLASEKVYTIMY---SCWHEKADERPTFKILLSNIL 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (444), Expect = 8e-51
 Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 34/295 (11%)

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           + + +  +L    ++     LG GA   V +        + A K +    +   +   +E
Sbjct: 17  VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
           +   S L HP +V L     D  + + +IY+++SGG L   + ++         +     
Sbjct: 74  IQTMSVLRHPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNK------MSEDEA 126

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSVPF 347
            +    + + + ++H   E   VH D+KP NI+ ++K+    KL DFGL           
Sbjct: 127 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181

Query: 348 LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA 407
             K   GT  + APE  +   V   TD+++ GV+   LL+G  P                
Sbjct: 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------- 231

Query: 408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
              L    +    + D      S +     R        + ++ + R  I + + 
Sbjct: 232 -ETLRNVKSCDWNMDDSAFSGISEDGKDFIR------KLLLADPNTRMTIHQALE 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-50
 Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 33/284 (11%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + + + +        
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKG----- 142

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT--VKGTFGYLA 360
           +     +  VHRD+   N +L  K   K+ DFGLA          +      K    ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
            E  Q  K + K+DV++FGV+L EL+T   P        + N       +L         
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQ-------- 249

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
               RL         +  V+     C   +   RP   E+++ +
Sbjct: 250 --GRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-50
 Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 39/285 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS--VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVP 243
           + LG G    V KG   + +    VA+K L  E  D         E  +   L +P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           ++G C        L+ +    G L ++L + +        +      ++   ++  + YL
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRH-------VKDKNIIELVHQVSMGMKYL 123

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFGYLAPE 362
                   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 363 YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEELL 422
              + K S K+DV++FGV++ E  +  +                  P      + V  +L
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAML 223

Query: 423 --DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
               R+ C +    ++  ++     C + +   RPG   +   LR
Sbjct: 224 EKGERMGCPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (434), Expect = 5e-50
 Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 29/284 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +    LG G    V++G       +VA+K L + D    + F +E  +   + HPN+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+G C       ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ 
Sbjct: 76  VQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAME 129

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAP 361
           YL    ++  +HRD+   N L+    + K+ DFGL+   +  +        K    + AP
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAP 185

Query: 362 EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL 421
           E   + K S K+DV+AFGV+L E+ T                     P     ++ V EL
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYEL 228

Query: 422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           L+   +   R      +V +   AC     S RP   EI     
Sbjct: 229 LEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 5e-49
 Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 47/308 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASS 235
           +N    R +G GA   VF+ +   L      T VA+K L +E   +    F RE  + + 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----------------GV 278
             +PNIV L+G C   +  + L+++Y++ G L   L                        
Sbjct: 73  FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            G   L  + +  +A  +A  +AYL    ER  VHRD+   N L+    + K+ DFGL+ 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188

Query: 339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQ 398
              +               ++ PE   + + + ++DV+A+GVVL E+ +           
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 399 GEENLVLWAKPILHRGMAAVEELLDP-RLKCTSRNSAQIARVIQAAAACISSEESRRPGI 457
                              +  + D   L C      ++  +++    C S   + RP  
Sbjct: 249 ----------------EEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSF 289

Query: 458 EEIIAILR 465
             I  IL+
Sbjct: 290 CSIHRILQ 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 7e-49
 Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 34/291 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSL 236
              ++ +V+G G    V+KG +    G     VAIK L     E  +  F  E  I    
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NI+ L G     +  + +I +Y+  G+L++ L EK                 +  GI
Sbjct: 67  SHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGI 119

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGT 355
           A  + YL N      VHRD+   NIL++S  + K+ DFGL+      P   +     K  
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 415
             + APE   + K +  +DV++FG+V+ E++T  +                  P      
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------PYWELSN 219

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG 466
             V + ++   +         + + Q    C   E +RRP   +I++IL  
Sbjct: 220 HEVMKAINDGFR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-48
 Identities = 68/320 (21%), Positives = 123/320 (38%), Gaps = 43/320 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-H 237
           ++     V+G G    V K   K   LR   AIKR+ +   K+  + F  EL +   L H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK---------KKGVRGNSTLPWSV 288
           HPNI+ L+G C      L+L  +Y   G+L   L +                 STL    
Sbjct: 70  HPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
               A  +A  + YL    ++  +HRD+   NIL+    + K+ DFGL+           
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182

Query: 349 CKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK 408
               +    ++A E   +   +  +DV+++GV+L E+++                    +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYE 237

Query: 409 PILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA----IL 464
            +              RL+       ++  +++    C   +   RP   +I+     +L
Sbjct: 238 KLPQ----------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRML 284

Query: 465 RGEEELIYCT-WKKHNFSGI 483
              +  +  T ++K  ++GI
Sbjct: 285 EERKTYVNTTLYEKFTYAGI 304

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  168 bits (426), Expect = 3e-48
 Identities = 63/282 (22%), Positives = 104/282 (36%), Gaps = 31/282 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LG GA   V +            K ++            E+ I + LHHP ++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L     D  + + LI +++SGG L   +  +         +  +          E + +
Sbjct: 90  NLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYK------MSEAEVINYMRQACEGLKH 142

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           +H   E  +VH DIKP NI+  +KK    K+ DFGLAT  +      + K    T  + A
Sbjct: 143 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAA 196

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           PE      V   TD++A GV+   LL+G  P       GE++L                 
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQN--------VKRC 243

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
             +      S  S +    I+     +  E  +R  + + + 
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 9e-48
 Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 38/288 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +               + IA+
Sbjct: 71  PHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNI------GSQYLLNWCVQIAK 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 418
           +A E   H   + ++DV+++GV + EL+T                     P      + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK-----------------PYDGIPASEI 222

Query: 419 EELLD--PRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAIL 464
             +L+   RL      +  +  ++     C   +   RP   E+I   
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-47
 Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 35/290 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSL 236
           +      LG G+   V +G+         SVA+K L  +     E+   F RE+    SL
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H N++ L G  + P   + ++ +    GSL   L + +               + A+ +
Sbjct: 69  DHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQV 120

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGT 355
           AE + YL     +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 415
           F + APE  +    S  +D + FGV L E+ T  +           N       I   G 
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEG- 231

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                    RL         I  V+     C + +   RP    +   L 
Sbjct: 232 --------ERLPRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 8e-47
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 38/295 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 241 IVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +              +++ +YV G +L   +H +         +      +V     
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADAC 121

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-LCKTVKGTF 356
           +++ + H   +  ++HRD+KP+NI++S+    K+ DFG+A   +           V GT 
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 357 GYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA 416
            YL+PE  +   V  ++DVY+ G VL E+LTG  P             +   PI      
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------ 232

Query: 417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIAILRG 466
                  P        SA +  V+      ++     R         +++ +  G
Sbjct: 233 -------PPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHNG 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 5e-46
 Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 36/300 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCREL-MIAS 234
                G+ LGRGA   V +     +  +     VA+K L +    S  +A   EL ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLP 285
             HH N+V L+G C  P   L +I ++   G+L  +L  K+                 L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
                  +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA        
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 346 PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL 405
                  +    ++APE       + ++DV++FGV+L E+ +               +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDE 244

Query: 406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                L  G          R++     + ++ + +     C   E S+RP   E++  L 
Sbjct: 245 EFCRRLKEG---------TRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-45
 Identities = 63/257 (24%), Positives = 106/257 (41%), Gaps = 19/257 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +F   ++LG+G+   VF  +        AIK L K+    D +       + +++ +  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  +       E  LF + +Y++GG L  H+    K          S     A  I  
Sbjct: 63  PFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHK-------FDLSRATFYAAEIIL 114

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGY 358
            + +LH    + +V+RD+K  NILL      K+ DFG+              T  GT  Y
Sbjct: 115 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 169

Query: 359 LAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV 418
           +APE     K +   D ++FGV+L E+L G+ P   +  +   + +    P   R +   
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE-- 227

Query: 419 EELLDPRLKCTSRNSAQ 435
           +E  D  +K   R   +
Sbjct: 228 KEAKDLLVKLFVREPEK 244

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 36/289 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
                GR +G G    V +G          +VAIK       +S +  F +E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP+IV L+G   +    +++I +  + G L   L  +K       +L  +     A  ++
Sbjct: 67  HPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLS 118

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            ++AYL     +  VHRDI   N+L+SS    KL DFGL+ +    S  +     K    
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174

Query: 358 YLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMA 416
           ++APE     + +  +DV+ FGV + E+L  G KP +  +       +   +        
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226

Query: 417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
                   RL         +  ++     C + + SRRP   E+ A L 
Sbjct: 227 --------RLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-44
 Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 31/297 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASS 235
              +  R LG+G+   V++G    +      T VAIK +++      +  F  E  +   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPWSVRYKV 292
            +  ++V L+G     +    +I + ++ G L+ +L   +  +  N        S   ++
Sbjct: 80  FNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A  IA+ +AYL+       VHRD+   N +++     K+ DFG+                
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
                +++PE  + G  +  +DV++FGVVL E+ T  +       QG  N  +    ++ 
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQVLRF-VME 250

Query: 413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE 469
                        L         +  +++    C       RP   EII+ ++ E E
Sbjct: 251 ----------GGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 2e-44
 Identities = 72/283 (25%), Positives = 109/283 (38%), Gaps = 34/283 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           +    VLG GA S V   +    +  VAIK + K+  E  +     E+ +   + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L          L+LI + VSGG L   + EK                ++   + ++V Y
Sbjct: 71  ALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGF-------YTERDASRLIFQVLDAVKY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           LH   +  +VHRD+KP N+L  S        + DFGL+      SV     T  GT GY+
Sbjct: 123 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE       S   D ++ GV+   LL G  P                  +  + + A  
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----------KLFEQILKAEY 226

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
           E   P     S ++    R        +  +  +R   E+ + 
Sbjct: 227 EFDSPYWDDISDSAKDFIR------HLMEKDPEKRFTCEQALQ 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 3e-44
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 21/256 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F   R LG G+   V   +        A+K L KE     +  +    E ++ S + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            I+ + G   D +Q +F+I  Y+ GG L   L + ++        P  V    A  +  +
Sbjct: 65  FIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRF-------PNPVAKFYAAEVCLA 116

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    + +++RD+KP NILL      K+ DFG A +     VP +  T+ GT  Y+
Sbjct: 117 LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPDYI 168

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE       +   D ++FG+++ E+L G  P            +L A+          E
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN--E 226

Query: 420 ELLDPRLKCTSRNSAQ 435
           ++ D   +  +R+ +Q
Sbjct: 227 DVKDLLSRLITRDLSQ 242

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 5e-44
 Identities = 70/296 (23%), Positives = 110/296 (37%), Gaps = 46/296 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D          E +E  +A  +E+ I 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L           FL++  +  G L  +L EK         L      K+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVT-------LSEKETRKI 115

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + E +  LH   +  +VHRD+KP NILL      KL DFG +            + V
Sbjct: 116 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREV 169

Query: 353 KGTFGYLAPEYFQ------HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW 406
            GT  YLAPE  +      H     + D+++ GV++  LL G  P   R+      +++ 
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229

Query: 407 AKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
                        +   P     S     +          +  +  +R   EE +A
Sbjct: 230 GNY----------QFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-44
 Identities = 53/280 (18%), Positives = 100/280 (35%), Gaps = 32/280 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LGRG    V +      + +   K +  +  +      +E+ I +   H NI+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNIL 64

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L       E+ L +I++++SG  +   ++           L           + E++ +
Sbjct: 65  HLHESFESMEE-LVMIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQF 117

Query: 303 LHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           LH      + H DI+P NI+  +++    K+ +FG A            + +     Y A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE 420
           PE  QH  VS  TD+++ G ++  LL+G  P  A   Q     ++ A+            
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------- 220

Query: 421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEI 460
                 +     S +    +      +  E   R    E 
Sbjct: 221 --TFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEA 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 70/305 (22%), Positives = 118/305 (38%), Gaps = 49/305 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSL 236
           +FS  R++GRG    V+  +        A+K LDK      + +  +      L + S+ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
             P IV +      P++ L  I   ++GG L  HL +             +     A  I
Sbjct: 65  DCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEI 116

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              + ++H    R VV+RD+KP+NILL      ++ D GLA   S            GT 
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 169

Query: 357 GYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 415
           GY+APE  Q G   D   D ++ G +L +LL G  P    + + +  +            
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------- 221

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEELIYCTW 475
                 L   ++     S ++  +++     +  + +RR G     A     +E+     
Sbjct: 222 ------LTMAVELPDSFSPELRSLLE---GLLQRDVNRRLGCLGRGA-----QEV----- 262

Query: 476 KKHNF 480
           K+  F
Sbjct: 263 KESPF 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 8e-43
 Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKE-DKESSKAFCRELMIA 233
                G+ LG GA   V   +   L        T VA+K L  +  ++       E+ + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 234 SSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNST 283
             +  H NI+ L+G C      L++I +Y S G+L  +L  ++                 
Sbjct: 73  KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L        A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA      
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 344 SVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENL 403
                    +    ++APE       + ++DV++FGV+L E+ T                
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------ 236

Query: 404 VLWAKPILHRGMAAVEELL--DPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
                P     +  + +LL    R+   S  + ++  +++    C  +  S+RP  ++++
Sbjct: 237 -----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLV 288

Query: 462 AIL 464
             L
Sbjct: 289 EDL 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-42
 Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 35/282 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
               +   G   L ++ + + GG L   + +     RG+         ++   I E++ Y
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQY 126

Query: 303 LHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           LH      + HRD+KP N+L +S     I KL DFG A  T++ +      T   T  Y+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYV 180

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE     K     D+++ GV++  LL G  P  +       + +  +  +  R      
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS------NHGLAISPGMKTRIRMGQY 234

Query: 420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEII 461
           E  +P     S     + R        + +E ++R  I E +
Sbjct: 235 EFPNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFM 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 9e-41
 Identities = 70/289 (24%), Positives = 111/289 (38%), Gaps = 40/289 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS      +   RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     +    + LI + V+GG L   L EK+        L      +    I 
Sbjct: 72  HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKES-------LTEEEATEFLKQIL 123

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVK 353
             V YLH      + H D+KP NI+L  + +P    K+ DFGLA      +     K + 
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIF 177

Query: 354 GTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 413
           GT  ++APE   +  +  + D+++ GV+   LL+G  P      Q            L  
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------ETLAN 227

Query: 414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
             A   E  D     TS  +    R        +  +  +R  I++ + 
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 50/290 (17%), Positives = 92/290 (31%), Gaps = 32/290 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +  GR +G G+   ++ G        VAIK    + K        E  I   +     +P
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            + +C        ++ + +     +      +K               +A  +   + Y+
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-------FSLKTVLLLADQMISRIEYI 119

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLC---DFGLATW-----TSAPSVPFLCKTVKGT 355
           H    +  +HRD+KP N L+   K   L    DFGLA       T         K + GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM 415
             Y +       + S + D+ + G VL+    G  P +  +   +               
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----- 231

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
               ++  P         ++ A  +     C S     +P    +  + R
Sbjct: 232 ----KMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 17/223 (7%)

Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 234 SSLHHPNIVPLVGFCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
               H NI+ +      P   +     +  ++ G  L + L  +         L      
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------LSNDHIC 112

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLC 349
                I   + Y+H      V+HRD+KPSN+LL++    K+CDFGLA             
Sbjct: 113 YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169

Query: 350 KTVKGTFGYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
                T  Y APE   + K      D+++ G +L E+L+ R  
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 35/303 (11%)

Query: 180 ATHNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL 236
           A   +     +G GA   VFK + +      VA+KR+  +  ++    +  RE+ +   L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 237 ---HHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               HPN+V L   C          L L++++V            + G      +P    
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG------VPTETI 118

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA   S        
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---L 172

Query: 350 KTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQG 399
            +V  T  Y APE       +   D+++ G +  E+   +                 + G
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 400 EENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEE 459
                 W + +     A   +   P  K  +        ++     C++   ++R     
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYS 289

Query: 460 IIA 462
            ++
Sbjct: 290 ALS 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 72/296 (24%), Positives = 108/296 (36%), Gaps = 30/296 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +       REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 243 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLF 132

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            S+AY+H      + HRDIKP N+LL     + KLCDFG A             +   + 
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSR 186

Query: 357 GYLAP-EYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWA-----KPI 410
            Y AP   F     +   DV++ G VL ELL G+          +   ++       +  
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISS----EESRRPGIEEIIA 462
           +        E   P++K          R    A A  S       + R    E  A
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-39
 Identities = 57/289 (19%), Positives = 107/289 (37%), Gaps = 50/289 (17%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLH 237
           +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 238 --HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
                ++ L+ +   P+    LI +             ++        L   +       
Sbjct: 66  SGFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGA------LQEELARSFFWQ 118

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           + E+V + H      V+HRDIK  NIL+  ++   KL DFG                  G
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDG 171

Query: 355 TFGYLAPEYFQHGKVSDK-TDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR 413
           T  Y  PE+ ++ +   +   V++ G++L +++ G  P E                    
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------ 213

Query: 414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
                EE++  ++    R S++   +I+    C++   S RP  EEI  
Sbjct: 214 -----EEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (357), Expect = 4e-39
 Identities = 48/293 (16%), Positives = 91/293 (31%), Gaps = 34/293 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           P V +         L+   +     +      +K                A  +   V  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-------FSVKTVAMAAKQMLARVQS 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATW-----TSAPSVPFLCKTV 352
           +H   E+ +V+RDIKP N L+            + DFG+  +     T         K +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 353 KGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
            GT  Y++       + S + D+ A G V +  L G  P +  +           + I  
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK---AATNKQKYERIGE 230

Query: 413 RGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR 465
           +  +       P  +  +    +  + +       +      P  + +  +  
Sbjct: 231 KKQS------TPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-38
 Identities = 61/292 (20%), Positives = 117/292 (40%), Gaps = 24/292 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+       + L+L+++++     +        G      +P  +       + + +
Sbjct: 63  IVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG------IPLPLIKSYLFQLLQGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           A+ H      V+HRD+KP N+L++++   KL DFGLA     P           T  Y A
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRA 170

Query: 361 PE-YFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----PILHRGM 415
           PE        S   D+++ G +  E++T R          +   +         ++  G+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAA-----ACISSEESRRPGIEEIIA 462
            ++ +      K   ++ +++   +           +  + ++R   +  +A
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-37
 Identities = 59/292 (20%), Positives = 96/292 (32%), Gaps = 33/292 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHHPNIV 242
             LG G  + V+K +       VAIK++    +  +K        RE+ +   L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+         + L++ ++                     L  S      L   + + Y
Sbjct: 64  GLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQGLEY 115

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPE 362
           LH   +  ++HRD+KP+N+LL    + KL DFGLA    +P           T  Y APE
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPE 170

Query: 363 YFQHGKVSD-KTDVYAFGVVLLELLTGRKPIEAR----------RLQGEENLVLWAKPIL 411
                ++     D++A G +L ELL     +                G      W     
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 412 HRGMAAVEELLDPRLKCTSRN-SAQIARVIQAAAACISSEESRRPGIEEIIA 462
                  +      L          +  +IQ            R    + + 
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-37
 Identities = 60/256 (23%), Positives = 97/256 (37%), Gaps = 18/256 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F   ++LG+G    V   +        A+K L KE    K+       E  +  +  HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L       ++ L  + +Y +GG L  HL  ++                    I  +
Sbjct: 66  FLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
           + YLH    R VV+RDIK  N++L      K+ DFGL     +           GT  YL
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE  +        D +  GVV+ E++ GR P   +  +    L+L  +    R ++   
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS--P 230

Query: 420 ELLDPRLKCTSRNSAQ 435
           E          ++  Q
Sbjct: 231 EAKSLLAGLLKKDPKQ 246

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 8e-37
 Identities = 56/304 (18%), Positives = 108/304 (35%), Gaps = 34/304 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            + K   +G+G    VFK +       VA+K++  E   +       RE+ I   L H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 241 IVPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           +V L+  C          +  ++L++ +          +   K          S   +V 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------FTLSEIKRVM 123

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKT 351
             +      L+      ++HRD+K +N+L++   + KL DFGLA   S    S P     
Sbjct: 124 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 352 VKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQGE 400
              T  Y  PE     +      D++  G ++ E+ T    ++            +L G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 401 ENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIA--RVIQAAAACISSEESRRPGIE 458
               +W     +     +E +   + K   R  A +     +      +  + ++R   +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 459 EIIA 462
           + + 
Sbjct: 301 DALN 304

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 9e-37
 Identities = 57/256 (22%), Positives = 98/256 (38%), Gaps = 21/256 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
            F + + LG G+   V   K        A+K LDK+     +  +    E  I  +++ P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V L     D    L+++ +YV+GG +  HL    +                A  I  +
Sbjct: 102 FLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGR-------FSEPHARFYAAQIVLT 153

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
             YLH      +++RD+KP N+L+  +   ++ DFG A             T+ GT   L
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEAL 205

Query: 360 APEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE 419
           APE       +   D +A GV++ E+  G  P  A +       ++  K       +   
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS--S 263

Query: 420 ELLDPRLKCTSRNSAQ 435
           +L D        +  +
Sbjct: 264 DLKDLLRNLLQVDLTK 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (333), Expect = 1e-35
 Identities = 56/294 (19%), Positives = 104/294 (35%), Gaps = 30/294 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +     +G G    V+K +     T  A+K  RL+KED+       RE+ I   L H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       ++ L L+++++     +     +         L         L +   +
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGI 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
           AY H   +R V+HRD+KP N+L++ +   K+ DFGLA     P   +    +   +    
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAP 169

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEAR----------RLQGEENLVLWAKPI 410
                  K S   D+++ G +  E++ G                 R+ G  N   W    
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 411 LHRGMAAVEELLDPRL--KCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA 462
                     + +P                ++      +  + ++R   ++ + 
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 1e-34
 Identities = 56/292 (19%), Positives = 100/292 (34%), Gaps = 24/292 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            + K   +G G    VFK K       VA+KR+  +  D+    +  RE+ +   L H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       ++   +                KK     N  L   +       + + +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC--------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA 360
            + H+   R V+HRD+KP N+L++     KL +FGLA     P   +    V   +    
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPP 170

Query: 361 PEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR-----LQGEENLVLWAKPILHRGM 415
              F     S   D+++ G +  EL    +P+         L+    L+          M
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 416 AAVEELLDPRLKCTSRNSAQIARVIQAAA-----ACISSEESRRPGIEEIIA 462
             + +     +   + +   +   + A         +     +R   EE + 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 7e-33
 Identities = 46/214 (21%), Positives = 87/214 (40%), Gaps = 23/214 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 241
           ++   R LGRG  S VF+         V +K L    K+      RE+ I  +L   PNI
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPNI 92

Query: 242 VPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           + L     DP  +   L++++V+    ++             TL           I +++
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKAL 142

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYL 359
            Y H      ++HRD+KP N+++  + +  +L D+GLA +               +  + 
Sbjct: 143 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFK 196

Query: 360 APEYFQ-HGKVSDKTDVYAFGVVLLELLTGRKPI 392
            PE    +       D+++ G +L  ++  ++P 
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-32
 Identities = 43/217 (19%), Positives = 87/217 (40%), Gaps = 23/217 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +   + +G GA   V     G     VAIK+L +    +  +K   REL +   + H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 240 NIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           N++ L+      E        +L+  ++  G+    L + +K       L       +  
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-------LGEDRIQFLVY 128

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            + + + Y+H      ++HRD+KP N+ ++     K+ DFGLA    +     +   V  
Sbjct: 129 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVT 181

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
            +           + +   D+++ G ++ E++TG+  
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-31
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 20/218 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDK----EDKESSKAFCRELMIASS 235
           NF   +VLG GA   VF  +      +    A+K L K    +  ++++    E  +   
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    E  L LI  Y++GG L  HL ++++                   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVGE 137

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           I  ++ +LH   +  +++RDIK  NILL S     L DFGL+    A           GT
Sbjct: 138 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGT 193

Query: 356 FGYLAPEYFQHGKVSD--KTDVYAFGVVLLELLTGRKP 391
             Y+AP+  + G        D ++ GV++ ELLTG  P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 23/216 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            +     +G GA   V           VA+K+L +       +K   REL +   + H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 241 IVPLVGFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           ++ L+          E     +  ++ G  L   +  +K        L       +   I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--------LTDDHVQFLIYQI 130

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
              + Y+H      ++HRD+KPSN+ ++     K+ DFGLA  T              T 
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATR 182

Query: 357 GYLAPEYFQHGKVSD-KTDVYAFGVVLLELLTGRKP 391
            Y APE   +    +   D+++ G ++ ELLTGR  
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 8e-31
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 23/216 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            +   + +G GA   V      +L  +VAIK+L +   ++  +K   REL++   ++H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 241 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           I+ L+      +     Q ++L+ + +     +    E                  +   
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----------DHERMSYLLYQ 127

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +   + +LH      ++HRD+KPSNI++ S    K+ DFGLA         F+      T
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVT 181

Query: 356 FGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKP 391
             Y APE        +  D+++ G ++ E++  +  
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (288), Expect = 5e-29
 Identities = 42/238 (17%), Positives = 82/238 (34%), Gaps = 12/238 (5%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +   R LG G  S V+  K  +  T VA+K +   DK  ++A   E+ +   ++  +   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--------RGNSTLPWSVRYKVALG 295
                 +    L   + +     +   +  +  G           +  +P     +++  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKTVKG 354
           +   + Y+H      ++H DIKP N+L+     P  L    +A   +A            
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 355 TFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILH 412
           T  Y +PE           D+++   ++ EL+TG    E                I+ 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.9 bits (178), Expect = 1e-15
 Identities = 26/168 (15%), Positives = 48/168 (28%), Gaps = 26/168 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA----------FCRELMIASSL 236
           G+++G G  S VF            +K          K           F    + ++  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
               +  L G  +                     +  +    +    +      +V   I
Sbjct: 64  EFRALQKLQGLAVPKVYAWE-----------GNAVLMELIDAKELYRVRVENPDEVLDMI 112

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            E VA  +    R +VH D+   N+L+S + I  + DF  +       
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	520
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.77
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.6
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.22
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.95

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=416.52  Aligned_cols=246  Identities=28%  Similarity=0.467  Sum_probs=206.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|+++.+++.||+|++.+..   ....+.+.+|+.+++.++|||||++++++.+. +.+++|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEE
Confidence            47999999999999999999999899999999986532   23356788999999999999999999998764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.+++...       ..+++..+..|+.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        85 mEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceee
Confidence            9999999999999864       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......    .....||+.|+|||++.+..++.++|||||||+||||++|+.||........                 +
T Consensus       155 ~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------------~  213 (263)
T d2j4za1         155 HAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----------------Y  213 (263)
T ss_dssp             CCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----------------H
Confidence            765433    2456799999999999999999999999999999999999999976432211                 1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.......+...+   ..+.+++.+||+.||++|||+.||++
T Consensus       214 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         214 KRISRVEFTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHTTCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCCccCC---HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            112222222222223   34667788999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=423.19  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=202.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.... .+..+.+.+|++++++++|||||++++++.+. +.+++|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEe
Confidence            57999999999999999999999899999999997653 23446789999999999999999999998774 55899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      ||++|+|.+++...       ..+++..+..|+.|++.||+|||+.+   |+||||||+||||++++.+||+|||+|+..
T Consensus        84 y~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          84 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999999653       56999999999999999999999988   999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      ............+||+.|+|||++.+..+ +.++|||||||+||||++|+.||......... ..               
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~---------------  217 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS---------------  217 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH---------------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH---------------
Confidence            54433333456789999999999988776 57899999999999999999999754332111 00               


Q ss_pred             HhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .......... ........+.+++.+||+.||++|||+.||++
T Consensus       218 ~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCCCC-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0000000000 00111235667889999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-53  Score=426.91  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=194.5

Q ss_pred             CcccceEEcccCceEEEEeeecCCCc---EEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      +|...++||+|+||+||+|.+..+++   .||||.+... .....+.|.+|+++|++++|||||+++|+|.+.+ .+++|
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~iv  105 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PVMII  105 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SCEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEEEE
Confidence            45667899999999999999865543   6899998654 4455678999999999999999999999987654 58999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.+++....      ..++|..+..|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+|+
T Consensus       106 ~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             EECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence            99999999999887643      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCc---ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhc
Q 010012          339 WTSAPSVPF---LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       339 ~~~~~~~~~---~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      .........   ......||+.|+|||++.++.++.++|||||||+||||+| |+.||......+   +..         
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~---------  244 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN---------  244 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---------
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence            765432211   1122457999999999999999999999999999999998 899997543221   111         


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        .+..  +.++..+...+   ..+.+++.+||+.||++|||+.||++.|+.+
T Consensus       245 --~i~~--~~~~~~~~~~~---~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         245 --AIEQ--DYRLPPPMDCP---SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             --HHHT--TCCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHc--CCCCCCCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              1111  11222222222   3467788999999999999999999999753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=423.18  Aligned_cols=259  Identities=29%  Similarity=0.450  Sum_probs=201.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      .++|...+.||+|+||+||+|+.+   ..||||++...  .....+.|.+|+.++++++|||||++++++.+  ..+++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEE
Confidence            368999999999999999999875   35999998654  34566789999999999999999999998754  347899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.+++....      ..++|..+..|+.||++||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        82 ~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             EECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             EecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence            99999999999997643      56999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ...............||+.|+|||++.+   +.++.++|||||||+||||+||+.||........  +    .....   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~----~~~~~---  223 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IFMVG---  223 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHH---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--H----HHHHh---
Confidence            7765443334456779999999999864   3578999999999999999999999976432211  1    01111   


Q ss_pred             hHHHHhhCcccC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          416 AAVEELLDPRLK-CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       416 ~~l~~~~d~~l~-~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                         .....+.+. .....+   ..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       224 ---~~~~~p~~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         224 ---RGYLSPDLSKVRSNCP---KAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ---HTSCCCCGGGSCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---cCCCCCcchhccccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               111222221 111122   35667889999999999999999999998643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-53  Score=425.79  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=212.5

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++....++|+..+.||+|+||+||+|.+..+++.||||++..... ..++|.+|+.++++++|||||+++++|.+.+ .+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-PF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCC-ee
Confidence            333445689999999999999999999988899999999976543 4567999999999999999999999987654 47


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|||||++|+|.+++.....     ..++|..+..|+.||+.||+|||+++   |+||||||+||||++++.+||+|||
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEeecccCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence            999999999999999976432     67999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +|+....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.......  .+.    ..     
T Consensus       161 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~----~~-----  228 (287)
T d1opja_         161 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY----EL-----  228 (287)
T ss_dssp             CTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HH-----
T ss_pred             ceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHH----HH-----
Confidence            9987655432 22344568999999999999999999999999999999999777764322111  110    01     


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                        +..-.  ++..+...+   ..+.+++.+||+.||++|||+.||++.|+..
T Consensus       229 --i~~~~--~~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         229 --LEKDY--RMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             --HHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --HhcCC--CCCCCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              11111  112122222   3567888999999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=420.91  Aligned_cols=250  Identities=22%  Similarity=0.367  Sum_probs=206.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++|||||++++++.+. +.+++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEe
Confidence            4799999999999999999999989999999999766555567899999999999999999999998775 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |++|+|.+++..        ..+++..+..|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        99 ~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             CTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            999999998764        45999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ...+.        ..
T Consensus       168 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~--------~~  231 (293)
T d1yhwa1         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIA--------TN  231 (293)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH--------HH
T ss_pred             cccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHH--------hC
Confidence            4332  23456799999999999999999999999999999999999999975432211      00111        11


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      -.+.+..+.   .....+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GTPELQNPE---KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSCCCSSGG---GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCcc---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111222111   12245677889999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=419.34  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=196.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-CCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|+.+.+++.||||++...  .....+.+.+|++++++++|||||++++++.+. +..+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999999989999999999765  344566789999999999999999999998754 3458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCCeEecCCCceEEeecCC
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      ||||++|+|.+++......   ...+++..++.++.|++.||+|||+.+  ..+||||||||+||||+.++.+||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999764321   257999999999999999999999864  23599999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      |+.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+   +.   .        
T Consensus       161 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~---~--------  224 (269)
T d2java1         161 ARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA---G--------  224 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---H--------
T ss_pred             eeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH---H--------
Confidence            987754322  2345679999999999999999999999999999999999999997543221   11   0        


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+...-.+.+  +...+   ..+.+++.+||+.||.+|||+.||++
T Consensus       225 ~i~~~~~~~~--~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 KIREGKFRRI--PYRYS---DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHTCCCCC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCC--CcccC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1111111111  11222   34667888999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=415.13  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=196.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||+||+|.+.+ +..||||++.... ...++|.+|++++++++|||||+++|+|.+.+ ..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEEEe
Confidence            578999999999999999999874 6789999997644 34468999999999999999999999987754 47999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |++|+|.+++....      ..++|..++.|+.|+|.||+|||+.+   |+||||||+||||++++.+||+|||+++...
T Consensus        82 ~~~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             cCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheecc
Confidence            99999999987643      56999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhC-CCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTG-RKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+|| ++||......   .+..           .+..
T Consensus       153 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~-----------~i~~  217 (263)
T d1sm2a_         153 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE-----------DIST  217 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHH-----------HHHH
T ss_pred             CCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHH-----------HHHh
Confidence            43322 22345699999999999999999999999999999999995 5555432211   1111           1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ...  ...+...+   ..+.+++.+||+.||++||||+||++.|+.+.
T Consensus       218 ~~~--~~~p~~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         218 GFR--LYKPRLAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TCC--CCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC--CCCccccC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            111  11111222   35678889999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=420.87  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=205.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      +.|+..+.||+|+||+||+|++..+++.||||++........+.+.+|++++++++|||||++++++.+. +.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEec
Confidence            4689999999999999999999989999999999877666677899999999999999999999998774 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      |++|+|.+++....      ..+++..+..|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        91 ~~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          91 CAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             CTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            99999999987643      56999999999999999999999988   9999999999999999999999999997653


Q ss_pred             CCCCCcccccccccCCccCchhcc-----cCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQ-----HGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ...  .......||+.|+|||++.     ...++.++|||||||+||||++|+.||.........      ..       
T Consensus       162 ~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~-------  226 (288)
T d2jfla1         162 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LK-------  226 (288)
T ss_dssp             HHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HH-------
T ss_pred             CCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HH-------
Confidence            221  1223467999999999984     456899999999999999999999999765432210      00       


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                       +...-.+.+..+.   .....+.+++.+||+.||.+|||+.|+++
T Consensus       227 -i~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         227 -IAKSEPPTLAQPS---RWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -HHHSCCCCCSSGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -HHcCCCCCCCccc---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1111111222111   12245677889999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=412.64  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|+..+.||+|+||+||+|.++ ++..||||++.... ...+.|.+|++++++++|||||+++|+|.+  +.+++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~E   87 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEE
Confidence            357899999999999999999986 47789999997654 344679999999999999999999998754  34689999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|.+++.....     ..++|..+..|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+|+..
T Consensus        88 y~~~g~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          88 YMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             CCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence            9999999998876542     46999999999999999999999988   999999999999999999999999999977


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... .......||+.|+|||++.++.++.++|||||||+||||+||..|+......  ..+..           .+..
T Consensus       160 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~-----------~i~~  225 (272)
T d1qpca_         160 EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ-----------NLER  225 (272)
T ss_dssp             SSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH-----------HHHT
T ss_pred             cCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHH-----------HHHh
Confidence            64332 2234557999999999999999999999999999999999965554432211  11110           1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ...+.  .+...+   ..+.+++.+||+.||++||||.+|+++|+.
T Consensus       226 ~~~~~--~p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         226 GYRMV--RPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCCCC--CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCC--CcccCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            11111  122222   346778899999999999999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=409.06  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC---CCcEEEEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLIY  259 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~~~LV~  259 (520)
                      ...+.||+|+||+||+|.+..++..||+|++...  .....+.|.+|++++++++|||||++++++.+.   +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5567899999999999999988999999998654  344567799999999999999999999998642   34578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec-CCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld-~~~~vkL~DFGla~  338 (520)
                      |||++|+|.+++...       ..+++..++.++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+
T Consensus        92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999764       56999999999999999999999865 4599999999999996 58899999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......    .....||+.|+|||++.+ +++.++|||||||+||||++|+.||.......  .+.   .        .+
T Consensus       164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~---~--------~i  225 (270)
T d1t4ha_         164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---R--------RV  225 (270)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---H--------HH
T ss_pred             eccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHH---H--------HH
Confidence            654332    345679999999999865 69999999999999999999999997532211  110   0        01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....+... +....   ..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~-~~~~~---~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         226 TSGVKPASF-DKVAI---PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTTCCCGGG-GGCCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HcCCCCccc-CccCC---HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111111100 11112   24667889999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=411.46  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=197.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC----cEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      ..|+..++||+|+||+||+|.++.++    ..||||++... ......+|.+|+.++++++|||||+++|+|.+.+ ..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-ceE
Confidence            57889999999999999999986543    47999999754 3344567999999999999999999999987654 589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +|||||.+|+|.+++....      ..++|..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        86 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence            9999999999999887643      57999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      |+....... ........||+.|+|||++.++.++.++|||||||+||||++|..|+.......  .+..          
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~----------  224 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----------  224 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----------
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH----------
Confidence            987654322 122234568999999999999999999999999999999999766654322111  1110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+.+...+  ..+...   ...+.+++.+||+.+|++||||.||+++|+.+
T Consensus       225 -~i~~~~~~--~~~~~~---~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         225 -AINDGFRL--PTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -HHHTTCCC--CCCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -HHhccCCC--CCchhh---HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence             11111111  112222   24577888999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=415.97  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=203.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++.+..   ....+.+.+|++++++++|||||++++++.+ ++.+++|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence            47999999999999999999998889999999997532   2334678999999999999999999998766 4568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.+++...       ..+++..++.++.|++.||+|||+.+   ||||||||+||||++++.+||+|||+|+
T Consensus        87 mEy~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccce
Confidence            9999999999998765       56999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .+.............||+.|+|||++.+..++.++|||||||+||||++|+.||.......                 ..
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----------------~~  219 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----------------IF  219 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HH
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-----------------HH
Confidence            8765433333455679999999999999999999999999999999999999998643221                 01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+....+..+...+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       220 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         220 QKIIKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHTTCCCCCTTCC---HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHcCCCCCCccCC---HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            112222222222222   34677889999999999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-52  Score=420.82  Aligned_cols=262  Identities=25%  Similarity=0.451  Sum_probs=205.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCC-----cEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~  254 (520)
                      ++|..++.||+|+||+||+|++...+     ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.+ .
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-P  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-e
Confidence            57899999999999999999886433     36999998654 333456788999999988 8999999999987654 5


Q ss_pred             EEEEEEecCCCChhHHhhhhccCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGV----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~----------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp  318 (520)
                      +++|||||++|+|.++|.......                .....++|..++.|+.||++||+|||+.+   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            899999999999999997643210                11246899999999999999999999988   99999999


Q ss_pred             CCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhcc
Q 010012          319 SNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRL  397 (520)
Q Consensus       319 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~  397 (520)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987665444333445678999999999999999999999999999999998 8999976433


Q ss_pred             ccchhhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 010012          398 QGEENLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILR  465 (520)
Q Consensus       398 ~~~~~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~  465 (520)
                      ...  +.    .+       +....  ++..+...+   ..+.+|+.+||+.||++|||++||++.|.
T Consensus       273 ~~~--~~----~~-------~~~~~--~~~~p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN--FY----KL-------IQNGF--KMDQPFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH--HH----HH-------HHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH--HH----HH-------HhcCC--CCCCCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211  10    11       11111  122222223   35677889999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=410.40  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             CCcccceE-EcccCceEEEEeeecC--CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRV-LGRGALSFVFKGKVGL--LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~-LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+  +.+++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence            56777774 9999999999997753  3457999999765 34556789999999999999999999999854  34799


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||||++|+|.+++....      ..+++..+..|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+|
T Consensus        86 vmE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             EEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhh
Confidence            999999999999986542      56999999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCC-cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          338 TWTSAPSVP-FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       338 ~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      +........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +..          
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~----------  223 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----------  223 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHH----------
T ss_pred             hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence            877654322 12234568999999999999999999999999999999998 999997643221   110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+....  ++..+...+   ..+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus       224 -~i~~~~--~~~~p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         224 -FIEQGK--RMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -HHHTTC--CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCCcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             111111  122222233   3466788999999999999999999998753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=421.39  Aligned_cols=201  Identities=29%  Similarity=0.463  Sum_probs=178.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|+..+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.+|++++|||||+++++|.+. ..+++||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence            46899999999999999999999989999999999764 334457889999999999999999999998775 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||++|+|.+++.+.       ..+++..+..++.|++.||.|||+ ++   |+||||||+||||+.++.+||+|||+|+
T Consensus        84 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  153 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  153 (322)
T ss_dssp             ECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             EcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcc
Confidence            999999999999864       469999999999999999999997 46   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhc
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARR  396 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~  396 (520)
                      ......    ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus       154 ~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         154 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            654322    245679999999999999999999999999999999999999997643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=407.48  Aligned_cols=248  Identities=26%  Similarity=0.422  Sum_probs=197.9

Q ss_pred             eEEcccCceEEEEeeec--CCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEecC
Q 010012          188 RVLGRGALSFVFKGKVG--LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~~  263 (520)
                      +.||+|+||+||+|.+.  .+++.||||++...  +....++|.+|+.++++++|||||+++|+|.+ + ..+||||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCC
Confidence            57999999999999864  34578999999654  33445789999999999999999999999854 3 4789999999


Q ss_pred             CCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCCC
Q 010012          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (520)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~~  343 (520)
                      +|+|.+++...       ..++|..+..|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+|+.....
T Consensus        91 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          91 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            99999999764       56999999999999999999999988   999999999999999999999999999876544


Q ss_pred             CCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHHh
Q 010012          344 SVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEEL  421 (520)
Q Consensus       344 ~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~~  421 (520)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+   +.    .       .+...
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~----~-------~i~~~  226 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----A-------MLEKG  226 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----H-------HHHTT
T ss_pred             ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HH----H-------HHHcC
Confidence            3221 2234569999999999999999999999999999999998 999997643221   11    0       11111


Q ss_pred             hCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          422 LDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       422 ~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                        .++..+...+   ..+.+++.+||+.||++|||+++|+++|+.
T Consensus       227 --~~~~~p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 --ERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             --CCCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCCcccC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence              1122222233   346678889999999999999999998874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-51  Score=400.33  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=209.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||+||+|+++ ++..||||++++... ..++|.+|+.++++++|||||+++|+|.+. +.+++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEc
Confidence            58999999999999999999986 578899999987543 346899999999999999999999998765 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|..++....      ..+++..+++|+.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        81 ~~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          81 MANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             CTTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             cCCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheecc
Confidence            99999999987654      56899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+   +.    .       .+.+
T Consensus       152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~----~-------~i~~  216 (258)
T d1k2pa_         152 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----E-------HIAQ  216 (258)
T ss_dssp             SSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH----H-------HHHT
T ss_pred             CCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH----H-------HHHh
Confidence            43322 2234569999999999999999999999999999999998 899997654321   11    0       1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      ..  ++..+...+   ..+.+++.+||+.||++|||+.+|++.|..
T Consensus       217 ~~--~~~~p~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 GL--RLYRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TC--CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC--CCCCccccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            11  122222222   356788899999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-50  Score=416.68  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=208.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|.+.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+|++++|||||++++++.+. +.+++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEc
Confidence            5899999999999999999999989999999999877766778899999999999999999999998764 568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CCCceEEeecCCccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLATW  339 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~~~vkL~DFGla~~  339 (520)
                      |++|+|.+++....      ..+++..+..|+.||+.||+|||+++   ||||||||+||||+  .++.+||+|||+|+.
T Consensus       105 ~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         105 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             CCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999986532      46999999999999999999999988   99999999999996  467899999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........      .           .
T Consensus       176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~-----------~  235 (350)
T d1koaa2         176 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------L-----------R  235 (350)
T ss_dssp             CCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-----------H
T ss_pred             ccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------H-----------H
Confidence            76443   23456799999999999999999999999999999999999999976432211      0           1


Q ss_pred             HhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+......... ........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111000 00111235678889999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-51  Score=411.92  Aligned_cols=250  Identities=27%  Similarity=0.372  Sum_probs=188.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch-HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      +.|...+.||+|+||+||+|.++.+++.||||++.+... .....+.+|+.++++++|||||++++++.+ ++.++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEe
Confidence            569999999999999999999998899999999976532 234567899999999999999999999766 456899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec---CCCceEEeecCCc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLA  337 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld---~~~~vkL~DFGla  337 (520)
                      ||+||+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||+.   +++.+||+|||+|
T Consensus        88 ~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          88 LVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             CCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             ccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence            99999999999753       56999999999999999999999988   99999999999994   5789999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......   .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +              
T Consensus       158 ~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~--------------  217 (307)
T d1a06a_         158 KMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L--------------  217 (307)
T ss_dssp             ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H--------------
T ss_pred             EEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H--------------
Confidence            87654332   245679999999999999999999999999999999999999997543221   1              


Q ss_pred             HHHhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...+.......+ .........+.+++.+||+.||++|||+.|+++
T Consensus       218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111111111111 001112245678889999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-51  Score=411.01  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=200.6

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .|+..+.||+|+||+||+|++..+++.||||++....   ....+.+.+|+.++++++|||||++++++.+. +.+++||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEE
Confidence            5899999999999999999998889999999997643   34456789999999999999999999998774 5589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      |||++|+|..++...       ..+++..++.|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus        95 E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             ECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999997766543       56999999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccCchhccc---CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchh
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQH---GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMA  416 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~  416 (520)
                      ....      ....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||........      ..        
T Consensus       165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~--------  224 (309)
T d1u5ra_         165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY--------  224 (309)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH--------
T ss_pred             cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HH--------
Confidence            5432      34569999999999864   4689999999999999999999999975432110      00        


Q ss_pred             HHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          417 AVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       417 ~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.....+.+. ....+   ..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~i~~~~~~~~~-~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         225 HIAQNESPALQ-SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHSCCCCCS-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCCCCC-CCCCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11111112221 11122   35677888999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-51  Score=409.03  Aligned_cols=266  Identities=25%  Similarity=0.380  Sum_probs=209.6

Q ss_pred             HhhCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC
Q 010012          179 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (520)
Q Consensus       179 ~at~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~  252 (520)
                      ...++|+..+.||+|+||+||+|+.+     .+++.||||++.... .+..++|.+|++++++++||||++++++|.+..
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34578999999999999999999874     345789999997653 345678999999999999999999999987654


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKG-----------------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~-----------------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrD  315 (520)
                       ..++||||+++|+|.+++......                 ......++|..++.|+.|++.||+|||+.+   |||||
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD  165 (301)
T d1lufa_          90 -PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  165 (301)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             -ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence             579999999999999999753210                 111245899999999999999999999988   99999


Q ss_pred             cCCCCeEecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCC-CCcch
Q 010012          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEA  394 (520)
Q Consensus       316 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~-~Pf~~  394 (520)
                      |||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998665443333345567999999999999999999999999999999999985 56765


Q ss_pred             hccccchhhHHhhhhHhhhchhHHHHhhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          395 RRLQGEENLVLWAKPILHRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       395 ~~~~~~~~lv~~~~~~~~~~~~~l~~~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ....+   +.              ..+.+.. ...+...+   ..+.+|+.+||+.+|++||||.||+++|+.+.
T Consensus       246 ~~~~e---~~--------------~~v~~~~~~~~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEE---VI--------------YYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHH---HH--------------HHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHH---HH--------------HHHHcCCCCCCCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43321   11              1111111 11122222   35778889999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=410.09  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc----EEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .+|+..++||+|+||+||+|.+..+++    .||+|++... .....++|.+|+.++++++|||||+++|+|.+.  ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence            479999999999999999999876665    5889988653 334567899999999999999999999999764  368


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +++||+.+|+|.+++....      ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+
T Consensus        87 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             EEEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccc
Confidence            9999999999999887653      57999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      |+...............||+.|+|||++.++.++.++|||||||+||||+| |.+||..........             
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------------  224 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------------  224 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------------
T ss_pred             ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------------
Confidence            998765544434445679999999999999999999999999999999998 888987644322111             


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+...  .++..+...   ...+.+++.+||+.||.+|||+.||++.|+..
T Consensus       225 -~i~~~--~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         225 -ILEKG--ERLPQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -HHHHT--CCCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcC--CCCCCCccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence             11111  112212222   23567788999999999999999999988764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-50  Score=413.46  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=207.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+|++++|||||++++++.+ +..+++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            479999999999999999999988899999999987766667788999999999999999999999876 4568999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec--CCCceEEeecCCccc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLATW  339 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld--~~~~vkL~DFGla~~  339 (520)
                      |++|+|.+++....      ..+++..++.|+.||+.||+|||+.+   ||||||||+||||+  .++.+||+|||+|+.
T Consensus       108 ~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         108 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CCCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence            99999998876532      56999999999999999999999988   99999999999998  678999999999998


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVE  419 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~  419 (520)
                      .....   ......||+.|+|||++.+..++.++|||||||+||||+||+.||........                 +.
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----------------~~  238 (352)
T d1koba_         179 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----------------LQ  238 (352)
T ss_dssp             CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----------------HH
T ss_pred             cCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HH
Confidence            76543   23456799999999999999999999999999999999999999975432211                 01


Q ss_pred             HhhCcccCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ELLDPRLKCT-SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ~~~d~~l~~~-~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+.......+ .........+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         239 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111100 001112245678889999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=402.56  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=204.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc------hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      +.|..++.||+|+||+||+|+++.+++.||||++.+..      ....+.|.+|+.+|++++|||||++++++.+. ..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDV   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEE
Confidence            57999999999999999999999899999999996532      12357899999999999999999999998764 568


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC----ceEE
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~----~vkL  331 (520)
                      +||||||++|+|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEe
Confidence            9999999999999999765       46999999999999999999999988   99999999999998776    5999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      +|||+|+.......   .....||+.|+|||++.+..++.++|||||||+||||++|+.||.........          
T Consensus       159 ~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------  225 (293)
T d1jksa_         159 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----------  225 (293)
T ss_dssp             CCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------
T ss_pred             cchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH----------
Confidence            99999987754332   34567999999999999999999999999999999999999999864332110          


Q ss_pred             hhchhHHHHhhCcccCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTS-RNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~-~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                             ..+......... ........+.+++.+||+.||.+|||+.||++
T Consensus       226 -------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         226 -------ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -------HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   111111110000 00011235678889999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=399.65  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=198.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|...+.||+|+||.||+|.+.  ++.||||+++.+.  ..+.|.+|++++++++|||||+++|+|.+..+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            47888999999999999999985  6789999997653  4467999999999999999999999998766668999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +++|+|.++|.....     ..++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          83 MAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence            999999999976532     45899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...     ....+|..|+|||++.++.++.++|||||||++|||+| |+.||......+   +..+           +..
T Consensus       155 ~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~-----------i~~  215 (262)
T d1byga_         155 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-----------VEK  215 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH-----------HTT
T ss_pred             CCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH-----------HHc
Confidence            332     33458999999999999999999999999999999998 788876543321   1111           111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ...+..  +...+   ..+.+++.+||+.||.+|||+.+|+++|+.++
T Consensus       216 ~~~~~~--~~~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         216 GYKMDA--PDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCC--CccCC---HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            112222  22222   34667889999999999999999999998653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=401.22  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|+.++.||+|+||+||+|.+++ +..||||++..... ..+.|.+|+.++++++|||||+++|+|.+  +..++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~E   91 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE   91 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEE
Confidence            3579999999999999999999975 46799999976543 44679999999999999999999999854  34689999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcccc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~  340 (520)
                      |+++|+|..++.....     ..++|..+..|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+..
T Consensus        92 y~~~g~l~~~~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          92 YMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             CCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             ecCCCchhhhhhhccc-----ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhc
Confidence            9999999999887543     56999999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          341 SAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       341 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ...... ......||+.|+|||++..+.++.++|||||||+||||++|..|+.......  .+..           .+..
T Consensus       164 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~-----------~i~~  229 (285)
T d1fmka3         164 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD-----------QVER  229 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH-----------HHHT
T ss_pred             cCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHH-----------HHHh
Confidence            543322 2234569999999999999999999999999999999999766654432211  1111           1111


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      ...+.  .+...+   ..+.+++.+||+.||++||+|.+|+++|+..
T Consensus       230 ~~~~~--~~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         230 GYRMP--CPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             TCCCC--CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             cCCCC--CCcccC---HHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            11111  122222   3567888999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=406.20  Aligned_cols=248  Identities=26%  Similarity=0.354  Sum_probs=206.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|...+.||+|+||+||+|+...+++.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+. +.+++|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccc
Confidence            57999999999999999999999999999999997542   23456788999999999999999999988764 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||++|+|.+++...       ..+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        84 ~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccc
Confidence            9999999999999875       56899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      .......  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.......   +              .
T Consensus       154 ~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~--------------~  214 (337)
T d1o6la_         154 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L--------------F  214 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H--------------H
T ss_pred             ccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H--------------H
Confidence            7654322  2345679999999999999999999999999999999999999998654321   1              1


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                      ..+....+..+...+.   .+.+++.+||++||.+||+     +.||++
T Consensus       215 ~~i~~~~~~~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         215 ELILMEEIRFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHCCCCCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhcCCCCCCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1111122222222333   4667889999999999995     778775

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=402.86  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=201.5

Q ss_pred             hCCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~  253 (520)
                      .++|...+.||+|+||.||+|.+..     +++.||||++... .....+.+..|+.++.++ +|+|||.+++++.+.+.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            3579999999999999999998643     3468999999754 334456788888887776 78999999999887777


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEec
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld  324 (520)
                      .+++|||||++|+|.+++.......         .....++|..+..++.||++||+|||+++   ||||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            7899999999999999998643210         01245899999999999999999999988   99999999999999


Q ss_pred             CCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCC-CCcchhccccchhh
Q 010012          325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENL  403 (520)
Q Consensus       325 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~-~Pf~~~~~~~~~~l  403 (520)
                      +++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. +||.......  .+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence            99999999999998766544433445667999999999999999999999999999999999964 5776433221  11


Q ss_pred             HHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          404 VLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       404 v~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                          ..       .+.+...+..  +...+   ..+.+++.+||+.||++|||+.||++.|+.+
T Consensus       247 ----~~-------~~~~~~~~~~--~~~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 ----CR-------RLKEGTRMRA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ----HH-------HHHHTCCCCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HH-------HHhcCCCCCC--CccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                11       1112122222  22222   3467888999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-49  Score=401.99  Aligned_cols=245  Identities=28%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..   ....+.+.+|+.+++.++|||||++++++.+. +.+++|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeE
Confidence            47999999999999999999999899999999997542   23456788999999999999999999998764 568999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ||||+||+|..++...       ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        83 mE~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          83 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eeecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccce
Confidence            9999999999998765       56889999999999999999999888   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....||+.|+|||++.+..++.++|||||||+||||++|+.||.......                 .+
T Consensus       153 ~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------------~~  210 (316)
T d1fota_         153 YVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----------------TY  210 (316)
T ss_dssp             ECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HH
T ss_pred             Eecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----------------HH
Confidence            765432     35679999999999999999999999999999999999999997643221                 11


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+.......+...+   ..+.+++.+||..||.+||     |+.+|++
T Consensus       211 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         211 EKILNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHHCCCCCCTTSC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHcCCCCCCCCCC---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            112222222222222   3466788899999999996     8999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=395.24  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=196.3

Q ss_pred             hCCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  256 (520)
                      .++|..++.||+|+||+||+|.+..+   +..||||.+... .....+.|.+|+.++++++|||||+++|++.+  +.++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence            35799999999999999999987543   356999998654 34456779999999999999999999999854  4579


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      +||||+++|+|.+++....      ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        84 iv~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence            9999999999999887643      57999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      |+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......   +..          
T Consensus       155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----------  220 (273)
T d1mp8a_         155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----------  220 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----------
T ss_pred             heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----------
Confidence            987654322 22345568999999999999999999999999999999998 899997654322   110          


Q ss_pred             hHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          416 AAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       416 ~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       .+....  +...+...+   ..+.+++.+||..||++|||+.||++.|+.+
T Consensus       221 -~i~~~~--~~~~~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         221 -RIENGE--RLPMPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -HHHTTC--CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCC--CCCCCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             111111  111122222   3567788999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-49  Score=391.90  Aligned_cols=260  Identities=26%  Similarity=0.358  Sum_probs=201.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---c
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~  254 (520)
                      .++|...+.||+|+||+||+|.+..+++.||||++.+.   .....+.|.+|+++++.++|||||++++++...+.   .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999999888999999999754   33455679999999999999999999998875432   3


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +|||||||+||+|.+++...       ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.++|+||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehh
Confidence            78999999999999988765       56999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCC-CcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          335 GLATWTSAPSV-PFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       335 Gla~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      |+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......      ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~  229 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRE  229 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHC
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhc
Confidence            99876543221 122345679999999999999999999999999999999999999997543221      11111111


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-GIEEIIAILRG  466 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-tm~eVl~~L~~  466 (520)
                      .       ..+........+   ..+.+++.+||+.||.+|| |++++++.|..
T Consensus       230 ~-------~~~~~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         230 D-------PIPPSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             C-------CCCGGGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             C-------CCCCchhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            0       000001111122   3566788899999999999 89999887764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.8e-49  Score=389.82  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=203.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---------hHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------KESSKAFCRELMIASSLH-HPNIVPLVGFCIDP  251 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---------~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~  251 (520)
                      ++|+..+.||+|+||+||+|+...+++.||||++.+..         ....+.+.+|+.++++++ |||||++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            58999999999999999999998889999999996542         123346889999999997 9999999999876 


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL  331 (520)
                      +..+|+|||||++|+|.++|...       ..+++..++.++.||++||+|||+++   |+||||||+||||+.++.+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEE
Confidence            45689999999999999999764       56999999999999999999999988   999999999999999999999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhccc------CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHH
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQH------GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVL  405 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~  405 (520)
                      +|||+++.......   .....||+.|+|||++.+      ..++.++||||+||+||||++|+.||.........    
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~----  224 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----  224 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH----
Confidence            99999987765332   345679999999999853      35788999999999999999999999865432111    


Q ss_pred             hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          406 WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       406 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                        ..+...       -.  .+..+ ........+.+++.+||+.+|++|||+.||++
T Consensus       225 --~~i~~~-------~~--~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 --RMIMSG-------NY--QFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --HHHHHT-------CC--CCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHhC-------CC--CCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              011110       00  11100 01112245778889999999999999999865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=395.42  Aligned_cols=256  Identities=25%  Similarity=0.404  Sum_probs=196.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCC---CcEEEEEEecCc---chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|+..+.||+|+||.||+|++...   ...||||++.+.   ..+..++|.+|+.++++++|||||+++|+|.++  ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence            5799999999999999999986432   247899998754   234457899999999999999999999998653  46


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++||||+++|+|.+++....      ..+++..+..++.|++.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             heeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence            89999999999999887654      46999999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCc-ccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccchhhHHhhhhHhhh
Q 010012          336 LATWTSAPSVPF-LCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       336 la~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      +++......... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.......   ..   ..+...
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~---~~i~~~  230 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKE  230 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTS
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---HHHHhC
Confidence            999775543221 2334568889999999999999999999999999999998 899997543321   11   111111


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                               ..++..+...+   ..+.+++.+||+.||++|||+.||++.|+.
T Consensus       231 ---------~~~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         231 ---------GERLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---------CCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCCCccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                     01111112222   346678899999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=396.57  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=203.4

Q ss_pred             ceEEcccCceEEEEeeecCCC---cEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEec
Q 010012          187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~~  262 (520)
                      .++||+|+||+||+|.+..++   ..||||+++.. .....++|.+|++++++++|||||+++|+|.+.+...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999985432   36999999753 45566889999999999999999999999988777789999999


Q ss_pred             CCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccCC
Q 010012          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (520)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~~  342 (520)
                      ++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++....
T Consensus       112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999987643      56889999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCCC--cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHHHH
Q 010012          343 PSVP--FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAVEE  420 (520)
Q Consensus       343 ~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l~~  420 (520)
                      ....  .......||+.|+|||++..+.++.++||||||+++|||+||..||.......  .   +...+. .+      
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~---~~~~i~-~g------  250 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--D---ITVYLL-QG------  250 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHH-TT------
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--H---HHHHHH-cC------
Confidence            3221  12334569999999999999999999999999999999999888876432211  1   111111 11      


Q ss_pred             hhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          421 LLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       421 ~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                         .+...+...+   ..+.+++.+||+.||++||+|.||++.|+.+.
T Consensus       251 ---~~~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 ---RRLLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             ---CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCcccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               1111122222   34677889999999999999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-48  Score=402.10  Aligned_cols=245  Identities=24%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV  258 (520)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+. ...++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccc
Confidence            57999999999999999999999899999999996532   23346788999999999999999999988764 458999


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      |||+.+|+|..++...       ..+++..++.|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus       120 ~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeee
Confidence            9999999999999765       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......     ....||+.|+|||++.+..++.++|||||||+||||+||+.||.......                 .+
T Consensus       190 ~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------------~~  247 (350)
T d1rdqe_         190 RVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----------------IY  247 (350)
T ss_dssp             ECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HH
T ss_pred             eccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----------------HH
Confidence            775432     34679999999999999999999999999999999999999997543211                 01


Q ss_pred             HHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 010012          419 EELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRP-----GIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----tm~eVl~  462 (520)
                      ..+.......+...+   ..+.+++.+||+.||.+|+     |+.+|++
T Consensus       248 ~~i~~~~~~~p~~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         248 EKIVSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHCCCCCCTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhcCCCCCCccCC---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            111112222222222   3467788899999999994     8999886

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-48  Score=400.48  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch---HHHHHH---HHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAF---CRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~---~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|.+.++||+|+||+||+|++..+++.||||++.+...   .....+   ..|+.+++.++|||||++++++.+. +.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEE
Confidence            589999999999999999999998999999999865321   112223   3457778888999999999988764 568


Q ss_pred             EEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecC
Q 010012          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFG  335 (520)
                      ++|||||++|+|.++|...       ..+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999999765       56899999999999999999999988   9999999999999999999999999


Q ss_pred             CccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          336 LATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       336 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      +|+......    .....||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+           
T Consensus       153 la~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----------  217 (364)
T d1omwa3         153 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------  217 (364)
T ss_dssp             TCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-----------
T ss_pred             eeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence            998776443    234579999999999975 4689999999999999999999999986543321111           


Q ss_pred             hhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          415 MAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                         ...........+...+   ..+.+++.+||+.||++|||     +.||++
T Consensus       218 ---~~~~~~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         218 ---DRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---HHHSSSCCCCCCSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---HHhcccCCCCCCCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               1112222222222222   34677888999999999999     577775

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=397.80  Aligned_cols=274  Identities=22%  Similarity=0.262  Sum_probs=202.5

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---cEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFLI  258 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~~~LV  258 (520)
                      ++|...+.||+|+||+||+|++.  ++.||||++..... ....+..|+..+.+++|||||+++++|.+.+.   .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            46788899999999999999974  78999999965432 22223345556678899999999999986543   47899


Q ss_pred             EEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCCeEecCCCceEEee
Q 010012          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       259 ~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      ||||++|+|.++|+.        ..++|..++.++.|+|.||.|||+..     .++||||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            999999999999975        45999999999999999999999741     34599999999999999999999999


Q ss_pred             cCCccccCCCCCC--cccccccccCCccCchhcccCC------CCCcCceeeHHHHHHHHHhCCCCcchhccccchh--h
Q 010012          334 FGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHGK------VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN--L  403 (520)
Q Consensus       334 FGla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~------~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~--l  403 (520)
                      ||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||..........  .
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            9999876543321  1234567999999999987542      5778999999999999999998876433221110  0


Q ss_pred             HH--hhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          404 VL--WAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       404 v~--~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                      ..  .........  .....++|.+............+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         232 VPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCSSCCHHHHHHH--HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHH--HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            00  000000000  1112223333222223345667889999999999999999999999998643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=394.80  Aligned_cols=264  Identities=24%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCC-------cEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~  251 (520)
                      .++|..++.||+|+||.||+|+...++       ..||||++.... .....++.+|+..+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            358999999999999999999875433       479999997654 34557788999999888 899999999998765


Q ss_pred             CCcEEEEEEecCCCChhHHhhhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       252 ~~~~~LV~E~~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                       ..+++|||||++|+|.+++......         ......+++..+..++.||+.||+|||+.+   ||||||||+|||
T Consensus        92 -~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          92 -GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             -SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             -CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence             4589999999999999999765311         111356999999999999999999999988   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |..||.......  
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence            99999999999999987765444334455679999999999999999999999999999999998 788887543221  


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                       +.    .       .+.....  +..+...+   ..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       246 -~~----~-------~i~~~~~--~~~p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 -LF----K-------LLKEGHR--MDKPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -HH----H-------HHHTTCC--CCCCSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HH----H-------HHHcCCC--CCCCccch---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             11    1       1111111  12122222   3467888999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=394.93  Aligned_cols=265  Identities=25%  Similarity=0.392  Sum_probs=209.9

Q ss_pred             hCCcccceEEcccCceEEEEeeec-----CCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCC
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~  253 (520)
                      .++|+.++.||+|+||.||+|++.     .+++.||||++.... ......|.+|+.+++.+ +|||||+++++|.+.. 
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~-  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence            358889999999999999999763     456789999997653 44556789999999998 6999999999987654 


Q ss_pred             cEEEEEEecCCCChhHHhhhhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeE
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKG-----------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~-----------~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NIL  322 (520)
                      .+++|||||++|+|.+++......           ......+++..+..++.||+.||+|||+++   ||||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence            479999999999999999865321           011246999999999999999999999988   999999999999


Q ss_pred             ecCCCceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHh-CCCCcchhccccch
Q 010012          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLT-GRKPIEARRLQGEE  401 (520)
Q Consensus       323 ld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELlt-G~~Pf~~~~~~~~~  401 (520)
                      ++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||........ 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999998766554444556789999999999999999999999999999999999 5555544332211 


Q ss_pred             hhHHhhhhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          402 NLVLWAKPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       402 ~lv~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                           ...+       +..-..+..  +...   ...+.+|+.+||+.||.+|||+.+|+++|++.
T Consensus       257 -----~~~~-------i~~~~~~~~--~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 -----FYKM-------IKEGFRMLS--PEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -----HHHH-------HHHTCCCCC--CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHH-------HhcCCCCCC--cccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                 0111       111111111  1112   24577888999999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=395.07  Aligned_cols=264  Identities=22%  Similarity=0.325  Sum_probs=210.3

Q ss_pred             CCcccceEEcccCceEEEEeeecC-----CCcEEEEEEecCc-chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~  255 (520)
                      ++|...+.||+|+||+||+|.+..     .++.||||+++.. .......|.+|++++++++|||||+++|+|... ...
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-Cce
Confidence            688999999999999999998752     3578999999754 344556789999999999999999999998664 457


Q ss_pred             EEEEEecCCCChhHHhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          256 FLIYKYVSGGSLERHLHEKKKG---VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       256 ~LV~E~~~~gsL~~~L~~~~~~---~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ++|||||++|+|.+++......   ......+++..+..|+.|+++||.|||+.+   |+||||||+||||++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999998764311   112245799999999999999999999987   9999999999999999999999


Q ss_pred             ecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCC-CCcchhccccchhhHHhhhhHh
Q 010012          333 DFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGR-KPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      |||+|+...............||+.|+|||.+.++.++.++|||||||+||||+||. +||.......            
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------------  243 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------------  243 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            999998765544333344556999999999999999999999999999999999985 6665433221            


Q ss_pred             hhchhHHHHhhCcc-cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcc
Q 010012          412 HRGMAAVEELLDPR-LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEEE  469 (520)
Q Consensus       412 ~~~~~~l~~~~d~~-l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~~  469 (520)
                           .+..+.+.. +..+...+   ..+.+++.+||+.+|.+||||.+|+++|+...+
T Consensus       244 -----~~~~i~~~~~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         244 -----VLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -----HHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -----HHHHHHhCCCCCCcccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 111112211 11122222   357788899999999999999999999987543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=395.37  Aligned_cols=251  Identities=20%  Similarity=0.290  Sum_probs=204.9

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E  260 (520)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+.+|+++|+.++|||||++++++.+. +.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEe
Confidence            3689999999999999999999998999999999987643 345688999999999999999999988764 56899999


Q ss_pred             ecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC--CceEEeecCCcc
Q 010012          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLAT  338 (520)
Q Consensus       261 ~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~--~~vkL~DFGla~  338 (520)
                      ||+||+|.+++....      ..+++..++.|+.||+.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++
T Consensus        82 ~~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999997542      46999999999999999999999988   9999999999999854  589999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhHH
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAAV  418 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~l  418 (520)
                      ......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........                 +
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-----------------~  212 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------I  212 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------H
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-----------------H
Confidence            765433   23456799999999999999999999999999999999999999976543211                 1


Q ss_pred             HHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          419 EELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       419 ~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+.......+.. .......+.+++.+||..||.+|||+.|+++
T Consensus       213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111110000 0001234678889999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=395.62  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc---hHHHHHHHHHHHHHH-hCCCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIAS-SLHHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|...+.||+|+||+||+|++..+++.||||++.+..   ....+.+..|..++. .++|||||++++++.+. +.+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeE
Confidence            57999999999999999999999999999999997542   223455667777665 68999999999998765 45899


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCc
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla  337 (520)
                      |||||++|+|.+++...       ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++
T Consensus        81 vmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchh
Confidence            99999999999999865       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhchhH
Q 010012          338 TWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGMAA  417 (520)
Q Consensus       338 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~~~  417 (520)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......                
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----------------  212 (320)
T d1xjda_         151 KENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------------  212 (320)
T ss_dssp             BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------
T ss_pred             hhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence            86654332  234567999999999999999999999999999999999999999865432110                


Q ss_pred             HHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 010012          418 VEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIE-EIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~-eVl~  462 (520)
                       ..+.......+...+   ..+.+++.+||+.||.+|||+. +|++
T Consensus       213 -~~i~~~~~~~p~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         213 -HSIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -HHHHHCCCCCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -HHHHcCCCCCCccCC---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             001111111122222   3467888999999999999995 6753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=391.88  Aligned_cols=261  Identities=25%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCc--EEEEEEecCc-chHHHHHHHHHHHHHHhC-CCCCeecEEEEEEcCCCcEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~L  257 (520)
                      ++|+..+.||+|+||+||+|.++.++.  .||||++... ..+..+.|.+|+++|+++ +|||||+++|+|.+. +.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence            578889999999999999999987665  4788887543 334566899999999998 799999999998875 45899


Q ss_pred             EEEecCCCChhHHhhhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCc
Q 010012          258 IYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~---------~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (520)
                      ||||+++|+|.++|+....         .......++|..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            9999999999999975410         0112367999999999999999999999988   999999999999999999


Q ss_pred             eEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCC-CcchhccccchhhHHhh
Q 010012          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRK-PIEARRLQGEENLVLWA  407 (520)
Q Consensus       329 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~-Pf~~~~~~~~~~lv~~~  407 (520)
                      +||+|||+|+.......   .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.......   +..  
T Consensus       166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~--  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE--  237 (309)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH--
T ss_pred             eEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence            99999999986543322   234468999999999999999999999999999999999765 665433211   111  


Q ss_pred             hhHhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 010012          408 KPILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGEE  468 (520)
Q Consensus       408 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~~  468 (520)
                               .+.+..  ++..+...+   ..+.+++.+||+.||++||||.||++.|+.+.
T Consensus       238 ---------~i~~~~--~~~~~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         238 ---------KLPQGY--RLEKPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             ---------HGGGTC--CCCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHhcC--CCCCCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     111111  111122222   35677888999999999999999999988653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=393.94  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             CCcccc-eEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHH-hCCCCCeecEEEEEEc---CCCcEE
Q 010012          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS-SLHHPNIVPLVGFCID---PEQGLF  256 (520)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~---~~~~~~  256 (520)
                      ++|.+. ++||+|+||+||+|.+..+++.||||++...     ..+.+|++++. .++|||||++++++.+   .+..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578876 4699999999999999888999999999643     34667998865 5589999999998754   234589


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEee
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~D  333 (520)
                      +|||||+||+|.+++....     ...+++..++.|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEECCCCCcHHHHHHhcC-----CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence            9999999999999997532     257999999999999999999999988   999999999999985   56799999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ||+|+.......   .....||+.|+|||++.+..|+.++|||||||+||||+||+.||...........          
T Consensus       158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~----------  224 (335)
T d2ozaa1         158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------  224 (335)
T ss_dssp             CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred             cceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----------
Confidence            999987655432   2456799999999999999999999999999999999999999986543221100          


Q ss_pred             chhHHHHhhCcccCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          414 GMAAVEELLDPRLKCTSR-NSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~-~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         ....+.......+.. .......+.+++.+||+.||++|||+.|+++
T Consensus       225 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         225 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               000111111111110 1122346788899999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=386.18  Aligned_cols=260  Identities=23%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcchHH-----HHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES-----SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      .++||+|+||+||+|.+..+++.||||++.......     .+.+.+|+.++++++|||||++++++.+. +.+++||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-Cceeehhhh
Confidence            578999999999999999899999999996543221     24688999999999999999999998765 458999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccccC
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~~~  341 (520)
                      +.++++..++...       ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          82 METDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             CSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             hcchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccC
Confidence            9888776665432       56899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc-hhHHH
Q 010012          342 APSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG-MAAVE  419 (520)
Q Consensus       342 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~-~~~l~  419 (520)
                      ....  ......||+.|+|||++... .++.++|||||||++|||++|+.||......+....+   ......- .....
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~  226 (299)
T d1ua2a_         152 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWP  226 (299)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSS
T ss_pred             CCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhcc
Confidence            4432  22345799999999998755 5799999999999999999999999765432211111   0000000 00000


Q ss_pred             ---HhhC-cccCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          420 ---ELLD-PRLKC-TSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       420 ---~~~d-~~l~~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                         .... ..... +...     ......+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence               0000 00000 0000     011246788999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=383.77  Aligned_cols=269  Identities=22%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch--HHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|.+..+++.||||++.....  ...+.+.+|++++++++|||||++++++.+. ..+++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEE
Confidence            589999999999999999999988899999999965432  2356788999999999999999999998775 4589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+.+ ++..++....     ...+++..++.++.|++.||+|||+.+   ||||||||+|||++.++.+||+|||+|+.
T Consensus        81 e~~~~-~~~~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             ECCSE-EHHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             eecCC-chhhhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCccee
Confidence            99965 4555554432     257999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh-chhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR-GMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-~~~~  417 (520)
                      ......  ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+....+........+ ....
T Consensus       152 ~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         152 FGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             HCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence            654332  234557999999999887665 578999999999999999999999764432211100000000000 0000


Q ss_pred             HHHhhCcccCC---CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELLDPRLKC---TSRN-----SAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~d~~l~~---~~~~-----~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      +....+.....   ....     ......+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000000000   0000     011245778899999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=380.56  Aligned_cols=240  Identities=24%  Similarity=0.373  Sum_probs=194.8

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcch------HHHHHHHHHHHHHHhCC--CCCeecEEEEEEcCCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQ  253 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~  253 (520)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+...      ....++.+|+.++++++  |||||++++++.+. +
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-D   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-S
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-C
Confidence            579999999999999999999998899999999865321      11234668999999986  89999999998764 4


Q ss_pred             cEEEEEEecCC-CChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-CCceEE
Q 010012          254 GLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKL  331 (520)
Q Consensus       254 ~~~LV~E~~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-~~~vkL  331 (520)
                      ..++||||+.+ +++.+++...       ..+++..++.++.||+.||+|||+.+   |+||||||+|||++. ++.+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             eEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEE
Confidence            58999999976 5777887654       56999999999999999999999988   999999999999985 479999


Q ss_pred             eecCCccccCCCCCCcccccccccCCccCchhcccCCC-CCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          332 CDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKV-SDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      +|||+|+......    .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||.....     .       
T Consensus       153 ~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------  216 (273)
T d1xwsa_         153 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------  216 (273)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------
T ss_pred             Cccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------
Confidence            9999998765432    245679999999999987765 5679999999999999999999975321     0       


Q ss_pred             hhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 LHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                                 .......+...+   ..+.+++.+||+.||++|||+.|+++
T Consensus       217 -----------~~~~~~~~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 -----------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----------HHCCCCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------hhcccCCCCCCC---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                       001111111222   34667888999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=380.46  Aligned_cols=270  Identities=21%  Similarity=0.275  Sum_probs=195.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCC-CcEEEEEEecCcch--HHHHHHHHHHHHHHh---CCCCCeecEEEEEEc----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKEDK--ESSKAFCRELMIASS---LHHPNIVPLVGFCID----  250 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~-~~~vAvK~l~~~~~--~~~~~~~~E~~il~~---l~HpnIv~l~g~~~~----  250 (520)
                      .++|.+.+.||+|+||+||+|++..+ ++.||||++.....  .....+.+|+.+++.   ++|||||+++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999998654 66799999865321  122345567766655   489999999998863    


Q ss_pred             CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceE
Q 010012          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (520)
Q Consensus       251 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vk  330 (520)
                      ....++++|||+.++++.......      ...+++..++.++.|++.||+|||+++   ||||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cCceEEEEEEeccCCchhhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCee
Confidence            234578999999887765544432      257999999999999999999999988   99999999999999999999


Q ss_pred             EeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhH
Q 010012          331 LCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPI  410 (520)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~  410 (520)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+......
T Consensus       157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999988654322   235667999999999999999999999999999999999999999865432211111100000


Q ss_pred             h-----hhchhHHHHhhCcccC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          411 L-----HRGMAAVEELLDPRLK--CTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       411 ~-----~~~~~~l~~~~d~~l~--~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .     ................  ...........+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0     0000000000000000  00000111235677889999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-46  Score=372.57  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=196.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc--hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|...+.||+|+||+||+|+++ +++.||||++....  ....+.+.+|+.+|++++|||||++++++.+.+ ..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEE
Confidence            58999999999999999999986 58999999997653  223568999999999999999999999987754 589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      ||+.++.+..+....       ..+++..+..|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+|..
T Consensus        80 e~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             ECCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EeehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence            999877666665432       57999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh-hhchhH
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL-HRGMAA  417 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-~~~~~~  417 (520)
                      ......  ......|++.|+|||.+... .++.++|||||||++|||++|+.||......+....+....... ......
T Consensus       150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  227 (286)
T d1ob3a_         150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN  227 (286)
T ss_dssp             HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence            654332  22345689999999998754 56899999999999999999999997643322111110000000 000000


Q ss_pred             HHHhh--CcccCC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          418 VEELL--DPRLKC------TSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       418 l~~~~--d~~l~~------~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .....  +.....      ..........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000  000000      0000111245778899999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-45  Score=368.55  Aligned_cols=261  Identities=19%  Similarity=0.240  Sum_probs=200.1

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEEEe
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~E~  261 (520)
                      ++|+..+.||+|+||+||+|++..+++.||||++.....  ..++..|+++++.++|+|+|..++++.......++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            579999999999999999999988899999999876432  245778999999999888777777777667778999999


Q ss_pred             cCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC---CCceEEeecCCcc
Q 010012          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLAT  338 (520)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~---~~~vkL~DFGla~  338 (520)
                      + +|+|...+....      ..+++..+..++.|++.||+|||+++   ||||||||+|||++.   +..+||+|||+|+
T Consensus        85 ~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          85 L-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             c-CCchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9 667777665432      57999999999999999999999988   999999999999863   5579999999999


Q ss_pred             ccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh
Q 010012          339 WTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR  413 (520)
Q Consensus       339 ~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~  413 (520)
                      ........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  234 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence            76543321     1234567999999999999989999999999999999999999999764433221111111000000


Q ss_pred             chhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 010012          414 GMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRG  466 (520)
Q Consensus       414 ~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~  466 (520)
                      .  ....     +  ....+   ..+.+++..||+.+|++||++.++.+.|+.
T Consensus       235 ~--~~~~-----~--~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         235 T--PIEV-----L--CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             S--CHHH-----H--TTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             C--ChhH-----h--ccCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            0  0000     0  01112   346677789999999999999999988875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=373.17  Aligned_cols=272  Identities=21%  Similarity=0.268  Sum_probs=198.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcc-hHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC---cEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLF  256 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~---~~~  256 (520)
                      +.+|...+.||+|+||+||+|.+..+++.||||++.+.. ....+.+.+|+++|++++|||||++++++.....   ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999998899999999997643 3456688999999999999999999999865321   224


Q ss_pred             EEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCC
Q 010012          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (520)
Q Consensus       257 LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGl  336 (520)
                      ++++|+.+|+|.+++..        ..+++..++.++.|++.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        87 ~l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             EEEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCc
Confidence            55566779999999964        45999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC-CcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhc
Q 010012          337 ATWTSAPSV-PFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRG  414 (520)
Q Consensus       337 a~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~  414 (520)
                      |+....... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...............
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            986543221 112345679999999999854 467889999999999999999999997654322211111110000000


Q ss_pred             ------hhHHHHhhCcccCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          415 ------MAAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       415 ------~~~l~~~~d~~l~~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                            ...................     .....+.+++.+||+.||.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0000000000000000000     011357789999999999999999999873

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=375.29  Aligned_cols=265  Identities=20%  Similarity=0.300  Sum_probs=196.1

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCC-----
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-----  253 (520)
                      .++|+..+.||+|+||+||+|.+..+++.||||++.+.  .....+.+.+|+.+|++++|||||+++++|...+.     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999989999999999754  33456678999999999999999999999875432     


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+ +.+|..+...        ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccc
Confidence            469999999 6678777653        46999999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh----
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK----  408 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----  408 (520)
                      ||+|+......     +...||+.|+|||++.+. .++.++||||+||++|||++|+.||................    
T Consensus       165 fg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            99998765432     345699999999998764 56899999999999999999999997654322111110000    


Q ss_pred             -hHhhhch----hHHHHhhCcccCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 010012          409 -PILHRGM----AAVEELLDPRLKCT---SRNSAQIARVIQAAAACISSEESRRPGIEEIIAI  463 (520)
Q Consensus       409 -~~~~~~~----~~l~~~~d~~l~~~---~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~  463 (520)
                       .......    ......+ +.....   .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000000    0000000 000000   0001112356788899999999999999999973

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=376.84  Aligned_cols=264  Identities=26%  Similarity=0.300  Sum_probs=194.9

Q ss_pred             CcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-----CCcEEE
Q 010012          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQGLFL  257 (520)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~~L  257 (520)
                      +|+..++||+|+||+||+|++..+++.||||++.....    .+.+|+++|++++|||||++++++...     ...++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            68889999999999999999998999999999976532    234799999999999999999998643     234789


Q ss_pred             EEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCC
Q 010012          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGL  336 (520)
Q Consensus       258 V~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGl  336 (520)
                      |||||+++.+..+......    ...+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEeccCCccHHHHHhhhhc----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence            9999987644444332221    267999999999999999999999888   99999999999999775 899999999


Q ss_pred             ccccCCCCCCcccccccccCCccCchhccc-CCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhhch
Q 010012          337 ATWTSAPSVPFLCKTVKGTFGYLAPEYFQH-GKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHRGM  415 (520)
Q Consensus       337 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~~~  415 (520)
                      ++.......   .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+  ...+-....
T Consensus       170 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i--~~~~g~~~~  244 (350)
T d1q5ka_         170 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI--IKVLGTPTR  244 (350)
T ss_dssp             CEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH--HHHHCCCCH
T ss_pred             hhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH--HHHhCCChH
Confidence            987654332   234579999999998865 46899999999999999999999999764432211111  100000000


Q ss_pred             hHHHHh----hCcccCCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          416 AAVEEL----LDPRLKCT-------SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       416 ~~l~~~----~d~~l~~~-------~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ..+...    .+..+...       .........+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001110    11111000       001112235778889999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-45  Score=367.60  Aligned_cols=271  Identities=19%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-------C
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  252 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-------~  252 (520)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  ......++.+|+++|++++||||+++++++...       +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5899999999999999999999888999999998654  223456788999999999999999999987553       2


Q ss_pred             CcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEe
Q 010012          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (520)
Q Consensus       253 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~  332 (520)
                      ..+++||||+.++.+.......       ..++...++.|+.|++.||.|||+.+   |+||||||+||||+.++.+||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEee
Confidence            3478999999887766544332       56899999999999999999999988   9999999999999999999999


Q ss_pred             ecCCccccCCCCCC--cccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          333 DFGLATWTSAPSVP--FLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       333 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |||+++........  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999866543211  112335699999999998765 689999999999999999999999976443221111111000


Q ss_pred             Hh-hhchh-----HHHHhhCcccCCCCCCHHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 IL-HRGMA-----AVEELLDPRLKCTSRNSAQ------IARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~-~~~~~-----~l~~~~d~~l~~~~~~~~~------~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .. .....     .....+.............      ...+.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00 00000     0000000000000000111      234668899999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=357.80  Aligned_cols=266  Identities=21%  Similarity=0.268  Sum_probs=202.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCCCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~~LV~  259 (520)
                      ++|+..+.||+|+||+||+|++..+++.||||+++..  ......++.+|+.+++.++|||||++++++.+.. ..++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEEe
Confidence            4799999999999999999999989999999998654  3345678899999999999999999999987754 578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeecCCccc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      +++.+++|..++...       ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.|+.
T Consensus        81 ~~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          81 EFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eeccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence            999999988877653       56899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccCchhcccCC-CCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHhhh----c
Q 010012          340 TSAPSVPFLCKTVKGTFGYLAPEYFQHGK-VSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPILHR----G  414 (520)
Q Consensus       340 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~----~  414 (520)
                      .......  .....++..|+|||.+.... ++.++|||||||++|||++|+.||.......  ............    .
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred             ccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhh
Confidence            7654322  23445788999999987665 6899999999999999999999975322211  111111000000    0


Q ss_pred             hhHHHHhhCc--------ccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 MAAVEELLDP--------RLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~~~l~~~~d~--------~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ........+.        ..............+.+++.+||+.||.+|||++||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000        00000011122245778889999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.6e-44  Score=356.18  Aligned_cols=262  Identities=19%  Similarity=0.233  Sum_probs=202.6

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC-CCeecEEEEEEcCCCcEEEEE
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~~LV~  259 (520)
                      .++|.+++.||+|+||+||+|++..+++.||||++.....  ...+.+|+++++.+.| +|++.+++++.+ ....++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEE
Confidence            3689999999999999999999998899999999865432  2356788899999976 899999988766 45578999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecC-----CCceEEeec
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCDF  334 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~-----~~~vkL~DF  334 (520)
                      ||+ +++|.+++....      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+||
T Consensus        81 e~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence            999 789999987643      56999999999999999999999988   999999999999974     568999999


Q ss_pred             CCccccCCCCCC-----cccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhh
Q 010012          335 GLATWTSAPSVP-----FLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKP  409 (520)
Q Consensus       335 Gla~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~  409 (520)
                      |+|+........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            999876543211     123356799999999999999999999999999999999999999976543322211111110


Q ss_pred             HhhhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 010012          410 ILHRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIAILRGE  467 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~~L~~~  467 (520)
                      .....  ...++.       ...+.   .+.+++..|+..+|++||+++.+.+.|+..
T Consensus       231 ~~~~~--~~~~l~-------~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         231 KKQST--PLRELC-------AGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHS--CHHHHT-------TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCC--ChHHhc-------CCCCH---HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            00000  011110       11223   466677789999999999999998887753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=366.43  Aligned_cols=265  Identities=20%  Similarity=0.316  Sum_probs=193.0

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcC-----CCc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  254 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~  254 (520)
                      ++|.+.++||+|+||+||+|.+..+++.||||++...  .....+++.+|+.++++++|||||++++++...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999989999999999754  344556788999999999999999999998643     346


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      +|+|||||.++ +.+.+.         ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEeccchH-HHHhhh---------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence            89999999665 444443         45899999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHh-h----hh
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLW-A----KP  409 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~-~----~~  409 (520)
                      |+++......   ......||+.|+|||++.+..+++++||||+||++|||++|+.||...........+.. .    ..
T Consensus       164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             hhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence            9988665432   23456799999999999999999999999999999999999999975432211111100 0    00


Q ss_pred             HhhhchhHHHHhhCccc---------------CCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          410 ILHRGMAAVEELLDPRL---------------KCT--SRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       410 ~~~~~~~~l~~~~d~~l---------------~~~--~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .+...........+...               ...  .........+.+|+.+||+.||++|||++||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11111111111111111               000  011233457889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-44  Score=364.36  Aligned_cols=262  Identities=19%  Similarity=0.261  Sum_probs=197.4

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcC-CCcEEEEE
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLIY  259 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~~~~LV~  259 (520)
                      ++|.+.+.||+|+||+||+|++..+++.||||+++...   .+++.+|+++|+.+. ||||+++++++... ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999999899999999997643   356889999999995 99999999988654 34589999


Q ss_pred             EecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCC-ceEEeecCCcc
Q 010012          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (520)
Q Consensus       260 E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~-~vkL~DFGla~  338 (520)
                      |||.+++|..+.          ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+
T Consensus       112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccce
Confidence            999999997653          45899999999999999999999988   99999999999998655 69999999998


Q ss_pred             ccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccch-hhHHh-hh-hHhhhc
Q 010012          339 WTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEE-NLVLW-AK-PILHRG  414 (520)
Q Consensus       339 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~-~lv~~-~~-~~~~~~  414 (520)
                      .......   .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+.. .. +.....
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7654332   2455699999999998765 4799999999999999999999999754322110 00000 00 000000


Q ss_pred             h--------hHHHHhhCcc-------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          415 M--------AAVEELLDPR-------LKCTSRNSAQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       415 ~--------~~l~~~~d~~-------l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      .        ..........       .............+.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0        0000000000       0000001112245778899999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-44  Score=363.32  Aligned_cols=253  Identities=26%  Similarity=0.319  Sum_probs=199.3

Q ss_pred             CCcccceEEcccCceEEEEeee---cCCCcEEEEEEecCcc----hHHHHHHHHHHHHHHhCCC-CCeecEEEEEEcCCC
Q 010012          182 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQ  253 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~  253 (520)
                      ++|+..+.||+|+||+||+|..   +.+++.||||++++..    ....+.+.+|++++++++| |||+++++++.+. .
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-T  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-T
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-C
Confidence            5799999999999999999986   4468899999986532    2234567899999999976 8999999987664 4


Q ss_pred             cEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEee
Q 010012          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (520)
Q Consensus       254 ~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~D  333 (520)
                      .+++||||+.+|+|.+++...       ..++......++.||+.||+|||+++   |+||||||+||||+.++.+||+|
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             ceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEee
Confidence            689999999999999999875       45788999999999999999999988   99999999999999999999999


Q ss_pred             cCCccccCCCCCCcccccccccCCccCchhcccC--CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhhhHh
Q 010012          334 FGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG--KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAKPIL  411 (520)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~  411 (520)
                      ||+|+........ ......|++.|+|||.+...  .++.++|||||||+||||++|+.||...........+       
T Consensus       173 FG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i-------  244 (322)
T d1vzoa_         173 FGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------  244 (322)
T ss_dssp             SSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-------
T ss_pred             ccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------
Confidence            9999876543322 23456799999999999754  4688999999999999999999999865543321111       


Q ss_pred             hhchhHHHHhhCcccCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 010012          412 HRGMAAVEELLDPRLKCTSRNSAQIARVIQAAAACISSEESRRPG-----IEEIIA  462 (520)
Q Consensus       412 ~~~~~~l~~~~d~~l~~~~~~~~~~~~l~~la~~Cl~~dP~~RPt-----m~eVl~  462 (520)
                            ...........+...   ...+.+++.+||+.||.+|||     ++|+++
T Consensus       245 ------~~~~~~~~~~~~~~~---s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         245 ------SRRILKSEPPYPQEM---SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------HHHHHHCCCCCCTTS---CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------HHhcccCCCCCcccC---CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  111111222212222   345677888999999999994     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=361.10  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             hCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCc--chHHHHHHHHHHHHHHhCCCCCeecEEEEEEcCC----Cc
Q 010012          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (520)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~  254 (520)
                      .++|+..+.||+|+||+||+|++..+++.||||++.+.  .....+.+.+|+++|++++|||||++++++....    ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999999889999999999754  3345567889999999999999999999875321    22


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCCCceEEeec
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~~~vkL~DF  334 (520)
                      .+++++|+.+|+|.+++..        ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccccc
Confidence            4567788889999999854        46999999999999999999999988   999999999999999999999999


Q ss_pred             CCccccCCCCCCcccccccccCCccCchhcccC-CCCCcCceeeHHHHHHHHHhCCCCcchhccccchhhHHhhh-----
Q 010012          335 GLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHG-KVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEENLVLWAK-----  408 (520)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-----  408 (520)
                      |++......     .....||..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+....     
T Consensus       166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999765432     2445699999999987665 46889999999999999999999997644322111111000     


Q ss_pred             hHhhhc-hhHHHHhhCcccCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 010012          409 PILHRG-MAAVEELLDPRLKCTSRNS-----AQIARVIQAAAACISSEESRRPGIEEIIA  462 (520)
Q Consensus       409 ~~~~~~-~~~l~~~~d~~l~~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPtm~eVl~  462 (520)
                      ...... ...................     .....+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000000 0000111110000000000     11235678899999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-39  Score=332.26  Aligned_cols=267  Identities=18%  Similarity=0.265  Sum_probs=193.3

Q ss_pred             CCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-----------CCCeecEEEEEEc
Q 010012          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCID  250 (520)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~~  250 (520)
                      .+|++.+.||+|+||+||+|+...+++.||||++.+.. ...+.+.+|+.+++.++           |+|||++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999998889999999997653 33457788998888775           5789999988754


Q ss_pred             -CCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCCeEecCCC-
Q 010012          251 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK-  327 (520)
Q Consensus       251 -~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~-~~~~~IiHrDLKp~NILld~~~-  327 (520)
                       .....+++++++..+...........    ...+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++ 
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             ccccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCc
Confidence             33456777777766654333333221    2678999999999999999999997 66   99999999999998665 


Q ss_pred             -----ceEEeecCCccccCCCCCCcccccccccCCccCchhcccCCCCCcCceeeHHHHHHHHHhCCCCcchhccccchh
Q 010012          328 -----IPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLAPEYFQHGKVSDKTDVYAFGVVLLELLTGRKPIEARRLQGEEN  402 (520)
Q Consensus       328 -----~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~ksDVwS~GvvL~ELltG~~Pf~~~~~~~~~~  402 (520)
                           .++++|||.+.......     ....||+.|+|||++....++.++||||+||+++||++|+.||..........
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                 49999999998654332     34569999999999999999999999999999999999999997644321111


Q ss_pred             ----hHHhhhh-------HhhhchhHHHHhhCcc-----c-------------CCCCCCHHHHHHHHHHHHHccccCCCC
Q 010012          403 ----LVLWAKP-------ILHRGMAAVEELLDPR-----L-------------KCTSRNSAQIARVIQAAAACISSEESR  453 (520)
Q Consensus       403 ----lv~~~~~-------~~~~~~~~l~~~~d~~-----l-------------~~~~~~~~~~~~l~~la~~Cl~~dP~~  453 (520)
                          +......       ...... ......+..     +             ............+.+|+.+||+.||.+
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             hhHHHHHHHHHhCCCCHHHhhccc-ccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence                1111000       000000 001111100     0             001123456678899999999999999


Q ss_pred             CCCHHHHHH
Q 010012          454 RPGIEEIIA  462 (520)
Q Consensus       454 RPtm~eVl~  462 (520)
                      |||++|+++
T Consensus       319 Rpta~e~L~  327 (362)
T d1q8ya_         319 RADAGGLVN  327 (362)
T ss_dssp             CBCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=4.2e-24  Score=199.06  Aligned_cols=164  Identities=18%  Similarity=0.154  Sum_probs=121.5

Q ss_pred             ccceEEcccCceEEEEeeecCCCcEEEEEEecCcc------------------hHHHHHHHHHHHHHHhCCCCCeecEEE
Q 010012          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------------------KESSKAFCRELMIASSLHHPNIVPLVG  246 (520)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------------------~~~~~~~~~E~~il~~l~HpnIv~l~g  246 (520)
                      .++++||+|+||+||+|.+. +++.||||++....                  ......+..|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            46789999999999999986 58899999875321                  011233456888999999999999886


Q ss_pred             EEEcCCCcEEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCCeEecCC
Q 010012          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (520)
Q Consensus       247 ~~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDLKp~NILld~~  326 (520)
                      +.   .  .+++|||++++.+.+              +++.....++.|++++|.|||+.+   |+||||||+|||++++
T Consensus        82 ~~---~--~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~  139 (191)
T d1zara2          82 WE---G--NAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             EE---T--TEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred             ec---C--CEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence            52   1  279999998765422              344456689999999999999988   9999999999999965


Q ss_pred             CceEEeecCCccccCCCCCCcccccccccCCccC------chhcccCCCCCcCceeeHHHHHH
Q 010012          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGYLA------PEYFQHGKVSDKTDVYAFGVVLL  383 (520)
Q Consensus       327 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~a------PE~~~~~~~s~ksDVwS~GvvL~  383 (520)
                      + ++|+|||+|.....+...          .|+.      .+.+ ...|+.++|+||..--++
T Consensus       140 ~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         140 G-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             E-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             C-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence            4 899999999766543211          1111      1222 356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=7.3e-07  Score=84.17  Aligned_cols=148  Identities=17%  Similarity=0.125  Sum_probs=93.0

Q ss_pred             HHHHhhCCcccceEEcccCceEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCC-CCCeecEEEEEEcCCCc
Q 010012          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  254 (520)
Q Consensus       176 ei~~at~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~  254 (520)
                      |+...-..|+..+..+.++.+.||+....  +..+.+|+...........+.+|...+..+. +--+.+++.+..+ ++.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~   84 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCc
Confidence            33444456665554443445689987643  5668889886554333445667888877664 3235666766544 455


Q ss_pred             EEEEEEecCCCChhHHhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 010012          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT---------------------------  307 (520)
Q Consensus       255 ~~LV~E~~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~---------------------------  307 (520)
                      .++||++++|.++.+.....         .   ....++.++++.+..||+..                           
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~---------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE---------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC---------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             eEEEEEeccccccccccccc---------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            78999999998775543210         1   11223444455555555311                           


Q ss_pred             -----------------------------CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 -----------------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 -----------------------------~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                                                   ...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                         1248999999999999987777799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.77  E-value=5.6e-05  Score=70.30  Aligned_cols=145  Identities=18%  Similarity=0.117  Sum_probs=80.2

Q ss_pred             EEcccCc-eEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCC--CCeecEEEEEEcCCCcEEEEEEecCCC
Q 010012          189 VLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (520)
Q Consensus       189 ~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~~LV~E~~~~g  265 (520)
                      .+..|.. +.||+..... +..+.+|.......   ..+..|+..++.+..  --+.+++.++.+. +..++||++++|-
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeecc
Confidence            4555554 6899987753 66788898765432   235567776665532  2356677765554 4578999999886


Q ss_pred             ChhHH--------------hhhhccCCCCCCCCC--HHHHHHHH--------------------HHHHHHHHHHHhC---
Q 010012          266 SLERH--------------LHEKKKGVRGNSTLP--WSVRYKVA--------------------LGIAESVAYLHNG---  306 (520)
Q Consensus       266 sL~~~--------------L~~~~~~~~~~~~l~--~~~~~~ia--------------------~qia~aL~yLH~~---  306 (520)
                      ++.+.              +...........++.  +.....-.                    ......+..+...   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            55321              111000000000111  00000000                    0011223333332   


Q ss_pred             -CCCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          307 -TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       307 -~~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                       ....++|+|+.|.|||++++..+-|.||+.+.
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence             12348999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.60  E-value=0.00014  Score=72.85  Aligned_cols=77  Identities=16%  Similarity=0.028  Sum_probs=46.5

Q ss_pred             ceEEcccCceEEEEeeecCCCcEEEEEEecCcc-------hHHHHHHHHHHHHHHhCC-C--CCeecEEEEEEcCCCcEE
Q 010012          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-------KESSKAFCRELMIASSLH-H--PNIVPLVGFCIDPEQGLF  256 (520)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~~~~~~  256 (520)
                      .+.||.|....||+......++.|+||.-...-       .....+...|.+.|+.+. +  ..+.+++.+  +.+. .+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~-~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC-CE
Confidence            356899999999999887667889999754210       111223445777776552 2  335556544  4444 37


Q ss_pred             EEEEecCCCC
Q 010012          257 LIYKYVSGGS  266 (520)
Q Consensus       257 LV~E~~~~gs  266 (520)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            9999997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.22  E-value=0.0049  Score=59.38  Aligned_cols=140  Identities=17%  Similarity=0.187  Sum_probs=73.6

Q ss_pred             eEEEEeeecCCCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCC--eecEEE----EEEcCCCcEEEEEEecCCCChh-
Q 010012          196 SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVG----FCIDPEQGLFLIYKYVSGGSLE-  268 (520)
Q Consensus       196 G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g----~~~~~~~~~~LV~E~~~~gsL~-  268 (520)
                      -.||++... +|..|++|+..... ....++..|...+..|....  ++..+.    .....+...+.++++++|..+. 
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            589999886 47889999876542 23456777877776663211  111111    1112234568899998763321 


Q ss_pred             -------------HHhhhhccC--CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCc
Q 010012          269 -------------RHLHEKKKG--VRGNSTLPWS-------------------VRYKVALGIAESVAYLHN----GTERC  310 (520)
Q Consensus       269 -------------~~L~~~~~~--~~~~~~l~~~-------------------~~~~ia~qia~aL~yLH~----~~~~~  310 (520)
                                   ..++.....  ......+++.                   .+..+...+.+.++.+..    ....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                         111111000  0001122221                   111122222223333322    22456


Q ss_pred             eEecccCCCCeEecCCCceEEeecCCccc
Q 010012          311 VVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (520)
Q Consensus       311 IiHrDLKp~NILld~~~~vkL~DFGla~~  339 (520)
                      +||+|+.|.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999754  45899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.20  E-value=0.0066  Score=60.09  Aligned_cols=73  Identities=14%  Similarity=0.195  Sum_probs=46.2

Q ss_pred             eEEcccCceEEEEeeecC-------CCcEEEEEEecCcchHHHHHHHHHHHHHHhCCCCCe-ecEEEEEEcCCCcEEEEE
Q 010012          188 RVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIY  259 (520)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~LV~  259 (520)
                      +.|+.|-.-.+|++....       ....|.+++.....  ......+|..+++.+.-.++ .++++++ .  +  .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~-~--~--g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIF-S--G--GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEc-C--C--ceEE
Confidence            578878888999987643       23557777665322  22344578888877743344 4666654 2  2  5899


Q ss_pred             EecCCCCh
Q 010012          260 KYVSGGSL  267 (520)
Q Consensus       260 E~~~~gsL  267 (520)
                      ||++|-.|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.95  E-value=0.15  Score=47.86  Aligned_cols=31  Identities=26%  Similarity=0.440  Sum_probs=27.4

Q ss_pred             CCceEecccCCCCeEecCCCceEEeecCCcc
Q 010012          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (520)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~vkL~DFGla~  338 (520)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4569999999999999998877899999864